PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kamphorst, AO; Wieland, A; Nasti, T; Yang, S; Zhang, R; Barber, DL; Konieczny, BT; Daugherty, CZ; Koenig, L; Yu, K; Sica, GL; Sharpe, AH; Freeman, GJ; Blazar, BR; Turka, LA; Owonikoko, TK; Pillai, RN; Ramalingam, SS; Araki, K; Ahmed, R				Kamphorst, Alice O.; Wieland, Andreas; Nasti, Tahseen; Yang, Shu; Zhang, Ruan; Barber, Daniel L.; Konieczny, Bogumila T.; Daugherty, Candace Z.; Koenig, Lydia; Yu, Ke; Sica, Gabriel L.; Sharpe, Arlene H.; Freeman, Gordon J.; Blazar, Bruce R.; Turka, Laurence A.; Owonikoko, Taofeek K.; Pillai, Rathi N.; Ramalingam, Suresh S.; Araki, Koichi; Ahmed, Rafi			Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent	SCIENCE			English	Article							CHRONIC VIRAL-INFECTION; RESPONSES; IMMUNITY; CANCER; PD-1; COSTIMULATION; BLOCKADE; EFFECTOR; MEMORY	Programmed cell death-1 (PD-1)-targeted therapies enhance T cell responses and show efficacy in multiple cancers, but the role of costimulatory molecules in this T cell rescue remains elusive. Here, we demonstrate that the CD28/B7 costimulatory pathway is essential for effective PD-1 therapy during chronic viral infection. Conditional gene deletion showed a cell-intrinsic requirement of CD28 for CD8 T cell proliferation after PD-1 blockade. B7-costimulation was also necessary for effective PD-1 therapy in tumor-bearing mice. In addition, we found that CD8 T cells proliferating in blood after PD-1 therapy of lung cancer patients were predominantly CD28-positive. Taken together, these data demonstrate CD28-costimulation requirement for CD8 T cell rescue and suggest an important role for the CD28/B7 pathway in PD-1 therapy of cancer patients.	[Kamphorst, Alice O.; Wieland, Andreas; Nasti, Tahseen; Yang, Shu; Barber, Daniel L.; Konieczny, Bogumila T.; Daugherty, Candace Z.; Araki, Koichi; Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Yang, Shu] Cent S Univ, Xiangya Sch Med, Changsha 410013, Hunan, Peoples R China; [Zhang, Ruan; Turka, Laurence A.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02144 USA; [Zhang, Ruan; Turka, Laurence A.] Harvard Med Sch, Boston, MA 02144 USA; [Barber, Daniel L.] NIAID, Parasit Dis Lab, Bethesda, MD 20892 USA; [Koenig, Lydia; Yu, Ke; Owonikoko, Taofeek K.; Pillai, Rathi N.; Ramalingam, Suresh S.] Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Sica, Gabriel L.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Sharpe, Arlene H.] Harvard Med Sch, Dept Microbiol & Immunol, Boston, MA 02115 USA; [Sharpe, Arlene H.] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Sharpe, Arlene H.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Freeman, Gordon J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Blazar, Bruce R.] Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA; [Yang, Shu] Tianjin Med Univ, Gen Hosp, Dept Neurol, Tianjin 300052, Peoples R China	Emory University; Central South University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emory University; Emory University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; University of Minnesota System; University of Minnesota Twin Cities; Tianjin Medical University	Ahmed, R (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	rahmed@emory.edu	Barber, Daniel L./V-1190-2019; Ramalingam, Suresh/AAV-7478-2020; Freeman, Gordon/AAC-5380-2019	Freeman, Gordon/0000-0002-7210-5616; Nasti, Tahseen/0000-0002-5650-1563; Kamphorst, Alice/0000-0002-9230-9501; Araki, Koichi/0000-0003-3478-6315	Merck [52507]; National Institutes of Health [R01 AI30048, P01 AI080192, P01 AI056299, P01 AI054456, R01 AI089955, R01 CA72669, R01 AI037691]; NATIONAL CANCER INSTITUTE [P01CA065493, R01CA072669] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034495, R01AI037691, P01AI054456, R01AI030048, ZIAAI001171, R01AI089955, R01AI034495, P01AI080192, P01AI056299] Funding Source: NIH RePORTER	Merck(Merck & Company); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Merck preclinical grant 52507 (R.A. and A.O.K.) and the National Institutes of Health grants R01 AI30048 (R.A.), P01 AI080192 (R.A. and G.J.F.), P01 AI056299 (A.H.S., R.A., G.J.F., and B.R.B.), P01 AI054456 (A.H.S.), R01 AI089955 (G.J.F.), R01 CA72669 (B.R.B.), and R01 AI037691 (L.A.T. and R.Z.). The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. We thank M. Ford (Emory University) for reagents and E. Eruslanov (University of Pennsylvania School of Medicine) for experimental advice. R.A., D.L.B., G.J.F., and A.H.S. are inventors on patent numbers US 8552154 B2, US 8652465 B2, and US 9102727 B2, held by Emory University (Atlanta), Dana-Farber Cancer Institute (Boston), Brigham and Women's Hospital (Boston), and Harvard University (Cambridge), which cover the topic of PD-1-directed immunotherapy. G.F. is the inventor on patent numbers US 6,808,710, US 7,101,550, US 7,638,492, US 7,700,301, US 7,432,059, US 7,709,214, US 7,722,868, US 7,635,757, US 7,038,013, US 6,936,704, and US 7,105,328 held by Dana-Farber Cancer Institute, which cover the topic of PD-1-directed immunotherapy.	Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Callahan MK, 2016, IMMUNITY, V44, P1069, DOI 10.1016/j.immuni.2016.04.023; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Eberlein J, 2012, J VIROL, V86, P1955, DOI 10.1128/JVI.05949-11; Esensten JH, 2016, IMMUNITY, V44, P973, DOI 10.1016/j.immuni.2016.04.020; Filaci G, 2007, J IMMUNOL, V179, P4323, DOI 10.4049/jimmunol.179.7.4323; Floyd TL, 2011, J IMMUNOL, V186, P2033, DOI 10.4049/jimmunol.1003015; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Kamphorst AO, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-1317; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kundig TM, 1996, IMMUNITY, V5, P41, DOI 10.1016/S1074-7613(00)80308-8; Li YF, 2010, J IMMUNOL, V184, P452, DOI 10.4049/jimmunol.0901101; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Moreno BH, 2016, CANCER IMMUNOL RES, V4, P845, DOI 10.1158/2326-6066.CIR-16-0060; Mueller SN, 2010, J CLIN INVEST, V120, P2508, DOI 10.1172/JCI40040; Paterson AM, 2011, J IMMUNOL, V187, P1097, DOI 10.4049/jimmunol.1003496; Pauken KE, 2015, TRENDS IMMUNOL, V36, P265, DOI 10.1016/j.it.2015.02.008; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013	25	527	555	9	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 31	2017	355	6332					1423	1427		10.1126/science.aaf0683	http://dx.doi.org/10.1126/science.aaf0683			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EQ1DL	28280249	Green Accepted			2022-12-28	WOS:000397809500043
J	Moore, JJ; Ravassard, PM; Ho, D; Acharya, L; Kees, AL; Vuong, C; Mehta, MR				Moore, Jason J.; Ravassard, Pascal M.; Ho, David; Acharya, Lavanya; Kees, Ashley L.; Vuong, Cliff; Mehta, Mayank R.			NEUROSCIENCE Dynamics of cortical dendritic membrane potential and spikes in freely behaving rats	SCIENCE			English	Article							WHOLE-CELL RECORDINGS; NEURONS IN-VITRO; PYRAMIDAL NEURONS; APICAL DENDRITES; LONG-TERM; PATCH-CLAMP; LAYER 2/3; SYNAPTIC INTEGRATION; ACTIVE DENDRITES; BASAL DENDRITES	Neural activity in vivo is primarily measured using extracellular somatic spikes, which provide limited information about neural computation. Hence, it is necessary to record from neuronal dendrites, which can generate dendritic action potentials (DAPs) in vitro, which can profoundly influence neural computation and plasticity. We measured neocortical sub-and suprathreshold dendritic membrane potential (DMP) from putative distal-most dendrites using tetrodes in freely behaving rats over multiple days with a high degree of stability and submillisecond temporal resolution. DAP firing rates were several-fold larger than somatic rates. DAP rates were also modulated by subthreshold DMP fluctuations, which were far larger than DAP amplitude, indicating hybrid, analog-digital coding in the dendrites. Parietal DAP and DMP exhibited egocentric spatial maps comparable to pyramidal neurons. These results have important implications for neural coding and plasticity.	[Moore, Jason J.; Ravassard, Pascal M.; Ho, David; Acharya, Lavanya; Kees, Ashley L.; Vuong, Cliff; Mehta, Mayank R.] Univ Calif Los Angeles, W M Keck Ctr Neurophys, Integrat Ctr Learning & Memory, Los Angeles, CA 90095 USA; [Moore, Jason J.; Ravassard, Pascal M.; Ho, David; Acharya, Lavanya; Kees, Ashley L.; Vuong, Cliff; Mehta, Mayank R.] Brain Res Inst, Los Angeles, CA 90095 USA; [Moore, Jason J.; Ho, David; Kees, Ashley L.; Mehta, Mayank R.] Univ Calif Los Angeles, Neurosci Interdept Program, Los Angeles, CA 90095 USA; [Ravassard, Pascal M.; Vuong, Cliff; Mehta, Mayank R.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Acharya, Lavanya] Univ Calif Los Angeles, Biomed Engn Interdept Program, Los Angeles, CA 90095 USA; [Mehta, Mayank R.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; [Mehta, Mayank R.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Moore, JJ; Mehta, MR (corresponding author), Univ Calif Los Angeles, W M Keck Ctr Neurophys, Integrat Ctr Learning & Memory, Los Angeles, CA 90095 USA.; Moore, JJ; Mehta, MR (corresponding author), Brain Res Inst, Los Angeles, CA 90095 USA.; Moore, JJ; Mehta, MR (corresponding author), Univ Calif Los Angeles, Neurosci Interdept Program, Los Angeles, CA 90095 USA.; Mehta, MR (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.; Mehta, MR (corresponding author), Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA.; Mehta, MR (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA.	jason.moore@ucla.edu; mayankmehta@ucla.edu	Acharya, Lavanya/S-8153-2019	Kees, Ashley/0000-0002-1611-2803; Mehta, Mayank/0000-0003-2005-2468; Ravassard, Pascal/0000-0002-7500-3623; Acharya, Lavanya/0000-0003-2419-5650				Aghajan ZM, 2015, NAT NEUROSCI, V18, P121, DOI 10.1038/nn.3884; Alcami P, 2012, J NEUROSCI, V32, P3118, DOI 10.1523/JNEUROSCI.5371-11.2012; Almog M, 2014, J NEUROSCI, V34, P182, DOI 10.1523/JNEUROSCI.2896-13.2014; AMITAI Y, 1993, CEREB CORTEX, V3, P26, DOI 10.1093/cercor/3.1.26; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Chauvette S, 2011, J NEUROSCI, V31, P14998, DOI 10.1523/JNEUROSCI.2339-11.2011; COENEN AML, 1972, EXP BRAIN RES, V14, P227, DOI 10.1007/BF00816160; Colbert CM, 1997, J NEUROSCI, V17, P6512; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; Deneve S, 2008, NEURAL COMPUT, V20, P91, DOI 10.1162/neco.2008.20.1.91; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Destexhe A, 2001, NEUROSCIENCE, V107, P13, DOI 10.1016/S0306-4522(01)00344-X; DeWeese Michael R, 2007, Curr Protoc Neurosci, VChapter 6, DOI 10.1002/0471142301.ns0622s38; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; FINCH DM, 1984, BRAIN RES, V301, P25, DOI 10.1016/0006-8993(84)90399-8; GILLESPIE JS, 1962, J PHYSIOL-LONDON, V162, P76, DOI 10.1113/jphysiol.1962.sp006915; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; Gold C, 2009, J NEUROPHYSIOL, V102, P3340, DOI 10.1152/jn.91365.2008; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Golding NL, 2001, J NEUROPHYSIOL, V86, P2998, DOI 10.1152/jn.2001.86.6.2998; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Hai A, 2010, J NEUROPHYSIOL, V104, P559, DOI 10.1152/jn.00265.2010; Hamill OP, 1991, CEREB CORTEX, V1, P48, DOI 10.1093/cercor/1.1.48; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Johnston D, 2008, TRENDS NEUROSCI, V31, P309, DOI 10.1016/j.tins.2008.03.004; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kaiser KMM, 2001, J PHYSIOL-LONDON, V535, P17, DOI 10.1111/j.1469-7793.2001.t01-1-00017.x; Kamondi A, 1998, J NEUROSCI, V18, P3919; KIM HG, 1993, J NEUROSCI, V13, P5301, DOI 10.1523/JNEUROSCI.13-12-05301.1993; Kim YJ, 2015, ELIFE, V4, DOI 10.7554/eLife.06414; Kumar A, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00038; Larkum ME, 2007, J NEUROSCI, V27, P8999, DOI 10.1523/JNEUROSCI.1717-07.2007; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2002, J NEUROSCI, V22, P6991; Ledergerber D, 2010, J NEUROSCI, V30, P13031, DOI 10.1523/JNEUROSCI.2254-10.2010; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Lee D, 2012, SCIENCE, V337, P849, DOI 10.1126/science.1221489; Lempka SF, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046001; Lenschow C, 2015, NEURON, V85, P718, DOI 10.1016/j.neuron.2014.12.059; Linsker R, 2008, NEURAL NETWORKS, V21, P1328, DOI 10.1016/j.neunet.2008.05.002; LLINAS R, 1971, J NEUROPHYSIOL, V34, P532, DOI 10.1152/jn.1971.34.4.532; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; London M, 2002, NAT NEUROSCI, V5, P332, DOI 10.1038/nn826; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; MCILWAIN JT, 1967, J NEUROPHYSIOL, V30, P1; Mehta MR, 2015, HIPPOCAMPUS, V25, P756, DOI 10.1002/hipo.22472; Mehta MR, 2004, TRENDS NEUROSCI, V27, P69, DOI 10.1016/j.tins.2003.12.004; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; Milojkovic BA, 2005, J MEMBRANE BIOL, V208, P155, DOI 10.1007/s00232-005-0827-7; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Nettleton JS, 2000, J NEUROPHYSIOL, V83, P3310, DOI 10.1152/jn.2000.83.6.3310; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; Nitz DA, 2006, NEURON, V49, P747, DOI 10.1016/j.neuron.2006.01.037; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; POCKBERGER H, 1991, BRAIN RES, V539, P181, DOI 10.1016/0006-8993(91)91619-C; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Ramon S., 1909, HISTOLOGIE SYSTEME N; Ravassard P, 2013, SCIENCE, V340, P1342, DOI 10.1126/science.1232655; REGEHR WG, 1989, J NEUROSCI METH, V30, P91, DOI 10.1016/0165-0270(89)90055-1; Remy S, 2007, P NATL ACAD SCI USA, V104, P17192, DOI 10.1073/pnas.0707919104; Remy S, 2009, NEURON, V61, P906, DOI 10.1016/j.neuron.2009.01.032; Resnik E, 2012, J NEUROSCI, V32, P8952, DOI 10.1523/JNEUROSCI.6460-11.2012; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; SAKMANN B, 1984, ANNU REV PHYSIOL, V46, P455, DOI 10.1146/annurev.ph.46.030184.002323; Saraga F, 2003, J PHYSIOL-LONDON, V552, P673, DOI 10.1113/jphysiol.2003.046177; Schmidt-Hieber C, 2013, NAT NEUROSCI, V16, P325, DOI 10.1038/nn.3340; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; SINGER W, 1970, EXP BRAIN RES, V10, P311; Smith SL, 2013, NATURE, V503, P115, DOI 10.1038/nature12600; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P272, DOI 10.1152/jn.1961.24.3.272; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Szarowski DH, 2003, BRAIN RES, V983, P23, DOI 10.1016/S0006-8993(03)03023-3; Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823; Waters J, 2003, J NEUROSCI, V23, P8558; Whitlock JR, 2012, NEURON, V73, P789, DOI 10.1016/j.neuron.2011.12.028; Williams JC, 2007, J NEURAL ENG, V4, P410, DOI 10.1088/1741-2560/4/4/007; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4	89	55	57	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331							eaaj1497	10.1126/science.aaj1497	http://dx.doi.org/10.1126/science.aaj1497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28280248	Green Submitted			2022-12-28	WOS:000397082900028
J	Rauner, N; Meuris, M; Zoric, M; Tiller, JC				Rauner, Nicolas; Meuris, Monika; Zoric, Mirjana; Tiller, Joerg C.			Enzymatic mineralization generates ultrastiff and tough hydrogels with tunable mechanics	NATURE			English	Article							POLYMER HYDROGELS; NANOCOMPOSITE HYDROGELS; FRACTURE-TOUGHNESS; BONE REGENERATION; HYBRID HYDROGELS; CARTILAGE; COMPOSITES; STIFFNESS; DESIGN; CELLS	The cartilage and skin of animals, which are made up of more than fifty per cent water, are rather stiff (having elastic moduli of up to 100 megapascals)(1,2) as well as tough and hard to break (with fracture energies of up to 9,000 joules per square metre)(3,4). Such features make these biological materials mechanically superior to existing synthetic hydrogels. Lately, progress has been made in synthesizing tough hydrogels, with double-network hydrogels achieving the toughness of skin(5) and inorganic-organic composites showing even better performance(6). However, these materials owe their toughness to high stretchability; in terms of stiffness, synthetic hydrogels cannot compete with their natural counterparts, with the best examples having elastic moduli of just 10 megapascals or less(7-11). Previously, we described the enzyme-induced precipitation and crystallization of hydrogels containing calcium carbonate, but the resulting materials were brittle(12). Here we report the enzymeinduced formation of amorphous calcium phosphate nanostructures that are homogenously distributed within polymer hydrogels. Our best materials have fracture energies of 1,300 joules per square metre even in their fully water-swollen state-a value superior to that of most known water-swollen synthetic materials. We are also able to modulate their stiffness up to 440 megapascals, well beyond that of cartilage and skin. Furthermore, the highly filled composite materials can be designed to be optically transparent and to retain most of their stretchability even when notched. We show that percolation drives the mechanical properties, particularly the high stiffness, of our uniformly mineralized hydrogels.	[Rauner, Nicolas; Meuris, Monika; Zoric, Mirjana; Tiller, Joerg C.] Tech Univ Dortmund, Emil Figge Str 66, D-44227 Dortmund, Germany	Dortmund University of Technology	Tiller, JC (corresponding author), Tech Univ Dortmund, Emil Figge Str 66, D-44227 Dortmund, Germany.	joerg.tiller@udo.edu						Arimoto H, 2015, SKIN RES TECHNOL, V21, P94, DOI 10.1111/srt.12163; BETTINI R, 1995, J CONTROL RELEASE, V37, P105, DOI 10.1016/0168-3659(95)00069-K; Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P477; Calvert P, 2009, ADV MATER, V21, P743, DOI 10.1002/adma.200800534; Chevallet M, 2006, NAT PROTOC, V1, P1852, DOI 10.1038/nprot.2006.288; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Douglas TEL, 2014, J TISSUE ENG REGEN M, V8, P906, DOI 10.1002/term.1616; Filmon R, 2000, J BIOMAT SCI-POLYM E, V11, P849, DOI 10.1163/156856200744057; Gao GR, 2015, ACS APPL MATER INTER, V7, P5029, DOI 10.1021/acsami.5b00704; Geise GM, 2011, J MEMBRANE SCI, V369, P130, DOI 10.1016/j.memsci.2010.11.054; Gkioni K, 2010, TISSUE ENG PART B-RE, V16, P577, DOI [10.1089/ten.teb.2010.0462, 10.1089/ten.TEB.2010.0462]; Hoffmann C, 2008, J MATER SCI-MATER M, V19, P907, DOI 10.1007/s10856-007-0165-7; Killion JA, 2013, MAT SCI ENG C-MATER, V33, P4203, DOI 10.1016/j.msec.2013.06.013; KOUTROUPI KS, 1990, J BIOMECH, V23, P281, DOI 10.1016/0021-9290(90)90018-X; Langer R, 1998, NATURE, V392, P5; Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x; Li JY, 2014, ACS MACRO LETT, V3, P520, DOI 10.1021/mz5002355; Lin ST, 2014, SOFT MATTER, V10, P7519, DOI 10.1039/c4sm01039f; Lin WC, 2010, MACROMOLECULES, V43, P2554, DOI 10.1021/ma901937r; Little CJ, 2011, TISSUE ENG PART B-RE, V17, P213, DOI [10.1089/ten.teb.2010.0572, 10.1089/ten.TEB.2010.0572]; Long R, 2016, SOFT MATTER, V12, P8069, DOI 10.1039/c6sm01694d; Luo YX, 2015, RSC ADV, V5, P43480, DOI 10.1039/c5ra04308e; Mayumi K, 2016, EXTREME MECH LETT, V6, P52, DOI 10.1016/j.eml.2015.12.002; Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822; Rauner N, 2015, MACROMOL RAPID COMM, V36, P224, DOI 10.1002/marc.201400426; Rauner N, 2014, ACTA BIOMATER, V10, P3942, DOI 10.1016/j.actbio.2014.05.021; Razmjou A, 2013, CHEM ENG J, V215, P913, DOI 10.1016/j.cej.2012.11.088; RIVLIN RS, 1953, J POLYM SCI, V10, P291, DOI 10.1002/pol.1953.120100303; Sato K, 2015, ADV MATER, V27, P6990, DOI 10.1002/adma.201502967; Schweizer S, 2007, MACROMOL BIOSCI, V7, P1085, DOI 10.1002/mabi.200600283; Simha NK, 2004, J MATER SCI-MATER M, V15, P631, DOI 10.1023/B:JMSM.0000026104.30607.c7; Song RQ, 2011, CRYSTENGCOMM, V13, P1249, DOI 10.1039/c0ce00419g; Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409; Tanriseven A, 2008, BIOCHEM ENG J, V39, P430, DOI 10.1016/j.bej.2007.10.011; Wegst UGK, 2004, PHILOS MAG, V84, P2167, DOI 10.1080/14786430410001680935; Yuan SS, 2014, J MATER SCI, V49, P5481, DOI 10.1007/s10853-014-8261-9; Zhao LZ, 2015, SOFT MATTER, V11, P9229, DOI 10.1039/c5sm01277e	37	156	157	28	519	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2017	543	7645					407	+		10.1038/nature21392	http://dx.doi.org/10.1038/nature21392			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9RN	28241140				2022-12-28	WOS:000396337400047
J	Malakoff, D; Cornwall, W				Malakoff, David; Cornwall, Warren			Trump targets environmental science for cuts	SCIENCE			English	News Item																			0	2	3	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI		1000	1001		10.1126/science.355.6329.1000	http://dx.doi.org/10.1126/science.355.6329.1000			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9VY	28280157				2022-12-28	WOS:000396348900007
J	Nel, AE; Malloy, TF				Nel, Andre E.; Malloy, Timothy F.			Policy reforms to update chemical safety testing	SCIENCE			English	Editorial Material							PREDICTIVE TOXICOLOGICAL APPROACH		[Nel, Andre E.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div NanoMed, Los Angeles, CA 90095 USA; [Nel, Andre E.; Malloy, Timothy F.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Malloy, Timothy F.] Univ Calif Los Angeles, Sch Law, Los Angeles, CA 90095 USA; [Malloy, Timothy F.] Univ Calif Los Angeles, Ctr Environm & Occupat Hlth, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Nel, AE (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div NanoMed, Los Angeles, CA 90095 USA.; Nel, AE (corresponding author), Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA.	anel@mednet.ucla.edu; malloy@law.ucla.edu	Nel, Andre E/J-2808-2012					Barroso J, 2016, ADV EXP MED BIOL, V856, P343, DOI 10.1007/978-3-319-33826-2_14; Browne P, 2015, ENVIRON SCI TECHNOL, V49, P8804, DOI 10.1021/acs.est.5b02641; Casey WM, 2016, TOX RESEARCH, V32, P9, DOI 10.5487/TR.2016.32.1.009; EPA, 2009, US ENV PROT AG STRAT; EPA, 2003, FRAM COMP TOX RES PR; Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P275, DOI 10.14573/altex.2013.3.275; Hartung T, 2009, TOXICOL SCI, V111, P233, DOI 10.1093/toxsci/kfp149; Kleinstreuer NC, 2016, REGUL TOXICOL PHARM, V76, P39, DOI 10.1016/j.yrtph.2016.01.007; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nel A, 2013, ACCOUNTS CHEM RES, V46, P607, DOI 10.1021/ar300022h; Nel AE, 2013, ACS NANO, V7, P6422, DOI 10.1021/nn4037927; NRC, 2007, TEST 21 CENT VIS STR; Wang X, 2015, ACS NANO, V9, P3032, DOI 10.1021/nn507243w	13	13	13	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI		1016	1018		10.1126/science.aak9919	http://dx.doi.org/10.1126/science.aak9919			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9VY	28280165				2022-12-28	WOS:000396348900014
J	Mendenhall, E				Mendenhall, Emily			Syndemics: a new path for global health research	LANCET			English	Editorial Material									[Mendenhall, Emily] Georgetown Univ, Edmund A Walsh Sch Foreign Serv, Sci Technol & Int Affairs Program, Intercultural Ctr Room 513, Washington, DC 20057 USA	Georgetown University	Mendenhall, E (corresponding author), Georgetown Univ, Edmund A Walsh Sch Foreign Serv, Sci Technol & Int Affairs Program, Intercultural Ctr Room 513, Washington, DC 20057 USA.	em1061@georgetown.edu						Arokiasamy P, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0402-8; Marshall M., 2014, DRINKING SMOKE TOBAC; Mendenhall E., 2012, SYNDEMIC SUFFERING S, DOI DOI 10.4324/9781315419459; Mendenhall E, 2017, LANCET, V389, P951, DOI 10.1016/S0140-6736(17)30402-6; Nichter M, 2016, MED ANTHROPOL Q, V30, P536, DOI 10.1111/maq.12319; Rhodes T, 2005, SOC SCI MED, V61, P1026, DOI 10.1016/j.socscimed.2004.12.024; Singer M, 2003, MED ANTHROPOL Q, V17, P423, DOI 10.1525/maq.2003.17.4.423; SINGER M, 1994, SOC SCI MED, V39, P931, DOI 10.1016/0277-9536(94)90205-4; Singer M., 2009, INTRO SYNDEMICS CRIT; Singer M., 1996, FREE INQ CREAT SOCIO, V24, P99, DOI [10.1093/jn/nxaa361, DOI 10.1093/jn/nxaa361]; Singer M, 2017, LANCET, V389, P941, DOI 10.1016/S0140-6736(17)30003-X; Tsai AC, 2017, LANCET, V389, P978, DOI 10.1016/S0140-6736(17)30403-8; Willen SS, 2017, LANCET, V389, P964, DOI 10.1016/S0140-6736(17)30261-1	13	70	71	1	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 4	2017	389	10072					889	891						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM4DL	28271827				2022-12-28	WOS:000395263400009
J	Gibbons, A				Gibbons, Ann			PALEOANTHROPOLOGY Close relative of Neandertals unearthed in China	SCIENCE			English	News Item																			0	1	1	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					899	899		10.1126/science.355.6328.899	http://dx.doi.org/10.1126/science.355.6328.899			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2YM	28254895				2022-12-28	WOS:000395181700016
J	Muller, DJ; Gaub, HE				Mueller, Daniel J.; Gaub, Hermann E.			Membrane proteins scrambling through a folding landscape	SCIENCE			English	Editorial Material							FORCE SPECTROSCOPY; BACTERIORHODOPSIN; MOLECULES; PATHWAYS; NETWORK		[Mueller, Daniel J.] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Gaub, Hermann E.] Ludwig Maximilians Univ Munchen, Dept Phys, D-80799 Munich, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Munich	Muller, DJ (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland.	daniel.mueller@bsse.ethz.ch; gaub@lmu.de	Müller, Daniel J./A-5967-2010	Müller, Daniel J./0000-0003-3075-0665				Damaghi M, 2011, ANGEW CHEM INT EDIT, V50, P7422, DOI 10.1002/anie.201101450; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Kappel C, 2011, BIOPHYS J, V100, P1109, DOI 10.1016/j.bpj.2011.01.004; Kessler M, 2006, J MOL BIOL, V357, P644, DOI 10.1016/j.jmb.2005.12.065; Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218; Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Serdiuk T, 2016, NAT CHEM BIOL, V12, P911, DOI [10.1038/nchembio.2169, 10.1038/NCHEMBIO.2169]; Stigler J, 2011, SCIENCE, V334, P512, DOI 10.1126/science.1207598; Thoma J, 2015, NAT STRUCT MOL BIOL, V22, P795, DOI 10.1038/nsmb.3087; Viani MB, 1999, J APPL PHYS, V86, P2258, DOI 10.1063/1.371039; Yu H, 2017, SCIENCE, V355, P945, DOI 10.1126/science.aah7124	12	8	8	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					907	908		10.1126/science.aam8370	http://dx.doi.org/10.1126/science.aam8370			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM2YM	28254899				2022-12-28	WOS:000395181700020
J	Neblo, MA; Minozzi, W; Esterling, KM; Green, J; Kingzette, J; Lazer, DMJ				Neblo, Michael A.; Minozzi, William; Esterling, Kevin M.; Green, Jon; Kingzette, Jonathon; Lazer, David M. J.			The need for a translational science of democracy	SCIENCE			English	Editorial Material							FIELD EXPERIMENT; POLITICS; POLARIZATION; OPINION; MEMBERS; IDEAL		[Neblo, Michael A.; Minozzi, William; Green, Jon; Kingzette, Jonathon] Ohio State Univ, Columbus, OH 43210 USA; [Esterling, Kevin M.] Univ Calif Riverside, Riverside, CA 92521 USA; [Lazer, David M. J.] Northeastern Univ, Boston, MA 02115 USA; [Lazer, David M. J.] Harvard Univ, Cambridge, MA 02138 USA	University System of Ohio; Ohio State University; University of California System; University of California Riverside; Northeastern University; Harvard University	Neblo, MA (corresponding author), Ohio State Univ, Columbus, OH 43210 USA.	neblo.1@osu.edu		Esterling, Kevin/0000-0002-5529-6422; Minozzi, William/0000-0001-9147-1788	Economic and Social Research Council [ES/N012283/1]; ESRC [ES/N012283/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	D.M.J.L. was supported by a grant (ES/N012283/1) from the Economic and Social Research Council.	Abramowitz AI, 2008, J POLIT, V70, P542, DOI 10.1017/S0022381608080493; Arceneaux Kevin., 2013, CHANGING MINDS CHANG; Bachtiger A., 2011, NCCR NEWSLETTER, V8, P5; Bakshy E, 2015, SCIENCE, V348, P1130, DOI 10.1126/science.aaa1160; Carson L, 2013, RHETOR DEMOCR DELIB, P1; Einsiedel EF, 2001, PUBLIC UNDERST SCI, V10, P83; Esterling KM, 2011, PUBLIC OPIN QUART, V75, P483, DOI 10.1093/poq/nfr001; Fishkin JS, 2014, EUR UNION POLIT, V15, P328, DOI 10.1177/1465116514531507; Fishkin JS, 2005, ACTA POLIT, V40, P284, DOI 10.1057/palgrave.ap.5500121; Gerber AS, 2008, AM POLIT SCI REV, V102, P33, DOI 10.1017/S000305540808009X; Gilens M, 2014, PERSPECT POLIT, V12, P564, DOI 10.1017/S1537592714001595; Hillygus DS, 2008, PERSUADABLE VOTER: WEDGE ISSUES IN PRESIDENTIAL CAMPAIGNS, P1; Johnston R, 2016, ANN AM ASSOC GEOGR, V106, P1047; Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547; Kirchherr, 2015, STRAITS TIMES; Lasswell HD, 1941, ETHICS, V51, P325, DOI 10.1086/290225; Minozzi W, 2015, P NATL ACAD SCI USA, V112, P3937, DOI 10.1073/pnas.1418188112; Neblo M., 2015, DELIBERATIVE DEMOCRA; Neblo MA, 2010, AM POLIT SCI REV, V104, P566, DOI 10.1017/S0003055410000298; Putnam R. D., 2001, BOWLING ALONE COLLAP; Rose Jonathan., 2007, CANADIAN PARLIAMENTA, V30, P9; Soss J, 2009, POLIT SCI QUART, V124, P95, DOI 10.1002/j.1538-165X.2009.tb00643.x; Warren ME, 2008, DESIGNING DELIBERATIVE DEMOCRACY: THE BRITISH COLUMBIA CITIZENS' ASSEMBLY, P1, DOI 10.1017/CBO9780511491177; Weeks EC, 2000, PUBLIC ADMIN REV, V60, P360, DOI 10.1111/0033-3352.00098	24	10	10	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					914	915		10.1126/science.aal3900	http://dx.doi.org/10.1126/science.aal3900			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM2YM	28254904				2022-12-28	WOS:000395181700025
J	Fritz, Z; Slowther, AM; Perkins, GD				Fritz, Zoe; Slowther, Anne-Marie; Perkins, Gavin D.			Resuscitation policy should focus on the patient, not the decision	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LIFE-SUSTAINING TREATMENT; CARDIOPULMONARY-RESUSCITATION; ORDERS; PREFERENCES; SURVIVAL; IMPACT		[Fritz, Zoe] Warwick Med Sch, Div Hlth Sci, Soc & Eth, Gibbet Hill Campus, Coventry CV4 7AL, W Midlands, England; [Fritz, Zoe] Warwick Med Sch, Div Hlth Sci, Acute Med, Gibbet Hill Campus, Coventry CV4 7AL, W Midlands, England; [Slowther, Anne-Marie] Warwick Med Sch, Div Hlth Sci, Clin Eth, Gibbet Hill Campus, Coventry CV4 7AL, W Midlands, England; [Perkins, Gavin D.] Warwick Med Sch, Div Hlth Sci, Crit Care Med, Gibbet Hill Campus, Coventry CV4 7AL, W Midlands, England; [Fritz, Zoe] Cambridge Univ Hosp, Soc & Eth, Cambridge, England; [Fritz, Zoe] Cambridge Univ Hosp, Acute Med, Cambridge, England; [Perkins, Gavin D.] Univ Warwick, Heart England NHS Fdn Trust, Crit Care Med, Coventry, W Midlands, England	University of Warwick; University of Warwick; University of Warwick; University of Warwick; University of Cambridge; University of Cambridge; Heart of England NHS Foundation Trust; University of Warwick	Fritz, Z (corresponding author), Warwick Med Sch, Div Hlth Sci, Soc & Eth, Gibbet Hill Campus, Coventry CV4 7AL, W Midlands, England.	zoe.fritz@addenbrookes.nhs.uk	Perkins, Gavin/E-7613-2010	Perkins, Gavin/0000-0003-3027-7548; Fritz, Zoe/0000-0001-9403-409X	National Institute for Health Research Health Service Delivery Research Programme [12/5001/55, 15/15/09]; Wellcome Trust [WT100577MA]; National Institute for Health Research [NF-SI-0514-10139, 12/5001/55, 15/15/09] Funding Source: researchfish	National Institute for Health Research Health Service Delivery Research Programme; Wellcome Trust(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR))	Some of the research reported in this paper was funded by the National Institute for Health Research Health Service Delivery Research Programme (project number 12/5001/55 and 15/15/09); some from the Wellcome Trust Grant WT100577MA.	Andrew E, 2017, RESUSCITATION, V110, P42, DOI 10.1016/j.resuscitation.2016.10.018; Aune S, 2005, RESUSCITATION, V65, P291, DOI 10.1016/j.resuscitation.2004.11.028; Beach MC, 2002, J AM GERIATR SOC, V50, P2057, DOI 10.1046/j.1532-5415.2002.50620.x; Chen JLT, 2008, AM HEART J, V156, P78, DOI 10.1016/j.ahj.2008.01.030; Cohen RI, 2009, J CRIT CARE, V24, P311, DOI 10.1016/j.jcrc.2008.01.007; Cohn S, 2013, QJM-INT J MED, V106, P165, DOI 10.1093/qjmed/hcs222; Findlay G, 2012, COMMUNICATION; Fried TR, 2006, ARCH INTERN MED, V166, P890, DOI 10.1001/archinte.166.8.890; Fritz Z, 2015, J EVAL CLIN PRACT, V21, P109, DOI 10.1111/jep.12256; Fritz Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070977; Fritz ZBM, 2014, RESUSCITATION, V85, P444, DOI 10.1016/j.resuscitation.2014.01.016; Girotra S, 2012, NEW ENGL J MED, V367, P1912, DOI 10.1056/NEJMoa1109148; Grasner JT, 2016, RESUSCITATI IN PRESS, DOI [10.1016/j.resuscitation.2016.10.001, DOI 10.1016/J.RESUSCITATION.2016.10.001]; Halpern SD, 2015, NEW ENGL J MED, V373, P2001, DOI 10.1056/NEJMp1509664; Henneman E A, 1994, Am J Crit Care, V3, P467; Hickman SE, 2015, J AM GERIATR SOC, V63, P341, DOI 10.1111/jgs.13248; Janssen DJA, 2012, CHEST, V141, P1251, DOI 10.1378/chest.11-1472; JUDE JR, 1961, JAMA-J AM MED ASSOC, V178, P1063, DOI 10.1001/jama.1961.03040500005002; Mentzelopoulos SD, 2016, RESUSCITATION, V100, P11, DOI 10.1016/j.resuscitation.2015.12.010; Perkins GD, 2016, DO NOT ATTEMPT CARDI; Pitcher D, 2017, BMJ-BRIT MED J, V356, P876; Rosenfeld KE, 2000, J GEN INTERN MED, V15, P620, DOI 10.1046/j.1525-1497.2000.06289.x; Rosoff PM, 2017, AM J BIOETHICS, V17, P26, DOI 10.1080/15265161.2016.1265163; Sivakumar R, 2004, J MED ETHICS, V30, P311, DOI 10.1136/jme.2002.002915; Sulzgruber P, 2016, EUR HEART J-ACUTE CA	25	49	48	2	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 28	2017	356								j813	10.1136/bmj.j813	http://dx.doi.org/10.1136/bmj.j813			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9JQ	28246084	Green Published, hybrid			2022-12-28	WOS:000395628100016
J	Mackenzie, L				Mackenzie, Linda			Robert Archibald Buchanan OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2017	356								j900	10.1136/bmj.j900	http://dx.doi.org/10.1136/bmj.j900			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KZ	28235845				2022-12-28	WOS:000395631800009
J	Stead, W				Stead, Wendy			Rosemary's Gifts	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Stead, Wendy] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Stead, Wendy] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Stead, W (corresponding author), Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA.; Stead, W (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	wstead@bidmc.harvard.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2017	317	7					697	698		10.1001/jama.2016.14695	http://dx.doi.org/10.1001/jama.2016.14695			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8WR	28241360				2022-12-28	WOS:000394901600014
J	Lanas, A; Chan, FKL				Lanas, Angel; Chan, Francis K. L.			Peptic ulcer disease	LANCET			English	Review							HELICOBACTER-PYLORI INFECTION; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PROTON-PUMP INHIBITORS; UPPER GASTROINTESTINAL HEMORRHAGE; CONTAINING QUADRUPLE THERAPY; EAST JAPAN EARTHQUAKE; DUODENAL-ULCER; TRIPLE THERAPY; DOUBLE-BLIND; TIME TRENDS	The rapidly declining prevalence of Helicobacter pylori infection and widespread use of potent anti-secretory drugs means peptic ulcer disease has become substantially less prevalent than it was two decades ago. Management has, however, become more challenging than ever because of the threat of increasing antimicrobial resistance worldwide and widespread use of complex anti-thrombotic therapy in the ageing population. Peptic ulcers not associated with H pylori infection or the use of non-steroidal anti-inflammatory drugs are now also imposing substantial diagnostic and therapeutic challenges. This Seminar aims to provide a balanced overview of the latest advances in the pathogenetic mechanisms of peptic ulcers, guidelines on therapies targeting H pylori infection, approaches to treatment of peptic ulcer complications associated with anti-inflammatory analgesics and anti-thrombotic agents, and the unmet needs in terms of our knowledge and management of this increasingly challenging condition.	[Lanas, Angel] Univ Zaragoza, Univ Clin Hosp Lozano Blesa, Serv Digest Dis, IIS Aragon,CIBEREHD, Zaragoza, Spain; [Chan, Francis K. L.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Lozano Blesa University Clinical Hospital; University of Zaragoza; Chinese University of Hong Kong; Prince of Wales Hospital	Lanas, A (corresponding author), Univ Clin Hosp Lozano Blesa, Serv Digest Dis, Calle San Juan Bosco 15, Zaragoza 50009, Spain.	alanas@unizar.es	Chan, Francis K. L./F-4851-2010	Chan, Francis K. L./0000-0001-7388-2436	Carlos III Health Institute [PI11/02578]	Carlos III Health Institute(Instituto de Salud Carlos III)	AL's work was partly funded by a grant (PI11/02578) from the Carlos III Health Institute.	Agreus L, 2016, HELICOBACTER, V21, P186, DOI 10.1111/hel.12267; Airoldi F, 2007, CIRCULATION, V116, P745, DOI 10.1161/CIRCULATIONAHA.106.686048; Garcia-Gonzalez MA, 2015, INT J CANCER, V137, P1362, DOI 10.1002/ijc.29500; Baker DE, 2009, REV GASTROENTEROL DI, V9, pE111; Barkun AN, 2010, GASTROINTEST ENDOSC, V72, P1138, DOI 10.1016/j.gie.2010.08.011; Beales ILP, 2001, GUT, V48, P782, DOI 10.1136/gut.48.6.782; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Bjarnason I, 2007, ALIMENT PHARM THER, V26, P95, DOI 10.1111/j.1365-2036.2007.03348.x; Chakravorty M, 2006, HUM MUTAT, V27, P411, DOI 10.1002/humu.20299; Chan FKL, 2006, NAT CLIN PRACT GASTR, V3, P563, DOI 10.1038/ncpgasthep0610; Chan FKL, 2017, GASTROENTEROLOGY, V152, P105, DOI 10.1053/j.gastro.2016.09.006; Chan FKL, 2013, GASTROENTEROLOGY, V144, P528, DOI 10.1053/j.gastro.2012.12.038; Chan FKL, 2010, LANCET, V376, P173, DOI 10.1016/S0140-6736(10)60673-3; Chan FKL, 2012, CLIN GASTROENTEROL H, V10, P753, DOI 10.1016/j.cgh.2012.03.027; Charpignon C, 2013, ALIMENT PHARM THER, V38, P946, DOI 10.1111/apt.12465; Chen MY, 2013, WORLD J GASTROENTERO, V19, P4242, DOI 10.3748/wjg.v19.i26.4242; Chen PY, 2016, ALIMENT PHARM THER, V44, P427, DOI 10.1111/apt.13712; Chuah SK, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003586; COOK DJ, 1992, GASTROENTEROLOGY, V102, P139, DOI 10.1016/0016-5085(92)91793-4; Cremades N, 2009, ACS CHEM BIOL, V4, P928, DOI 10.1021/cb900166q; Crooks CJ, 2013, GASTROENTEROLOGY, V144, P1384, DOI 10.1053/j.gastro.2013.02.040; Cryer B, 1999, GASTROENTEROLOGY, V117, P17, DOI 10.1016/S0016-5085(99)70545-7; Cryer B, 2013, AM J GASTROENTEROL, V108, P392, DOI 10.1038/ajg.2012.467; De DD, 2015, WORLD J GASTROENTERO, V21, P2883, DOI 10.3748/wjg.v21.i10.2883; Dell Vale J, 2015, HARRISONS PRINCIPLES, P1911; Dore MP, 2016, GUT, V65, P870, DOI 10.1136/gutjnl-2015-311019; Dumbleton JS, 2015, EBIOMEDICINE, V2, P1200, DOI 10.1016/j.ebiom.2015.07.012; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; ElOmar EM, 1997, GASTROENTEROLOGY, V113, P15, DOI 10.1016/S0016-5085(97)70075-1; Fallone CA, 2016, GASTROENTEROLOGY, V151, P51, DOI 10.1053/j.gastro.2016.04.006; Fock KM, 2009, J GASTROEN HEPATOL, V24, P1587, DOI 10.1111/j.1440-1746.2009.05982.x; Furuta T, 2002, GASTROENTEROLOGY, V123, P92, DOI 10.1053/gast.2002.34156; Garcia-Gonzalez MA, 2003, CLIN EXP IMMUNOL, V134, P525, DOI 10.1111/j.1365-2249.2003.02325.x; Gatta L, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4587; Gisbert JP, 2015, ALIMENT PHARM THER, V41, P768, DOI 10.1111/apt.13128; Gisbert JP, 2012, ALIMENT PHARM THER, V35, P209, DOI 10.1111/j.1365-2036.2011.04937.x; Gisbert JP, 2011, ALIMENT PHARM THER, V34, P604, DOI 10.1111/j.1365-2036.2011.04770.x; Gisbert JP, 2009, ALIMENT PHARM THER, V30, P791, DOI 10.1111/j.1365-2036.2009.04105.x; Gonzalez-Perez A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101768; Graham DY, 2016, GASTROENTEROLOGY, V151, P9, DOI 10.1053/j.gastro.2016.05.009; Graham DY, 2014, CLIN GASTROENTEROL H, V12, P177, DOI 10.1016/j.cgh.2013.05.028; Gralnek IM, 2015, ENDOSCOPY, V47, pA1, DOI 10.1055/s-0034-1393172; Guo T, 2013, MOL MED REP, V7, P299, DOI 10.3892/mmr.2012.1165; Hsu PI, 2015, WORLD J GASTROENTERO, V21, P12954, DOI 10.3748/wjg.v21.i45.12954; Hsu PI, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002104; Huang JQ, 2002, LANCET, V359, P14, DOI 10.1016/S0140-6736(02)07273-2; Hunfeld NG, 2009, ALIMENT PHARM THER, V31, P150, DOI 10.1111/j.1365-2036.2009.04150.x; Hung LCT, 2005, GASTROENTEROLOGY, V128, P1845, DOI 10.1053/j.gastro.2005.03.026; Kanno T, 2015, J GASTROENTEROL, V50, P31, DOI 10.1007/s00535-014-0940-4; Kiss S, 2016, ALIMENT PHARM THER, V43, P924, DOI 10.1111/apt.13564; KURATA JH, 1992, GASTROENTEROLOGY, V102, P902, DOI 10.1016/0016-5085(92)90176-Y; Lanas A, 2006, GUT, V55, P1731, DOI 10.1136/gut.2005.080754; Lanas A, 2011, ALIMENT PHARM THER, V33, P585, DOI 10.1111/j.1365-2036.2010.04563.x; Lanas A, 2003, CURR PHARM DESIGN, V9, P2253, DOI 10.2174/1381612033453992; Lanas A, 2001, GENES IMMUN, V2, P415, DOI 10.1038/sj.gene.6363798; LANAS AI, 1995, GASTROENTEROLOGY, V109, P1124, DOI 10.1016/0016-5085(95)90570-7; Lanas A, 2016, AM J GASTROENTEROL, V111, P1085, DOI 10.1038/ajg.2016.166; Lanas A, 2015, CLIN GASTROENTEROL H, V13, P906, DOI 10.1016/j.cgh.2014.11.007; Lau JYW, 2013, LANCET, V381, P2033, DOI 10.1016/S0140-6736(13)60596-6; Lau JYW, 1999, NEW ENGL J MED, V340, P751, DOI 10.1056/NEJM199903113401002; Leow AHR, 2016, ALIMENT PHARM THER, V43, P831, DOI 10.1111/apt.13550; Levenstein S, 2015, CLIN GASTROENTEROL H, V13, P498, DOI 10.1016/j.cgh.2014.07.052; LIGUMSKY M, 1983, GASTROENTEROLOGY, V84, P756; Malfertheiner P., 2017, Gut, V66, P6, DOI [10.1136/gutjnl-2016-312288, DOI 10.1136/GUTJNL-2016-312288]; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Malmi H, 2014, ALIMENT PHARM THER, V39, P496, DOI 10.1111/apt.12620; Marmo R, 2003, GASTROINTEST ENDOSC, V57, P62, DOI 10.1067/mge.2003.48; Masclee GMC, 2014, GASTROENTEROLOGY, V147, P784, DOI 10.1053/j.gastro.2014.06.007; Mayerle J, 2013, JAMA-J AM MED ASSOC, V309, P1912, DOI 10.1001/jama.2013.4350; McColl KEL, 2009, GASTROENTEROL CLIN N, V38, P353, DOI 10.1016/j.gtc.2009.03.004; MeyerRosberg K, 1996, GASTROENTEROLOGY, V111, P886, DOI 10.1016/S0016-5085(96)70056-2; Molina-Infante J, 2013, GASTROENTEROLOGY, V145, P121, DOI 10.1053/j.gastro.2013.03.050; MOSS SF, 1992, LANCET, V340, P930, DOI 10.1016/0140-6736(92)92816-X; Murakami K, 2016, GUT, V65, P1439, DOI 10.1136/gutjnl-2015-311304; Ng FH, 2010, GASTROENTEROLOGY, V138, P82, DOI 10.1053/j.gastro.2009.09.063; Nyssen OP, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009034.pub2; Perini RF, 2003, CURR PHARM DESIGN, V9, P2207, DOI 10.2174/1381612033454027; Regula J, 2006, AM J GASTROENTEROL, V101, P1747, DOI 10.1111/j.1572-0241.2006.00686.x; ROBERT A, 1991, LIFE SCI, V48, P123, DOI 10.1016/0024-3205(91)90405-Z; ROSENSTOCK SJ, 1995, GUT, V36, P819, DOI 10.1136/gut.36.6.819; Rostom A, 2009, DRUG HEALTHC PATIENT, V1, P47; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Sachar H, 2014, JAMA INTERN MED, V174, P1755, DOI 10.1001/jamainternmed.2014.4056; Scarpignato C, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0285-8; Scheiman JM, 2007, LANCET, V369, P1580, DOI 10.1016/S0140-6736(07)60722-3; Shiotani A, 2002, MED CLIN N AM, V86, P1447, DOI 10.1016/S0025-7125(02)00083-4; Shiotani A, 2015, CURR PHARM DESIGN, V21, P5066, DOI 10.2174/1381612821666150915105537; Shiotani A, 2014, J GASTROEN HEPATOL, V29, P47, DOI 10.1111/jgh.12770; Sigthorsson G, 1998, GUT, V43, P506, DOI 10.1136/gut.43.4.506; SILVERSTEIN FE, 1995, ANN INTERN MED, V123, P241, DOI 10.7326/0003-4819-123-4-199508150-00001; Singh G, 1999, J RHEUMATOL, V26, P18; Sonnenberg A, 2013, ALIMENT PHARM THER, V38, P329, DOI 10.1111/apt.12380; Sonnenberg A, 2007, GASTROENTEROLOGY, V132, P2320, DOI 10.1053/j.gastro.2007.03.108; Sonnenberg A, 2007, AM J GASTROENTEROL, V102, P1101, DOI 10.1111/j.1572-0241.2007.01157.x; Sostres C, 2015, AM J GASTROENTEROL, V110, P684, DOI 10.1038/ajg.2015.98; Sostres C, 2011, NAT REV GASTRO HEPAT, V8, P385, DOI 10.1038/nrgastro.2011.97; Sreedharan A, 2010, COCHRANE DB SYST REV, V7; Stanley AJ, 2011, ALIMENT PHARM THER, V34, P470, DOI 10.1111/j.1365-2036.2011.04747.x; Sugimoto M, 2009, CLIN MICROBIOL INFEC, V15, P835, DOI 10.1111/j.1469-0691.2009.02769.x; Sun QJ, 2010, HELICOBACTER, V15, P233, DOI 10.1111/j.1523-5378.2010.00758.x; Sung JJY, 2007, GUT, V56, P1364, DOI 10.1136/gut.2007.123976; Sung JJY, 2010, ANN INTERN MED, V152, P1, DOI 10.7326/0003-4819-152-1-201001050-00179; Taha AS, 2009, LANCET, V374, P119, DOI 10.1016/S0140-6736(09)61246-0; Tanikawa C, 2012, NAT GENET, V44, P430, DOI 10.1038/ng.1109; Trejo-de la O A, 2015, INNATE IMMUN-LONDON, V21, P706, DOI 10.1177/1753425915587130; Trespalacios-Rangel AA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160007; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801; Villoria A, 2008, ALIMENT PHARM THER, V28, P868, DOI 10.1111/j.1365-2036.2008.03807.x; Wallace JL, 1997, GASTROENTEROLOGY, V112, P1000, DOI 10.1053/gast.1997.v112.pm9041264; Wallace JL, 2011, GASTROENTEROLOGY, V141, P1314, DOI 10.1053/j.gastro.2011.06.075; Wang CH, 2010, ARCH INTERN MED, V170, P751, DOI 10.1001/archinternmed.2010.100; Wang F, 2014, CANCER LETT, V345, P196, DOI 10.1016/j.canlet.2013.08.016; Wang PY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/616018; Witt D.M., 2012, ARCH INTERN MED, P1; Wong GLH, 2012, CLIN GASTROENTEROL H, V10, P1124, DOI 10.1016/j.cgh.2012.06.012; Wong GLH, 2009, GASTROENTEROLOGY, V137, P525, DOI 10.1053/j.gastro.2009.05.006; Yamanaka K, 2013, WORLD J GASTROENTERO, V19, P7426, DOI 10.3748/wjg.v19.i42.7426; Yamaoka Y, 2014, FUTURE ONCOL, V10, P1487, DOI [10.2217/fon.14.29, 10.2217/FON.14.29]; Yuan JQ, 2016, ALIMENT PHARM THER, V44, P785, DOI 10.1111/apt.13776; Yuan JQ, 2016, ALIMENT PHARM THER, V43, P1262, DOI 10.1111/apt.13642; Yuan Y, 2013, COCHRANE DB SYST REV, V12; Zaki M, 2013, AM J PHYSIOL-GASTR L, V304, pG715, DOI 10.1152/ajpgi.00187.2012; Zeng M, 2015, LANCET, V386, P1457, DOI 10.1016/S0140-6736(15)60310-5; Zhang BB, 2014, MOL BIOL REP, V41, P7241, DOI 10.1007/s11033-014-3610-y; Zhang BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057167	126	305	324	12	122	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 5	2017	390	10094					613	624		10.1016/S0140-6736(16)32404-7	http://dx.doi.org/10.1016/S0140-6736(16)32404-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC5BM	28242110				2022-12-28	WOS:000406855800025
J	Kugathasan, S; Denson, LA; Walters, TD; Kim, MO; Marigorta, UM; Schirmer, M; Mondal, K; Liu, C; Griffiths, A; Noe, JD; Crandall, WV; Snapper, S; Rabizadeh, S; Rosh, JR; Shapiro, JM; Guthery, S; Mack, DR; Kellermayer, R; Kappelman, MD; Steiner, S; Moulton, DE; Keljo, D; Cohen, S; Oliva-Hemker, M; Heyman, MB; Otley, AR; Baker, SS; Evans, JS; Kirschner, BS; Patel, AS; Ziring, D; Trapnell, BC; Sylvester, FA; Stephens, MC; Baldassano, RN; Markowitz, JF; Cho, J; Xavier, RJ; Huttenhower, C; Aronow, BJ; Gibson, G; Hyams, JS; Dubinsky, MC				Kugathasan, Subra; Denson, Lee A.; Walters, Thomas D.; Kim, Mi-Ok; Marigorta, Urko M.; Schirmer, Melanie; Mondal, Kajari; Liu, Chunyan; Griffiths, Anne; Noe, Joshua D.; Crandall, Wallace V.; Snapper, Scott; Rabizadeh, Shervin; Rosh, Joel R.; Shapiro, Jason M.; Guthery, Stephen; Mack, David R.; Kellermayer, Richard; Kappelman, Michael D.; Steiner, Steven; Moulton, Dedrick E.; Keljo, David; Cohen, Stanley; Oliva-Hemker, Maria; Heyman, Melvin B.; Otley, Anthony R.; Baker, Susan S.; Evans, Jonathan S.; Kirschner, Barbara S.; Patel, Ashish S.; Ziring, David; Trapnell, Bruce C.; Sylvester, Francisco A.; Stephens, Michael C.; Baldassano, Robert N.; Markowitz, James F.; Cho, Judy; Xavier, Ramnik J.; Huttenhower, Curtis; Aronow, Bruce J.; Gibson, Greg; Hyams, Jeffrey S.; Dubinsky, Marla C.			Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study	LANCET			English	Article							INFLIXIMAB; RESECTION; THERAPY; ILEAL	Background Stricturing and penetrating complications account for substantial morbidity and health-care costs in paediatric and adult onset Crohn's disease. Validated models to predict risk for complications are not available, and the effect of treatment on risk is unknown. Methods We did a prospective inception cohort study of paediatric patients with newly diagnosed Crohn's disease at 28 sites in the USA and Canada. Genotypes, antimicrobial serologies, ileal gene expression, and ileal, rectal, and faecal microbiota were assessed. A competing-risk model for disease complications was derived and validated in independent groups. Propensity-score matching tested the effect of anti-tumour necrosis factor alpha (TNF alpha) therapy exposure within 90 days of diagnosis on complication risk. Findings Between Nov 1, 2008, and June 30, 2012, we enrolled 913 patients, 78 (9%) of whom experienced Crohn's disease complications. The validated competing-risk model included age, race, disease location, and antimicrobial serologies and provided a sensitivity of 66% (95% CI 51-82) and specificity of 63% (55-71), with a negative predictive value of 95% (94-97). Patients who received early anti-TNF alpha therapy were less likely to have penetrating complications (hazard ratio [HR] 0.30, 95% CI 0.10-0.89; p=0.0296) but not stricturing complication (1.13, 0.51-2.51; 0.76) than were those who did not receive early anti-TNF alpha therapy. Ruminococcus was implicated in stricturing complications and Veillonella in penetrating complications. Ileal genes controlling extracellular matrix production were upregulated at diagnosis, and this gene signature was associated with stricturing in the risk model (HR 1.70, 95% CI 1.12-2.57; p=0.0120). When this gene signature was included, the model's specificity improved to 71%. Interpretation Our findings support the usefulness of risk stratification of paediatric patients with Crohn's disease at diagnosis, and selection of anti-TNF alpha therapy.	[Kugathasan, Subra; Mondal, Kajari] Emory Univ, Sch Med, Div Pediat Gastroenterol, 1760 Haygood Dr,W427, Atlanta, GA 30322 USA; [Kugathasan, Subra; Cohen, Stanley] Childrens Healthcare Atlanta, Atlanta, GA USA; [Denson, Lee A.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA; [Kim, Mi-Ok; Liu, Chunyan] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Trapnell, Bruce C.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA; [Aronow, Bruce J.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Walters, Thomas D.; Griffiths, Anne] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Pediat Gastroenterol Hepatol & Nutr, Toronto, ON, Canada; [Marigorta, Urko M.; Gibson, Greg] Georgia Inst Technol, Ctr Integrat Genom, Atlanta, GA 30332 USA; [Schirmer, Melanie; Xavier, Ramnik J.; Huttenhower, Curtis] Broad Inst MIT & Harvard, Cambridge, MA USA; [Schirmer, Melanie; Huttenhower, Curtis] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Noe, Joshua D.] Med Coll Wisconsin, Dept Pediat Gastroenterol Hepatol & Nutr, Milwaukee, WI 53226 USA; [Crandall, Wallace V.] Ohio State Univ, Coll Med, Dept Pediat Gastroenterol, Nationwide Childrens Hosp, Columbus, OH 43210 USA; [Snapper, Scott] Boston Childrens Hosp, Dept Gastroenterol & Nutr, Boston, MA USA; [Rabizadeh, Shervin] Cedars Sinai Med Ctr, Dept Pediat, Los Angeles, CA 90048 USA; [Rosh, Joel R.] Goryeb Childrens Hosp, Dept Pediat, Morristown, NJ USA; [Shapiro, Jason M.] Hasbro Childrens Hosp, Dept Pediat, Providence, RI USA; [Guthery, Stephen] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Mack, David R.] Childrens Hosp Eastern Ontario, IBD Ctr, Dept Pediat, Ottawa, ON, Canada; [Mack, David R.] Univ Ottawa, Ottawa, ON, Canada; [Kellermayer, Richard] Texas Childrens Hosp, Baylor Coll Med, Sect Pediat Gastroenterol, Houston, TX 77030 USA; [Kappelman, Michael D.; Sylvester, Francisco A.] Univ North Carolina Chapel Hill, Dept Pediat, Chapel Hill, NC USA; [Steiner, Steven] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Moulton, Dedrick E.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [Keljo, David] UPMC, Childrens Hosp Pittsburgh, Dept Gastroenterol, Pittsburgh, PA USA; [Cohen, Stanley] Childrens Ctr Digest Hlth Care, Atlanta, GA USA; [Oliva-Hemker, Maria] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Heyman, Melvin B.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Otley, Anthony R.] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; [Baker, Susan S.] SUNY Buffalo, Dept Digest Dis, Buffalo, NY USA; [Baker, Susan S.] SUNY Buffalo, Nutr Ctr, Buffalo, NY USA; [Evans, Jonathan S.] Nemours Childrens Specialty Care, Dept Pediat, Jacksonville, FL USA; [Kirschner, Barbara S.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Patel, Ashish S.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX USA; [Ziring, David] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Stephens, Michael C.] Mayo Clin, Dept Pediat Gastroenterol, Rochester, MN USA; [Baldassano, Robert N.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Markowitz, James F.] Northwell Hlth, Dept Pediat, New York, NY USA; [Cho, Judy; Dubinsky, Marla C.] Mt Sinai Hosp, Dept Pediat, New York, NY 10029 USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Gastrointestinal Unit, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Xavier, Ramnik J.] MIT, Ctr Microbiome Informat & Therapeut, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Hyams, Jeffrey S.] Connecticut Childrens Med Ctr, Div Digest Dis Hepatol & Nutr, Hartford, CT USA	Emory University; Children's Healthcare of Atlanta (CHOA); Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University System of Georgia; Georgia Institute of Technology; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; Medical College of Wisconsin; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Harvard University; Boston Children's Hospital; Cedars Sinai Medical Center; Atlantic Health System; Hasbro Children's Hospital; Utah System of Higher Education; University of Utah; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Baylor College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Indiana University System; Indiana University Bloomington; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; University of California System; University of California San Francisco; Dalhousie University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Chicago; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Mayo Clinic; University of Pennsylvania; Northwell Health; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Connecticut Children's Medical Center	Kugathasan, S (corresponding author), Emory Univ, Sch Med, Div Pediat Gastroenterol, 1760 Haygood Dr,W427, Atlanta, GA 30322 USA.	skugath@emory.edu	Schirmer, Melanie/HDN-5528-2022; Marigorta, Urko M/L-9512-2014	Otley, Anthony/0000-0002-7371-9302; Oliva-Hemker, Maria/0000-0002-4054-7372; Schirmer, Melanie/0000-0001-6456-3679; Patel, Ashish/0000-0002-4435-2644; Marigorta, Urko M/0000-0002-9087-6609; Ziring, David/0000-0002-5318-9906; Kirschner, Barbara/0000-0003-4640-2438; Kim, Mi-Ok/0000-0002-7712-3653	Crohn's and Colitis Foundation of America; Cincinnati Children's Hospital Research Foundation Digestive Health Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL127672, R01HL118342, R01HL085453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392, P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099568] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America; Cincinnati Children's Hospital Research Foundation Digestive Health Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Crohn's and Colitis Foundation of America, Cincinnati Children's Hospital Research Foundation Digestive Health Center.	Benchimol EI, 2014, GASTROENTEROLOGY, V147, P803, DOI 10.1053/j.gastro.2014.06.023; Burke JP, 2007, AM J GASTROENTEROL, V102, P439, DOI 10.1111/j.1572-0241.2006.01010.x; Burke JP, 2013, INT J COLORECTAL DIS, V28, P1401, DOI 10.1007/s00384-013-1698-5; Casteele NV, 2012, GUT, V61, P321, DOI 10.1136/gut.2010.236869; Cleynen I, 2016, LANCET, V387, P156, DOI 10.1016/S0140-6736(15)00465-1; Crombe V, 2011, INFLAMM BOWEL DIS, V17, P2144, DOI 10.1002/ibd.21615; Cutler DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128074; Di Sabatino A, 2009, GUT, V58, P777, DOI 10.1136/gut.2008.149096; Dubinsky MC, 2008, CLIN GASTROENTEROL H, V6, P1105, DOI 10.1016/j.cgh.2008.04.032; Eder P, 2015, SCI REP-UK, V5, DOI 10.1038/srep10223; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Glavan TW, 2016, MUCOSAL IMMUNOL, V9, P677, DOI 10.1038/mi.2015.92; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Lazarev M, 2010, INFLAMM BOWEL DIS, V16, P830, DOI 10.1002/ibd.21118; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Machiels Kathleen, 2014, Gut, V63, P1275, DOI 10.1136/gutjnl-2013-304833; Markowitz J, 2009, INFLAMM BOWEL DIS, V15, P714, DOI 10.1002/ibd.20831; Odes S, 2007, J CROHNS COLITIS, V1, P87, DOI 10.1016/j.crohns.2007.08.004; Parsons L, REDUCING BIAS PROPEN; Principi Mariabeatrice, 2013, World J Gastrointest Pathophysiol, V4, P100, DOI 10.4291/wjgp.v4.i4.100; Rieder F, 2013, GUT, V62, P1072, DOI 10.1136/gutjnl-2012-304353; Rungoe C, 2014, GUT, V63, P1607, DOI 10.1136/gutjnl-2013-305607; Siegel CA, 2011, INFLAMM BOWEL DIS, V17, P30, DOI 10.1002/ibd.21386; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Turner D, 2017, J PEDIATR GASTR NUTR, V64, P254, DOI 10.1097/MPG.0000000000001227; Uchida K, 2004, BLOOD, V103, P1089, DOI 10.1182/blood-2003-05-1565; Van Assche G, 2013, J CROHNS COLITIS, V7, P950, DOI 10.1016/j.crohns.2013.01.011; Vernier-Massouille G, 2008, GASTROENTEROLOGY, V135, P1106, DOI 10.1053/j.gastro.2008.06.079; Walters TD, 2014, GASTROENTEROLOGY, V146, P383, DOI 10.1053/j.gastro.2013.10.027	30	336	341	2	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2017	389	10080					1710	1718		10.1016/S0140-6736(17)30317-3	http://dx.doi.org/10.1016/S0140-6736(17)30317-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET3BG	28259484	Green Accepted, Green Submitted			2022-12-28	WOS:000400151000028
J	Tsai, KL; Yu, XD; Gopalan, S; Chao, TC; Zhang, Y; Florens, L; Washburn, MP; Murakami, K; Conaway, RC; Conaway, JW; Asturias, FJ				Tsai, Kuang-Lei; Yu, Xiaodi; Gopalan, Sneha; Chao, Ti-Chun; Zhang, Ying; Florens, Laurence; Washburn, Michael P.; Murakami, Kenji; Conaway, Ronald C.; Conaway, Joan W.; Asturias, Francisco J.			Mediator structure and rearrangements required for holoenzyme formation	NATURE			English	Article							RNA-POLYMERASE-II; SUBUNIT ARCHITECTURE; PROTEOMIC ANALYSIS; TRANSCRIPTION; INITIATION; COMPLEX; YEAST; IDENTIFICATION; MICROSCOPY; VISUALIZATION	The conserved Mediator co-activator complex has an essential role in the regulation of RNA polymerase II transcription in all eukaryotes. Understanding the structure and interactions of Mediator is crucial for determining how the complex influences transcription initiation and conveys regulatory information to the basal transcription machinery. Here we present a 4.4 angstrom resolution cryo-electron microscopy map of Schizosaccharomyces pombe Mediator in which conserved Mediator subunits are individually resolved. The essential Med14 subunit works as a central backbone that connects the Mediator head, middle and tail modules. Comparison with a 7.8 angstrom resolution cryo-electron microscopy map of a Mediator-RNA polymerase II holoenzyme reveals that changes in the structure of Med14 facilitate a large-scale Mediator rearrangement that is essential for holoenzyme formation. Our study suggests that access to different conformations and crosstalk between structural elements are essential for the Mediator regulation mechanism, and could explain the capacity of the complex to integrate multiple regulatory signals.	[Tsai, Kuang-Lei; Yu, Xiaodi; Asturias, Francisco J.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Gopalan, Sneha; Zhang, Ying; Florens, Laurence; Washburn, Michael P.; Conaway, Ronald C.; Conaway, Joan W.] Stowers Inst Med Res, Kansas City, MO USA; [Gopalan, Sneha; Zhang, Ying; Florens, Laurence; Washburn, Michael P.; Conaway, Ronald C.; Conaway, Joan W.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Chao, Ti-Chun] Univ Calif San Diego, Sch Med, Inst Genom Med, La Jolla, CA 92093 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Murakami, Kenji] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Conaway, Ronald C.; Conaway, Joan W.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS USA; [Murakami, Kenji] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Asturias, Francisco J.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA	Scripps Research Institute; Stowers Institute for Medical Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Kansas; University of Kansas Medical Center; Stanford University; University of Kansas; University of Kansas Medical Center; University of Pennsylvania; Pennsylvania Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus	Asturias, FJ (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.; Asturias, FJ (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	francisco.asturias@ucdenver.edu		Gopalan, Sneha/0000-0002-3223-4632; Florens, Laurence/0000-0002-9310-6650	US National Institutes of Health [R01 GM67167, R01 GM41628]; Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067167, R01GM041628] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health grants R01 GM67167 (F.J.A.) and R01 GM41628 (R.C.C. and J.W.C) and by a grant to the Stowers Institute from the Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation. We thank C. Gustafsson for providing the Med7-TAP, Med13 Delta S. pombe strain used for the high-resolution EM analysis. S.G. contribution will fulfil, in part, requirements for her PhD thesis research as a student registered with the Open University.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Baidoobonso SM, 2007, J BIOL CHEM, V282, P5551, DOI 10.1074/jbc.M609484200; Baumli S., J BIOL CHEM; Boube M, 2002, CELL, V110, P143, DOI 10.1016/S0092-8674(02)00830-9; Cai G, 2009, STRUCTURE, V17, P559, DOI 10.1016/j.str.2009.01.016; Cevher MA, 2014, NAT STRUCT MOL BIOL, V21, P1028, DOI 10.1038/nsmb.2914; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Elmlund H, 2006, P NATL ACAD SCI USA, V103, P15788, DOI 10.1073/pnas.0607483103; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; Fan HY, 1996, GENETICS, V142, P749; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Florens Laurence, 2006, V328, P159; Gibbons BJ, 2012, P NATL ACAD SCI USA, V109, P1949, DOI 10.1073/pnas.1105266109; He Y, 2016, NATURE, V533, P359, DOI 10.1038/nature17970; Henderson R, 2012, STRUCTURE, V20, P205, DOI 10.1016/j.str.2011.12.014; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Imasaki T, 2011, NATURE, V475, P240, DOI 10.1038/nature10162; Kitazono AA, 2002, YEAST, V19, P141, DOI 10.1002/yea.806; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Koschubs T, 2010, NUCLEIC ACIDS RES, V38, P3186, DOI 10.1093/nar/gkq029; Koschubs T, 2009, EMBO J, V28, P69, DOI 10.1038/emboj.2008.254; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lariviere L, 2013, NUCLEIC ACIDS RES, V41, P9266, DOI 10.1093/nar/gkt704; Lariviere L, 2012, NATURE, V492, P448, DOI 10.1038/nature11670; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Louder RK, 2016, NATURE, V531, P604, DOI 10.1038/nature17394; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Meyer KD, 2010, NAT STRUCT MOL BIOL, V17, P753, DOI 10.1038/nsmb.1816; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murakami K, 2015, P NATL ACAD SCI USA, V112, P13543, DOI 10.1073/pnas.1518255112; Murakami K, 2013, SCIENCE, V342, P709, DOI 10.1126/science.1238724; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; Naar AM, 2002, GENE DEV, V16, P1339, DOI 10.1101/gad.987602; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plaschka C, 2016, NATURE, V533, P353, DOI 10.1038/nature17990; Plaschka C, 2015, NATURE, V518, P376, DOI 10.1038/nature14229; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; Robinson PJ, 2016, CELL, V166, P1411, DOI 10.1016/j.cell.2016.08.050; Robinson PJ, 2015, ELIFE, V4, DOI 10.7554/eLife.08719; Robinson PJJ, 2012, P NATL ACAD SCI USA, V109, P17931, DOI 10.1073/pnas.1215241109; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Spahr H, 2009, P NATL ACAD SCI USA, V106, P9185, DOI 10.1073/pnas.0903361106; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Svejstrup JQ, 1997, P NATL ACAD SCI USA, V94, P6075, DOI 10.1073/pnas.94.12.6075; Taatjes DJ, 2004, NAT STRUCT MOL BIOL, V11, P664, DOI 10.1038/nsmb789; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Takagi Y, 2005, J BIOL CHEM, V280, P31200, DOI 10.1074/jbc.C500150200; Takahashi H, 2009, GENES CELLS, V14, P53, DOI 10.1111/j.1365-2443.2008.01250.x; Tsai KL, 2014, CELL, V157, P1430, DOI 10.1016/j.cell.2014.05.015; Tsai KL, 2013, NAT STRUCT MOL BIOL, V20, P611, DOI 10.1038/nsmb.2549; Wang XJ, 2014, CELL RES, V24, P796, DOI 10.1038/cr.2014.64; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	60	91	93	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2017	544	7649					196	+		10.1038/nature21393	http://dx.doi.org/10.1038/nature21393			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6EK	28241144	Green Accepted			2022-12-28	WOS:000398897900030
J	Sie, EJ; Lui, CH; Lee, YH; Fu, L; Kong, J; Gedik, N				Sie, Edbert J.; Lui, Chun Hung; Lee, Yi-Hsien; Fu, Liang; Kong, Jing; Gedik, Nuh			Large, valley-exclusive Bloch-Siegert shift in monolayer WS2	SCIENCE			English	Article							MOS2; VALLEYTRONICS; POLARIZATION	Coherent interaction with off-resonance light can be used to shift the energy levels of atoms, molecules, and solids. The dominant effect is the optical Stark shift, but there is an additional contribution from the so-called Bloch-Siegert shift that has eluded direct and exclusive observation in solids. We observed an exceptionally large Bloch-Siegert shift in monolayer tungsten disulfide (WS2) under infrared optical driving. By controlling the light helicity, we could confine the Bloch-Siegert shift to occur only at one valley, and the optical Stark shift at the other valley, because the two effects obey opposite selection rules at different valleys. Such a large and valley-exclusive Bloch-Siegert shift allows for enhanced control over the valleytronic properties of two-dimensional materials.	[Sie, Edbert J.; Fu, Liang; Gedik, Nuh] MIT, Dept Phys, Cambridge, MA 02139 USA; [Lui, Chun Hung] Univ Calif Riverside, Dept Phys & Astron, Riverside, CA 92521 USA; [Lee, Yi-Hsien] Natl Tsing Hua Univ, Mat Sci & Engn, Hsinchu 30013, Taiwan; [Kong, Jing] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California Riverside; National Tsing Hua University; Massachusetts Institute of Technology (MIT)	Gedik, N (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	gedik@mit.edu	Lee, Yi-Hsien/AAA-6972-2019	Sie, Edbert Jarvis/0000-0003-3477-6459; /0000-0002-6394-4987; Lui, Chun Hung/0000-0002-1470-328X	U.S. Department of Energy, BES DMSE; Gordon and Betty Moore Foundation's EPiQS Initiative [GBMF4540]; NSF Science and Technology Center for Integrated Quantum Materials [DMR-1231319]; Asian Office of Aerospace Research and Development/Office of Naval Research Global grant [FA2386-16-1-4009]; Ministry of Science and Technology, Taiwan [105-2112-M-007-032-MY3, 105-2119-M-007-027]	U.S. Department of Energy, BES DMSE(United States Department of Energy (DOE)); Gordon and Betty Moore Foundation's EPiQS Initiative; NSF Science and Technology Center for Integrated Quantum Materials(National Science Foundation (NSF)); Asian Office of Aerospace Research and Development/Office of Naval Research Global grant; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	We thank Q. Ma and Y. Bie for the assistance during absorption measurement. N.G. and E.J.S. thank M. Zwierlein and J. Kono for the stimulating discussions. N.G. and E.J.S. acknowledge support from the U.S. Department of Energy, BES DMSE (experimental setup and data acquisition), and from the Gordon and Betty Moore Foundation's EPiQS Initiative grant GBMF4540 (data analysis and manuscript writing); J.K. and L.F. acknowledge support from NSF Science and Technology Center for Integrated Quantum Materials grant DMR-1231319 (material growth and theory); Y.-H.L. acknowledges support from the Asian Office of Aerospace Research and Development/Office of Naval Research Global grant FA2386-16-1-4009 and Ministry of Science and Technology, Taiwan, grants 105-2112-M-007-032-MY3 and 105-2119-M-007-027 (material growth).	AUTLER SH, 1955, PHYS REV, V100, P703, DOI 10.1103/PhysRev.100.703; BETHE HA, 1947, PHYS REV, V72, P339, DOI 10.1103/PhysRev.72.339; Bloch F, 1940, PHYS REV, V57, P522, DOI 10.1103/PhysRev.57.522; Cao T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1882; Chernikov A, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.076802; CRISP MD, 1991, PHYS REV A, V43, P2430, DOI 10.1103/PhysRevA.43.2430; Forn-Diaz P, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.237001; Grimm R, 2000, ADV ATOM MOL OPT PHY, V42, P95, DOI 10.1016/S1049-250X(08)60186-X; Grynberg G, 1998, ATOM PHOTON INTERACT; Kim J, 2014, SCIENCE, V346, P1205, DOI 10.1126/science.1258122; Kundu A, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.016802; LAMB WE, 1947, PHYS REV, V72, P241, DOI 10.1103/PhysRev.72.241; Liu XZ, 2015, NAT PHOTONICS, V9, P30, DOI [10.1038/nphoton.2014.304, 10.1038/NPHOTON.2014.304]; Mai C, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.041414; Mai C, 2014, NANO LETT, V14, P202, DOI 10.1021/nl403742j; Mak KF, 2014, SCIENCE, V344, P1489, DOI 10.1126/science.1250140; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Mak KF, 2012, NAT NANOTECHNOL, V7, P494, DOI [10.1038/nnano.2012.96, 10.1038/NNANO.2012.96]; Niemczyk T, 2010, NAT PHYS, V6, P772, DOI 10.1038/NPHYS1730; Rivera P, 2016, SCIENCE, V351, P688, DOI 10.1126/science.aac7820; Schaibley JR, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.55; SHIRLEY JH, 1965, PHYS REV, V138, pB979, DOI 10.1103/PhysRev.138.B979; Sie EJ, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.125417; Sie EJ, 2015, NAT MATER, V14, P290, DOI 10.1038/nmat4156; Tuorila J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.257003; Wu SF, 2013, NAT PHYS, V9, P149, DOI 10.1038/nphys2524; Xiao D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196802; Xu XD, 2014, NAT PHYS, V10, P343, DOI [10.1038/NPHYS2942, 10.1038/nphys2942]; Zeng HL, 2012, NAT NANOTECHNOL, V7, P490, DOI [10.1038/nnano.2012.95, 10.1038/NNANO.2012.95]	29	74	75	2	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI		1066	1069		10.1126/science.aal2241	http://dx.doi.org/10.1126/science.aal2241			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9VY	28280203	Green Submitted			2022-12-28	WOS:000396348900042
J	Boire, A; Zou, YL; Shieh, J; Macalinao, DG; Pentsova, E; Massague, J				Boire, Adrienne; Zou, Yilong; Shieh, Jason; Macalinao, Danilo G.; Pentsova, Elena; Massague, Joan			Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis	CELL			English	Article							BREAST-CANCER METASTASIS; ANAPHYLATOXIN C3A; BRAIN-METASTASIS; CHOROID-PLEXUS; MOLECULAR-MECHANISMS; BALANCED VIEW; TUMOR; RECEPTOR; CARCINOMATOSIS; CELLS	We molecularly dissected leptomeningeal metastasis, or spread of cancer to the cerebrospinal fluid (CSF), which is a frequent and fatal condition mediated by unknown mechanisms. We selected lung and breast cancer cell lines for the ability to infiltrate and grow in CSF, a remarkably acellular, mitogenpoor metastasis microenvironment. Complement component 3 (C3) was upregulated in four leptomeningeal metastatic models and proved necessary for cancer growth within the leptomeningeal space. In human disease, cancer cells within the CSF produced C3 in correlation with clinical course. C3 expression in primary tumors was predictive of leptomeningeal relapse. Mechanistically, we found that cancer-cell-derived C3 activates the C3a receptor in the choroid plexus epithelium to disrupt the blood-CSF barrier. This effect allows plasma components, including amphiregulin, and other mitogens to enter the CSF and promote cancer cell growth. Pharmacologic interference with C3 signaling proved therapeutically beneficial in suppressing leptomeningeal metastasis in these preclinical models.	[Boire, Adrienne; Pentsova, Elena] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10065 USA; [Boire, Adrienne; Zou, Yilong; Shieh, Jason; Macalinao, Danilo G.; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	j-massague@ski.mskcc.org	Boire, Adrienne/AAJ-9352-2021; Boire, Adrienne/AAA-3578-2022	Boire, Adrienne/0000-0002-9029-1248; Boire, Adrienne/0000-0002-9029-1248; Macalinao, Danilo/0000-0002-3188-2611; Massague, Joan/0000-0001-9324-8408; Zou, Yilong/0000-0001-8198-6067	NIH [P01-CA129243, U54-163167, P30 CA008748]; DOD [W81XWH-12-0074]; Alan and Sandra Gerry Metastasis Research Initiative; MSKCC Clinical Scholars Training Program; Solomon R. and Rebecca D. Baker Foundation; NATIONAL CANCER INSTITUTE [P30CA008748, U54CA163167, P01CA129243] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Alan and Sandra Gerry Metastasis Research Initiative; MSKCC Clinical Scholars Training Program; Solomon R. and Rebecca D. Baker Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We wish to thank J. Posner for insightful discussions, historical perspective, and assistance with experimental design. We also wish to thank L. DeAngelis and members of the Massague laboratory for helpful discussion. This work was supported by NIH grants (P01-CA129243, U54-163167, and P30 CA008748), a DOD Innovator award (W81XWH-12-0074), and the Alan and Sandra Gerry Metastasis Research Initiative (to J.M.), as well as the MSKCC Clinical Scholars Training Program and the Solomon R. and Rebecca D. Baker Foundation (to A.B.).	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Addison CL, 2010, J CLIN ONCOL, V28, P5247, DOI 10.1200/JCO.2010.31.0805; Ames RS, 1996, J BIOL CHEM, V271, P20231, DOI 10.1074/jbc.271.34.20231; Ames RS, 2001, J IMMUNOL, V166, P6341, DOI 10.4049/jimmunol.166.10.6341; An YJ, 2015, INT J CANCER, V136, P162, DOI 10.1002/ijc.28949; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bajic G, 2015, EMBO J, V34, P2735, DOI 10.15252/embj.201591881; Bao LH, 2011, KIDNEY INT, V80, P524, DOI 10.1038/ki.2011.158; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Bowman RL, 2016, CELL REP, V17, P2445, DOI 10.1016/j.celrep.2016.10.052; BOYLE R, 1980, POSTGRAD MED J, V56, P149, DOI 10.1136/pgmj.56.653.149; Brower JV, 2016, J CLIN NEUROSCI, V27, P130, DOI 10.1016/j.jocn.2015.11.012; Chen Q, 2016, NATURE, V533, P493, DOI 10.1038/nature18268; Chen Q, 2011, CANCER CELL, V20, P538, DOI 10.1016/j.ccr.2011.08.025; Clarke JL, 2010, NEUROLOGY, V74, P1449, DOI 10.1212/WNL.0b013e3181dc1a69; Cunningham KE, 2012, ANN NY ACAD SCI, V1258, P34, DOI 10.1111/j.1749-6632.2012.06526.x; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drouin SM, 2001, J IMMUNOL, V166, P2025, DOI 10.4049/jimmunol.166.3.2025; Floege J, 2016, LANCET, V387, P2036, DOI 10.1016/S0140-6736(16)00272-5; Glover RL, 2014, NEUROLOGY, V82, pE183, DOI 10.1212/WNL.0000000000000455; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Humbles AA, 2000, NATURE, V406, P998, DOI 10.1038/35023175; Hutamekalin P, 2010, J PHARMACOL SCI, V112, P56, DOI 10.1254/jphs.09180FP; Kakonen SM, 2002, J BIOL CHEM, V277, P24571, DOI 10.1074/jbc.M202561200; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kesari S, 2003, NEUROL CLIN, V21, P25, DOI 10.1016/S0733-8619(02)00032-4; Khan MA, 2014, RESP MED, V108, P543, DOI 10.1016/j.rmed.2014.01.005; KOKKORIS CP, 1983, CANCER, V51, P154, DOI 10.1002/1097-0142(19830101)51:1<154::AID-CNCR2820510130>3.0.CO;2-K; Lee TH, 2003, J BIOL CHEM, V278, P5277, DOI 10.1074/jbc.M210063200; Lemos-Gonzalez Y, 2007, BRIT J CANCER, V96, P1569, DOI 10.1038/sj.bjc.6603770; Li C, 2011, CYTOKINE, V56, P435, DOI 10.1016/j.cyto.2011.07.021; Lippoldt A, 2000, BRAIN RES, V854, P197, DOI 10.1016/S0006-8993(99)02355-0; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Massague J, 2016, NATURE, V529, P298, DOI 10.1038/nature17038; Matter K, 2003, METHODS, V30, P228, DOI 10.1016/S1046-2023(03)00029-X; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262; Mizutani N, 2009, J IMMUNOL, V183, P4039, DOI 10.4049/jimmunol.0901468; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; OGRODOWSKI JL, 1991, KIDNEY INT, V40, P1141, DOI 10.1038/ki.1991.326; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Reijneveld JC, 1999, J NEURO-ONCOL, V42, P137, DOI 10.1023/A:1006237917632; Ricklin D, 2016, NAT REV NEPHROL, V12, P383, DOI 10.1038/nrneph.2016.70; Schwartz H, 2016, CANCER RES, V76, P4359, DOI 10.1158/0008-5472.CAN-16-0485; Scott BJ, 2013, AM J CANCER RES, V3, P117; Sevenich L, 2014, NAT CELL BIOL, V16, P876, DOI 10.1038/ncb3011; Spector R, 2006, PHARM RES-DORDR, V23, P2515, DOI 10.1007/s11095-006-9091-5; Spector R, 2015, EXP NEUROL, V273, P57, DOI 10.1016/j.expneurol.2015.07.027; Spector R, 2015, EXP NEUROL, V267, P78, DOI 10.1016/j.expneurol.2015.02.032; Svatonova J, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/495402; Tang ZY, 2009, J AM SOC NEPHROL, V20, P593, DOI 10.1681/ASN.2008040434; USHIO Y, 1977, J NEUROPATH EXP NEUR, V36, P228, DOI 10.1097/00005072-197703000-00003; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Waki F, 2009, J NEURO-ONCOL, V93, P205, DOI 10.1007/s11060-008-9758-3; Walbert T, 2010, FUTURE ONCOL, V6, P287, DOI 10.2217/FON.09.167; Waning DL, 2014, CLIN CANCER RES, V20, P3071, DOI 10.1158/1078-0432.CCR-13-1590; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; Zhang L, 2015, NATURE, V527, P100, DOI 10.1038/nature15376	60	145	153	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2017	168	6					1101	+		10.1016/j.cell.2017.02.025	http://dx.doi.org/10.1016/j.cell.2017.02.025			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8ZF	28283064	Green Accepted, Bronze			2022-12-28	WOS:000396287900017
J	Choi, S; Choi, J; Landig, R; Kucsko, G; Zhou, HY; Isoya, J; Jelezko, F; Onoda, S; Sumiya, H; Khemani, V; von Keyserlingk, C; Yao, NY; Demler, E; Lukin, MD				Choi, Soonwon; Choi, Joonhee; Landig, Renate; Kucsko, Georg; Zhou, Hengyun; Isoya, Junichi; Jelezko, Fedor; Onoda, Shinobu; Sumiya, Hitoshi; Khemani, Vedika; von Keyserlingk, Curt; Yao, Norman Y.; Demler, Eugene; Lukin, Mikhail D.			Observation of discrete time-crystalline order in a disordered dipolar many-body system	NATURE			English	Article							LOCALIZATION; THERMALIZATION; ELECTRON; DIAMOND; SPIN	Understanding quantum dynamics away from equilibrium is an outstanding challenge in the modern physical sciences. Out-of-equilibrium systems can display a rich variety of phenomena, including self-organized synchronization and dynamical phase transitions(1,2). More recently, advances in the controlled manipulation of isolated many-body systems have enabled detailed studies of non-equilibrium phases in strongly interacting quantum matter(3-6); for example, the interplay between periodic driving, disorder and strong interactions has been predicted to result in exotic 'time-crystalline' phases(7), in which a system exhibits temporal correlations at integer multiples of the fundamental driving period, breaking the discrete time-translational symmetry of the underlying drive(8-12). Here we report the experimental observation of such discrete time-crystalline order in a driven, disordered ensemble of about one million dipolar spin impurities in diamond at room temperature(13-15). We observe long-lived temporal correlations, experimentally identify the phase boundary and find that the temporal order is protected by strong interactions. This order is remarkably stable to perturbations, even in the presence of slow thermalization(16,17). Our work opens the door to exploring dynamical phases of matter and controlling interacting, disordered many-body systems(18-20).	[Choi, Soonwon; Choi, Joonhee; Landig, Renate; Kucsko, Georg; Zhou, Hengyun; Khemani, Vedika; Demler, Eugene; Lukin, Mikhail D.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Choi, Joonhee] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Isoya, Junichi] Univ Tsukuba, Res Ctr Knowledge Commun, Tsukuba, Ibaraki 3058550, Japan; [Jelezko, Fedor] Univ Ulm, Inst Quantenopt, D-89081 Ulm, Germany; [Jelezko, Fedor] Univ Ulm, Ctr Integrated Quantum Sci & Technol, D-89081 Ulm, Germany; [Onoda, Shinobu] Takasaki Adv Radiat Res Inst, Natl Inst Quantum & Radiol Sci & Technol, 1233 Watanuki, Takasaki, Gunma 3701292, Japan; [Sumiya, Hitoshi] Sumitomo Elect Ind Ltd, Itami, Hyogo 6640016, Japan; [von Keyserlingk, Curt] Princeton Univ, Princeton Ctr Theoret Sci, Princeton, NJ 08544 USA; [Yao, Norman Y.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	Harvard University; Harvard University; University of Tsukuba; Ulm University; Ulm University; National Institutes for Quantum Science & Technology; Sumitomo Electric Industries; Princeton University; University of California System; University of California Berkeley	Lukin, MD (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	lukin@physics.harvard.edu	Demler, Eugene/ABG-1933-2021; Yao, Norman/A-3929-2009	Demler, Eugene/0000-0002-2499-632X; Choi, Soonwon/0000-0002-1247-062X; Kucsko, Georg/0000-0002-4189-3154; Yao, Norman/0000-0003-0194-7266; Sumiya, Hitoshi/0000-0002-0790-3216; von Keyserlingk, Curt/0000-0001-6235-6430	CUA; NSSEFF; ARO MURI; Moore Foundation; Harvard Society of Fellows; Princeton Center for Theoretical Science; Miller Institute for Basic Research in Science; Kwanjeong Educational Foundation; Samsung Fellowship; Purcell Fellowship; NSF [PHY-1506284, DMR-1308435]; Japan Society for the Promotion of Science KAKENHI [26246001]; LDRD Program of LBNL under US DOE [DE-AC02-05CH11231]; EU (FP7, Horizons, ERC); DFG; SNF; Volkswagenstiftung; BMBF; Direct For Mathematical & Physical Scien [1308435, 1506284] Funding Source: National Science Foundation	CUA; NSSEFF; ARO MURI(MURI); Moore Foundation(Gordon and Betty Moore Foundation); Harvard Society of Fellows; Princeton Center for Theoretical Science; Miller Institute for Basic Research in Science; Kwanjeong Educational Foundation; Samsung Fellowship(Samsung); Purcell Fellowship; NSF(National Science Foundation (NSF)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); LDRD Program of LBNL under US DOE(United States Department of Energy (DOE)); EU (FP7, Horizons, ERC); DFG(German Research Foundation (DFG)); SNF; Volkswagenstiftung(Volkswagen); BMBF(Federal Ministry of Education & Research (BMBF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank D. A. Huse, S. L. Sondhi, A. Vishwanath and M. Zaletel for discussions, and N. P. De Leon and P. C. Maurer for fabricating the diamond nanobeam and experimental help. This work was supported in part by CUA, NSSEFF, ARO MURI, Moore Foundation, Harvard Society of Fellows, Princeton Center for Theoretical Science, Miller Institute for Basic Research in Science, Kwanjeong Educational Foundation, Samsung Fellowship, Purcell Fellowship, NSF PHY-1506284, NSF DMR-1308435, Japan Society for the Promotion of Science KAKENHI (No. 26246001), LDRD Program of LBNL under US DOE Contract No. DE-AC02-05CH11231, EU (FP7, Horizons 2020, ERC), DFG, SNF, Volkswagenstiftung and BMBF.	Abanin DA, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.256803; ADLER R, 1946, P IRE, V34, P351, DOI 10.1109/JRPROC.1946.229930; ANDERSON PW, 1958, PHYS REV, V109, P1492, DOI 10.1103/PhysRev.109.1492; [Anonymous], 2016, PREPRINT; Basko DM, 2006, ANN PHYS-NEW YORK, V321, P1126, DOI 10.1016/j.aop.2005.11.014; Cappellaro P, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.032311; Childress L, 2006, SCIENCE, V314, P281, DOI 10.1126/science.1131871; Choi J., PHYS REV LE IN PRESS; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; de Lange G, 2010, SCIENCE, V330, P60, DOI 10.1126/science.1192739; Doherty MW, 2013, PHYS REP, V528, P1, DOI 10.1016/j.physrep.2013.02.001; Else DV, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.090402; Kaufman AM, 2016, SCIENCE, V353, P794, DOI 10.1126/science.aaf6725; Khemani V, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.250401; Kucsko G., 2016, PREPRINT; Langen T, 2015, SCIENCE, V348, P207, DOI 10.1126/science.1257026; LI TY, 1975, AM MATH MON, V82, P985, DOI 10.2307/2318254; Nandkishore R, 2015, ANNU REV CONDEN MA P, V6, P15, DOI 10.1146/annurev-conmatphys-031214-014726; Rey AM, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.052305; Sacha K, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.033617; Schreiber M, 2015, SCIENCE, V349, P842, DOI 10.1126/science.aaa7432; Smith J, 2016, NAT PHYS, V12, P907, DOI [10.1038/nphys3783, 10.1038/NPHYS3783]; von Keyserlingk CW, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.085112; WAUGH JS, 1968, PHYS REV LETT, V20, P180, DOI 10.1103/PhysRevLett.20.180; Wilczek F, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.160401; Yao NY, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.030401; Yao NY, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.243002	31	613	616	10	165	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2017	543	7644					221	+		10.1038/nature21426	http://dx.doi.org/10.1038/nature21426			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0GQ	28277511	Green Submitted, Green Accepted			2022-12-28	WOS:000395688700034
J	Emmons, KM; Colditz, GA				Emmons, Karen M.; Colditz, Graham A.			Realizing the Potential of Cancer Prevention - The Role of Implementation Science	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							AREA VACCINATION COVERAGE; UNITED-STATES; BREAST-CANCER; CERVICAL ABNORMALITIES; CONSOLIDATED FRAMEWORK; RISK REDUCTION; SMOKING; HEALTH; PROGRAM; CARE		[Emmons, Karen M.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Colditz, Graham A.] Washington Univ, Sch Med, Div Publ Hlth Sci, 660 S Euclid Ave, St Louis, MO 63110 USA	Harvard University; Harvard T.H. Chan School of Public Health; Washington University (WUSTL)	Colditz, GA (corresponding author), Washington Univ, Sch Med, Div Publ Hlth Sci, 660 S Euclid Ave, St Louis, MO 63110 USA.	colditzg@wudosis.wustl.edu	Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291	NCI NIH HHS [P30 CA091842] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altice CK, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw205; [Anonymous], 1986, Br Med J (Clin Res Ed), V293, P659; Bevers TB, 2015, J NATL COMPR CANC NE, V13, P880, DOI 10.6004/jnccn.2015.0105; Boonn A., 2016, STATE CIGARETTE EXCI; Brotherton JML, 2011, LANCET, V377, P2085, DOI 10.1016/S0140-6736(11)60551-5; Brownson RC, 2006, ANNU REV PUBL HEALTH, V27, P341, DOI 10.1146/annurev.publhealth.27.021405.102137; Byers T, 2016, CA-CANCER J CLIN, V66, P359, DOI 10.3322/caac.21348; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Centers for Disease Control and Prevention, 2016, YOUTH RISK BEH SURV; Centers for Disease Control and Prevention, COPD; Centers for Disease Control and Prevention, 2016, CDC FACT SHEET VIR H; Chaloupka FJ, 2012, TOB CONTROL, V21, P172, DOI 10.1136/tobaccocontrol-2011-050417; Chiang CJ, 2013, JAMA-J AM MED ASSOC, V310, P974, DOI 10.1001/jama.2013.276701; Colditz GA, 1997, CANCER CAUSE CONTROL, V8, pS1; Colditz GA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003218; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Department of Health and Human Services, 2014, HLTH CONSMOK 50 YE; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Emmons K M, 1993, Am J Health Promot, V8, P43; Emmons KM, 2000, HEALTH EDUC BEHAV, V27, P483, DOI 10.1177/109019810002700410; Fiore MC, 2008, JAMA-J AM MED ASSOC, V299, P2083, DOI 10.1001/jama.299.17.2083; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Gertig DM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-227; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Hill HA, 2015, MMWR-MORBID MORTAL W, V64, P889, DOI 10.15585/mmwr.mm6433a1; Himelhoch S, 2003, AM J PSYCHIAT, V160, P2228, DOI 10.1176/appi.ajp.160.12.2228; Institute of Medicine, 2015, SPREAD SCAL SUST POP; Koh HK, 2012, JAMA-J AM MED ASSOC, V308, P767, DOI 10.1001/jama.2012.9741; Krauth D, 2015, TOB INDUC DIS, V13, DOI 10.1186/s12971-015-0059-2; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Liang ST, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0477-4; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; Martinez-Gutierrez J, 2013, J IMMIGR MINOR HEALT, V15, P993, DOI 10.1007/s10903-012-9701-8; Martino S, 2004, J NATL CANCER I, V96, P1751, DOI 10.1093/jnci/djh319; McAfee T, 2015, NEW ENGL J MED, V372, P5, DOI 10.1056/NEJMp1411437; Moore LV, 2015, MMWR-MORBID MORTAL W, V64, P709; Rabin BA, 2010, AM J PREV MED, V38, P443, DOI 10.1016/j.amepre.2009.12.035; Reagan-Steiner S, 2016, MMWR-MORBID MORTAL W, V65, P850, DOI 10.15585/mmwr.mm6533a4; Rebbeck TR, 2009, JNCI-J NATL CANCER I, V101, P80, DOI 10.1093/jnci/djn442; Richard P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029665; Shi YY, 2015, PSYCHIAT SERV, V66, P610, DOI 10.1176/appi.ps.201400328; Ward B.W., 2016, EARLY RELEASE SELECT; Warnecke RB, 2008, AM J PUBLIC HEALTH, V98, P1608, DOI 10.2105/AJPH.2006.102525; Willett WC, 1996, SCI AM, V275, P88, DOI 10.1038/scientificamerican0996-88; Xu X, 2015, AM J PREV MED, V48, P326, DOI 10.1016/j.amepre.2014.10.012	45	59	62	2	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2017	376	10					986	990		10.1056/NEJMsb1609101	http://dx.doi.org/10.1056/NEJMsb1609101			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9JA	28273020	Green Accepted, Green Published			2022-12-28	WOS:000395626500018
J	Fogerty, RL; Greenwald, JL; McDermott, S; Lin, AE; Stone, JR				Fogerty, Robert L.; Greenwald, Jeffrey L.; McDermott, Shaunagh; Lin, Angela E.; Stone, James R.			Case 7-2017: A 73-Year-Old Man with Confusion and Recurrent Epistaxis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; WEBER-RENDU-SYNDROME; VASCULAR MALFORMATIONS; LIVER-DISEASE; DIAGNOSIS		[Fogerty, Robert L.] Yale Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Greenwald, Jeffrey L.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [McDermott, Shaunagh] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Stone, James R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Greenwald, Jeffrey L.] Harvard Med Sch, Dept Med, Boston, MA USA; [McDermott, Shaunagh] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Lin, Angela E.] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Stone, James R.] Harvard Med Sch, Dept Pathol, Boston, MA USA	Yale University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Fogerty, RL (corresponding author), Yale Sch Med, Dept Internal Med, New Haven, CT 06510 USA.			Fogerty, Robert/0000-0001-9119-7707	GlaxoSmithKline; Alnylam Pharmaceuticals; USP Labs	GlaxoSmithKline(GlaxoSmithKline); Alnylam Pharmaceuticals; USP Labs	Dr. Stone reports receiving consulting fees from GlaxoSmithKline, lecture fees from Alnylam Pharmaceuticals, and fees from USP Labs for expert testimony in a case regarding dimethylamylamine toxicity. No other potential conflict of interest relevant to this article was reported.	Begbie ME, 2003, POSTGRAD MED J, V79, P18, DOI 10.1136/pmj.79.927.18; Bernhardt BA, 2012, GENET MED, V14, P604, DOI 10.1038/gim.2011.56; Byard RW, 2001, J FORENSIC SCI, V46, P698; Caseiro MM, 2012, NEW ENGL J MED, V366, pE13, DOI 10.1056/NEJMicm1109272; Chowdhry Vivek, 2015, J Anaesthesiol Clin Pharmacol, V31, P410, DOI 10.4103/0970-9185.161686; Dupuis-Girod S, 2014, MABS-AUSTIN, V6, P793, DOI 10.4161/mabs.28025; Dupuis-Girod S, 2012, JAMA-J AM MED ASSOC, V307, P948, DOI 10.1001/jama.2012.250; Faughnan ME, 2011, J MED GENET, V48, P73, DOI 10.1136/jmg.2009.069013; Garcia-Tsao G, 2000, NEW ENGL J MED, V343, P931, DOI 10.1056/NEJM200009283431305; Ginon I, 2013, EUR J INTERN MED, V24, pE35, DOI 10.1016/j.ejim.2012.12.013; Ha D, 2012, BMJ CASE REP, V2012; KITZMAN DW, 1988, MAYO CLIN PROC, V63, P137, DOI 10.1016/S0025-6196(12)64946-5; Larson AM, 2003, J CLIN GASTROENTEROL, V36, P149, DOI 10.1097/00004836-200302000-00013; McCormack CA, 2016, FORENSIC SCI MED PAT, V12, P139, DOI 10.1007/s12024-016-9773-1; McDonald J, 2011, GENET MED, V13, P607, DOI 10.1097/GIM.0b013e3182136d32; Nicoleau A, 1999, NEW ENGL J MED, V340, P1800, DOI 10.1056/NEJM199906103402305; Samol A, 2012, CARDIOVASC PATHOL, V21, P515, DOI 10.1016/j.carpath.2012.02.004; Sawabe M, 2001, ARCH PATHOL LAB MED, V125, P1219; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Trembath RC, 2001, NEW ENGL J MED, V345, P325, DOI 10.1056/NEJM200108023450503; Whitehead KJ, 2016, JAMA-J AM MED ASSOC, V316, P943, DOI 10.1001/jama.2016.11724	21	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2017	376	10					972	980		10.1056/NEJMcpc1613462	http://dx.doi.org/10.1056/NEJMcpc1613462			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JA	28273029				2022-12-28	WOS:000395626500015
J	Lim, AI; Li, Y; Lopez-Lastra, S; Stadhouders, R; Paul, F; Casrouge, A; Serafini, N; Puel, A; Bustamante, J; Surace, L; Masse-Ranson, G; David, E; Strick-Marchand, H; Le Bourhis, L; Cocchi, R; Topazio, D; Graziano, P; Muscarella, LA; Rogge, L; Norel, X; Sallenave, JM; Allez, M; Graf, T; Hendriks, RW; Casanova, JL; Amit, I; Yssel, H; Di Santo, JP				Lim, Ai Ing; Li, Yan; Lopez-Lastra, Silvia; Stadhouders, Ralph; Paul, Franziska; Casrouge, Armanda; Serafini, Nicolas; Puel, Anne; Bustamante, Jacinta; Surace, Laura; Masse-Ranson, Guillemette; David, Eyal; Strick-Marchand, Helene; Le Bourhis, Lionel; Cocchi, Roberto; Topazio, Davide; Graziano, Paolo; Muscarella, Lucia Anna; Rogge, Lars; Norel, Xavier; Sallenave, Jean-Michel; Allez, Matthieu; Graf, Thomas; Hendriks, Rudi W.; Casanova, Jean-Laurent; Amit, Ido; Yssel, Hans; Di Santo, James P.			Systemic Human ILC Precursors Provide a Substrate for Tissue ILC Differentiation	CELL			English	Article							INNATE LYMPHOID-CELLS; HEMATOPOIETIC STEM-CELLS; TRANSCRIPTION FACTOR; FUNCTIONAL PLASTICITY; B-CELL; PROGENITOR; FETAL; EXPRESSION; HOMEOSTASIS; GENERATION	Innate lymphoid cells (ILCs) represent innate versions of T helper and cytotoxic T cells that differentiate from committed ILC precursors (ILCPs). How ILCPs give rise to mature tissue-resident ILCs remains unclear. Here, we identify circulating and tissue ILCPs in humans that fail to express the transcription factors and cytokine outputs of mature ILCs but have these signature loci in an epigenetically poised configuration. Human ILCPs robustly generate all ILC subsets in vitro and in vivo. While human ILCPs express low levels of retinoic acid receptor (RAR)-related orphan receptor C (RORC) transcripts, these cells are found in RORC-deficient patients and retain potential forEOMES(+) natural killer (NK) cells, interferon gamma-positive (IFN-gamma(+)) ILC1s, interleukin (IL)-13(+) ILC2s, and for IL-22(+), but not for IL-17A(+) ILC3s. Our results support a model of tissue ILC differentiation ("ILC-poiesis''), whereby diverse ILC subsets are generated in situ from systemically distributed ILCPs in response to local environmental signals.	[Lim, Ai Ing; Li, Yan; Lopez-Lastra, Silvia; Casrouge, Armanda; Serafini, Nicolas; Surace, Laura; Masse-Ranson, Guillemette; Strick-Marchand, Helene; Di Santo, James P.] Inst Pasteur, Innate Immun Unit, F-75724 Paris, France; [Lim, Ai Ing; Li, Yan; Lopez-Lastra, Silvia; Casrouge, Armanda; Serafini, Nicolas; Surace, Laura; Masse-Ranson, Guillemette; Strick-Marchand, Helene; Di Santo, James P.] INSERM, U1223, F-75015 Paris, France; [Lim, Ai Ing; Sallenave, Jean-Michel] Univ Paris Diderot, Sorbonne Paris Cite, F-75205 Paris, France; [Lopez-Lastra, Silvia] Univ Paris 11, Paris Saclay, F-91405 Orsay, France; [Stadhouders, Ralph; Graf, Thomas] Barcelona Inst Sci & Technol, Ctr Genom Regulat, Barcelona 08003, Spain; [Paul, Franziska; David, Eyal; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Puel, Anne; Bustamante, Jacinta; Casanova, Jean-Laurent] INSERM, U1163, Necker Branch, Lab Human Genet Infect Dis, F-75015 Paris, France; [Puel, Anne; Bustamante, Jacinta; Casanova, Jean-Laurent] Paris Descartes Univ, Imagine Inst, F-75015 Paris, France; [Le Bourhis, Lionel; Allez, Matthieu] Hop St Louis, INSERM, U1160, Inst Univ Hematol, F-75010 Paris, France; [Cocchi, Roberto; Topazio, Davide; Graziano, Paolo; Muscarella, Lucia Anna] Sci Inst Res & Hlth Care Casa Sollievo della Soff, I-71013 San Giovanni Rotondo, Italy; [Rogge, Lars] Inst Pasteur, Immunoregulat Unit, F-75724 Paris, France; [Norel, Xavier] CHU Xavier Bichat, LVTS, INSERM, U1148, F-75877 Paris, France; [Sallenave, Jean-Michel] Univ Sorbonne Paris Cite, Univ Paris Diderot, Fac Med Site Bichat, INSERM,U1152, F-75018 Paris, France; [Allez, Matthieu] Hop St Louis, AP HP, Gastroenterol Dept, F-75010 Paris, France; [Hendriks, Rudi W.] Erasmus MC, Dept Pulm Med, NL-3000 CA Rotterdam, Netherlands; [Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA; [Casanova, Jean-Laurent] Howard Hughes Med Inst, New York, NY 10065 USA; [Casanova, Jean-Laurent] Necker Hosp Sick Children, Pediat Hematol Immunol Unit, F-75015 Paris, France; [Yssel, Hans] Ctr Immunol & Malad Infect, INSERM, U1135, F-75013 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Weizmann Institute of Science; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; IRCCS Casa Sollievo Della Sofferenza; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Erasmus University Rotterdam; Erasmus MC; Rockefeller University; Howard Hughes Medical Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Di Santo, JP (corresponding author), Inst Pasteur, Innate Immun Unit, F-75724 Paris, France.; Di Santo, JP (corresponding author), INSERM, U1223, F-75015 Paris, France.	james.di-santo@pasteur.fr	Graziano, Paolo/AAC-9802-2022; Bustamante, Jacinta/H-7877-2017; Li, Yan/Z-3402-2019; Strick-Marchand, Helene/M-6525-2014; Puel, Anne/H-7305-2017; Casanova, Jean-Laurent/I-3418-2017; SERAFINI, nicolas/S-5675-2019; Muscarella, Lucia Anna/K-5979-2016; Stadhouders, Ralph/J-8663-2015; Norel, Xavier/C-5978-2011; Yssel, Hans/C-6406-2009; Yssel, Hans/AFV-2907-2022; Di Santo, James P/M-4298-2014; Rogge, Lars/GYJ-6142-2022; SALLENAVE, Jean-Michel/J-3746-2017	Graziano, Paolo/0000-0001-7066-7896; Bustamante, Jacinta/0000-0002-3439-2482; Li, Yan/0000-0001-7612-3953; Puel, Anne/0000-0003-2603-0323; SERAFINI, nicolas/0000-0002-7440-4353; Muscarella, Lucia Anna/0000-0002-1866-8151; Stadhouders, Ralph/0000-0002-1060-5607; Norel, Xavier/0000-0003-0734-3359; Yssel, Hans/0000-0001-7454-1836; Yssel, Hans/0000-0001-7454-1836; Di Santo, James P/0000-0002-7146-1862; SALLENAVE, Jean-Michel/0000-0002-8595-6970; surace, laura/0000-0001-8152-0611; Lopez Lastra, Silvia/0000-0003-2391-6858; Strick-Marchand, Helene/0000-0002-0519-214X; Hendriks, Rudi/0000-0003-2291-0382; Paul, Franziska/0000-0003-0344-6764; Allez, Matthieu/0000-0002-2012-7522; LIM, AI ING/0000-0001-8834-3136; Le Bourhis, Lionel/0000-0002-7524-3539; Rogge, Lars/0000-0003-1262-9204; CASROUGE, Armanda/0000-0002-7356-0901; Casanova, Jean-Laurent/0000-0002-7782-4169	Fondation ARC; EMBO [ALTF 1201-2014]; Marie Curie [H2020-MSCA-IF-2014]; Institut Pasteur; Inserm; Laboratoire d'Excellence REVIVE [ANR-10-LBX-73]; FP7 [317057, HEALTH-F3-2012-305578]	Fondation ARC; EMBO(European Molecular Biology Organization (EMBO)); Marie Curie(European Commission); Institut Pasteur(European Commission); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Laboratoire d'Excellence REVIVE; FP7	We thank all the members of Innate Immunity Unit for helpful discussions, the Centre de Recherche Translationnelle, F. Pala and O. Fiquet (Institut Pasteur), and A. Sparaneo (Casa Sollievo della Sofferenza) for technical assistance. A.I.L. is a scholar in Pasteur-Paris University (PPU) International PhD program and supported by FP7 under grant agreement 317057 (HOMIN) and the Fondation ARC. R.S. was supported by EMBO (ALTF 1201-2014) and Marie Curie (H2020-MSCA-IF-2014). Other support included grants from the Institut Pasteur, Inserm, Laboratoire d'Excellence REVIVE (ANR-10-LBX-73), and FP7 under grant agreement HEALTH-F3-2012-305578 (PathCO) and 317057 (HOMIN). J.P.D. is a founder of AXENIS and a member of its advisory board.	Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chea S, 2016, CELL REP, V14, P1500, DOI 10.1016/j.celrep.2016.01.015; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Dallas MH, 2005, J EXP MED, V201, P1361, DOI 10.1084/jem.20042450; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Hazenberg MD, 2014, BLOOD, V124, P700, DOI 10.1182/blood-2013-11-427781; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hoorweg K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00072; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Juelke K, 2016, CURR OPIN IMMUNOL, V38, P75, DOI 10.1016/j.coi.2015.11.005; Kim B.S., 2015, COLD SPRING HARB PER, V7; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Koues OI, 2016, CELL, V165, P1134, DOI 10.1016/j.cell.2016.04.014; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Legrand N, 2011, P NATL ACAD SCI USA, V108, P13224, DOI 10.1073/pnas.1101398108; Lim AI, 2016, J EXP MED, V213, P569, DOI 10.1084/jem.20151750; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Mohtashami M, 2010, J IMMUNOL, V185, P867, DOI 10.4049/jimmunol.1000782; Montaldo E, 2014, IMMUNITY, V41, P988, DOI 10.1016/j.immuni.2014.11.010; Munneke JM, 2014, BLOOD, V124, P812, DOI 10.1182/blood-2013-11-536888; Okada S, 2015, SCIENCE, V349, P606, DOI 10.1126/science.aaa4282; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Renoux VM, 2015, IMMUNITY, V43, P394, DOI 10.1016/j.immuni.2015.07.011; Rollini P, 2007, STEM CELLS DEV, V16, P281, DOI 10.1089/scd.2006.0096; Rongvaux A, 2013, ANNU REV IMMUNOL, V31, P635, DOI 10.1146/annurev-immunol-032712-095921; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schmidt C, 2015, NAT METHODS, V12, P963, DOI [10.1038/nmeth.3542, 10.1038/NMETH.3542]; Scoville SD, 2016, IMMUNITY, V44, P1140, DOI 10.1016/j.immuni.2016.04.007; Seehus CR, 2015, NAT IMMUNOL, V16, P599, DOI 10.1038/ni.3168; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Serafini N, 2014, J EXP MED, V211, P199, DOI 10.1084/jem.20131038; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yang Q, 2015, NAT IMMUNOL, V16, P1044, DOI 10.1038/ni.3248; Zhang Z, 2015, J CLIN INVEST, V125, P3692, DOI 10.1172/JCI82124; Zook EC, 2016, J EXP MED, V213, P687, DOI 10.1084/jem.20150851	48	304	306	1	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2017	168	6					1086	+		10.1016/j.cell.2017.02.021	http://dx.doi.org/10.1016/j.cell.2017.02.021			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8ZF	28283063	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000396287900016
J	Suzuki, HI; Young, RA; Sharp, PA				Suzuki, Hiroshi I.; Young, Richard A.; Sharp, Phillip A.			Super-Enhancer-Mediated RNA Processing Revealed by Integrative MicroRNA Network Analysis	CELL			English	Article							CELL IDENTITY; GENE-EXPRESSION; TRANSCRIPTION FACTORS; DIFFERENTIATION; DATABASE; COMPLEX; TARGETS; IMPACT; MEMORY; DROSHA	Super-enhancers are an emerging subclass of regulatory regions controlling cell identity and disease genes. However, their biological function and impact on miRNA networks are unclear. Here, we report that super-enhancers drive the biogenesis of master miRNAs crucial for cell identity by enhancing both transcription and Drosha/DGCR8-mediated primary miRNA ( pri-miRNA) processing. Super-enhancers, together with broad H3K4me3 domains, shape a tissue-specific and evolutionarily conserved atlas of miRNAexpression and function. CRISPR/Cas9 genomics revealed that super-enhancer constituents act cooperatively and facilitate Drosha/DGCR8 recruitment and pri-miRNA processing to boost cell-specific miRNA production. The BET-bromodomain inhibitor JQ1 preferentially inhibits super-enhancerdirected cotranscriptional pri-miRNA processing. Furthermore, super-enhancers are characterized by pervasive interaction with DGCR8/Drosha and DGCR8/Drosha-regulated mRNA stability control, suggesting unique RNA regulation at super-enhancers. Finally, super-enhancers mark multiple miRNAsassociated with cancer hallmarks. This study presents principles underlying miRNA biology in health and disease and an unrecognized higher-order property of super-enhancers in RNA processing beyond transcription.	[Suzuki, Hiroshi I.; Sharp, Phillip A.] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Young, Richard A.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Young, Richard A.; Sharp, Phillip A.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Sharp, PA (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Sharp, PA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sharppa@mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Suzuki, Hiroshi/0000-0003-4682-5086	JSPS Postdoctoral Fellowship for Research Abroad; Uehara Memorial Foundation; United States Public Health Service from the NIH [R01-CA133404]; Koch Institute from the NCI [P30-CA14051]; NATIONAL CANCER INSTITUTE [P30CA014051, P01CA042063, R01CA133404] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	JSPS Postdoctoral Fellowship for Research Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); United States Public Health Service from the NIH; Koch Institute from the NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank S. Dubbury, A. Chiu, C.K. JnBaptiste, B.J. Abraham, and members of Sharp laboratories for discussions and assistance and S. Levine and the staff of the BioMicro Center at MIT for sequencing support. H.I.S. is supported by JSPS Postdoctoral Fellowship for Research Abroad and Uehara Memorial Foundation. The results here are in part based upon data generated by the TCGA Research Network: https://cancergenome.nih.gov/. R.A.Y. is a founder and P.A.S. is a board member of Syros Pharmaceuticals, which is developing SE directed agents, none of which were used in the study. This research has been supported by United States Public Health Service grant R01-CA133404 (to P.A.S.) from the NIH and partially by Koch Institute Support (core) grant P30-CA14051 from the NCI.	Alarcon CR, 2015, CELL, V162, P1299, DOI 10.1016/j.cell.2015.08.011; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Benayoun BA, 2014, CELL, V158, P673, DOI 10.1016/j.cell.2014.06.027; Bosson AD, 2014, MOL CELL, V56, P347, DOI 10.1016/j.molcel.2014.09.018; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; de Dieuleveult M, 2016, NATURE, V530, P113, DOI 10.1038/nature16505; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Gromak N, 2013, CELL REP, V5, P1499, DOI 10.1016/j.celrep.2013.11.032; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hay D, 2016, NAT GENET, V48, P895, DOI 10.1038/ng.3605; Hnisz D, 2015, MOL CELL, V58, P362, DOI 10.1016/j.molcel.2015.02.014; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Karginov FV, 2010, MOL CELL, V38, P781, DOI 10.1016/j.molcel.2010.06.001; Kim TM, 2011, CANCER RES, V71, P3387, DOI 10.1158/0008-5472.CAN-10-4117; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Kwon SC, 2016, CELL, V164, P81, DOI 10.1016/j.cell.2015.12.019; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin CQ, 2011, GENE DEV, V25, P1486, DOI 10.1101/gad.2059211; Liu HM, 2016, MOL CELL, V63, P420, DOI 10.1016/j.molcel.2016.06.014; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lund AH, 2010, CELL DEATH DIFFER, V17, P209, DOI 10.1038/cdd.2009.58; Macias S, 2015, MOL CELL, V60, P873, DOI 10.1016/j.molcel.2015.11.011; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/NMETH.2078, 10.1038/nmeth.2078]; Nojima T, 2015, CELL, V161, P526, DOI 10.1016/j.cell.2015.03.027; Park CY, 2010, HUM MOL GENET, V19, pR169, DOI 10.1093/hmg/ddq367; Porstner M, 2015, EUR J IMMUNOL, V45, P1206, DOI 10.1002/eji.201444637; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Schnetz MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001023; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Shin HY, 2016, NAT GENET, V48, P904, DOI 10.1038/ng.3606; Skene PJ, 2015, ELIFE, V4, DOI 10.7554/eLife.09225; Squadrito ML, 2012, CELL REPORTS, V1, P141, DOI 10.1016/j.celrep.2011.12.005; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Theocharidis A, 2009, NAT PROTOC, V4, P1535, DOI 10.1038/nprot.2009.177; Tiscornia G, 2010, GENE DEV, V24, P2732, DOI 10.1101/gad.1982910; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang DF, 2014, BIOINFORMATICS, V30, P2237, DOI 10.1093/bioinformatics/btu155; Wang HP, 2014, NAT IMMUNOL, V15, P393, DOI 10.1038/ni.2846; Wang WY, 2012, LEARN MEMORY, V19, P359, DOI 10.1101/lm.026492.112; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zamudio JR, 2014, CELL, V156, P920, DOI 10.1016/j.cell.2014.01.041; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	58	165	173	1	89	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2017	168	6					1000	+		10.1016/j.cell.2017.02.015	http://dx.doi.org/10.1016/j.cell.2017.02.015			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8ZF	28283057	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000396287900009
J	Zimetbaum, P				Zimetbaum, Peter			Atrial Fibrillation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ANTITHROMBOTIC THERAPY; PREVENT STROKE; RHYTHM CONTROL; WARFARIN; RISK; DABIGATRAN; ARRHYTHMIAS; DRONEDARONE; AMIODARONE; RECURRENCE								American College of Physicians	American College of Physicians	American College of Physicians.	[Anonymous], 1989, NEW ENGL J MED, V321, P406; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Connolly SJ, 2009, NEW ENGL J MED, V360, P2066, DOI 10.1056/NEJMoa0901301; Connolly SJ, 2016, NEW ENGL J MED, V375, P1131, DOI 10.1056/NEJMoa1607887; Connolly SJ, 2011, NEW ENGL J MED, V365, P2268, DOI 10.1056/NEJMoa1109867; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Eikelboom JW, 2013, NEW ENGL J MED, V369, P1206, DOI 10.1056/NEJMoa1300615; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575; Heidenreich PA, 2016, CIRC-CARDIOVASC QUAL, V9, P443, DOI [10.1161/HCQ.0000000000000018, 10.1016/j.jacc.2016.03.521]; Hohnloser SH, 2000, LANCET, V356, P1789, DOI 10.1016/S0140-6736(00)03230-X; Hohnloser SH, 2009, NEW ENGL J MED, V360, P668, DOI 10.1056/NEJMoa0803778; January CT, 2014, J AM COLL CARDIOL, V64, P2246, DOI [10.1016/j.jacc.2014.03.022, 10.1016/j.jacc.2014.03.021, 10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000142]; Kannel WB, 2009, CARDIOL CLIN, V27, P13, DOI 10.1016/j.ccl.2008.09.015; NAITO M, 1983, AM HEART J, V106, P284, DOI 10.1016/0002-8703(83)90194-1; PAGE RL, 1994, CIRCULATION, V89, P224, DOI 10.1161/01.CIR.89.1.224; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; POLLACK CV, 2015, NEW ENGL J MED, V373, P511, DOI DOI 10.1056/NEJMOA1502000; Reddy VY, 2013, CIRCULATION, V127, P720, DOI 10.1161/CIRCULATIONAHA.112.114389; Redfield MM, 2000, MAYO CLIN PROC, V75, P790, DOI 10.4065/75.8.790; Reynolds MR, 2006, AM HEART J, V152, P1097, DOI 10.1016/j.ahj.2006.08.011; Roy D, 2000, NEW ENGL J MED, V342, P913, DOI 10.1056/NEJM200003303421302; Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789; Sanna T, 2014, NEW ENGL J MED, V370, P2478, DOI 10.1056/NEJMoa1313600; Van Gelder IC, 2010, NEW ENGL J MED, V362, P1363, DOI 10.1056/NEJMoa1001337; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; Zabalgoitia M, 1998, J AM COLL CARDIOL, V31, P1622, DOI 10.1016/S0735-1097(98)00146-6; Zimetbaum P., 2010, ANN INTERN MED, V153; Zimetbaum P, 2010, ANN INTERN MED, V153; Zimetbaum P, 2007, NEW ENGL J MED, V356, P935, DOI 10.1056/NEJMct065916; Zimetbaum P, 2012, CIRCULATION, V125, P381, DOI 10.1161/CIRCULATIONAHA.111.019927; Zimetbaum P, 2010, CIRCULATION, V122, P1629, DOI 10.1161/CIRCULATIONAHA.109.925610	36	106	114	3	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2017	166	5					ITC33	ITC47		10.7326/AITC201703070	http://dx.doi.org/10.7326/AITC201703070			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BO	28265666				2022-12-28	WOS:000396432800001
J	Casey, BM; Thom, EA; Peaceman, AM; Varner, MW; Sorokin, Y; Hirtz, DG; Reddy, UM; Wapner, RJ; Thorp, JM; Saade, G; Tita, ATN; Rouse, DJ; Sibai, B; Iams, JD; Mercer, BM; Tolosa, J; Caritis, SN; VanDorsten, JP				Casey, B. M.; Thom, E. A.; Peaceman, A. M.; Varner, M. W.; Sorokin, Y.; Hirtz, D. G.; Reddy, U. M.; Wapner, R. J.; Thorp, J. M., Jr.; Saade, G.; Tita, A. T. N.; Rouse, D. J.; Sibai, B.; Iams, J. D.; Mercer, B. M.; Tolosa, J.; Caritis, S. N.; VanDorsten, J. P.		Eunice Kennedy Shriver Natl Inst C; Human Dev Maternal-Fetal Med Units	Treatment of Subclinical Hypothyroidism or Hypothyroxinemia in Pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMERICAN THYROID ASSOCIATION; POPULATION-BASED COHORT; MATERNAL HYPOTHYROXINEMIA; COMPLICATING PREGNANCY; ENDOCRINE-SOCIETY; DISEASE; DYSFUNCTION; POSTPARTUM; MANAGEMENT; DEFICIENCY	BACKGROUND Subclinical thyroid disease during pregnancy may be associated with adverse outcomes, including a lower-than-normal IQ in offspring. It is unknown whether levothyroxine treatment of women who are identified as having subclinical hypothyroidism or hypothyroxinemia during pregnancy improves cognitive function in their children. METHODS We screened women with a singleton pregnancy before 20 weeks of gestation for subclinical hypothyroidism, defined as a thyrotropin level of 4.00 mU or more per liter and a normal free thyroxine (T-4) level (0.86 to 1.90 ng per deciliter [11 to 24 pmol per liter]), and for hypothyroxinemia, defined as a normal thyrotropin level (0.08 to 3.99 mU per liter) and a low free T-4 level (<0.86 ng per deciliter). In separate trials for the two conditions, women were randomly assigned to receive levothyroxine or placebo. Thyroid function was assessed monthly, and the levothyroxine dose was adjusted to attain a normal thyrotropin or free T-4 level (depending on the trial), with sham adjustments for placebo. Children underwent annual developmental and behavioral testing for 5 years. The primary outcome was the IQ score at 5 years of age (or at 3 years of age if the 5-year examination was missing) or death at an age of less than 3 years. RESULTS A total of 677 women with subclinical hypothyroidism underwent randomization at a mean of 16.7 weeks of gestation, and 526 with hypothyroxinemia at a mean of 17.8 weeks of gestation. In the subclinical hypothyroidism trial, the median IQ score of the children was 97 (95% confidence interval [CI], 94 to 99) in the levothyroxine group and 94 (95% CI, 92 to 96) in the placebo group (P = 0.71). In the hypothyroxinemia trial, the median IQ score was 94 (95% CI, 91 to 95) in the levothyroxine group and 91 (95% CI, 89 to 93) in the placebo group (P = 0.30). In each trial, IQ scores were missing for 4% of the children. There were no significant between-group differences in either trial in any other neurocognitive or pregnancy outcomes or in the incidence of adverse events, which was low in both groups. CONCLUSIONS Treatment for subclinical hypothyroidism or hypothyroxinemia beginning between 8 and 20 weeks of gestation did not result in significantly better cognitive outcomes in children through 5 years of age than no treatment for those conditions.	[Casey, B. M.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Saade, G.] Univ Texas Med Branch, Galveston, TX 77555 USA; [Sibai, B.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Childrens Mem Hermann Hosp, Houston, TX 77030 USA; [Thom, E. A.] George Washington Univ, Biostat Ctr, Washington, DC USA; [Peaceman, A. M.] Northwestern Univ, Chicago, IL 60611 USA; [Varner, M. W.] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA; [Sorokin, Y.] Wayne State Univ, Detroit, MI USA; [Hirtz, D. G.] NINDS, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Reddy, U. M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA; [Wapner, R. J.] Columbia Univ, New York, NY USA; [Thorp, J. M., Jr.] Univ North Carolina Chapel Hill, Chapel Hill, NC USA; [Tita, A. T. N.] Univ Alabama Birmingham, Birmingham, AL USA; [Rouse, D. J.] Brown Univ, Providence, RI 02912 USA; [Iams, J. D.] Ohio State Univ, Columbus, OH 43210 USA; [Mercer, B. M.] Case Western Reserve Univ, MetroHlth Med Ctr, Cleveland, OH 44106 USA; [Tolosa, J.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Caritis, S. N.] Univ Pittsburgh, Pittsburgh, PA USA; [VanDorsten, J. P.] Med Univ South Carolina, Charleston, SC USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Health Science Center Houston; George Washington University; Northwestern University; Utah System of Higher Education; University of Utah; Wayne State University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Columbia University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Alabama System; University of Alabama Birmingham; Brown University; University System of Ohio; Ohio State University; Case Western Reserve University; MetroHealth System; Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Medical University of South Carolina	Casey, BM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.	brian.casey@utsouthwestern.edu		Tita, Alan/0000-0002-7244-9056; Wapner, Ronald/0000-0003-0727-1244	Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD34116, HD40512, HD27917, HD34208, HD40485, HD40560, HD53097, HD27869, HD40500, HD40545, HD27915, HD40544, HD53118, HD21410, HD36801]; National Institute of Neurological Disorders and Stroke; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [UG1HD040544, U10HD021410, U10HD040544, U10HD034116, UG1HD040560, UG1HD053097, U10HD053097, U10HD053118, U10HD034208, UG1HD087230, UG1HD027869, U10HD040485, U10HD036801, U10HD027915, UG1HD027915, U10HD040500, U10HD027917, UG1HD040512, UG1HD040485, UG1HD034208, UG1HD040545, UG1HD040500, U10HD027869, U10HD040512, U10HD040560, UG1HD034116, U10HD040545] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD036801] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by grants (HD34116, HD40512, HD27917, HD34208, HD40485, HD40560, HD53097, HD27869, HD40500, HD40545, HD27915, HD40544, HD53118, HD21410, and HD36801) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Neurological Disorders and Stroke.	Abalovich M, 2002, THYROID, V12, P63, DOI 10.1089/105072502753451986; Abalovich M, 2007, J CLIN ENDOCR METAB, V92, pS1, DOI 10.1210/jc.2007-0141; ACHENBACH TM, 1991, MONOGR SOC RES CHILD, V56, pR5; Allan WC, 2000, J MED SCREEN, V7, P127, DOI 10.1136/jms.7.3.127; [Anonymous], 2007, ASS IOD DEF DIS MON; Blatt AJ, 2012, J CLIN ENDOCR METAB, V97, P777, DOI 10.1210/jc.2011-2038; Casey BM, 2005, OBSTET GYNECOL, V105, P239, DOI 10.1097/01.AOG.0000152345.99421.22; Casey BM, 2007, OBSTET GYNECOL, V109, P1129, DOI 10.1097/01.AOG.0000262054.03531.24; Cleary-Goldman J, 2008, OBSTET GYNECOL, V112, P85, DOI 10.1097/AOG.0b013e3181788dd7; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P257, DOI 10.1023/A:1022602400621; DAVIS LE, 1988, OBSTET GYNECOL, V72, P108; Gharib H, 2005, J CLIN ENDOCR METAB, V90, P581, DOI 10.1210/jc.2004-1231; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Kilpatrick S, 2002, INT J GYNECOL OBSTET, V79, P171; Lazarus JH, 2012, NEW ENGL J MED, V366, P493, DOI 10.1056/NEJMoa1106104; LEUNG AS, 1993, OBSTET GYNECOL, V81, P349; Mannisto T, 2009, J CLIN ENDOCR METAB, V94, P772, DOI 10.1210/jc.2008-1520; Modesto T, 2015, JAMA PEDIATR, V169, P838, DOI 10.1001/jamapediatrics.2015.0498; Negro R, 2006, J CLIN ENDOCR METAB, V91, P2587, DOI 10.1210/jc.2005-1603; Pop VJ, 2003, CLIN ENDOCRINOL, V59, P282, DOI 10.1046/j.1365-2265.2003.01822.x; Pop VJ, 1999, CLIN ENDOCRINOL, V50, P149, DOI 10.1046/j.1365-2265.1999.00639.x; Rosenberger WF, 2002, RANDOMIZATION CLIN T; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087; Su PY, 2011, J CLIN ENDOCR METAB, V96, P3234, DOI 10.1210/jc.2011-0274; Tudela CM, 2012, OBSTET GYNECOL, V119, P983, DOI 10.1097/AOG.0b013e318250aeeb; Vermiglio F, 2004, J CLIN ENDOCR METAB, V89, P6054, DOI 10.1210/jc.2004-0571; Wilson KL, 2012, OBSTET GYNECOL, V119, P315, DOI 10.1097/AOG.0b013e318240de6a	27	228	249	0	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2017	376	9					815	825		10.1056/NEJMoa1606205	http://dx.doi.org/10.1056/NEJMoa1606205			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JK	28249134	Green Submitted, Green Accepted			2022-12-28	WOS:000395627500005
J	McWilliams, JM; Schwartz, AL				McWilliams, J. Michael; Schwartz, Aaron L.			Focusing on High-Cost Patients - The Key to Addressing High Costs?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MEDICARE; CARE; PROGRAM		[McWilliams, J. Michael; Schwartz, Aaron L.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA; [McWilliams, J. Michael] Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	McWilliams, JM (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA.; McWilliams, JM (corresponding author), Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA.				NATIONAL INSTITUTE ON AGING [P01AG032952] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG032952] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		McWilliams JM, 2016, JAMA-J AM MED ASSOC, V316, P1711, DOI 10.1001/jama.2016.12049; McWilliams JM, 2014, JAMA INTERN MED, V174, P938, DOI 10.1001/jamainternmed.2014.1073; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Schwartz AL, 2015, JAMA INTERN MED, V175, P1815, DOI 10.1001/jamainternmed.2015.4525; Schwartz AL, 2014, JAMA INTERN MED, V174, P1067, DOI 10.1001/jamainternmed.2014.1541	5	41	41	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2017	376	9					807	809		10.1056/NEJMp1612779	http://dx.doi.org/10.1056/NEJMp1612779			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9JK	28249127	Green Accepted			2022-12-28	WOS:000395627500002
J	Ruzicka, T; Hanifin, JM; Furue, M; Pulka, G; Mlynarczyk, I; Wollenberg, A; Galus, R; Etoh, T; Mihara, R; Yoshida, H; Stewart, J; Kabashima, K				Ruzicka, Thomas; Hanifin, Jon M.; Furue, Masutaka; Pulka, Grazyna; Mlynarczyk, Izabela; Wollenberg, Andreas; Galus, Ryszard; Etoh, Takafumi; Mihara, Ryosuke; Yoshida, Hiroki; Stewart, Jonathan; Kabashima, Kenji		XCIMA Study Grp	Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VISUAL ANALOG SCALE; T-CELLS; INTERLEUKIN-31 RECEPTOR; SUICIDAL IDEATION; IL-31; PRURITUS; ECZEMA; ITCH; SKIN; ACTIGRAPHY	BACKGROUND Interleukin-31 may play a role in the pathobiologic mechanism of atopic dermatitis and pruritus. We wanted to assess the efficacy and safety of nemolizumab (CIM331), a humanized antibody against interleukin-31 receptor A, in the treatment of atopic dermatitis. METHODS In this phase 2, randomized, double-blind, placebo-controlled, 12-week trial, we assigned adults with moderate-to-severe atopic dermatitis that was inadequately controlled by topical treatments to receive subcutaneous nemolizumab (at a dose of 0.1 mg, 0.5 mg, or 2.0 mg per kilogram of body weight) or placebo every 4 weeks or an exploratory dose of 2.0 mg of nemolizumab per kilogram every 8 weeks. The primary end point was the percentage improvement from baseline in the score on the pruritus visual-analogue scale (on which a negative change indicates improvement) at week 12. Secondary end points included changes in the score on the Eczema Area and Severity Index (EASI, on which a negative change indicates improvement), and body-surface area of atopic dermatitis. RESULTS Of 264 patients who underwent randomization, 216 (82%) completed the study. At week 12, among the patients who received nemolizumab every 4 weeks, changes on the pruritus visual-analogue scale were -43.7% in the 0.1-mg group, -59.8% in the 0.5-mg group, and -63.1% in the 2.0-mg group, versus -20.9% in the placebo group (P<0.01 for all comparisons). Changes on the EASI were -23.0%, -42.3%, and -40.9%, respectively, in the nemolizumab groups, versus -26.6% in the placebo group. Respective changes in body-surface area affected by atopic dermatitis were -7.5%, -20.0%, and -19.4% with nemolizumab, versus -15.7% with placebo. Among the patients receiving nemolizumab every 4 weeks, treatment discontinuations occurred in 9 of 53 patients (17%) in the 0.1-mg group, in 9 of 54 (17%) in the 0.5-mg group, and in 7 of 52 (13%) in the 2.0-mg group, versus in 9 of 53 (17%) in the placebo group. CONCLUSIONS In this phase 2 trial, nemolizumab at all monthly doses significantly improved pruritus in patients with moderate-to-severe atopic dermatitis, which showed the efficacy of targeting interleukin-31 receptor A. The limited size and length of the trial preclude conclusions regarding adverse events.	[Ruzicka, Thomas; Wollenberg, Andreas] Ludwig Maximilians Univ Munchen, Dept Dermatol & Allergol, Frauenlobstr 9-11, D-80337 Munich, Germany; [Hanifin, Jon M.] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA; [Furue, Masutaka] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka, Japan; [Etoh, Takafumi] Tokyo Teishin Hosp, Tokyo, Japan; [Mihara, Ryosuke; Yoshida, Hiroki] Chugai Pharmaceut, Tokyo, Japan; [Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan; [Kabashima, Kenji] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan; [Pulka, Grazyna] Jagiellonian Univ, Sch Med, Krakow, Poland; [Mlynarczyk, Izabela] Dermatol Clin, Acad Hlth, Rzeszow, Poland; [Galus, Ryszard] Med Univ Warsaw, Dept Histol & Embryol, Ctr Biostruct, Warsaw, Poland; [Stewart, Jonathan] Chugai Pharma Europe, London, England	University of Munich; Oregon Health & Science University; Kyushu University; Chugai Pharmaceutical Co., Ltd.; Roche Holding; Kyoto University; Japan Science & Technology Agency (JST); Jagiellonian University; Medical University of Warsaw; Chugai Pharmaceutical Co., Ltd.; Roche Holding	Ruzicka, T (corresponding author), Ludwig Maximilians Univ Munchen, Dept Dermatol & Allergol, Frauenlobstr 9-11, D-80337 Munich, Germany.	thomas.ruzicka@med.uni-muenchen.de	Kabashima, Kenji/G-2521-2014	Kabashima, Kenji/0000-0002-0773-0554	Chugai Pharmaceutical	Chugai Pharmaceutical	Supported by Chugai Pharmaceutical.	Bando T, 2006, NEUROSCIENCE, V142, P1263, DOI 10.1016/j.neuroscience.2006.07.009; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Bilsborough J, 2006, J ALLERGY CLIN IMMUN, V117, P418, DOI 10.1016/j.jaci.2005.10.046; Cevikbas F, 2014, J ALLERGY CLIN IMMUN, V133, P448, DOI 10.1016/j.jaci.2013.10.048; Chrostowska-Plak D, 2013, J EUR ACAD DERMATOL, V27, pE239, DOI 10.1111/j.1468-3083.2012.04578.x; Cornelissen C, 2012, EUR J CELL BIOL, V91, P552, DOI 10.1016/j.ejcb.2011.07.006; Eichenfield LF, 2014, J AM ACAD DERMATOL, V71, P116, DOI 10.1016/j.jaad.2014.03.023; Feld M, 2016, J ALLERGY CLIN IMMUN, V138, P500, DOI 10.1016/j.jaci.2016.02.020; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Frankel HC, 2012, AM J CLIN DERMATOL, V13, P113, DOI 10.2165/11597780-000000000-00000; Furue M, 2013, ACTA DERM-VENEREOL, V93, P214, DOI 10.2340/00015555-1446; Gittler JK, 2012, J ALLERGY CLIN IMMUN, V130, P1344, DOI 10.1016/j.jaci.2012.07.012; Hanel KH, 2016, J IMMUNOL, V196, P3233, DOI 10.4049/jimmunol.1402943; Halvorsen JA, 2014, J INVEST DERMATOL, V134, P1847, DOI 10.1038/jid.2014.70; Halvorsen JA, 2012, ACTA DERM-VENEREOL, V92, P543, DOI 10.2340/00015555-1251; Hanifin JM, 2001, EXP DERMATOL, V10, P11, DOI 10.1034/j.1600-0625.2001.100102.x; Hawro T, 2014, ALLERGY, V69, P113, DOI 10.1111/all.12316; Hong J, 2011, SEMIN CUTAN MED SURG, V30, P71, DOI 10.1016/j.sder.2011.05.002; Hyde M, 2007, J SLEEP RES, V16, P213, DOI 10.1111/j.1365-2869.2007.00588.x; Kabashima K, 2013, J DERMATOL SCI, V70, P3, DOI 10.1016/j.jdermsci.2013.02.001; Kato A, 2014, J DERMATOL SCI, V74, P229, DOI 10.1016/j.jdermsci.2014.02.009; Kido-Nakahara M, 2015, ACTA DERM-VENEREOL, V95, P345, DOI 10.2340/00015555-1972; Langenbruch A, 2014, J EUR ACAD DERMATOL, V28, P719, DOI 10.1111/jdv.12154; Lichstein KL, 2006, SLEEP, V29, P232; Nemoto O, 2016, BRIT J DERMATOL, V174, P296, DOI 10.1111/bjd.14207; Nobbe S, 2012, ACTA DERM-VENEREOL, V92, P24, DOI 10.2340/00015555-1191; Nomura T, 2014, J DERMATOL SCI, V76, P3, DOI 10.1016/j.jdermsci.2014.07.010; O'Hare E, 2015, SLEEP BREATH, V19, P91, DOI 10.1007/s11325-014-0967-z; Oaklander AL, 2002, PAIN, V96, P9, DOI 10.1016/S0304-3959(01)00400-6; Oyama S, 2016, EXP DERMATOL; Reich A, 2012, ACTA DERM-VENEREOL, V92, P497, DOI 10.2340/00015555-1265; Ring J, 2012, J EUR ACAD DERMATOL, V26, P1045, DOI 10.1111/j.1468-3083.2012.04635.x; Ruzicka T, 1997, NEW ENGL J MED, V337, P816, DOI 10.1056/NEJM199709183371203; Sidbury R, 2014, J AM ACAD DERMATOL, V71, P327, DOI 10.1016/j.jaad.2014.03.030; Silverberg JI, 2015, J INVEST DERMATOL, V135, P56, DOI 10.1038/jid.2014.325; Sonkoly E, 2006, J ALLERGY CLIN IMMUN, V117, P411, DOI 10.1016/j.jaci.2005.10.033; STALDER JF, 1993, DERMATOLOGY, V186, P23, DOI 10.1159/000247298; Szegedi K, 2012, EXP DERMATOL, V21, P431, DOI 10.1111/j.1600-0625.2012.01487.x; Takeuchi S, 2015, BRIT J DERMATOL, V173, P250, DOI 10.1111/bjd.13557; Wollenberg A, 2016, J EUR ACAD DERMATOL, V30, P729, DOI 10.1111/jdv.13599; Yosipovitch G, 2013, NEW ENGL J MED, V368, P1625, DOI 10.1056/NEJMcp1208814	41	338	353	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2017	376	9					826	835		10.1056/NEJMoa1606490	http://dx.doi.org/10.1056/NEJMoa1606490			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JK	28249150				2022-12-28	WOS:000395627500006
J	Voelker, R				Voelker, Rebecca			Hospital Costs for Birth Defects Reach Tens of Billions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2017	317	8					799	799		10.1001/jama.2017.0551	http://dx.doi.org/10.1001/jama.2017.0551			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM7PW	28245332				2022-12-28	WOS:000395505600010
J	Zapata, JA; Lai, AR; Moriates, C				Zapata, Josue A.; Lai, Andrew R.; Moriates, Christopher			Is Excessive Resource Utilization an Adverse Event?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Zapata, Josue A.] San Francisco Vet Affairs, Med Ctr, San Francisco, CA 94110 USA; [Zapata, Josue A.; Lai, Andrew R.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Moriates, Christopher] Univ Texas Austin, Dell Med Sch, 1501 Red River Dr,Hlth Learning Bldg,Room 2-323, Austin, TX 78712 USA	University of California System; University of California San Francisco; University of Texas System; University of Texas Austin	Moriates, C (corresponding author), Univ Texas Austin, Dell Med Sch, 1501 Red River Dr,Hlth Learning Bldg,Room 2-323, Austin, TX 78712 USA.	cmoriates@austin.utexas.edu		Moriates, Christopher/0000-0002-3153-2558				Chassin MR, 2015, JAMA-J AM MED ASSOC, V313, P1795, DOI 10.1001/jama.2015.3818; Fisher ES, 1999, JAMA-J AM MED ASSOC, V281, P446, DOI 10.1001/jama.281.5.446; Institute of Medicine Report, 2012, BEST CARE LOWER COST; Levinson WS., 2014, UNDERSTANDING MED PR; Moriates C, 2013, JAMA-J AM MED ASSOC, V310, P577, DOI 10.1001/jama.2013.7516; Stammen LA, 2015, JAMA-J AM MED ASSOC, V314, P2384, DOI 10.1001/jama.2015.16353	6	11	11	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2017	317	8					849	850		10.1001/jama.2017.0698	http://dx.doi.org/10.1001/jama.2017.0698			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM7PW	28245327				2022-12-28	WOS:000395505600023
J	Scott, J				Scott, John			Sisir Kumar Roy OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2017	356								j907	10.1136/bmj.j907	http://dx.doi.org/10.1136/bmj.j907			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KZ	28235808				2022-12-28	WOS:000395631800012
J	Bach, RG				Bach, Richard G.			Review: Long-term dual-antiplatelet therapy (DAPT) after PCI is no better than short-term DAPT, even with diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							IMPLANTATION		[Bach, Richard G.] Washington Univ, Sch Med, St Louis, MO 63130 USA	Washington University (WUSTL)	Bach, RG (corresponding author), Washington Univ, Sch Med, St Louis, MO 63130 USA.		Bach, Richard G/G-9764-2011; Bach, Richard/AAI-2515-2021					Capodanno D, 2015, J AM COLL CARDIOL, V66, P1639, DOI 10.1016/j.jacc.2015.05.085; Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Thukkani AK, 2015, J AM COLL CARDIOL, V66, P1091, DOI 10.1016/j.jacc.2015.06.1339; Yeh RW, 2016, JAMA-J AM MED ASSOC, V315, P1735, DOI 10.1001/jama.2016.3775	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2017	166	4					JC22	JC22		10.7326/ACPJC-2017-166-4-022	http://dx.doi.org/10.7326/ACPJC-2017-166-4-022			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7FO	28241295				2022-12-28	WOS:000394786700010
J	Breitenstein, C; Grewe, T; Floel, A; Ziegler, W; Springer, L; Martus, P; Huber, W; Willmes, K; Ringelstein, EB; Haeusler, KG; Abel, S; Glindemann, R; Domahs, F; Regenbrecht, F; Schlenck, KJ; Thomas, M; Obrig, H; de Langen, E; Rocker, R; Wigbers, F; Ruehmkorf, C; Hempen, I; List, J				Breitenstein, Caterina; Grewe, Tanja; Floeel, Agnes; Ziegler, Wolfram; Springer, Luise; Martus, Peter; Huber, Walter; Willmes, Klaus; Ringelstein, E. Bernd; Haeusler, Karl Georg; Abel, Stefanie; Glindemann, Ralf; Domahs, Frank; Regenbrecht, Frank; Schlenck, Klaus-Juergen; Thomas, Marion; Obrig, Hellmuth; de Langen, Ernst; Rocker, Roman; Wigbers, Franziska; Ruehmkorf, Christina; Hempen, Indra; List, Jonathan			Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting	LANCET			English	Article							PARALLEL-GROUP; COMMUNICATION; REHABILITATION; RELIABILITY; IMPACT; LIFE	Background Treatment guidelines for aphasia recommend intensive speech and language therapy for chronic (>= 6 months) aphasia after stroke, but large-scale, class 1 randomised controlled trials on treatment effectiveness are scarce. We aimed to examine whether 3 weeks of intensive speech and language therapy under routine clinical conditions improved verbal communication in daily-life situations in people with chronic aphasia after stroke. Methods In this multicentre, parallel group, superiority, open-label, blinded-endpoint, randomised controlled trial, patients aged 70 years or younger with aphasia after stroke lasting for 6 months or more were recruited from 19 inpatient or outpatient rehabilitation centres in Germany. An external biostatistician used a computer-generated permuted block randomisation method, stratified by treatment centre, to randomly assign participants to either 3 weeks or more of intensive speech and language therapy (>= 10 h per week) or 3 weeks deferral of intensive speech and language therapy. The primary endpoint was between-group difference in the change in verbal communication effectiveness in everyday life scenarios (Amsterdam-Nijmegen Everyday Language Test A-scale) from baseline to immediately after 3 weeks of treatment or treatment deferral. All analyses were done using the modified intention-to-treat population (those who received 1 day or more of intensive treatment or treatment deferral). This study is registered with ClinicalTrials.gov, number NCT01540383. Findings We randomly assigned 158 patients between April 1, 2012, and May 31, 2014. The modified intention-to-treat population comprised 156 patients (78 per group). Verbal communication was significantly improved from baseline to after intensive speech and language treatment (mean difference 2.61 points [SD 4.94]; 95% CI 1.49 to 3.72), but not from baseline to after treatment deferral (-0.03 points [4.04]; -0.94 to 0.88; between-group difference Cohen's d 0.58; p=0.0004). Eight patients had adverse events during therapy or treatment deferral (one car accident [in the control group], two common cold [one patient per group], three gastrointestinal or cardiac symptoms [all intervention group], two recurrent stroke [one in intervention group before initiation of treatment, and one before group assignment had occurred]); all were unrelated to study participation. Interpretation 3 weeks of intensive speech and language therapy significantly enhanced verbal communication in people aged 70 years or younger with chronic aphasia after stroke, providing an effective evidence-based treatment approach in this population. Future studies should examine the minimum treatment intensity required for meaningful treatment effects, and determine whether treatment effects cumulate over repeated intervention periods.	[Breitenstein, Caterina; Ringelstein, E. Bernd; Thomas, Marion; Rocker, Roman; Wigbers, Franziska; Ruehmkorf, Christina; Hempen, Indra] Univ Munster, Dept Gen Neurol, Munster, Germany; [Breitenstein, Caterina; Ringelstein, E. Bernd; Thomas, Marion; Rocker, Roman; Wigbers, Franziska; Ruehmkorf, Christina; Hempen, Indra] Univ Munster, Dept Neurol, Munster, Germany; [Grewe, Tanja] Fresenius Univ Appl Sci, Fac Hlth & Social Sci, Idstein, Germany; [Grewe, Tanja] Fresenius Univ Appl Sci, Fac Hlth & Social Sci, Hamburg, Germany; [Floeel, Agnes; Haeusler, Karl Georg; List, Jonathan] NeuroCure Clin Res Ctr, Washington, DC USA; [Floeel, Agnes; Haeusler, Karl Georg; List, Jonathan] Ctr Stroke Res Berlin, Washington, DC USA; [Floeel, Agnes; Haeusler, Karl Georg; List, Jonathan] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany; [Floeel, Agnes] Ernst Moritz Arndt Univ Greifswald, Dept Neurol, Greifswald, Germany; [Ziegler, Wolfram] Ludwig Maximilians Univ Munchen, Inst Phonet & Speech Proc, Clin Neuropsychol Res Grp, Munich, Germany; [Martus, Peter] Univ Tubingen, Inst Clin Epidemiol & Appl Biostatist, Tubingen, Germany; [Willmes, Klaus; Abel, Stefanie] Rhein Westfal TH Aachen, Clin & Cognit Neurosci, Aachen, Germany; [Willmes, Klaus] Rhein Westfal TH Aachen, Clin & Neuropsychol, Aachen, Germany; [Abel, Stefanie] Rhein Westfal TH Aachen, Univ Hosp, Dept Neurol, Aachen, Germany; [Abel, Stefanie] Univ Manchester, Sch Biol Sci, Manchester, Lancs, England; [Glindemann, Ralf] Bogenhausen Hosp, Neuropsychol Dept, Munich, Germany; [Domahs, Frank] Univ Marburg, Inst German Linguist, Marburg, Germany; [Regenbrecht, Frank; Obrig, Hellmuth] Univ Leipzig, Max Planck Inst Cognit & Brain Sci, Clin Cognit Neurol, Leipzig, Germany; [Schlenck, Klaus-Juergen] M&I Fachklinik Enzensberg, Fuessen, Germany; [de Langen, Ernst] Reha Ctr Passauer Wolf, Bad Griesbach, Germany	University of Munster; University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ernst Moritz Arndt Universitat Greifswald; University of Munich; Eberhard Karls University of Tubingen; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University Hospital; University of Manchester; Munchen Klinik; Philipps University Marburg; Leipzig University; Max Planck Society	Breitenstein, C (corresponding author), Univ Munster, Dept Gen Neurol, Munster, Germany.	caterina.breitenstein@uni-muenster.de	Häusler, Karl Georg/AAS-5962-2021; Willmes, Klaus F/A-1268-2014; Floel, Agnes/A-9426-2017; Bruehl, Stefanie/D-3059-2017; Schulz, Jorg B./D-9786-2012	Willmes, Klaus F/0000-0002-9012-0553; Bruehl, Stefanie/0000-0003-4826-1990; Villringer, Arno/0000-0003-2604-2404; Schulz, Jorg B./0000-0002-8903-0593	German Federal Ministry of Education and Research; German Society for Aphasia Research and Treatment; German Federal Ministry of Education and Research (BMBF) [01GY1144]; German Society for Aphasia Research and Treatment (GAB)	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Society for Aphasia Research and Treatment; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Society for Aphasia Research and Treatment (GAB)	German Federal Ministry of Education and Research and the German Society for Aphasia Research and Treatment.; This investigator-initiated trial was funded by the German Federal Ministry of Education and Research (BMBF; identifier, 01GY1144) and the German Society for Aphasia Research and Treatment (GAB). Further acknowledgements are given in the appendix.	Allen L, 2012, TOP STROKE REHABIL, V19, P523, DOI 10.1310/tsr1906-523; Bakheit AMO, 2007, CLIN REHABIL, V21, P885, DOI 10.1177/0269215507078486; Baumgaertner A, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-308; Bhogal SK, 2003, STROKE, V34, P987, DOI 10.1161/01.STR.0000062343.64383.D0; BLOMERT L, 1994, APHASIOLOGY, V8, P381, DOI 10.1080/02687039408248666; Bowen A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4407; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Brady MC, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000425.pub4; Cherney LR, 2011, CURR NEUROL NEUROSCI, V11, P560, DOI 10.1007/s11910-011-0227-6; de Jong-Hagelstein M, 2011, J NEUROL NEUROSUR PS, V82, P399, DOI 10.1136/jnnp.2010.210559; Dickey L, 2010, ARCH PHYS MED REHAB, V91, P196, DOI 10.1016/j.apmr.2009.09.020; Dignam J, 2015, STROKE, V46, P2206, DOI 10.1161/STROKEAHA.115.009522; Dijkerman HC, 1996, J ROY COLL PHYS LOND, V30, P538; Doesborgh SJC, 2004, STROKE, V35, P141, DOI 10.1161/01.STR.0000105460.52928.A6; Doucet T., 2012, Annals of Physical and Rehabilitation Medicine, V55, P112, DOI 10.1016/j.rehab.2012.01.007; Ellis C, 2012, STROKE, V43, P1429, DOI 10.1161/STROKEAHA.111.647339; Fisher A, 2014, J STROKE CEREBROVASC, V23, P759, DOI 10.1016/j.jstrokecerebrovasdis.2013.06.035; Hilari K, 2003, STROKE, V34, P1944, DOI 10.1161/01.STR.0000081987.46660.ED; Hilari K, 2011, DISABIL REHABIL, V33, P211, DOI 10.3109/09638288.2010.508829; Huber W, 1984, Adv Neurol, V42, P291; Knecht S, 2016, J NEUROL NEUROSUR PS, V87, P526, DOI 10.1136/jnnp-2015-310344; Laska AC, 2011, CEREBROVASC DIS EXTR, V1, P66, DOI 10.1159/000329835; LOMAS J, 1989, J SPEECH HEAR DISORD, V54, P113, DOI 10.1044/jshd.5401.113; Meinzer M, 2005, STROKE, V36, P1462, DOI 10.1161/01.STR.0000169941.29831.2a; Pollock A, 2012, LANCET NEUROL, V11, P209, DOI 10.1016/S1474-4422(12)70029-7; Pulvermuller F, 2001, STROKE, V32, P1621, DOI 10.1161/01.STR.32.7.1621; Ramos-Murguialday A, 2013, ANN NEUROL, V74, P100, DOI 10.1002/ana.23879; Robey RR, 1998, J SPEECH LANG HEAR R, V41, P172, DOI 10.1044/jslhr.4101.172; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; WERTZ RT, 1986, ARCH NEUROL-CHICAGO, V43, P653, DOI 10.1001/archneur.1986.00520070011008; Willmes K., 1999, VERBALER NONVERBALER	31	142	146	4	58	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 15	2017	389	10078					1528	1538		10.1016/S0140-6736(17)30067-3	http://dx.doi.org/10.1016/S0140-6736(17)30067-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER7OP	28256356	Green Submitted			2022-12-28	WOS:000399002900026
J	Mosialou, I; Shikhel, S; Liu, JM; Maurizi, A; Luo, N; He, ZY; Huang, YR; Zong, HH; Friedman, RA; Barasch, J; Lanzano, P; Deng, LY; Leibel, RL; Rubin, M; Nicholas, T; Chung, W; Zeltser, LM; Williams, KW; Pessin, JE; Kousteni, S				Mosialou, Ioanna; Shikhel, Steven; Liu, Jian-Min; Maurizi, Antonio; Luo, Na; He, Zhenyan; Huang, Yiru; Zong, Haihong; Friedman, Richard A.; Barasch, Jonathan; Lanzano, Patricia; Deng, Liyong; Leibel, Rudolph L.; Rubin, Mishaela; Nicholas, Thomas; Chung, Wendy; Zeltser, Lori M.; Williams, Kevin W.; Pessin, Jeffrey E.; Kousteni, Stavroula			MC4R-dependent suppression of appetite by bone-derived lipocalin 2	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; INSULIN-RECEPTOR; BODY-WEIGHT; ENERGY-BALANCE; NEURONS; OSTEOBLASTS; OBESITY; EXPRESSION; MICE; PROOPIOMELANOCORTIN	Bone has recently emerged as a pleiotropic endocrine organ that secretes at least two hormones, FGF23 and osteocalcin, which regulate kidney function and glucose homeostasis, respectively. These findings have raised the question of whether other bone-derived hormones exist and what their potential functions are. Here we identify, through molecular and genetic analyses in mice, lipocalin 2 (LCN2) as an osteoblast-enriched, secreted protein. Loss-and gain-of-function experiments in mice demonstrate that osteoblast-derived LCN2 maintains glucose homeostasis by inducing insulin secretion and improves glucose tolerance and insulin sensitivity. In addition, osteoblast-derived LCN2 inhibits food intake. LCN2 crosses the blood-brain barrier, binds to the melanocortin 4 receptor (MC4R) in the paraventricular and ventromedial neurons of the hypothalamus and activates an MC4R-dependent anorexigenic (appetite-suppressing) pathway. These results identify LCN2 as a bone-derived hormone with metabolic regulatory effects, which suppresses appetite in a MC4R-dependent manner, and show that the control of appetite is an endocrine function of bone.	[Mosialou, Ioanna; Shikhel, Steven; Liu, Jian-Min; Maurizi, Antonio; Luo, Na; Kousteni, Stavroula] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [He, Zhenyan; Huang, Yiru] Southern Med Univ, Zhujiang Hosp, Dept Neurosurg, Guangzhou 510515, Guangdong, Peoples R China; [He, Zhenyan; Huang, Yiru; Williams, Kevin W.] Univ Texas Southwestern Med Ctr Dallas, Div Hypothalam Res, Dallas, TX 75390 USA; [Zong, Haihong; Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Med & Mol Pharmacol, Bronx, NY 10461 USA; [Friedman, Richard A.] Columbia Univ, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, Biomed Informat Shared Resource,Dept Biomed Infor, New York, NY 10032 USA; [Barasch, Jonathan] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Lanzano, Patricia; Deng, Liyong; Leibel, Rudolph L.; Chung, Wendy] Columbia Univ, Coll Phys & Surg, Naomi Berrie Diabet Ctr, New York, NY 10032 USA; [Lanzano, Patricia; Deng, Liyong; Leibel, Rudolph L.; Chung, Wendy] Columbia Univ, Coll Phys & Surg, Div Mol Genet, Dept Pediat, New York, NY 10032 USA; [Rubin, Mishaela] Columbia Univ, Coll Phys & Surg, Metab Bone Dis Unit, Dept Med, New York, NY 10032 USA; [Nicholas, Thomas] Columbia Univ, Coll Phys & Surg, Dept Med Nephrol, New York, NY 10032 USA; [Zeltser, Lori M.] Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY 10032 USA; [Zeltser, Lori M.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Liu, Jian-Min] Shanghai Jiao Tong Univ, Sch Med, Shanghai Rui Jin Hosp, Dept Endocrine & Metab Dis, Shanghai 200025, Peoples R China; [Maurizi, Antonio] Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy	Columbia University; Southern Medical University - China; University of Texas System; University of Texas Southwestern Medical Center Dallas; Yeshiva University; Albert Einstein College of Medicine; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Shanghai Jiao Tong University; University of L'Aquila	Kousteni, S (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA.	sk2836@cumc.columbia.edu	Maurizi, Antonio/AAI-7728-2020; Williams, Kevin W/ABD-5818-2021; Williams, Kevin W/AAA-4243-2020	Williams, Kevin W/0000-0002-8434-8658; Williams, Kevin W/0000-0002-8434-8658; Liu, Jian-min/0000-0002-0179-1751; Maurizi, Antonio/0000-0002-7027-4694	National Institutes of Health [R01AR054447, P01AG032959, R01AR055931, R01DK100699, R01DK52431, P30DK26687, P30DK063608]; NOVO Nordisk; T32 Training Grant [DK07328]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055931, R01AR054447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007328, P30DK020541, P30DK063608, P30DK026687, P60DK020541, R01DK100699, R01DK052431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG032959] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NOVO Nordisk(Novo Nordisk); T32 Training Grant; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors are grateful to A. Tarasenco for technical assistance, the Histology and Metabolic Unit facility of the Diabetes and Endocrinology Research Center (DERC, NIDDK DK063608-07), R. Tomaino of the Taplin Mass Spectrometry Facility, Harvard Medical School and the Albert Einstein DRTC Animal Physiology Core (NIDDK DK20541). This work was supported by the National Institutes of Health R01AR054447, P01AG032959 and R01AR055931 to S.K., R01DK100699 to K.W.W., R01DK52431 to R.L.L. and W.C., P30DK26687 to R.L.L. and W.C., P30DK063608 to R.L.L. and W.C., NOVO Nordisk to S.K and by the T32 Training Grant DK07328 to S.S.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Batterham RL, 2006, CELL METAB, V4, P223, DOI 10.1016/j.cmet.2006.08.001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berglund ED, 2014, NAT NEUROSCI, V17, P911, DOI 10.1038/nn.3737; Bhattacharyya N, 2012, TRENDS ENDOCRIN MET, V23, P610, DOI 10.1016/j.tem.2012.07.002; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Butler AA, 2002, NEUROPEPTIDES, V36, P77, DOI 10.1054/npep.2002.0890; Choudhury AI, 2005, J CLIN INVEST, V115, P940; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, P24; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Coll AP, 2004, J CLIN ENDOCR METAB, V89, P2557, DOI 10.1210/jc.2004-0428; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Garfield AS, 2015, NAT NEUROSCI, V18, P863, DOI 10.1038/nn.4011; Guo H, 2010, DIABETES, V59, P1376, DOI 10.2337/db09-1735; Hinney A, 2006, J CLIN ENDOCR METAB, V91, P1761, DOI 10.1210/jc.2005-2056; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Kalajzic Z, 2002, BONE, V31, P654, DOI 10.1016/S8756-3282(02)00912-2; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; Kode A, 2012, J CLIN INVEST, V122, P3490, DOI 10.1172/JCI64906; Kublaoui BM, 2006, MOL ENDOCRINOL, V20, P2483, DOI 10.1210/me.2005-0483; Larsen LH, 2005, J CLIN ENDOCR METAB, V90, P219, DOI 10.1210/jc.2004-0497; Law IKM, 2010, DIABETES, V59, P872, DOI 10.2337/db09-1541; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Lin Y, 2001, J BIOL CHEM, V276, P42077, DOI 10.1074/jbc.M107101200; Liu HY, 2003, J NEUROSCI, V23, P7143, DOI 10.1523/JNEUROSCI.23-18-07143.2003; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Myers MG, 2012, NATURE, V491, P357, DOI 10.1038/nature11705; Nix MA, 2013, CHEM BIOL, V20, P784, DOI 10.1016/j.chembiol.2013.04.015; Paragas N, 2011, NAT MED, V17, P216, DOI 10.1038/nm.2290; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Qiang GF, 2016, MOL METAB, V5, P480, DOI 10.1016/j.molmet.2016.05.005; Rached MT, 2010, J CLIN INVEST, V120, P357, DOI 10.1172/JCI39901; Scheller EL, 2016, TRENDS ENDOCRIN MET, V27, P392, DOI 10.1016/j.tem.2016.03.016; Sohn JW, 2011, NEURON, V71, P488, DOI 10.1016/j.neuron.2011.06.012; Soukas A, 2000, GENE DEV, V14, P963; Ste Marie L, 2000, P NATL ACAD SCI USA, V97, P12339, DOI 10.1073/pnas.220409497; van den Pol AN, 2009, J NEUROSCI, V29, P4622, DOI 10.1523/JNEUROSCI.3249-08.2009; Williams KW, 2014, CELL METAB, V20, P471, DOI 10.1016/j.cmet.2014.06.002; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yoshikawa Y, 2011, J BONE MINER RES, V26, P2012, DOI 10.1002/jbmr.417; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200	51	203	220	11	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2017	543	7645					385	+		10.1038/nature21697	http://dx.doi.org/10.1038/nature21697			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9RN	28273060	Green Accepted			2022-12-28	WOS:000396337400043
J	Kupferschmidt, K				Kupferschmidt, Kai			At 10, Europe's 'excellence' fund ponders changes	SCIENCE			English	News Item																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI		1002	1003		10.1126/science.355.6329.1002	http://dx.doi.org/10.1126/science.355.6329.1002			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9VY	28280159				2022-12-28	WOS:000396348900009
J	Shen, Y; Wang, Y; Chen, T; Gao, F; Gong, JH; Abramczyk, D; Walker, R; Zhao, HC; Chen, SH; Liu, W; Luo, YS; Muller, CA; Paul-Dubois-Taine, A; Alver, B; Stracquadanio, G; Mitchell, LA; Luo, ZQ; Fan, YQ; Zhou, BJ; Wen, B; Tan, FJ; Wang, YJ; Zi, J; Xie, ZX; Li, BZ; Yang, K; Richardson, SM; Jiang, H; French, CE; Nieduszynski, CA; Koszul, R; Marston, AL; Yuan, YJ; Wang, J; Bader, JS; Dai, JB; Boeke, JD; Xu, X; Cai, YZ; Yang, HM				Shen, Yue; Wang, Yun; Chen, Tai; Gao, Feng; Gong, Jianhui; Abramczyk, Dariusz; Walker, Roy; Zhao, Hongcui; Chen, Shihong; Liu, Wei; Luo, Yisha; Mueller, Carolin A.; Paul-Dubois-Taine, Adrien; Alver, Bonnie; Stracquadanio, Giovanni; Mitchell, Leslie A.; Luo, Zhouqing; Fan, Yanqun; Zhou, Baojin; Wen, Bo; Tan, Fengji; Wang, Yujia; Zi, Jin; Xie, Zexiong; Li, Bingzhi; Yang, Kun; Richardson, Sarah M.; Jiang, Hui; French, Christopher E.; Nieduszynski, Conrad A.; Koszul, Romain; Marston, Adele L.; Yuan, Yingjin; Wang, Jian; Bader, Joel S.; Dai, Junbiao; Boeke, Jef D.; Xu, Xun; Cai, Yizhi; Yang, Huanming			Deep functional analysis of synII, a 770-kilobase synthetic yeast chromosome	SCIENCE			English	Article							TRANSFER-RNA DECAY; GENOME; SEQUENCE; DUPLICATION; EXPLORATION; ALIGNMENT; CLONING; GENES; ACID	Here, we report the successful design, construction, and characterization of a 770-kilobase synthetic yeast chromosome II (synII). Our study incorporates characterization at multiple levels-including phenomics, transcriptomics, proteomics, chromosome segregation, and replication analysis-to provide a thorough and comprehensive analysis of a synthetic chromosome. Our Trans-Omics analyses reveal a modest but potentially relevant pervasive up-regulation of translational machinery observed in synII, mainly caused by the deletion of 13 transfer RNAs. By both complementation assays and SCRaMbLE (synthetic chromosome rearrangement and modification by loxP-mediated evolution), we targeted and debugged the origin of a growth defect at 37 degrees C in glycerol medium, which is related to misregulation of the high-osmolarity glycerol response. Despite the subtle differences, the synII strain shows highly consistent biological processes comparable to the native strain.	[Shen, Yue; Wang, Yun; Chen, Tai; Gao, Feng; Gong, Jianhui; Zhao, Hongcui; Chen, Shihong; Fan, Yanqun; Zhou, Baojin; Wen, Bo; Tan, Fengji; Wang, Yujia; Zi, Jin; Jiang, Hui; Wang, Jian; Xu, Xun; Yang, Huanming] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Shen, Yue; Abramczyk, Dariusz; Walker, Roy; Liu, Wei; Luo, Yisha; Paul-Dubois-Taine, Adrien; Alver, Bonnie; French, Christopher E.; Marston, Adele L.; Cai, Yizhi] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3BF, Midlothian, Scotland; [Mueller, Carolin A.; Nieduszynski, Conrad A.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Stracquadanio, Giovanni; Yang, Kun; Richardson, Sarah M.] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Stracquadanio, Giovanni; Richardson, Sarah M.; Bader, Joel S.] Johns Hopkins Univ, Sch Engn, Dept Biomed Engn, Baltimore, MD 21218 USA; [Mitchell, Leslie A.; Bader, Joel S.; Boeke, Jef D.] NYU, Langone Med Ctr, Inst Syst Genet, ACLSW Room 503,430 East 29th St, New York, NY 10016 USA; [Luo, Zhouqing; Dai, Junbiao] Tsinghua Univ, Key Lab Ind Biocatalysis, Minist Educ, Ctr Synthet & Syst Biol,Sch Life Sci, Beijing 100084, Peoples R China; [Xie, Zexiong; Li, Bingzhi; Yuan, Yingjin] Tianjin Univ, Key Lab Syst Bioengn, Minist Educ,Sch Chem Engn & Technol, SynBio Res Platform,Collaborat Innovat Ctr Chem S, Tianjin 300072, Peoples R China; [Koszul, Romain] Inst Pasteur, CNRS, UMR3525, Dept Genomes & Genet, 25-28 Rue Docteur Roux, F-75724 Paris 15, France; [Shen, Yue; Yang, Huanming] James D Watson Inst Genome Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Shen, Yue; Wang, Yun; Chen, Tai; Xu, Xun] BGI Qingdao, Qingdao 266555, Peoples R China; [Stracquadanio, Giovanni] Univ Essex, Sch Comp Sci & Elect Engn, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England	Beijing Genomics Institute (BGI); University of Edinburgh; University of Oxford; Johns Hopkins University; Johns Hopkins University; New York University; NYU Langone Medical Center; Tsinghua University; Tianjin University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Beijing Genomics Institute (BGI); University of Essex	Yang, HM (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.; Cai, YZ (corresponding author), Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3BF, Midlothian, Scotland.; Yang, HM (corresponding author), James D Watson Inst Genome Sci, Hangzhou 310058, Zhejiang, Peoples R China.	yizhi.cai@ed.ac.uk; yanghm@genomics.cn	Stracquadanio, Giovanni/AAL-2648-2021; li, bing/GWQ-9617-2022; Xu, Xun/AAI-6763-2020; Dai, Junbiao/AAB-8328-2021; Luo, Zhouqing/E-3186-2017; Wen, Bo/I-1259-2019; Zi, Jin/AAH-8620-2020; Nieduszynski, Conrad/B-2170-2010; li, bz/GVR-7133-2022; Cai, Yizhi/A-3550-2010	Stracquadanio, Giovanni/0000-0001-9819-3645; Xu, Xun/0000-0002-5338-5173; Dai, Junbiao/0000-0002-5299-4700; Luo, Zhouqing/0000-0001-5426-5176; Wen, Bo/0000-0003-2261-3150; Nieduszynski, Conrad/0000-0003-2001-076X; Zhou, Baojin/0000-0002-8255-3439; Walker, Roy/0000-0003-0960-4591; Koszul, Romain/0000-0002-3086-1173; Chen, Shihong/0000-0003-2999-0426; Marston, Adele/0000-0002-3596-9407; Cai, Yizhi/0000-0003-1663-2865; Richardson, Sarah/0000-0002-9820-9421; Mitchell, Leslie/0000-0001-7869-9817	China National High Technology Research and Development Program ("863" Program) [2012AA02A708]; National Natural Science Foundation of China [21621004, 21390203]; University of Edinburgh; Scottish Universities Life Sciences Alliance and Biotechnology and Biological Sciences Research Council [BB/M005690/1, BB/M025640/1, BB/M00029X/1]; Wellcome Trust [090903, 092076]; U.S. NSF [MCB-1026068, MCB-1158201, MCB-1445545]; U.S. Department of Energy [DE-FG02097ER25308]; National Science Foundation of China [31471254]; Chinese Ministry of Science and Technology [2012CB725201]; ERASynBio; Agence Nationale pour la Recherche [IESY ANR-14-SYNB-0001-03]; BBSRC [BB/M005690/1, BB/K007211/1, BB/M025640/1, BB/M00029X/1, BB/N016858/1, BB/K007211/2, BB/M005690/2] Funding Source: UKRI; EPSRC [EP/P017401/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M00029X/1, BBS/OS/GC/000001, BB/K007211/2, BB/K007211/1, BB/M005690/1, BB/N016858/1, BB/M025640/1, BB/M005690/2] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/P017401/1] Funding Source: researchfish; Div Of Molecular and Cellular Bioscience [1616111] Funding Source: National Science Foundation	China National High Technology Research and Development Program ("863" Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Edinburgh; Scottish Universities Life Sciences Alliance and Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); U.S. NSF(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); ERASynBio; Agence Nationale pour la Recherche(French National Research Agency (ANR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The project was funded by China National High Technology Research and Development Program ("863" Program: 2012AA02A708) to H.Y. and National Natural Science Foundation of China (21621004 and 21390203) to Y.Y.; a Chancellor's Fellowship from the University of Edinburgh, a start-up fund from Scottish Universities Life Sciences Alliance and Biotechnology and Biological Sciences Research Council grants (BB/M005690/1, BB/M025640/1, and BB/M00029X/1) to Y.C.; the Wellcome Trust to A.M. (090903 and 092076); U.S. NSF grants MCB-1026068 and MCB-1158201 to J.D.B.; U.S. NSF grant MCB-1445545 to J.S.B.; and U.S. Department of Energy grant DE-FG02097ER25308 to S.M.R. Work at Tsinghua University was supported by National Science Foundation of China grant 31471254 and Chinese Ministry of Science and Technology grant 2012CB725201 to J.D. Funding from ERASynBio and Agence Nationale pour la Recherche (IESY ANR-14-SYNB-0001-03) to R.K. We thank W. Zhang for many comments on the manuscript. J.D.B. and J.S.B. are founders and directors of Neochromosome Inc. J.D.B. serves as a scientific advisor to Recombinetics Inc. and Sample6, Inc. These arrangements are reviewed and managed by the committees on conflict of interest at New York University Langone Medical Center (J.D.B.) and Johns Hopkins University (J.S.B.). Y.C., H.Y., and J.D.B. conceived the concept and designed the experiments. L.M., G.S., S.M.R., J.S.B., and J.D.B. designed the synII chromosome. Y.S., Y.W., T.C., J.G., Y.L., and Y.C. designed experiments. T.C., F.G., H.Z., Y.S., S.C., D.A., Z.L., R.W., W.L., and F.T. performed experiments. Y.W. and J.G. analyzed genomic and RNA-seq data. Y.F., B.Z., and J.G. analyzed mass spectrometry and LC-MS data. Y.S. and D.A. analyzed synII cell cycle data. C.M. and C.N. analyzed synII replication timing profiles. G.M., H.M., and R.K. analyzed synII 3C/3D structure. The manuscript was written by Y.S., Y.W., T.C., F.G., J.D., and Y.C., with input from C.M., C.N., R.K., C.F., A.M., J.S.B, J.D.B., and H.Y. and with comments provided by all other authors. SynII genomic sequencing data and RNA-seq data have been deposited in the Sequence Read Archive (SRA) sequence database (www.ncbi.nlm.nih.gov/sra/), accession code SRP062892. Proteomics data have been submitted to the ProteomeXchange (www.proteomexchange.org/), accession code PXD003435. The metabolomics and lipidomics data have been deposited to the MetaboLights metabolomics repository (accession number MTBLS296; accessed via link www.ebi.ac.uk/metabolights/MTBLS296). The designed and sequenced synII information is uploaded with accession codes CP013607 and CP013608 on GenBank. Additional information [synII design diagram, PCRTag sequences, variants in physical strain (yeast_chr02_9_01), PCR primers, and summary of megachunks, chunks, and minichunks] related to synII can be accessed on the Sc2.0 website (www.syntheticyeast.org).	Alexandrov A, 2006, MOL CELL, V21, P87, DOI 10.1016/j.molcel.2005.10.036; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Annaluru N, 2014, SCIENCE, V344, P55, DOI 10.1126/science.1249252; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bitinaite J, 2007, NUCLEIC ACIDS RES, V35, P1992, DOI 10.1093/nar/gkm041; Bloom-Ackermann Z, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004084; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Brachat S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r45; COLLEAUX L, 1988, P NATL ACAD SCI USA, V85, P6022, DOI 10.1073/pnas.85.16.6022; Dewe JM, 2012, RNA, V18, P1886, DOI 10.1261/rna.033654.112; Di Rienzi SC, 2009, GENOME BIOL EVOL, V1, P350, DOI 10.1093/gbe/evp034; Dymond J, 2012, BIOENGINEERED, V3, P168, DOI 10.4161/bbug.19543; Dymond JS, 2011, NATURE, V477, P471, DOI 10.1038/nature10403; FELDMANN H, 1994, EMBO J, V13, P5795, DOI 10.1002/j.1460-2075.1994.tb06923.x; Fernius J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000629; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Herschleb J, 2007, NAT PROTOC, V2, P677, DOI 10.1038/nprot.2007.94; Jewison T, 2012, NUCLEIC ACIDS RES, V40, pD815, DOI 10.1093/nar/gkr916; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kim SK, 2010, J MICROBIOL BIOTECHN, V20, P356, DOI 10.4014/jmb.0909.09041; Langkjaer RB, 2000, J MOL BIOL, V304, P271, DOI 10.1006/jmbi.2000.4209; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lartigue C, 2007, SCIENCE, V317, P632, DOI 10.1126/science.1144622; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lindstrom DL, 2009, GENETICS, V183, P413, DOI 10.1534/genetics.109.106229; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Menzella HG, 2005, NAT BIOTECHNOL, V23, P1171, DOI 10.1038/nbt1128; Mercy G, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4597; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Mitchell LA, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4831; Muller CA, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt878; Muller M, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2818565; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Ozier-Kalogeropoulos O, 1998, NUCLEIC ACIDS RES, V26, P5511, DOI 10.1093/nar/26.23.5511; Parenteau J, 2008, MOL BIOL CELL, V19, P1932, DOI 10.1091/mbc.E07-12-1254; Parenteau J, 2015, CELL REP, V13, P2516, DOI 10.1016/j.celrep.2015.11.033; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Richardson SM, 2017, SCIENCE, V355, P1040, DOI 10.1126/science.aaf4557; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; RYCHLIK W, 1990, NUCLEIC ACIDS RES, V18, P6409, DOI 10.1093/nar/18.21.6409; Shen Y, 2016, GENOME RES, V26, P36, DOI 10.1101/gr.193433.115; Tanigawa M, 2012, MOL CELL BIOL, V32, P2861, DOI 10.1128/MCB.06111-11; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wen B, 2014, PROTEOMICS, V14, P2280, DOI 10.1002/pmic.201300361; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Wu Y, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4706; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Xie ZX, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4704; Zhang WM, 2017, SCIENCE, V355, DOI 10.1126/science.aaf3981	53	143	176	17	249	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI				eaaf4791	10.1126/science.aaf4791	http://dx.doi.org/10.1126/science.aaf4791			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9VY	28280153	Green Accepted, Green Submitted			2022-12-28	WOS:000396348900034
J	Hu, B; Lara-Tejero, M; Kong, QK; Galan, JE; Liu, J				Hu, Bo; Lara-Tejero, Maria; Kong, Qingke; Galan, Jorge E.; Liu, Jun			In Situ Molecular Architecture of the Salmonella Type III Secretion Machine	CELL			English	Article							BACTERIAL FLAGELLAR MOTORS; PROTEIN SECRETION; SORTING PLATFORM; EXPORT APPARATUS; TERMINAL DOMAIN; SYSTEM; TYPHIMURIUM; NEEDLE; VISUALIZATION; INJECTISOME	Type III protein secretion systems have specifically evolved to deliver bacterially encoded proteins into target eukaryotic cells. The core elements of this multi-protein machine are the envelope-associated needle complex, the inner membrane export apparatus, and a large cytoplasmic sorting platform. Here, we report a high-resolution in situ structure of the Salmonella Typhimurium type III secretion machine obtained by high-throughput cryo-electron tomography and sub-tomogram averaging. Through molecular modeling and comparative analysis of machines assembled with protein-tagged components or from different deletion mutants, we determined the molecular architecture of the secretion machine in situ and localized its structural components. We also show that docking of the sorting platform results in significant conformational changes in the needle complex to provide the symmetry adaptation required for the assembly of the entire secretion machine. These studies provide major insight into the structure and assembly of a broadly distributed protein secretion machine.	[Hu, Bo; Liu, Jun] Univ Texas Med Sch Houston, Dept Pathol & Lab Med, Houston, TX 77030 USA; [Lara-Tejero, Maria; Galan, Jorge E.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06536 USA; [Kong, Qingke] Univ Florida, Coll Vet Med, Dept Infect Dis, Gainesville, FL 32608 USA	University of Texas System; University of Texas Health Science Center Houston; Yale University; State University System of Florida; University of Florida	Liu, J (corresponding author), Univ Texas Med Sch Houston, Dept Pathol & Lab Med, Houston, TX 77030 USA.; Galan, JE (corresponding author), Yale Univ, Sch Med, Dept Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06536 USA.	jorge.galan@yale.edu; jun.liu.1@uth.tmc.edu	Kong, Qingke/K-3384-2019		National Institute of Allergy and Infectious Diseases [AI030492, AI112680]; National Institute of General Medicine [GM107629]; Welch Foundation [AU-1714]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI112680, R01AI030492, R01AI087946, R37AI030492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107629] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Galan laboratory for critical reading of the manuscript. This work was supported by grants AI030492 (to J.E.G.) and AI112680 (to Q.K.) from the National Institute of Allergy and Infectious Diseases, GM107629 from the National Institute of General Medicine (to J.L.), and AU-1714 from the Welch Foundation (to J.L.).	Abrusci P, 2013, NAT STRUCT MOL BIOL, V20, P99, DOI 10.1038/nsmb.2452; Agulleiro JI, 2015, J STRUCT BIOL, V189, P147, DOI 10.1016/j.jsb.2014.11.009; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Akeda Y, 2004, J BACTERIOL, V186, P2402, DOI 10.1128/JB.186.8.2402-2412.2004; Bergeron JRC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003307; Burkinshaw BJ, 2014, BBA-MOL CELL RES, V1843, P1649, DOI 10.1016/j.bbamcr.2014.01.035; Carleton HA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2594; Chang YW, 2016, SCIENCE, V351, DOI 10.1126/science.aad2001; Charro N, 2015, EXPERT OPIN DRUG DIS, V10, P373, DOI 10.1517/17460441.2015.1019860; Chatterjee S, 2013, BIOCHEMISTRY-US, V52, P2508, DOI 10.1021/bi400160a; Ciferri C, 2015, J STRUCT BIOL, V192, P159, DOI 10.1016/j.jsb.2015.09.016; Ciferri C, 2012, ELIFE, V1, DOI 10.7554/eLife.00005; Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200; Cornelis GR, 2010, BIOL CHEM, V391, P745, DOI 10.1515/BC.2010.079; Diepold A, 2010, EMBO J, V29, P1928, DOI 10.1038/emboj.2010.84; Erhardt M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000299; FRANCIS NR, 1994, J MOL BIOL, V235, P1261, DOI 10.1006/jmbi.1994.1079; GALAN JE, 1990, INFECT IMMUN, V58, P1879; Galan JE, 2014, ANNU REV MICROBIOL, V68, P415, DOI 10.1146/annurev-micro-092412-155725; Galkin VE, 2010, J MOL BIOL, V396, P1392, DOI 10.1016/j.jmb.2010.01.001; Gu LL, 2015, MOLECULES, V20, P17659, DOI 10.3390/molecules200917659; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hu B, 2015, P NATL ACAD SCI USA, V112, P1047, DOI 10.1073/pnas.1411610112; Ibuki T, 2011, NAT STRUCT MOL BIOL, V18, P277, DOI 10.1038/nsmb.1977; Imada K, 2016, P NATL ACAD SCI USA, V113, P3633, DOI 10.1073/pnas.1524025113; Jackson MW, 2000, FEMS MICROBIOL LETT, V186, P85, DOI 10.1111/j.1574-6968.2000.tb09086.x; KANIGA K, 1994, MOL MICROBIOL, V13, P555, DOI 10.1111/j.1365-2958.1994.tb00450.x; Kawamoto A, 2013, SCI REP-UK, V3, DOI 10.1038/srep03369; Kosarewicz A, 2012, PHILOS T R SOC B, V367, P1140, DOI 10.1098/rstb.2011.0205; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Lara-Tejero M, 2011, SCIENCE, V331, P1188, DOI 10.1126/science.1201476; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Loquet A, 2012, NATURE, V486, P276, DOI 10.1038/nature11079; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Makino F, 2016, SCI REP-UK, V6, DOI 10.1038/srep33341; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McDowell MA, 2011, J BIOL CHEM, V286, P30606, DOI 10.1074/jbc.M111.243865; Morado DR, 2016, JOVE-J VIS EXP, DOI 10.3791/53608; Nans A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10114; Notti RQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8125; Pallen MJ, 2005, FEMS MICROBIOL REV, V29, P201, DOI 10.1016/j.femsre.2005.01.001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Radics J, 2014, NAT STRUCT MOL BIOL, V21, P82, DOI 10.1038/nsmb.2722; Schraidt O, 2011, SCIENCE, V331, P1192, DOI 10.1126/science.1199358; Spaeth KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000579; Thomas D, 2001, J BACTERIOL, V183, P6404, DOI 10.1128/JB.183.21.6404-6412.2001; Tsou LK, 2016, J AM CHEM SOC, V138, P2209, DOI 10.1021/jacs.5b11575; Wagner S, 2010, P NATL ACAD SCI USA, V107, P17745, DOI 10.1073/pnas.1008053107; Winkler H, 2007, J STRUCT BIOL, V157, P126, DOI 10.1016/j.jsb.2006.07.014; Worrall LJ, 2010, PROTEIN SCI, V19, P1091, DOI 10.1002/pro.382	53	128	130	0	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2017	168	6					1065	+		10.1016/j.cell.2017.02.022	http://dx.doi.org/10.1016/j.cell.2017.02.022			20	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8ZF	28283062	Green Accepted, Bronze			2022-12-28	WOS:000396287900014
J	di Biase, L; Picillo, M; Freitas, ME; Bui, E; Fasano, A				di Biase, Lazzaro; Picillo, Marina; Freitas, Maria Eliza; Bui, Esther; Fasano, Alfonso			Hepatitis C Virus-Related Hepatic Myelopathy After Treatment With Sofosbuvir and Ribavirin: A Case Report	ANNALS OF INTERNAL MEDICINE			English	Letter							DISEASE		[di Biase, Lazzaro] Campus Biomed Univ Rome, Rome, Italy; [Picillo, Marina] Univ Salerno, Salerno, Italy; [Freitas, Maria Eliza] Toronto Western Hosp, Toronto, ON, Canada; [Freitas, Maria Eliza] Univ Hlth Network, Toronto, ON, Canada; [Bui, Esther; Fasano, Alfonso] Toronto Western Hosp, Univ Hlth Network, Toronto, ON, Canada; [Bui, Esther; Fasano, Alfonso] Univ Toronto, Toronto, ON, Canada	University Campus Bio-Medico - Rome Italy; University of Salerno; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	di Biase, L (corresponding author), Campus Biomed Univ Rome, Rome, Italy.		picillo, marina/AAC-2210-2019; di Biase, Lazzaro/AAK-4842-2020; Picillo, Marina/AAF-4297-2020; Fasano, Alfonso/K-2558-2018	picillo, marina/0000-0001-9025-137X; di Biase, Lazzaro/0000-0001-8753-757X; Fasano, Alfonso/0000-0001-5346-0180	Paul and Susan Hansen Clinical Fellowship Award; University of Toronto, McLaughlin Centre; Michael J. Fox Foundation	Paul and Susan Hansen Clinical Fellowship Award; University of Toronto, McLaughlin Centre; Michael J. Fox Foundation	Dr. Freitas is supported by the Paul and Susan Hansen Clinical Fellowship Award. Dr. Fasano is supported by grants from the University of Toronto, McLaughlin Centre, and Michael J. Fox Foundation.	Caldwell C, 2010, LIVER TRANSPLANT, V16, P818, DOI 10.1002/lt.22077; Conn HO, 2006, SCAND J GASTROENTERO, V41, P619, DOI 10.1080/00365520500318932; LIVERSED.LA, 1966, LANCET, V1, P277; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145	4	5	5	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2017	166	5					379	380		10.7326/L16-0038	http://dx.doi.org/10.7326/L16-0038			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BO	28265655				2022-12-28	WOS:000396432800020
J	Carruthers, J; Holmes, A; Majeed, A				Carruthers, Jack; Holmes, Alison; Majeed, Azeem			A suspected viral rash in pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RUBELLA		[Carruthers, Jack; Majeed, Azeem] Imperial Coll London, Dept Primary Care & Publ Hlth, London, England; [Holmes, Alison] Imperial Coll London, Dept Med, London, England	Imperial College London; Imperial College London	Carruthers, J (corresponding author), Imperial Coll London, Dept Primary Care & Publ Hlth, London, England.	jack.carruthers@gmail.com		Majeed, Azeem/0000-0002-2357-9858	Northwest London National Institute for Collaboration for Leadership in Applied Health Research and Care; Imperial NIHR Biomedical Research Centre	Northwest London National Institute for Collaboration for Leadership in Applied Health Research and Care; Imperial NIHR Biomedical Research Centre(National Institute for Health Research (NIHR))	Thanks to KF for her invaluable input in the role of providing the patient's perspective. Imperial College London is grateful for support from the Northwest London National Institute for Collaboration for Leadership in Applied Health Research and Care and the Imperial NIHR Biomedical Research Centre. The views expressed in this publication are those of the authors.	Ahmad SSY, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1062; Banatvala JE, 2004, LANCET, V363, P1127, DOI 10.1016/S0140-6736(04)15897-2; Banerjee A, 2016, ALERT RUBELLA INFECT; Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049; Best JM, 2002, BRIT MED J, V325, P147, DOI 10.1136/bmj.325.7356.147; Health Protection Agency, 2011, GUID VIR RASH PREGN; Jones SV, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3489; MacMahon E, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1790; Mangtani P, 2007, EPIDEMIOL INFECT, V135, P139, DOI 10.1017/S0950268806006479; Miller E., 1993, Reviews in Medical Microbiology, V4, P222; Plotkin SA, 2006, CLIN INFECT DIS, V43, pS164, DOI 10.1086/505950; Royal College of Obstetricians and Gynaecologists RCoM Public Health England, 2016, INT RCOG RCM PHE HPS; Schrag SJ, 2003, OBSTET GYNECOL, V102, P753, DOI 10.1016/S0029-7844(03)00671-9; WHO, 2016, SIT REP ZIK VIR MICR; World Health Organization, 2016, WHO VACC PREV DIS MO; World Health Organization, 2014, VAR HERP ZOST WHO PO; World Health Organization, 2014, GLOB IMM DAT SEC GLO	17	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2017	356								j512	10.1136/bmj.j512	http://dx.doi.org/10.1136/bmj.j512			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JX	28258109	Green Published			2022-12-28	WOS:000395628800011
J	Kischkewitz, M; Okamoto, K; Muck-Lichtenfeld, C; Studer, A				Kischkewitz, Marvin; Okamoto, Kazuhiro; Mueck-Lichtenfeld, Christian; Studer, Armido			Radical-polar crossover reactions of vinylboron ate complexes	SCIENCE			English	Article							BORONIC ESTERS; FLUORINE; CHEMISTRY	Vinyl boronic esters are valuable substrates for Suzuki-Miyaura cross-coupling reactions. However, boron-substituted alkenes have drawn little attention as radical acceptors, and the radical chemistry of vinylboron ate complexes is underexplored. We show here that carbon radicals add efficiently to vinylboron ate complexes and that their adduct radical anions undergo radical-polar crossover: A 1,2-alkyl/aryl shift from boron to the alpha-carbon sp(2) center provides secondary or tertiary alkyl boronic esters. In contrast to the Suzuki-Miyaura coupling, a transition metal is not required, and two carbon-carbon bonds are formed. The valuable boronic ester moiety remains in the product and can be used in follow-up chemistry, enlarging the chemical space of the method. The cascade uses commercial starting materials and provides access to perfluoroalkylated alcohols, gamma-lactones, gamma-hydroxy alkylnitriles, and compounds bearing quaternary carbon centers.	[Kischkewitz, Marvin; Mueck-Lichtenfeld, Christian; Studer, Armido] Univ Munster, Organ Chem Inst, Corrensstr 40, D-48149 Munster, Germany; [Okamoto, Kazuhiro] Kyoto Univ, Grad Sch Engn, Dept Energy & Hydrocarbon Chem, Nishikyo Ku, Kyoto 6158510, Japan	University of Munster; Kyoto University	Studer, A (corresponding author), Univ Munster, Organ Chem Inst, Corrensstr 40, D-48149 Munster, Germany.	studer@uni-muenster.de	Okamoto, Kazuhiro/B-1804-2015; Okamoto, Kazuhiro/AAZ-6447-2021; Mück-Lichtenfeld, Christian/B-2868-2010	Okamoto, Kazuhiro/0000-0001-8562-3167; Okamoto, Kazuhiro/0000-0001-8562-3167; Mück-Lichtenfeld, Christian/0000-0002-9742-7400; Studer, Armido/0000-0002-1706-513X	Naito Foundation; University of Munster; European Research Council [692640]; Grants-in-Aid for Scientific Research [17K05861] Funding Source: KAKEN	Naito Foundation(Naito Memorial Foundation); University of Munster; European Research Council(European Research Council (ERC)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the Naito Foundation (fellowship to K.O.), the University of Munster, and the European Research Council (advanced grant agreement no. 692640) for supporting this work. Additional data supporting the conclusions are in the supplementary materials. M.K., K.O., and A.S. conceived and designed the experiments and analyzed the data. M.K. and K.O. performed the experiments, C.M.-L. conducted all computations, and A.S. wrote the manuscript.	Bonet A, 2014, NAT CHEM, V6, P584, DOI [10.1038/NCHEM.1971, 10.1038/nchem.1971]; Charpentier J, 2015, CHEM REV, V115, P650, DOI 10.1021/cr500223h; Liang T, 2013, ANGEW CHEM INT EDIT, V52, P8214, DOI 10.1002/anie.201206566; MATTESON DS, 1960, J AM CHEM SOC, V82, P4228, DOI 10.1021/ja01501a029; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; MIYAURA N, 1979, TETRAHEDRON LETT, V20, P3437, DOI 10.1016/S0040-4039(01)95429-2; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Purser S, 2008, CHEM SOC REV, V37, P320, DOI 10.1039/b610213c; Quiclet-Sire B, 2015, J AM CHEM SOC, V137, P6762, DOI 10.1021/jacs.5b03893; Studer A, 2016, ANGEW CHEM INT EDIT, V55, P58, DOI 10.1002/anie.201505090; Studer A, 2014, NAT CHEM, V6, P765, DOI 10.1038/nchem.2031; Studer A, 2012, ANGEW CHEM INT EDIT, V51, P8950, DOI 10.1002/anie.201202624; Walton JC, 2000, J AM CHEM SOC, V122, P5455, DOI 10.1021/ja9944812; Zhang L, 2016, SCIENCE, V351, P70, DOI 10.1126/science.aad6080; Zweifel, 1967, J AM CHEM SOC, V89, DOI DOI 10.1021/JA00990A061	15	147	147	3	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					936	+		10.1126/science.aal3803	http://dx.doi.org/10.1126/science.aal3803			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2YM	28254937				2022-12-28	WOS:000395181700035
J	Roehr, B				Roehr, Bob			John "Mickey" Nardo Pioneer in trial reanalysis OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item							MAJOR DEPRESSION; PAROXETINE; EFFICACY					BobRoehr@aol.com						Doshi P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2865; Keller MB, 2001, J AM ACAD CHILD PSY, V40, P762, DOI 10.1097/00004583-200107000-00010; Le Noury J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4320; Loder E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3601; Tanne JH, 2009, BRIT MED J, V338, DOI 10.1136/bmj.a3188	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2017	356								j1146	10.1136/bmj.j1146	http://dx.doi.org/10.1136/bmj.j1146			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JX	28258186				2022-12-28	WOS:000395628800007
J	Tagliabue, A; Bowie, AR; Boyd, PW; Buck, KN; Johnson, KS; Saito, MA				Tagliabue, Alessandro; Bowie, Andrew R.; Boyd, Philip W.; Buck, Kristen N.; Johnson, Kenneth S.; Saito, Mak A.			The integral role of iron in ocean biogeochemistry	NATURE			English	Review							SOUTHERN-OCEAN; DISSOLVED IRON; NORTH-ATLANTIC; MARINE-PHYTOPLANKTON; ORGANIC COMPLEXATION; ATMOSPHERIC CO2; BINDING LIGANDS; PACIFIC; FERTILIZATION; LIMITATION	The micronutrient iron is now recognized to be important in regulating the magnitude and dynamics of ocean primary productivity, making it an integral component of the ocean's biogeochemical cycles. In this Review, we discuss how a recent increase in observational data for this trace metal has challenged the prevailing view of the ocean iron cycle. Instead of focusing on dust as the major iron source and emphasizing iron's tight biogeochemical coupling to major nutrients, a more complex and diverse picture of the sources of iron, its cycling processes and intricate linkages with the ocean carbon and nitrogen cycles has emerged.	[Tagliabue, Alessandro] Univ Liverpool, Sch Environm Sci, Dept Earth Ocean & Ecol Sci, Liverpool, Merseyside, England; [Bowie, Andrew R.; Boyd, Philip W.] Univ Tasmania, Cooperat Res Ctr, Inst Marine & Antarctic Studies & Antarctic Clima, Hobart, Tas, Australia; [Buck, Kristen N.] Univ S Florida, Tampa, FL USA; [Johnson, Kenneth S.] Monterey Bay Aquarium Res Inst, Monterey, CA USA; [Saito, Mak A.] Woods Hole Oceanog Inst, Woods Hole, MA USA	University of Liverpool; University of Tasmania; State University System of Florida; University of South Florida; Monterey Bay Aquarium Research Institute; Woods Hole Oceanographic Institution	Tagliabue, A (corresponding author), Univ Liverpool, Sch Environm Sci, Dept Earth Ocean & Ecol Sci, Liverpool, Merseyside, England.	a.tagliabue@liverpool.ac.uk	Johnson, Kenneth S/F-9742-2011; Saito, Mak/ADT-4986-2022; Boyd, Philip W/J-7624-2014; Bowie, Andrew/C-8677-2013	Johnson, Kenneth S/0000-0001-5513-5584; Boyd, Philip W/0000-0001-7850-1911; Bowie, Andrew/0000-0002-5144-7799	Natural Environment Research Council [NE/N0010791, NE/N009525/1]; Royal Society; Australian Research Council [FT130100037, DP150100345, FL160100131]; Antarctic Climate and Ecosystems Cooperative Research Centre; National Science Foundation [OCE-1446327, PLR-1443483, NSF-1435-556]; David and Lucile Packard Foundation; Gordon Betty Moore Foundation [3782]; NERC [NE/N009525/1] Funding Source: UKRI; Directorate For Geosciences [1446327] Funding Source: National Science Foundation; Division Of Ocean Sciences [1260233] Funding Source: National Science Foundation	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society(Royal Society of London); Australian Research Council(Australian Research Council); Antarctic Climate and Ecosystems Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); National Science Foundation(National Science Foundation (NSF)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Gordon Betty Moore Foundation(Gordon and Betty Moore Foundation); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	A.T. acknowledges support from Natural Environment Research Council (NE/N0010791 and NE/N009525/1) and the Royal Society. A.R.B. acknowledges support from the Australian Research Council (FT130100037 and DP150100345) and the Antarctic Climate and Ecosystems Cooperative Research Centre. P.W.B. acknowledges support from the Australian Research Council (Laureate Fellowship FL160100131). K.N.B. acknowledges support from the National Science Foundation (OCE-1446327 and PLR-1443483). K.S.J. acknowledges support by the David and Lucile Packard Foundation. M.A.S. acknowledges support from National Science Foundation (NSF-1435-556) and the Gordon Betty Moore Foundation (3782).	ANDERSON MA, 1982, LIMNOL OCEANOGR, V27, P789, DOI 10.4319/lo.1982.27.5.0789; Anderson R.F., 2005, OCEANOGRAPHY, V18, P76, DOI [DOI 10.5670/0CEAN0G.2005.31), DOI 10.5670/0CEAN0G.2005.31]; Archer DE, 2000, GLOBAL BIOGEOCHEM CY, V14, P269, DOI 10.1029/1999GB900053; Blain S, 2007, NATURE, V446, P1070, DOI 10.1038/nature05700; Bonnain C, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00082; Bopp L, 2013, BIOGEOSCIENCES, V10, P6225, DOI 10.5194/bg-10-6225-2013; Bowie AR, 2015, BIOGEOSCIENCES, V12, P4421, DOI 10.5194/bg-12-4421-2015; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Boyd PW, 2015, GLOBAL BIOGEOCHEM CY, V29, P1028, DOI 10.1002/2014GB005014; Boyd PW, 2015, MAR CHEM, V173, P52, DOI 10.1016/j.marchem.2014.12.003; Boyd PW, 2010, NAT GEOSCI, V3, P675, DOI [10.1038/NGEO964, 10.1038/ngeo964]; Boyd PW, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002494; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; BRAND LE, 1983, LIMNOL OCEANOGR, V28, P1182, DOI 10.4319/lo.1983.28.6.1182; BROECKER WS, 1985, J GEOPHYS RES-OCEANS, V90, P6925, DOI 10.1029/JC090iC04p06925; BRULAND KW, 1979, ANAL CHIM ACTA, V105, P233, DOI 10.1016/S0003-2670(01)83754-5; Buck KN, 2015, DEEP-SEA RES PT II, V116, P152, DOI 10.1016/j.dsr2.2014.11.016; Charette MA, 2015, MAR CHEM, V177, P184, DOI 10.1016/j.marchem.2015.01.001; Cheize M, 2012, ANAL CHIM ACTA, V736, P45, DOI 10.1016/j.aca.2012.05.011; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Conway TM, 2014, NATURE, V511, P212, DOI 10.1038/nature13482; Cooper LHN, 1935, PROC R SOC SER B-BIO, V118, P419, DOI 10.1098/rspb.1935.0064; Croot PL, 2001, GEOPHYS RES LETT, V28, P3425, DOI 10.1029/2001GL013023; CULLEN JJ, 1991, LIMNOL OCEANOGR, V36, P1578, DOI 10.4319/lo.1991.36.8.1578; de Baar H.J.W., 2001, BIOGEOCHEMISTRY IRON, P123; de Baar HJW, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002601; Duteil O, 2013, BIOGEOSCIENCES, V10, P7723, DOI 10.5194/bg-10-7723-2013; Dutkiewicz S, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002342; Dutkiewicz S, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004039; Elrod VA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020216; Falkowski P., 2007, AQUATIC PHOTOSYNTHES, P488; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Gerringa LJA, 2015, MAR CHEM, V177, P434, DOI 10.1016/j.marchem.2015.04.007; GLEDHILL M, 1994, MAR CHEM, V47, P41, DOI 10.1016/0304-4203(94)90012-4; Gledhill M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00069; GOLDBERG ED, 1954, J GEOL, V62, P249, DOI 10.1086/626161; GORDON RM, 1982, NATURE, V299, P611, DOI 10.1038/299611a0; GRAN H. H., 1931, Conseil Perm. Internat. pour I'Explor. de la Mer. Rapp. et Proces-Verb., V75, P37; Hain MP, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003790; HART T. JOHN, 1934, DISCOVERY REPTS [GOV DEPENDENCIES FALKLAND ISLS], V8, P1; HARVEY H. W., 1933, JOUR MARINE BIOL ASSOC UNITED KINGDOM, V19, P253; Hogle SL, 2014, METALLOMICS, V6, P1107, DOI 10.1039/c4mt00031e; HUDSON RJM, 1990, LIMNOL OCEANOGR, V35, P1002, DOI 10.4319/lo.1990.35.5.1002; Hutchins DA, 2002, LIMNOL OCEANOGR, V47, P997, DOI 10.4319/lo.2002.47.4.0997; Hutchins DA, 1998, LIMNOL OCEANOGR, V43, P1037, DOI 10.4319/lo.1998.43.6.1037; Ito T, 2005, J MAR RES, V63, P813, DOI 10.1357/0022240054663231; Jaccard SL, 2016, NATURE, V530, P207, DOI 10.1038/nature16514; Jenkins WJ, 2015, DEEP-SEA RES PT II, V116, P6, DOI 10.1016/j.dsr2.2014.11.018; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; JOHNSON K. S, 2007, EOS T AGU, V88, P131, DOI [10.1029/2007EO110003, DOI 10.1029/2007E0110003]; Johnson KS, 1997, MAR CHEM, V57, P137, DOI 10.1016/S0304-4203(97)00043-1; JOOS F, 1991, NATURE, V349, P772, DOI 10.1038/349772a0; Klunder MB, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007133; Klunder MB, 2011, DEEP-SEA RES PT II, V58, P2678, DOI 10.1016/j.dsr2.2010.10.042; Lam PJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033294; Lambert F, 2015, GEOPHYS RES LETT, V42, P6014, DOI 10.1002/2015GL064250; LANDING WM, 1987, GEOCHIM COSMOCHIM AC, V51, P29, DOI 10.1016/0016-7037(87)90004-4; Lis H, 2015, ISME J, V9, P1003, DOI 10.1038/ismej.2014.199; Liu XW, 2002, MAR CHEM, V77, P43, DOI 10.1016/S0304-4203(01)00074-3; Lund DC, 2016, SCIENCE, V351, P478, DOI 10.1126/science.aad4296; Mackey KRM, 2015, P NATL ACAD SCI USA, V112, P9944, DOI 10.1073/pnas.1509448112; Maldonado MT, 1999, DEEP-SEA RES PT II, V46, P2447, DOI 10.1016/S0967-0645(99)00071-5; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; MARTIN JH, 1990, NATURE, V345, P156, DOI 10.1038/345156a0; Martin JH, 1990, GLOBAL BIOGEOCHEM CY, V4, P5, DOI 10.1029/GB004i001p00005; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Martinez-Garcia A, 2014, SCIENCE, V343, P1347, DOI 10.1126/science.1246848; Martiny AC, 2013, NAT GEOSCI, V6, P279, DOI [10.1038/NGEO1757, 10.1038/ngeo1757]; Mawji E, 2015, MAR CHEM, V177, P1, DOI 10.1016/j.marchem.2015.04.005; Mawji E, 2011, MAR CHEM, V124, P90, DOI 10.1016/j.marchem.2010.12.005; Middleton JL, 2016, GEOPHYS RES LETT, V43, P3848, DOI 10.1002/2016GL068408; Moffett JW, 2007, DEEP-SEA RES PT I, V54, P1341, DOI 10.1016/j.dsr.2007.04.004; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/NGEO1765, 10.1038/ngeo1765]; Moore CM, 2009, NAT GEOSCI, V2, P867, DOI 10.1038/ngeo667; Moore CM, 2006, GLOBAL CHANGE BIOL, V12, P626, DOI 10.1111/j.1365-2486.2006.01122.x; Moore JK, 2001, DEEP-SEA RES PT II, V49, P463; Morel FMM, 2008, LIMNOL OCEANOGR, V53, P400, DOI 10.4319/lo.2008.53.1.0400; Nishioka J, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004055; Parekh P, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002280; Pollard RT, 2009, NATURE, V457, P577, DOI 10.1038/nature07716; Ratnarajah L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125134; Ratnarajah L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114067; RAVEN JA, 1988, NEW PHYTOL, V109, P279, DOI 10.1111/j.1469-8137.1988.tb04196.x; Resing JA, 2015, NATURE, V523, P200, DOI 10.1038/nature14577; Rijkenberg MJA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101323; Rubin M, 2011, NAT GEOSCI, V4, P529, DOI 10.1038/NGEO1181; RUE EL, 1995, MAR CHEM, V50, P117, DOI 10.1016/0304-4203(95)00031-L; Ruud J. T., 1930, RAPPORTS PROCES VERB, V5, P347, DOI [10.1093/ICESJMS/5.3.347, DOI 10.1093/ICESJMS/5.3.347]; Saito MA, 2014, SCIENCE, V345, P1173, DOI 10.1126/science.1256450; Saito MA, 2013, NAT GEOSCI, V6, P775, DOI [10.1038/ngeo1893, 10.1038/NGEO1893]; Schlosser C, 2014, P NATL ACAD SCI USA, V111, P1438, DOI 10.1073/pnas.1318670111; Schlosser C, 2012, LIMNOL OCEANOGR, V57, P684, DOI 10.4319/lo.2012.57.3.0684; Sedwick PN, 2015, DEEP-SEA RES PT II, V116, P166, DOI 10.1016/j.dsr2.2014.11.004; SETTLE DM, 1980, SCIENCE, V207, P1167, DOI 10.1126/science.6986654; Shaked Y, 2005, LIMNOL OCEANOGR, V50, P872, DOI 10.4319/lo.2005.50.3.0872; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Slemons LO, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003693; Sohm JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048315; Strzepek RF, 2011, LIMNOL OCEANOGR, V56, P1983, DOI 10.4319/lo.2011.56.6.1983; Sunda WG, 1997, NATURE, V390, P389, DOI 10.1038/37093; Tagliabue A, 2009, CLIM PAST, V5, P695, DOI 10.5194/cp-5-695-2009; Tagliabue A, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003363; Tagliabue A, 2016, GLOBAL BIOGEOCHEM CY, V30, P149, DOI 10.1002/2015GB005289; Tagliabue A, 2014, GEOPHYS RES LETT, V41, P7227, DOI 10.1002/2014GL061066; Tagliabue A, 2014, NAT GEOSCI, V7, P314, DOI [10.1038/ngeo2101, 10.1038/NGEO2101]; Tagliabue A, 2014, GEOPHYS RES LETT, V41, P920, DOI 10.1002/2013GL059059; Tagliabue A, 2010, NAT GEOSCI, V3, P252, DOI 10.1038/NGEO818; Tortell PD, 1996, NATURE, V383, P330, DOI 10.1038/383330a0; Twining BS, 2015, PROG OCEANOGR, V137, P261, DOI 10.1016/j.pocean.2015.07.001; Twining BS, 2014, LIMNOL OCEANOGR, V59, P689, DOI 10.4319/lo.2014.59.3.0689; Twining BS, 2013, ANNU REV MAR SCI, V5, P191, DOI 10.1146/annurev-marine-121211-172322; Volker C, 2015, MAR CHEM, V173, P67, DOI 10.1016/j.marchem.2014.11.008; von der Heyden BP, 2012, SCIENCE, V338, P1199, DOI 10.1126/science.1227504; Wagener T, 2010, BIOGEOSCIENCES, V7, P3769, DOI 10.5194/bg-7-3769-2010; Watson AJ, 2000, NATURE, V407, P730, DOI 10.1038/35037561; Waugh DW, 2013, SCIENCE, V339, P568, DOI 10.1126/science.1225411; Weber L, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002340; Weber T, 2014, P NATL ACAD SCI USA, V111, P8741, DOI 10.1073/pnas.1317193111; WILLIAMS RJP, 1981, PROC R SOC SER B-BIO, V213, P361, DOI 10.1098/rspb.1981.0071; Wozniak AS, 2015, MAR CHEM, V173, P162, DOI 10.1016/j.marchem.2014.11.002; Wu JF, 2001, SCIENCE, V293, P847, DOI 10.1126/science.1059251	121	324	339	65	618	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2017	543	7643					51	59		10.1038/nature21058	http://dx.doi.org/10.1038/nature21058			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0AA	28252066	Green Accepted			2022-12-28	WOS:000395671500031
J	Graner, S; Svensson, T; Beau, AB; Damase-Michel, C; Engeland, A; Furu, K; Hviid, A; Haberg, SE; Molgaard-Nielsen, D; Pasternak, B; Kieler, H				Graner, Sophie; Svensson, Tobias; Beau, Anna-Belle; Damase-Michel, Christine; Engeland, Anders; Furu, Kari; Hviid, Anders; Haberg, Siri Eldevik; Molgaard-Nielsen, Ditte; Pasternak, Bjrn; Kieler, Helle			Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFLUENZA-VIRUS INFECTION; H1N1 INFLUENZA; OSELTAMIVIR; VACCINATION; EFEMERIS; SAFETY; COHORT; WOMEN	OBJECTIVE To evaluate the possible effects of exposure to neuraminidase inhibitors during embryo-fetal life with respect to adverse neonatal outcomes and congenital malformations. DESIGN Population based multinational observational cohort study and meta-analysis. Setting National registers covering information on maternal healthcare, births, and prescriptions in Denmark, Norway, and Sweden and the EFEMERIS database from the Haute-Garonne district in France. PARTICIPANTS All women together with their singleton infants born between 1 January 2008 and 31 December 2010. Only infants born at 154 days of gestation or later were included. Infants were defined as exposed if the women filled a prescription during pregnancy for either of the two neuraminidase inhibitors oseltamivir or zanamivir. MAIN OUTCOMES Low birth weight, low Apgar score, preterm birth, small for gestational age birth, stillbirth, neonatal mortality, neonatal morbidity, and congenital malformations. Crude and adjusted hazard ratios of preterm birth were estimated using Cox regression models. Crude and adjusted odds ratios for other outcomes were estimated by logistic regression models. RESULTS The study included 5824 (0.8%) exposed women and their infants and 692 232 who were not exposed. Exposure to neuraminidase inhibitors in utero was not associated with increased risks of any of the investigated neonatal outcomes, including low birth weight (adjusted odds ratio 0.77, 95% confidence interval 0.65 to 0.91), low Apgar score (adjusted odds ratio 0.87, 0.67 to 1.14), preterm birth (adjusted hazard ratio 0.97, 0.86 to 1.10), small for gestational age birth (adjusted odds ratio 0.72, 0.59 to 0.87), stillbirth (adjusted odds ratio 0.81, 0.51 to 1.30), neonatal mortality (adjusted odds ratio 1.13, 0.56 to 2.28), and neonatal morbidity (adjusted odds ratio 0.92, 0.86 to 1.00). No increased risk of congenital malformations overall associated with maternal exposure was observed during the first trimester (adjusted odds ratio 1.06, 0.77 to 1.48). Similarly, no significantly increased risks of any of the outcomes were observed in an analysis restricted to oseltamivir alone. CONCLUSIONS This large multinational register study found no increased risks of adverse neonatal outcomes or congenital malformations associated with exposure to neuraminidase inhibitors during embryo-fetal life. The results support previously reported findings that the use of neuraminidase inhibitors is not associated with increased risks of adverse fetal or neonatal outcomes.	[Graner, Sophie; Svensson, Tobias; Kieler, Helle] Karolinska Inst, Karolinska Univ Hosp, Ctr Pharmacoepidemiol, Dept Med, SE-17176 Stockholm, Sweden; [Graner, Sophie] Karolinska Univ Hosp, Dept Obstet & Gynecol, SE-17176 Stockholm, Sweden; [Beau, Anna-Belle; Damase-Michel, Christine] Univ Toulouse 3, UMR INSERM, CHU Toulouse, Serv Pharmacol Med, FR-1027 Toulouse, France; [Engeland, Anders; Furu, Kari; Haberg, Siri Eldevik] Norwegian Inst Publ Hlth, Div Mental & Phys Hlth, POB 4404, NO-0403 Oslo, Norway; [Engeland, Anders] Univ Bergen, Dept Global Publ Hlth & Primary Care, NO-5020 Bergen, Norway; [Hviid, Anders; Molgaard-Nielsen, Ditte; Pasternak, Bjrn] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark; [Pasternak, Bjrn] Karolinska Inst, Karolinska Univ Hosp, Dept Med Solna, Clin Epidemiol Unit, SE-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Norwegian Institute of Public Health (NIPH); University of Bergen; Statens Serum Institut; Karolinska Institutet; Karolinska University Hospital	Graner, S (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Ctr Pharmacoepidemiol, Dept Med, SE-17176 Stockholm, Sweden.; Graner, S (corresponding author), Karolinska Univ Hosp, Dept Obstet & Gynecol, SE-17176 Stockholm, Sweden.	Sofie.graner@ki.se	Damase, Christine/AAC-3835-2019; Engeland, Anders/AAG-7437-2021; Pasternak, Bjorn/H-5739-2012; Hviid, Anders/AAH-4319-2020; Beau, Anna-belle/AAA-1993-2019	Pasternak, Bjorn/0000-0002-2097-8466; Hviid, Anders/0000-0002-7509-9127; Beau, Anna-belle/0000-0003-4631-100X; Kieler, Helle/0000-0001-9338-7133; Damase-Michel, Christine/0000-0001-5018-0108	Karolinska Institutet, Sweden; Universite Toulouse III, France; Norwegian Institute of Public Health; University of Bergen, Norway; Statens Serum Institut, Denmark; Novo Nordisk Foundation; Danish Medical Research Council; Novo Nordisk Fonden [NNF14OC0008847] Funding Source: researchfish	Karolinska Institutet, Sweden(Karolinska Institutet); Universite Toulouse III, France; Norwegian Institute of Public Health; University of Bergen, Norway; Statens Serum Institut, Denmark; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Fonden(Novo Nordisk Foundation)	The study was funded by the authors' institutions: the Karolinska Institutet, Sweden; Universite Toulouse III, France; Norwegian Institute of Public Health and University of Bergen, Norway; and Statens Serum Institut, Denmark. AH is supported by a Hallas-Moller stipend from the Novo Nordisk Foundation. BP is supported by a research grant from the Danish Medical Research Council.	Beau AB, 2014, VACCINE, V32, P1254, DOI 10.1016/j.vaccine.2014.01.021; Beau AB, 2014, BJOG-INT J OBSTET GY, V121, P895, DOI 10.1111/1471-0528.12617; Berveiller P, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.07.023; Boyd PA, 2011, BIRTH DEFECTS RES A, V91, pS2, DOI 10.1002/bdra.20780; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Delgado-Rodriguez M, 2012, J ANTIMICROB CHEMOTH, V67, P1739, DOI 10.1093/jac/dks098; Donner B, 2010, DRUG SAFETY, V33, P631, DOI 10.2165/11536370-000000000-00000; Dubar G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013112; Dunstan HJ, 2014, BJOG-INT J OBSTET GY, V121, P901, DOI 10.1111/1471-0528.12640; Egger M., 2008, SYSTEMATIC REV HLTH; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Greer LG, 2010, OBSTET GYNECOL, V115, P711, DOI 10.1097/AOG.0b013e3181d44752; Haberg SE, 2013, NEW ENGL J MED, V368, P333, DOI 10.1056/NEJMoa1207210; Harris RJ, 2008, STATA J, V8, P3, DOI 10.1177/1536867X0800800102; Huang H, 2016, J MATERN-FETAL NEO M, P1, DOI DOI 10.1007/S10915-016-0264-Z; Hviid A, 2017, JAMA PEDIATR, V171, P239, DOI 10.1001/jamapediatrics.2016.4023; Lacroix I, 2009, EUR J CLIN PHARMACOL, V65, P839, DOI 10.1007/s00228-009-0647-2; Langhoff-Roos J, 2014, ACTA OBSTET GYN SCAN, V93, P132, DOI 10.1111/aogs.12302; Longo S, 2014, EARLY HUM DEV, V90, pS42, DOI 10.1016/S0378-3782(14)70014-3; Ludvigsson JF, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5585; Ludvigsson JF, 2013, EUR J EPIDEMIOL, V28, P579, DOI 10.1007/s10654-013-9813-z; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Meijer WJ, 2015, ACTA OBSTET GYN SCAN, V94, P797, DOI 10.1111/aogs.12680; Mosby LG, 2011, AM J OBSTET GYNECOL, V205, P10, DOI 10.1016/j.ajog.2010.12.033; Nanovskaya TN, 2012, J MATERN-FETAL NEO M, V25, P2312, DOI 10.3109/14767058.2012.693993; Rosen M, 2002, SCAND J PUBLIC HEALT, V30, P81, DOI 10.1080/140349401753683444; Saito S, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.04.007; Selmer R, 2016, PHARMACOEPIDEM DR S, V25, P1160, DOI 10.1002/pds.4033; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Socialstyrelsen, 2016, LAK; Svensson T, 2011, PHARMACOEPIDEM DR S, V20, P1030, DOI 10.1002/pds.2194; WHO, 2009, GUID ATC CLASS DDD A; Worley Kevin C, 2008, Infect Dis Obstet Gynecol, V2008, P927574, DOI 10.1155/2008/927574; Xie HY, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.015; Yates L, 2010, HEALTH TECHNOL ASSES, V14, P121	35	19	21	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 28	2017	356								j629	10.1136/bmj.j629	http://dx.doi.org/10.1136/bmj.j629			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JQ	28246106	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-28	WOS:000395628100015
J	Slomski, A				Slomski, Anita			Listerine May Help Control Spread of Gonorrhea	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2017	317	8					798	798		10.1001/jama.2017.1130	http://dx.doi.org/10.1001/jama.2017.1130			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM7PW	28245320				2022-12-28	WOS:000395505600008
J	Vangipuram, R; Tyring, SK				Vangipuram, Ramya; Tyring, Stephen K.			A 55-Year-Old Man With a Painful Rash on the Sole of His Foot	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HERPES-ZOSTER; ACYCLOVIR; TRIAL		[Vangipuram, Ramya; Tyring, Stephen K.] Ctr Clin Studies, 451 N Texas Ave, Webster, TX 77598 USA; [Tyring, Stephen K.] Univ Texas Houston, Hlth Sci Ctr, Dept Dermatol, Houston, TX 77025 USA	University of Texas System; University of Texas Health Science Center Houston	Vangipuram, R (corresponding author), Ctr Clin Studies, 451 N Texas Ave, Webster, TX 77598 USA.	rvangip@gmail.com						Creed R, 2010, MUCOCUTANEOUS MANIFESTATIONS OF VIRAL DISEASES, 2ND EDITION, P98; Decroix J, 2000, J EUR ACAD DERMATOL, V14, P23, DOI 10.1046/j.1468-3083.2000.00020.x; Hernandez PO, 2011, J CLIN VIROL, V52, P344, DOI 10.1016/j.jcv.2011.08.014; Schmader K, 2016, CLIN GERIATR MED, V32, P539, DOI 10.1016/j.cger.2016.02.011; Whitley RJ, 2009, JAMA-J AM MED ASSOC, V302, P73, DOI 10.1001/jama.2009.822; Whitley RJ, 1996, ANN INTERN MED, V125, P376, DOI 10.7326/0003-4819-125-5-199609010-00004; WOOD MJ, 1994, NEW ENGL J MED, V330, P896, DOI 10.1056/NEJM199403313301304	7	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2017	317	8					851	852		10.1001/jama.2016.20894	http://dx.doi.org/10.1001/jama.2016.20894			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM7PW	28245302				2022-12-28	WOS:000395505600024
J	[Anonymous]				[Anonymous]			Youths Recognize Costs of Smoking	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2017	317	8					799	799		10.1001/jama.2017.0723	http://dx.doi.org/10.1001/jama.2017.0723			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM7PW	28245333				2022-12-28	WOS:000395505600011
J	Fedry, J; Liu, YJ; Pehau-Arnaudet, G; Pei, JM; Li, WH; Tortorici, MA; Traincard, F; Meola, A; Bricogne, G; Grishin, NV; Snell, WJ; Rey, FA; Krey, T				Fedry, Juliette; Liu, Yanjie; Pehau-Arnaudet, Gerard; Pei, Jimin; Li, Wenhao; Tortorici, M. Alejandra; Traincard, Francois; Meola, Annalisa; Bricogne, Gerard; Grishin, Nick V.; Snell, William J.; Rey, Felix A.; Krey, Thomas			The Ancient Gamete Fusogen HAP2 Is a Eukaryotic Class II Fusion Protein	CELL			English	Article							VIRUS ENVELOPE PROTEIN; SEMLIKI-FOREST-VIRUS; CRYSTAL-STRUCTURE; SEXUAL REPRODUCTION; MEMBRANE; GLYCOPROTEIN; CHLAMYDOMONAS; GENE; FERTILIZATION; GCS1	Sexual reproduction is almost universal in eukaryotic life and involves the fusion of male and female haploid gametes into a diploid cell. The sperm-restricted single-pass transmembrane protein HAP2-GCS1 has been postulated to function in membrane merger. Its presence in the major eukaryotic taxa-animals, plants, and protists (including important human pathogens like Plasmodium)-suggests that many eukaryotic organisms share a common gamete fusion mechanism. Here, we report combined bioinformatic, biochemical, mutational, and X-ray crystallographic studies on the unicellular alga Chlamydomonas reinhardtii HAP2 that reveal homology to class II viral membrane fusion proteins. We further show that targeting the segment corresponding to the fusion loop by mutagenesis or by antibodies blocks gamete fusion. These results demonstrate that HAP2 is the gamete fusogen and suggest a mechanism of action akin to viral fusion, indicating a way to block Plasmodium transmission and highlighting the impact of virus-cell genetic exchanges on the evolution of eukaryotic life.	[Fedry, Juliette; Tortorici, M. Alejandra; Meola, Annalisa; Rey, Felix A.; Krey, Thomas] Inst Pasteur, Unite Virol Struct, 25-28 Rue Docteur Roux, F-75724 Paris, France; [Fedry, Juliette; Tortorici, M. Alejandra; Meola, Annalisa; Rey, Felix A.; Krey, Thomas] CNRS, UMR 3569, 25-28 Rue Docteur Roux, F-75724 Paris, France; [Fedry, Juliette] Univ Paris 05, Sorbonne Paris Cite, Inst Pasteur, Rue Docteur Roux, F-75015 Paris, France; [Fedry, Juliette; Krey, Thomas] Hannover Med Sch, Inst Virol, D-30625 Hannover, Germany; [Liu, Yanjie; Li, Wenhao; Snell, William J.] Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA; [Pehau-Arnaudet, Gerard] Inst Pasteur, CNRS, UMR 3528, Ultrapole, 25-28 Rue Docteur Roux, F-75015 Paris, France; [Pei, Jimin; Grishin, Nick V.] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, 6000 Harry Hines Blvd, Dallas, TX 75390 USA; [Pei, Jimin; Grishin, Nick V.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, 6000 Harry Hines Blvd, Dallas, TX 75390 USA; [Pei, Jimin; Grishin, Nick V.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, 6000 Harry Hines Blvd, Dallas, TX 75390 USA; [Traincard, Francois] Inst Pasteur, Dept Biol Struct & Chim, Plateforme Ingn Anticorps, F-75015 Paris, France; [Bricogne, Gerard] Global Phasing Ltd, Sheraton House,Castle Pk, Cambridge CB3 0AX, England; [Krey, Thomas] German Ctr Infect Res DZIF, D-30625 Hannover, Germany; [Snell, William J.] Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Hannover Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Global Phasing Limited; German Center for Infection Research; University System of Maryland; University of Maryland College Park	Rey, FA; Krey, T (corresponding author), Inst Pasteur, Unite Virol Struct, 25-28 Rue Docteur Roux, F-75724 Paris, France.; Rey, FA; Krey, T (corresponding author), CNRS, UMR 3569, 25-28 Rue Docteur Roux, F-75724 Paris, France.; Krey, T (corresponding author), Hannover Med Sch, Inst Virol, D-30625 Hannover, Germany.; Snell, WJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.; Krey, T (corresponding author), German Ctr Infect Res DZIF, D-30625 Hannover, Germany.; Snell, WJ (corresponding author), Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA.	wsnell1@umd.edu; felix.rey@pasteur.fr; krey.thomas@mh-hannover.de		Fedry, Juliette/0000-0002-6592-4269; pehau-arnaudet, gerard/0000-0001-6479-9470; Tortorici, M. Alejandra/0000-0002-2260-2577; Rey, Felix/0000-0002-9953-7988	ERC [340371]; Institut Pasteur and CNRS; NIH [GM56778, GM094575]; UTSW HI/HR Program; Welch Foundation [I-1505]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094575, R01GM056778] Funding Source: NIH RePORTER	ERC(European Research Council (ERC)European Commission); Institut Pasteur and CNRS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UTSW HI/HR Program; Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Francis-Andre Wollmann and Sandrine Bujaldon for discussions and help with initial experiments; Fredrick Grinnell, Saikat Mukhopadhyay, Michael Henne, and Margaret Phillips of UT Southwestern for helpful discussions; the crystallization platform of the Pasteur Proteopole for technical help; Remi Fronzes for help with native PAGE experiments; Vincent Olieric and the staff of synchrotron beamlines PX-III at the Swiss Light Source, Proxima-1 and -2 at SOLEIL and ID29 and ID30-3 at the European Synchrotron Radiation Facility for help during data collection; members of the Rey and Snell labs for discussions; and M. Nilges and the Equipement d'excellence CACSICE for providing the Falcon II direct electron detector. F.A.R. acknowledges funding from the ERC Advanced grant project (340371) CelCelFus for this work, which also used general support from Institut Pasteur and CNRS. W.J.S. was supported by a grant from the NIH (GM56778) and acknowledges funding from the UTSW HI/HR Program. N.V.G. is funded, in part, by a grant from the NIH (GM094575) and the Welch Foundation (I-1505). J.F. benefitted from an Allocation ministerielle pour l'Ecole Polytechnique AMX.	Backovic M, 2011, ADV EXP MED BIOL, V714, P91, DOI 10.1007/978-94-007-0782-5_3; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belzile O, 2013, CURR BIOL, V23, P1460, DOI 10.1016/j.cub.2013.06.025; Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203; Blagborough AM, 2009, VACCINE, V27, P5187, DOI 10.1016/j.vaccine.2009.06.069; Blaise S, 2003, P NATL ACAD SCI USA, V100, P13013, DOI 10.1073/pnas.2132646100; Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064; Bricogne G., 2010, BUSTER VERSION 2 9; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cole ES, 2014, CURR BIOL, V24, P2168, DOI 10.1016/j.cub.2014.07.064; Denner J, 2016, APMIS, V124, P31, DOI 10.1111/apm.12474; Dessau M, 2013, P NATL ACAD SCI USA, V110, P1696, DOI 10.1073/pnas.1217780110; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; DuBois RM, 2013, NATURE, V493, P552, DOI 10.1038/nature11741; Ebchuqin E, 2014, BIOCHEM BIOPH RES CO, V451, P522, DOI 10.1016/j.bbrc.2014.08.006; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Frame IG, 2001, GENE, V263, P219, DOI 10.1016/S0378-1119(00)00567-9; Gibbons DL, 2003, CELL, V114, P573, DOI 10.1016/S0092-8674(03)00683-4; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guardado-Calvo P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005813; Halldorsson S, 2016, P NATL ACAD SCI USA, V113, P7154, DOI 10.1073/pnas.1603827113; Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Johnson MA, 2004, GENETICS, V168, P971, DOI 10.1534/genetics.104.029447; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Kadlec J, 2008, NAT STRUCT MOL BIOL, V15, P1024, DOI 10.1038/nsmb.1484; Kawai-Toyooka H, 2014, EUKARYOT CELL, V13, P648, DOI 10.1128/EC.00330-13; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Klein DE, 2013, J VIROL, V87, P2287, DOI 10.1128/JVI.02957-12; KLIMJACK MR, 1994, J VIROL, V68, P6940, DOI 10.1128/JVI.68.11.6940-6946.1994; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Liao MF, 2010, J VIROL, V84, P5730, DOI 10.1128/JVI.00170-10; Liao MF, 2005, J CELL BIOL, V171, P111, DOI 10.1083/jcb.200507075; Lillie FR, 1913, SCIENCE, V38, P524, DOI 10.1126/science.38.980.524; Liu YJ, 2008, GENE DEV, V22, P1051, DOI 10.1101/gad.1656508; Liu YJ, 2015, DEVELOPMENT, V142, P962, DOI 10.1242/dev.118844; Liu YJ, 2010, DEVELOPMENT, V137, P1473, DOI 10.1242/dev.044743; Luca VC, 2013, J VIROL, V87, P818, DOI 10.1128/JVI.01950-12; Malik HS, 2000, GENOME RES, V10, P1307, DOI 10.1101/gr.145000; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Millay DP, 2016, P NATL ACAD SCI USA, V113, P2116, DOI 10.1073/pnas.1600101113; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Misamore MJ, 2003, MOL BIOL CELL, V14, P2530, DOI 10.1091/mbc.E02-12-0790; Miura K, 2013, INFECT IMMUN, V81, P4377, DOI 10.1128/IAI.01056-13; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Mori T, 2006, NAT CELL BIOL, V8, P64, DOI 10.1038/ncb1345; Mori T, 2014, CURR BIOL, V24, P170, DOI 10.1016/j.cub.2013.11.030; Nayak V, 2009, J VIROL, V83, P4338, DOI 10.1128/JVI.02574-08; Ning J, 2013, GENE DEV, V27, P1198, DOI 10.1101/gad.212746.112; Okabe M, 2013, DEVELOPMENT, V140, P4471, DOI 10.1242/dev.090613; Perez-Vargas J, 2014, CELL, V157, P407, DOI 10.1016/j.cell.2014.02.020; Pinello JF, 2017, CURR BIOL, V27, P651, DOI 10.1016/j.cub.2017.01.049; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; SINDEN RE, 1976, PROC R SOC SER B-BIO, V193, P55, DOI 10.1098/rspb.1976.0031; Snell W.J., 2009, WITMAN GB, VSecond Edition, P369, DOI 10.1016/B978-0-12-370873-1.00049-6; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sprunck S, 2012, SCIENCE, V338, P1093, DOI 10.1126/science.1223944; Steele RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007680; Stiasny K, 2002, J VIROL, V76, P3784, DOI 10.1128/JVI.76.8.3784-3790.2002; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; von Besser K, 2006, DEVELOPMENT, V133, P4761, DOI 10.1242/dev.02683; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Weinert T, 2015, NAT METHODS, V12, P131, DOI 10.1038/nmeth.3211; Willensky S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005948; Wong JL, 2010, TRENDS CELL BIOL, V20, P134, DOI 10.1016/j.tcb.2009.12.007	69	103	106	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2017	168	5					904	+		10.1016/j.cell.2017.01.024	http://dx.doi.org/10.1016/j.cell.2017.01.024			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8YB	28235200	Green Published, hybrid			2022-12-28	WOS:000396284800018
J	Gostin, LO				Gostin, Lawrence O.			How Will President Trump's Policies Affect Domestic and Global Health and Development?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20057 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20057 USA.	gostin@law.georgetown.edu							0	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2017	317	7					685	686		10.1001/jama.2017.0235	http://dx.doi.org/10.1001/jama.2017.0235			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8WR	28241344				2022-12-28	WOS:000394901600003
J	Johnson, BE; Pagan, ER				Johnson, Bruce E.; Pagan, Elvis R.			Guideline: An expert panel found that calcium intake is safe from a cardiovascular perspective	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Johnson, Bruce E.; Pagan, Elvis R.] Virginia Tech Carilion Sch Med, Roanoke, VA 24016 USA		Johnson, BE (corresponding author), Virginia Tech Carilion Sch Med, Roanoke, VA 24016 USA.							Bailey RL, 2010, J NUTR, V140, P817, DOI 10.3945/jn.109.118539; Chung M, 2016, ANN INTERN MED, V165, P856, DOI 10.7326/M16-1165; Tai V, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4183	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2017	166	4					JC16	JC16		10.7326/ACPJC-2017-166-4-016	http://dx.doi.org/10.7326/ACPJC-2017-166-4-016			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7FO	28241289				2022-12-28	WOS:000394786700004
J	Lagu, T; Metayer, K; Moran, M; Ortiz, L; Priya, A; Goff, SL; Lindenauer, PK				Lagu, Tara; Metayer, Katherine; Moran, Michael; Ortiz, Leidy; Priya, Aruna; Goff, Sarah L.; Lindenauer, Peter K.			Website Characteristics and Physician Reviews on Commercial Physician-RatingWebsites	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Lagu, Tara; Priya, Aruna; Goff, Sarah L.; Lindenauer, Peter K.] Baystate Med Ctr, Ctr Qual Care Res, 280 Chestnut St,Third Floor, Springfield, MA 01199 USA; [Metayer, Katherine] Colby Coll, Waterville, ME 04901 USA; [Moran, Michael] Coll Holy Cross, Worcester, MA 01610 USA; [Ortiz, Leidy] Tufts Univ, Medford, MA 02155 USA	Baystate Medical Center; Colby College; College of the Holy Cross; Tufts University	Lagu, T (corresponding author), Baystate Med Ctr, Ctr Qual Care Res, 280 Chestnut St,Third Floor, Springfield, MA 01199 USA.	lagutc@gmail.com	Lagu, Tara/GPT-5173-2022		National Heart, Lung, and Blood Institute [K01HL114745, 1K24HL132008]; National Institute of Child Health and Development of the National Institutes of Health [K23HD080870-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD080870] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL132008, K01HL114745] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Child Health and Development of the National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by grants K01HL114745 (Dr Lagu) and 1K24HL132008 (Dr Lindenauer) from the National Heart, Lung, and Blood Institute and grant K23HD080870-01A1 from the National Institute of Child Health and Development (Dr Goff) of the National Institutes of Health.	Gao GG, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2003; Hanauer DA, 2014, JAMA-J AM MED ASSOC, V311, P734, DOI 10.1001/jama.2013.283194; Lagu T, 2010, J GEN INTERN MED, V25, P942, DOI 10.1007/s11606-010-1383-0; Lee TH, HARVARD BUSINESS REV; Schlesinger M, 2015, NEW ENGL J MED, V373, P675, DOI 10.1056/NEJMsb1502361	5	41	41	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2017	317	7					766	768		10.1001/jama.2016.18553	http://dx.doi.org/10.1001/jama.2016.18553			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8WR	28241346	Green Accepted, Bronze			2022-12-28	WOS:000394901600025
J	Hunter, DJ; Frumkin, H; Jha, A				Hunter, David J.; Frumkin, Howard; Jha, Ashish			Preventive Medicine for the Planet and Its Peoples	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hunter, David J.; Jha, Ashish] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Jha, Ashish] Harvard Inst Global Hlth, Cambridge, MA USA; [Frumkin, Howard] Univ Washington, Seattle, WA 98195 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Washington; University of Washington Seattle	Hunter, DJ (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.			Frumkin, Howard/0000-0001-7079-3534				[Anonymous], PLANET; Crimmins A, 2016, IMPACTS CLIMATE CHAN; Krygsman K., 2016, LETS TALK HLTH CLIMA; Ogden NH, 2014, ENVIRON HEALTH PERSP, V122, P631, DOI 10.1289/ehp.1307799; Ross KR, 2016, AM J RESP CRIT CARE, V193, P359, DOI 10.1164/rccm.201512-2395ED; Vezzulli L, 2016, P NATL ACAD SCI USA, V113, pE5062, DOI 10.1073/pnas.1609157113	6	17	18	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 27	2017	376	17					1605	1607		10.1056/NEJMp1702378	http://dx.doi.org/10.1056/NEJMp1702378			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ET2AY	28249124				2022-12-28	WOS:000400071900001
J	Kannan, K; Gibson, DG				Kannan, Krishna; Gibson, Daniel G.			Yeast genome, by design	SCIENCE			English	Editorial Material									[Kannan, Krishna; Gibson, Daniel G.] Synthet Genom Inc, 11149 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Gibson, Daniel G.] J Craig Venter Inst, 4120 Capricorn Lane, La Jolla, CA 92037 USA	J. Craig Venter Institute	Gibson, DG (corresponding author), Synthet Genom Inc, 11149 North Torrey Pines Rd, La Jolla, CA 92037 USA.; Gibson, DG (corresponding author), J Craig Venter Inst, 4120 Capricorn Lane, La Jolla, CA 92037 USA.	dgibson@syntheticgenomics.com		Kannan, Krishna/0000-0002-2301-7900				Annaluru N, 2014, SCIENCE, V344, P55, DOI 10.1126/science.1249252; Dymond JS, 2011, NATURE, V477, P471, DOI 10.1038/nature10403; Eisenstein M, 2017, NAT METHODS, V14, P117, DOI 10.1038/nmeth.4158; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Hutchison CA, 2016, SCIENCE, V351, DOI 10.1126/science.aad6253; Mercy G, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4597; Mitchell LA, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4831; Richardson SM, 2017, SCIENCE, V355, P1040, DOI 10.1126/science.aaf4557; Shen Y, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4791; Spitale RC, 2013, NAT CHEM BIOL, V9, P18, DOI [10.1038/NCHEMBIO.1131, 10.1038/nchembio.1131]; Wu Y, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4706; Xie ZX, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4704; Zhang WM, 2017, SCIENCE, V355, DOI 10.1126/science.aaf3981	15	11	14	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI		1024	+		10.1126/science.aam9739	http://dx.doi.org/10.1126/science.aam9739			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9VY	28280169				2022-12-28	WOS:000396348900018
J	Sokol, J				Sokol, Joshua			HUBBLE TROUBLE	SCIENCE			English	Editorial Material																			0	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI		1010	1014		10.1126/science.355.6329.1010	http://dx.doi.org/10.1126/science.355.6329.1010			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9VY	28280163				2022-12-28	WOS:000396348900013
J	Frachetti, MD; Smith, CE; Traub, CM; Williams, T				Frachetti, Michael D.; Smith, C. Evan; Traub, Cynthia M.; Williams, Tim			Nomadic ecology shaped the highland geography of Asia's Silk Roads	NATURE			English	Article							MOBILE PASTORALISM; CHINA; AGRICULTURE; PATTERNS; STATES	There are many unanswered questions about the evolution of the ancient 'Silk Roads' across Asia. This is especially the case in their mountainous stretches, where harsh terrain is seen as an impediment to travel. Considering the ecology and mobility of inner Asian mountain pastoralists, we use 'flow accumulation' modelling to calculate the annual routes of nomadic societies (from 750 m to 4,000 m elevation). Aggregating 500 iterations of the model reveals a high-resolution flow network that simulates how centuries of seasonal nomadic herding could shape discrete routes of connectivity across the mountains of Asia. We then compare the locations of known high-elevation Silk Road sites with the geography of these optimized herding flows, and find a significant correspondence in mountainous regions. Thus, we argue that highland Silk Road networks (from 750 m to 4,000 m) emerged slowly in relation to long-established mobility patterns of nomadic herders in the mountains of inner Asia.	[Frachetti, Michael D.; Smith, C. Evan] Washington Univ, Dept Anthropol, SAIE Lab, 1 Brookings Dr,CB 1114, St Louis, MO 63130 USA; [Traub, Cynthia M.] Washington Univ, Univ Lib, 1 Brookings Dr,CB 1061, St Louis, MO 63130 USA; [Williams, Tim] UCL, Inst Archaeol, 31-34 Gordon Sq, London WC1H 0PY, England	Washington University (WUSTL); Washington University (WUSTL); University of London; University College London	Frachetti, MD (corresponding author), Washington Univ, Dept Anthropol, SAIE Lab, 1 Brookings Dr,CB 1114, St Louis, MO 63130 USA.	frachetti@wustl.edu	Frachetti, Michael/AAZ-1273-2020	Traub, Cynthia/0000-0001-5036-4118; Frachetti, Michael/0000-0001-6906-4334; Williams, Tim/0000-0001-8503-5920	Washington University in St. Louis	Washington University in St. Louis	Funding for research at the SAIE laboratory was provided by Washington University in St. Louis (M.D.F.). C. Copp and M. Webb provided assistance with modelling and coding in the SAIE laboratory and GIS laboratory of Washington University in St. Louis. C. Chady assisted in copy editing. An early version of the pastoralist participation model was presented at the Advanced Seminar 'New Geospatial Approaches in Anthropology' at the School for Advanced Research, March 6-10, 2016. P. Daly, R. Pinhasi, G. Larson and D. Meltzer provided commentary on drafts of this article.	Angourakis A, 2014, J ARCHAEOL METHOD TH, V21, P405, DOI 10.1007/s10816-013-9197-0; [Anonymous], THESIS; Barfield Th, 2001, NOMADS SEDENTARY WOR, P234; Barnard H., 2008, COTSEN ADV SEMINAR S, V4, P603; Beckwith CI, 2009, EMPIRES OF THE SILK ROAD: A HISTORY OF CENTRAL EURASIA FROM THE BRONZE AGE TO THE PRESENT, P1; BROSSEDER URSULA, 2011, XIONGNU ARCHAEOLOGY, V5; Chase-Dunn C, 2010, SOC EVOL HIST, V9, P52; Christian D, 2000, J WORLD HIST, V11, P1, DOI 10.1353/jwh.2000.0004; Ciolek TM, 2012, OLD WORLD TRADE ROUT; Daly P., 2006, DIGITAL ARCHAEOLOGY, P128; de la Vaissiere E, 2005, SOGDIAN TRADERS HIST; DiCosmo N, 1996, ANTHR ARCHEOL EURAS, V34, P87; Doumani PN, 2015, ARCHAEOL RES ASIA, V1-2, P17, DOI 10.1016/j.ara.2015.01.001; Foltz R., 1999, RELIG SILK ROAD; Frachetti MD, 2014, J FIELD ARCHAEOL, V39, P195, DOI 10.1179/0093469014Z.00000000085; Frachetti MD, 2014, RECONFIGURING THE SILK ROAD: NEW RESEARCH ON EAST-WEST EXCHANGE IN ANTIQUITY, P41; Frachetti MD, 2012, CURR ANTHROPOL, V53, P2, DOI 10.1086/663692; FRACHETTI Michael D., 2008, PAST LANDSC SOC INT; Frank AndreGuner., 1992, B CONCERN ASIA SCHOL, V24, P50; Hansen, 2012, SILK ROAD NEW HIST; Harris DR, 1996, P PREHIST SOC, V62, P423, DOI DOI 10.1017/S0079497X00002863; Honeychurch W, 2014, J ARCHAEOL RES, V22, P277, DOI 10.1007/s10814-014-9073-9; Jenkerson C.B., 2010, EMODIS USER FRIENDLY, DOI [10.3133/ofr20101055, DOI 10.3133/OFR20101055]; Jia PW, 2011, J FIELD ARCHAEOL, V36, P269, DOI 10.1179/009346911X13140904382057; Khazanov A.M., 2005, SHIFTS DRIFTS NOMAD, P163; Khazanov Anatoly, 1994, NOMADS OUTSIDE WORLD; Kuzmina I. E., 2003, PREHISTORIC STEPPE A, P203; Liu XY, 2016, HOLOCENE, V26, P1556, DOI 10.1177/0959683616646842; Mei J, 2003, MUSEUM E ANTIQUITIES, P31; Miller BK, 2014, J ECON SOC HIST ORIE, V57, P1, DOI 10.1163/15685209-12341340; Miller NF, 2016, HOLOCENE, V26, P1566, DOI 10.1177/0959683616641742; Outram AK, 2012, J ARCHAEOL SCI, V39, P2424, DOI 10.1016/j.jas.2012.02.009; Possehl G. L., 1979, S ASIAN ARCHAEOLOGY, V1, P537; Potts Daniel, 2014, NOMADISM IRAN ANTIQU; Robinson S, 2005, NOMAD PEOPLES, V9, P199, DOI 10.3167/082279405781826146; Rogers J. D., 2007, ASIAN PERSPECT, V46, P249, DOI [DOI 10.1353/ASI.2007.0017, DOI 10.1353/asi.2007.0017]; Rogers J, 2012, J ARCHAEOL RES, V20, P205, DOI 10.1007/s10814-011-9053-2; Salzman PC, 2002, J ANTHROPOL RES, V58, P245, DOI 10.1086/jar.58.2.3631038; Seland EH, 2015, COGENT ARTS HUMANITE, V2, DOI 10.1080/23311983.2015.1110272; Sobolev L.N., 1960, KORMOVYE RESURSY KAZ; Spengler R, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3382; Spengler RN, 2015, J WORLD PREHIST, V28, P215, DOI 10.1007/s10963-015-9087-3; Stevens CJ, 2016, HOLOCENE, V26, P1541, DOI 10.1177/0959683616650268; Stride S, 2009, WORLD ARCHAEOL, V41, P73, DOI 10.1080/00438240802655302; Whitfield S., 2015, LIFE SILK ROAD; Whitfield S., 1999, LIFE SILK ROAD; Williams Tim, 2014, SILK ROADS ICOMOS TH; Yang JD, 2015, J AM ORIENTAL SOC, V135, P421, DOI 10.7817/jameroriesoci.135.3.421	48	103	111	13	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2017	543	7644					193	+		10.1038/nature21696	http://dx.doi.org/10.1038/nature21696			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EN0GQ	28277506	Green Submitted			2022-12-28	WOS:000395688700029
J	Mandell, DS; Barry, CL				Mandell, David S.; Barry, Colleen L.			Care for Autism and Other Disabilities - A Future in Jeopardy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SPECTRUM DISORDER; CHILDREN		[Mandell, David S.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Mandell, David S.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Mandell, David S.] Univ Penn, Ctr Mental Hlth Policy & Serv Res, Philadelphia, PA 19104 USA; [Barry, Colleen L.] Johns Hopkins Ctr Mental Hlth & Addict Policy Res, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Barry, Colleen L.] Johns Hopkins Wendy Klag Ctr Autism & Dev Disabil, Baltimore, MD USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Mandell, DS (corresponding author), Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA.; Mandell, DS (corresponding author), Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA.; Mandell, DS (corresponding author), Univ Penn, Ctr Mental Hlth Policy & Serv Res, Philadelphia, PA 19104 USA.		Mandell, David S/H-2730-2012	Mandell, David S/0000-0001-8240-820X				Institute of Medicine, 2004, IMM SAF REV VACC AUT; Maglione MA, 2014, PEDIATRICS, V134, P325, DOI 10.1542/peds.2014-1079; Mandell DS, 2016, JAMA PEDIATR, V170, P887, DOI 10.1001/jamapediatrics.2016.1049; Strauss V., 2016, WASHINGTON POST; Stuart EA, 2017, HEALTH AFFAIR, V36, P337, DOI 10.1377/hlthaff.2016.0824	5	3	3	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2017	376	10							e15	10.1056/NEJMp1700697	http://dx.doi.org/10.1056/NEJMp1700697			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9JA	28273015				2022-12-28	WOS:000395626500005
J	Maziade, M				Maziade, Michel			At Risk for Serious Mental Illness - Screening Children of Patients with Mood Disorders or Schizophrenia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Maziade, Michel] Ctr Integre Univ Sante, Quebec City, PQ, Canada; [Maziade, Michel] Serv Sociaux Capitale Natl, Quebec City, PQ, Canada; [Maziade, Michel] Univ Laval, Fac Med, Quebec City, PQ, Canada	Laval University	Maziade, M (corresponding author), Ctr Integre Univ Sante, Quebec City, PQ, Canada.; Maziade, M (corresponding author), Serv Sociaux Capitale Natl, Quebec City, PQ, Canada.; Maziade, M (corresponding author), Univ Laval, Fac Med, Quebec City, PQ, Canada.							Cannon TD, 2016, AM J PSYCHIAT, V173, P980, DOI 10.1176/appi.ajp.2016.15070890; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C; Maziade M, 2014, JAMA PEDIATR, V168, P3, DOI 10.1001/jamapediatrics.2013.3871; McGorry P, 2012, SCHIZOPHRENIA BULL, V38, P221, DOI 10.1093/schbul/sbr185; Paccalet T, 2016, SCHIZOPHR RES, V175, P186, DOI 10.1016/j.schres.2016.04.038	5	13	13	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2017	376	10					910	912		10.1056/NEJMp1612520	http://dx.doi.org/10.1056/NEJMp1612520			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9JA	28273009				2022-12-28	WOS:000395626500003
J	Yissachar, N; Zhou, Y; Ung, L; Lai, NY; Mohan, JF; Ehrlicher, A; Weitz, DA; Kasper, DL; Chiu, IM; Mathis, D; Benoist, C				Yissachar, Nissan; Zhou, Yan; Ung, Lloyd; Lai, Nicole Y.; Mohan, James F.; Ehrlicher, Allen; Weitz, David A.; Kasper, Dennis L.; Chiu, Isaac M.; Mathis, Diane; Benoist, Christophe			An Intestinal Organ Culture System Uncovers a Role for the Nervous System in Microbe-Immune Crosstalk	CELL			English	Article							ROOT GANGLION NEURONS; IN-VITRO; SENSORY NEURONS; HUMAN GUT; T-CELLS; PAIN; INFLAMMATION; RECEPTOR; DISEASE; INDUCE	Investigation of host-environment interactions in the gut would benefit from a culture system that maintained tissue architecture yet allowed tight experimental control. We devised a microfabricated organ culture system that viably preserves the normal multicellular composition of the mouse intestine, with luminal flow to control perturbations (e.g., microbes, drugs). It enables studying short-term responses of diverse gut components (immune, neuronal, etc.). We focused on the early response to bacteria that induce either Th17 or RORg(+) T-regulatory (Treg) cells in vivo. Transcriptional responses partially reproduced in vivo signatures, but these microbes elicited diametrically opposite changes in expression of a neuronal-specific gene set, notably nociceptive neuropeptides. We demonstrated activation of sensory neurons by microbes, correlating with RORg(+) Treg induction. Colonic RORg(+) Treg frequencies increased in mice lacking TAC1 neuropeptide precursor and decreased in capsaicin-diet fed mice. Thus, differential engagement of the enteric nervous system may partake in bifurcating pro-or anti-inflammatory responses to microbes.	[Yissachar, Nissan; Zhou, Yan; Lai, Nicole Y.; Mohan, James F.; Kasper, Dennis L.; Chiu, Isaac M.; Mathis, Diane; Benoist, Christophe] Harvard Med Sch, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA; [Ung, Lloyd; Ehrlicher, Allen; Weitz, David A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Ung, Lloyd; Ehrlicher, Allen; Weitz, David A.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University	Chiu, IM; Mathis, D; Benoist, C (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA.	isaac_chiu@hms.harvard.edu; cbdm@hms.harvard.edu; cbdm@hms.harvard.edu	Lai, Nicole/HDL-8077-2022; Chiu, Isaac/R-3803-2016	Ung, Warren/0000-0003-3352-9974; Ehrlicher, Allen/0000-0003-3030-979X; Chiu, Isaac/0000-0002-0723-4841; Yissachar, Nissan/0000-0002-7647-9754	UCB; JPB Foundation; NIH [R37-AI051530, DP2AT009499]; Harvard Digestive Disease Center pilot grant; Schuyler Pierce Memorial Fellowship; JDRF [3-2014-216]; National Center for Complementary & Integrative Health [DP2AT009499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051530, K22AI114810, R37AI051530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER	UCB(UCB Pharma SA); JPB Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Disease Center pilot grant; Schuyler Pierce Memorial Fellowship; JDRF(Juvenile Diabetes Research Foundation); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank N. Surana, E. Sefik, T. Tan, and W. Ebina for microbial strains or insightful discussions; A. T. Sherpa, J. Ramos, and K. Hattori for help with mice; A. Rhoads, L. Yang, and G. Gopalan for help with expression profiling; G. Buruzula and C. Araneo for help with sorting; K. Mills for multi-electrode array; P. Ma for help with whole mount staining; C. Gerard and B. Lu for NK1R-KO mice; and C. Laplace for help with graphics. This work was supported by a Sponsored Research Agreement from UCB, the JPB Foundation, a gift from the Howalt family and by NIH grants R37-AI051530 to C.B. and D.M., and NIH DP2AT009499 and a Harvard Digestive Disease Center pilot grant to I.M.C. N.Y. was supported by a Schuyler Pierce Memorial Fellowship. J.F.M. was supported by JDRF Post-Doctoral Fellowship 3-2014-216.	Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Baral P, 2016, CELL HOST MICROBE, V19, P755, DOI 10.1016/j.chom.2016.05.010; Cao YQ, 1998, NATURE, V392, P390, DOI 10.1038/32897; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chiu IM, 2014, ELIFE, V3, DOI 10.7554/eLife.04660; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082; Cunin P, 2011, J IMMUNOL, V186, P4175, DOI 10.4049/jimmunol.1002535; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Geva-Zatorsky N, 2017, CELL, V168, P928, DOI 10.1016/j.cell.2017.01.022; Gonzalez-Rey E, 2007, NAT REV IMMUNOL, V7, P52, DOI 10.1038/nri1984; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Janelsins BM, 2013, BLOOD, V121, P2923, DOI 10.1182/blood-2012-07-446054; JENKINSON EJ, 1994, CURR OPIN IMMUNOL, V6, P293, DOI 10.1016/0952-7915(94)90104-X; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kim HJ, 2016, P NATL ACAD SCI USA, V113, pE7, DOI 10.1073/pnas.1522193112; Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j; Kovalenko PL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079745; Lecuyer E, 2014, IMMUNITY, V40, P608, DOI 10.1016/j.immuni.2014.03.009; Mao YK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2478; Margolis KG, 2016, TRENDS IMMUNOL, V37, P487, DOI 10.1016/j.it.2016.05.003; Meseguer V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4125; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Ochoa-Cortes F, 2010, AM J PHYSIOL-GASTR L, V299, pG723, DOI 10.1152/ajpgi.00494.2009; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Qi J, 2011, J IMMUNOL, V186, P6417, DOI 10.4049/jimmunol.1001241; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; Robinson DR, 2004, NEUROGASTROENT MOTIL, V16, P113, DOI 10.1046/j.1365-2982.2003.00456.x; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schnupf P, 2015, NATURE, V520, P99, DOI 10.1038/nature14027; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Steinhoff MS, 2014, PHYSIOL REV, V94, P265, DOI 10.1152/physrev.00031.2013; Tan LL, 2008, NEUROSCIENCE, V156, P334, DOI 10.1016/j.neuroscience.2008.06.071; Tan TG, 2016, P NATL ACAD SCI USA, V113, pE8141, DOI 10.1073/pnas.1617460113; Thaiss CA, 2016, NATURE, V535, P65, DOI 10.1038/nature18847; Tsilingiri K, 2012, GUT, V61, P1007, DOI 10.1136/gutjnl-2011-300971; Weinstock JV, 2003, J IMMUNOL, V171, P3762, DOI 10.4049/jimmunol.171.7.3762; Xia YN, 1996, SCIENCE, V273, P347, DOI 10.1126/science.273.5273.347; Xu ZZ, 2015, NAT MED, V21, P1326, DOI 10.1038/nm.3978	47	129	136	3	75	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2017	168	6					1135	+		10.1016/j.cell.2017.02.009	http://dx.doi.org/10.1016/j.cell.2017.02.009			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8ZF	28262351	Green Accepted, Bronze			2022-12-28	WOS:000396287900020
J	Hampton, T				Hampton, Tracy			New Insights on How Immune Cells Breach Blood Vessel Walls	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2017	317	9					899	899		10.1001/jama.2017.1067	http://dx.doi.org/10.1001/jama.2017.1067			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM8DM	28267843				2022-12-28	WOS:000395541500003
J	Levis, C; Costa, FRC; Bongers, F; Pena-Claros, M; Clement, CR; Junqueira, AB; Neves, EG; Tamanaha, EK; Figueiredo, FOG; Salomao, RP; Castilho, CV; Magnusson, WE; Phillips, OL; Guevara, JE; Sabatier, D; Molino, JF; Lopez, DC; Mendoza, AM; Pitman, NCA; Duque, A; Vargas, PN; Zartman, CE; Vasquez, R; Andrade, A; Camargo, JL; Feldpausch, TR; Laurance, SGW; Laurance, WF; Killeen, TJ; Nascimento, HEM; Montero, JC; Mostacedo, B; Amaral, IL; Vieira, ICG; Brienen, R; Castellanos, H; Terborgh, J; Carim, MDV; Guimaraes, JRD; Coelho, LD; Matos, FDD; Wittmann, F; Mogollon, HF; Damasco, G; Davila, N; Garcia-Villacorta, R; Coronado, ENH; Emilio, T; Lima, DD; Schietti, J; Souza, P; Targhetta, N; Comiskey, JA; Marimon, BS; Marimon, BH; Neill, D; Alonso, A; Arroyo, L; Carvalho, FA; de Souza, FC; Dallmeier, F; Pansonato, MP; Duivenvoorden, JF; Fine, PVA; Stevenson, PR; Araujo-Murakami, A; Aymard, GA; Baraloto, CC; do Amaral, DD; Engel, J; Henkel, TW; Maas, P; Petronelli, P; Revilla, JDC; Stropp, J; Daly, D; Gribel, R; Paredes, MR; Silveira, M; Thomas-Caesar, R; Baker, TR; da Silva, NF; Ferreira, LV; Peres, CA; Silman, MR; Ceron, C; Valverde, FC; Di Fiore, A; Jimenez, EM; Mora, MCP; Toledo, M; Barbosa, EM; Bonates, LCD; Arboleda, NC; Farias, ED; Fuentes, A; Guillaumet, JL; Jorgensen, PM; Malhi, Y; Miranda, IPD; Phillips, JF; Prieto, A; Rudas, A; Ruschel, AR; Silva, N; von Hildebrand, P; Vos, VA; Zent, EL; Zent, S; Cintra, BBL; Nascimento, MT; Oliveira, AA; Ramirez-Angulo, H; Ramos, JF; Rivas, G; Schongart, J; Sierra, R; Tirado, M; van der Heijden, G; Torre, EV; Wang, O; Young, KR; Baider, C; Cano, A; Farfan-Rios, W; Ferreira, C; Hoffman, B; Mendoza, C; Mesones, I; Torres-Lezama, A; Medina, MNU; van Andel, TR; Villarroel, D; Zagt, R; Alexiades, MN; Balslev, H; Garcia-Cabrera, K; Gonzales, T; Hernandez, L; Huamantupa-Chuquimaco, I; Manzatto, AG; Milliken, W; Cuenca, WP; Pansini, S; Pauletto, D; Arevalo, FR; Reis, NFC; Sampaio, AF; Giraldo, LEU; Sandoval, EHV; Gamarra, LV; Vela, CIA; ter Steege, H				Levis, C.; Costa, F. R. C.; Bongers, F.; Pena-Claros, M.; Clement, C. R.; Junqueira, A. B.; Neves, E. G.; Tamanaha, E. K.; Figueiredo, F. O. G.; Salomao, R. P.; Castilho, C. V.; Magnusson, W. E.; Phillips, O. L.; Guevara, J. E.; Sabatier, D.; Molino, J. -F.; Lopez, D. Cardenas; Mendoza, A. M.; Pitman, N. C. A.; Duque, A.; Vargas, P. Nunez; Zartman, C. E.; Vasquez, R.; Andrade, A.; Camargo, J. L.; Feldpausch, T. R.; Laurance, S. G. W.; Laurance, W. F.; Killeen, T. J.; Nascimento, H. E. Mendona; Montero, J. C.; Mostacedo, B.; Amaral, I. L.; Vieira, I. C. Guimaraes; Brienen, R.; Castellanos, H.; Terborgh, J.; Carim, M. de Jesus Veiga; Guimaraes, J. R. da Silva; Coelho, L. de Souza; Matos, F. D. de Almeida; Wittmann, F.; Mogollon, H. F.; Damasco, G.; Davila, N.; Garcia-Villacorta, R.; Coronado, E. N. H.; Emilio, T.; Lima Filho, D. de Andrade; Schietti, J.; Souza, P.; Targhetta, N.; Comiskey, J. A.; Marimon, B. S.; Marimon, B. -H., Jr.; Neill, D.; Alonso, A.; Arroyo, L.; Carvalho, F. A.; de Souza, F. C.; Dallmeier, F.; Pansonato, M. P.; Duivenvoorden, J. F.; Fine, P. V. A.; Stevenson, P. R.; Araujo-Murakami, A.; Aymard, G. A.; Baraloto, C. C.; do Amaral, D. D.; Engel, J.; Henkel, T. W.; Maas, P.; Petronelli, P.; Revilla, J. D. Cardenas; Stropp, J.; Daly, D.; Gribel, R.; Paredes, M. Rios; Silveira, M.; Thomas-Caesar, R.; Baker, T. R.; da Silva, N. F.; Ferreira, L. V.; Peres, C. A.; Silman, M. R.; Ceron, C.; Valverde, F. C.; Di Fiore, A.; Jimenez, E. M.; Mora, M. C. Penuela; Toledo, M.; Barbosa, E. M.; Bonates, L. C. de Matos; Arboleda, N. C.; Farias, E. de Sousa; Fuentes, A.; Guillaumet, J. -L.; Jorgensen, P. Moller; Malhi, Y.; Miranda, I. P. de Andrade; Phillips, J. F.; Prieto, A.; Rudas, A.; Ruschel, A. R.; Silva, N.; von Hildebrand, P.; Vos, V. A.; Zent, E. L.; Zent, S.; Cintra, B. B. L.; Nascimento, M. T.; Oliveira, A. A.; Ramirez-Angulo, H.; Ramos, J. F.; Rivas, G.; Schongart, J.; Sierra, R.; Tirado, M.; van der Heijden, G.; Torre, E. V.; Wang, O.; Young, K. R.; Baider, C.; Cano, A.; Farfan-Rios, W.; Ferreira, C.; Hoffman, B.; Mendoza, C.; Mesones, I.; Torres-Lezama, A.; Medina, M. N. U.; van Andel, T. R.; Villarroel, D.; Zagt, R.; Alexiades, M. N.; Balslev, H.; Garcia-Cabrera, K.; Gonzales, T.; Hernandez, L.; Huamantupa-Chuquimaco, I.; Manzatto, A. G.; Milliken, W.; Cuenca, W. P.; Pansini, S.; Pauletto, D.; Arevalo, F. R.; Reis, N. F. Costa; Sampaio, A. F.; Giraldo, L. E. Urrego; Sandoval, E. H. Valderrama; Gamarra, L. Valenzuela; Vela, C. I. A.; ter Steege, H.			Persistent effects of pre-Columbian plant domestication on Amazonian forest composition	SCIENCE			English	Article							PATTERNS; CULTIVATION; EVOLUTION; SELECTION; HISTORY; CLIMATE; REGION; SOILS	The extent to which pre-Columbian societies altered Amazonian landscapes is hotly debated. We performed a basin-wide analysis of pre-Columbian impacts on Amazonian forests by overlaying known archaeological sites in Amazonia with the distributions and abundances of 85 woody species domesticated by pre-Columbian peoples. Domesticated species are five times more likely than nondomesticated species to be hyperdominant. Across the basin, the relative abundance and richness of domesticated species increase in forests on and around archaeological sites. In southwestern and eastern Amazonia, distance to archaeological sites strongly influences the relative abundance and richness of domesticated species. Our analyses indicate that modern tree communities in Amazonia are structured to an important extent by a long history of plant domestication by Amazonian peoples.	[Levis, C.; Figueiredo, F. O. G.] INPA, Programa Grad Ecol, Av Andre Araujo 2936, BR-69067375 Manaus, Amazonas, Brazil; [Levis, C.; Bongers, F.; Pena-Claros, M.] Wageningen Univ & Res, Forest Ecol & Forest Management Grp, Droevendaalsesteeg 3, POB 47, NL-6700 AA Wageningen, Netherlands; [Costa, F. R. C.; Magnusson, W. E.; Zartman, C. E.; Nascimento, H. E. Mendona; Amaral, I. L.; Coelho, L. de Souza; Matos, F. D. de Almeida; Emilio, T.; Lima Filho, D. de Andrade; Schietti, J.; Souza, P.; Carvalho, F. A.; de Souza, F. C.; Pansonato, M. P.; Revilla, J. D. Cardenas; Gribel, R.; Barbosa, E. M.; Bonates, L. C. de Matos; Farias, E. de Sousa; Miranda, I. P. de Andrade; Ramos, J. F.; Ferreira, C.] INPA, Coordenacao Biodiversidade, Av Andre Araujo 2936, BR-69067375 Manaus, Amazonas, Brazil; [Clement, C. R.] INPA, Coordenacao Tecnol Inovacao, Av Andre Araujo 2936, BR-69067375 Manaus, Amazonas, Brazil; [Junqueira, A. B.] Wageningen Univ & Res, Dept Soil Qual, Droevendaalsesteeg 4, POB 47, NL-6700 AA Wageningen, Netherlands; [Neves, E. G.] Univ Sao Paulo, Museu Arqueol Etnol USP, Av Prof Almeida Prado 1466, BR-05508900 Sao Paulo, SP, Brazil; [Neves, E. G.] Harvard Univ, Dept Anthropol, 21 Divinity Ave, Cambridge, MA 02138 USA; [Tamanaha, E. K.] Inst Desenvolvimento Sustentavel Mamiraua, Lab Arqueol, Estrada Bexiga 2584, BR-69553225 Tefe, Amazonas, Brazil; [Salomao, R. P.; Vieira, I. C. Guimaraes; do Amaral, D. D.; Ferreira, L. V.] Coordenacao Botan, Museu Paraense Emilio Goeldi, Av Magalhaes Barata 376, BR-66040170 Belem, PA, Brazil; [Castilho, C. V.] EMBRAPA Ctr Pesquisa Agroflorestal Roraima, BR-69301970 Boa Vista, Brazil; [Phillips, O. L.; Feldpausch, T. R.; Brienen, R.; Coronado, E. N. H.; de Souza, F. C.; Baker, T. R.; Cintra, B. B. L.] Univ Leeds, Sch Geog, Woodhouse Lane, Leeds LS2 9JT, W Yorkshire, England; [Guevara, J. E.; Andrade, A.; Amaral, I. L.; Damasco, G.; Alonso, A.; Fine, P. V. A.; Araujo-Murakami, A.; Mesones, I.; Alexiades, M. N.] Univ Calif, Dept Integrat Biol, Berkeley, CA 94720 USA; [Guevara, J. E.] Univ San Francisco Quito, Colegio Ciencias Biol, Diego Robles Via Interocean, Quito, Ecuador; [Sabatier, D.; Molino, J. -F.; Engel, J.] Univ Montpellier, CNRS,INRA, AMAP, IRD,Cirad, Montpellier, France; [Lopez, D. Cardenas] Herbario Amazonico Colombiano, Inst SINCHI, Calle 20 5-44, Bogota, DC, Colombia; [Mendoza, A. M.; Vasquez, R.; Gamarra, L. Valenzuela] Jardin Botan Missouri, Oxapampa, Pasco, Peru; [Pitman, N. C. A.] Sci & Educ, Field Museum, 1400 S Lake Shore Dr, Chicago, IL 60605 USA; [Duque, A.] Univ Nacl Colombia, Dept Ciencias Forest, Calle 64 x Cra 65, Antioquia 1027, Colombia; [Vargas, P. Nunez; Giraldo, L. E. Urrego] Univ Nacl San Antonio Abad Cusco, Herbario Vargas, Ave Cultura No 733, Cuzco, Peru; [Andrade, A.; Camargo, J. L.; Huamantupa-Chuquimaco, I.] INPA, Projeto Dinam Biol Fragmentos Florestais, Av Andre Araujo 2936, BR-69067375 Manaus, Amazonas, Brazil; [Feldpausch, T. R.] Univ Exeter, Coll Life & Environm Sci, Geog, Exeter EX4 4RJ, Devon, England; [Laurance, S. G. W.; Laurance, W. F.] James Cook Univ, Ctr Trop Environm & Sustainabil Sci, Cairns, Qld 4878, Australia; [Killeen, T. J.] James Cook Univ, Coll Sci & Engn, Cairns, Qld 4878, Australia; [Montero, J. C.] Agteca Amazon, Santa Cruz, CA, Bolivia; [Montero, J. C.; Toledo, M.] Univ Autonoma Gabriel Rene Moreno, Inst Boliviano Investigac Forestal, FCA UAGRM, Santa Cruz, CA, Bolivia; [Mostacedo, B.] INPA, Coordenacao Biodiversidade, Av Andre Araujo 2936, BR-69060001 Manaus, Amazonas, Brazil; [Castellanos, H.] Univ Autonoma Gabriel Rene Moreno, Fac Ciencias Agricolas, Santa Cruz, CA, Bolivia; [Terborgh, J.] Univ Nacl Expt Guayana, Bolivar, Venezuela; [Vieira, I. C. Guimaraes; Guimaraes, J. R. da Silva] Duke Univ, Nicholas Sch Environm, Ctr Trop Conservat, Durham, NC 27708 USA; [Wittmann, F.] Inst Pesquisas Cient Tecnol Amapa IEPA, Dept Botan, Campus IEPA Fazendinha, BR-68912250 Amapa, Brazil; [Wittmann, F.] KIT, Inst Geog & Geoecol, Dep Wetland Ecol, Josefstr 1, Karlsruhe, Germany; [Wittmann, F.] Max Planck Inst Chem, Biogeochemistry, Hahn Meitner Weg 1, D-55128 Mainz, Germany; [Davila, N.] Endangered Species Coalit, 8530 Geren Rd, Silver Spring, MD 20901 USA; [Garcia-Villacorta, R.] Univ Estadual Campinas, Biol Vegetal, Caixa Postal 6109, BR-13083970 Campinas, SP, Brazil; [Garcia-Villacorta, R.] Univ Edinburgh, Inst Mol Plant Sci, Mayfield Rd, Edinburgh EH3 5LR, Midlothian, Scotland; [Coronado, E. N. H.] Royal Bot Garden Edinburgh, 20a Inverleith Row, Edinburgh EH3 5LR, Midlothian, Scotland; [Emilio, T.; Milliken, W.] Inst Investigaciones Amazonia Peruana, Jose Quinones km 2 5, Loreto, Peru; [Emilio, T.] Comparat Plant & Fungal Biol, Royal Bot Gardens, Kew, Richmond TW9 3AB, Surrey, England; [Comiskey, J. A.] INPA, MAUA Working Grp, Av Andre Araujo 2936, BR-69067375 Manaus, Amazonas, Brazil; [Comiskey, J. A.] Inventory & Monitoring Program, Natl Pk Serv, 120 Chatham Lane, Fredericksburg, VA 22405 USA; [Comiskey, J. A.] Smithsonian Inst, 1100 Jefferson Dr,SW, Washington, DC 20560 USA; [Marimon, B. S.; Marimon, B. -H., Jr.] Univ Estado Mato Grosso, Programa Pos Grad Ecol Conservacao, Nova Xavantina, MT, Brazil; [Alonso, A.] Univ Estatal Amazon, Ecosistemas, Biodiversidad Conservacion Especies, Km 2 2 via Tena Paso Lateral, Pastaza, Ecuador; [Arroyo, L.; Araujo-Murakami, A.; Villarroel, D.] Smithsonian Conservat Biol Inst, Ctr Conservat & Sustainabil, Natl Zoological Pk, Washington, DC 20013 USA; [Carvalho, F. A.] Univ Autonoma Gabriel Rene Moreno, Museo Historia Nat Noel Kempff Mercado, Avenida Irala 565 Casilla Post 2489, Santa Cruz, CA, Bolivia; [Carvalho, F. A.] Univ Fed Rio Grande do Norte, Dept Botan Zool, Ctr Biociencias, Campus Univ, BR-59078970 Natal, RN, Brazil; [Oliveira, A. A.; Baider, C.] Smithsonian Conservat Biol Inst, Ctr Conservat Educ & Sustainabil, MRC 0705, Natl Zoological Pk, Washington, DC 20013 USA; [Pansonato, M. P.] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Rua Matao Trav 14, BR-05508090 Sao Paulo, SP, Brazil; [Stevenson, P. R.; Cano, A.; Medina, M. N. U.] Univ Amsterdam, Inst Biodivers & Ecosystem Dynam, Sci pk 904, Amsterdam, Netherlands; [Aymard, G. A.] Univ Ios Andes, Lab Ecol Bosques Trop & Primatol, Carrera 1 18a 10, Bogota, DF 111711, Colombia; [Baraloto, C. C.] Herbario Univ PORT, Programa Ciencias Agro el Mar, UNELLEZ Guanare, Portuguesa 3350, Venezuela; [Engel, J.] Florida Int Univ, Int Ctr Trop Bot ICTB, Dept Biol Sci, 11200 SW 8th St, Miami, FL 33199 USA; [Engel, J.] INRA, UMR Ecol Forets Guyane, Campus agronomique, Kourou 97379, French Guiana; [Henkel, T. W.] Humboldt State Univ, Dept Biol Sci, 1 Harpst St, Arcata, CA 95521 USA; [Maas, P.] Naturalis Biodivers Ctr, Taxon & Systemat, POB 9517, NL-2300 RA Leiden, Netherlands; [Petronelli, P.] Univ Guyane, CNRS, Cirad UMR Ecofog, AgrosParisTech,CNRS, Campus Agronomique, F-97310 Kourou, France; [Stropp, J.] Univ Fed Alagoas, Inst Biol & Hlth Sci, Av Lourival Melo Mota S-N Tabuleiro Martins, BR-57072970 Maceio, AL, Brazil; [Daly, D.] New York Bot Garden, 2900 Southern Blvd, Bronx, NY 10458 USA; [Paredes, M. Rios] Serv Biodiversidad EIRL, Iquitos, Loreto, Peru; [Silveira, M.] Univ Fed Acre, Museu Univ, Lab Bot Ecol Vegetal, Ctr Ciencias Biol Nat, BR-69915559 Rio Branco, AC, Brazil; [Thomas-Caesar, R.] Iwokrama Int Programme Rainforest Conservat, Georgetown, Guyana; [da Silva, N. F.; Schongart, J.] INPA, Coordenacao Dinam Ambiental, Av Andre Araujo 2936, BR-69067375 Manaus, Amazonas, Brazil; [Peres, C. A.] Univ East Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Silman, M. R.; Farfan-Rios, W.; Garcia-Cabrera, K.] Wake Forest Univ, Biol Dept, 1834 Wake Forest Rd, Winston Salem, NC 27106 USA; [Silman, M. R.; Ceron, C.; Garcia-Cabrera, K.] Wake Forest Univ, Ctr Energy Environm & Sustainabil, 1834 Wake Forest Rd, Winston Salem, NC 27106 USA; [Ceron, C.] Alfredo Paredes Univ Cent, Escuela Biol Herbario, Ap Postal 17-01-2177, Quito, Pichincha, Ecuador; [Valverde, F. C.] Andes Amazon Biodivers Program, Madre Dios, Madre de Dios, Peru; [Di Fiore, A.] Univ Texas, Dept Anthropol, Austin, TX 78712 USA; [Jimenez, E. M.] Univ Nacl Colombia Sede Amazonia, Grupo Ecol Ecosistemas Terr Trop, Leticia, Amazonas, Colombia; [Mora, M. C. Penuela] Univ Reg Amazon IKIAM, Km 7 via Muyuna, Napo, Ecuador; [Arboleda, N. C.] Inst SINCHI, Herbario Amazonico Colombiano, Calle 20 5-44, Bogota, DF, Colombia; [Farias, E. de Sousa] Inst Leonidas Maria Deane, Lab Ecol Doencas Transmissiveis Amazonia EDTA, Fiocruz MS, Rua Terezina 476, BR-69060001 Manaus, Amazonas, Brazil; [Farias, E. de Sousa] IOC Fiocruz MS, Programa Posgrad Biodiversidade & Saude, Pav Arthur Neiva Terreo, Av Brasil 4365 Manguinhos, BR-21040360 Rio De Janeiro, RJ, Brazil; [Fuentes, A.] Univ UMSA, Herbario Nacl Bolivia, Casilla 10077 Correo Cent, La Paz, Bolivia; [Fuentes, A.; Jorgensen, P. Moller] Missouri Bot Garden, POB 299, St Louis, MO 63166 USA; [Guillaumet, J. -L.] Museum Natl Hist Nat Paris, Dept EV, 16 rue Buffon, F-75005 Paris, France; [Malhi, Y.] Univ Oxford, Environm Change Inst, Ctr Environm, Dyson Perrins Bldg,S Pk Rd, Oxford OX1 3QY, England; [Phillips, J. F.] Fdn Puerto Rastrojo, Cra 10 24-76 Oficina 1201, Bogota, DC, Colombia; [Prieto, A.; Rudas, A.] Univ Nacl Colombia, Inst Ciencias Nat, Apartado 7945, Bogota, DC, Colombia; [Ruschel, A. R.] Embrapa Amazonia Oriental, Dr Eneas Pinheiro S-N, BR-66095100 Belem, PA, Brazil; [Silva, N.] Univ Fed Rural Amazonia, Inst Ciencia Agr, Presidente Tancredo Neves 2501, BR-66077901 Belem, PA, Brazil; [von Hildebrand, P.] Fdn Estn Biol, Cra 10 24-76 Oficina 1201, Bogota, DF, Colombia; [Vos, V. A.] Univ Autonoma Beni Jose Ballivian, Campus Univ Final Av Ejercito, Riberalta, Beni, Bolivia; [Vos, V. A.] Ctr Invest & Promoc Campesinado, Reg Norte Amazon, C Nicanor Gonzalo Salvatierra No 362, Riberalta, Beni, Bolivia; [Zent, E. L.; Zent, S.] IVIC, Human Ecol Lab, Caracas 1020A, Venezuela; [Nascimento, M. T.] Univ Estadual Norte Fluminense, Lab Ciencias Ambientais, Alberto Lamego 2000, BR-28013620 Campos Dos Goyatacazes, RJ, Brazil; [Ramirez-Angulo, H.; Torre, E. V.; Torres-Lezama, A.] Univ Andes, Inst Invest el Desarrollo Foresta INDEFOR, Merida 5101, Venezuela; [Rivas, G.] USFQ, Colegio Ciencias Biol & Ambientales, COCIBA, Quito, Pichincha, Ecuador; [Rivas, G.] USFQ, Galapagos Inst Arts & Sci, GAIAS, Quito, Pichincha, Ecuador; [Rivas, G.] Univ Florida, Dept Wildlife Ecol & Conservat, 110 Newins Ziegler Hall, Gainesville, FL 32611 USA; [Sierra, R.; Tirado, M.] GeoIS, El Dia 369 & El Telegrafo, 3 Piso, Quito, Pichincha, Ecuador; [van der Heijden, G.] Univ Wisconsin Milwaukee, Dept Biol Sci, Milwaukee, WI 53202 USA; [van der Heijden, G.] Smithsonian Trop Res Inst, Apartado Postal 0843-03092, Panama City, Panama; [Torre, E. V.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Wang, O.] Univ Arizona, Environm Sci & Policy, Flagstaff, AZ 86011 USA; [Young, K. R.] Univ Texas, Geog & Environm, 305 E 23rd St,CLA Bldg, Austin, TX 78712 USA; [Baider, C.] Minist Agro Ind & Food Secur, Agr Serv, Mauritius Herbarium, Reduit, Mauritius; [Hoffman, B.] Amazon Conservat Team, Doekhieweg Oost 24, Paramaribo, Suriname; [Mendoza, C.] Manejo Forestal Tierras Trop Bolivia, FOMABO, Sacta, Cochabamba, Bolivia; [Mendoza, C.] UMSS, Escuela Ciencias Forest ESFOR, Sacta, Cochabamba, Bolivia; [Medina, M. N. U.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [van Andel, T. R.; ter Steege, H.] Nat Biodivers Ctr, Biodivers Dynam, POB 9517, NL-2300 RA Leiden, Netherlands; [Zagt, R.] Tropenbos Int, Lawickse Allee 11,POB 232, NL-6700 AE Wageningen, Netherlands; [Alexiades, M. N.] Univ Kent, Sch Anthropol & Conservat, Marlowe Bldg, Canterbury CT2 7NR, Kent, England; [Balslev, H.] Aarhus Univ, Dept Bioscience, Bldg 1540 Ny Munkegade, DK-8000 Aarhus, Denmark; [Gonzales, T.] ACEER Fdn, Jiron Cusco N 370, Puerto Maldonado, Madre De Dios, Peru; [Hernandez, L.] Univ Nacl Expt Guayana, Ctr Invest Ecol Guayana, Calle Chile, Puerto Ordaz, Bolivar, Venezuela; [Manzatto, A. G.] Univ Fed Rondonia, Dept Biol, Rodovia BR 364 S-N Km 9-5, BR-76824027 Porto Velho, RO, Brazil; [Cuenca, W. P.] Univ Tecn Norte, Herbario Nacl Ecuador, Quito, Pichincha, Ecuador; [Pansini, S.; Reis, N. F. Costa] Univ Fed Rondonia, PGDRA, Rodovia BR 364 S-N Km 9-5, BR-76824027 Porto Velho, RO, Brazil; [Pauletto, D.] Univ Fed Oeste Para, Inst Biodiversidade & Floresta, Rua Vera Paz,Campus Tapajos, BR-68015110 Santarem, PA, Brazil; [Arevalo, F. R.; Sandoval, E. H. Valderrama] Univ Nacl Amazonia Peruana, Fac Biol, Pevas 5ta Cdra, Iquitos, Loreto, Peru; [Sampaio, A. F.] Univ Fed Rondonia, Programa Posgrad Biodiversidade & Biotecnol, PPG Bionorte, Campus Porto Velho,Km 9-5, BR-76824027 Porto Velho, RO, Brazil; [Sandoval, E. H. Valderrama] Univ Missouri, Dept Biol, St Louis, MO 63121 USA; [Vela, C. I. A.] Univ Nacl San Antonio Abad Cusco, Fac Ciencias Forestales & Medio Ambiente, Jiron San Martin 451, Puerto Maldonado, Madre De Dios, Peru; [ter Steege, H.] Free Univ Amsterdam, Syst Ecol, De Boelelaan 1087, NL-1081 HV Amsterdam, Netherlands	Institute Nacional de Pesquisas da Amazonia; Wageningen University & Research; Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia; Wageningen University & Research; Universidade de Sao Paulo; Harvard University; Museu Paraense Emilio Goeldi; University of Leeds; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); CIRAD; INRAE; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Field Museum of Natural History (Chicago); Universidad Nacional de Colombia; Universidad Nacional de San Antonio Abad del Cusco; Institute Nacional de Pesquisas da Amazonia; University of Exeter; James Cook University; James Cook University; Institute Nacional de Pesquisas da Amazonia; Duke University; Helmholtz Association; Karlsruhe Institute of Technology; Max Planck Society; Universidade Estadual de Campinas; University of Edinburgh; Royal Botanic Gardens, Kew; Institute Nacional de Pesquisas da Amazonia; United States Department of the Interior; Smithsonian Institution; Universidade do Estado de Mato Grosso; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Universidade Federal do Rio Grande do Norte; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Universidade de Sao Paulo; University of Amsterdam; Universidad de los Andes (Colombia); State University System of Florida; Florida International University; INRAE; California State University System; California State Polytechnic University, Humboldt; Naturalis Biodiversity Center; Centre National de la Recherche Scientifique (CNRS); Universidade Federal de Alagoas; New York Botanical Garden; Institute Nacional de Pesquisas da Amazonia; University of East Anglia; Wake Forest University; Wake Forest University; University of Texas System; University of Texas Austin; Universidad Nacional de Colombia; Fundacao Oswaldo Cruz; Missouri Botanical Gardens; Museum National d'Histoire Naturelle (MNHN); University of Oxford; Universidad Nacional de Colombia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal Rural da Amazonia (UFRA); Venezuelan Institute Science Research; Universidade Estadual do Norte Fluminense; University of Los Andes Venezuela; State University System of Florida; University of Florida; University of Wisconsin System; University of Wisconsin Milwaukee; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Washington; University of Washington Seattle; University of Arizona; University of Texas System; University of Texas Austin; University System of Maryland; University of Maryland College Park; Naturalis Biodiversity Center; University of Kent; Aarhus University; Universidade Federal de Rondonia; Universidade Federal de Rondonia; Universidade Federal do Oeste do Para; Universidad Nacional de la Amazonia Peruana; Universidade Federal de Rondonia; University of Missouri System; University of Missouri Saint Louis; Universidad Nacional de San Antonio Abad del Cusco; Vrije Universiteit Amsterdam	Levis, C (corresponding author), INPA, Programa Grad Ecol, Av Andre Araujo 2936, BR-69067375 Manaus, Amazonas, Brazil.	carollevis@gmail.com; hans.tersteege@naturalis.nl	Camargo, José Luís C/C-3137-2015; Silveira, Marcos/H-7906-2013; Damasco, Gabriel/AGV-1909-2022; Peres, Carlos Augusto/N-8275-2019; de Castilho, Carolina Volkmer/I-6618-2019; Vieira, Ima C.G./H-6897-2012; Junqueira, Andre Braga/M-1142-2016; de Oliveira, Alexandre Adalardo/G-8830-2012; Brienen, Roel/AAU-9959-2020; Ruschel, ademir/AAL-8382-2021; Junior, Ben Hur Marimon/E-7330-2013; Steege, Hans ter/B-5866-2011; Junior, Ben Hur Marimon/AAT-9354-2020; Farfan-Rios, William/J-9881-2015; Marimon, Beatriz/J-6389-2012; Vos, Vincent/ABA-1492-2020; Emilio, Thaise/A-6221-2013; Aymard, Gerardo/ABE-9203-2020; Nascimento, Marcelo T/D-2824-2013; Miranda, Ires/AAV-3431-2020; Pitman, Nigel C A/A-7681-2008; Oliveira, Alexandre/ABH-1255-2020; Phillips, Oliver/A-1523-2011; Schietti, Juliana/B-8226-2015; Costa, Flavia/K-4386-2014; Balslev, Hendrik/AAE-4071-2020; Pauletto, Daniela/AAX-4777-2020; Stropp, Juliana/AAF-7946-2020; Clement, Charles Roland/G-6081-2010; Feldpausch, Ted/D-3436-2009; Fuentes, Alfredo F./FNZ-7942-2022; Barbosa, Edelcilio/GVS-2956-2022; Manzatto, Angelo Gilberto/F-6557-2015; van der Heijden, Geertje/AAB-4102-2019; Laurance, William F/B-2709-2012; Molino, Jean-François/C-5011-2009; Cano, Ángela/N-9392-2017; Schietti, Juliana/AAV-7451-2020; Peres, Carlos A./B-1276-2013; SALOMÃO, RAFAEL/AAU-1306-2020; Peres, Carlos A./ABE-8361-2020; Rivas-Torres, Gonzalo/AAZ-3146-2021; BBL Cintra, Bruno/AAE-5019-2019; Baraloto, Christopher/ABG-2500-2020; Feldpausch, Ted/ABH-3123-2020; Laurance, Susan/G-6021-2011; Goes Neves, Eduardo/B-8377-2014; Gribel, Rogerio/C-5392-2013; Honorio Coronado, Euridice Nora/K-3412-2015; Zent, Eglee/O-7640-2014	Silveira, Marcos/0000-0003-0485-7872; Damasco, Gabriel/0000-0001-9768-520X; de Castilho, Carolina Volkmer/0000-0002-1064-2758; Vieira, Ima C.G./0000-0003-1233-318X; Junqueira, Andre Braga/0000-0003-3681-1705; de Oliveira, Alexandre Adalardo/0000-0001-5526-8109; Brienen, Roel/0000-0002-5397-5755; Ruschel, ademir/0000-0002-0352-5238; Steege, Hans ter/0000-0002-8738-2659; Farfan-Rios, William/0000-0002-3196-0317; Marimon, Beatriz/0000-0003-3105-2914; Vos, Vincent/0000-0002-0388-8530; Emilio, Thaise/0000-0001-5415-1822; Aymard, Gerardo/0000-0001-9405-0508; Nascimento, Marcelo T/0000-0003-4492-3344; Miranda, Ires/0000-0002-0414-2183; Pitman, Nigel C A/0000-0002-9211-2880; Oliveira, Alexandre/0000-0001-5526-8109; Phillips, Oliver/0000-0002-8993-6168; Schietti, Juliana/0000-0002-1687-4373; Costa, Flavia/0000-0002-9600-4625; Pauletto, Daniela/0000-0003-1855-6077; Stropp, Juliana/0000-0002-2831-4066; Clement, Charles Roland/0000-0002-8421-1029; Feldpausch, Ted/0000-0002-6631-7962; Barbosa, Edelcilio/0000-0003-1331-8563; Manzatto, Angelo Gilberto/0000-0002-6414-8966; van der Heijden, Geertje/0000-0002-2110-5173; Laurance, William F/0000-0003-4430-9408; Molino, Jean-François/0000-0001-8853-7133; Cano, Ángela/0000-0002-5090-7730; Schietti, Juliana/0000-0002-1687-4373; Peres, Carlos A./0000-0002-1588-8765; SALOMÃO, RAFAEL/0000-0003-0947-0132; Peres, Carlos A./0000-0002-1588-8765; BBL Cintra, Bruno/0000-0002-5116-2654; Baraloto, Christopher/0000-0001-7322-8581; Feldpausch, Ted/0000-0002-6631-7962; Young, Kenneth R./0000-0003-0866-1260; Jimenez, Eliana M./0000-0002-8610-1771; Fuentes, Alfredo/0000-0003-4848-4182; Comiskey, James/0000-0001-6710-1269; Baider, Claudia/0000-0002-2203-2076; Laurance, Susan/0000-0002-2831-2933; Levis, Carolina/0000-0002-8425-9479; Milliken, William/0000-0002-3926-6661; Goes Neves, Eduardo/0000-0002-2830-2735; Pena-Claros, Marielos/0000-0001-9134-6733; Vilanova, Emilio/0000-0001-6289-5127; Neill, David Alan/0000-0002-5143-9430; Gribel, Rogerio/0000-0002-0850-5578; Guimaraes, Jose Renan/0000-0003-2055-7642; Engel, Julien/0000-0002-8078-9309; Hernandez, Lionel/0000-0002-7279-1003; Penuela Mora, Maria Cristina/0000-0002-9611-1359; Honorio Coronado, Euridice Nora/0000-0003-2314-590X; Sierra, Rodrigo/0000-0002-1146-2943; Campana Camargo, Jose Luis/0000-0003-0370-9878; Sabatier, Daniel/0000-0003-0883-1530; Mostacedo, Bonifacio/0000-0003-3806-2445; Schongart, Jochen/0000-0002-7696-9657; Zent, Eglee/0000-0002-7475-7335	Asociacion para la Conservacion de la Cuenca Amazonica/Amazon Conservation Association (ACCA/ACA); Alberta Mennega Stichting; ALCOA Suriname; Banco de la Republica; Centre for Agricultural Research in Suriname (CELOS Suriname); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (Plano Nacional de Pos-Graduacao); CAPES Ciencia sem Fronteiras [PVE 177/2012]; Conselho Nacional de Desenvovimento Cientifico e Tecnoloico of Brazil (CNPq) [573721/2008-4, CNPq 558318/2009-6, 457544/2012-0, 304088/2011-0, 306368/2013-7, 473308/2009-6, 52.0103/2009-2, 201573/2014-8, 207400/2014-8, 307807-2009-6, 479599/2008-4, 458210/2014-5, 303851/2015-5]; Colciencias; Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [09/53369-6, 465/2010]; PRONEX-FAPEAM [1600/2006]; Gordon and Betty Moore Foundation; Guyana Forestry Commission; Investissement d'Avenir grant of the French L'AgenceNationale de la Recherche (ANR) [ANR-10-LABX-0025]; Instituto Venezolano de Investigaciones Cientificas of Venezuela; Lincoln Park Zoo; Margaret Mee Amazon Trust; Margot Marsh Foundation; Marie Sklodowska-Curie/European Union [706011]; Ministerio da Ciencia, Tecnologia e Inovacao (MCTI)-Museu Paraense Emilio Goeldi [407232/2013-3-PVE-MEC/MCTI/CAPES/CNPq]; Miquel fonds; Netherlands Foundation for the Advancement of Tropical Research WOTRO [WB85-335, W84-581]; Nuffic; Primate Conservation; Stichting het van Eeden-fonds; Shell Prospecting and Development of Peru; Tropenbos International; UniAndes; Variety Woods Guyana; U.S. National Science Foundation [DEB-0918591, DEB-1258112, DEB-1556338]; Wenner-Gren Foundation; Venezuela National Council for Scientific Research and Technology (CONICIT); Wageningen University (Interdisciplinary Research and Education Fund Terra Preta program and FOREFRONT program); Aarhus University; Wake Forest University; WWF-Guianas; Natural Environment Research Council (UK); Gordon and Betty Moore Foundation European Union; European Research Council; Royal Society Wolfson Research Merit Award; Natural Environment Research Council [NE/M022021/1, NE/D01025X/1, NE/J023418/1, NE/N012542/1, NE/B504630/1, NE/B503384/1, NE/N011570/1] Funding Source: researchfish; The British Council [275556724] Funding Source: researchfish; NERC [NE/D01025X/1, NE/M022021/1, NE/N011570/1, NE/J023418/1, NE/N012542/1] Funding Source: UKRI	Asociacion para la Conservacion de la Cuenca Amazonica/Amazon Conservation Association (ACCA/ACA); Alberta Mennega Stichting; ALCOA Suriname; Banco de la Republica; Centre for Agricultural Research in Suriname (CELOS Suriname); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (Plano Nacional de Pos-Graduacao)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES Ciencia sem Fronteiras(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvovimento Cientifico e Tecnoloico of Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)(Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); PRONEX-FAPEAM(Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Guyana Forestry Commission; Investissement d'Avenir grant of the French L'AgenceNationale de la Recherche (ANR)(French National Research Agency (ANR)); Instituto Venezolano de Investigaciones Cientificas of Venezuela; Lincoln Park Zoo; Margaret Mee Amazon Trust; Margot Marsh Foundation; Marie Sklodowska-Curie/European Union; Ministerio da Ciencia, Tecnologia e Inovacao (MCTI)-Museu Paraense Emilio Goeldi; Miquel fonds; Netherlands Foundation for the Advancement of Tropical Research WOTRO; Nuffic; Primate Conservation; Stichting het van Eeden-fonds; Shell Prospecting and Development of Peru; Tropenbos International; UniAndes; Variety Woods Guyana; U.S. National Science Foundation(National Science Foundation (NSF)); Wenner-Gren Foundation; Venezuela National Council for Scientific Research and Technology (CONICIT); Wageningen University (Interdisciplinary Research and Education Fund Terra Preta program and FOREFRONT program); Aarhus University; Wake Forest University; WWF-Guianas; Natural Environment Research Council (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Gordon and Betty Moore Foundation European Union; European Research Council(European Research Council (ERC)European Commission); Royal Society Wolfson Research Merit Award(Royal Society of London); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); The British Council; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This paper was made possible by the work of hundreds of different scientists and research institutions in the Amazon over the past 80 years. This work was supported by Asociacion para la Conservacion de la Cuenca Amazonica/Amazon Conservation Association (ACCA/ACA); Alberta Mennega Stichting; ALCOA Suriname; Banco de la Republica; Centre for Agricultural Research in Suriname (CELOS Suriname); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (Plano Nacional de Pos-Graduacao); CAPES Ciencia sem Fronteiras (PVE 177/2012); Conselho Nacional de Desenvovimento Cientifico e Tecnoloico of Brazil (CNPq) Projects CNPq/FAPEAM-INCT CENBAM (573721/2008-4), PPBio Manaus (CNPq 558318/2009-6), CNPq-PPBio-AmOc (457544/2012-0), CNPq-PQ (304088/2011-0 and 306368/2013-7), Hidroveg Universal CNPq (473308/2009-6), Projeto Cenarios FINEP/CNPq (52.0103/2009-2), CNPq-SWE (201573/2014-8), CNPq-SWE (207400/2014-8), CNPq Universal (307807-2009-6), CNPq Universal (479599/2008-4), CNPq Universal 458210/2014-5, and CNPq Universal 303851/2015-5; Colciencias; Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM) projects with Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (09/53369-6 and 465/2010) and PRONEX-FAPEAM (1600/2006); Gordon and Betty Moore Foundation; Guyana Forestry Commission; Investissement d'Avenir grant of the French L'AgenceNationale de la Recherche (ANR) (Centre d'Etude de la Biodiversite Amazonienne: ANR-10-LABX-0025); Instituto Venezolano de Investigaciones Cientificas of Venezuela; Lincoln Park Zoo; Margaret Mee Amazon Trust; Margot Marsh Foundation; Marie Sklodowska-Curie/European Union's Horizon 2020 (706011); Ministerio da Ciencia, Tecnologia e Inovacao (MCTI)-Museu Paraense Emilio Goeldi-Proc. 407232/2013-3-PVE-MEC/MCTI/CAPES/CNPq; Miquel fonds; Netherlands Foundation for the Advancement of Tropical Research WOTRO: grants WB85-335 and W84-581; Nuffic; Primate Conservation; Stichting het van Eeden-fonds; Shell Prospecting and Development of Peru; Tropenbos International; UniAndes; Variety Woods Guyana; U.S. National Science Foundation Projects (DEB-0918591, DEB-1258112, and DEB-1556338) and Wenner-Gren Foundation; Venezuela National Council for Scientific Research and Technology (CONICIT); Wageningen University (Interdisciplinary Research and Education Fund Terra Preta program and FOREFRONT program); Aarhus University; Wake Forest University; and WWF-Guianas and grants to RAINFOR from the Natural Environment Research Council (UK) and the Gordon and Betty Moore Foundation European Union. O.L.P. is supported by a European Research Council Advanced Grant and a Royal Society Wolfson Research Merit Award. We thank J. Chave, A. Vincentini, C. Vriesendorp, U. Lombardo, and H. Prumers for providing data and B. Monteiro Flores for constructive comments on the manuscript. A. B. J. and E.K.T. thank all archaeologists who contributed with archaeological coordinates. All data described in the paper are present in the main text and the supplementary materials, and custom R scripts used in analyses are provided in the supplementary materials. Additional data related to this paper can be obtained by contacting authors. C.L., H.t.S., F.R.C.C, F.B., M.P.-C., C. R. C., and A. B. J conceived the study and designed the analyses. C.L. and H.t.S. carried out most analyses. C.L., H.t.S., F.R.C.C, F.B., M.P.-C., C. R. C., A. B. J, and N.C.A.P. wrote the manuscript. All of the other authors contributed data, discussed further analyses, and commented on various versions of the manuscript.; r r This is contribution 708 of the technical series of the Biological Dynamics of Forest Fragments Project (BDFFP).	ALDEN D, 1976, P AM PHILOS SOC, V120, P103; Arroyo-Kalin M, 2012, QUATERN INT, V249, P4, DOI 10.1016/j.quaint.2011.08.004; Boivin NL, 2016, P NATL ACAD SCI USA, V113, P6388, DOI 10.1073/pnas.1525200113; Bush MB, 2016, J ECOL, V104, P1370, DOI 10.1111/1365-2745.12600; Bush MB, 2015, J BIOGEOGR, V42, P2277, DOI 10.1111/jbi.12638; Clement C. R., 2010, Diversity, V2, P72; Clement CR, 2015, P ROY SOC B-BIOL SCI, V282, P32, DOI 10.1098/rspb.2015.0813; Clement CR, 1999, ECON BOT, V53, P188, DOI 10.1007/BF02866498; Crevels M, 2008, STUD LANG C, V90, P151; Darwin C., 1959, WHATS NEW, V67, P2; Emilio T, 2014, PLANT ECOL DIVERS, V7, P215, DOI 10.1080/17550874.2013.772257; Erickson CL, 2006, HIST ECOL SER, P187; Esquinas-Alcazar J, 2005, NAT REV GENET, V6, P946, DOI 10.1038/nrg1729; Esquivel-Muelbert A, 2017, ECOGRAPHY, V40, P618, DOI 10.1111/ecog.01904; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Junqueira AB, 2010, BIODIVERS CONSERV, V19, P1933, DOI 10.1007/s10531-010-9813-1; Kennedy J, 2012, QUATERN INT, V249, P140, DOI 10.1016/j.quaint.2011.06.020; Levis C., 2014, ANTES ORELLANA, P305; Lombardo U, 2011, GEOGR HELV, V3, P173, DOI [10.5194/gh-66-173-2011, DOI 10.5194/GH-66-173-2011]; Mayle FE, 2008, PHILOS T R SOC B, V363, P1829, DOI 10.1098/rstb.2007.0019; McMichael CH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2475; McMichael CH, 2012, SCIENCE, V336, P1429, DOI 10.1126/science.1219982; McMichael CH, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00141; Neves EG, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P29, DOI 10.1007/1-4020-2597-1_3; O'Fallon BD, 2011, P NATL ACAD SCI USA, V108, P20444, DOI 10.1073/pnas.1112563108; Peres CA, 2016, P NATL ACAD SCI USA, V113, P892, DOI 10.1073/pnas.1516525113; Piperno DR, 2015, HOLOCENE, V25, P1588, DOI 10.1177/0959683615588374; Piperno DR, 2011, CURR ANTHROPOL, V52, pS453, DOI 10.1086/659998; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Quesada CA, 2012, BIOGEOSCIENCES, V9, P2203, DOI 10.5194/bg-9-2203-2012; Rindos D., 1984, ORIGINS AGR EVOLUTIO, P154; Roosevelt AC, 2013, ANTHROPOCENE, V4, P69, DOI 10.1016/j.ancene.2014.05.001; Santos Eduardo José Melo dos, 2015, Bol. Mus. Para. Emílio Goeldi. Ciênc. hum., V10, P217, DOI 10.1590/1981-81222015000200003; Schietti J, 2014, PLANT ECOL DIVERS, V7, P241, DOI 10.1080/17550874.2013.783642; Stahl PW, 2015, HOLOCENE, V25, P1598, DOI 10.1177/0959683615588372; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; Thomas E, 2015, J BIOGEOGR, V42, P1367, DOI 10.1111/jbi.12540; Thomas E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047676; Walker RS, 2011, P ROY SOC B-BIOL SCI, V278, P2562, DOI 10.1098/rspb.2010.2579; Zohary D, 2004, ECON BOT, V58, P5, DOI 10.1663/0013-0001(2004)058[0005:USATEO]2.0.CO;2	41	277	293	3	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					925	+		10.1126/science.aal0157	http://dx.doi.org/10.1126/science.aal0157			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2YM	28254935	Green Accepted			2022-12-28	WOS:000395181700033
J	Srivastava, R				Srivastava, Ranjana			The Interpreter	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Srivastava, Ranjana] Monash Hlth, Dept Med Oncol, Melbourne, Vic, Australia		Srivastava, R (corresponding author), Monash Hlth, Dept Med Oncol, Melbourne, Vic, Australia.								0	3	3	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2017	376	9					812	813		10.1056/NEJMp1613163	http://dx.doi.org/10.1056/NEJMp1613163			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9JK	28249139				2022-12-28	WOS:000395627500004
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: When organ donation isn't a donation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				BMA, 2017, ORG DON; Fabre J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4973; Morris S, 2016, GUARDIAN; NHS Blood and Transplant, 2017, INTR PAT SEL ORG ALL; Shepherd L, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0131-4	5	5	5	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 28	2017	356								j1028	10.1136/bmj.j1028	http://dx.doi.org/10.1136/bmj.j1028			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JQ	28246093	Bronze, Green Published			2022-12-28	WOS:000395628100004
J	Turcotte, LM; Liu, Q; Yasui, Y; Arnold, MA; Hammond, S; Howell, RM; Smith, SA; Weathers, RE; Henderson, TO; Gibson, TM; Leisenring, W; Armstrong, GT; Robison, LL; Neglia, JP				Turcotte, Lucie M.; Liu, Qi; Yasui, Yutaka; Arnold, Michael A.; Hammond, Sue; Howell, Rebecca M.; Smith, Susan A.; Weathers, Rita E.; Henderson, Tara O.; Gibson, Todd M.; Leisenring, Wendy; Armstrong, Gregory T.; Robison, Leslie L.; Neglia, Joseph P.			Temporal Trends in Treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970-2015	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							2ND MALIGNANT NEOPLASMS; ACUTE LYMPHOBLASTIC-LEUKEMIA; LONG-TERM SURVIVORS; HODGKINS-DISEASE; NORDIC COUNTRIES; ADULT SURVIVORS; LATE MORTALITY; BREAST-CANCER; COHORT; LYMPHOMA	IMPORTANCE Cancer treatments are associated with subsequent neoplasms in survivors of childhood cancer. It is unknown whether temporal changes in therapy are associated with changes in subsequent neoplasm risk. OBJECTIVE To quantify the association between temporal changes in treatment dosing and subsequent neoplasm risk. DESIGN, SETTING, AND PARTICIPANTS Retrospective, multicenter cohort study of 5-year cancer survivors diagnosed before age 21 years from pediatric tertiary hospitals in the United States and Canada between 1970-1999, with follow-up through December 2015. EXPOSURES Radiation and chemotherapy dose changes over time. MAIN OUTCOMES AND MEASURES Subsequent neoplasm 15-year cumulative incidence, cumulative burden, and standardized incidence ratios for subsequent malignancies, compared by treatment decade. Multivariable models assessed relative rates (RRs) of subsequent neoplasms by 5-year increments, adjusting for demographic and clinical characteristics. Mediation analyses assessed whether changes in rates of subsequent neoplasms over time were mediated by treatment variable modifications. RESULTS Among 23 603 survivors of childhood cancer (mean age at diagnosis, 7.7 years; 46% female) the most common initial diagnoses were acute lymphoblastic leukemia, Hodgkin lymphoma, and astrocytoma. During a mean follow-up of 20.5 years (374 638 person-years at risk), 1639 survivors experienced 3115 subsequent neoplasms, including 1026 malignancies, 233 benign meningiomas, and 1856 nonmelanoma skin cancers. The most common subsequent malignancies were breast and thyroid cancers. Proportions of individuals receiving radiation decreased (77% for 1970s vs 33% for 1990s), as did median dose (30 Gy [interquartile range, 24-44] for 1970s vs 26 Gy [interquartile range, 18-45] for 1990s). Fifteen-year cumulative incidence of subsequent malignancies decreased by decade of diagnosis (2.1% [95% CI, 1.7%-2.4%] for 1970s, 1.7%[95% CI, 1.5%-2.0%] for 1980s, 1.3% [95% CI, 1.1%-1.5%] for 1990s). Reference absolute rates per 1000 person-years were 1.12 (95% CI, 0.84-1.57) for subsequent malignancies, 0.16 (95% CI, 0.06-0.41) for meningiomas, and 1.71 (95% CI, 0.88-3.33) for nonmelanoma skin cancers for survivors with reference characteristics (no chemotherapy, splenectomy, or radiation therapy; male; attained age 28 years). Standardized incidence ratios declined for subsequent malignancies over treatment decades, with advancing attained age. Relative rates declined with each 5-year increment for subsequent malignancies (RR, 0.87 [95% CI, 0.82-0.93]; P<.001), meningiomas (RR, 0.85 [95% CI, 0.75-0.97]; P=.03), and nonmelanoma skin cancers (RR, 0.75 [95% CI, 0.67-0.84]; P<.001). Radiation dose changes were associated with reduced risk for subsequent malignancies, meningiomas, and nonmelanoma skin cancers. CONCLUSIONS AND RELEVANCE Among survivors of childhood cancer, the risk of subsequent malignancies at 15 years after initial cancer diagnosis remained increased for those diagnosed in the 1990s, although the risk was lower compared with those diagnosed in the 1970s. This lower risk was associated with reduction in therapeutic radiation dose.	[Turcotte, Lucie M.] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Liu, Qi; Yasui, Yutaka] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Yasui, Yutaka; Gibson, Todd M.; Armstrong, Gregory T.; Robison, Leslie L.] St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, Memphis, TN 38105 USA; [Arnold, Michael A.; Hammond, Sue] Ohio State Univ, Columbus, OH 43210 USA; [Howell, Rebecca M.; Smith, Susan A.; Weathers, Rita E.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA; [Henderson, Tara O.] Univ Chicago, Chicago, IL 60637 USA; [Leisenring, Wendy] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Alberta; St Jude Children's Research Hospital; University System of Ohio; Ohio State University; University of Texas System; UTMD Anderson Cancer Center; University of Chicago; Fred Hutchinson Cancer Center	Turcotte, LM (corresponding author), Univ Minnesota, Div Pediat Hematol Oncol, 420 Delaware St SE,MMC 484, Minneapolis, MN 55455 USA.	turc0023@umn.edu	Robison, Leslie/N-8122-2018; Arnold, Michael/GPW-8074-2022; Gibson, Todd M/N-6999-2018; Armstrong, Gregory/N-8096-2018; Yasui, Yutaka/E-2564-2015	Gibson, Todd M/0000-0002-8718-699X; Yasui, Yutaka/0000-0002-7717-8638; Arnold, Michael/0000-0002-6921-3720; Neglia, Joseph/0000-0002-5525-0598; Leisenring, Wendy/0000-0001-7405-0906	National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000114]; National Cancer Institute [CA55727]; Cancer Center Support (CORE) grant [CA21765]; American Lebanese-Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [P30CA021765, U24CA055727] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Support (CORE) grant; American Lebanese-Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (UL1TR000114, B.R. Blazar, principal investigator) and the National Cancer Institute (CA55727, G.T. Armstrong, principal investigator). Support to St Jude Children's Research Hospital also provided by the Cancer Center Support (CORE) grant (CA21765, C. Roberts, principal investigator) and the American Lebanese-Syrian Associated Charities (ALSAC).	Armstrong GT, 2016, NEW ENGL J MED, V374, P833, DOI 10.1056/NEJMoa1510795; Armstrong GT, 2011, J CLIN ONCOL, V29, P3056, DOI 10.1200/JCO.2011.34.6585; Armstrong GT, 2010, RADIAT RES, V174, P840, DOI 10.1667/RR1903.1; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bhakta N, 2016, LANCET ONCOL, V17, P1325, DOI 10.1016/S1470-2045(16)30215-7; Bhatia S, 2003, J CLIN ONCOL, V21, P4386, DOI 10.1200/JCO.2003.11.059; Bhatia S, 1996, NEW ENGL J MED, V334, P745, DOI 10.1056/NEJM199603213341201; Bhatia S, 2015, J CLIN ONCOL, V33, P3055, DOI 10.1200/JCO.2014.59.8052; Borgmann A, 2008, EUR J CANCER, V44, P257, DOI 10.1016/j.ejca.2007.09.019; Dong HR, 2015, AM J EPIDEMIOL, V181, P532, DOI 10.1093/aje/kwu289; Friedman DL, 2010, JNCI-J NATL CANCER I, V102, P1083, DOI 10.1093/jnci/djq238; Fritz APC., 2013, INT CLASSIFICATION D; Garwicz S, 2000, INT J CANCER, V88, P672, DOI 10.1002/1097-0215(20001115)88:4<672::AID-IJC24>3.0.CO;2-N; Green DM, 2014, PEDIATR BLOOD CANCER, V61, P53, DOI 10.1002/pbc.24679; Green DM, 2013, PEDIATR BLOOD CANCER, V60, P1083, DOI 10.1002/pbc.24487; Green DM, 2000, J CLIN ONCOL, V18, P1492, DOI 10.1200/JCO.2000.18.7.1492; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hudson MM, 2012, PEDIATR BLOOD CANCER, V58, P334, DOI 10.1002/pbc.23385; Hudson MM, 2003, JAMA-J AM MED ASSOC, V290, P1583, DOI 10.1001/jama.290.12.1583; Inskip PD, 2009, J CLIN ONCOL, V27, P3901, DOI 10.1200/JCO.2008.20.7738; Jenkinson HC, 2004, BRIT J CANCER, V91, P1905, DOI 10.1038/sj.bjc.6602226; Kim SH, 2015, ANN SURG ONCOL, V22, P859, DOI 10.1245/s10434-014-4070-2; Kurt BA, 2012, PEDIATR BLOOD CANCER, V59, P126, DOI 10.1002/pbc.24017; Leisenring WM, 2009, J CLIN ONCOL, V27, P2319, DOI 10.1200/JCO.2008.21.1813; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Mertens AC, 2008, JNCI-J NATL CANCER I, V100, P1368, DOI 10.1093/jnci/djn310; Olsen JH, 2009, JNCI-J NATL CANCER I, V101, P806, DOI 10.1093/jnci/djp104; Omer B, 2012, BRIT J HAEMATOL, V158, P615, DOI 10.1111/j.1365-2141.2012.09211.x; Pole JD, 2015, CANCER EPIDEM BIOMAR, V24, P1585, DOI 10.1158/1055-9965.EPI-15-0360; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; Reulen RC, 2011, JAMA-J AM MED ASSOC, V305, P2311, DOI 10.1001/jama.2011.747; Robison LL, 2009, J CLIN ONCOL, V27, P2308, DOI 10.1200/JCO.2009.22.3339; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; Schaapveld M, 2015, NEW ENGL J MED, V373, P2499, DOI 10.1056/NEJMoa1505949; Sigurdson AJ, 2005, LANCET, V365, P2014, DOI 10.1016/S0140-6736(05)66695-0; Turcotte LM, 2015, J CLIN ONCOL, V33, P3568, DOI 10.1200/JCO.2015.60.9487	36	130	134	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2017	317	8					814	824		10.1001/jama.2017.0693	http://dx.doi.org/10.1001/jama.2017.0693			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM7PW	28245323	Green Accepted			2022-12-28	WOS:000395505600019
J	Schwartz, MLB; Williams, MS; Murray, MF				Schwartz, Marci L. B.; Williams, Marc S.; Murray, Michael F.			Adding Protective Genetic Variants to Clinical Reporting of Genomic Screening Results Restoring Balance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DISEASE		[Schwartz, Marci L. B.; Williams, Marc S.; Murray, Michael F.] Geisinger Hlth Syst, Genom Med Inst, Danville, PA USA	Geisinger Health System	Murray, MF (corresponding author), Geisinger Hlth Syst, 190 Welles St,Ste 128, Forty Ft, PA 18704 USA.	mfmurray1@geisinger.edu		Schwartz, Marci/0000-0002-7643-0862	Regeneron Pharmaceuticals	Regeneron Pharmaceuticals(Regeneron)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Ms Schwartz reported that her salary is partially funded by a grant from Regeneron Pharmaceuticals. Dr Murray reported receiving grant funding from Regeneron Pharmaceuticals and serving on the advisory boards of Invitae and Merck. Dr Williams reported no disclosures.	Abul-Husn NS, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7000; Ayers KL, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2725-z; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Dewey FE, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6814; Harper AR, 2015, NAT REV GENET, V16, P689, DOI 10.1038/nrg4017; Maron BJ, 2009, JAMA-J AM MED ASSOC, V302, P1681, DOI 10.1001/jama.2009.1507; National Institutes of Health, 2016, ALL US RES PROGR PRE; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30	8	11	11	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2017	317	15					1527	1528		10.1001/jama.2017.1533	http://dx.doi.org/10.1001/jama.2017.1533			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ES2YN	28288260				2022-12-28	WOS:000399393900009
J	Pries, CEH; Castanha, C; Porras, RC; Torn, MS				Pries, Caitlin E. Hicks; Castanha, C.; Porras, R. C.; Torn, M. S.			The whole-soil carbon flux in response to warming	SCIENCE			English	Article							ORGANIC-CARBON; TEMPERATURE SENSITIVITY; CLIMATE; RESPIRATION; DECOMPOSITION; MATTER; CO2; FEEDBACKS; PROFILES; DYNAMICS	Soil organic carbon harbors three times as much carbon as Earth's atmosphere, and its decomposition is a potentially large climate change feedback and major source of uncertainty in climate projections. The response of whole-soil profiles to warming has not been tested in situ. In a deep warming experiment in mineral soil, we found that CO2 production from all soil depths increased with 4 degrees C warming; annual soil respiration increased by 34 to 37%. All depths responded to warming with similar temperature sensitivities, driven by decomposition of decadal-aged carbon. Whole-soil warming reveals a larger soil respiration response than many in situ experiments (most of which only warm the surface soil) and models.	[Pries, Caitlin E. Hicks; Castanha, C.; Porras, R. C.; Torn, M. S.] Lawrence Berkeley Natl Lab, Climate Sci Dept, Climate & Ecosyst Sci Div, Berkeley, CA 94720 USA; [Torn, M. S.] Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Pries, CEH; Torn, MS (corresponding author), Lawrence Berkeley Natl Lab, Climate Sci Dept, Climate & Ecosyst Sci Div, Berkeley, CA 94720 USA.; Torn, MS (corresponding author), Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA.	cehpries@lbl.gov; mstorn@lbl.gov	Torn, Margaret S/D-2305-2015; Torn, Margaret/CAF-8960-2022; Castanha, Cristina/D-3247-2015; Castanha, Cristina/X-6352-2019; Porras, Rachel/M-7179-2017; Hicks Pries, Caitlin/A-1368-2014	Torn, Margaret S/0000-0002-8174-0099; Torn, Margaret/0000-0002-8174-0099; Castanha, Cristina/0000-0001-7327-5169; Castanha, Cristina/0000-0001-7327-5169; Hicks Pries, Caitlin/0000-0003-0813-2211	Terrestrial Ecosystem Science Program by the Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy [DE-AC02-05CH11231]	Terrestrial Ecosystem Science Program by the Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy(United States Department of Energy (DOE))	Data presented in this paper are available in tables S3 to S5 and at DOI: 10.17040/ISCN/1346192. This work was supported as part of the Terrestrial Ecosystem Science Program by the Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy under contract DE-AC02-05CH11231. We thank B. Zhu, B. Curtis, E. Brodie, P. Nico, W. Riley, N. Tas, R. Abramoff, K. Georgiou, P. Cook, A. Morales, J. Erspamer, A. Thomson, J. York, C. O'Neill, C. West, and E. Poppleton.	Berhe AA, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000751; Bond-Lamberty B, 2010, BIOGEOSCIENCES, V7, P1915, DOI 10.5194/bg-7-1915-2010; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Carey JC, 2016, P NATL ACAD SCI USA, V113, P13797, DOI 10.1073/pnas.1605365113; Crowther TW, 2016, NATURE, V540, P104, DOI 10.1038/nature20150; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; DAVIDSON EA, 1995, TELLUS B, V47, P550, DOI 10.1034/j.1600-0889.47.issue5.3.x; ESWARAN H, 1993, SOIL SCI SOC AM J, V57, P192, DOI 10.2136/sssaj1993.03615995005700010034x; Eusterhues K, 2003, ORG GEOCHEM, V34, P1591, DOI 10.1016/j.orggeochem.2003.08.007; Fierer N, 2005, ECOSYSTEMS, V8, P412, DOI 10.1007/s10021-003-0151-y; Fierer N, 2003, GLOBAL CHANGE BIOL, V9, P1322, DOI 10.1046/j.1365-2486.2003.00663.x; Gabriel CE, 2014, SOIL BIOL BIOCHEM, V68, P373, DOI 10.1016/j.soilbio.2013.10.009; Gillabel J, 2010, GLOBAL CHANGE BIOL, V16, P2789, DOI 10.1111/j.1365-2486.2009.02132.x; Goldstein AH, 2000, AGR FOREST METEOROL, V101, P113, DOI 10.1016/S0168-1923(99)00168-9; Hanson PJ, 2011, GLOBAL CHANGE BIOL, V17, P1083, DOI 10.1111/j.1365-2486.2010.02221.x; Jenkinson DS, 2008, EUR J SOIL SCI, V59, P400, DOI 10.1111/j.1365-2389.2008.01026.x; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Kirtman B., 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Koarashi J, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002034; Kochy M, 2015, SOIL-GERMANY, V1, P351, DOI 10.5194/soil-1-351-2015; Koven CD, 2013, BIOGEOSCIENCES, V10, P7109, DOI 10.5194/bg-10-7109-2013; Le Quere C, 2016, EARTH SYST SCI DATA, V8, P605, DOI 10.5194/essd-8-605-2016; Lu M, 2013, ECOLOGY, V94, P726, DOI 10.1890/12-0279.1; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Pang XY, 2015, BIOGEOCHEMISTRY, V126, P85, DOI 10.1007/s10533-015-0141-0; Phillips CL, 2013, BIOGEOSCIENCES, V10, P7999, DOI 10.5194/bg-10-7999-2013; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Reichstein M, 2008, J PLANT NUTR SOIL SC, V171, P344, DOI 10.1002/jpln.200700075; Rumpel C, 2011, PLANT SOIL, V338, P143, DOI 10.1007/s11104-010-0391-5; Salome C, 2010, GLOBAL CHANGE BIOL, V16, P416, DOI 10.1111/j.1365-2486.2009.01884.x; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Todd-Brown KEO, 2013, BIOGEOSCIENCES, V10, P1717, DOI 10.5194/bg-10-1717-2013; Wu ZT, 2011, GLOBAL CHANGE BIOL, V17, P927, DOI 10.1111/j.1365-2486.2010.02302.x	33	251	263	96	781	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 31	2017	355	6332					1420	1422		10.1126/science.aal1319	http://dx.doi.org/10.1126/science.aal1319			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EQ1DL	28280251	Green Published			2022-12-28	WOS:000397809500042
J	Adashi, EY; Krishna, GR; Gruppuso, PA				Adashi, Eli Y.; Krishna, Gopika R.; Gruppuso, Philip A.			For-Profit Medical Schools-A Flexnerian Legacy Upended	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Adashi, Eli Y.; Krishna, Gopika R.; Gruppuso, Philip A.] Brown Univ, Warren Alpert Med Sch, 272 George St, Providence, RI 02906 USA	Brown University	Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Sch, 272 George St, Providence, RI 02906 USA.	eli_adashi@brown.edu			National Institutes of Health [R25HD068835]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R25HD068835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by grant R25HD068835 from the National Institutes of Health (Dr Gruppuso).	Commission on Osteopathic College Accreditation, 2015, HOUS DEL ANN REP; Flexner A., 1910, MEDICAL ED US CANADA; Liaison Committee on Medical Education, 2012, FUNCT STRUCT MED SCH; Liaison Committee on Medical Education, 2014, FUNCT STRUCT MED SCH; Liaison Committee on Medical Education, 1989, FUNCT STRUCT MED SCH; Robertson K, 2015, CALIFORNIA NORTHSTAT; Shomaker TS, 2010, ACAD MED, V85, P363, DOI 10.1097/ACM.0b013e3181c865b8; Smith AA, 2015, PIPELINE HISPANIC DO; US Department of Justice, 1996, FIN JUDGM US AM BAR	9	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2017	317	12					1209	1210		10.1001/jama.2017.0920	http://dx.doi.org/10.1001/jama.2017.0920			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP7KX	28241197				2022-12-28	WOS:000397557800012
J	Zhang, ZP; Tanaka, K; Yu, JQ				Zhang, Zhipeng; Tanaka, Keita; Yu, Jin-Quan			Remote site-selective C-H activation directed by a catalytic bifunctional template	NATURE			English	Article							BOND ACTIVATION; ASYMMETRIC CATALYSIS; BIMETALLIC CATALYSIS; META; COMPLEXES; ALKENYLATION; SUBSTITUTION; ALKYLATION; ARYLATION; LIGANDS	In chemical syntheses, the activation of carbon-hydrogen (C-H) bonds converts them directly into carbon-carbon or carbonheteroatom bonds without requiring any prior functionalization. C-H activation can thus substantially reduce the number of steps involved in a synthesis. A single specific C-H bond in a substrate can be activated by using a 'directing' (usually a functional) group to obtain the desired product selectively(1-5). The applicability of such a C-H activation reaction can be severely curtailed by the distance of the C-H bond in question from the directing group, and by the shape of the substrate, but several approaches have been developed to overcome these limitations(6-12). In one such approach, an understanding of the distal and geometric relationships between the functional groups and C-H bonds of a substrate has been exploited to achieve meta-selective C-H activation by using a covalently attached, U-shaped template(13-17). However, stoichiometric installation of this template has not been feasible in the absence of an appropriate functional group on which to attach it. Here we report the design of a catalytic, bifunctional nitrile template that binds a heterocyclic substrate via a reversible coordination instead of a covalent linkage. The two metal centres coordinated to this template have different roles: one reversibly anchors substrates near the catalyst, and the other cleaves remote C-H bonds. Using this strategy, we demonstrate remote, site-selective C-H olefination of heterocyclic substrates that do not have the necessary functional groups for covalently attaching templates.	[Zhang, Zhipeng; Tanaka, Keita; Yu, Jin-Quan] Scripps Res Inst, Dept Chem, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA	Scripps Research Institute	Yu, JQ (corresponding author), Scripps Res Inst, Dept Chem, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	yu200@scripps.edu	Zhang, Zhipeng/AAI-9440-2020	Zhang, Zhipeng/0000-0003-2767-0904; Tanaka, Keita/0000-0001-9638-1044	Scripps Research Institute; United States National Institutes of Health (National Institute of General Medical Sciences) [1R01 GM102265]; Ito Foundation for International Education Exchange; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102265] Funding Source: NIH RePORTER	Scripps Research Institute; United States National Institutes of Health (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ito Foundation for International Education Exchange; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge The Scripps Research Institute and the United States National Institutes of Health (the National Institute of General Medical Sciences, grant no. 1R01 GM102265) for financial support. We thank the Ito Foundation for International Education Exchange (predoctoral fellowship to K.T.).	Alvarado RJ, 2005, INORG CHEM, V44, P7951, DOI 10.1021/ic051103r; Bera M, 2015, ANGEW CHEM INT EDIT, V54, P8515, DOI 10.1002/anie.201503112; BRESLOW R, 1980, ACCOUNTS CHEM RES, V13, P170, DOI 10.1021/ar50150a002; CHENG PH, 1990, INORG CHIM ACTA, V169, P19; Chu L, 2015, ACS CENTRAL SCI, V1, P394, DOI 10.1021/acscentsci.5b00312; Colby DA, 2010, CHEM REV, V110, P624, DOI 10.1021/cr900005n; Das S, 2006, SCIENCE, V312, P1941, DOI 10.1126/science.1127899; Daugulis O, 2009, ACCOUNTS CHEM RES, V42, P1074, DOI 10.1021/ar9000058; Flemming JP, 2008, ORG BIOMOL CHEM, V6, P1215, DOI 10.1039/b716954j; Hofmann N, 2013, J AM CHEM SOC, V135, P5877, DOI 10.1021/ja401466y; Konsler RG, 1998, J AM CHEM SOC, V120, P10780, DOI 10.1021/ja982683c; Kuninobu Y, 2015, NAT CHEM, V7, P712, DOI [10.1038/NCHEM.2322, 10.1038/nchem.2322]; Lee S, 2013, J AM CHEM SOC, V135, P18778, DOI 10.1021/ja4107034; Leow D, 2012, NATURE, V486, P518, DOI 10.1038/nature11158; Li J, 2015, J AM CHEM SOC, V137, P13894, DOI 10.1021/jacs.5b08435; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; Martinez-Martinez AJ, 2014, SCIENCE, V346, P834, DOI 10.1126/science.1259662; Nakao Y, 2008, J AM CHEM SOC, V130, P2448, DOI 10.1021/ja710766j; Park J, 2012, CHEM SOC REV, V41, P6931, DOI 10.1039/c2cs35129c; Phipps RJ, 2009, SCIENCE, V323, P1593, DOI 10.1126/science.1169975; Saidi O, 2011, J AM CHEM SOC, V133, P19298, DOI 10.1021/ja208286b; Shibasaki M, 2002, CHEM REV, V102, P2187, DOI 10.1021/cr010297z; SNIECKUS V, 1990, CHEM REV, V90, P879, DOI 10.1021/cr00104a001; STORK G, 1971, J AM CHEM SOC, V93, P4074, DOI 10.1021/ja00745a056; Tang RY, 2014, NATURE, V507, P215, DOI 10.1038/nature12963; Taylor RD, 2014, J MED CHEM, V57, P5845, DOI 10.1021/jm4017625; Tsai CC, 2010, J AM CHEM SOC, V132, P11887, DOI 10.1021/ja1061246; van den Beuken EK, 1998, TETRAHEDRON, V54, P12985, DOI 10.1016/S0040-4020(98)00319-6; Vitaku E, 2014, J MED CHEM, V57, P10257, DOI 10.1021/jm501100b; Yang YF, 2014, J AM CHEM SOC, V136, P344, DOI 10.1021/ja410485g	30	166	166	19	285	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2017	543	7646					538	542		10.1038/nature21418	http://dx.doi.org/10.1038/nature21418			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO9OM	28273068	Green Accepted			2022-12-28	WOS:000397018000048
J	Reese, A				Reese, April			Blackouts cast Australia's green energy in dim light	SCIENCE			English	News Item																			0	3	3	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI		1001	1002		10.1126/science.355.6329.1001	http://dx.doi.org/10.1126/science.355.6329.1001			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9VY	28280158				2022-12-28	WOS:000396348900008
J	Nieto, H; Dearden, J; Dale, S; Doshi, J				Nieto, Hannah; Dearden, James; Dale, Stacey; Doshi, Jayesh			10-MINUTE CONSULTATION Paediatric hearing loss	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Nieto, Hannah; Dearden, James] Univ Birmingham, Inst Metab & Syst Res, Edgbaston, England; [Dearden, James] North Devon Dist Hosp, Barnstaple, Devon, England; [Dale, Stacey] Cedars Surg, Swanley, Kent, England; [Doshi, Jayesh] Heart England NHS Fdn Trust, Heartlands Hosp, Birmingham, W Midlands, England	University of Birmingham; Heart of England NHS Foundation Trust	Nieto, H (corresponding author), Univ Birmingham, Inst Metab & Syst Res, Edgbaston, England.	dixonh@adf.bham.ac.uk	Doshi, Jayesh/GVS-0906-2022	Doshi, Jayesh/0000-0001-8807-1871				[Anonymous], 2015, NHS CHOIC GLUE EAR; [Anonymous], 2014, SUSP CHOL; [Anonymous], 2015, AC OT MED IN PRES; BARAFF LJ, 1993, PEDIATR INFECT DIS J, V12, P389, DOI 10.1097/00006454-199305000-00008; Paludetti G, 2012, ACTA OTORHINOLARYNGO, V32, P347; Wasson JD, 2016, INT J AUDIOL, V55, pS77, DOI 10.1080/14992027.2016.1184765	6	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2017	356								j803	10.1136/bmj.j803	http://dx.doi.org/10.1136/bmj.j803			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BU	28279954				2022-12-28	WOS:000396433400014
J	Zarocostas, J				Zarocostas, John			Controversy embroils selection of new Global Fund head	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 4	2017	389	10072					E3	E3		10.1016/S0140-6736(17)30633-5	http://dx.doi.org/10.1016/S0140-6736(17)30633-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM4DL	28258756				2022-12-28	WOS:000395263400001
J	Fisher, DJ; Carpenter, JR; Morris, TP; Freeman, SC; Tierney, JF				Fisher, David J.; Carpenter, James R.; Morris, Tim P.; Freeman, Suzanne C.; Tierney, Jayne F.			Meta-analytical methods to identify who benefits most from treatments: daft, deluded, or deft approach?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PARTICIPANT DATA METAANALYSIS; INDIVIDUAL PATIENT DATA; RANDOMIZED-TRIALS; REGRESSION; LEVEL	Identifying which individuals benefit most from particular treatments or other interventions underpins so-called personalised or stratified medicine. However, single trials are typically underpowered for exploring whether participant characteristics, such as age or disease severity, determine an individual's response to treatment. A meta-analysis of multiple trials, particularly one where individual participant data (IPD) are available, provides greater power to investigate interactions between participant characteristics (covariates) and treatment effects. We use a published IPD meta-analysis to illustrate three broad approaches used for testing such interactions. Based on another systematic review of recently published IPD meta-analyses, we also show that all three approaches can be applied to aggregate data as well as IPD. We also summarise which methods of analysing and presenting interactions are in current use, and describe their advantages and disadvantages. We recommend that testing for interactions using within-trials information alone (the deft approach) becomes standard practice, alongside graphical presentation that directly visualises this.	[Fisher, David J.; Carpenter, James R.; Morris, Tim P.; Freeman, Suzanne C.; Tierney, Jayne F.] UCL, MRC Clin Trials Unit, London Hub Trials Methodol Res, London, England; [Carpenter, James R.] London Sch Hyg & Trop Med, Dept Med Stat, London, England	Medical Research Council Clinical Trials Unit; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Fisher, DJ (corresponding author), UCL, MRC Clin Trials Unit, London Hub Trials Methodol Res, London, England.	d.fisher@ucl.ac.uk	Morris, Tim/AAY-5573-2021	Fisher, David/0000-0002-2512-2296; Carpenter, James/0000-0003-3890-6206; Tierney, Jayne/0000-0002-4734-3014; Morris, Tim/0000-0001-5850-3610	UK Medical Research Council (MRC); MRC London Hub for Trials Methodology Research [MC_EX_G0800814]; Medical Research Council [MC_UU_12023/21, 1406188] Funding Source: researchfish; MRC [MC_UU_12023/21] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC London Hub for Trials Methodology Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council (MRC) via core funding for the MRC Clinical Trials Unit at University College London, and grant funding for the MRC London Hub for Trials Methodology Research (MC_EX_G0800814). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berlin JA, 2002, STAT MED, V21, P371, DOI 10.1002/sim.1023; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Burdett S, 2014, LANCET, V383, P1561, DOI 10.1016/S0140-6736(13)62159-5; Donegan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128804; Fearon P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000443.pub3; Fisher DJ, 2011, J CLIN EPIDEMIOL, V64, P949, DOI 10.1016/j.jclinepi.2010.11.016; Fisher DJ, 2015, STATA J, V15, P369, DOI 10.1177/1536867X1501500203; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Riley RD, 2008, STAT MED, V27, P1870, DOI 10.1002/sim.3165; Ronellenfitsch U, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008107.pub2; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Simmonds MC, 2007, STAT MED, V26, P2982, DOI 10.1002/sim.2768; Simmonds M, 2015, CONTEMP CLIN TRIALS, V45, P76, DOI 10.1016/j.cct.2015.06.012; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; Stewart LA, 2002, EVAL HEALTH PROF, V25, P76, DOI 10.1177/0163278702025001006; Thompson SG, 2005, LANCET, V365, P341, DOI 10.1016/S0140-6736(05)17790-3; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Tierney JF, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001855; Vale CL, 2012, CANCER TREAT REV, V38, P618, DOI 10.1016/j.ctrv.2011.11.002; Zhang S, 2015, J CLIN ONCOL, V33, P1697, DOI 10.1200/JCO.2014.59.8862	20	104	104	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2017	356								j573	10.1136/bmj.j573	http://dx.doi.org/10.1136/bmj.j573			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JX	28258124	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-28	WOS:000395628800012
J	Bittiner, B				Bittiner, Bruce			Pauline Bittiner OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2017	356								j898	10.1136/bmj.j898	http://dx.doi.org/10.1136/bmj.j898			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KZ	28235880				2022-12-28	WOS:000395631800008
J	Moody, C				Moody, Caroline			Thomas Laurence Moody OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2017	356								j904	10.1136/bmj.j904	http://dx.doi.org/10.1136/bmj.j904			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KZ	28235794				2022-12-28	WOS:000395631800011
J	Budoff, MJ; Ellenberg, SS; Lewis, CE; Mohler, ER; Wenger, NK; Bhasin, S; Barrett-Connor, E; Swerdloff, RS; Stephens-Shields, A; Cauley, JA; Crandall, JP; Cunningham, GR; Ensrud, KE; Gill, TM; Matsumoto, AM; Molitch, ME; Nakanishi, R; Nezarat, N; Matsumoto, S; Hou, XL; Basaria, S; Diem, SJ; Wang, C; Cifelli, D; Snyder, PJ				Budoff, Matthew J.; Ellenberg, Susan S.; Lewis, Cora E.; Mohler, Emile R., III; Wenger, Nanette K.; Bhasin, Shalender; Barrett-Connor, Elizabeth; Swerdloff, Ronald S.; Stephens-Shields, Alisa; Cauley, Jane A.; Crandall, Jill P.; Cunningham, Glenn R.; Ensrud, Kristine E.; Gill, Thomas M.; Matsumoto, Alvin M.; Molitch, Mark E.; Nakanishi, Rine; Nezarat, Negin; Matsumoto, Suguru; Hou, Xiaoling; Basaria, Shehzad; Diem, Susan J.; Wang, Christina; Cifelli, Denise; Snyder, Peter J.			Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ENDOGENOUS SEX-HORMONES; INTRAVASCULAR ULTRASOUND; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; PROGRESSION; CT; MORTALITY; RISK; ANGIOGRAPHY	IMPORTANCE Recent studies have yielded conflicting results as to whether testosterone treatment increases cardiovascular risk. OBJECTIVE To test the hypothesis that testosterone treatment of older men with low testosterone slows progression of noncalcified coronary artery plaque volume. DESIGN, SETTING, AND PARTICIPANTS Double-blinded, placebo-controlled trial at 9 academic medical centers in the United States. The participants were 170 of 788 men aged 65 years or older with an average of 2 serum testosterone levels lower than 275 ng/dL (82 men assigned to placebo, 88 to testosterone) and symptoms suggestive of hypogonadism who were enrolled in the Testosterone Trials between June 24, 2010, and June 9, 2014. INTERVENTION Testosterone gel, with the dose adjusted to maintain the testosterone level in the normal range for young men, or placebo gel for 12 months. MAIN OUTCOMES AND MEASURES The primary outcomewas noncalcified coronary artery plaque volume, as determined by coronary computed tomographic angiography. Secondary outcomes included total coronary artery plaque volume and coronary artery calcium score (range of 0 to >400 Agatston units, with higher values indicating more severe atherosclerosis). RESULTS Of 170 men who were enrolled, 138 (73 receiving testosterone treatment and 65 receiving placebo) completed the study and were available for the primary analysis. Among the 138 men, the mean (SD) age was 71.2 (5.7) years, and 81% were white. At baseline, 70 men (50.7%) had a coronary artery calcification score higher than 300 Agatston units, reflecting severe atherosclerosis. For the primary outcome, testosterone treatment compared with placebo was associated with a significantly greater increase in noncalcified plaque volume from baseline to 12 months (from median values of 204mm3 to 232 mm(3) vs 317 mm(3) to 325 mm(3), respectively; estimated difference, 41 mm(3); 95% CI, 14 to 67 mm(3); P = .003). For the secondary outcomes, the median total plaque volume increased from baseline to 12 months from 272 mm(3) to 318 mm(3) in the testosterone group vs from 499 mm(3) to 541 mm(3) in the placebo group (estimated difference, 47 mm(3); 95% CI, 13 to 80 mm(3); P=.006), and the median coronary artery calcification score changed from 255 to 244 Agatston units in the testosterone group vs 494 to 503 Agatston units in the placebo group (estimated difference, -27 Agatston units; 95% CI, -80 to 26 Agatston units). No major adverse cardiovascular events occurred in either group. CONCLUSIONS AND RELEVANCE Among older men with symptomatic hypogonadism, treatment with testosterone gel for 1 year compared with placebo was associated with a significantly greater increase in coronary artery noncalcified plaque volume, as measured by coronary computed tomographic angiography. Larger studies are needed to understand the clinical implications of this finding.	[Budoff, Matthew J.; Nakanishi, Rine; Nezarat, Negin; Matsumoto, Suguru] Harbor UCLA Med Ctr, Div Cardiol, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Ellenberg, Susan S.; Stephens-Shields, Alisa; Hou, Xiaoling; Cifelli, Denise] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lewis, Cora E.] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA; [Mohler, Emile R., III] Univ Penn, Sect Vasc Med, Div Cardiovasc Dis, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wenger, Nanette K.] Emory Univ, Sch Med, Div Cardiol, Dept Med,Emory Heart & Vasc Ctr, Atlanta, GA 30322 USA; [Bhasin, Shalender; Basaria, Shehzad] Harvard Med Sch, Brigham & Womens Hosp, Res Program Mens Hlth Aging & Metab, Boston, MA USA; [Barrett-Connor, Elizabeth] Univ Calif San Diego, Sch Med, Dept Family & Prevent Med, Div Epidemiol, La Jolla, CA 92093 USA; [Swerdloff, Ronald S.; Wang, Christina] Harbor UCLA, Los Angeles Biomed Res Inst, Div Endocrinol, Torrance, CA USA; [Cauley, Jane A.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Crandall, Jill P.] Albert Einstein Coll Med, Div Endocrinol, Bronx, NY 10467 USA; [Crandall, Jill P.] Albert Einstein Coll Med, Div Geriatr, Bronx, NY 10467 USA; [Cunningham, Glenn R.] Baylor Coll Med, Dept Med, Div Diabet Endocrinol & Metab, Houston, TX 77030 USA; [Cunningham, Glenn R.] Baylor St Lukes Med Ctr, Houston, TX USA; [Cunningham, Glenn R.] Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA; [Ensrud, Kristine E.; Diem, Susan J.] Univ Minnesota, Dept Med, Div Epidemiol & Community Hlth, Box 736 UMHC, Minneapolis, MN 55455 USA; [Ensrud, Kristine E.] Minneapolis VA Hlth Care Syst, Minneapolis, MN USA; [Gill, Thomas M.] Yale Sch Med, Div Geriatr Med, New Haven, CT USA; [Matsumoto, Alvin M.] Univ Washington, Sch Med, Geriatr Res Educ & Clin Ctr, VA Puget Sound Hlth Syst, Seattle, WA USA; [Matsumoto, Alvin M.] Univ Washington, Sch Med, Dept Internal Med, Div Gerontol & Geriatr Med, Seattle, WA USA; [Molitch, Mark E.] Northwestern Univ, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Snyder, Peter J.] Univ Penn, Div Endocrinol Diabet & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of Pennsylvania; Pennsylvania Medicine; University of Alabama System; University of Alabama Birmingham; University of Pennsylvania; Pennsylvania Medicine; Emory University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Yale University; Geriatric Research Education & Clinical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Northwestern University; Feinberg School of Medicine; University of Pennsylvania; Pennsylvania Medicine	Snyder, PJ (corresponding author), Univ Penn, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	pjs@mail.med.upenn.edu	Gill, Thomas M./H-7043-2019; Matsumoto, Alvin/AAH-6096-2020; Budoff, Matthew/ABD-5175-2021	Gill, Thomas M./0000-0002-6450-0368; Budoff, Matthew/0000-0002-9616-1946; Ensrud, Kristine/0000-0002-9069-3036; Basaria, Shehzad/0000-0003-1749-8549	National Institute on Aging [U01 AG030644, K07AG043587]; National Heart, Lung, and Blood Institute; National Institute of Neurological Diseases and Stroke; National Institute of Child Health and Human Development; AndroGel; placebo gel; National Institute of Diabetes and Digestive and Kidney Diseases [DK079626]; Claude D. Pepper Older Americans Independence Centers grant from the National Institute on Aging [P30-AG021342]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK079626, P30DK079626, P30DK020541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K07AG043587, U01AG030644, P30AG021342] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); AndroGel; placebo gel; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Claude D. Pepper Older Americans Independence Centers grant from the National Institute on Aging; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Testosterone Trials were supported by grant U01 AG030644 from the National Institute on Aging, supplemented by funds from the National Heart, Lung, and Blood Institute. Additional funding was provided by the National Institute of Neurological Diseases and Stroke and the National Institute of Child Health and Human Development. AbbVie provided funding, AndroGel, and placebo gel. Dr Lewis was supported by grant DK079626 from the National Institute of Diabetes and Digestive and Kidney Diseases to the University of Alabama at Birmingham Diabetes Research and Training Center. Dr Gill is the recipient of Academic Leadership Award K07AG043587 from the National Institute on Aging, and the Yale Field Center is supported in part by the Claude D. Pepper Older Americans Independence Centers grant P30-AG021342 from the National Institute on Aging.	Abd Alamir M, 2016, CORONARY ARTERY DIS, V27, P95, DOI 10.1097/MCA.0000000000000321; Arbab-Zadeh A, 2015, J AM COLL CARDIOL, V65, P846, DOI 10.1016/j.jacc.2014.11.041; Baillargeon J, 2014, ANN PHARMACOTHER, V48, P1138, DOI 10.1177/1060028014539918; Baillargeon J, 2013, JAMA INTERN MED, V173, P1465, DOI 10.1001/jamainternmed.2013.6895; BARRETTCONNOR E, 1988, CIRCULATION, V78, P539, DOI 10.1161/01.CIR.78.3.539; Basaria S, 2015, JAMA-J AM MED ASSOC, V314, P570, DOI 10.1001/jama.2015.8881; Basaria S, 2010, NEW ENGL J MED, V363, P109, DOI 10.1056/NEJMoa1000485; Boogers MJ, 2012, EUR HEART J, V33, P1007, DOI 10.1093/eurheartj/ehr465; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Cauley JA, 2015, J GERONTOL A-BIOL, V70, P1105, DOI 10.1093/gerona/glv031; Dalager MG, 2011, INT J CARDIOVAS IMAG, V27, P593, DOI 10.1007/s10554-010-9695-z; Finkle WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085805; Fischer C, 2013, J CARDIOVASC COMPUT, V7, P256, DOI 10.1016/j.jcct.2013.08.006; Gaur S, 2016, EUR HEART J, V37, P1220, DOI 10.1093/eurheartj/ehv690; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Hamirani YS, 2011, INT J CARDIOL, V149, P270, DOI 10.1016/j.ijcard.2011.02.056; Khaw KT, 2007, CIRCULATION, V116, P2694, DOI 10.1161/CIRCULATIONAHA.107.719005; Kloner RA, 2016, J AM COLL CARDIOL, V67, P545, DOI 10.1016/j.jacc.2015.12.005; Matsumoto S, 2016, J NUTR, V146, p427S, DOI 10.3945/jn.114.202424; Miszalski-Jamka T, 2012, INT J CARDIOVAS IMAG, V28, P621, DOI 10.1007/s10554-011-9799-0; Muraleedharan V, 2013, EUR J ENDOCRINOL, V169, P725, DOI 10.1530/EJE-13-0321; Oh JY, 2002, DIABETES CARE, V25, P55, DOI 10.2337/diacare.25.1.55; Papadopoulou SL, 2012, JACC-CARDIOVASC IMAG, V5, pS28, DOI 10.1016/j.jcmg.2012.01.009; Raff Gilbert L, 2009, J Cardiovasc Comput Tomogr, V3, P122, DOI 10.1016/j.jcct.2009.01.001; Samady H, 2011, CIRCULATION, V124, P779, DOI 10.1161/CIRCULATIONAHA.111.021824; Schuhbaeck A, 2014, EUR RADIOL, V24, P2300, DOI 10.1007/s00330-014-3253-3; Shores MM, 2012, J CLIN ENDOCR METAB, V97, P2050, DOI 10.1210/jc.2011-2591; Smith GD, 2005, CIRCULATION, V112, P332, DOI 10.1161/CIRCULATIONAHA.104.489088; Snyder PJ, 2016, NEW ENGL J MED, V374, P611, DOI 10.1056/NEJMoa1506119; Snyder PJ, 2014, CLIN TRIALS, V11, P362, DOI 10.1177/1740774514524032; Srinivas-Shankar U, 2010, J CLIN ENDOCR METAB, V95, P639, DOI 10.1210/jc.2009-1251; Vigen R, 2013, JAMA-J AM MED ASSOC, V310, P1829, DOI 10.1001/jama.2013.280386; Zeb I, 2013, ATHEROSCLEROSIS, V231, P198, DOI 10.1016/j.atherosclerosis.2013.08.019	33	216	221	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2017	317	7					708	716		10.1001/jama.2016.21043	http://dx.doi.org/10.1001/jama.2016.21043			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8WR	28241355	Green Accepted, Green Published			2022-12-28	WOS:000394901600018
J	Pinsky, WW				Pinsky, William W.			The Importance of International Medical Graduates in the United States	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARE; PHYSICIAN		[Pinsky, William W.] Educ Commiss Foreign Med Grad, 3624 Market St,4th Floor, Philadelphia, PA 19104 USA		Pinsky, WW (corresponding author), Educ Commiss Foreign Med Grad, 3624 Market St,4th Floor, Philadelphia, PA 19104 USA.	wpinsky@ecfmg.org						American College of Physicians, 2005, ROL INT MED GRAD US; Mandel J, 2016, CHEST, V149, P895, DOI 10.1016/j.chest.2016.01.009; Mullan F, 2015, NEW ENGL J MED, V373, P2397, DOI 10.1056/NEJMp1511707; National Residency Matching Program, 2016, RES DAT 2016 MAIN RE; Norcini JJ, 2008, J HEALTH CARE POOR U, V19, P493, DOI 10.1353/hpu.0.0015; Norcini JJ, 2010, HEALTH AFFAIR, V29, P1461, DOI 10.1377/hlthaff.2009.0222; Obama BH, 2017, NEW ENGL J MED, V376, P297, DOI 10.1056/NEJMp1616577; Rabinowitz HK, 2012, ACAD MED, V87, P488, DOI 10.1097/ACM.0b013e3182488b19	8	24	24	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 6	2017	166	11					840	+		10.7326/M17-0505	http://dx.doi.org/10.7326/M17-0505			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW7NJ	28265642				2022-12-28	WOS:000402700200010
J	Worrall, L; Foster, A				Worrall, Linda; Foster, Abby			Does intensity matter in aphasia rehabilitation?	LANCET			English	Editorial Material							TOP 10; STROKE; PEOPLE; LIFE		[Worrall, Linda; Foster, Abby] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia; [Worrall, Linda; Foster, Abby] La Trobe Univ, Sch Allied Hlth, Discipline Speech Pathol, Melbourne, Vic, Australia	University of Queensland; La Trobe University	Worrall, L (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia.; Worrall, L (corresponding author), La Trobe Univ, Sch Allied Hlth, Discipline Speech Pathol, Melbourne, Vic, Australia.	l.worrall@uq.edu.au	Foster, Abby/AAL-6420-2021	Foster, Abby/0000-0002-7787-8765				Allen L, 2012, TOP STROKE REHABIL, V19, P523, DOI 10.1310/tsr1906-523; Brady MC, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000425.pub4; Breitenstein C, 2016, LANCET; Cherney LR, 2011, CURR NEUROL NEUROSCI, V11, P560, DOI 10.1007/s11910-011-0227-6; Davidson B, 2008, TOP STROKE REHABIL, V15, P325, DOI 10.1310/tsr1504-325; El Hachioui H, 2013, J NEUROL NEUROSUR PS, V84, P310, DOI 10.1136/jnnp-2012-302596; Ellis C, 2012, STROKE, V43, P1429, DOI 10.1161/STROKEAHA.111.647339; Engelter ST, 2006, STROKE, V37, P1379, DOI 10.1161/01.STR.0000221815.64093.8c; Hilari K, 2009, INT J LANG COMM DIS, V44, P193, DOI 10.1080/13682820802008820; Katz RC, 2000, INT J LANG COMM DIS, V35, P303; Pollock A, 2012, LANCET NEUROL, V11, P209, DOI 10.1016/S1474-4422(12)70029-7; Rose M, 2014, INT J SPEECH-LANG PA, V16, P169, DOI 10.3109/17549507.2013.794474; Simmons-Mackie N, 2017, APHASIOLOGY, V31, P131, DOI 10.1080/02687038.2016.1180662	13	7	8	2	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 15	2017	389	10078					1494	1495		10.1016/S0140-6736(17)30546-9	http://dx.doi.org/10.1016/S0140-6736(17)30546-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ER7OP	28256354				2022-12-28	WOS:000399002900005
J	Cascales, E				Cascales, Eric			Inside the Chamber of Secrets of the Type III Secretion System	CELL			English	Editorial Material							RESOLUTION; NEEDLE	The bacterial type III secretion system is a specialized machine that injects effectors into eukaryotic cells to manipulate the host cell physiology. In this issue of Cell, Hu et al. use cryo-electron tomography to reveal an unprecedented level of details regarding the architecture of this machine and the conformational changes that occur during its assembly.	[Cascales, Eric] Aix Marseille Univ, CNRS, Lab Ingn Syst Macromol, UMR 7255,Inst Microbiol Mediterranee, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Cascales, E (corresponding author), Aix Marseille Univ, CNRS, Lab Ingn Syst Macromol, UMR 7255,Inst Microbiol Mediterranee, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	cascales@imm.cnrs.fr	CASCALES, ERIC/G-7420-2011	CASCALES, ERIC/0000-0003-0611-9179	Centre National de la Recherche Scientifique; Aix-Marseille Universite; Agence Nationale de la Recherche [ANR-14-CE14-0006-02, ANR-15-CE11-0019-01]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite; Agence Nationale de la Recherche(French National Research Agency (ANR))	Work in the E.C. laboratory is supported by the Centre National de la Recherche Scientifique, the Aix-Marseille Universite, and grants from the Agence Nationale de la Recherche (ANR-14-CE14-0006-02 and ANR-15-CE11-0019-01).	Burkinshaw BJ, 2014, BBA-MOL CELL RES, V1843, P1649, DOI 10.1016/j.bbamcr.2014.01.035; Chang YW, 2016, SCIENCE, V351, DOI 10.1126/science.aad2001; Diepold A, 2014, FEMS MICROBIOL REV, V38, P802, DOI 10.1111/1574-6976.12061; Fujii T, 2012, P NATL ACAD SCI USA, V109, P4461, DOI 10.1073/pnas.1116126109; Galan JE, 2014, ANNU REV MICROBIOL, V68, P415, DOI 10.1146/annurev-micro-092412-155725; Hu B, 2017, CELL, V168, P1065, DOI 10.1016/j.cell.2017.02.022; Hu B, 2015, P NATL ACAD SCI USA, V112, P1047, DOI 10.1073/pnas.1411610112; Kudryashev M, 2013, ELIFE, V2, DOI 10.7554/eLife.00792; Schraidt O, 2011, SCIENCE, V331, P1192, DOI 10.1126/science.1199358; Worrall LJ, 2016, NATURE, V540, P597, DOI 10.1038/nature20576	10	6	6	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2017	168	6					949	951		10.1016/j.cell.2017.02.028	http://dx.doi.org/10.1016/j.cell.2017.02.028			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8ZF	28283066	Green Submitted, Bronze			2022-12-28	WOS:000396287900002
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Are we too captivated by precision medicine?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2015, WASHINGTON POST; Catapult Precision Medicine, CYT; Health Education England, 2015, PREC MED WHAT IS IT; Higginson IJ, 2014, LANCET RESP MED, V2, P979, DOI 10.1016/S2213-2600(14)70226-7; Hoffmann TC, 2017, JAMA INTERN MED, V177, P407, DOI 10.1001/jamainternmed.2016.8254; NHS England, 2015, PERS MED STRAT; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; US National Library of Medicine, WHAT IS PREC MED IN	8	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2017	356								j1168	10.1136/bmj.j1168	http://dx.doi.org/10.1136/bmj.j1168			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BU	28279961	Bronze, Green Published			2022-12-28	WOS:000396433400004
J	Pennisi, E				Pennisi, Elizabeth			GENOMICS Sequencing all life captivates biologists	SCIENCE			English	News Item																			0	12	13	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					894	895		10.1126/science.355.6328.894	http://dx.doi.org/10.1126/science.355.6328.894			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2YM	28254891				2022-12-28	WOS:000395181700012
J	Barasch, J; Zager, R; Bonventre, JV				Barasch, Jonathan; Zager, Richard; Bonventre, Joseph V.			Acute kidney injury: a problem of definition	LANCET			English	Editorial Material							FAILURE		[Barasch, Jonathan] Columbia Univ, Dept Med, New York, NY 10032 USA; [Zager, Richard] Univ Washington, Fred Hutchinson Canc Ctr, Washington, DC USA; [Bonventre, Joseph V.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA	Columbia University; Fred Hutchinson Cancer Center; University of Washington; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Barasch, J (corresponding author), Columbia Univ, Dept Med, New York, NY 10032 USA.	jmb4@columbia.edu			Abbvie; Amgen; Astellas; Pfizer; UCB Pharma; Takeda; Boehringer Ingelheim for research on acute kidney injury and chronic kidney disease; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072381] Funding Source: NIH RePORTER	Abbvie(AbbVie); Amgen(Amgen); Astellas(Astellas Pharmaceuticals); Pfizer(Pfizer); UCB Pharma(UCB Pharma SA); Takeda(Takeda Pharmaceutical Company Ltd); Boehringer Ingelheim for research on acute kidney injury and chronic kidney disease(Boehringer Ingelheim); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	JB is a co-inventor on patents 8592170, 7977110, and 7776824 related to neutrophil gelatinase-associated lipocalin (NGAL); Columbia University initiated an exclusive license with Bioporto (2017) for patents related to NGAL. RZ declares no competing interests. JVB reports personal fees for advisory board meetings from Abbvie, Amgen, Astellas, Pfizer, UCB Pharma, and Takeda; has received a grant from Boehringer Ingelheim for research on acute kidney injury and chronic kidney disease; is a co-inventor on patents 6664385 and 7696321 related to kidney injury molecule-1 (KIM-1) assigned to Partners Healthcare with royalties paid by R and D, Astute, Biogen, Sekisui, and Ortho; and declares equity in Medibeacon (developing methods to measure glomerular filtration rate in real time), in Sentien (developing an extracorporeal device to potentially treat acute kidney injury), in Goldfinch Biopharma (developing precision therapies for kidney disease), and in Thrasos Therapeutics (developing BMP/Smad peptides to potentially treat acute kidney injury).	Brisco MA, 2016, J CARD FAIL, V22, P753, DOI 10.1016/j.cardfail.2016.06.423; Coca SG, 2010, KIDNEY INT, V78, P926, DOI 10.1038/ki.2010.259; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Haase M, 2012, NAT REV NEPHROL, V8, P735, DOI 10.1038/nrneph.2012.197; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Murray PT, 2014, KIDNEY INT, V85, P513, DOI 10.1038/ki.2013.374; Nickolas TL, 2012, J AM COLL CARDIOL, V59, P246, DOI 10.1016/j.jacc.2011.10.854; Sharma A, 2014, NEPHRON CLIN PRACT, V127, P94, DOI 10.1159/000363721; Waikar SS, 2013, CLIN TRIALS, V10, P696, DOI 10.1177/1740774513497540; Yuen PST, 2006, PHYSIOL GENOMICS, V25, P375, DOI 10.1152/physiolgenomics.00223.2005	11	56	57	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 25	2017	389	10071					779	781		10.1016/S0140-6736(17)30543-3	http://dx.doi.org/10.1016/S0140-6736(17)30543-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9UU	28248160	Green Accepted			2022-12-28	WOS:000394966400012
J	Fletcher, M				Fletcher, Martin			Ronald Frank Fletcher OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2017	356								j902	10.1136/bmj.j902	http://dx.doi.org/10.1136/bmj.j902			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KZ	28235807				2022-12-28	WOS:000395631800010
J	Santosa, A				Santosa, Ailiana			A better world towards convergence of longevity?	LANCET			English	Editorial Material							EPIDEMIOLOGIC TRANSITION		[Santosa, Ailiana] Umea Univ, Ctr Demog & Ageing Res, S-90187 Umea, Sweden	Umea University	Santosa, A (corresponding author), Umea Univ, Ctr Demog & Ageing Res, S-90187 Umea, Sweden.	ailiana.santosa@umu.se	Santosa, Ailiana/AAY-9372-2020	Santosa, Ailiana/0000-0002-1848-2867				Alkema Leontine, 2015, Foresight (Colch), V2015, P19; Booth H, 2008, ANN ACTUAR SCI, V3, P3, DOI 10.1017/S1748499500000440; Dong X, 2016, NATURE, V538, P257, DOI 10.1038/nature19793; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Kontis V, 2017, LANCET; OLSHANSKY SJ, 1990, SCIENCE, V250, P634, DOI 10.1126/science.2237414; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Raftery AE, 2012, P NATL ACAD SCI USA, V109, P13915, DOI 10.1073/pnas.1211452109; Santosa A, 2014, GLOBAL HEALTH ACTION, V7, P56, DOI 10.3402/gha.v7.23574; United Nations Department of Economic and Social Affairs, 2015, WORLD POPULATION PRO	10	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 1	2017	389	10076					1278	1279		10.1016/S0140-6736(17)30314-8	http://dx.doi.org/10.1016/S0140-6736(17)30314-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EQ2OF	28237262	hybrid			2022-12-28	WOS:000397908700006
J	Hui, EF; Cheung, J; Zhu, J; Su, XL; Taylor, MJ; Wallweber, HA; Sasmal, DK; Huang, J; Kim, JM; Mellman, I; Vale, RD				Hui, Enfu; Cheung, Jeanne; Zhu, Jing; Su, Xiaolei; Taylor, Marcus J.; Wallweber, Heidi A.; Sasmal, Dibyendu K.; Huang, Jun; Kim, Jeong M.; Mellman, Ira; Vale, Ronald D.			T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition	SCIENCE			English	Article							CANCER-IMMUNOTHERAPY; PD-1 EXPRESSION; ACTIVATION; EXHAUSTION; KINASE; ANTI-PD-1; RESPONSES; SAFETY; MICROCLUSTERS; STIMULATION	Programmed cell death-1 (PD-1) is a coinhibitory receptor that suppresses T cell activation and is an important cancer immunotherapy target. Upon activation by its ligand PD-L1, PD-1 is thought to suppress signaling through the T cell receptor (TCR). By titrating PD-1 signaling in a biochemical reconstitution system, we demonstrate that the co-receptor CD28 is strongly preferred over the TCR as a target for dephosphorylation by PD-1-recruited Shp2 phosphatase. We also show that CD28, but not the TCR, is preferentially dephosphorylated in response to PD-1 activation by PD-L1 in an intact cell system. These results reveal that PD-1 suppresses T cell function primarily by inactivating CD28 signaling, suggesting that costimulatory pathways play key roles in regulating effector T cell function and responses to anti-PD-L1/PD-1 therapy.	[Hui, Enfu; Su, Xiaolei; Taylor, Marcus J.; Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Hui, Enfu; Su, Xiaolei; Taylor, Marcus J.; Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Cheung, Jeanne; Zhu, Jing; Wallweber, Heidi A.; Kim, Jeong M.; Mellman, Ira] Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA; [Sasmal, Dibyendu K.; Huang, Jun] Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA; [Hui, Enfu] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Roche Holding; Genentech; University of Chicago; University of California System; University of California San Diego	Vale, RD (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.; Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.; Mellman, I (corresponding author), Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA.	mellman.ira@gene.com; ron.vale@ucsf.edu	Sasmal, Dibyendu/ABD-2318-2021; Mellman, Ira/ABG-5896-2020	Sasmal, Dibyendu/0000-0003-4148-5326; Mellman, Ira/0000-0002-6132-7299	NIH [R21AI120010, R00AI106941]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI106941, R21AI120010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038499] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Wang (Shanghai-Tech University) and F. Kai (University of California, San Francisco) for help with retrovirus transduction of primary T cells; N. Stuurman for training in TIRF microscopy; J. James (now at University of Cambridge) for providing the lentiviral transfer plasmid pHR-PD-L1-mCherry; A. Weiss (University of California, San Francisco) for providing the retrovirus vectors pMSCV, pCL-Eco, and anti-Lck antibody; and J. Ditlev (M. Rosen's laboratory, University of Texas Southwestern Medical Center) for providing His8-LAT. The data presented are tabulated in the main paper and the supplementary materials. We acknowledge R. Ahmed, A. Kamphorst, and members of the Vale laboratory for comments and discussions. R.D.V. is an investigator of the Howard Hughes Medical Institute. D.K.S. was supported by NIH grant R21AI120010 and the Chicago Biomedical Consortium. J.H. was supported by NIH grants R00AI106941 and R21AI120010.	Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Bennett F, 2003, J IMMUNOL, V170, P711, DOI 10.4049/jimmunol.170.2.711; BERGMAN M, 1992, EMBO J, V11, P2919, DOI 10.1002/j.1460-2075.1992.tb05361.x; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Choudhuri K, 2014, NATURE, V507, P118, DOI 10.1038/nature12951; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Fehrenbacher L, 2016, LANCET, V387, P1837, DOI 10.1016/S0140-6736(16)00587-0; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hui EF, 2014, NAT STRUCT MOL BIOL, V21, P133, DOI 10.1038/nsmb.2762; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Kamphorst AO, 2017, SCIENCE, V355, P1423, DOI 10.1126/science.aaf0683; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Oestreich KJ, 2008, J IMMUNOL, V181, P4832, DOI 10.4049/jimmunol.181.7.4832; Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Pauken KE, 2015, TRENDS IMMUNOL, V36, P265, DOI 10.1016/j.it.2015.02.008; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Riley JL, 2009, IMMUNOL REV, V229, P114, DOI 10.1111/j.1600-065X.2009.00767.x; Rizvi NA, 2015, LANCET ONCOL, V16, P257, DOI 10.1016/S1470-2045(15)70054-9; Rudd CE, 2008, NAT REV IMMUNOL, V8, P153, DOI 10.1038/nri2253; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Sheppard KA, 2004, FEBS LETT, V574, P37, DOI 10.1016/j.febslet.2004.07.083; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Tian RJ, 2015, P NATL ACAD SCI USA, V112, pE1594, DOI 10.1073/pnas.1503286112; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Yang J, 2003, J BIOL CHEM, V278, P6516, DOI 10.1074/jbc.M210430200; Yokosuka T, 2008, IMMUNITY, V29, P589, DOI 10.1016/j.immuni.2008.08.011; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Zang XX, 2006, GENOMICS, V88, P841, DOI 10.1016/j.ygeno.2006.08.012; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zikherman J, 2010, IMMUNITY, V32, P342, DOI 10.1016/j.immuni.2010.03.006; Zinselmeyer BH, 2013, J EXP MED, V210, P757, DOI 10.1084/jem.20121416	47	812	856	16	261	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 31	2017	355	6332					1428	+		10.1126/science.aaf1292	http://dx.doi.org/10.1126/science.aaf1292			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EQ1DL	28280247	Green Submitted, Green Accepted			2022-12-28	WOS:000397809500044
J	Halevy, I; Bachan, A				Halevy, I.; Bachan, A.			The geologic history of seawater pH	SCIENCE			English	Article							OCEAN; OXYGEN; CONSTRAINTS; FEEDBACK; CYCLE; MODEL	Although pH is a fundamental property of Earth's oceans, critical to our understanding of seawater biogeochemistry, its long-timescale geologic history is poorly constrained. We constrain seawater pH through time by accounting for the cycles of the major components of seawater. We infer an increase from early Archean pH values between -6.5 and 7.0 and Phanerozoic values between -7.5 and 9.0, which was caused by a gradual decrease in atmospheric pCO(2) in response to solar brightening, alongside a decrease in hydrothermal exchange between seawater and the ocean crust. A lower pH in Earth's early oceans likely affected the kinetics of chemical reactions associated with the origin of life, the energetics of early metabolisms, and climate through the partitioning of CO2 between the oceans and atmosphere.	[Halevy, I.] Weizmann Inst Sci, Dept Earth & Planetary Sci, Rehovot, Israel; [Bachan, A.] Stanford Univ, Sch Earth Energy & Environm Sci, Stanford, CA 94305 USA	Weizmann Institute of Science; Stanford University	Halevy, I (corresponding author), Weizmann Inst Sci, Dept Earth & Planetary Sci, Rehovot, Israel.	itay.halevy@weizmann.ac.il	HALEVY, ITAY/K-1364-2012; Halevy, Itay/W-9850-2019	HALEVY, ITAY/0000-0002-7325-8139; Halevy, Itay/0000-0002-7325-8139	European Research Council [337183]	European Research Council(European Research Council (ERC)European Commission)	I.H. acknowledges funding from the European Research Council Starting Grant 337183. I.H. conceived the research, developed, and analyzed the model, and wrote the paper. A.B. contributed to the discussion and writing.	Alt JC, 2003, CR GEOSCI, V335, P853, DOI 10.1016/j.crte.2003.02.001; [Anonymous], 2004, COMPILATION RATE PAR; Berg J. M., 2015, BIOCHEMISTRY; Blattler CL, 2017, NAT GEOSCI, V10, P41, DOI [10.1038/ngeo2844, 10.1038/NGEO2844]; Coogan LA, 2015, EARTH PLANET SC LETT, V415, P38, DOI 10.1016/j.epsl.2015.01.027; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; GROTZINGER JP, 1993, J GEOL, V101, P235, DOI 10.1086/648218; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; Holland HD., 1984, CHEM EVOLUTION ATMOS; Jaffres JBD, 2007, EARTH-SCI REV, V83, P83, DOI 10.1016/j.earscirev.2007.04.002; KEMPE S, 1985, CHEM GEOL, V53, P95, DOI 10.1016/0009-2541(85)90023-3; Kharecha P, 2005, GEOBIOLOGY, V3, P53, DOI 10.1111/j.1472-4669.2005.00049.x; Kirschvink JL, 2000, P NATL ACAD SCI USA, V97, P1400, DOI 10.1073/pnas.97.4.1400; Lowell RP, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016536; Lyons TW, 2014, NATURE, V506, P307, DOI 10.1038/nature13068; MACLEOD G, 1994, ORIGINS LIFE EVOL B, V24, P19, DOI 10.1007/BF01582037; NOACK Y, 1989, J SEDIMENT PETROL, V59, P717; Pagani M, 2005, GEOCHIM COSMOCHIM AC, V69, P953, DOI 10.1016/j.gca.2004.07.029; Planavsky NJ, 2012, P NATL ACAD SCI USA, V109, P18300, DOI 10.1073/pnas.1120387109; Raven J., 2005, 1205 ROYAL SOC; Takeno N., 2005, 419 RES CTR DEEP GEO; Tosca NJ, 2011, EARTH PLANET SC LETT, V306, P11, DOI 10.1016/j.epsl.2011.03.041; Ueno Y, 2006, NATURE, V440, P516, DOI 10.1038/nature04584; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; WALKER JCG, 1983, NATURE, V302, P518, DOI 10.1038/302518a0; Zeebe RE, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001663; Zeebe RE, 2001, PALAEOGEOGR PALAEOCL, V170, P49, DOI 10.1016/S0031-0182(01)00226-7	29	160	161	13	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI		1069	1071		10.1126/science.aal4151	http://dx.doi.org/10.1126/science.aal4151			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9VY	28280204				2022-12-28	WOS:000396348900043
J	Lau, MS; Schwartz, MG; Kundu, S; Savol, AJ; Wang, PI; Marr, SK; Grau, DJ; Schorderet, P; Sadreyev, RI; Tabin, CJ; Kingston, RE				Lau, Mei Sheng; Schwartz, Matthew G.; Kundu, Sharmistha; Savol, Andrej J.; Wang, Peggy I.; Marr, Sharon K.; Grau, Daniel J.; Schorderet, Patrick; Sadreyev, Ruslan I.; Tabin, Clifford J.; Kingston, Robert E.			Mutation of a nucleosome compaction region disrupts Polycomb-mediated axial patterning	SCIENCE			English	Article							GROUP PROTEINS; CHROMATIN; COMPLEX; PRC1; MICE; REPRESSOR	Nucleosomes play important structural and regulatory roles by tightly wrapping the DNA that constitutes the metazoan genome. The Polycomb group (PcG) proteins modulate nucleosomes to maintain repression of key developmental genes, including Hox genes whose temporal and spatial expression is tightly regulated to guide patterning of the anterior-posterior body axis. CBX2, a component of the mammalian Polycomb repressive complex 1 (PRC1), contains a compaction region that has the biochemically defined activity of bridging adjacent nucleosomes. Here, we demonstrate that a functional compaction region is necessary for proper body patterning, because mutating this region leads to homeotic transformations similar to those observed with PcG loss-of-function mutations. We propose that CBX2-driven nucleosome compaction is a key mechanism by which PcG proteins maintain gene silencing during mouse development.	[Lau, Mei Sheng; Kundu, Sharmistha; Savol, Andrej J.; Wang, Peggy I.; Marr, Sharon K.; Grau, Daniel J.; Schorderet, Patrick; Sadreyev, Ruslan I.; Kingston, Robert E.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Lau, Mei Sheng; Schwartz, Matthew G.; Savol, Andrej J.; Wang, Peggy I.; Tabin, Clifford J.; Kingston, Robert E.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Sadreyev, Ruslan I.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Sadreyev, Ruslan I.] Harvard Med Sch, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Kingston, RE (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Kingston, RE (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.	kingston@molbio.mgh.harvard.edu		Marr, Sharon/0000-0001-6958-5949; Lau, Mei Sheng/0000-0002-7867-9426; Schwartz, Matthew/0000-0001-9549-9868	Agency of Science, Research and Technology, Singapore; NIH [GM043901, HD032443, P30DK040561]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032443, R01HD032443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043901] Funding Source: NIH RePORTER	Agency of Science, Research and Technology, Singapore; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Press and S. Miller for guidance on mouse work; R. Mostoslavsky, J. Lee, and the R.E.K. laboratory for discussions; G. Zhou and L. Wu for advice on generating mutant mice; and J. Cochrane, S. Miller, and I. Tchasovnikarova for critical reading of the manuscript. This work was supported by the Agency of Science, Research and Technology, Singapore (M.S.L.), NIH (GM043901 to R.E.K., HD032443 to C.J.T., and P30DK040561 to R. I. S.). ChIP-seq and RNA-seq data sets are available under Gene Expression Omnibus (GEO) accession numbers GSE86085 and GSE89929. M.S.L. and R.E.K. designed the project. M.G.S. performed skeletal analyses; S. K. performed ChIP for qPCR and ChIP-seq from wild-type mESCs; S.K.M. performed mouse genotyping; D.J.G. performed chromatin remodeling assays; and M.S.L. conducted all other experiments. P.S. advised on mouse work. A. J. S., P. I. W., and R. I. S. performed bioinformatics analyses. M.S.L., M. G. S., P. S., C.J.T., and R.E.K. wrote the manuscript.	Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Core N, 1997, DEVELOPMENT, V124, P721; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Gil J, 2014, TRENDS CELL BIOL, V24, P632, DOI 10.1016/j.tcb.2014.06.005; Grau DJ, 2011, GENE DEV, V25, P2210, DOI 10.1101/gad.17288211; Illingworth RS, 2015, GENE DEV, V29, P1897, DOI 10.1101/gad.268151.115; Isono K, 2013, DEV CELL, V26, P565, DOI 10.1016/j.devcel.2013.08.016; Katoh-Fukui Y, 1998, NATURE, V393, P688, DOI 10.1038/31482; King IFG, 2005, MOL CELL BIOL, V25, P6578, DOI 10.1128/MCB.25.15.6578-6591.2005; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Pengelly AR, 2015, GENE DEV, V29, P1487, DOI 10.1101/gad.265439.115; Pengelly AR, 2013, SCIENCE, V339, P698, DOI 10.1126/science.1231382; Schoorlemmer J, 1997, EMBO J, V16, P5930, DOI 10.1093/emboj/16.19.5930; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Wani AH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10291	17	84	84	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI					10.1126/science.aah5403	http://dx.doi.org/10.1126/science.aah5403			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9VY	28280206	Green Accepted			2022-12-28	WOS:000396348900046
J	Liberal, I; Mahmoud, AM; Li, Y; Edwards, B; Engheta, N				Liberal, Inigo; Mahmoud, Ahmed M.; Li, Yue; Edwards, Brian; Engheta, Nader			Photonic doping of epsilon-near-zero media	SCIENCE			English	Article							INDIUM TIN OXIDE	Doping a semiconductor with foreign atoms enables the control of its electrical and optical properties. We transplant the concept of doping to macroscopic photonics, demonstrating that two-dimensional dielectric particles immersed in a two-dimensional epsilon-near-zero medium act as dopants that modify the medium's effective permeability while keeping its effective permittivity near zero, independently of their positions within the host. The response of a large body can be tuned with a single impurity, including cases such as engineering perfect magnetic conductor and epsilon-and-mu-near-zero media with nonmagnetic constituents. This effect is experimentally demonstrated at microwave frequencies via the observation of geometry-independent tunneling. This methodology might provide a new pathway for engineering electromagnetic metamaterials and reconfigurable optical systems.	[Liberal, Inigo; Mahmoud, Ahmed M.; Li, Yue; Edwards, Brian; Engheta, Nader] Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA; [Mahmoud, Ahmed M.] Amer Univ Cairo, Dept Phys, Cairo, Egypt; [Li, Yue] Tsinghua Univ, Dept Elect Engn, Beijing 100084, Peoples R China	University of Pennsylvania; Egyptian Knowledge Bank (EKB); American University Cairo; Tsinghua University	Engheta, N (corresponding author), Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA.	engheta@ee.upenn.edu	Li, Yue/B-7669-2016	Li, Yue/0000-0001-9562-3136; Liberal, Inigo/0000-0003-2620-6392; Engheta, Nader/0000-0003-3219-9520; Edwards, Brian/0000-0001-9354-125X; Mahmoud, Ahmed/0000-0002-5784-9502	Vannevar Bush Faculty Fellowship program; Basic Research Office of the Assistant Secretary of Defense for Research and Engineering; Office of Naval Research [N00014-16-1-2029]; U.S. Air Force Office of Scientific Research Multidisciplinary University Research Initiative [FA9550-12-1-0488, FA9550-14-1-0389]; National Natural Science Foundation of China [61301001]	Vannevar Bush Faculty Fellowship program; Basic Research Office of the Assistant Secretary of Defense for Research and Engineering; Office of Naval Research(Office of Naval Research); U.S. Air Force Office of Scientific Research Multidisciplinary University Research Initiative; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We acknowledge partial support from the Vannevar Bush Faculty Fellowship program, sponsored by the Basic Research Office of the Assistant Secretary of Defense for Research and Engineering and funded by the Office of Naval Research through grant N00014-16-1-2029, and partial support from the U.S. Air Force Office of Scientific Research Multidisciplinary University Research Initiative Awards FA9550-12-1-0488 and FA9550-14-1-0389. Y.L. acknowledges partial support from the National Natural Science Foundation of China under grant 61301001. All data used to obtain our conclusions are present in the main paper and/or the supplementary materials. Additional data related to this paper may be requested from N.E.	Alam MZ, 2016, SCIENCE, V352, P795, DOI 10.1126/science.aae0330; Alu A, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.075153; Capretti A, 2015, OPT LETT, V40, P1500, DOI 10.1364/OL.40.001500; Caspani L, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.233901; Edwards B, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.033903; Eleftheriades GV, 2005, NEGATIVE-REFRACTION METAMATERIALS: FUNDAMENTAL PRINCIPLES AND APPLICATIONS, P1, DOI 10.1002/0471744751; Engheta N., 2006, METAMATERIALS PHYS E, DOI 10.1002/0471784192.; Enoch S, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.213902; Erwin SC, 2005, NATURE, V436, P91, DOI 10.1038/nature03832; Giovampaola C. D., 2016, PHYS REV B, V93; Ikonen P., 2007, METAMATERIALS, V1, P89, DOI DOI 10.1016/J.METMAT.2007.09.003; Liberal I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10989; Liberal I, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600987; Mahmoud AM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6638; Monticone F, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.213903; Sedra A. S., 1998, MICROELECTRONIC CIRC; Sievenpiper D, 1999, IEEE T MICROW THEORY, V47, P2059, DOI 10.1109/22.798001; Sihvola A., 1999, ELECTROMAGNETIC WAVE; Silveirinha M, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.075119; Silveirinha M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.157403; Silveirinha MG, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.245109; Silveirinha MG, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.023813; Sokhoyan R, 2013, OPT EXPRESS, V21, P32279, DOI 10.1364/OE.21.032279; Sze S. M., 2006, PHYS SEMICONDUCTOR D; Nguyen VC, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.233908; Wu Y, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.085111; Wurfel P., 2016, PHYS SOLAR CELLS BAS; Ziolkowski RW, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.046608	28	158	161	18	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI					10.1126/science.aal2672	http://dx.doi.org/10.1126/science.aal2672			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9VY	28280202				2022-12-28	WOS:000396348900040
J	Kroschwald, S; Alberti, S				Kroschwald, Sonja; Alberti, Simon			Gel or Die: Phase Separation as a Survival Strategy	CELL			English	Editorial Material							PROTEINS	Stress conditions trigger protein assembly by demixing from the cytoplasm, but the biological significance is still unclear. In this issue of Cell, Riback et al. report that the yeast poly(A)-binding protein 1 (Pab1) is a phase-separating stress sensor that boosts organismal fitness under physiological stress conditions.	[Kroschwald, Sonja; Alberti, Simon] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Alberti, S (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	alberti@mpi-cbg.de	Alberti, Simon/ABB-8277-2021; Alberti, Simon/B-2822-2017	Alberti, Simon/0000-0003-4017-6505				Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; EDELSTEIN SJ, 1980, BIOPHYS J, V32, P347, DOI 10.1016/S0006-3495(80)84961-7; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Kessler SH, 1998, MOL CELL BIOL, V18, P51, DOI 10.1128/MCB.18.1.51; Munder MC, 2016, ELIFE, V5, DOI 10.7554/eLife.09347; Petrovska I, 2014, ELIFE, V3, DOI 10.7554/eLife.02409; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Riback JA, 2017, CELL, V168, P1028, DOI 10.1016/j.cell.2017.02.027; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006	9	32	32	3	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2017	168	6					947	948		10.1016/j.cell.2017.02.029	http://dx.doi.org/10.1016/j.cell.2017.02.029			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8ZF	28283065	Bronze			2022-12-28	WOS:000396287900001
J	Parikh, RB; Milstein, A; Jain, SH				Parikh, Ravi B.; Milstein, Arnold; Jain, Sachin H.			Getting Real about Health Care Costs - A Broader Approach to Cost Stewardship in Medical Education	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Parikh, Ravi B.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Milstein, Arnold; Jain, Sachin H.] Stanford Univ, Stanford, CA 94305 USA; [Jain, Sachin H.] CareMore Hlth Syst, Cerritos, CA USA	Harvard University; Brigham & Women's Hospital; Stanford University	Parikh, RB (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.							Association of American Medical Colleges, NUMB MED SCH INCL TO; DiGioia Anthony M, 2016, AMA J Ethics, V18, P33, DOI 10.1001/journalofethics.2016.18.1.medu2-1601; Moriates C, 2015, ACAD MED, V90, P421, DOI 10.1097/ACM.0000000000000545; Riegelman R, 2006, ACAD MED, V81, P391, DOI 10.1097/00001888-200604000-00014; Stammen LA, 2015, JAMA-J AM MED ASSOC, V314, P2384, DOI 10.1001/jama.2015.16353	5	7	7	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2017	376	10					913	915		10.1056/NEJMp1612517	http://dx.doi.org/10.1056/NEJMp1612517			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9JA	28273018				2022-12-28	WOS:000395626500004
J	Khera, AV; Won, HH; Peloso, GM; O'Dushlaine, C; Liu, D; Stitziel, NO; Natarajan, P; Nomura, A; Emdin, CA; Gupta, N; Borecki, IB; Asselta, R; Duga, S; Merlini, PA; Correa, A; Kessler, T; Wilson, JG; Bown, MJ; Hall, AS; Braund, PS; Carey, DJ; Murray, MF; Kirchner, HL; Leader, JB; Lavage, DR; Manus, JN; Hartzel, DN; Samani, NJ; Schunkert, H; Marrugat, J; Elosua, R; McPherson, R; Farrall, M; Watkins, H; Lander, ES; Rader, DJ; Danesh, J; Ardissino, D; Gabriel, S; Willer, C; Abecasis, GR; Saleheen, D; Dewey, FE; Kathiresan, S				Khera, Amit V.; Won, Hong-Hee; Peloso, Gina M.; O'Dushlaine, Colm; Liu, Dajiang; Stitziel, Nathan O.; Natarajan, Pradeep; Nomura, Akihiro; Emdin, Connor A.; Gupta, Namrata; Borecki, Ingrid B.; Asselta, Rosanna; Duga, Stefano; Merlini, Piera Angelica; Correa, Adolfo; Kessler, Thorsten; Wilson, James G.; Bown, Matthew J.; Hall, Alistair S.; Braund, Peter S.; Carey, David J.; Murray, Michael F.; Kirchner, H. Lester; Leader, Joseph B.; Lavage, Daniel R.; Manus, J. Neil; Hartzel, Dustin N.; Samani, Nilesh J.; Schunkert, Heribert; Marrugat, Jaume; Elosua, Roberto; McPherson, Ruth; Farrall, Martin; Watkins, Hugh; Lander, Eric S.; Rader, Daniel J.; Danesh, John; Ardissino, Diego; Gabriel, Stacey; Willer, Cristen; Abecasis, Goncalo R.; Saleheen, Danish; Dewey, Frederick E.; Kathiresan, Sekar		Myocardial Infarction Genetics; DiscovEHR Study Grp; CARDIoGRAM Exome Consortium; Global Lipids Genetics Consortium	Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-FUNCTION MUTATIONS; NONFASTING TRIGLYCERIDES; RISK; VARIANTS; CHOLESTEROL; POPULATION; DEFICIENCY; RABBITS; APOC3	IMPORTANCE The activity of lipoprotein lipase (LPL) is the rate-determining step in clearing triglyceride-rich lipoproteins from the circulation. Mutations that damage the LPL gene (LPL) lead to lifelong deficiency in enzymatic activity and can provide insight into the relationship of LPL to human disease. OBJECTIVE To determine whether rare and/or common variants in LPL are associated with early-onset coronary artery disease (CAD). DESIGN, SETTING, AND PARTICIPANTS In a cross-sectional study, LPL was sequenced in 10 CAD case-control cohorts of the multinational Myocardial Infarction Genetics Consortium and a nested CAD case-control cohort of the Geisinger Health System DiscovEHR cohort between 2010 and 2015. Common variants were genotyped in up to 305 699 individuals of the Global Lipids Genetics Consortium and up to 120 600 individuals of the CARDIoGRAM Exome Consortium between 2012 and 2014. Study-specific estimates were pooled via meta-analysis. EXPOSURES Rare damaging mutations in LPL included loss-of-function variants and missense variants annotated as pathogenic in a human genetics database or predicted to be damaging by computer prediction algorithms trained to identify mutations that impair protein function. Common variants in the LPL gene region included those independently associated with circulating triglyceride levels. MAIN OUTCOMES AND MEASURES Circulating lipid levels and CAD. RESULTS Among 46 891 individuals with LPL gene sequencing data available, the mean (SD) age was 50 (12.6) years and 51% were female. A total of 188 participants (0.40%; 95% CI, 0.35%-0.46%) carried a damaging mutation in LPL, including 105 of 32 646 control participants (0.32%) and 83 of 14 245 participants with early-onset CAD (0.58%). Compared with 46 703 noncarriers, the 188 heterozygous carriers of an LPL damaging mutation displayed higher plasma triglyceride levels (19.6mg/dL; 95% CI, 4.6-34.6mg/dL) and higher odds of CAD (odds ratio = 1.84; 95% CI, 1.35-2.51; P < .001). An analysis of 6 common LPL variants resulted in an odds ratio for CAD of 1.51 (95% CI, 1.39-1.64; P = 1.1 x 10(-22)) per 1-SD increase in triglycerides. CONCLUSIONS AND RELEVANCE The presence of rare damaging mutations in LPL was significantly associated with higher triglyceride levels and presence of coronary artery disease. However, further research is needed to assess whether there are causal mechanisms by which heterozygous lipoprotein lipase deficiency could lead to coronary artery disease.	[Khera, Amit V.; Peloso, Gina M.; Natarajan, Pradeep; Nomura, Akihiro; Emdin, Connor A.; Gupta, Namrata; Lander, Eric S.; Gabriel, Stacey; Kathiresan, Sekar] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Khera, Amit V.; Natarajan, Pradeep; Nomura, Akihiro; Emdin, Connor A.; Kathiresan, Sekar] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA USA; [Khera, Amit V.; Natarajan, Pradeep; Nomura, Akihiro; Emdin, Connor A.; Kathiresan, Sekar] Harvard Med Sch, Massachusetts Gen Hosp, Div Cardiol, Boston, MA USA; [Won, Hong-Hee] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Samsung Med Ctr, Seoul, South Korea; [Peloso, Gina M.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [O'Dushlaine, Colm; Borecki, Ingrid B.; Dewey, Frederick E.] Regeneron Genet Ctr, Tarrytown, NY USA; [Liu, Dajiang] Penn State Coll Med, Dept Publ Hlth Sci, Inst Personalized Med, Hershey, PA USA; [Stitziel, Nathan O.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Stitziel, Nathan O.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Stitziel, Nathan O.] Washington Univ, Sch Med, McDonnell Genome Inst, St Louis, MO USA; [Asselta, Rosanna; Duga, Stefano] Humanitas Univ, Dept Biomed Sci, Milan, Italy; [Asselta, Rosanna; Duga, Stefano] Humanitas Clin & Res Ctr, Milan, Italy; [Merlini, Piera Angelica] Osped Niguarda Ca Granda, Milan, Italy; [Correa, Adolfo] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Kessler, Thorsten] Munich Heart Alliance, Munich, Germany; [Kessler, Thorsten; Schunkert, Heribert] Tech Univ Munich, Deutsch Herzzentrum Munchen, Deutsch Zentrum Herz Kreislauf Forsch, Munich, Germany; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Bown, Matthew J.; Braund, Peter S.; Samani, Nilesh J.] Univ Leicester, NIHR Leicester Cardiovasc Biomed Res Unit, Dept Cardiovasc Sci, Leicester, Leics, England; [Hall, Alistair S.] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, England; [Carey, David J.; Murray, Michael F.; Kirchner, H. Lester; Leader, Joseph B.; Lavage, Daniel R.; Manus, J. Neil; Hartzel, Dustin N.] Geisinger Hlth Syst, Danville, PA USA; [Marrugat, Jaume; Elosua, Roberto] Hosp Mar, Cardiovasc Epidemiol & Genet, Res Inst, Barcelona, Spain; [McPherson, Ruth] Univ Ottawa, Inst, Ottawa, ON, Canada; [Farrall, Martin; Watkins, Hugh] Univ Oxford, Div Cardiovasc Med, Radcliffe Dept Med, Oxford, England; [Farrall, Martin; Watkins, Hugh] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Rader, Daniel J.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Danesh, John] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England; [Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, NIHR Blood & Transplant Res Unit Donor Hlth & Gen, Cambridge, England; [Danesh, John; Saleheen, Danish] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ardissino, Diego] Azienda Osped Univ Parma, Div Cardiol, Parma, Italy; [Ardissino, Diego] Assoc Studio Trombosi Cardiol, Pavia, Italy; [Willer, Cristen] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Willer, Cristen] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Willer, Cristen] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Abecasis, Goncalo R.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Boston University; Regeneron; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Humanitas University; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Mississippi; University of Mississippi Medical Center; Munich Heart Alliance; German Centre for Cardiovascular Research; German Heart Centre Munich; Technical University of Munich; University of Mississippi; University of Mississippi Medical Center; University of Leicester; University of Leeds; Geisinger Health System; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Ottawa; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Pennsylvania; University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; University of Pennsylvania; Pennsylvania Medicine; University of Parma; University Hospital of Parma; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kathiresan, S (corresponding author), Broad Inst, Program Med & Populat Genet, Cambridge, MA USA.; Kathiresan, S (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA USA.; Kathiresan, S (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Div Cardiol, Boston, MA USA.	skathiresan1@mgh.harvard.edu	Girelli, Domenico/B-1183-2008; Won, Hong-Hee/D-2672-2011; Ardissino, Diego/AAC-4041-2022; Nomura, Akihiro/ABE-2871-2020; Hall, Alistair/K-1953-2019; Kessler, Thorsten/AAI-7292-2021; Stitziel, Nathan/AAL-8413-2021; Asselta, Rosanna/AAC-2367-2019; Kessler, Thorsten/O-7426-2015; Natarajan, Pradeep/H-9764-2019; Duga, Stefano/F-8173-2014; Bown, Matthew/P-1957-2016	Girelli, Domenico/0000-0001-9684-1899; Won, Hong-Hee/0000-0001-5719-0552; Nomura, Akihiro/0000-0001-6647-8240; Kessler, Thorsten/0000-0003-3326-1621; Stitziel, Nathan/0000-0002-4963-8211; Asselta, Rosanna/0000-0001-5351-0619; Natarajan, Pradeep/0000-0001-8402-7435; Duga, Stefano/0000-0003-3457-1410; Liu, Dajiang/0000-0001-6553-858X; Bown, Matthew/0000-0002-6180-3611; ELOSUA, ROBERTO/0000-0001-8235-0095; solinas, emilia/0000-0003-3532-1317; Hall, Alistair/0000-0003-0306-7887; Lavage, Dani/0000-0002-9570-2931; Marrugat, Jaume/0000-0003-3320-554X	ACCF/Merck Cardiovascular Research Fellowship from the American College of Cardiology Foundation; Merck; John S. Ladue Memorial Fellowship at Harvard Medical School; KL2/Catalyst Medical Research Investigator Training award from Harvard Catalyst - National Institutes of Health [TR001100]; National Research Foundation of Korea - Ministry of Science, ICT and Future Planning [2016R1C1B2007920]; National Heart, Lung, and Blood Institute [K01HL125751, HL109946, HL127564, R01 HL127564, HHSN268201300046C, HHSN268201300047C, HHSN268201300048C, HHSN268201300049C, HHSN268201300050C, RC2 HL103010, RC2 HL102923, RC2 HL102924, RC2 HL102925, RC2 HL102926]; National Institutes of Health [K08 HL114642, R01 HL131961, 5U54HG003067]; Regeneron Genetics Center; Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Canada Foundation for Innovation; core award [090532/Z/09/Z]; Institutional Strategic Support Fund from the Wellcome Trust; British Heart Foundation Centre of Research Excellence [RE/13/1/30181]; UK Medical Research Council; British Heart Foundation; UK National Institute for Health Research; European Commission Framework Programme; Massachusetts General Hospital; Donovan Family Foundation; Wellcome Trust; EU Framework 6; Pfizer; Novartis; UK Medical Research Council [MR/L003120/1]; British Heart Foundation [RG/13/13/30194]; UK National Institute for Health Research Cambridge Biomedical Research Centre; European Research Council [268834]; European Commission Framework Programme 7 [HEALTH-F2-2012-279233]; National Institute on Minority Health and Health Disparities; Spanish Ministry of Economy and Innovation through the Carlos III Health Institute [Red Investigacion Cardiovascular RD12/0042, PI09/90506]; European Funds for Development (ERDF-FEDER); Catalan Research and Technology Innovation Interdepartmental Commission [2014SGR240]; British Heart Foundation (British Heart Foundation Family Heart Study) [RG2000010]; UK Aneurysm Growth Study [CS/14/2/30841]; National Institute for Health Research (NIHR Leicester Cardiovascular Biomedical Research Unit Biomedical Research Informatics Centre for Cardiovascular Science) [IS_BRU_0211_20033]; German Federal Ministry of Education and Research; FP7 European Union project CVgenes@target [261123]; Fondation Leducq (CADgenomics: Understanding Coronary Artery Disease Genes) [12CVD02]; Deutsche Forschungsgemeinschaft [SFB 1123]; Italian Ministry of Health [RFPS-2007-3-644382]; Programma di ricerca Regione-Universita Strategic Programmes from the Regione Emilia-Romagna; MRC [MR/L003120/1, MR/L01629X/1] Funding Source: UKRI; British Heart Foundation [CS/14/2/30841, RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/L01629X/1, MR/L003120/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001100] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131961, K08HL114642, R01HL127564, R01HL109946, R35HL135824, K01HL125751, RC2HL102925, RC2HL103010, RC2HL102924, RC2HL102926, RC2HL102923] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	ACCF/Merck Cardiovascular Research Fellowship from the American College of Cardiology Foundation; Merck(Merck & Company); John S. Ladue Memorial Fellowship at Harvard Medical School; KL2/Catalyst Medical Research Investigator Training award from Harvard Catalyst - National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea - Ministry of Science, ICT and Future Planning; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Regeneron Genetics Center(Regeneron); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); core award; Institutional Strategic Support Fund from the Wellcome Trust; British Heart Foundation Centre of Research Excellence(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); UK National Institute for Health Research(National Institute for Health Research (NIHR)); European Commission Framework Programme(European Commission); Massachusetts General Hospital(General Electric); Donovan Family Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); EU Framework 6; Pfizer(Pfizer); Novartis(Novartis); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); UK National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); European Research Council(European Research Council (ERC)European Commission); European Commission Framework Programme 7; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Spanish Ministry of Economy and Innovation through the Carlos III Health Institute; European Funds for Development (ERDF-FEDER); Catalan Research and Technology Innovation Interdepartmental Commission; British Heart Foundation (British Heart Foundation Family Heart Study); UK Aneurysm Growth Study; National Institute for Health Research (NIHR Leicester Cardiovascular Biomedical Research Unit Biomedical Research Informatics Centre for Cardiovascular Science); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); FP7 European Union project CVgenes@target; Fondation Leducq (CADgenomics: Understanding Coronary Artery Disease Genes)(Leducq Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Italian Ministry of Health(Ministry of Health, Italy); Programma di ricerca Regione-Universita Strategic Programmes from the Regione Emilia-Romagna; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Dr Khera was supported by an ACCF/Merck Cardiovascular Research Fellowship from the American College of Cardiology Foundation and Merck, a John S. Ladue Memorial Fellowship at Harvard Medical School, and KL2/Catalyst Medical Research Investigator Training award TR001100 from Harvard Catalyst funded by the National Institutes of Health. DrWon was supported by grant 2016R1C1B2007920 from the National Research Foundation of Korea funded by the Ministry of Science, ICT and Future Planning. Dr Peloso was supported by grant K01HL125751 from the National Heart, Lung, and Blood Institute. Dr Stitziel was supported by grants K08 HL114642 and R01 HL131961 from the National Institutes of Health. Drs Carey, Murray, and Kirchner and Messrs Leader, Lavage, Manus, and Hartzel were supported by the Regeneron Genetics Center. Dr McPherson was supported by grants from the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Canada, and the Canada Foundation for Innovation. Dr Farrall was supported by core award 090532/Z/09/Z and the Institutional Strategic Support Fund from the Wellcome Trust and grant RE/13/1/30181 from the British Heart Foundation Centre of Research Excellence. Dr Lander was supported by grant 5U54HG003067 from the National Institutes of Health. Dr Danesh was supported by grants from the UK Medical Research Council, the British Heart Foundation, the UK National Institute for Health Research, and the European Commission Framework Programme. Dr Willer was supported by grants HL109946 and HL127564 from the National Heart, Lung, and Blood Institute. Dr Abecasis was supported by a grant from the National Institutes of Health. Dr Kathiresan was supported by a research scholar award from the Massachusetts General Hospital, the Donovan Family Foundation, and grant R01 HL127564 from the National Heart, Lung, and Blood Institute. Field work, genotyping, and standard clinical chemistry assays in the Pakistan Risk of Myocardial Infarction Study (PROMIS) were principally supported by grants awarded to the University of Cambridge from the British Heart Foundation, UK Medical Research Council, Wellcome Trust, EU Framework 6-funded Bloodomics Integrated Project, Pfizer, Novartis, and Merck. Additional support for PROMIS was provided by the UK Medical Research Council (MR/L003120/1), British Heart Foundation (RG/13/13/30194), UK National Institute for Health Research Cambridge Biomedical Research Centre, European Research Council (268834), and European Commission Framework Programme 7 (HEALTH-F2-2012-279233). The Jackson Heart Study was supported by contracts HHSN268201300046C, HHSN268201300047C, HHSN268201300048C, HHSN268201300049C, and HHSN268201300050C from the National Heart, Lung, and Blood Institute and the National Institute on Minority Health and Health Disparities. The Registre Gironi del COR (Gerona Heart Registry; REGICOR) study was supported by the Spanish Ministry of Economy and Innovation through the Carlos III Health Institute (Red Investigacion Cardiovascular RD12/0042, PI09/90506), by the European Funds for Development (ERDF-FEDER), and by the Catalan Research and Technology Innovation Interdepartmental Commission (2014SGR240).; Samples for the cohort in the Leicester Myocardial Infarction study were collected as part of projects funded by the British Heart Foundation (British Heart Foundation Family Heart Study, RG2000010; UK Aneurysm Growth Study, CS/14/2/30841) and the National Institute for Health Research (NIHR Leicester Cardiovascular Biomedical Research Unit Biomedical Research Informatics Centre for Cardiovascular Science, IS_BRU_0211_20033). The South German Myocardial Infarction study was supported by the German Federal Ministry of Education and Research in the context of the e:Med program (e:AtheroSysMed) and the FP7 European Union project CVgenes@target (261123). Additional grants were received from the Fondation Leducq (CADgenomics: Understanding Coronary Artery Disease Genes, 12CVD02). This study was also supported through the Deutsche Forschungsgemeinschaft cluster of excellence "Inflammation at Interfaces" and SFB 1123. The Atherosclerosis, Thrombosis, and Vascular Biology Italian Study (ATVB) was supported by grant RFPS-2007-3-644382 from the Italian Ministry of Health and by Programma di ricerca Regione-Universita 2010-2012 Area 1 Strategic Programmes from the Regione Emilia-Romagna. Funding for the Exome Sequencing Project Early-Onset Myocardial Infarction study was provided by grants RC2 HL103010 (HeartGO), RC2 HL102923 (LungGO), and RC2 HL102924 (WHISP) from the National Heart, Lung, and Blood Institute. Exome sequencing was performed through grants RC2 HL102925 (BroadGO) and RC2 HL102926 (SeattleGO) from the National Heart, Lung, and Blood Institute. Exome sequencing in ATVB, the Precocious Coronary Artery Disease study (PROCARDIS), the Ottawa Heart Study, PROMIS, South German Myocardial Infarction study, and the Jackson Heart Study was supported by grant 5U54HG003067 from the National Institutes of Health (Drs Lander and Gabriel). The DiscovEHR study was supported in part by the Regeneron Genetics Center.	Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Benn M, 2016, EUR HEART J, V37, P1384, DOI 10.1093/eurheartj/ehw028; Brunzell JD, 2000, METABOLIC MOL BASIS, P2789; Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Dewey FF, 2016, NEW ENGL J MED, V374, P1123, DOI 10.1056/NEJMoa1510926; Do R, 2015, NATURE, V518, P102, DOI 10.1038/nature13917; ECKEL RH, 1989, NEW ENGL J MED, V320, P1060; Jensen MK, 2009, AM HEART J, V157, P384, DOI 10.1016/j.ahj.2008.10.008; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Jorgensen AB, 2013, EUR HEART J, V34, P1826, DOI 10.1093/eurheartj/ehs431; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liu DJJ, 2014, NAT GENET, V46, P200, DOI 10.1038/ng.2852; Liu XM, 2016, HUM MUTAT, V37, P235, DOI 10.1002/humu.22932; Mannucci PM, 2003, CIRCULATION, V107, P1117, DOI 10.1161/01.CIR.0000051465.94572.D0; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; MIESENBOCK G, 1993, J CLIN INVEST, V91, P448, DOI 10.1172/JCI116222; Myocardial IG, 2016, NEW ENGL J MED, V374, P1134, DOI DOI 10.1056/NEJM0A1507652; Nioi P, 2016, NEW ENGL J MED, V374, P2131, DOI 10.1056/NEJMoa1508419; Nordestgaard BG, 1997, CIRCULATION, V96, P1737, DOI 10.1161/01.CIR.96.6.1737; NORDESTGAARD BG, 1995, ARTERIOSCL THROM VAS, V15, P534, DOI 10.1161/01.ATV.15.4.534; NORDESTGAARD BG, 1988, ARTERIOSCLEROSIS, V8, P421, DOI 10.1161/01.ATV.8.4.421; Nordestgaard BG, 2016, CIRC RES, V118, P547, DOI 10.1161/CIRCRESAHA.115.306249; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Saleheen D, 2009, EUR J EPIDEMIOL, V24, P329, DOI 10.1007/s10654-009-9334-y; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Senti M, 2001, ARTERIOSCL THROM VAS, V21, P415, DOI 10.1161/01.ATV.21.3.415; Stitziel NO, 2014, NEW ENGL J MED, V371, P2072, DOI 10.1056/NEJMoa1405386; Taylor HA, 2005, ETHNIC DIS, V15, pS4; Thomsen M, 2014, CLIN CHEM, V60, P737, DOI 10.1373/clinchem.2013.219881; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	37	105	107	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2017	317	9					937	946		10.1001/jama.2017.0972	http://dx.doi.org/10.1001/jama.2017.0972			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM8DM	28267856	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000395541500013
J	Frischkorn, K				Frischkorn, Kyle			Sailing through uncertainty	SCIENCE			English	Editorial Material									[Frischkorn, Kyle] Columbia Univ, New York, NY 10027 USA	Columbia University	Frischkorn, K (corresponding author), Columbia Univ, New York, NY 10027 USA.								0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					986	986		10.1126/science.355.6328.986	http://dx.doi.org/10.1126/science.355.6328.986			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM2YM	28254947				2022-12-28	WOS:000395181700045
J	You, J; Bohannon, J; Stone, R				You, Jia; Bohannon, John; Stone, Richard			THE IMMIGRATION ORDER Raising the drawbridge	SCIENCE			English	News Item																			0	2	2	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					896	896		10.1126/science.355.6328.896	http://dx.doi.org/10.1126/science.355.6328.896			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2YM	28254892				2022-12-28	WOS:000395181700013
J	Geha, R; Peters, M; Gill, RM; Dhaliwal, G				Geha, Rabih; Peters, Marion; Gill, Ryan M.; Dhaliwal, Gurpreet			Histology Rings True	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							Q-FEVER; HEPATIC GRANULOMAS; DIAGNOSIS; DISEASE		[Peters, Marion] Univ Calif San Francisco, Div Gastroenterol, San Francisco, CA 94143 USA; [Geha, Rabih; Peters, Marion; Dhaliwal, Gurpreet] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Gill, Ryan M.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Dhaliwal, Gurpreet] San Francisco VA Med Ctr, Med Serv, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Geha, R (corresponding author), 505 Parnassus Ave,Rm 987, San Francisco, CA 94143 USA.	rabih.geha@ucsf.edu			Philips Healthcare	Philips Healthcare	Dr. Peters reports receiving honoraria from Merck, Roche, Johnson & Johnson, Gilead Sciences, Abbott, and Genentech; Dr. Gill, receiving consulting fees from Philips Healthcare; and Dr. Dhaliwal, receiving honoraria from the ISMIE Mutual Insurance and Physicians' Reciprocal Insurers. No other potential conflict of interest relevant to this article was reported.	Anderson A, 2013, MMWR RECOMM REP, V62, P1; [Anonymous], 2013, Q FEV STAT EP; [Anonymous], 2015, UT COMM DIS ANN REP; Camacho M T, 2005, J Autoimmune Dis, V2, P10, DOI 10.1186/1740-2557-2-10; CLARK WH, 1951, ARCH INTERN MED, V88, P155, DOI 10.1001/archinte.1951.03810080023003; Flamm SL, 2012, CLIN LIVER DIS, V16, P387, DOI 10.1016/j.cld.2012.03.013; Fournier PE, 1998, J CLIN MICROBIOL, V36, P1823, DOI 10.1128/JCM.36.7.1823-1834.1998; Hennes EM, 2008, HEPATOLOGY, V48, P169, DOI 10.1002/hep.22322; Lagana SM, 2010, CLIN LIVER DIS, V14, P605, DOI 10.1016/j.cld.2010.07.005; Lamps LW, 2008, ADV ANAT PATHOL, V15, P309, DOI 10.1097/PAP.0b013e31818a6477; MARAZUELA M, 1991, HUM PATHOL, V22, P607, DOI 10.1016/0046-8177(91)90240-P; Rose NR, 2001, J CLIN INVEST, V107, P943, DOI 10.1172/JCI12673; Tissot-Dupont H, 2004, EMERG INFECT DIS, V10, P1264, DOI 10.3201/eid1007.030724	13	1	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2017	376	9					869	874		10.1056/NEJMcps1609391	http://dx.doi.org/10.1056/NEJMcps1609391			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9JK	28249146				2022-12-28	WOS:000395627500012
J	Grapin-Botton, A; Serup, P				Grapin-Botton, Anne; Serup, Palle			Parsing the Pancreas	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Grapin-Botton, Anne; Serup, Palle] Univ Copenhagen, Danish Stem Cell Ctr DanStem, Fac Hlth & Med Sci, Copenhagen, Denmark	University of Copenhagen	Grapin-Botton, A (corresponding author), Univ Copenhagen, Danish Stem Cell Ctr DanStem, Fac Hlth & Med Sci, Copenhagen, Denmark.		Serup, Palle/A-7407-2011	Serup, Palle/0000-0002-0858-590X; Grapin-Botton, Anne/0000-0002-1202-5235	Novo Nordisk Fonden [NNF14OC0010717] Funding Source: researchfish; Novo Nordisk Foundation Section for Basic Stem Cell Biology [Grapin-Botton Group NNF, Serup Group NNF] Funding Source: researchfish	Novo Nordisk Fonden(Novo Nordisk Foundation); Novo Nordisk Foundation Section for Basic Stem Cell Biology		Baron M, 2016, CELL SYST, V3, P346, DOI 10.1016/j.cels.2016.08.011; Muraro MJ, 2016, CELL SYST, V3, P385, DOI 10.1016/j.cels.2016.09.002; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; Wang YJ, 2016, CELL METAB, V24, P616, DOI 10.1016/j.cmet.2016.09.007; Xin YR, 2016, CELL METAB, V24, P608, DOI 10.1016/j.cmet.2016.08.018	5	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2017	376	9					886	888		10.1056/NEJMcibr1616217	http://dx.doi.org/10.1056/NEJMcibr1616217			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9JK	28249148				2022-12-28	WOS:000395627500016
J	Pitcher, D; Fritz, Z; Wang, M; Spiller, JA				Pitcher, David; Fritz, Zoe; Wang, Madeleine; Spiller, Juliet A.			PRACTICE POINTER Emergency care and resuscitation plans	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIOPULMONARY-RESUSCITATION; DECISION-MAKING; ORDERS; LIFE; END		[Pitcher, David] Resuscitat Council UK, Tavistock House, London WC1H 9HR, England; [Fritz, Zoe] Addenbrookes Hosp, Cambridge Univ Hosp, Dept Acute Med, Cambridge CB2 0QQ, England; [Spiller, Juliet A.] Marie Curie Hosp Edinburgh, Palliat Med, Edinburgh, Midlothian, Scotland	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Pitcher, D (corresponding author), Resuscitat Council UK, Tavistock House, London WC1H 9HR, England.	david.pitcher@resus.org.uk	Spiller, Juliet/GWC-7042-2022	Fritz, Zoe/0000-0001-9403-409X				Beed M, 2015, RESUSCITATION, V86, P31, DOI 10.1016/j.resuscitation.2014.10.002; Caldwell G, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3769; Detering KM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1345; Ebell MH, 2013, JAMA INTERN MED, V173, P1872, DOI 10.1001/jamainternmed.2013.10037; Field RA, 2014, RESUSCITATION, V85, P1418, DOI 10.1016/j.resuscitation.2014.08.024; Fritz Z, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j813; Fritz Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070977; Fritz Z, 2010, J MED ETHICS, V36, P593, DOI 10.1136/jme.2010.035725; Harris D, 2009, RESUSCITATION, V80, P1275, DOI 10.1016/j.resuscitation.2009.07.008; Heslop P., 2013, CONFIDENTIAL INQUIRY; Mockford C, 2015, RESUSCITATION, V88, P99, DOI 10.1016/j.resuscitation.2014.11.016; Mullick A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6064; Musa I, 2015, AGE AGEING, V44, P371, DOI 10.1093/ageing/afv041; National Confidential Enquiry into Patient Outcome and Death (NCEPOD), 2012, TIM TO INT; Perkins GD, 2016, HLTH SERV DELIV RES, V4; Rosenfeld KE, 2000, J GEN INTERN MED, V15, P620, DOI 10.1046/j.1525-1497.2000.06289.x; Seymour J, 2004, SOC SCI MED, V59, P57, DOI 10.1016/j.socscimed.2003.10.005	17	16	16	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 28	2017	356								j876	10.1136/bmj.j876	http://dx.doi.org/10.1136/bmj.j876			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JQ	28246080	hybrid, Green Published			2022-12-28	WOS:000395628100017
J	Liao, JM; Stack, CB; Griswold, ME; Localio, AR				Liao, Joshua M.; Stack, Catharine B.; Griswold, Michael E.; Localio, A. Russell			Annals Understanding Clinical Research: Intention-to-Treat Analysis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TRIALS		Univ Penn, Philadelphia, PA 19104 USA; [Stack, Catharine B.] Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA; Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Liao, Joshua M.] Univ Penn, Dept Med, 3400 Spruce St, Philadelphia, PA 19104 USA; [Griswold, Michael E.] Univ Mississippi, Dept Data Sci, Med Ctr, New Guyton Suite G651,2500 North State St, Jackson, MS 39216 USA; [Localio, A. Russell] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, 635 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA	University of Pennsylvania; American College of Physicians; University of Mississippi; University of Mississippi Medical Center; University of Pennsylvania; University of Mississippi; University of Mississippi Medical Center; University of Pennsylvania	Liao, JM (corresponding author), Univ Penn, Dept Med, 3400 Spruce St, Philadelphia, PA 19104 USA.	joshliao@mail.med.upenn.edu						Delitto A, 2015, ANN INTERN MED, V162, P465, DOI 10.7326/M14-1420; Dunn G, 2003, BRIT J PSYCHIAT, V183, P323, DOI 10.1192/bjp.183.4.323; Gravel J, 2007, CLIN TRIALS, V4, P350, DOI 10.1177/1740774507081223; Hernan MA, 2013, ANN INTERN MED, V159, P560, DOI 10.7326/0003-4819-159-8-201310150-00709; Hernan MA, 2012, CLIN TRIALS, V9, P48, DOI 10.1177/1740774511420743; Liao JM, 2017, ANN INTERN MED, V166, P596, DOI 10.7326/M17-0195; Little RJ, 2000, ANNU REV PUBL HEALTH, V21, P121, DOI 10.1146/annurev.publhealth.21.1.121; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Skrondal A, 2004, GEN LATENT VARIABLE, P427; Toh S., 2008, INT J BIOSTAT, DOI [10.2202/1557-4679.1117, DOI 10.2202/1557-4679.1117]	10	7	8	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 2	2017	166	9					662	+		10.7326/M17-0196	http://dx.doi.org/10.7326/M17-0196			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6IR	28288485				2022-12-28	WOS:000400395500011
J	Woolhandler, S; Himmelstein, DU				Woolhandler, Steffie; Himmelstein, David U.			Single-Payer Reform: The Only Way to Fulfill the President's Pledge of More Coverage, Better Benefits, and Lower Costs	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							UNITED-STATES; CANADA; CARE		[Woolhandler, Steffie; Himmelstein, David U.] CUNY Hunter Coll, New York, NY 10021 USA; [Woolhandler, Steffie; Himmelstein, David U.] 255 West 90th St, New York, NY 10024 USA	City University of New York (CUNY) System; Hunter College (CUNY)	Woolhandler, S (corresponding author), 255 West 90th St, New York, NY 10024 USA.	swoolhan@hunter.cuny.edu						[Anonymous], 2016, BETTER WAY OUR VISIO; Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; ENTERLINE PE, 1973, NEW ENGL J MED, V289, P1174, DOI 10.1056/NEJM197311292892206; Himmelstein DU, 2014, HEALTH AFFAIR, V33, P1586, DOI 10.1377/hlthaff.2013.1327; Newport F, 2016, MAJORITY US SUPPORT; Physicians for a National Health Program, 2016, MUCH WOULD SINGL PAY; Pozen A, 2010, INQUIRY-J HEALTH CAR, V47, P124, DOI 10.5034/inquiryjrnl_47.02.124; The Boards of Trustees Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds, 2016, 2016 ANN REP BOARDS; Wilder CS, 1968, VITAL HLTH STAT, V10, p[10, 1]; Woolhandler S, 2003, NEW ENGL J MED, V349, P768, DOI 10.1056/NEJMsa022033	10	18	18	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 18	2017	166	8					587	+		10.7326/M17-0302	http://dx.doi.org/10.7326/M17-0302			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ES1RF	28241256				2022-12-28	WOS:000399304000019
J	Chughtai, M; Khlopas, A; Mont, MA				Chughtai, Morad; Khlopas, Anton; Mont, Michael A.			Fixation methods in the management of hip fractures	LANCET			English	Editorial Material							FEMORAL-NECK		[Chughtai, Morad; Khlopas, Anton; Mont, Michael A.] Cleveland Clin, Dept Orthopaed Surg, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Mont, MA (corresponding author), Cleveland Clin, Dept Orthopaed Surg, Cleveland, OH 44195 USA.	montm@ccf.org	Khlopas, Anton/U-4587-2019					[Anonymous], 2017, LANCET; Beck M, 2004, CLIN ORTHOP RELAT R, P149, DOI 10.1097/01.blo.0000128296.28666.35; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; Elmallah RK, 2017, J ARTHROPLASTY, V32, P351, DOI 10.1016/j.arth.2016.08.006; Hoshino CM, 2015, INJURY, V46, P474, DOI 10.1016/j.injury.2014.12.008; Johnell O, 2004, OSTEOPOROSIS INT, V15, P897, DOI 10.1007/s00198-004-1627-0; Mistry JB, 2016, J ARTHROPLASTY, V31, P2422, DOI 10.1016/j.arth.2016.03.060; Panteli M, 2015, INJURY, V46, P445, DOI 10.1016/j.injury.2014.12.031; Parker MJ., 2001, COCHRANE DB SYST REV, V4, P1467; STROMQVIST B, 1988, J BONE JOINT SURG BR, V70, P192, DOI 10.1302/0301-620X.70B2.3346286	10	2	3	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 15	2017	389	10078					1493	1494		10.1016/S0140-6736(17)30551-2	http://dx.doi.org/10.1016/S0140-6736(17)30551-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ER7OP	28262270				2022-12-28	WOS:000399002900004
J	Beagrie, RA; Scialdone, A; Schueler, M; Kraemer, DCA; Chotalia, M; Xie, SQ; Barbieri, M; de Santiago, I; Lavitas, LM; Branco, MR; Fraser, J; Dostie, J; Game, L; Dillon, N; Edwards, PAW; Nicodemi, M; Pombo, A				Beagrie, Robert A.; Scialdone, Antonio; Schueler, Markus; Kraemer, Dorothee C. A.; Chotalia, Mita; Xie, Sheila Q.; Barbieri, Mariano; de Santiago, Ines; Lavitas, Liron-Mark; Branco, Miguel R.; Fraser, James; Dostie, Josee; Game, Laurence; Dillon, Niall; Edwards, Paul A. W.; Nicodemi, Mario; Pombo, Ana			Complex multi-enhancer contacts captured by genome architecture mapping	NATURE			English	Article							RNA-POLYMERASE-II; CHROMOSOME CONFORMATION CAPTURE; EMBRYONIC STEM-CELLS; HI-C DATA; ORGANIZATION; TRANSCRIPTION; GENES; REVEALS; DOMAINS; PRINCIPLES	The organization of the genome in the nucleus and the interactions of genes with their regulatory elements are key features of transcriptional control and their disruption can cause disease. Here we report a genome-wide method, genome architecture mapping (GAM), for measuring chromatin contacts and other features of three-dimensional chromatin topology on the basis of sequencing DNA from a large collection of thin nuclear sections. We apply GAM to mouse embryonic stem cells and identify enrichment for specific interactions between active genes and enhancers across very large genomic distances using a mathematical model termed SLICE (statistical inference of co-segregation). GAM also reveals an abundance of three-way contacts across the genome, especially between regions that are highly transcribed or contain super-enhancers, providing a level of insight into genome architecture that, owing to the technical limitations of current technologies, has previously remained unattainable. Furthermore, GAM highlights a role for gene-expressionspecific contacts in organizing the genome in mammalian nuclei.	[Beagrie, Robert A.; Schueler, Markus; Kraemer, Dorothee C. A.; Barbieri, Mariano; Lavitas, Liron-Mark; Pombo, Ana] Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, Epigenet Regulat & Chromatin Architecture Grp, Robert Rossle St, D-13125 Berlin, Germany; [Beagrie, Robert A.; Chotalia, Mita; Xie, Sheila Q.; de Santiago, Ines; Lavitas, Liron-Mark; Branco, Miguel R.; Pombo, Ana] Imperial Coll London, MRC London Inst Med Sci, Genome Funct Grp, Hammersmith Hosp Campus, London W12 0NN, England; [Beagrie, Robert A.] Imperial Coll London, MRC London Inst Med Sci, Gene Regulat & Chromatin Grp, Hammersmith Hosp Campus, London W12 0NN, England; [Scialdone, Antonio; Nicodemi, Mario] Univ Napoli Fed II INFN Napoli, Complesso Univ Monte, Dipartimento Fis, I-80126 Naples, Italy; [Pombo, Ana] BIH, D-10117 Berlin, Germany; [Fraser, James; Dostie, Josee] McGill Univ, Goodman Canc Res Ctr, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Game, Laurence] Imperial Coll London, MRC London Inst Med Sci, Genom Lab, Hammersmith Hosp Campus, London W12 0NN, England; [Edwards, Paul A. W.] Univ Cambridge, Hutchison MRC Res Ctr, Dept Pathol, Cambridge CB2 0XZ, England; [Pombo, Ana] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Scialdone, Antonio] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England; [Xie, Sheila Q.] Imperial Coll London, MRC London Inst Med Sci, Single Mol Imaging Grp, Hammersmith Hosp Campus, London W12 0NN, England; [de Santiago, Ines] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr,Robinson Way, Cambridge CB2 1TN, England; [Branco, Miguel R.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London E1 2AT, England	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Imperial College London; Imperial College London; Berlin Institute of Health; McGill University; Imperial College London; University of Cambridge; Humboldt University of Berlin; Wellcome Trust Sanger Institute; Imperial College London; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of London; Queen Mary University London	Pombo, A (corresponding author), Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, Epigenet Regulat & Chromatin Architecture Grp, Robert Rossle St, D-13125 Berlin, Germany.; Pombo, A (corresponding author), Imperial Coll London, MRC London Inst Med Sci, Genome Funct Grp, Hammersmith Hosp Campus, London W12 0NN, England.; Nicodemi, M (corresponding author), Univ Napoli Fed II INFN Napoli, Complesso Univ Monte, Dipartimento Fis, I-80126 Naples, Italy.; Pombo, A (corresponding author), BIH, D-10117 Berlin, Germany.; Pombo, A (corresponding author), Humboldt Univ, Inst Biol, D-10115 Berlin, Germany.	mario.nicodemi@na.infn.it; ana.pombo@mdc-berlin.de	de Santiago, Ines/AAP-5859-2020; Branco, Miguel/H-9509-2019; Pombo, Ana/A-1045-2010; Edwards, Paul A/M-8291-2014; Nicodemi, Mario/K-1815-2015	de Santiago, Ines/0000-0002-8172-1322; Branco, Miguel/0000-0001-9447-1548; Pombo, Ana/0000-0002-7493-6288; Edwards, Paul A/0000-0002-4789-3374; Beagrie, Robert/0000-0003-1076-5595; Scialdone, Antonio/0000-0002-4956-2843; Nicodemi, Mario/0000-0002-8416-6416	Medical Research Council, UK; Helmholtz Foundation; MRC-Technology; Berlin Institute of Health (BIH); Breast Cancer Campaign; Cancer Research UK; Canadian Institutes of Health Research (CIHR) [MOP-86716, CAP-120350]; CINECA ISCRA [HP10CYFPS5, HP10CRTY8P]; MRC [MC_U120036884, MC_U120061476] Funding Source: UKRI; Medical Research Council [MC_U120036884, MC_U120061476, 1116071] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Helmholtz Foundation(Helmholtz Association); MRC-Technology; Berlin Institute of Health (BIH); Breast Cancer Campaign; Cancer Research UK(Cancer Research UK); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CINECA ISCRA(CINECA, Italy); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Walter for critically reading the manuscript; C. Ferrai and E. Brookes for preparing mES cells; S. Robin, M.-F. Sagot and K. N. Natarajan for initial contributions to the statistical and bioinformatic analyses of GAM; T. Baslan and J. Hicks for suggestions on sequencing strategy; J. Pang from Illumina for help with HiSeq recipes; O. Clarke from Zeiss Microdissection Systems for advice on microdissection; K. Semrau from MYcroarray for advice on MYtag probes; P. A. Dear for advice about HAPPY mapping; T. Rito for help with ImageJ scripts; and D. Henrique and W. Bickmore for providing mES cell lines. The work was supported by the Medical Research Council, UK (A. P., R.A.B., M.C., S.Q.X., I.d.S., L.M.L., M.R.B., L.G., N. D.), by the Helmholtz Foundation (A. P., R.A.B., M.S., D. C. A. K., M.B.), by MRC-Technology (A. P., M.C., M.R.B.), by the Berlin Institute of Health (BIH; A. P., M.B.), by Breast Cancer Campaign (P. A. W. E.) and by Cancer Research UK (P. A. W. E.). Work by J. D. and J.F. was supported by grants from the Canadian Institutes of Health Research (CIHR) (MOP-86716, CAP-120350). Work by M. N. was supported by CINECA ISCRA grants no. HP10CYFPS5 and no. HP10CRTY8P. M. N. also acknowledges computer resources from INFN and Scope at the University of Naples.	Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; Ay F, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1236-7; Barbieri M, 2012, P NATL ACAD SCI USA, V109, P16173, DOI 10.1073/pnas.1204799109; Baslan T, 2012, NAT PROTOC, V7, P1024, DOI 10.1038/nprot.2012.039; Beagrie RA, 2016, BIOESSAYS, V38, P881, DOI 10.1002/bies.201600032; Belmont AS, 2014, CURR OPIN CELL BIOL, V26, P69, DOI 10.1016/j.ceb.2013.10.002; Binder K, 1997, REP PROG PHYS, V60, P487, DOI 10.1088/0034-4885/60/5/001; Binder K, 2010, GRAD TEXTS PHYS, P1, DOI 10.1007/978-3-642-03163-2; Branco MR, 2008, CHROMOSOME RES, V16, P413, DOI 10.1007/s10577-008-1230-x; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Chiariello AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29775; Crane E, 2015, NATURE, V523, P240, DOI 10.1038/nature14450; Darrow EM, 2016, P NATL ACAD SCI USA, V113, pE4504, DOI 10.1073/pnas.1609643113; DEAR PH, 1989, NUCLEIC ACIDS RES, V17, P6795, DOI 10.1093/nar/17.17.6795; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Ferrai C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000270; Gavrilov AA, 2013, NUCLEIC ACIDS RES, V41, P3563, DOI 10.1093/nar/gkt067; Grand RS, 2014, NUCLEIC ACIDS RES, V42, P12585, DOI 10.1093/nar/gku965; Guillot PV, 2004, EXP CELL RES, V295, P460, DOI 10.1016/j.yexcr.2004.01.020; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hu M, 2012, BIOINFORMATICS, V28, P3131, DOI 10.1093/bioinformatics/bts570; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Ing-Simmons E, 2015, GENOME RES, V25, P504, DOI 10.1101/gr.184986.114; Kruse K, 2013, NUCLEIC ACIDS RES, V41, P701, DOI 10.1093/nar/gks1096; Lee K, 2015, GENE DEV, V29, P1992, DOI 10.1101/gad.255265.114; LEWONTIN RC, 1964, GENETICS, V49, P49; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu Z, 2014, ELIFE, V3, DOI 10.7554/eLife.04236; Mayer R, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-44; MCDOWALL A, 1989, EUR J CELL BIOL, V49, P281; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Nicodemi M, 2009, BIOPHYS J, V96, P2168, DOI 10.1016/j.bpj.2008.12.3919; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; O'Sullivan JM, 2013, NUCLEUS-PHILA, V4, P390, DOI 10.4161/nucl.26513; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Pombo A, 1999, J HISTOCHEM CYTOCHEM, V47, P471, DOI 10.1177/002215549904700405; Pombo A, 1999, EMBO J, V18, P2241, DOI 10.1093/emboj/18.8.2241; Pombo A, 2007, HISTOCHEM CELL BIOL, V128, P97, DOI 10.1007/s00418-007-0310-x; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Proudfoot NJ, 2016, SCIENCE, V352, DOI 10.1126/science.aad9926; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rochman M, 2009, MOL CELL, V35, P642, DOI 10.1016/j.molcel.2009.07.002; Rodley CDM, 2009, FUNGAL GENET BIOL, V46, P879, DOI 10.1016/j.fgb.2009.07.006; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shopland LS, 2003, J CELL BIOL, V162, P981, DOI 10.1083/jcb.200303131; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; van Berkum Nynke L, 2010, J Vis Exp, DOI 10.3791/1869; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Williamson I, 2014, GENE DEV, V28, P2778, DOI 10.1101/gad.251694.114; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716	63	340	347	2	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2017	543	7646					519	+		10.1038/nature21411	http://dx.doi.org/10.1038/nature21411			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO9OM	28273065	Green Accepted, Green Submitted			2022-12-28	WOS:000397018000044
J	Jiao, X; Doamekpor, SK; Bird, JG; Nickels, BE; Tong, L; Hart, RP; Kiledjian, M				Jiao, Xinfu; Doamekpor, Selom K.; Bird, Jeremy G.; Nickels, Bryce E.; Tong, Liang; Hart, Ronald P.; Kiledjian, Megerditch			5 ' End Nicotinamide Adenine Dinucleotide Cap in Human Cells Promotes RNA Decay through DXO-Mediated deNADding	CELL			English	Article							EUKARYOTIC MESSENGER-RNA; QUALITY-CONTROL MECHANISM; HELA NUCLEAR EXTRACT; SOFTWARE; PROTEIN; IDENTIFICATION; METHYLATION; STABILITY; SITE; TRANSCRIPTION	Eukaryotic mRNAs generally possess a 50 end N7 methyl guanosine (m(7)G) cap that promotes their translation and stability. However, mammalian mRNAs can also carry a 50 end nicotinamide adenine dinucleotide (NAD(+)) cap that, in contrast to the m(7)G cap, does not support translation but instead promotes mRNA decay. The mammalian and fungal noncanonical DXO/Rai1 decapping enzymes efficiently remove NAD(+) caps, and cocrystal structures of DXO/Rai1 with 30-NADP(+) illuminate the molecular mechanism for how the "deNADding'' reaction produces NAD(+) and 50 phosphate RNA. Removal of DXO from cells increases NAD(+)-capped mRNA levels and enables detection of NAD(+)-capped intronic small nucleolar RNAs (snoRNAs), suggesting NAD(+) caps can be added to 50-processed termini. Our findings establish NAD(+) as an alternative mammalian RNA cap and DXO as a deNADding enzyme modulating cellular levels of NAD(+)-capped RNAs. Collectively, these data reveal that mammalian RNAs can harbor a 50 end modification distinct from the classical m(7)G cap that promotes rather than inhibits RNA decay.	[Jiao, Xinfu; Hart, Ronald P.; Kiledjian, Megerditch] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; [Doamekpor, Selom K.; Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Bird, Jeremy G.; Nickels, Bryce E.] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; [Bird, Jeremy G.; Nickels, Bryce E.] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Columbia University; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Kiledjian, M (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA.	kiledjian@biology.rutgers.edu	Nickels, Bryce/AAF-2549-2020; Doamekpor, Selom Kofi/P-8563-2019; Hart, Ronald P/D-5219-2009; Hart, Ronald P/G-6530-2019	Hart, Ronald P/0000-0003-4836-8712; Hart, Ronald P/0000-0003-4836-8712; Bird, Jeremy/0000-0003-2690-8474; Tong, Liang/0000-0002-0563-6468; Kiledjian, Megerditch/0000-0001-8099-0451; Nickels, Bryce/0000-0001-7449-8831	NIH [GM118059, GM118093, GM067005, P41 GM103403]; NIH-ORIP HEI [S10 RR029205]; U.S. Department of Energy (DOE) Office of Science User Facility [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, R35GM118093, R35GM118059, R01GM067005, R01GM090059] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-ORIP HEI; U.S. Department of Energy (DOE) Office of Science User Facility(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Kiledjian lab for helpful discussions. This work was supported by NIH grants GM118059 (to B.E.N.), GM118093 (to L.T.), and GM067005 (to M.K.). This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines, funded by the NIH (P41 GM103403). The Pilatus 6M detector on 24-ID-C beam line is funded by a NIH-ORIP HEI grant (S10 RR029205). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated by Argonne National Laboratory under contract no. DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bird JG, 2016, NATURE, V535, P444, DOI 10.1038/nature18622; Chang JH, 2012, NAT STRUCT MOL BIOL, V19, P1011, DOI 10.1038/nsmb.2381; Chen CYA, 2008, METHOD ENZYMOL, V448, P335, DOI 10.1016/S0076-6879(08)02617-7; Coleman TM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh007; Cooke C, 1996, MOL CELL BIOL, V16, P2579; Dieci G, 2009, GENOMICS, V94, P83, DOI 10.1016/j.ygeno.2009.05.002; Dudoit S, 2003, BIOTECHNIQUES, P45; EDERY I, 1985, P NATL ACAD SCI USA, V82, P7590, DOI 10.1073/pnas.82.22.7590; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrari R, 2004, BIOCHEM BIOPH RES CO, V315, P376, DOI 10.1016/j.bbrc.2004.01.071; Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4; FILIPOWICZ W, 1978, FEBS LETT, V96, P1, DOI 10.1016/0014-5793(78)81049-7; FURUICHI Y, 1977, NATURE, V266, P235, DOI 10.1038/266235a0; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GILMARTIN GM, 1988, GENE DEV, V2, P578, DOI 10.1101/gad.2.5.578; Grudzien-Nogalska E, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1379; HART RP, 1985, CELL, V43, P677, DOI 10.1016/0092-8674(85)90240-5; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; Jiao XF, 2013, MOL CELL, V50, P104, DOI 10.1016/j.molcel.2013.02.017; Jiao XF, 2010, NATURE, V467, P608, DOI 10.1038/nature09338; Jiao XF, 2006, MOL CELL, V24, P713, DOI 10.1016/j.molcel.2006.10.013; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kawaji H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-157; Kiss AM, 2004, MOL CELL BIOL, V24, P5797, DOI 10.1128/MCB.24.13.5797-5807.2004; KONARSKA MM, 1984, CELL, V38, P731, DOI 10.1016/0092-8674(84)90268-X; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/nmeth.3453, 10.1038/NMETH.3453]; Liu SW, 2008, METHOD ENZYMOL, V448, P3, DOI 10.1016/S0076-6879(08)02601-3; Martinez-Salas E, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/391546; MATTAJ IW, 1986, CELL, V46, P905, DOI 10.1016/0092-8674(86)90072-3; Mauer J, 2017, NATURE, V541, P371, DOI 10.1038/nature21022; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; MUTHUKRISHNAN S, 1975, J BIOL CHEM, V250, P9336; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; Schattner P, 2006, RNA, V12, P15, DOI 10.1261/rna.2210406; Scheer H, 2016, TRENDS GENET, V32, P607, DOI 10.1016/j.tig.2016.08.003; Scott DD, 2013, BBA-GENE REGUL MECH, V1829, P654, DOI 10.1016/j.bbagrm.2013.01.009; SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8; SHUMAN S, 1995, PROG NUCLEIC ACID RE, V50, P101, DOI 10.1016/S0079-6603(08)60812-0; SONENBERG N, 1979, P NATL ACAD SCI USA, V76, P4345, DOI 10.1073/pnas.76.9.4345; Song MG, 2013, RNA, V19, P390, DOI 10.1261/rna.037309.112; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang VYF, 2015, NUCLEIC ACIDS RES, V43, P6596, DOI 10.1093/nar/gkv620; Wang ZR, 1999, MOL CELL BIOL, V19, P4552; Wang ZR, 2001, CELL, V107, P751, DOI 10.1016/S0092-8674(01)00592-X; WEI CM, 1975, NATURE, V257, P251, DOI 10.1038/257251a0; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; Xiang S, 2009, NATURE, V458, P784, DOI 10.1038/nature07731; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377	54	111	116	3	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2017	168	6					1015	+		10.1016/j.cell.2017.02.019	http://dx.doi.org/10.1016/j.cell.2017.02.019			23	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8ZF	28283058	Green Accepted, Bronze			2022-12-28	WOS:000396287900010
J	Miller, S; Wherry, LR				Miller, Sarah; Wherry, Laura R.			Health and Access to Care during the First 2 Years of the ACA Medicaid Expansions	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COVERAGE	BACKGROUND By September 2015, a total of 29 states and Washington, D.C., were participating in Medicaid expansions under the Affordable Care Act. We examined whether Medicaid expansions were associated with changes in insurance coverage, health care use, and health among low-income adults. METHODS We compared changes in outcomes during the 2 years after implementation of the Medicaid expansion (2014 and 2015) relative to the 4 years before expansion (2010 through 2013) in states with and without expansions, using data from the National Health Interview Survey. The sample consisted of 60,766 U.S. citizens who were 19 to 64 years of age and had incomes below 138% of the federal poverty level. Outcomes included insurance coverage, access to and use of medical care in the past 12 months, and health status as reported by the respondents. RESULTS A total of 29 states and Washington, D.C., expanded Medicaid by September 1, 2015. In year 2 after implementation, uninsurance rates were reduced in expansion states relative to nonexpansion states (difference-in-differences estimate, -8.2 percentage points; P < 0.001) and rates of Medicaid coverage were increased (difference-in-differences estimate, 15.6 percentage points; P < 0.001). Expansions were not associated with significant changes in the likelihood of a doctor visit or overnight hospital stay or health status as reported by the respondent. However, as compared with nonexpansion states, expansion states had a decrease in reports of inability to afford needed follow-up care (difference-in-differences estimate, -3.4 percentage points; P = 0.002) and in reports of worry about paying medical bills (difference-indifferences estimate, -7.9 percentage points; P = 0.002) and an increase in reports of medical care being delayed because of wait times for appointments (difference-indifferences estimate, 2.6 percentage points; P = 0.02). CONCLUSIONS Medicaid expansion was associated with increased insurance coverage and access to care during the second year of implementation, but it was also associated with longer wait times for appointments, which suggests that challenges in access to care persist.	[Miller, Sarah] Univ Michigan, Ross Sch Business, Ann Arbor, MI 48109 USA; [Miller, Sarah] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Wherry, Laura R.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of Michigan System; University of Michigan; National Bureau of Economic Research; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Miller, S (corresponding author), Univ Michigan, Ross Sch Business R4416, 701 Tappan Ave, Ann Arbor, MI 48109 USA.	mille@umich.edu						Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Benitez JA, 2016, HEALTH AFFAIR, V35, P528, DOI 10.1377/hlthaff.2015.1294; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Cameron A., 2007, MICROECONOMETRICS ME; Center for Medicare and Medicaid Services, 2014, EL NONC MED CHIP; Centers for Disease Control and Prevention, 2006, VAR EST GUID NHIS 20; Dorn Stan, 2014, WHAT IS RESULT STATE; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; Golberstein E, 2015, HEALTH AFFAIR, V34, P1688, DOI 10.1377/hlthaff.2015.0290; Karaca-Mandic P, 2012, HEALTH SERV RES, V47, P255, DOI 10.1111/j.1475-6773.2011.01314.x; McMorrow S, 2016, HEALTH AFFAIR, V35, P1810, DOI 10.1377/hlthaff.2016.0941; National Center for Health Statistics, 2016, MULT IMP FAM INC PER; Owens R, 2015, IND PENT UP DEM NEW; Pines JM, 2016, HEALTH AFFAIR, V35, P1480, DOI 10.1377/hlthaff.2015.1632; Simon K, 2017, J POLICY ANAL MANAGE; Sommers BD, 2016, JAMA INTERN MED, V176, P1501, DOI 10.1001/jamainternmed.2016.4419; Sommers BD, 2016, HEALTH AFFAIR, V35, P96, DOI 10.1377/hlthaff.2015.0917; Sommers BD, 2015, JAMA-J AM MED ASSOC, V314, P366, DOI 10.1001/jama.2015.8421; Westfall P.H., 1993, RESAMPLING BASED MUL; Wherry LR, 2016, ANN INTERN MED, V164, P795, DOI 10.7326/M15-2234	20	281	281	3	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2017	376	10					947	956		10.1056/NEJMsa1612890	http://dx.doi.org/10.1056/NEJMsa1612890			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9JA	28273021	Bronze			2022-12-28	WOS:000395626500011
J	Channin, DS				Channin, David S.			Why Physician Leaders of Health Care Organizations Should Participate in Direct Patient Care	ANNALS OF INTERNAL MEDICINE			English	Letter									[Channin, David S.] Insightful Med Informat, Vestal, NY USA		Channin, DS (corresponding author), Insightful Med Informat, Vestal, NY USA.							Detsky AS, 2016, ANN INTERN MED, V165, P519, DOI 10.7326/M16-0820	1	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2017	166	5					376	376		10.7326/L16-0625	http://dx.doi.org/10.7326/L16-0625			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BO	28265661				2022-12-28	WOS:000396432800014
J	Kantarjian, H; Stein, A; Gokbuget, N; Fielding, AK; Schuh, AC; Ribera, JM; Wei, A; Dombret, H; Foa, R; Bassan, R; Arslan, O; Sanz, MA; Bergeron, J; Demirkan, F; Lech-Maranda, E; Rambaldi, A; Thomas, X; Horst, HA; Bruggemann, M; Klapper, W; Wood, BL; Fleishman, A; Nagorsen, D; Holland, C; Zimmerman, Z; Topp, MS				Kantarjian, Hagop; Stein, Anthony; Goekbuget, Nicola; Fielding, Adele K.; Schuh, Andre C.; Ribera, Josep-Maria; Wei, Andrew; Dombret, Herve; Foa, Robin; Bassan, Renato; Arslan, Onder; Sanz, Miguel A.; Bergeron, Julie; Demirkan, Fatih; Lech-Maranda, Ewa; Rambaldi, Alessandro; Thomas, Xavier; Horst, Heinz-August; Brueggemann, Monika; Klapper, Wolfram; Wood, Brent L.; Fleishman, Alex; Nagorsen, Dirk; Holland, Christopher; Zimmerman, Zachary; Topp, Max S.			Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE LYMPHOCYTIC-LEUKEMIA; INOTUZUMAB OZOGAMICIN; ADULT PATIENTS; HYPER-CVAD; T-CELLS; PROGNOSTIC-SIGNIFICANCE; MONOCLONAL-ANTIBODY; SALVAGE; CHEMOIMMUNOTHERAPY; RITUXIMAB	BACKGROUND Blinatumomab, a bispecific monoclonal antibody construct that enables CD3-positive T cells to recognize and eliminate CD19-positive acute lymphoblastic leukemia (ALL) blasts, was approved for use in patients with relapsed or refractory B-cell precursor ALL on the basis of single-group trials that showed efficacy and manageable toxic effects. METHODS In this multi-institutional phase 3 trial, we randomly assigned adults with heavily pre-treated B-cell precursor ALL, in a 2: 1 ratio, to receive either blinatumomab or standardof- care chemotherapy. The primary end point was overall survival. RESULTS Of the 405 patients who were randomly assigned to receive blinatumomab (271 patients) or chemotherapy (134 patients), 376 patients received at least one dose. Overall survival was significantly longer in the blinatumomab group than in the chemotherapy group. The median overall survival was 7.7 months in the blinatumomab group and 4.0 months in the chemotherapy group (hazard ratio for death with blinatumomab vs. chemotherapy, 0.71; 95% confidence interval [CI], 0.55 to 0.93; P = 0.01). Remission rates within 12 weeks after treatment initiation were significantly higher in the blinatumomab group than in the chemotherapy group, both with respect to complete remission with full hematologic recovery (34% vs. 16%, P<0.001) and with respect to complete remission with full, partial, or incomplete hematologic recovery (44% vs. 25%, P<0.001). Treatment with blinatumomab resulted in a higher rate of event-free survival than that with chemotherapy (6-month estimates, 31% vs. 12%; hazard ratio for an event of relapse after achieving a complete remission with full, partial, or incomplete hematologic recovery, or death, 0.55; 95% CI, 0.43 to 0.71; P<0.001), as well as a longer median duration of remission (7.3 vs. 4.6 months). A total of 24% of the patients in each treatment group underwent allogeneic stem-cell transplantation. Adverse events of grade 3 or higher were reported in 87% of the patients in the blinatumomab group and in 92% of the patients in the chemotherapy group. CONCLUSIONS Treatment with blinatumomab resulted in significantly longer overall survival than chemotherapy among adult patients with relapsed or refractory B-cell precursor ALL.	[Kantarjian, Hagop] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Stein, Anthony] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Fleishman, Alex; Nagorsen, Dirk; Zimmerman, Zachary] Amgen Inc, Thousand Oaks, CA USA; [Goekbuget, Nicola] Goethe Univ, Univ Hosp, Dept Med 2, Frankfurt, Germany; [Horst, Heinz-August; Brueggemann, Monika] Univ Hosp Schleswig Holstein, Med Dept 2, Campus Kiel, Kiel, Germany; [Klapper, Wolfram] Univ Hosp Schleswig Holstein, Hematopathol Sect, Campus Kiel, Kiel, Germany; [Klapper, Wolfram] Univ Hosp Schleswig Holstein, Lymph Node Registry, Campus Kiel, Kiel, Germany; [Topp, Max S.] Univ Klinikums Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany; [Fielding, Adele K.] Royal Free Hosp, London, England; [Fielding, Adele K.] UCL, Inst Canc, London, England; [Schuh, Andre C.] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Bergeron, Julie] Hop Maison Neuve Rosemont, Ctr Integre Univ Sante & Serv Sociaux Est Ile Mon, Montreal, PQ, Canada; [Ribera, Josep-Maria] Univ Autonoma Barcelona, ICO Hosp Univ Germans Trias & Pujol, Jose Carreras Res Inst, Barcelona, Spain; [Sanz, Miguel A.] Univ Valencia, Dept Med, Hosp Univ & Politecn La Fe, Valencia, Spain; [Sanz, Miguel A.] Inst Carlos III, Ctr Invest Biomed Red Canc, Madrid, Spain; [Wei, Andrew] Alfred Hosp, Melbourne, Vic, Australia; [Wei, Andrew] Monash Univ, Melbourne, Vic, Australia; [Dombret, Herve] Hop St Louis, AP HP, Inst Univ Hematol, Paris, France; [Thomas, Xavier] Ctr Hosp Lyon Sud, Pierre Benite, France; [Foa, Robin] Univ Sapienza Roma, Dipartimento Biotecnol Cellulari & Ematol, Azienda Osped Policlin Umberto 1, Ematol, Rome, Italy; [Bassan, Renato] Osped Dell Angelo, Azienda Unita Locale Socio Sanitaria 12 Veneziana, Venice, Italy; [Rambaldi, Alessandro] Univ Milan, Azienda Socio Sanitaria Terr Papa Giovanni 23, Milan, Italy; [Arslan, Onder] Ankara Univ, Tip Fak, Cebeci Arastirma & Uygulama Hastanesi, Ankara, Turkey; [Demirkan, Fatih] Dokuz Eylul Univ, Tip Fak, Izmir, Turkey; [Lech-Maranda, Ewa] Inst Hematol & Transfuzjol, Warsaw, Poland; [Lech-Maranda, Ewa] Ctr Med Ksztalcenia Podyplomowego, Warsaw, Poland; [Wood, Brent L.] Univ Washington, Med Ctr, Seattle, WA 98195 USA; [Holland, Christopher] Amgen Inc, Washington, DC USA	University of Texas System; UTMD Anderson Cancer Center; City of Hope; Amgen; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Universite de Montreal; Autonomous University of Barcelona; Catalan Institute of Oncology; Hospital Universitari i Politecnic La Fe; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Florey Institute of Neuroscience & Mental Health; Monash University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; Sapienza University Rome; University Hospital Sapienza Rome; ULSS 3 Serenissima; Ospedale dell'Angelo Mestre; University of Milan; Ankara University; Dokuz Eylul University; Institute of Hematology & Blood Transfusion; Centre of Postgraduate Medical Education - Poland; University of Washington; University of Washington Seattle; Amgen	Kantarjian, H (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, 1515 Holcombe Blvd, Houston, TX 77030 USA.	hkantarjian@mdanderson.org	Rambaldi, Alessandro/M-6172-2019; Demirkan, Fatih/AAD-6403-2019; Sanz, Miguel A./F-7485-2018; Ribera, JM/B-8181-2009; Lech-Maranda, Ewa/AAH-5474-2020; Fielding, Adele/AFM-9369-2022; Rambaldi, Alessandro/P-2603-2018	Rambaldi, Alessandro/0000-0002-3739-7502; Demirkan, Fatih/0000-0002-1172-8668; Sanz, Miguel A./0000-0003-1489-1177; Ribera, JM/0000-0003-1042-6024; Lech-Maranda, Ewa/0000-0001-9592-0851; Rambaldi, Alessandro/0000-0002-3739-7502; Wei, Andrew/0000-0002-7514-3298	Amgen; Pfizer; Bristol-Myers Squibb; Novartis Pharmaceuticals; Ariad Pharmaceuticals; Celgene/Juno Therapeutics; Roche/Genentech; Jazz Pharmaceuticals; Kite Pharma; Foa; Genentech; Janssen; Gilead Sciences; Celgene; Sandoz; Sunesis Pharmaceuticals; Boehringer Ingelheim; Regeneron Pharmaceuticals; NATIONAL CANCER INSTITUTE [P50CA100632, P30CA016672] Funding Source: NIH RePORTER	Amgen(Amgen); Pfizer(Pfizer); Bristol-Myers Squibb(Bristol-Myers Squibb); Novartis Pharmaceuticals(Novartis); Ariad Pharmaceuticals; Celgene/Juno Therapeutics(Bristol-Myers SquibbCelgene Corporation); Roche/Genentech(Roche HoldingGenentech); Jazz Pharmaceuticals(Jazz Pharmaceuticals); Kite Pharma; Foa; Genentech(Roche HoldingGenentech); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Gilead Sciences(Gilead Sciences); Celgene(Bristol-Myers SquibbCelgene Corporation); Sandoz(Novartis); Sunesis Pharmaceuticals; Boehringer Ingelheim(Boehringer Ingelheim); Regeneron Pharmaceuticals(Regeneron); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Amgen.; Dr. Kantarjian reports receiving grant support from Amgen, Pfizer, Bristol-Myers Squibb, Novartis Pharmaceuticals, and Ariad Pharmaceuticals; Dr. Stein, receiving lecture fees from Amgen; Dr. Gokbuget, serving on an advisory board for Kite Pharma (uncompensated), receiving fees for serving on advisory boards from Amgen, Pfizer, and Celgene/Juno Therapeutics, travel support from Amgen and Pfizer, and grant support from Amgen; Dr. Fielding, receiving fees for lectures and serving on an advisory board from Amgen; Dr. Schuh, receiving fees for serving on an advisory board from Amgen; Dr. Wei, receiving fees for serving on an advisory board and grant support from Amgen; Dr. Dombret, receiving honoraria from Roche/Genentech, Amgen, Pfizer, Ariad Pharmaceuticals, Novartis Pharmaceuticals, Celgene, Jazz Pharmaceuticals, Agios Pharmaceuticals, Sunesis Pharmaceuticals, Ambit Biosciences (now DaiichiSankyo), Karyopharm Therapeutics, Kite Pharma, Menarini, Astellas, Janssen, Servier, and Seattle Genetics, consulting fees from Amgen and Celgene, and grant support from Roche/Genentech, Amgen, Ariad Pharmaceuticals, Jazz Pharmaceuticals, and Kite Pharma; Dr. Foa, receiving fees for serving on advisory boards from Roche, Genentech, Janssen, Celgene, Ariad Pharmaceuticals, and Amgen, and lecture fees from Roche, Genentech, Janssen, Gilead Sciences, Celgene, Novartis Pharmaceuticals, and Sandoz; Dr. Bassan, receiving fees for consulting and serving on advisory boards from Amgen; Dr. Arslan, receiving fees for serving on an advisory board from Amgen; Dr. Rambaldi, receiving lecture fees and travel support from Amgen; Dr. Horst, receiving study fees from Sunesis Pharmaceuticals and Boehringer Ingelheim; Dr. Bruggemann, receiving fees for serving on advisory boards from Incyte and Amgen, lecture fees from Roche and Amgen, grant support from Amgen, and financial support for reference diagnostics from Affimed, Regeneron Pharmaceuticals, and Amgen; Dr. Klapper, receiving grant support to his institution from Roche, Novartis Pharmaceuticals, Regeneron Pharmaceuticals, and Janssen; Dr. Wood, receiving honoraria from Amgen and Seattle Genetics and holding laboratory service agreements with Pfizer, Juno Therapeutics, and Seattle Genetics; Mr. Fleishman, Dr. Nagorsen, Mr. Holland, and Dr. Zimmerman, being employees of and holding stock in Amgen; Mr. Holland, also holding stock in MacroGenics; and Dr. Topp, receiving fees for serving on advisory boards from Amgen, Regeneron Pharmaceuticals, Affimed, Jazz Pharmaceuticals, Gilead Sciences, and Pfizer and travel support from Amgen, Roche, Regeneron Pharmaceuticals, and Affimed. No other potential conflict of interest relevant to this article was reported.; We thank Robert Dawson of CACTUS Communications for graphics support, funded by Amgen; and Geoffrey Smith of Amgen and Jonathan Latham for medical writing support, funded by Amgen.	Bassan R, 2011, J CLIN ONCOL, V29, P532, DOI 10.1200/JCO.2010.30.1382; Borowitz MJ, 2015, BLOOD, V126, P964, DOI 10.1182/blood-2015-03-633685; Bruggemann M, 2010, LEUKEMIA, V24, P521, DOI 10.1038/leu.2009.268; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Dreier T, 2002, INT J CANCER, V100, P690, DOI 10.1002/ijc.10557; Fielding AK, 2007, BLOOD, V109, P944, DOI 10.1182/blood-2006-05-018192; Gokbuget N, 2012, BLOOD, V120, P1868, DOI 10.1182/blood-2011-09-377713; Gokbuget N, 2012, BLOOD, V120, P2032, DOI 10.1182/blood-2011-12-399287; Gokbuget N, 2011, LEUKEMIAS: PRINCIPLES AND PRACTICE OF THERAPY, P217; Gokbuget N, 2000, HEMATOL ONCOL CLIN N, V14, P1307, DOI 10.1016/S0889-8588(05)70188-X; Hoelzer D, 2012, BLOOD REV, V26, P25, DOI 10.1016/j.blre.2011.08.001; Hoffmann P, 2005, INT J CANCER, V115, P98, DOI 10.1002/ijc.20908; Jabbour E, 2016, LANCET, V387, P2360, DOI 10.1016/S0140-6736(16)00164-1; Jabbour E, 2015, CANCER-AM CANCER SOC, V121, P2517, DOI 10.1002/cncr.29383; Jabbour E, 2015, BLOOD, V125, P4010, DOI 10.1182/blood-2014-08-596403; Kantarjian H, 2004, CANCER-AM CANCER SOC, V101, P2788, DOI 10.1002/cncr.20668; Kantarjian H, 2013, CANCER-AM CANCER SOC, V119, P2728, DOI 10.1002/cncr.28136; Kantarjian H, 2012, J CLIN ONCOL, V30, P3876, DOI 10.1200/JCO.2012.41.6768; Kantarjian H, 2012, LANCET ONCOL, V13, P403, DOI 10.1016/S1470-2045(11)70386-2; Kantarjian HM, 2016, NEW ENGL J MED, V375, P740, DOI 10.1056/NEJMoa1509277; Kantarjian HM, 2010, CANCER-AM CANCER SOC, V116, P5568, DOI 10.1002/cncr.25354; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Loffler A, 2003, LEUKEMIA, V17, P900, DOI 10.1038/sj.leu.2402890; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Maury S, 2016, NEW ENGL J MED, V375, P1044, DOI 10.1056/NEJMoa1605085; O'Brien S, 2008, CANCER-AM CANCER SOC, V113, P3186, DOI 10.1002/cncr.23919; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Oriol A, 2010, HAEMATOL-HEMATOL J, V95, P589, DOI 10.3324/haematol.2009.014274; Raponi S, 2011, LEUKEMIA LYMPHOMA, V52, P1098, DOI 10.3109/10428194.2011.559668; Ribrag V, 2016, LANCET, V387, P2402, DOI 10.1016/S0140-6736(15)01317-3; Tavernier E, 2007, LEUKEMIA, V21, P1907, DOI 10.1038/sj.leu.2404824; Thomas DA, 1999, CANCER-AM CANCER SOC, V86, P1216, DOI 10.1002/(SICI)1097-0142(19991001)86:7<1216::AID-CNCR17>3.0.CO;2-O; Thomas DA, 2006, CANCER-AM CANCER SOC, V106, P1569, DOI 10.1002/cncr.21776; Thomas DA, 2010, J CLIN ONCOL, V28, P3880, DOI 10.1200/JCO.2009.26.9456; Thomas DA, 2009, BLOOD, V113, P6330, DOI 10.1182/blood-2008-04-151860; Topp MS, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.222.222; Topp MS, 2015, LANCET ONCOL, V16, P57, DOI 10.1016/S1470-2045(14)71170-2; Topp MS, 2014, J CLIN ONCOL, V32, P4134, DOI 10.1200/JCO.2014.56.3247; Zugmaier G, 2014, BLOOD, V124	40	987	1014	8	119	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2017	376	9					836	847		10.1056/NEJMoa1609783	http://dx.doi.org/10.1056/NEJMoa1609783			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JK	28249141	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000395627500007
J	Landon, BE				Landon, Bruce E.			Tipping the Scale - The Norms Hypothesis and Primary Care Physician Behavior	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Landon, Bruce E.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA; [Landon, Bruce E.] Beth Israel Deaconess Med Ctr, Div Gen Internal Med & Primary Care, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Landon, BE (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA.; Landon, BE (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Internal Med & Primary Care, Boston, MA 02215 USA.				NATIONAL INSTITUTE ON AGING [P01AG032952] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG032952] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Frank RG, 2007, J HEALTH ECON, V26, P1101, DOI 10.1016/j.jhealeco.2007.08.002; Glied S, 2002, J HEALTH ECON, V21, P337, DOI 10.1016/S0167-6296(01)00131-X; McWilliams JM, 2015, NEW ENGL J MED, V373, P777, DOI 10.1056/NEJMc1507320; NEWHOUSE JP, 1978, J HUM RESOUR, V13, P159, DOI 10.2307/145251	4	8	8	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2017	376	9					810	811		10.1056/NEJMp1510923	http://dx.doi.org/10.1056/NEJMp1510923			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9JK	28249130	Green Accepted			2022-12-28	WOS:000395627500003
J	Perkel, JM				Perkel, Jeffrey M.			How bioinformatics tools are bringing genetic analysis to the masses	NATURE			English	Editorial Material														Perkel, Jeffrey/0000-0001-5699-1008				Cruz CD, 2016, J VIROL METHODS, V235, P158, DOI 10.1016/j.jviromet.2016.06.001; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Li PE, 2017, NUCLEIC ACIDS RES, V45, P67, DOI 10.1093/nar/gkw1027	3	5	5	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2017	543	7643					137	+		10.1038/543137a	http://dx.doi.org/10.1038/543137a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0AA	28252089	Bronze			2022-12-28	WOS:000395671500049
J	Yeom, B; Sain, T; Lacevic, N; Bukharina, D; Cha, SH; Waas, AM; Arruda, EM; Kotov, NA				Yeom, Bongjun; Sain, Trisha; Lacevic, Naida; Bukharina, Daria; Cha, Sang-Ho; Waas, Anthony M.; Arruda, Ellen M.; Kotov, Nicholas A.			Abiotic tooth enamel	NATURE			English	Article							MECHANICAL-PROPERTIES; BIOLOGICAL-MATERIALS; DESIGN STRATEGIES; NACRE; COMPOSITES; MICROSTRUCTURE; MINERALIZATION; DEFORMATION; BIOMIMETICS; STIFFNESS	Tooth enamel comprises parallel microscale and nanoscale ceramic columns or prisms interlaced with a soft protein matrix(1-3). This structural motif is unusually consistent across all species from all geological eras(4-6). Such invariability-especially when juxtaposed with the diversity of other tissues-suggests the existence of a functional basis. Here we performed ex vivo replication of enamel-inspired columnar nanocomposites by sequential growth of zinc oxide nanowire carpets followed by layer-by-layer deposition of a polymeric matrix around these. We show that the mechanical properties of these nanocomposites, including hardness, are comparable to those of enamel despite the nanocomposites having a smaller hard-phase content. Our abiotic enamels have viscoelastic figures of merit (VFOM) and weight-adjusted VFOM that are similar to, or higher than, those of natural tooth enamels-we achieve values that exceed the traditional materials limits of 0.6 and 0.8, respectively. VFOM values describe resistance to vibrational damage, and our columnar composites demonstrate that lightweight materials of unusually high resistance to structural damage from shocks, environmental vibrations and oscillatory stress can be made using biomimetic design. The previously inaccessible combinations of high stiffness, damping and light weight that we achieve in these layer-by-layer composites are attributed to efficient energy dissipation in the interfacial portion of the organic phase. The in vivo contribution of this interfacial portion to macroscale deformations along the tooth's normal is maximized when the architecture is columnar, suggesting an evolutionary advantage of the columnar motif in the enamel of living species. We expect our findings to apply to all columnar composites and to lead to the development of high-performance load-bearing materials.	[Yeom, Bongjun; Bukharina, Daria; Cha, Sang-Ho; Kotov, Nicholas A.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Yeom, Bongjun] Myongji Univ, Dept Chem Engn, Yongin 17058, South Korea; [Sain, Trisha] Michigan Technol Univ, Mech Engn Engn Mech, Houghton, MI 49931 USA; [Lacevic, Naida] Univ Illinois, Illinois Appl Res Inst, Champaign, IL 61820 USA; [Cha, Sang-Ho] Kyonggi Univ, Dept Chem Engn, Suwon 443760, South Korea; [Waas, Anthony M.] Univ Michigan, Dept Aerosp Engn, Ann Arbor, MI 48109 USA; [Waas, Anthony M.] Univ Washington, William E Boeing Dept Aeronaut & Astronaut, Seattle, WA 98195 USA; [Arruda, Ellen M.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Arruda, Ellen M.; Kotov, Nicholas A.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Arruda, Ellen M.] Univ Michigan, Program Macromol Sci & Engn, Ann Arbor, MI 48109 USA; [Kotov, Nicholas A.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA; [Kotov, Nicholas A.] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA; [Kotov, Nicholas A.] Michigan Ctr Integrat Res Crit Care, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Myongji University; Michigan Technological University; University of Illinois System; University of Illinois Urbana-Champaign; Kyonggi University; University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kotov, NA (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.; Kotov, NA (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.; Kotov, NA (corresponding author), Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.; Kotov, NA (corresponding author), Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA.; Kotov, NA (corresponding author), Michigan Ctr Integrat Res Crit Care, Ann Arbor, MI 48109 USA.	kotov@umich.edu	Kotov, Nicholas/AAZ-4204-2021	Kotov, Nicholas/0000-0002-6864-5804; , Trisha/0000-0002-0163-7105	DARPA [HR0011-10-C-0192]; NextGen Aeronautics; NSF [ECS-0601345, CBET 0933384, CBET 0932823, CBET 1036672, DMR-0320740, DMR-9871177]; US Department of Defense [MURI W911NF-12-1-0407]; National Research Foundation of Korea (NRF) - Government of Korea (Ministry of Education) [NRF-2015R1D1A1A01058029]	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NextGen Aeronautics; NSF(National Science Foundation (NSF)); US Department of Defense(United States Department of Defense); National Research Foundation of Korea (NRF) - Government of Korea (Ministry of Education)	We acknowledge support from DARPA (grant HR0011-10-C-0192, MATLOG programme) and NextGen Aeronautics. We also acknowledge support from the NSF under grants ECS-0601345, CBET 0933384, CBET 0932823 and CBET 1036672. This work was also partially supported by the US Department of Defense under grant award no. MURI W911NF-12-1-0407. We thank the University of Michigan's Electron Microscopy and Analysis Laboratory (EMAL) for assistance with electron microscopy, and the NSF for grants (numbers DMR-0320740 and DMR-9871177) funding the purchase of the JEOL 2010F analytical electron microscope used in this work. This work was supported by a National Research Foundation of Korea (NRF) grant (no. NRF-2015R1D1A1A01058029) funded by the Government of Korea (Ministry of Education). We also thank A. Jung for help with scanning electron microscopy.	Achrai B, 2013, ACTA BIOMATER, V9, P5890, DOI 10.1016/j.actbio.2012.12.023; Balooch G, 2004, J BIOMECH, V37, P1223, DOI 10.1016/j.jbiomech.2003.12.012; Cho BK, 2004, SCIENCE, V305, P1598, DOI 10.1126/science.1100872; Cuif JP, 2012, MINERALS-BASEL, V2, P11, DOI 10.3390/min2010011; Erb RM, 2012, SCIENCE, V335, P199, DOI 10.1126/science.1210822; Espinosa HD, 2009, PROG MATER SCI, V54, P1059, DOI 10.1016/j.pmatsci.2009.05.001; Greene LE, 2003, ANGEW CHEM INT EDIT, V42, P3031, DOI 10.1002/anie.200351461; He LH, 2008, J MECH BEHAV BIOMED, V1, P18, DOI 10.1016/j.jmbbm.2007.05.001; Hu KS, 2014, PROG POLYM SCI, V39, P1934, DOI 10.1016/j.progpolymsci.2014.03.001; Hwang SH, 2011, BIOL REV, V86, P183, DOI 10.1111/j.1469-185X.2010.00142.x; JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056; Killian CE, 2009, J AM CHEM SOC, V131, P18404, DOI 10.1021/ja907063z; Lakes RS, 2001, NATURE, V410, P565, DOI 10.1038/35069035; Li YN, 2011, INT J SOLIDS STRUCT, V48, P1044, DOI 10.1016/j.ijsolstr.2010.12.008; Lowenstam HA, 1989, BIOMINERALIZATION; Meaud J, 2014, ACS NANO, V8, P3468, DOI 10.1021/nn500284m; Meyers MA, 2013, SCIENCE, V339, P773, DOI 10.1126/science.1220854; Moradian-Oldak J, 2012, FRONT BIOSCI-LANDMRK, V17, P1996, DOI 10.2741/4034; Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865; Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422; Podsiadlo P, 2007, SCIENCE, V318, P80, DOI 10.1126/science.1143176; Ruan Q, 2015, J MATER CHEM B, V3, P3112, DOI 10.1039/c5tb00163c; Ryou H, 2012, J MECH BEHAV BIOMED, V7, P3, DOI 10.1016/j.jmbbm.2011.08.010; Sarikaya M, 1999, P NATL ACAD SCI USA, V96, P14183, DOI 10.1073/pnas.96.25.14183; Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906; Wang RZ, 1997, PHILOS T R SOC B, V352, P469, DOI 10.1098/rstb.1997.0034; Wang RZ, 2001, J MATER RES, V16, P2485, DOI 10.1557/JMR.2001.0340; Wang YC, 2004, MAT SCI ENG A-STRUCT, V370, P41, DOI 10.1016/j.msea.2003.08.071; Weaver JC, 2012, SCIENCE, V336, P1275, DOI 10.1126/science.1218764; Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j; Zhang P, 2014, J APPL MECH-T ASME, V81, DOI 10.1115/1.4026239	31	136	137	23	403	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2017	543	7643					95	+		10.1038/nature21410	http://dx.doi.org/10.1038/nature21410			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0AA	28252079				2022-12-28	WOS:000395671500039
J	Medalie, L; Cifu, AS				Medalie, Lisa; Cifu, Adam S.			Management of Chronic Insomnia Disorder in Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CLINICAL-PRACTICE GUIDELINE; COGNITIVE-BEHAVIORAL THERAPY; AMERICAN-COLLEGE		[Medalie, Lisa; Cifu, Adam S.] Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA	University of Chicago	Cifu, AS (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Brasure M, 2016, ANN INTERN MED, V165, P113, DOI 10.7326/M15-1782; Buysse DJ, 2013, JAMA-J AM MED ASSOC, V309, P706, DOI 10.1001/jama.2013.193; Hara KM, 2015, COGN BEHAV THERAPY, V44, P162, DOI 10.1080/16506073.2014.998705; Morin CM, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1242-3; Qaseem A, 2016, ANN INTERN MED, V165, P125, DOI 10.7326/M15-2175; Rybarczyk B, 2013, CLIN GERONTOLOGIST, V36, P70, DOI 10.1080/07317115.2012.731478; Wilt TJ, 2016, ANN INTERN MED, V165, P103, DOI 10.7326/M15-1781; Wu JQ, 2015, JAMA INTERN MED, V175, P1461, DOI 10.1001/jamainternmed.2015.3006; Xu M, 2011, SLEEP MED, V12, P65, DOI 10.1016/j.sleep.2010.09.003	10	22	29	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2017	317	7					762	763		10.1001/jama.2016.19004	http://dx.doi.org/10.1001/jama.2016.19004			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8WR	28241342				2022-12-28	WOS:000394901600024
J	Luyckx, VA; Perico, N; Somaschini, M; Manfellotto, D; Valensise, H; Cetin, I; Simeoni, U; Allegaert, K; Vikse, BE; Steegers, EA; Adu, D; Montini, G; Remuzzi, G; Brenner, BM				Luyckx, Valerie A.; Perico, Norberto; Somaschini, Marco; Manfellotto, Dario; Valensise, Herbert; Cetin, Irene; Simeoni, Umberto; Allegaert, Karel; Vikse, Bjorn Egil; Steegers, Eric A.; Adu, Dwomoa; Montini, Giovanni; Remuzzi, Giuseppe; Brenner, Barry M.		Writing Grp Low Birth Weight; Nephron Number Working Grp	A developmental approach to the prevention of hypertension and kidney disease: a report from the Low Birth Weight and Nephron Number Working Group	LANCET			English	Editorial Material							GROWTH RESTRICTION; PROSPECTIVE COHORT; BLOOD-PRESSURE; GLOBAL BURDEN; BORN PRETERM; INJURY; RISK; CHILDREN; PREECLAMPSIA; PREVALENCE		[Luyckx, Valerie A.] Univ Zurich, Inst Biomed Eth, Zurich, Switzerland; [Perico, Norberto; Remuzzi, Giuseppe] IRCCS Ist Ric Farmacol Mario Negri, Clin Res Ctr Rare Dis Aldo & Cele Dacco, Bergamo, Italy; [Remuzzi, Giuseppe] IRCCS Ist Ric Farmacol Mario Negri, Ctr Anna Maria Astori, Sci & Technol Pk Kilometro Rosso, Bergamo, Italy; [Somaschini, Marco] St Anna Clin, Neonatol Unit, Lugano, Switzerland; [Manfellotto, Dario] San Giovanni Calibita Fatebenefratelli Hosp, Dept Internal Med, AFaR Div, Fatebenefratelli Fdn, Rome, Italy; [Valensise, Herbert] Tor Vergata Univ, Dept Obstet & Gynecol, Rome, Italy; [Cetin, Irene] Univ Milan, Unit Obstet & Gynecol, Dept Biomed & Clin Sci, Hosp L Sacco, Milan, Italy; [Cetin, Irene] Univ Milan, Ctr Fetal Res Giorgio Pardi, Milan, Italy; [Simeoni, Umberto] Univ Lausanne, Serv Pediat, Lausanne, Switzerland; [Allegaert, Karel] Sophia Childrens Univ Hosp, Intens Care & Dept Pediat Surg, Erasmus Med Ctr, Rotterdam, Netherlands; [Allegaert, Karel] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium; [Vikse, Bjorn Egil] Haugesund Hosp, Dept Med, Haugesund, Norway; [Vikse, Bjorn Egil] Univ Bergen, Dept Clin Med, Bergen, Norway; [Steegers, Eric A.] Erasmus Univ, Med Ctr Rotterdam, Div Obstet & Prenatal Med, Dept Obstet & Gynaecol, Rotterdam, Netherlands; [Adu, Dwomoa] Univ Ghana, Sch Med & Dent, Accra, Ghana; [Montini, Giovanni] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Pediat Nephrol & Dialysis Unit, Dept Clin Sci & Community Hlth, Milan, Italy; [Remuzzi, Giuseppe] Azienda Socio Sanitaria Terr ASST Papa Giovanni 2, Unit Nephrol Dialysis & Transplantat, Bergamo, Italy; [Remuzzi, Giuseppe] Univ Milan, Dept Biomed & Clin Sci, Milan, Italy; [Brenner, Barry M.] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; [Brenner, Barry M.] Harvard Med Sch, Boston, MA USA	University of Zurich; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Rome Tor Vergata; University of Milan; Luigi Sacco Hospital; University of Milan; University of Lausanne; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; KU Leuven; University of Bergen; Erasmus University Rotterdam; Erasmus MC; University of Ghana; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; ASST Papa Giovanni XXIII; University of Milan; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Remuzzi, G (corresponding author), IRCCS Ist Ric Farmacol Mario Negri, Ctr Anna Maria Astori, Sci & Technol Pk, I-24126 Bergamo, Italy.	giuseppe.remuzzi@marionegri.it	Perico, Norberto/ABH-3222-2020; Simeoni, Umberto/GRO-6971-2022; Valensise, Herbert/AAC-1345-2019; SIMEONI, Umberto/AAQ-1870-2021; Luyckx, Valerie/J-9747-2019; Montini, Giovanni/AAC-6612-2022; allegaert, karel/C-3611-2016; Ramenghi, Luca/AAB-4067-2020; cetin, irene/K-6112-2016; Romagnani, Paola/A-4309-2008; Remuzzi, Giuseppe/V-9766-2017	Perico, Norberto/0000-0002-3147-4327; Simeoni, Umberto/0000-0003-0730-9337; SIMEONI, Umberto/0000-0003-0730-9337; Luyckx, Valerie/0000-0001-7066-8135; Montini, Giovanni/0000-0002-7350-4475; allegaert, karel/0000-0001-9921-5105; Ramenghi, Luca/0000-0003-0065-762X; cetin, irene/0000-0002-9217-3034; Romagnani, Paola/0000-0002-1774-8088; Escribano, Joaquin/0000-0002-5041-459X; Remuzzi, Giuseppe/0000-0002-6194-3446	Menarini International Foundation; Medical Research Council [U1475000003, MC_UU_12011/4, MC_UP_A620_1016, MC_UU_12011/3] Funding Source: researchfish; MRC [MC_UP_A620_1016, MC_UU_12011/4, MC_UU_12011/3] Funding Source: UKRI	Menarini International Foundation(Menarini Group); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful for the support and generosity of the Menarini International Foundation and would like to thank Alessandro Casini for his enthusiasm (Rozzano, Milan, Italy). Furthermore, we would like to acknowledge the additional contribution of the Chiesi Foundation (Parma, Italy) and the Italian Society of Nephrology.	BARKER DJP, 1986, LANCET, V1, P1077; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bogaerts A, 2013, OBSTET GYNECOL, V122, P999, DOI 10.1097/AOG.0b013e3182a7f63e; Boivin A, 2012, CAN MED ASSOC J, V184, P1777, DOI 10.1503/cmaj.120143; BRENNER BM, 1988, AM J HYPERTENS, V1, P335, DOI 10.1093/ajh/1.4.335; Bruel A, 2016, PEDIATR NEPHROL, V31, P2365, DOI 10.1007/s00467-016-3444-z; Carmody JB, 2014, CLIN J AM SOC NEPHRO, V9, P2036, DOI 10.2215/CJN.05190514; Cetin I, 2013, CURR OPIN CLIN NUTR, V16, P310, DOI 10.1097/MCO.0b013e32835e8d9c; Chang HH, 2013, LANCET, V381, P223, DOI 10.1016/S0140-6736(12)61856-X; Chaturvedi S, 2017, PEDIATR NEPHROL, V32, P227, DOI 10.1007/s00467-015-3298-9; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; de Jong F, 2012, HYPERTENSION, V59, P226, DOI 10.1161/HYPERTENSIONAHA.111.181784; DeVore GR, 2015, AM J OBSTET GYNECOL, V213, P5, DOI 10.1016/j.ajog.2015.05.024; Geelhoed JJM, 2010, CIRCULATION, V122, P1192, DOI 10.1161/CIRCULATIONAHA.110.936674; Hanna MH, 2016, CURR OPIN PEDIATR, V28, P180, DOI 10.1097/MOP.0000000000000311; Keijzer-Veen MG, 2005, J AM SOC NEPHROL, V16, P2762, DOI 10.1681/ASN.2004090783; Khalsa DDK, 2016, PEDIATR NEPHROL, V31, P1509, DOI 10.1007/s00467-016-3384-7; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; Luyckx VA, 2015, NAT REV NEPHROL, V11, P135, DOI 10.1038/nrneph.2014.251; Mammen C, 2012, AM J KIDNEY DIS, V59, P523, DOI 10.1053/j.ajkd.2011.10.048; McCarthy EA, 2014, LANCET, V384, P835, DOI 10.1016/S0140-6736(14)61416-1; Mjoen G, 2014, KIDNEY INT, V86, P162, DOI 10.1038/ki.2013.460; Mueller TF, 2012, J AM SOC NEPHROL, V23, P1462, DOI 10.1681/ASN.2011111080; Selewski DT, 2015, PEDIATRICS, V136, pE463, DOI 10.1542/peds.2014-3819; Sovio U, 2015, LANCET, V386, P2089, DOI 10.1016/S0140-6736(15)00131-2; Steegers-Theunissen RPM, 2015, REPROD FERT DEVELOP, V27, P712, DOI 10.1071/RD14386; The Low Birth Weight and Nephron Number Working Group, NEPHRON IN PRESS; Vikse BE, 2013, LANCET, V382, P104, DOI 10.1016/S0140-6736(13)60741-2; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; White SL, 2009, AM J KIDNEY DIS, V54, P248, DOI 10.1053/j.ajkd.2008.12.042; World Health Organization, 2016, GOOD MAT NUTR BEST S	31	96	98	2	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 22	2017	390	10092					424	428		10.1016/S0140-6736(17)30576-7	http://dx.doi.org/10.1016/S0140-6736(17)30576-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FB1NU	28284520	Green Accepted, Green Submitted			2022-12-28	WOS:000405911300031
J	Chamberlain, JJ; Herman, WH; Leal, S; Rhinehart, AS; Shubrook, JH; Skolnik, N; Kalyani, RR				Chamberlain, James J.; Herman, William H.; Leal, Sandra; Rhinehart, Andrew S.; Shubrook, Jay H.; Skolnik, Neil; Kalyani, Rita Rastogi			Pharmacologic Therapy for Type 2 Diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes	ANNALS OF INTERNAL MEDICINE			English	Article							CARDIOVASCULAR OUTCOMES; BOLUS INSULIN; BASAL-BOLUS; PREMIXED INSULIN; REGIMENS; SAFETY; UPDATE; DRUGS	Description: The American Diabetes Association (ADA) annually updates the Standards of Medical Care in Diabetes to provide clinicians, patients, researchers, payers, and other interested parties with evidence-based recommendations for the diagnosis and management of patients with diabetes. Methods: For the 2017 Standards, the ADA Professional Practice Committee updated previous MEDLINE searches performed from 1 January 2016 to November 2016 to add, clarify, or revise recommendations based on new evidence. The committee rates the recommendations as A, B, or C, depending on the quality of evidence, or E for expert consensus or clinical experience. The Standards were reviewed and approved by the Executive Committee of the ADA Board of Directors, which includes health care professionals, scientists, and laypersons. Feedback from the larger clinical community informed revisions. Recommendations: This synopsis focuses on recommendations from the 2017 Standards about pharmacologic approaches to glycemic treatment of type 2 diabetes.	[Chamberlain, James J.] St Marks Hosp, 1160 East 3900 South,Suite 1200, Salt Lake City, UT 84124 USA; [Chamberlain, James J.] St Marks Diabet Ctr, Internal Med St Marks, 1160 East 3900 South,Suite 1200, Salt Lake City, UT 84124 USA; [Herman, William H.] Univ Michigan, 1000 Wall St,Room 6108 SPC 5714, Ann Arbor, MI 48105 USA; [Leal, Sandra] SinfoniaRx, One East Toole, Tucson, AZ 85701 USA; [Rhinehart, Andrew S.] Glytec, 770 Pelham Rd,Suite 210, Greenville, SC 29615 USA; [Shubrook, Jay H.] Touro Univ, Coll Osteopath Med, 1310 Club Dr,Admin & Fac 1,Room 117, Vallejo, CA 94592 USA; [Skolnik, Neil] Abington Jefferson Hlth, Abington Family Med, 500 Old York Rd,Suite 108, Jenkintown, PA 19046 USA; [Kalyani, Rita Rastogi] Johns Hopkins Univ, Div Endocrinol Diabet & Metab, 1830 East Monument St,Suite 333, Baltimore, MD 21287 USA	University of Michigan System; University of Michigan; Touro University California; Abington Memorial Hospital; Johns Hopkins University	Chamberlain, JJ (corresponding author), St Marks Hosp, 1160 East 3900 South,Suite 1200, Salt Lake City, UT 84124 USA.; Chamberlain, JJ (corresponding author), St Marks Diabet Ctr, Internal Med St Marks, 1160 East 3900 South,Suite 1200, Salt Lake City, UT 84124 USA.	jimchammd@yahoo.com						American Diabetes Association, 2017, Diabetes Care, V40, pS6; [Anonymous], 2017, DIABETES CARE, V40, pS1, DOI 10.2337/dc17-S001; [Anonymous], 2016, RED BOOK ONLINE ONLI; Aroda VR, 2016, J CLIN ENDOCR METAB, V101, P1754, DOI 10.1210/jc.2015-3754; Bennett WL, 2011, ANN INTERN MED, V154, P602, DOI 10.7326/0003-4819-154-9-201105030-00336; Blonde L, 2009, DIABETES OBES METAB, V11, P623, DOI 10.1111/j.1463-1326.2009.01060.x; Diamant M, 2014, DIABETES CARE, V37, P2763, DOI 10.2337/dc14-0876; Dieuzeide G, 2014, PRIM CARE DIABETES, V8, P111, DOI 10.1016/j.pcd.2013.07.005; Eng C, 2014, LANCET, V384, P2228, DOI 10.1016/S0140-6736(14)61335-0; Giugliano D, 2016, ENDOCRINE, V51, P417, DOI 10.1007/s12020-015-0718-3; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Institute for Clinical and Economic Review, 2014, CONTR MAN PAT TYP 2; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Mathieu C, 2013, ACTA CLIN BELG, V68, P28, DOI 10.2143/ACB.68.1.2062716; Palmer SC, 2016, JAMA-J AM MED ASSOC, V316, P313, DOI 10.1001/jama.2016.9400; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; U. S. Food and Drug Administration, 2016, METF CONT DRUGS DRUG; U. S. Food and Drug Administration, 2015, SGLT2 INH DRUG SAF C; US Food and Drug Administration, 2016, DIAB MED CONT SAX AL; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	23	80	86	3	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 18	2017	166	8					572	+		10.7326/M16-2937	http://dx.doi.org/10.7326/M16-2937			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ES1RF	28288484				2022-12-28	WOS:000399304000017
J	Gold, DA; Caron, A; Fournier, GP; Summons, RE				Gold, David A.; Caron, Abigail; Fournier, Gregory P.; Summons, Roger E.			Paleoproterozoic sterol biosynthesis and the rise of oxygen	NATURE			English	Article							HYDROCARBON BIOMARKERS; MIXED MODELS; EVOLUTION; BACTERIA; EUKARYOTES; PROTEINS; FOSSILS; ORIGIN; OCEAN; ROOT	Natural products preserved in the geological record can function as 'molecular fossils', providing insight into organisms and physiologies that existed in the deep past. One important group of molecular fossils is the steroidal hydrocarbons (steranes), which are the diagenetic remains of sterol lipids. Complex sterols with modified side chains are unique to eukaryotes, although simpler sterols can also be synthesized by a few bacteria(1). Sterol biosynthesis is an oxygen-intensive process; thus, the presence of complex steranes in ancient rocks not only signals the presence of eukaryotes, but also aerobic metabolic processes(2). In 1999, steranes were reported in 2.7 billion year (Gyr)-old rocks from the Pilbara Craton in Australia(3), suggesting a long delay between photosynthetic oxygen production and its accumulation in the atmosphere (also known as the Great Oxidation Event) 2.45-2.32 Gyr ago(4). However, the recent reappraisal and rejection of these steranes as contaminants(5) pushes the oldest reported steranes forward to around 1.64 Gyr ago (ref. 6). Here we use a molecular clock approach to improve constraints on the evolution of sterol biosynthesis. We infer that stem eukaryotes shared functionally modern sterol biosynthesis genes with bacteria via horizontal gene transfer. Comparing multiple molecular clock analyses, we find that the maximum marginal probability for the divergence time of bacterial and eukaryal sterol biosynthesis genes is around 2.31 Gyr ago, concurrent with the most recent geochemical evidence for the Great Oxidation Event(7). Our results therefore indicate that simple sterol biosynthesis existed well before the diversification of living eukaryotes, substantially predating the oldest detected sterane biomarkers (approximately 1.64 Gyr ago(6)), and furthermore, that the evolutionary history of sterol biosynthesis is tied to the first widespread availability of molecular oxygen in the ocean-atmosphere system.	[Gold, David A.; Caron, Abigail; Fournier, Gregory P.; Summons, Roger E.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Gold, David A.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	Massachusetts Institute of Technology (MIT); California Institute of Technology	Summons, RE (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	rsummons@mit.edu	Gold, David/I-5398-2012; Summons, Roger Everett/AAL-3789-2020	Gold, David/0000-0003-0135-4022; Caron, Abigail/0000-0002-0906-8218	Agouron Institute Geobiology Fellowship; Simons Foundation Collaboration on the Origins of Life; National Science Foundation programme 'Frontiers of Earth System Dynamics' [EAR-1338810]; National Science Foundation programme 'Integrated Earth Systems' [IES-1615426]	Agouron Institute Geobiology Fellowship; Simons Foundation Collaboration on the Origins of Life; National Science Foundation programme 'Frontiers of Earth System Dynamics'; National Science Foundation programme 'Integrated Earth Systems'(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We gratefully acknowledge funding from the Agouron Institute Geobiology Fellowship to D.A.G. and the Simons Foundation Collaboration on the Origins of Life to R.E.S. and G.P.F. Additional support was provided by the National Science Foundation programme 'Frontiers of Earth System Dynamics' (EAR-1338810) to R.E.S., and the National Science Foundation programme 'Integrated Earth Systems' (IES-1615426) to G.P.F.	Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; Banta AB, 2015, P NATL ACAD SCI USA, V112, P13478, DOI 10.1073/pnas.1511482112; Battistuzzi FU, 2015, MOL BIOL EVOL, V32, P1907, DOI 10.1093/molbev/msv075; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Benton MJ, 2015, PALAEONTOL ELECTRON, V18; Berney C, 2006, P ROY SOC B-BIOL SCI, V273, P1867, DOI 10.1098/rspb.2006.3537; Brocks JJ, 2016, GEOBIOLOGY, V14, P129, DOI 10.1111/gbi.12165; Brocks JJ, 2005, NATURE, V437, P866, DOI 10.1038/nature04068; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; Derelle R, 2015, P NATL ACAD SCI USA, V112, pE693, DOI 10.1073/pnas.1420657112; Desmond E, 2009, GENOME BIOL EVOL, V1, P364, DOI 10.1093/gbe/evp036; Douzery EJP, 2004, P NATL ACAD SCI USA, V101, P15386, DOI 10.1073/pnas.0403984101; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; French KL, 2015, P NATL ACAD SCI USA, V112, P5915, DOI 10.1073/pnas.1419563112; Gold DA, 2016, P NATL ACAD SCI USA, V113, P2684, DOI 10.1073/pnas.1512614113; Gold DA, 2015, EVOL DEV, V17, P315, DOI 10.1111/ede.12168; He D, 2014, CURR BIOL, V24, P465, DOI 10.1016/j.cub.2014.01.036; Illing CJ, 2014, ORG GEOCHEM, V76, P26, DOI 10.1016/j.orggeochem.2014.07.006; Love GD., 2008, PALEONTOL SOC PAP, V14, P67; Luo GM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600134; Lyons TW, 2014, NATURE, V506, P307, DOI 10.1038/nature13068; Parfrey LW, 2011, P NATL ACAD SCI USA, V108, P13624, DOI 10.1073/pnas.1110633108; Pearson A, 2003, P NATL ACAD SCI USA, V100, P15352, DOI 10.1073/pnas.2536559100; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; SUMMONS RE, 1988, GEOCHIM COSMOCHIM AC, V52, P2625, DOI 10.1016/0016-7037(88)90031-2; Summons RE, 2006, PHILOS T R SOC B, V361, P951, DOI 10.1098/rstb.2006.1837; Wei JH, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00990; Yin ZJ, 2015, P NATL ACAD SCI USA, V112, pE1453, DOI 10.1073/pnas.1414577112	33	55	59	3	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2017	543	7645					420	+		10.1038/nature21412	http://dx.doi.org/10.1038/nature21412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9RN	28264195	Green Published			2022-12-28	WOS:000396337400050
J	Wise, J				Wise, Jacqui			Mental health: patients and service in crisis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jacquiyoung1@gmail.com						Burns T, 2013, LANCET, V381, P1627, DOI 10.1016/S0140-6736(13)60107-5; Commission to Review the Provision of Acute Inpatient Psychiatric Care for Adults, 2016, OLD PROBL NEW SOL IM; Dyer C, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1993; Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i773; Mental Welfare Commission of Scotland, 2015, MENT HLTH ACT MON; UK Police, 2016, US POL CELLS THOS ME	6	5	5	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2017	356								j1141	10.1136/bmj.j1141	http://dx.doi.org/10.1136/bmj.j1141			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO9NF	28288959				2022-12-28	WOS:000397014700001
J	Collins, MG				Collins, Margaret Goud			All the Boats on the Ocean How Government Subsidies Led to Global Overf shing	SCIENCE			English	Book Review									[Collins, Margaret Goud] IIASA, Falmouth, MA USA		Collins, MG (corresponding author), IIASA, Falmouth, MA USA.	collins@iiasa.ac.at						Finley C., 2017, ALL BOATS OCEAN GOVT; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243	2	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI		1030	1030						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9VY	28280173				2022-12-28	WOS:000396348900024
J	Mercy, G; Mozziconacci, J; Scolari, VF; Yang, K; Zhao, GH; Thierry, A; Luo, YS; Mitchell, LA; Shen, M; Shen, Y; Walker, R; Zhang, WM; Wu, Y; Xie, ZX; Luo, ZQ; Cai, YZ; Dai, JB; Yang, HM; Yuan, YJ; Boeke, JD; Bader, JS; Muller, H; Koszul, R				Mercy, Guillaume; Mozziconacci, Julien; Scolari, Vittore F.; Yang, Kun; Zhao, Guanghou; Thierry, Agnes; Luo, Yisha; Mitchell, Leslie A.; Shen, Michael; Shen, Yue; Walker, Roy; Zhang, Weimin; Wu, Yi; Xie, Ze-Xiong; Luo, Zhouqing; Cai, Yizhi; Dai, Junbiao; Yang, Huanming; Yuan, Ying-Jin; Boeke, Jef D.; Bader, Joel S.; Muller, Heloise; Koszul, Romain			3D organization of synthetic and scrambled chromosomes	SCIENCE			English	Article							IN-VIVO; YEAST; PRINCIPLES	Although the design of the synthetic yeast genome Sc2.0 is highly conservative with respect to gene content, the deletion of several classes of repeated sequences and the introduction of thousands of designer changes may affect genome organization and potentially alter cellular functions. We report here the Hi-C-determined three-dimensional (3D) conformations of Sc2.0 chromosomes. The absence of repeats leads to a smoother contact pattern and more precisely tractable chromosome conformations, and the largescale genomic organization is globally unaffected by the presence of synthetic chromosome(s). Two exceptions are synIII, which lacks the silent mating-type cassettes, and synXII, specifically when the ribosomal DNA is moved to another chromosome. We also exploit the contact maps to detect rearrangements induced in SCRaMbLE (synthetic chromosome rearrangement and modification by loxP-mediated evolution) strains.	[Mercy, Guillaume; Scolari, Vittore F.; Thierry, Agnes; Muller, Heloise; Koszul, Romain] Inst Pasteur, Dept Genomes & Genet, Spatial Regulat Genomes, F-75015 Paris, France; [Mercy, Guillaume; Scolari, Vittore F.; Thierry, Agnes; Muller, Heloise; Koszul, Romain] CNRS, UMR3525, F-75015 Paris, France; [Mercy, Guillaume] Univ Paris 06, Univ Pierre & Marie Curie, Sorbonne Univ, F-75005 Paris, France; [Mozziconacci, Julien] Sorbonne Univ, Univ Paris 6, Univ Pierre & Marie Curie, Lab Phys Theor Matiere Condensee,CNRS,UMR7600, Paris, France; [Yang, Kun; Bader, Joel S.] Johns Hopkins Univ, Whiting Sch Engn, Dept Biomed Engn, Baltimore, MD 21218 USA; [Yang, Kun; Bader, Joel S.] Johns Hopkins Univ, Whiting Sch Engn, High Throughput Biol Ctr, Baltimore, MD 21218 USA; [Zhao, Guanghou; Zhang, Weimin; Luo, Zhouqing; Dai, Junbiao] Tsinghua Univ, Key Lab Ind Biocatalysis, Minist Educ, Key Lab Bioinformat,Ctr Synthet & Syst Biol,Sch L, Beijing 100084, Peoples R China; [Luo, Yisha; Shen, Yue; Walker, Roy; Cai, Yizhi] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3BF, Midlothian, Scotland; [Mitchell, Leslie A.; Shen, Michael; Boeke, Jef D.] NYU, Inst Syst Genet, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Mitchell, Leslie A.; Shen, Michael; Boeke, Jef D.] NYU, Dept Biochem & Mol Pharmacol, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Shen, Yue; Yang, Huanming] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Shen, Yue] BGI Qingdao, Qingdao 266555, Peoples R China; [Wu, Yi; Xie, Ze-Xiong; Yuan, Ying-Jin] Tianjin Univ, Key Lab Syst Bioengn, Minist Educ,Sch Chem Engn & Technol, SynBio Res Platform,Collaborat Innovat Ctr Chem S, Tianjin 300072, Peoples R China; [Yang, Huanming] James D Watson Inst Genome Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Muller, Heloise] Inst Curie, Dynam Noyau UMR3664, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Johns Hopkins University; Johns Hopkins University; Tsinghua University; University of Edinburgh; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Tianjin University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Muller, H; Koszul, R (corresponding author), Inst Pasteur, Dept Genomes & Genet, Spatial Regulat Genomes, F-75015 Paris, France.; Muller, H; Koszul, R (corresponding author), CNRS, UMR3525, F-75015 Paris, France.; Muller, H (corresponding author), Inst Curie, Dynam Noyau UMR3664, Paris, France.	heloise.muller@curie.fr; romain.koszul@pasteur.fr	Zhao, Guanghou/E-7834-2017; Dai, Junbiao/AAB-8328-2021; Luo, Zhouqing/E-3186-2017; Scolari, Vittore Ferdinando/ABB-9806-2020; Mozziconacci, Julien/M-4731-2019; Cai, Yizhi/A-3550-2010	Zhao, Guanghou/0000-0002-3192-5423; Dai, Junbiao/0000-0002-5299-4700; Luo, Zhouqing/0000-0001-5426-5176; Scolari, Vittore Ferdinando/0000-0003-3490-0579; Mitchell, Leslie/0000-0001-7869-9817; Koszul, Romain/0000-0002-3086-1173; Wu, Yi/0000-0002-2539-9228; Mercy, Guillaume/0000-0002-6274-5927; Cai, Yizhi/0000-0003-1663-2865; Walker, Roy/0000-0003-0960-4591	European Research Council (ERC) under the 7th Framework Program (FP7, ERC) [260822]; Agence Nationale pour la Recherche (ANR) [MeioRec ANR-13-BSV6-0012-02]; ERASynBio; ANR [IESY ANR-14-SYNB-0001-03]; Pasteur-Roux Fellowships; National Science Foundation of China [31471254]; Tsinghua University Initiative Scientific Research Program [2011Z02296]; Ph.D. Programs Foundation of Ministry of Education of China [20110002120055]; Chinese Ministry of Science and Technology [2012CB725201]; Natural Science Foundation of China [21621004, 21390203]; University of Edinburgh; Scottish Universities Life Sciences Alliance; U.K. Biotechnology and Biological Sciences Research Council [BB/M005690/1, BB/M025640/1, BB/M00029X/1]; Shenzhen Engineering Laboratory for Clinical Molecular Diagnostic Promotion [JZF] [(2016)884]; U.S. National Science Foundation [MCB-0718846, MCB-1026068, MCB-0546446, MCB-1445545]; Biotechnology and Biological Sciences Research Council [BB/M00029X/1, BB/M025640/1, BB/M005690/2, BB/M005690/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1419736] Funding Source: researchfish; BBSRC [BB/M00029X/1, BB/M025640/1, BB/M005690/2, BB/M005690/1] Funding Source: UKRI; Direct For Biological Sciences [1445537, 1616111] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007308] Funding Source: NIH RePORTER	European Research Council (ERC) under the 7th Framework Program (FP7, ERC)(European Research Council (ERC)); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); ERASynBio; ANR(French National Research Agency (ANR)); Pasteur-Roux Fellowships; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University Initiative Scientific Research Program; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Edinburgh; Scottish Universities Life Sciences Alliance; U.K. Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Shenzhen Engineering Laboratory for Clinical Molecular Diagnostic Promotion [JZF]; U.S. National Science Foundation(National Science Foundation (NSF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Cournac, M. Marbouty, and L. Lazar-Stefanita for fruitful discussions and advice. This research was supported by funding to R.K. from the European Research Council (ERC) under the 7th Framework Program (FP7/2007-2013, ERC grant agreement 260822), Agence Nationale pour la Recherche (ANR) (MeioRec ANR-13-BSV6-0012-02), and ERASynBio and ANR (IESY ANR-14-SYNB-0001-03). H.M. and V.F.S are partly supported by Pasteur-Roux Fellowships. J.D. was funded by the National Science Foundation of China (31471254), Tsinghua University Initiative Scientific Research Program (2011Z02296), Ph.D. Programs Foundation of Ministry of Education of China (20110002120055), and the Chinese Ministry of Science and Technology (2012CB725201). Y.-J.Y. was supported by the Natural Science Foundation of China (21621004 and 21390203). Y.C. was funded by a Chancellor's Fellowship from the University of Edinburgh, a startup fund from the Scottish Universities Life Sciences Alliance, and grants from the U.K. Biotechnology and Biological Sciences Research Council (BB/M005690/1, BB/M025640/1, and BB/M00029X/1). Y.S. was supported by a research grant from the Shenzhen Engineering Laboratory for Clinical Molecular Diagnostic Promotion [JZF no. (2016)884]. This work was supported in part by funding from the U.S. National Science Foundation (grants MCB-0718846 and MCB-1026068 to J.D.B. and J.S.B. and MCB-0546446 and MCB-1445545 to J.S.B.). J.D.B. and J.S.B. are founders and directors of Neochromosome. J.D.B. serves as a scientific advisor to Recombinetics and Sample6. These arrangements are reviewed and managed by the committees on conflict of interest at the New York University Langone Medical Center (J.D.B.) and Johns Hopkins University (J.S.B.). FASTQ files of the reads have been deposited in the Sequence Read Archive database under accession number SRP070421.	Annaluru N, 2014, SCIENCE, V344, P55, DOI 10.1126/science.1249252; Belton JM, 2015, CELL REP, V13, P1855, DOI 10.1016/j.celrep.2015.10.063; Bradnam KR, 1999, MOL BIOL EVOL, V16, P666, DOI 10.1093/oxfordjournals.molbev.a026149; Burgess SM, 1999, GENE DEV, V13, P1871, DOI 10.1101/gad.13.14.1871; Burton JN, 2013, NAT BIOTECHNOL, V31, P1119, DOI 10.1038/nbt.2727; Bystricky K, 2005, J CELL BIOL, V168, P375, DOI 10.1083/jcb.200409091; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Cournac A, 2016, METHODS MOL BIOL, V1361, P227, DOI 10.1007/978-1-4939-3079-1_13; Cournac A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-436; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Dymond J, 2012, BIOENGINEERED, V3, P168, DOI 10.4161/bbug.19543; Dymond JS, 2011, NATURE, V477, P471, DOI 10.1038/nature10403; Flot JF, 2015, FEBS LETT, V589, P2966, DOI 10.1016/j.febslet.2015.04.034; Guacci V, 1997, MOL BIOL CELL, V8, P957, DOI 10.1091/mbc.8.6.957; Guidi M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0766-2; Haeusler RA, 2004, CELL CYCLE, V3, P273; HILDEBRANDT ER, 1995, CELL, V81, P331, DOI 10.1016/0092-8674(95)90386-0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kaplan N, 2013, NAT BIOTECHNOL, V31, P1143, DOI 10.1038/nbt.2768; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lesne A, 2014, NAT METHODS, V11, P1141, DOI [10.1038/nmeth.3104, 10.1038/NMETH.3104]; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Louis EJ, 2005, BIOESSAYS, V27, P685, DOI 10.1002/bies.20259; Marie-Nelly H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6695; Marie-Nelly H, 2014, BIOINFORMATICS, V30, P2105, DOI 10.1093/bioinformatics/btu162; Miele A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000478; Mitchell LA, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4831; Oakes M, 1998, J CELL BIOL, V143, P23, DOI 10.1083/jcb.143.1.23; Rabl C, 1885, MORPHOL JB, V10, P214; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richardson SM, 2017, SCIENCE, V355, P1040, DOI 10.1126/science.aaf4557; Schober H, 2008, GENOME RES, V18, P261, DOI 10.1101/gr.6687808; SHARP PM, 1993, NUCLEIC ACIDS RES, V21, P179, DOI 10.1093/nar/21.2.179; Shen Y, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4791; Shen Y, 2016, GENOME RES, V26, P36, DOI 10.1101/gr.193433.115; Taddei A, 2012, GENETICS, V192, P107, DOI 10.1534/genetics.112.140608; Therizols P, 2010, P NATL ACAD SCI USA, V107, P2025, DOI 10.1073/pnas.0914187107; Thompson M, 2003, SCIENCE, V302, P1399, DOI 10.1126/science.1089814; Wu Y, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4706; Xie ZX, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4704; Zhang WM, 2017, SCIENCE, V355, DOI 10.1126/science.aaf3981	42	76	89	6	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI				eaaf4597	10.1126/science.aaf4597	http://dx.doi.org/10.1126/science.aaf4597			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9VY	28280150	Green Accepted, Green Submitted			2022-12-28	WOS:000396348900037
J	Wu, Y; Li, BZ; Zhao, M; Mitchell, LA; Xie, ZX; Lin, QH; Wang, X; Xiao, WH; Wang, Y; Zhou, X; Liu, H; Li, X; Ding, MZ; Liu, D; Zhang, L; Liu, BL; Wu, XL; Li, FF; Dong, XT; Jia, B; Zhang, WZ; Jiang, GZ; Liu, Y; Bai, X; Song, TQ; Chen, Y; Zhou, SJ; Zhu, RY; Gao, F; Kuang, Z; Wang, XY; Shen, M; Yang, K; Stracquadanio, G; Richardson, SM; Lin, YC; Wang, LH; Walker, R; Luo, YS; Ma, PS; Yang, HM; Cai, YZ; Dai, JB; Bader, JS; Boeke, JD; Yuan, YJ				Wu, Yi; Li, Bing-Zhi; Zhao, Meng; Mitchell, Leslie A.; Xie, Ze-Xiong; Lin, Qiu-Hui; Wang, Xia; Xiao, Wen-Hai; Wang, Ying; Zhou, Xiao; Liu, Hong; Li, Xia; Ding, Ming-Zhu; Liu, Duo; Zhang, Lu; Liu, Bao-Li; Wu, Xiao-Le; Li, Fei-Fei; Dong, Xiu-Tao; Jia, Bin; Zhang, Wen-Zheng; Jiang, Guo-Zhen; Liu, Yue; Bai, Xue; Song, Tian-Qing; Chen, Yan; Zhou, Si-Jie; Zhu, Rui-Ying; Gao, Feng; Kuang, Zheng; Wang, Xuya; Shen, Michael; Yang, Kun; Stracquadanio, Giovanni; Richardson, Sarah M.; Lin, Yicong; Wang, Lihui; Walker, Roy; Luo, Yisha; Ma, Ping-Sheng; Yang, Huanming; Cai, Yizhi; Dai, Junbiao; Bader, Joel S.; Boeke, Jef D.; Yuan, Ying-Jin			Bug mapping and fitness testing of chemically synthesized chromosome X	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST; BINDING; PROTEIN; DIVERSITY; SEQUENCE; NETWORK; SITES	Debugging a genome sequence is imperative for successfully building a synthetic genome. As part of the effort to build a designer eukaryotic genome, yeast synthetic chromosome X (synX), designed as 707,459 base pairs, was synthesized chemically. SynX exhibited good fitness under a wide variety of conditions. A highly efficient mapping strategy called pooled PCRTag mapping (PoPM), which can be generalized to any watermarked synthetic chromosome, was developed to identify genetic alterations that affect cell fitness ("bugs"). A series of bugs were corrected that included a large region bearing complex amplifications, a growth defect mapping to a recoded sequence in FIP1, and a loxPsymsite affecting promoter function of ATP2. PoPM is a powerful tool for synthetic yeast genome debugging and an efficient strategy for phenotype-genotype mapping.	[Wu, Yi; Li, Bing-Zhi; Zhao, Meng; Xie, Ze-Xiong; Lin, Qiu-Hui; Wang, Xia; Xiao, Wen-Hai; Wang, Ying; Zhou, Xiao; Liu, Hong; Li, Xia; Ding, Ming-Zhu; Liu, Duo; Zhang, Lu; Liu, Bao-Li; Wu, Xiao-Le; Li, Fei-Fei; Dong, Xiu-Tao; Jia, Bin; Zhang, Wen-Zheng; Jiang, Guo-Zhen; Liu, Yue; Bai, Xue; Song, Tian-Qing; Chen, Yan; Zhou, Si-Jie; Zhu, Rui-Ying; Gao, Feng; Ma, Ping-Sheng; Yuan, Ying-Jin] Tianjin Univ, Sch Chem Engn & Technol, Minist Educ, Key Lab Syst Bioengn, Tianjin 300072, Peoples R China; [Wu, Yi; Li, Bing-Zhi; Zhao, Meng; Xie, Ze-Xiong; Lin, Qiu-Hui; Wang, Xia; Xiao, Wen-Hai; Wang, Ying; Zhou, Xiao; Liu, Hong; Li, Xia; Ding, Ming-Zhu; Liu, Duo; Zhang, Lu; Liu, Bao-Li; Wu, Xiao-Le; Li, Fei-Fei; Dong, Xiu-Tao; Jia, Bin; Zhang, Wen-Zheng; Jiang, Guo-Zhen; Liu, Yue; Bai, Xue; Song, Tian-Qing; Chen, Yan; Zhou, Si-Jie; Zhu, Rui-Ying; Gao, Feng; Ma, Ping-Sheng; Yuan, Ying-Jin] Tianjin Univ, SynBio Res Platform, Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Tianjin 300072, Peoples R China; [Mitchell, Leslie A.; Kuang, Zheng; Wang, Xuya; Shen, Michael; Boeke, Jef D.] NYU, Inst Syst Genet, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Mitchell, Leslie A.; Kuang, Zheng; Wang, Xuya; Shen, Michael; Boeke, Jef D.] NYU, Dept Biochem & Mol Pharmacol, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Yang, Kun; Stracquadanio, Giovanni; Richardson, Sarah M.; Bader, Joel S.] Johns Hopkins Univ, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Yang, Kun; Stracquadanio, Giovanni; Richardson, Sarah M.; Bader, Joel S.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA; [Stracquadanio, Giovanni] Univ Essex, Sch Comp Sci & Elect Engn, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England; [Lin, Yicong; Wang, Lihui; Dai, Junbiao] Tsinghua Univ, Key Lab Ind Biocatalysis, Minist Educ, Ctr Synthet & Syst Biol,Sch Life Sci, Beijing 100084, Peoples R China; [Walker, Roy; Luo, Yisha; Cai, Yizhi] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3BF, Midlothian, Scotland; [Yang, Huanming] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Yang, Huanming] James D Watson Inst Genome Sci, Hangzhou 310058, Zhejiang, Peoples R China	Tianjin University; Tianjin University; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Johns Hopkins University; Johns Hopkins University; University of Essex; Tsinghua University; University of Edinburgh; Beijing Genomics Institute (BGI)	Yuan, YJ (corresponding author), Tianjin Univ, Sch Chem Engn & Technol, Minist Educ, Key Lab Syst Bioengn, Tianjin 300072, Peoples R China.; Yuan, YJ (corresponding author), Tianjin Univ, SynBio Res Platform, Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Tianjin 300072, Peoples R China.	yjyuan@tju.edu.cn	Stracquadanio, Giovanni/AAL-2648-2021; 陈, 艳/AHB-8379-2022; Kuang, Zheng/ABG-3667-2021; Dai, Junbiao/AAB-8328-2021; Gao, Feng/C-9913-2009; li, bing/GWQ-9617-2022; li, bz/GVR-7133-2022; Cai, Yizhi/A-3550-2010	Stracquadanio, Giovanni/0000-0001-9819-3645; Dai, Junbiao/0000-0002-5299-4700; Gao, Feng/0000-0002-9563-3841; Xie, Zexiong/0000-0002-6214-9009; Walker, Roy/0000-0003-0960-4591; Liu, Yue/0000-0002-8051-5156; Cai, Yizhi/0000-0003-1663-2865; Mitchell, Leslie/0000-0001-7869-9817; Richardson, Sarah/0000-0002-9820-9421; Wu, Yi/0000-0002-2539-9228	"863" program [2012AA02A708]; "973" program [2014CB745100]; Ministry of Science and Technology [2015DFA00960]; China National Natural Science Foundation of China [21390203, 21621004]; U.S. NSF [MCB-1026068, MCB-1158201, MCB-1445545]; U.S. Department of Energy [DE-FG02097ER25308]; Chancellor's Fellowship from the University of Edinburgh; Scottish Universities Life Sciences Alliance (SULSA); Biotechnology and Biological Sciences Research Counci [BB/M005690/1, BB/M025640/1, BB/M00029X/1]; Biotechnology and Biological Sciences Research Council [BB/M005690/1, BBS/OS/GC/000001, BB/M00029X/1, BB/M005690/2, BB/M025640/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/P017401/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007308] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1616111] Funding Source: National Science Foundation; BBSRC [BB/M00029X/1, BB/M005690/2, BB/M025640/1, BB/M005690/1] Funding Source: UKRI; EPSRC [EP/P017401/1] Funding Source: UKRI	"863" program(National High Technology Research and Development Program of China); "973" program(National Basic Research Program of China); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); China National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. NSF(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); Chancellor's Fellowship from the University of Edinburgh; Scottish Universities Life Sciences Alliance (SULSA); Biotechnology and Biological Sciences Research Counci(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Work in Tianjin University was funded by "863" program: 2012AA02A708, "973" program: 2014CB745100, and international cooperative project: 2015DFA00960 from the Ministry of Science and Technology, and China National Natural Science Foundation of China: 21390203 and 21621004. U.S. research was funded by U.S. NSF grants MCB-1026068, MCB-1158201 to J.D.B. and MCB-1445545 to J.S.B., and U.S. Department of Energy DE-FG02097ER25308 to S.M.R.. J.D.B. and J.S.B. are founders and directors of Neochromosome Inc. J.D.B. serves as a scientific advisor to Recombinetics Inc. and Sample6, Inc. These arrangements are reviewed and managed by the committees on Conflict of interest at NYU Langone Medical Center (J.D.B.) and Johns Hopkins University (J.S.B.). U.K. research was funded by a Chancellor's Fellowship from the University of Edinburgh, a start-up fund from Scottish Universities Life Sciences Alliance (SULSA), and Biotechnology and Biological Sciences Research Counci grants BB/M005690/1, BB/M025640/1, and BB/M00029X/1 to Y.C. We thank A. Heguy and the staff at NYU's Genome Technology Center for outstanding deep-sequencing services. Additional information (synX design diagram, PCRTag sequences, Feature summary table (wild-type X, designed synX, physical strain yYW0115; yeast_chr10_9_01), Variants in physical strain (yeast_chr10_9_01), Minichunk plasmids, PCR primers) related to synX can be accessed on the Sc2.0 website http://syntheticyeast.org, under main menu Sc2.0. Data. All genomic data for this paper are available under the Sc2.0 umbrella BioProject accession number PRJNA351844. Requests for materials should be addressed to Y.-J. Yuan (yjyuan@tju.edu.cn).	Agmon N, 2015, ACS SYNTH BIOL, V4, P853, DOI 10.1021/sb500372z; Annaluru N, 2014, SCIENCE, V344, P55, DOI 10.1126/science.1249252; Baker M, 2011, NATURE, V473, P403, DOI 10.1038/473403a; Ben-Shitrit T, 2012, NAT METHODS, V9, P373, DOI [10.1038/NMETH.1890, 10.1038/nmeth.1890]; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Dymond J, 2012, BIOENGINEERED, V3, P168, DOI 10.4161/bbug.19543; Dymond JS, 2011, NATURE, V477, P471, DOI 10.1038/nature10403; Falcon AA, 2005, FEMS MICROBIOL LETT, V250, P245, DOI 10.1016/j.femsle.2005.07.018; FUTCHER B, 1988, GENETICS, V118, P411; Galibert F, 1996, EMBO J, V15, P2031, DOI 10.1002/j.1460-2075.1996.tb00557.x; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GRAHAM IR, 1994, NUCLEIC ACIDS RES, V22, P124, DOI 10.1093/nar/22.2.124; Idrissi FZ, 1999, BIOCHEM J, V341, P477, DOI 10.1042/0264-6021:3410477; Johnston M, 1996, CURR BIOL, V6, P500, DOI 10.1016/S0960-9822(02)00526-2; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Mitchell LA, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4831; Mitchell LA, 2014, P NATL ACAD SCI USA, V111, P17003, DOI 10.1073/pnas.1414399111; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Picotti P, 2013, NATURE, V494, P266, DOI 10.1038/nature11835; Richardson SM, 2017, SCIENCE, V355, P1040, DOI 10.1126/science.aaf4557; SALTZGABERMULLER J, 1983, J BIOL CHEM, V258, P1465; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; Shen Y, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4791; Shen Y, 2016, GENOME RES, V26, P36, DOI 10.1101/gr.193433.115; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Xie ZX, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4704; Yarrington RM, 2012, GENETICS, V190, P523, DOI 10.1534/genetics.111.136648; Yona AH, 2013, ELIFE, V2, DOI 10.7554/eLife.01339; Zhang WM, 2017, SCIENCE, V355, DOI 10.1126/science.aaf3981	31	127	133	25	228	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI				aaf4706	10.1126/science.aaf4706	http://dx.doi.org/10.1126/science.aaf4706			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9VY	28280152	Green Accepted			2022-12-28	WOS:000396348900035
J	Martin, WF; Thauer, RK				Martin, William F.; Thauer, Rudolf K.			Energy in Ancient Metabolism	CELL			English	Editorial Material								Modern metabolism would not work without ATP and phosphate, but in primordial biochemical networks, energy currencies might have been simpler. Goldford et al. report a novel systems approach to reconstructing energetics in ancient metabolism, with very interesting results.	[Martin, William F.] Univ Dusseldorf, Inst Mol Evolut, D-40225 Dusseldorf, Germany; [Thauer, Rudolf K.] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany	Heinrich Heine University Dusseldorf; Max Planck Society	Martin, WF (corresponding author), Univ Dusseldorf, Inst Mol Evolut, D-40225 Dusseldorf, Germany.	bill@hhu.de	Martin, William F./O-5446-2015	Martin, William F./0000-0003-1478-6449				ANDREESEN JR, 1994, ANTON LEEUW INT J G, V66, P223, DOI 10.1007/BF00871641; Basen M, 2017, EXTREMOPHILES, V21, P15, DOI 10.1007/s00792-016-0873-3; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; DECKER K, 1970, ANGEW CHEM INT EDIT, V9, P138, DOI 10.1002/anie.197001381; Fuchs G, 2011, ANNU REV MICROBIOL, V65, P631, DOI 10.1146/annurev-micro-090110-102801; Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07; Semenov SN, 2016, NATURE, V537, P656, DOI 10.1038/nature19776; Sleep NH, 2011, PHILOS T R SOC B, V366, P2857, DOI 10.1098/rstb.2011.0129; WALD G, 1964, P NATL ACAD SCI USA, V52, P595, DOI 10.1073/pnas.52.2.595	10	26	26	1	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2017	168	6					953	955		10.1016/j.cell.2017.02.032	http://dx.doi.org/10.1016/j.cell.2017.02.032			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8ZF	28283068	Bronze			2022-12-28	WOS:000396287900004
J	Hampton, T				Hampton, Tracy			Weakened Connectivity in Fetal Brains Prior to Preterm Birth	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2017	317	9					899	899		10.1001/jama.2017.1385	http://dx.doi.org/10.1001/jama.2017.1385			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4NM	28267844				2022-12-28	WOS:000426801600002
J	Munoz, W; Tremblay, R; Levenstein, D; Rudy, B				Munoz, William; Tremblay, Robin; Levenstein, Daniel; Rudy, Bernardo			Layer-specific modulation of neocortical dendritic inhibition during active wakefulness	SCIENCE			English	Article							BARREL CORTEX; GABAERGIC INTERNEURONS; CELLULAR MECHANISM; PYRAMIDAL NEURONS; VISUAL-CORTEX; ORGANIZATION; INTEGRATION; CIRCUITS; DYNAMICS; THALAMUS	gamma-Aminobutyric acid (GABA) ergic inputs are strategically positioned to gate synaptic integration along the dendritic arbor of pyramidal cells. However, their spatiotemporal dynamics during behavior are poorly understood. Using an optical-tagging electrophysiological approach to record and label somatostatin-expressing (Sst) interneurons (GABAergic neurons specialized for dendritic inhibition), we discovered a layer-specific modulation of their activity in behaving mice. Sst interneuron subtypes, residing in different cortical layers and innervating complementary laminar domains, exhibited opposite activity changes during transitions to active wakefulness. The relative weight of vasoactive intestinal peptide-expressing (Vip) interneuron-mediated inhibition of distinct Sst interneurons and cholinergic modulation determined their in vivo activity. These results reveal a state-dependent laminar influence of Sst interneuron-mediated inhibition, with implications for the compartmentalized regulation of dendritic signaling in the mammalian neocortex.	[Munoz, William; Tremblay, Robin; Levenstein, Daniel; Rudy, Bernardo] NYU, Sch Med, Inst Neurosci, 550 First Ave, New York, NY 10016 USA; [Munoz, William; Tremblay, Robin; Levenstein, Daniel; Rudy, Bernardo] NYU, Sch Med, Dept Neurosci & Physiol, 550 First Ave, New York, NY 10016 USA; [Levenstein, Daniel] NYU, Ctr Neural Sci, 4 Washington Pl, New York, NY 10003 USA; [Rudy, Bernardo] NYU, Sch Med, Dept Anesthesiol Perioperat Care & Pain Med, 550 First Ave, New York, NY 10016 USA	New York University; New York University; New York University; New York University	Rudy, B (corresponding author), NYU, Sch Med, Inst Neurosci, 550 First Ave, New York, NY 10016 USA.; Rudy, B (corresponding author), NYU, Sch Med, Dept Neurosci & Physiol, 550 First Ave, New York, NY 10016 USA.; Rudy, B (corresponding author), NYU, Sch Med, Dept Anesthesiol Perioperat Care & Pain Med, 550 First Ave, New York, NY 10016 USA.	bernardo.rudy@nyumc.org	Levenstein, Daniel/AGJ-7255-2022	Munoz, William/0000-0002-1354-3472; Rudy, Bernardo/0000-0001-5748-6900; Levenstein, Daniel/0000-0002-5507-9145	NIH [R01NS30989, R21NS093987, P01NS074972]; National Research Service Award (NRSA) fellowship [F31NS087919]; Natural Sciences and Engineering Research Council of Canada (NSERC); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030989, P01NS074972, R21NS093987] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award (NRSA) fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to G. Buzsaki, G. Fishell, R. Froemke, W. Gan, R. Hardstone, I. Kruglikov, K. Kuchibhotla, S. Lee, M. Long, and M. Nigro for helpful discussions and comments on the manuscript. We are also grateful to Y. Hashikawa for assistance with histological analyses. Key reagents were provided by S. Tonegawa (Chrm1-conditional mice), J. Wess (Chrm3-conditional mice), J. Dimidschstein and G. Fishell (AAV-mDlx-ChR2 virus), J. Basu and S. Sternson (AAV-DIO-PSAM<SUP>L141F</SUP>-GlyR virus), and Z. J. Huang (AAV-fDIO-mCherry virus). Chrm1-conditional mice are available from S. Tonegawa under a material transfer agreement with the Massachusetts Institute of Technology. Chrm3-conditional mice are available from J. Wess under a material transfer agreement with the National Institute of Diabetes and Digestive and Kidney Diseases. This work was supported by NIH grants R01NS30989, R21NS093987, and P01NS074972 to B.R.; National Research Service Award (NRSA) fellowship F31NS087919 to W.M.; and a Graduate Research Fellowship to R.T. from the Natural Sciences and Engineering Research Council of Canada (NSERC). Electrophysiological and histological data in this manuscript are stored in the laboratory computers. MATLAB-based data processing codes can be accessed online (https://github.com/dlevenstein/DLevenstein-Code).	Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Chen NY, 2015, NAT NEUROSCI, V18, P892, DOI 10.1038/nn.4002; Chiu CQ, 2013, SCIENCE, V340, P759, DOI 10.1126/science.1234274; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; de Kock CPJ, 2009, P NATL ACAD SCI USA, V106, P16446, DOI 10.1073/pnas.0904143106; Dimidschstein J, 2016, NAT NEUROSCI, V19, P1743, DOI 10.1038/nn.4430; Eggermann E, 2014, CELL REP, V9, P1654, DOI 10.1016/j.celrep.2014.11.005; Fu Y, 2014, CELL, V156, P1139, DOI 10.1016/j.cell.2014.01.050; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Jiang XL, 2015, SCIENCE, V350, DOI 10.1126/science.aac9462; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; Kawaguchi Y, 1997, J NEUROPHYSIOL, V78, P1743, DOI 10.1152/jn.1997.78.3.1743; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Larkum M, 2013, TRENDS NEUROSCI, V36, P141, DOI 10.1016/j.tins.2012.11.006; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Lee S, 2013, NAT NEUROSCI, V16, P1662, DOI 10.1038/nn.3544; Lee S, 2010, J NEUROSCI, V30, P16796, DOI 10.1523/JNEUROSCI.1869-10.2010; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; McGinley MJ, 2015, NEURON, V87, P1143, DOI 10.1016/j.neuron.2015.09.012; McGinley MJ, 2015, NEURON, V87, P179, DOI 10.1016/j.neuron.2015.05.038; Mullner FE, 2015, NEURON, V87, P576, DOI 10.1016/j.neuron.2015.07.003; Munoz W, 2014, CELL REP, V9, P2304, DOI 10.1016/j.celrep.2014.11.042; Munoz W, 2014, CURR OPIN NEUROBIOL, V26, P149, DOI 10.1016/j.conb.2014.02.015; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Nelson A, 2016, NEURON, V90, P635, DOI 10.1016/j.neuron.2016.03.031; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Poulet JFA, 2012, NAT NEUROSCI, V15, P370, DOI 10.1038/nn.3035; Pronneke A, 2015, CEREB CORTEX, V25, P4854, DOI 10.1093/cercor/bhv202; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tremblay R, 2016, NEURON, V91, P260, DOI 10.1016/j.neuron.2016.06.033; Urbain N, 2015, CELL REP, V13, P647, DOI 10.1016/j.celrep.2015.09.029; Xu H, 2013, NEURON, V77, P155, DOI 10.1016/j.neuron.2012.11.004; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Yu JN, 2016, NAT NEUROSCI, V19, P1647, DOI 10.1038/nn.4412; Zhang SY, 2014, SCIENCE, V345, P660, DOI 10.1126/science.1254126	48	159	159	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					954	958		10.1126/science.aag2599	http://dx.doi.org/10.1126/science.aag2599			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2YM	28254942				2022-12-28	WOS:000395181700040
J	Yu, H; Siewny, MGW; Edwards, DT; Sanders, AW; Perkins, TT				Yu, Hao; Siewny, Matthew G. W.; Edwards, Devin T.; Sanders, Aric W.; Perkins, Thomas T.			Hidden dynamics in the unfolding of individual bacteriorhodopsin proteins	SCIENCE			English	Article							MOLECULE FORCE SPECTROSCOPY; SINGLE CALMODULIN MOLECULES; FOLDING ENERGY LANDSCAPES; MEMBRANE-PROTEINS; MICROSCOPY; STABILITY; VELOCITY; NETWORK; TITIN	Protein folding occurs as a set of transitions between structural states within an energy landscape. An oversimplified view of the folding process emerges when transiently populated states are undetected because of limited instrumental resolution. Using force spectroscopy optimized for 1-microsecond resolution, we reexamined the unfolding of individual bacteriorhodopsin molecules in native lipid bilayers. The experimental data reveal the unfolding pathway in unprecedented detail. Numerous newly detected intermediates-many separated by as few as two or three amino acids-exhibited complex dynamics, including frequent refolding and state occupancies of <10 mu s. Equilibrium measurements between such states enabled the folding free-energy landscape to be deduced. These results sharpen the picture of the mechanical unfolding of membrane proteins and, more broadly, enable experimental access to previously obscured protein dynamics.	[Yu, Hao; Siewny, Matthew G. W.; Edwards, Devin T.; Perkins, Thomas T.] NIST, JILA, Boulder, CO 80309 USA; [Yu, Hao; Siewny, Matthew G. W.; Edwards, Devin T.; Perkins, Thomas T.] Univ Colorado, Boulder, CO 80309 USA; [Siewny, Matthew G. W.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Sanders, Aric W.] Natl Inst Stand & Technol, Radio Frequency Technol Div, Boulder, CO 80305 USA; [Perkins, Thomas T.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder	Perkins, TT (corresponding author), NIST, JILA, Boulder, CO 80309 USA.; Perkins, TT (corresponding author), Univ Colorado, Boulder, CO 80309 USA.; Perkins, TT (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	tperkins@jila.colorado.edu	; Sanders, Aric/P-6914-2014	Perkins, Thomas/0000-0003-4826-9490; Sanders, Aric/0000-0003-3371-8054; YU, HAO/0000-0003-1589-7781; EDWARDS, DEVIN/0000-0002-2612-9561	National Institute of Health Molecular Biophysics Training Grant [T32 GM-065103]; National Research Council; National Science Foundation [DBI-135398, Phys-1125844]; National Institute of Standards and Technology (NIST); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065103] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1353987] Funding Source: National Science Foundation	National Institute of Health Molecular Biophysics Training Grant; National Research Council; National Science Foundation(National Science Foundation (NSF)); National Institute of Standards and Technology (NIST)(National Institute of Standards & Technology (NIST) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank L. Randall for providing halobacterium and protocols for preparing BR samples, L. Uyetake for purifying BR, G. King and A. Churnside for initial AFM studies of BR, M. Woodside for critical reading of the manuscript, and G. Emmanuel for sharing code for a hidden Markov model. The data presented in this paper, including supplementary figures, is available via Dryad (http://dx.doi.org/10.5061/dryad.g0n2d). This work was supported by a National Institute of Health Molecular Biophysics Training Grant Slot to M.G.W.S. (T32 GM-065103), a National Research Council Fellowship to D.T.E., the National Science Foundation (DBI-135398; Phys-1125844), and National Institute of Standards and Technology (NIST). T.T.P. is a staff member of NIST's quantum physics division.	BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BIPPES CA, 2011, Patent No. 74086601; Borgia A, 2008, ANNU REV BIOCHEM, V77, P101, DOI 10.1146/annurev.biochem.77.060706.093102; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Chung HS, 2012, SCIENCE, V335, P981, DOI 10.1126/science.1215768; Cossio P, 2015, P NATL ACAD SCI USA, V112, P14248, DOI 10.1073/pnas.1519633112; Cymer F, 2015, J MOL BIOL, V427, P999, DOI 10.1016/j.jmb.2014.09.014; Dill KA, 2012, SCIENCE, V338, P1042, DOI 10.1126/science.1219021; Dudko OK, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.108101; Edwards DT, 2015, NANO LETT, V15, P7091, DOI 10.1021/acs.nanolett.5b03166; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; He CZ, 2015, ANGEW CHEM INT EDIT, V54, P9921, DOI 10.1002/anie.201502938; Jahn M, 2016, P NATL ACAD SCI USA, V113, P1232, DOI 10.1073/pnas.1518827113; Junker JP, 2009, SCIENCE, V323, P633, DOI 10.1126/science.1166191; Kappel C, 2011, BIOPHYS J, V100, P1109, DOI 10.1016/j.bpj.2011.01.004; Kessler M, 2006, J MOL BIOL, V357, P644, DOI 10.1016/j.jmb.2005.12.065; Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; Manuel AP, 2015, P NATL ACAD SCI USA, V112, P7183, DOI 10.1073/pnas.1419490112; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; Muller DJ, 2002, BIOPHYS J, V83, P3578, DOI 10.1016/S0006-3495(02)75358-7; Nam GM, 2016, PROTEIN SCI, V25, P123, DOI 10.1002/pro.2727; Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218; Neupane K, 2016, SCIENCE, V352, P239, DOI 10.1126/science.aad0637; Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143; Onoa B, 2003, SCIENCE, V299, P1892, DOI 10.1126/science.1081338; Petrosyan R, 2015, NANO LETT, V15, P3624, DOI 10.1021/acs.nanolett.5b01223; Preiner J, 2007, BIOPHYS J, V93, P930, DOI 10.1529/biophysj.106.096982; Puchner EM, 2012, ANNU REV BIOPHYS, V41, P497, DOI 10.1146/annurev-biophys-050511-102301; Rhee YM, 2005, J PHYS CHEM B, V109, P6780, DOI 10.1021/jp045544s; Rico F, 2013, SCIENCE, V342, P741, DOI 10.1126/science.1239764; Sapra KT, 2006, J MOL BIOL, V355, P640, DOI 10.1016/j.jmb.2005.10.080; Savinov A, 2014, BBA-GENE REGUL MECH, V1839, P1030, DOI 10.1016/j.bbagrm.2014.04.005; Stigler J, 2011, SCIENCE, V334, P512, DOI 10.1126/science.1207598; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; Woodside MT, 2006, SCIENCE, V314, P1001, DOI 10.1126/science.1133601; Zhang YJ, 2013, P NATL ACAD SCI USA, V110, P16432, DOI 10.1073/pnas.1309101110; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048; Zocher M, 2012, ACS NANO, V6, P961, DOI 10.1021/nn204624p	40	148	148	4	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					945	949		10.1126/science.aah7124	http://dx.doi.org/10.1126/science.aah7124			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2YM	28254940	Green Accepted			2022-12-28	WOS:000395181700038
J	Afshar, M; Alhussein, M				Afshar, Mehdi; Alhussein, Mosaad			Iodide-Associated Sialadenitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Afshar, Mehdi] McGill Univ, Montreal, PQ, Canada; [Alhussein, Mosaad] Univ Toronto, Toronto, ON, Canada	McGill University; University of Toronto	Afshar, M (corresponding author), McGill Univ, Montreal, PQ, Canada.	m.afshar.h@gmail.com		Afshar, Mehdi/0000-0003-0927-9549					0	5	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2017	376	9					868	868		10.1056/NEJMicm1609848	http://dx.doi.org/10.1056/NEJMicm1609848			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9JK	28249137				2022-12-28	WOS:000395627500010
J	Walther, DM; Kasturi, P; Zheng, M; Pinkert, S; Vecchi, G; Ciryam, P; Morimoto, RI; Dobson, CM; Vendruscolo, M; Mann, M; Hartl, FU				Walther, Dirk M.; Kasturi, Prasad; Zheng, Min; Pinkert, Stefan; Vecchi, Giulia; Ciryam, Prajwal; Morimoto, Richard I.; Dobson, Christopher M.; Vendruscolo, Michele; Mann, Matthias; Hartl, F. Ulrich			Widespread Proteome Remodeling and Aggregation in Aging C. elegans (vol 161, pg 919, 2015)	CELL			English	Correction												uhartl@biochem.mpg.de	Kasturi, Prasad/GLT-6507-2022; Vendruscolo, Michele/F-5901-2012	Kasturi, Prasad/0000-0002-3611-5489; Vendruscolo, Michele/0000-0002-3616-1610	NATIONAL INSTITUTE ON AGING [P01AG049665] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG049665] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Walther DM, 2015, CELL, V161, P919, DOI 10.1016/j.cell.2015.03.032	1	11	11	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2017	168	5					944	944		10.1016/j.cell.2016.12.041	http://dx.doi.org/10.1016/j.cell.2016.12.041			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8YB	28235202	Bronze, Green Submitted			2022-12-28	WOS:000396284800021
J	Betz, ME; Ranney, ML; Wintemute, GJ				Betz, Marian E.; Ranney, Megan L.; Wintemute, Garen J.			Physicians, Patients, and Firearms: The Courts Say "Yes"	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SAFETY		UC Davis Sch Med, Sacramento, CA USA; Univ Colorado, Sch Med, Denver, CO USA; Brown Univ, Warren Alpert Med Sch, Rhode Isl Hosp, Providence, RI 02912 USA; [Betz, Marian E.] Univ Colorado, Dept Emergency Med, 12401 East 17th Ave B-215, Aurora, CO 80045 USA; [Ranney, Megan L.] Brown Univ, Warren Alpert Med Sch, Dept Emergency Med, 593 Eddy St,Claverick 2, Providence, RI 02903 USA; [Wintemute, Garen J.] UC Davis Med Ctr, Violence Prevent Res Program, 2315 Stockton Blvd, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; Brown University; University of California System; University of California Davis	Betz, ME (corresponding author), Univ Colorado, Dept Emergency Med, 12401 East 17th Ave B-215, Aurora, CO 80045 USA.	marian.betz@ucdenver.edu	Betz, Marian/H-3303-2017	Betz, Marian/0000-0003-1643-6565	California Wellness Foundation [2014255]; Heising-Simons Foundation [2016-219]	California Wellness Foundation; Heising-Simons Foundation	Dr. Wintemute's work on this project was supported by The California Wellness Foundation (grant 2014255) and the Heising-Simons Foundation (grant 2016-219).	Betz ME, 2016, ANN INTERN MED, V165, P543, DOI 10.7326/M16-0739; Betz ME, 2015, JAMA-J AM MED ASSOC, V314, P449, DOI 10.1001/jama.2015.7055; Garbutt JM, 2016, J PEDIATR-US, V179, P166, DOI 10.1016/j.jpeds.2016.08.019; McCourt AD, 2017, JAMA INTERN MED, V177, P96, DOI 10.1001/jamainternmed.2016.5704; National Shooting Sports Foundation, 2014, FIR RESP HOM; Office of the Attorney General of Massachusetts, 2017, TALK PAT GUN SAF; Weinberger SE, 2015, ANN INTERN MED, V162, P513, DOI 10.7326/M15-0337; Wintemute GJ, 2016, ANN INTERN MED, V165, P205, DOI 10.7326/M15-2905	8	10	10	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2017	166	10					745	+		10.7326/M17-0489	http://dx.doi.org/10.7326/M17-0489			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU7UM	28265644				2022-12-28	WOS:000401240200020
J	Bibbins-Domingo, K; Whitlock, E; Wolff, T; Ngo-Metzger, Q; Phillips, WR; Davidson, KW; Krist, AH; Lin, JS; Mangione, CM; Kurth, AE; Garcia, FAR; Curry, SJ; Grossman, DC; Landefeld, CS; Epling, JW; Siu, AL				Bibbins-Domingo, Kirsten; Whitlock, Evelyn; Wolff, Tracy; Ngo-Metzger, Quyen; Phillips, William R.; Davidson, Karina W.; Krist, Alex H.; Lin, Jennifer S.; Mangione, Carol M.; Kurth, Ann E.; Garcia, Francisco A. R.; Curry, Susan J.; Grossman, David C.; Landefeld, C. Seth; Epling, John W., Jr.; Siu, Albert L.			Developing Recommendations for Evidence-Based Clinical Preventive Services for Diverse Populations: Methods of the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Article							CARDIOVASCULAR-DISEASE PREVENTION; PHYSICAL-ACTIVITY; HEALTHFUL DIET; ADULTS; INTERVENTIONS; INFECTION; PROMOTE	The U.S. Preventive Services Task Force (USPSTF) summarizes the principles and considerations that guide development of its recommendations for diverse U.S. populations. It uses these principles through each step in the evidence-based guideline process: developing the research plan, conducting the evidence review, developing the recommendation, and communicating to guideline users. Three recent recommendations provide examples of how the USPSTF has used these principles: the 2015 recommendation on screening for abnormal blood glucose and type 2 diabetes; the 2016 recommendation on screening for breast cancer; and the recommendation on screening for prostate cancer, which is currently in progress. A more comprehensive list of recommendations that includes considerations for specific populations is also provided.	[Bibbins-Domingo, Kirsten] Univ Calif San Francisco, Dept Med, 550 16th St,Box 1364, San Francisco, CA 94158 USA; [Whitlock, Evelyn] Patient Ctr Outcomes Res Inst, 1828 L St NW,Suite 900, Washington, DC 20036 USA; [Wolff, Tracy; Ngo-Metzger, Quyen] Agcy Healthcare Res & Qual, 5600 Fishers Lane, Rockville, MD 20857 USA; [Phillips, William R.] Univ Washington, Dept Family Med, Box 356390, Seattle, WA 98195 USA; [Grossman, David C.] Grp Hlth Res Inst, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA; [Davidson, Karina W.] Columbia Univ, Med Ctr, 622 West 168th St, New York, NY 10032 USA; [Siu, Albert L.] Mt Sinai Med Ctr, One Gustave L Levy Pl,Box 1070, New York, NY 10029 USA; [Krist, Alex H.] Virginia Commonwealth Univ, One Capital Sq,830 East Main St,Room 631, Richmond, VA 23219 USA; [Lin, Jennifer S.] Kaiser Permanente, Res Affiliates Evidence Based Practice Ctr, 3800 North Interstate Ave, Portland, OR 97227 USA; [Mangione, Carol M.] Univ Calif Los Angeles, 10940 Wilshire Blvd,Suite 700, Los Angeles, CA 90024 USA; Yale Univ, New Haven, CT USA; [Garcia, Francisco A. R.] Pima Cty Dept Hlth, 3950 South Country Club Rd,Suite 100, Tucson, AZ 85714 USA; [Curry, Susan J.] Univ Iowa, Coll Publ Hlth Bldg,Room S153A, Iowa City, IA 52242 USA; [Landefeld, C. Seth] Univ Alabama Birmingham, Boshell Diabet Bldg,Room 420, Birmingham, AL 35233 USA; [Epling, John W., Jr.] SUNY Upstate Med Univ, Madison Irving Med Ctr, Suite 200,475 Irving Ave, Syracuse, NY 13210 USA; [Kurth, Ann E.] Yale Univ, 400 West Campus Dr, Orange, CT 06477 USA	University of California System; University of California San Francisco; Agency for Healthcare Research & Quality; University of Washington; University of Washington Seattle; Columbia University; Icahn School of Medicine at Mount Sinai; Virginia Commonwealth University; Kaiser Permanente; University of California System; University of California Los Angeles; Yale University; University of Iowa; University of Alabama System; University of Alabama Birmingham; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Yale University	Bibbins-Domingo, K (corresponding author), Care of Nicolella L, Agcy Healthcare Res & Qual, 5600 Fishers Lane, Rockville, MD 20857 USA.		Phillips, William R./V-1065-2017; Epling, John W/J-1097-2019; Davidson, Karina/AAG-2388-2019; Davidson, Karina/GWC-0996-2022	Phillips, William R./0000-0003-2802-4349; Epling, John W/0000-0001-9445-8669; Davidson, Karina/0000-0002-9162-477X; Davidson, Karina/0000-0002-9162-477X	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Dr. Bibbins-Domingo is the current chair of the U.S. Preventive Services Task Force (USPSTF) and has been a member since 2010. Dr. Whitlock reports a contract for support work from Kaiser Permanente during the conduct of the study. Dr. Lin reports funding from the Agency for Healthcare Research and Quality to support the USPSTF during the conduct of the study. Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOflnterestForms.do?msNum=M16-2656.	Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P962, DOI 10.1001/jama.2016.11046; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V315, P2564, DOI 10.1001/jama.2016.5989; Freeman HP, 2005, NIH PUBLICATION; Golden SH, 2012, J CLIN ENDOCR METAB, V97, pE1579, DOI 10.1210/jc.2012-2043; LeFevre ML, 2014, ANN INTERN MED, V161, P587, DOI 10.7326/M14-1796; LeFevre ML, 2014, ANN INTERN MED, V161, P281, DOI 10.7326/M14-1204; LeFevre ML, 2014, ANN INTERN MED, V161, P58, DOI 10.7326/M14-1018; Moyer VA, 2013, ANN INTERN MED, V158, P478, DOI 10.7326/0003-4819-158-6-201303190-00588; Moyer VA, 2012, ANN INTERN MED, V157, P367, DOI 10.7326/0003-4819-157-5-201209040-00486; Siu AL, 2015, ANN INTERN MED, V163, P861, DOI 10.7326/M15-2345; Siu AL, 2016, ANN INTERN MED, V164, P279, DOI 10.7326/M15-2886; Siu AL, 2015, ANN INTERN MED, V163, P622, DOI 10.7326/M15-2023; U.S. Preventive Services Task Force, 2016, AB THE USPSTF; U.S. Preventive Services Task Force, 2016, SCREEN PROST CANC US; Whitlock EP, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0437-3	15	18	18	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 18	2017	166	8					565	+		10.7326/M16-2656	http://dx.doi.org/10.7326/M16-2656			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ES1RF	28265649	Green Submitted			2022-12-28	WOS:000399304000016
J	McCullough, PA; Zhang, J; Ronco, C				McCullough, Peter A.; Zhang, Jun; Ronco, Claudio			Volume expansion and contrast-induced acute kidney injury	LANCET			English	Editorial Material							INTRAARTERIAL; METAANALYSIS; TRIALS; RISK		[McCullough, Peter A.] Baylor Univ, Med Ctr, Dallas, TX 75226 USA; [McCullough, Peter A.; Zhang, Jun] Baylor Heart & Vasc Inst, Dallas, TX 75226 USA; [McCullough, Peter A.] Baylor Jack & Jane Hamilton Heart & Vasc Hosp, Dallas, TX 75226 USA; [McCullough, Peter A.] Heart Hosp, Plano, TX USA; [Ronco, Claudio] St Bortolo Hosp, Dept Nephrol Dialysis & Transplantat, Vicenza, Italy; [Ronco, Claudio] Int Renal Res Inst, Vicenza, Italy	Baylor University; Baylor University Medical Center; ULSS 8 Berica; Ospedale San Bortolo di Vicenza	McCullough, PA (corresponding author), Baylor Univ, Med Ctr, Dallas, TX 75226 USA.; McCullough, PA (corresponding author), Baylor Heart & Vasc Inst, Dallas, TX 75226 USA.; McCullough, PA (corresponding author), Baylor Jack & Jane Hamilton Heart & Vasc Hosp, Dallas, TX 75226 USA.; McCullough, PA (corresponding author), Heart Hosp, Plano, TX USA.	peteramccullough@gmail.com		Ronco, Claudio/0000-0002-6697-4065				Bethel MA, 2012, CURR CARDIOL REP, V14, DOI 10.1007/s11886-011-0229-7; Brar SS, 2014, LANCET, V383, P1814, DOI 10.1016/S0140-6736(14)60689-9; Briguori C, 2016, AM HEART J, V173, P67, DOI 10.1016/j.ahj.2015.12.005; Dann RS, 2005, J BIOPHARM STAT, V15, P85, DOI 10.1081/BIP-200040844; Larsen Timothy R, 2016, Proc (Bayl Univ Med Cent), V29, P12; Maioli M, 2014, J AM COLL CARDIOL, V63, P1387, DOI 10.1016/j.jacc.2014.01.025; McCullough PA, 2016, J AM COLL CARDIOL, V68, P1465, DOI 10.1016/j.jacc.2016.05.099; McCullough PA, 2013, CONTRIB NEPHROL, V182, P13, DOI 10.1159/000349963; McCullough PA, 2011, CARDIORENAL MED, V1, P220, DOI 10.1159/000332384; McCullough PA, 2011, BMC MED IMAGING, V11, DOI 10.1186/1471-2342-11-12; Nijssen EC, 2017, LANCET	11	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 1	2017	389	10076					1277	1278		10.1016/S0140-6736(17)30540-8	http://dx.doi.org/10.1016/S0140-6736(17)30540-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EQ2OF	28236468				2022-12-28	WOS:000397908700005
J	Guerriero, JL; Sotayo, A; Ponichtera, HE; Castrillon, JA; Pourzia, AL; Schad, S; Johnson, SF; Carrasco, RD; Lazo, S; Bronson, RT; Davis, SP; Lobera, M; Nolan, MA; Letai, A				Guerriero, Jennifer L.; Sotayo, Alaba; Ponichtera, Holly E.; Castrillon, Jessica A.; Pourzia, Alexandra L.; Schad, Sara; Johnson, Shawn F.; Carrasco, Ruben D.; Lazo, Suzan; Bronson, Roderick T.; Davis, Scott P.; Lobera, Mercedes; Nolan, Michael A.; Letai, Anthony			Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages	NATURE			English	Article							CELLS; PROGRESSION; EXPRESSION; THERAPY; CANCER; RESPONSES; EFFICACY; MODULATE; DEFINES; PROTEIN	Although the main focus of immuno-oncology has been manipulating the adaptive immune system, harnessing both the innate and adaptive arms of the immune system might produce superior tumour reduction and elimination. Tumour-associated macrophages often have net pro-tumour effects(1), but their embedded location and their untapped potential provide impetus to discover strategies to turn them against tumours. Strategies that deplete (anti-CSF-1 antibodies and CSF-1R inhibition)(2,3) or stimulate (agonistic anti-CD40 or inhibitory anti-CD47 antibodies)(4,5) tumour-associated macrophages have had some success. We hypothesized that pharmacologic modulation of macrophage phenotype could produce an anti-tumour effect. We previously reported that a first-in-class selective class IIa histone deacetylase (HDAC) inhibitor, TMP195, influenced human monocyte responses to the colony-stimulating factors CSF-1 and CSF-2 in vitro(6). Here, we utilize a macrophage-dependent autochthonous mouse model of breast cancer to demonstrate that in vivo TMP195 treatment alters the tumour microenvironment and reduces tumour burden and pulmonary metastases by modulating macrophage phenotypes. TMP195 induces the recruitment and differentiation of highly phagocytic and stimulatory macrophages within tumours. Furthermore, combining TMP195 with chemotherapy regimens or T-cell checkpoint blockade in this model significantly enhances the durability of tumour reduction. These data introduce class IIa HDAC inhibition as a means to harness the anti-tumour potential of macrophages to enhance cancer therapy.	[Guerriero, Jennifer L.; Sotayo, Alaba; Ponichtera, Holly E.; Castrillon, Jessica A.; Pourzia, Alexandra L.; Schad, Sara; Johnson, Shawn F.; Lazo, Suzan; Letai, Anthony] Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02115 USA; [Carrasco, Ruben D.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Bronson, Roderick T.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Davis, Scott P.; Lobera, Mercedes; Nolan, Michael A.] GlaxoSmithKline, 200 Technol Sq Suite 602, Cambridge, MA 02139 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; GlaxoSmithKline	Letai, A (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02115 USA.; Nolan, MA (corresponding author), GlaxoSmithKline, 200 Technol Sq Suite 602, Cambridge, MA 02139 USA.	Michael.A.Nolan@gsk.com; Anthony_Letai@dfci.harvard.edu		Castrillon Lal, Jessica/0000-0001-5462-2671	NIH NCI [F32CA180733, R01CA205967]; Friends of Dana-Farber, Dancing for a Cure; GlaxoSmithKline; NATIONAL CANCER INSTITUTE [F32CA180733] Funding Source: NIH RePORTER	NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Friends of Dana-Farber, Dancing for a Cure; GlaxoSmithKline(GlaxoSmithKline); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Benowitz and C. Leach for their support and discussions in the preparation of the manuscript. This work was supported by NIH NCI F32CA180733 (J.L.G.), The Friends of Dana-Farber, Dancing for a Cure (J.L.G.), NIH NCI R01CA205967 (A.L.) and a sponsored research agreement from GlaxoSmithKline (A.L., J.L.G.).	Ahn GO, 2010, P NATL ACAD SCI USA, V107, P8363, DOI 10.1073/pnas.0911378107; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Bos PD, 2013, J EXP MED, V210, P2435, DOI 10.1084/jem.20130762; Burgos ES, 2015, J BIOL CHEM, V290, P9674, DOI 10.1074/jbc.M115.636894; Dahan R, 2015, CANCER CELL, V28, P285, DOI 10.1016/j.ccell.2015.08.004; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Di Giorgio E, 2015, CELL MOL LIFE SCI, V72, P73, DOI 10.1007/s00018-014-1727-8; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Garber K, 2007, J NATL CANCER I, V99, P991, DOI 10.1093/jnci/djm056; Gul N, 2014, J CLIN INVEST, V124, P812, DOI 10.1172/JCI66776; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Huang FJ, 2010, DEV BIOL, V344, P1035, DOI 10.1016/j.ydbio.2010.06.023; Jain RK, 2014, CANCER CELL, V26, P605, DOI 10.1016/j.ccell.2014.10.006; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lobera M, 2013, NAT CHEM BIOL, V9, P319, DOI [10.1038/nchembio.1223, 10.1038/NCHEMBIO.1223]; Lohela M, 2014, P NATL ACAD SCI USA, V111, pE5086, DOI 10.1073/pnas.1419899111; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Theodoulou NH, 2016, J MED CHEM, V59, P1425, DOI 10.1021/acs.jmedchem.5b00256; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; van der Sluis TC, 2015, CANCER IMMUNOL RES, V3, P1042, DOI 10.1158/2326-6066.CIR-15-0052; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Zhang M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153550	35	311	331	12	200	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2017	543	7645					428	+		10.1038/nature21409	http://dx.doi.org/10.1038/nature21409			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9RN	28273064	Green Accepted			2022-12-28	WOS:000396337400052
J	LePage, DP; Metcalf, JA; Bordenstein, SR; On, JM; Perlmutter, JI; Shropshire, JD; Layton, EM; Funkhouser-Jones, LJ; Beckmann, JF; Bordenstein, SR				LePage, Daniel P.; Metcalf, Jason A.; Bordenstein, Sarah R.; On, Jungmin; Perlmutter, Jessamyn I.; Shropshire, J. Dylan; Layton, Emily M.; Funkhouser-Jones, Lisa J.; Beckmann, John F.; Bordenstein, Seth R.			Prophage WO genes recapitulate and enhance Wolbachia-induced cytoplasmic incompatibility	NATURE			English	Article							DROSOPHILA-MELANOGASTER; PHAGE WO; PROTEIN; EXPRESSION; DATABASE; MODEL	The genus Wolbachia is an archetype of maternally inherited intracellular bacteria that infect the germline of numerous invertebrate species worldwide. They can selfishly alter arthropod sex ratios and reproductive strategies to increase the proportion of the infected matriline in the population. The most common reproductive manipulation is cytoplasmic incompatibility, which results in embryonic lethality in crosses between infected males and uninfected females. Females infected with the same Wolbachia strain rescue this lethality. Despite more than 40 years of research(1) and relevance to symbiont-induced speciation(2,3), as well as control of arbovirus vectors(4-6) and agricultural pests(7), the bacterial genes underlying cytoplasmic incompatibility remain unknown. Here we use comparative and transgenic approaches to demonstrate that two differentially transcribed, co-diverging genes in the eukaryotic association module of prophage WO8 from Wolbachia strain wMel recapitulate and enhance cytoplasmic incompatibility. Dual expression in transgenic, uninfected males of Drosophila melanogaster crossed to uninfected females causes embryonic lethality. Each gene additively augments embryonic lethality in crosses between infected males and uninfected females. Lethality associates with embryonic defects that parallel those of wild-type cytoplasmic incompatibility and is notably rescued by wMel-infected embryos in all cases. The discovery of cytoplasmic incompatibility factor genes cifA and cifB pioneers genetic studies of prophage WO-induced reproductive manipulations and informs the continuing use of Wolbachia to control dengue and Zika virus transmission to humans.	[LePage, Daniel P.; Metcalf, Jason A.; Bordenstein, Sarah R.; On, Jungmin; Perlmutter, Jessamyn I.; Shropshire, J. Dylan; Layton, Emily M.; Funkhouser-Jones, Lisa J.; Bordenstein, Seth R.] Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Beckmann, John F.] Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA; [Bordenstein, Seth R.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University; Yale University; Vanderbilt University	Bordenstein, SR (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	s.bordenstein@vanderbilt.edu		Shropshire, Dylan/0000-0003-4221-2178; Layton, Emily/0000-0002-7869-0916	National Institutes of Health (NIH) [R21 HD086833]; National Science Foundation [IOS 1456778, DEB-1501398]; NIH [5T32GM008554, T32GM07347, AI081322, CA68485, DK20593, DK58404, DK59637, EY08126]; Division Of Environmental Biology [1501398] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [1456778] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD086833] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK059637, U24DK059637, P30DK058404, P60DK020593, P30DK020593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008554, T32GM007347] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) R21 HD086833 and National Science Foundation IOS 1456778 to Seth R.B., National Science Foundation DEB-1501398 and NIH 5T32GM008554 training grant support to D.P.L., NIH T32GM07347 training grant support for J.A.M. to the Vanderbilt Medical Scientist Training Program, and NIH AI081322 to A.M.F. Imaging was performed in part through the use of the Vanderbilt University Medical Center Cell Imaging Shared Resource (supported by NIH grants CA68485, DK20593, DK58404, DK59637, and EY08126). We thank K. Jernigan and P. Snider for help with preliminary studies, and A. Brooks for assistance with figure preparation.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Beckmann JF, 2013, INSECT BIOCHEM MOLEC, V43, P867, DOI 10.1016/j.ibmb.2013.07.002; Beckmann JF, 2013, INSECT BIOCHEM MOLEC, V43, P272, DOI 10.1016/j.ibmb.2012.12.007; Bordenstein SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13155; Bordenstein SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029106; Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543; Bossan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019757; Brucker RM, 2012, TRENDS ECOL EVOL, V27, P443, DOI 10.1016/j.tree.2012.03.011; Callaini G, 1996, J INVERTEBR PATHOL, V67, P55, DOI 10.1006/jipa.1996.0009; Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021; Casiraghi M, 2001, PARASITOLOGY, V122, P93, DOI 10.1017/S0031182000007149; Chatzispyrou IA, 2015, CANCER RES, V75, P4446, DOI 10.1158/0008-5472.CAN-15-1626; Duron O, 2006, HEREDITY, V96, P493, DOI 10.1038/sj.hdy.6800831; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferguson SB, 2012, J CELL SCI, V125, P1407, DOI 10.1242/jcs.090381; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Foe V. E., 1993, DEV DROSOPHILA MELAN, pCh 3; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Gutzwiller F, 2015, G3-GENES GENOM GENET, V5, P2843, DOI 10.1534/g3.115.021931; Hurvich CM., 1993, J TIME SER ANAL, V14, P271, DOI 10.1111/j.1467-9892.1993.tb00144.x; Ishmael N, 2009, MICROBIOL-SGM, V155, P2211, DOI 10.1099/mic.0.027581-0; Jaenike J, 2006, PLOS BIOL, V4, P1852, DOI 10.1371/journal.pbio.0040325; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Klasson L, 2008, MOL BIOL EVOL, V25, P1877, DOI 10.1093/molbev/msn133; Klasson L, 2009, P NATL ACAD SCI USA, V106, P5725, DOI 10.1073/pnas.0810753106; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Landmann F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000343; Lassy CW, 1996, MECH DEVELOP, V57, P47, DOI 10.1016/0925-4773(96)00527-8; LePage DP, 2014, PEERJ, V2, DOI 10.7717/peerj.678; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Lorenzen MD, 2008, P NATL ACAD SCI USA, V105, P10085, DOI 10.1073/pnas.0800444105; Metcalf JA, 2014, PEERJ, V2, DOI 10.7717/peerj.529; O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797; Poinsot D, 1998, GENETICS, V150, P227; Reynolds KT, 2002, GENET RES, V80, P79, DOI 10.1017/S0016672302005827; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Serbus LR, 2008, ANNU REV GENET, V42, P683, DOI 10.1146/annurev.genet.41.110306.130354; Shropshire JD, 2016, MBIO, V7, DOI 10.1128/mBio.01785-15; Southall T. D., 2008, CSH PROTOC, V2008, P49; Vallenet D., 2009, DATABASE-OXFORD, V2009, DOI DOI 10.1093/DATABASE/BAP021; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Werren J. H., 2009, COLD SPRING HARB PRO, V2009; White-Cooper Helen, 2012, Spermatogenesis, V2, P11; WRIGHT JD, 1981, J INVERTEBR PATHOL, V38, P409, DOI 10.1016/0022-2011(81)90109-9; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Yamada R, 2007, GENETICS, V177, P801, DOI 10.1534/genetics.106.068486; YEN JH, 1971, NATURE, V232, P657, DOI 10.1038/232657a0; Zabalou S, 2004, P NATL ACAD SCI USA, V101, P15042, DOI 10.1073/pnas.0403853101; Zabalou S, 2008, GENETICS, V178, P2145, DOI 10.1534/genetics.107.086488; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	55	231	235	29	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2017	543	7644					243	+		10.1038/nature21391	http://dx.doi.org/10.1038/nature21391			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0GQ	28241146	Green Accepted			2022-12-28	WOS:000395688700039
J	Jenkins, LD				Jenkins, Lekelia Danielle			The Death and Life of the Great Lakes	SCIENCE			English	Book Review									[Jenkins, Lekelia Danielle] Arizona State Univ, Sch Future Innovat Soc, Tempe, AZ 85281 USA	Arizona State University; Arizona State University-Tempe	Jenkins, LD (corresponding author), Arizona State Univ, Sch Future Innovat Soc, Tempe, AZ 85281 USA.	kiki.jenkins@asu.edu						Egan D., 2017, DEATH LIFE GREAT LAK	1	0	0	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					917	917		10.1126/science.aal5118	http://dx.doi.org/10.1126/science.aal5118			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM2YM	28254906				2022-12-28	WOS:000395181700027
J	Horton, R				Horton, Richard			Offline: The Paris Spring for public health policy	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 25	2017	389	10071					784	784		10.1016/S0140-6736(17)30561-5	http://dx.doi.org/10.1016/S0140-6736(17)30561-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9UU	28248163	Bronze			2022-12-28	WOS:000394966400015
J	DeLoughery, T				DeLoughery, Thomas			Guideline: A hemoglobin threshold of 7 to 8 g/dL is recommended for hemodynamically stable hospitalized patients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[DeLoughery, Thomas] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	DeLoughery, T (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.							Adams RC., 1942, SURG GYNECOL OBSTET, V3, P603; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Heddle NM, 2016, NEW ENGL J MED, V375, P1937, DOI 10.1056/NEJMoa1609014	3	1	1	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2017	166	4					JC15	JC15		10.7326/ACPJC-2017-166-4-015	http://dx.doi.org/10.7326/ACPJC-2017-166-4-015			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7FO	28241288				2022-12-28	WOS:000394786700003
J	Juncadella, AC; Feuerstein, JD				Juncadella, Anna C.; Feuerstein, Joseph D.			In uncomplicated, left-sided acute diverticulitis, observation did not differ from antibiotics for recovery	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Juncadella, Anna C.; Feuerstein, Joseph D.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Juncadella, AC (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.		Feuerstein, Joseph David/AAF-5183-2020					Chabok A, 2012, BRIT J SURG, V99, P532, DOI 10.1002/bjs.8688; Feuerstein JD, 2016, MAYO CLIN PROC, V91, P1094, DOI 10.1016/j.mayocp.2016.03.012; Hjern F, 2007, SCAND J GASTROENTERO, V42, P41, DOI 10.1080/00365520600780650; Shabanzadeh DM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009092.pub2; Stollman N, 2015, GASTROENTEROLOGY, V149, P1944, DOI 10.1053/j.gastro.2015.10.003	5	3	3	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2017	166	4					JC18	JC18		10.7326/ACPJC-2017-166-4-018	http://dx.doi.org/10.7326/ACPJC-2017-166-4-018			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7FO	28241291				2022-12-28	WOS:000394786700006
J	Lewinson, RT; Stefanyshyn, DJ				Lewinson, Ryan T.; Stefanyshyn, Darren J.			Unloading Shoes for Self-management of Knee Osteoarthritis	ANNALS OF INTERNAL MEDICINE			English	Letter									[Lewinson, Ryan T.; Stefanyshyn, Darren J.] Univ Calgary, Calgary, AB, Canada	University of Calgary	Lewinson, RT (corresponding author), Univ Calgary, Calgary, AB, Canada.				Alberta Innovates [201300001] Funding Source: researchfish	Alberta Innovates		Bennell KL, 2013, ARTHRITIS RHEUM-US, V65, P701, DOI 10.1002/art.37788; Hinman RS, 2016, ANN INTERN MED, V165, P381, DOI 10.7326/M16-0453; Lewinson RT, 2016, ANN BIOMED ENG, V44, P3173, DOI 10.1007/s10439-016-1696-1; Lewinson RT, 2016, GAIT POSTURE, V48, P99, DOI 10.1016/j.gaitpost.2016.04.012	4	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2017	166	4					311	312		10.7326/L16-0632	http://dx.doi.org/10.7326/L16-0632			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7FO	28241300				2022-12-28	WOS:000394786700028
J	Zeng, Y; Feng, QS; Hesketh, T; Christensen, K; Vaupel, JW				Zeng, Yi; Feng, Qiushi; Hesketh, Therese; Christensen, Kaare; Vaupel, James W.			Survival, disabilities in activities of daily living, and physical and cognitive functioning among the oldest-old in China: a cohort study	LANCET			English	Article							ELDERLY POPULATION; HEALTH; TRENDS; DEMENTIA; MORTALITY; AGES; PREVALENCE; MORBIDITY; ADULTS; RATES	Background The oldest-old (those aged >= 80 years) are the most rapidly growing age group globally, and are most in need of health care and assistance. We aimed to assess changes in mortality, disability in activities of daily living, and physical and cognitive functioning among oldest-old individuals between 1998 and 2008. Methods We used data from the Chinese Longitudinal Healthy Longevity Study. Three pairs of cohorts aged 80-89 years, 90-99 years, and 100-105 years (in total, 19 528 oldest-old participants) were examined; the two cohorts in each pair were born 10 years apart, with the same age at the time of the assessment in the 1998 and 2008 surveys. Four health outcomes were investigated: annual death rate, Activities of Daily Living (ADL), physical performance in three tests and cognitive function measured by Mini-Mental State Examination (MMSE). We used different tests and multivariate regression analyses to examine the cohort differences. Findings Controlling for various confounding factors, we noted that annual mortality among oldest-old individuals was substantially reduced between 0.2% and 1.3% in 1998-2008 compared with individuals of the same age born 10 years previously, and that disability according to activities of daily living had significantly reduced annually between 0.8% and 2.8%. However, cognitive impairment in the later cohorts increased annually between 0.7% and 2.2% and objective physical performance capacity (standing up from a chair, picking up a book from the floor, and turning around 360 degrees) decreased anually between 0.4% and 3.8%. We also noted that female mortality was substantially lower than male mortality among the oldest-old, but that women's functional capacities in activities of daily living, cognition, and physical performance were worse than their male counterparts. Interpretation Advances in medications, lifestyle, and socioeconomics might compress activities of daily living disability, that is, benefits of success, but lifespan extension might expand disability of physical and cognitive functioning as more frail, elderly individuals survive with health problems, that is, costs of success.	[Zeng, Yi] Duke Univ, Ctr Study Aging & Human Dev, Med Sch, Durham, NC 27708 USA; [Zeng, Yi] Peking Univ, Raissun Inst Adv Studies, Natl Sch Dev, Hlth Aging & Dev Studies, Beijing, Peoples R China; [Feng, Qiushi] Natl Univ Singapore, Ctr Family & Populat Res, Dept Sociol, Singapore, Singapore; [Hesketh, Therese] UCL, Inst Global Hlth, London, England; [Hesketh, Therese] Zhejiang Univ, Sch Publ Hlth, Inst Global Hlth, Hangzhou, Zhejiang, Peoples R China; [Christensen, Kaare] Univ Southern Denmark, Inst Publ Hlth, Unit Epidemiol Biostat & Biodemog, Danish Aging Res Ctr, Odense, Denmark; [Vaupel, James W.] Max Planck Inst Demog Res, Rostock, Germany	Duke University; Peking University; National University of Singapore; University of London; University College London; Zhejiang University; University of Southern Denmark; Max Planck Society	Zeng, Y (corresponding author), Duke Univ, Ctr Study Aging & Human Dev, Med Sch, Durham, NC 27708 USA.	zengyi@nsd.pku.edu.cn	Feng, Qiushi/A-7483-2012; Christensen, Kaare/C-2360-2009	Feng, Qiushi/0000-0002-3572-4442; Christensen, Kaare/0000-0002-5429-5292; Vaupel, James/0000-0003-0783-3905; Hesketh, Therese/0000-0002-7564-9221	National Natural Science Foundation of China; National Institute on Aging/National Institutes of Health; United Nations Funds for Population Activities; National Natural Science Foundation of China [71110107025, 71233001, 71490732]; National Institute on Aging/National Institutes of Health [R01AG023627-10, 2P01AG031719]; NATIONAL INSTITUTE ON AGING [R01AG023627, P01AG031719, P30AG034424] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute on Aging/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); United Nations Funds for Population Activities; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute on Aging/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Natural Science Foundation of China, National Institute on Aging/National Institutes of Health, United Nations Funds for Population Activities.; We thank Xiaomin Shi, Zhaoxue Yin, Jieshi Luo, and Yuebin Lv (China Center for Diseases Control and Prevention), Yuzhi Liu, Chunyuan Zhang, Yun Zhou, and Zhenzhen Zheng (Peking University), Zhenyu Xiao, Liqun Tao, Qin Xu, and Ye Yuan (Chinese Center for Aging Science Research), and Jie Zhan (China Social Science Academy) for their contributions to the Chinese Longitudinal Healthy Longevity Survey (CLHLS), and we thank all interviewees and their families for their voluntary participation in the CLHLS study. We are very grateful for comments provided by Danan Gu and research assistance provided by Huashuai Chen and Muqi Guo. This study was funded by the National Natural Science Foundation of China (71110107025, 71233001, 71490732), National Institute on Aging/National Institutes of Health (R01AG023627-10; 2P01AG031719), and United Nations Funds for Population Activities.	Chan KY, 2013, LANCET, V381, P2016, DOI 10.1016/S0140-6736(13)60221-4; Christensen K, 2013, LANCET, V382, P1507, DOI 10.1016/S0140-6736(13)60777-1; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; COALE AJ, 1991, DEMOGRAPHY, V28, P293, DOI 10.2307/2061281; Dodge Hiroko H, 2012, Int J Alzheimers Dis, V2012, P956354, DOI 10.1155/2012/956354; Engberg H, 2013, AGING CLIN EXP RES, V25, P517, DOI 10.1007/s40520-013-0122-x; Feng QS, 2010, J AM GERIATR SOC, V58, P1952, DOI 10.1111/j.1532-5415.2010.03013.x; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; GRUENBERG EM, 1977, MILBANK FUND Q, V55, P3, DOI 10.2307/3349592; Huang W, 2013, SOC SCI MED, V98, P54, DOI 10.1016/j.socscimed.2013.08.021; Liang YJ, 2015, J GERONTOL A-BIOL, V70, P739, DOI 10.1093/gerona/glu204; MANTON KG, 1982, MILBANK FUND Q, V60, P183, DOI 10.2307/3349767; Martin LG, 2014, POPUL DEV REV, V40, P475, DOI 10.1111/j.1728-4457.2014.00694.x; Matthews FE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11398; Parker MG, 2007, GERONTOLOGIST, V47, P150, DOI 10.1093/geront/47.2.150; Parker MG, 2005, J GERONTOL A-BIOL, V60, P1351, DOI 10.1093/gerona/60.10.1351; Robine JM, 2004, J GERONTOL A-BIOL, V59, P590, DOI 10.1093/gerona/59.6.M590; Satizabal CL, 2016, NEW ENGL J MED, V374, P523, DOI 10.1056/NEJMoa1504327; Theou O, 2015, AGE AGEING, V44, P471, DOI 10.1093/ageing/afv010; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; Verbrugge LM, 2016, J GERONTOL B; Vestergaard S, 2015, AGING MENT HEALTH, V19, P400, DOI 10.1080/13607863.2014.944089; WAIDMANN T, 1995, MILBANK Q, V73, P253, DOI 10.2307/3350259; Wang Z, 1998, Genus, V54, P123; Wu YT, 2014, INT J GERIATR PSYCH, V29, P1212, DOI 10.1002/gps.4148; Yi Zeng, 2007, DEMOGRAPHY, V44, P497, DOI DOI 10.1353/DEM.2007.0033; Zeng Y., 2010, SAGE HDB SOCIAL GERO, P420; Zeng Y, 2012, CHINA ECON J, V5, P131, DOI 10.1080/17538963.2013.764677	29	279	293	44	249	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 22	2017	389	10079					1619	1629		10.1016/S0140-6736(17)30548-2	http://dx.doi.org/10.1016/S0140-6736(17)30548-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ES5EK	28285816	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000399560000029
J	Feldman, R; Wang, CN				Feldman, Robin; Wang, Connie			A Citizen's Pathway Gone Astray - Delaying Competition from Generic Drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Feldman, Robin; Wang, Connie] Univ Calif San Francisco, Hastings Coll Law, San Francisco, CA 94102 USA	University of California System; University of California San Francisco	Feldman, R (corresponding author), Univ Calif San Francisco, Hastings Coll Law, San Francisco, CA 94102 USA.							Carrier Michael A., 2012, CARDOZO L REV, V34, P249; Feldman R, DRUG WARS IN PRESS; Feldman R, STANF TECHN IN PRESS; Report to Congress, 2015, 7 FOOD DRUG ADM	4	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 20	2017	376	16					1499	1501		10.1056/NEJMp1700202	http://dx.doi.org/10.1056/NEJMp1700202			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ES4VV	28248550	Green Published			2022-12-28	WOS:000399534600002
J	Harrison, SE; Sozen, B; Christodoulou, N; Kyprianou, C; Zernicka-Goetz, M				Harrison, Sarah Ellys; Sozen, Berna; Christodoulou, Neophytos; Kyprianou, Christos; Zernicka-Goetz, Magdalena			Assembly of embryonic and extraembryonic stem cells to mimic embryogenesis in vitro	SCIENCE			English	Article							EARLY MOUSE EMBRYO; VISCERAL ENDODERM; SELF-ORGANIZATION; PLURIPOTENT CELLS; 3-DIMENSIONAL CULTURE; EXPRESSION PATTERN; MESODERM FORMATION; AXIS FORMATION; DIFFERENTIATION; LINEAGE	Mammalian embryogenesis requires intricate interactions between embryonic and extraembryonic tissues to orchestrate and coordinate morphogenesis with changes in developmental potential. Here, we combined mouse embryonic stem cells (ESCs) and extraembryonic trophoblast stem cells (TSCs) in a three-dimensional scaffold to generate structures whose morphogenesis is markedly similar to that of natural embryos. By using genetically modified stem cells and specific inhibitors, we show that embryogenesis of ESC- and TSC-derived embryos-ETS-embryos-depends on cross-talk involving Nodal signaling. When ETS-embryos develop, they spontaneously initiate expression of mesoderm and primordial germ cell markers asymmetrically on the embryonic and extraembryonic border, in response to Wnt and BMP signaling. Our study demonstrates the ability of distinct stem cell types to self-assemble in vitro to generate embryos whose morphogenesis, architecture, and constituent cell types resemble those of natural embryos.	[Harrison, Sarah Ellys; Sozen, Berna; Christodoulou, Neophytos; Kyprianou, Christos; Zernicka-Goetz, Magdalena] Univ Cambridge, Dept Physiol Dev & Neurosci, Mammalian Embryo & Stem Cell Grp, Downing St, Cambridge CB2 3DY, England; [Sozen, Berna] Akdeniz Univ, Fac Med, Dept Histol & Embryol, TR-07070 Antalya, Turkey	University of Cambridge; Akdeniz University	Zernicka-Goetz, M (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Mammalian Embryo & Stem Cell Grp, Downing St, Cambridge CB2 3DY, England.	mzg@mole.bio.cam.ac.uk	Christodoulou, Neophytos/AAB-7645-2019; SOZEN, BERNA/I-8904-2017	Christodoulou, Neophytos/0000-0003-4338-5847; SOZEN, BERNA/0000-0001-5834-5819; Kyprianou, Christos/0000-0001-8516-9195; Zernicka-Goetz, Magdalena/0000-0002-7004-2471	Wellcome Trust; ERC; Biotechnology and Biological Sciences Research Council; Scientific and Technological Research Council of Turkey [2214/A]; Biotechnology and Biological Sciences Research Council [1351927, 1497839] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); ERC(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We are grateful to D. Glover, M. Shahbazi, S. Vuoristo, and F. Antonica for helpful feedback on the manuscript; A. Hupalowska for drawing models (Figs. 1A, 2I, and 8) and G. Recher for 3D rendering (Fig. 1, B and D); the creators of the "Bioemergences" platform for providing image analysis tools; and V. Kuskoff, A. Surani, and B. Herrmann for providing T:GFP ESCs and Stella: GFP ESCs. We are grateful to the Wellcome Trust and ERC for supporting this work. S.E.H. and C.K. are both supported by Biotechnology and Biological Sciences Research Council doctoral training partnership studentships. B.S. is supported by the International Research Fellowship Program 2214/A from Scientific and Technological Research Council of Turkey, and M.Z.-G. by the Wellcome Trust. S.E.H. served as an intern in the Cambridge, UK, office of Science/AAAS. M.Z.-G. and S.E.H. are inventors on a patent application (1615343.9) submitted by Cell Guidance Systems, in which the University of Cambridge and the Wellcome Trust are beneficiaries, that covers the method and medium composition used to generate "stem cell-derived embryos." S.E.H. and B. S. carried out experiments and data analysis on ETS-embryos. N.C. and C.K. carried out experiments on natural embryos. M.Z.-G. conceived and supervised the study and wrote the paper with the help of S.E.H. and B. S.	Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Bedzhov I, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0538; Bedzhov I, 2014, NAT PROTOC, V9, P2732, DOI 10.1038/nprot.2014.186; Bedzhov I, 2014, CELL, V156, P1032, DOI 10.1016/j.cell.2014.01.023; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Ben-Haim N, 2006, DEV CELL, V11, P313, DOI 10.1016/j.devcel.2006.07.005; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; Camus A, 2006, DEV BIOL, V295, P743, DOI 10.1016/j.ydbio.2006.03.047; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Faure E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms9674; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Ferrer-Vaquer A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-121; Fuchs C, 2012, CELLS TISSUES ORGANS, V195, P377, DOI 10.1159/000328712; Gunesdogan U, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0543; Guzman-Ayala M, 2004, P NATL ACAD SCI USA, V101, P15656, DOI 10.1073/pnas.0405429101; HERRMANN BG, 1991, DEVELOPMENT, V113, P913; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kimura-Yoshida C, 2005, DEV CELL, V9, P639, DOI 10.1016/j.devcel.2005.09.011; Kubaczka C, 2014, STEM CELL REP, V2, P232, DOI 10.1016/j.stemcr.2013.12.013; Kumar A, 2015, DEV BIOL, V400, P1, DOI 10.1016/j.ydbio.2014.12.016; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Leung CY, 2015, CURR OPIN GENET DEV, V34, P71, DOI 10.1016/j.gde.2015.08.002; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mesnard D, 2006, DEVELOPMENT, V133, P2497, DOI 10.1242/dev.02413; Niakan KK, 2013, NAT PROTOC, V8, P1028, DOI 10.1038/nprot.2013.049; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Ohinata Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107308; Park CB, 2011, BIOL REPROD, V84, P1103, DOI 10.1095/biolreprod.110.087239; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; Peng GD, 2016, DEV CELL, V36, P681, DOI 10.1016/j.devcel.2016.02.020; R Core Team, R LANG ENV STAT COMP; Rhee JM, 2006, GENESIS, V44, P202, DOI 10.1002/dvg.20203; Rivera-Perez JA, 2005, DEV BIOL, V288, P363, DOI 10.1016/j.ydbio.2005.09.012; Robertson EJ, 2014, SEMIN CELL DEV BIOL, V32, P73, DOI 10.1016/j.semcdb.2014.03.028; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; Scialdone A, 2016, NATURE, V535, P289, DOI 10.1038/nature18633; Shahbazi MN, 2016, NAT CELL BIOL, V18, P700, DOI 10.1038/ncb3347; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tanaka Satoshi, 2006, V329, P35; ten Berge D, 2008, CELL STEM CELL, V3, P508, DOI 10.1016/j.stem.2008.09.013; van den Brink SC, 2014, DEVELOPMENT, V141, P4231, DOI 10.1242/dev.113001; Villasenor A, 2010, DEVELOPMENT, V137, P4295, DOI 10.1242/dev.052993; Warmflash A, 2014, NAT METHODS, V11, P847, DOI [10.1038/NMETH.3016, 10.1038/nmeth.3016]; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Wu Q, 2013, DEVELOPMENT, V140, P291, DOI 10.1242/dev.087882; Xia Y, 2014, NAT PROTOC, V9, P2693, DOI 10.1038/nprot.2014.182; Yamamoto M, 2004, NATURE, V428, P387, DOI 10.1038/nature02418; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	58	219	226	3	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 14	2017	356	6334							eaal1810	10.1126/science.aal1810	http://dx.doi.org/10.1126/science.aal1810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER7SM	28254784	Green Submitted			2022-12-28	WOS:000399013800026
J	Tobler, R; Rohrlach, A; Soubrier, J; Bover, P; Llamas, B; Tuke, J; Bean, N; Abdullah-Highfold, A; Agius, S; O'Donoghue, A; O'Loughlin, I; Sutton, P; Zilio, F; Walshe, K; Williams, AN; Turney, CSM; Williams, M; Richards, SM; Mitchell, RJ; Kowal, E; Stephen, JR; Williams, L; Haak, W; Cooper, A				Tobler, Ray; Rohrlach, Adam; Soubrier, Julien; Bover, Pere; Llamas, Bastien; Tuke, Jonathan; Bean, Nigel; Abdullah-Highfold, Ali; Agius, Shane; O'Donoghue, Amy; O'Loughlin, Isabel; Sutton, Peter; Zilio, Fran; Walshe, Keryn; Williams, Alan N.; Turney, Chris S. M.; Williams, Matthew; Richards, Stephen M.; Mitchell, Robert J.; Kowal, Emma; Stephen, John R.; Williams, Lesley; Haak, Wolfgang; Cooper, Alan			Aboriginal mitogenomes reveal 50,000 years of regionalism in Australia	NATURE			English	Article							HUMAN OCCUPATION SITE; PALEOENVIRONMENTAL CHANGE; DEVILS-LAIR; ANCIENT; MEGAFAUNA; COLONIZATION; PLEISTOCENE; CALIBRATION; ARCHAEOLOGY; SETTLEMENT	Aboriginal Australians represent one of the longest continuous cultural complexes known. Archaeological evidence indicates that Australia and New Guinea were initially settled approximately 50 thousand years ago (ka); however, little is known about the processes underlying the enormous linguistic and phenotypic diversity within Australia. Here we report 111 mitochondrial genomes (mitogenomes) from historical Aboriginal Australian hair samples, whose origins enable us to reconstruct Australian phylogeographic history before European settlement. Marked geographic patterns and deep splits across the major mitochondrial haplogroups imply that the settlement of Australia comprised a single, rapid migration along the east and west coasts that reached southern Australia by 49-45 ka. After continent-wide colonization, strong regional patterns developed and these have survived despite substantial climatic and cultural change during the late Pleistocene and Holocene epochs. Remarkably, we find evidence for the continuous presence of populations in discrete geographic areas dating back to around 50 ka, in agreement with the notable Aboriginal Australian cultural attachment to their country.	[Tobler, Ray; Soubrier, Julien; Bover, Pere; Llamas, Bastien; Williams, Matthew; Richards, Stephen M.; Haak, Wolfgang; Cooper, Alan] Univ Adelaide, Sch Biol Sci, Australian Ctr Ancient DNA, Adelaide, SA 5005, Australia; [Rohrlach, Adam; Tuke, Jonathan; Bean, Nigel] Univ Adelaide, Sch Math Sci, Adelaide, SA 5005, Australia; [Rohrlach, Adam; Tuke, Jonathan; Bean, Nigel] Univ Adelaide, ARC Ctr Excellence Math & Stat Frontiers, Adelaide, SA 5005, Australia; [Soubrier, Julien] SA Pathol, Genet & Mol Pathol, Adelaide, SA 5000, Australia; [Abdullah-Highfold, Ali; Agius, Shane; O'Donoghue, Amy; O'Loughlin, Isabel; Sutton, Peter; Zilio, Fran; Walshe, Keryn] South Australian Museum, Adelaide, SA 5005, Australia; [Sutton, Peter] Univ Adelaide, Sch Biol Sci, Adelaide, SA 5005, Australia; [Turney, Chris S. M.] Univ New South Wales, Sch Biol Earth & Environm Sci, Palaeontol Geobiol & Earth Arch Res Ctr, Sydney, NSW 2052, Australia; [Turney, Chris S. M.] Univ New South Wales, Sch Biol Earth & Environm Sci, Climate Change Res Ctr, Sydney, NSW 2052, Australia; [Williams, Matthew] Australian Natl Univ, Coll Arts & Social Sci, Sch Archaeol & Anthropol, Canberra, ACT 0200, Australia; [Mitchell, Robert J.] La Trobe Univ, Dept Biochem & Genet, Bundoora, Vic 3086, Australia; [Kowal, Emma] Deakin Univ, Alfred Deakin Inst, Melbourne, Vic 3125, Australia; [Stephen, John R.] Waite Res Precinct, Australian Genome Res Facil, Adelaide, SA 5064, Australia; [Williams, Lesley] Commun Elder & Cultural Advisor, Cherbourg, Qld, Australia; [Haak, Wolfgang] Max Planck Inst Sci Human Hist, Dept Archeogenet, D-07745 Jena, Germany; [Cooper, Alan] Univ Adelaide, Inst Environm, Adelaide, SA 5005, Australia	University of Adelaide; University of Adelaide; University of Adelaide; SA Pathology; South Australian Museum; University of Adelaide; University of New South Wales Sydney; University of New South Wales Sydney; Australian National University; La Trobe University; Deakin University; University of Adelaide	Cooper, A (corresponding author), Univ Adelaide, Sch Biol Sci, Australian Ctr Ancient DNA, Adelaide, SA 5005, Australia.; Cooper, A (corresponding author), Univ Adelaide, Inst Environm, Adelaide, SA 5005, Australia.	alan.cooper@adelaide.edu.au	Tobler, Ray/AAE-6745-2020; Rohrlach, Adam B/H-8415-2017; Llamas, Bastien/Y-2781-2018; Turney, Chris S M/P-8701-2018; Haak, Wolfgang/Z-4947-2019; Rohrlach, Adam/AAD-2530-2019; Llamas, Bastien/AAK-1693-2021; Bean, Nigel G/I-2261-2014; Soubrier, Julien/AAX-9560-2021	Rohrlach, Adam B/0000-0002-4204-5018; Llamas, Bastien/0000-0002-5550-9176; Turney, Chris S M/0000-0001-6733-0993; Haak, Wolfgang/0000-0003-2475-2007; Rohrlach, Adam/0000-0002-4204-5018; Llamas, Bastien/0000-0002-5550-9176; Bean, Nigel G/0000-0002-5351-3104; Soubrier, Julien/0000-0001-9350-7369; Kowal, Emma/0000-0003-3866-3224; Richards, Stephen M/0000-0002-7604-2368; Cooper, Alan/0000-0002-7738-7851; Tuke, Jonathan/0000-0002-1688-8951; Tobler, Raymond/0000-0002-4603-1473; Bover Arbos, Pedro/0000-0003-2942-2840	South Australian Museum; Australian Research Council; University of Adelaide Environment Institute; Genographic Project; Bioplatforms Australia; University of Adelaide Human Research Ethics Committee [H-2014-252]	South Australian Museum; Australian Research Council(Australian Research Council); University of Adelaide Environment Institute; Genographic Project; Bioplatforms Australia; University of Adelaide Human Research Ethics Committee	We acknowledge the support and involvement of the Point Pearce, Cherbourg and Koonibba communities and the individual families. We also acknowledge the work of N. Tindale, J. Birdsell and members of the original Board for Archaeological Research expeditions collecting the specimens. We thank the South Australian Museum, Australian Research Council, University of Adelaide Environment Institute, the Genographic Project and Bioplatforms Australia for support, and S. Ulm, G. Gower, I. Mathieson, L. O'Brien, S. Easteal, M. Vilar, C. Stringer and ACAD colleagues for helpful comments and advice. The Aboriginal Heritage Project webpage is https://www.adelaide.edu.au/acad/ahp/, and this work was carried out under the auspices of the University of Adelaide Human Research Ethics Committee, project approval H-2014-252.	Abdi H, 2007, ENCY MEASUREMENT STA, V2, P651; Balme J, 2009, QUATERN INT, V202, P59, DOI 10.1016/j.quaint.2008.10.002; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Bergstrom A, 2016, CURR BIOL, V26, P809, DOI 10.1016/j.cub.2016.01.028; Best DJ, 1975, APPL STAT, V4, P377, DOI DOI 10.2307/2347111; Bird MI, 2003, QUATERNARY SCI REV, V22, P1805, DOI 10.1016/S0277-3791(03)00151-3; Bird MI, 2016, P NATL ACAD SCI USA, V113, P11477, DOI 10.1073/pnas.1608470113; Bowdler S., 1977, SUNDA SAHUL PREHISTO, P205; Bowman GM., 1985, AUST ARCHAEOL, V20, P58, DOI [10.1080/03122417.1985.12092985, DOI 10.1080/03122417.1985.12092985]; Cooper A, 2013, SCIENCE, V342, P321, DOI 10.1126/science.1244869; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1658/1100-9233(2003)014[0927:VAPORF]2.0.CO;2; DORTCH C, 1979, WORLD ARCHAEOL, V10, P258, DOI 10.1080/00438243.1979.9979736; Dortch C. E., 1996, AUST ARCHAEOL, V43, P28; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Fehren-Schmitz L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127141; Fitzsimmons KE, 2013, QUATERNARY SCI REV, V74, P78, DOI 10.1016/j.quascirev.2012.09.007; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Greenacre M., 2007, CORRES ANAL PRACTICE; Griggs Sutton E., 2003, IMPERIUM IMPERIO; GROUBE L, 1986, NATURE, V324, P453, DOI 10.1038/324453a0; Hamm G, 2016, NATURE, V539, P280, DOI 10.1038/nature20125; Heupink TH, 2016, P NATL ACAD SCI USA, V113, P6892, DOI 10.1073/pnas.1521066113; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Hogg AG, 2013, RADIOCARBON, V55, P1889, DOI 10.2458/azu_js_rc.55.16783; Hudjashov G, 2007, P NATL ACAD SCI USA, V104, P8726, DOI 10.1073/pnas.0702928104; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; Kaufman L, 1987, 1 INT C, P405; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Knapp M, 2012, METHODS MOL BIOL, V840, P155, DOI 10.1007/978-1-61779-516-9_19; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Lewis SE, 2013, QUATERNARY SCI REV, V74, P115, DOI 10.1016/j.quascirev.2012.09.006; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Llamas B, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501385; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Maechler, 2016, CLUSTER ANAL BASICS; Malaspinas AS, 2016, NATURE, V538, P207, DOI 10.1038/nature18299; Mcallister P, 2013, HUM BIOL, V85, P485, DOI 10.3378/027.085.0322; Metcalf JL, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501682; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Nagle N, 2016, AM J PHYS ANTHROPOL, V159, P367, DOI 10.1002/ajpa.22886; O'Connell JF, 2015, J ARCHAEOL SCI, V56, P73, DOI 10.1016/j.jas.2015.02.020; O'Connor S, 2010, RADIOCARBON, V52, P1158, DOI 10.1017/S0033822200046233; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pellekaan SV, 2013, QUATERN INT, V285, P44, DOI 10.1016/j.quaint.2011.04.014; Petchey F, 2004, RADIOCARBON, V46, P1005, DOI 10.1017/S0033822200036079; Posth C, 2016, CURR BIOL, V26, P827, DOI 10.1016/j.cub.2016.01.037; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ramsey CB, 2013, RADIOCARBON, V55, P720, DOI 10.1017/S0033822200057878; Ramsey CB, 2009, RADIOCARBON, V51, P1023, DOI 10.1017/S0033822200034093; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Redd AJ, 1999, AM J HUM GENET, V65, P808, DOI 10.1086/302533; Reeves JM, 2013, QUATERNARY SCI REV, V74, P97, DOI 10.1016/j.quascirev.2012.11.027; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Rieux A, 2016, MOL ECOL, V25, P1911, DOI 10.1111/mec.13586; Roberts R.G., 1998, ANCIENT TL, V16, P19; Roberts RG, 1997, RADIAT MEAS, V27, P819, DOI 10.1016/S1350-4487(97)00221-7; ROBERTS RG, 1994, QUATERNARY SCI REV, V13, P575, DOI 10.1016/0277-3791(94)90080-9; Roberts RG, 2001, SCIENCE, V292, P1888, DOI 10.1126/science.1060264; ROBERTS RG, 1990, NATURE, V345, P153, DOI 10.1038/345153a0; Rohland N, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0624; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Saltre F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10511; Schubert M, 2014, NAT PROTOC, V9, P1056, DOI 10.1038/nprot.2014.063; Smith M., 2013, ARCHAEOLOGY AUSTR DE; Turney CSM, 2001, QUATERNARY RES, V55, P3, DOI 10.1006/qres.2000.2195; Ulm S, 2013, QUATERN INT, V285, P182, DOI 10.1016/j.quaint.2012.03.046; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; White J.P., 1982, PREHISTORY AUSTR NEW; Williams AN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128661; Williams AN, 2013, J ARCHAEOL SCI, V40, P4612, DOI 10.1016/j.jas.2013.06.015	78	104	107	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2017	544	7649					180	+		10.1038/nature21416	http://dx.doi.org/10.1038/nature21416			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	ER6EK	28273067				2022-12-28	WOS:000398897900027
J	Reusch, JEB; Manson, JE				Reusch, Jane E. B.; Manson, JoAnn E.			Management of Type 2 Diabetes in 2017 Getting to Goal	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARDIOVASCULAR OUTCOMES; ASSOCIATION; STATEMENT		[Reusch, Jane E. B.] Univ Colorado, Anschutz Med Ctr, Ctr Womens Hlth Res, Denver, CO 80202 USA; [Reusch, Jane E. B.] Denver VA Med Ctr, Denver, CO USA; [Manson, JoAnn E.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Manson, JoAnn E.] Harvard Med Sch, Boston, MA USA; [Manson, JoAnn E.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Manson, JE (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, 900 Commonwealth Ave,Third Floor, Boston, MA 02215 USA.	jmanson@rics.bwh.harvard.edu		Reusch, Jane/0000-0001-8620-1003	AstraZeneca; Merck; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000154] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002046] Funding Source: NIH RePORTER	AstraZeneca(AstraZeneca); Merck(Merck & Company); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Veterans Affairs(US Department of Veterans Affairs)	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Reusch reported receiving grant funding from AstraZeneca and Merck; and serving on the board of directors for the American Diabetes Association. No other disclosures were reported.	Garber AJ, 2016, ENDOCR PRACT, V22, P84, DOI 10.4158/EP151126.CS; Holden SE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153594; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Sherr D, 2015, DIABETES EDUCATOR, V41, P616, DOI 10.1177/0145721715599268; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	6	91	99	1	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2017	317	10					1015	1016		10.1001/jama.2017.0241	http://dx.doi.org/10.1001/jama.2017.0241			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO5DO	28249081	Green Accepted			2022-12-28	WOS:000396713400009
J	Ritchlin, CT; Colbert, RA; Gladman, DD				Ritchlin, Christopher T.; Colbert, Robert A.; Gladman, Dafna D.			Psoriatic Arthritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							JUVENILE IDIOPATHIC ARTHRITIS; PLACEBO-CONTROLLED TRIAL; AXIAL SPONDYLOARTHRITIS; ANKYLOSING-SPONDYLITIS; RHEUMATOID-ARTHRITIS; RISK-FACTORS; MONOCLONAL-ANTIBODY; DISEASE-ACTIVITY; DOUBLE-BLIND; T-CELLS		[Ritchlin, Christopher T.] Univ Rochester, Sch Med, Div Rheumatol Allergy & Immunol, 601 Elmwood Ave,Box 695, Rochester, NY 14642 USA; [Colbert, Robert A.] NIAMSD, Pediat Translat Res Branch, Bethesda, MD 20892 USA; [Gladman, Dafna D.] Toronto Western Hosp, Krembil Res Inst, Psoriat Arthrit Program, Univ Hlth Network, Toronto, ON, Canada; [Gladman, Dafna D.] Toronto Western Hosp, Ctr Prognosis Studies Rheumat Dis, Toronto, ON, Canada	University of Rochester; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Ritchlin, CT (corresponding author), Univ Rochester, Sch Med, Div Rheumatol Allergy & Immunol, 601 Elmwood Ave,Box 695, Rochester, NY 14642 USA.	christopher_ritchlin@urmc.rochester.edu		ritchlin, christopher/0000-0002-2602-1219; Gladman, Dafna/0000-0002-9074-0592	AbbVie; Novartis Pharmaceuticals; Sun Pharmaceutical Industries; Pfizer; UCB Pharmaceuticals; Amgen; Janssen Pharmaceuticals; Eli Lilly; Celgene; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041184] Funding Source: NIH RePORTER	AbbVie(AbbVie); Novartis Pharmaceuticals(Novartis); Sun Pharmaceutical Industries; Pfizer(Pfizer); UCB Pharmaceuticals(UCB Pharma SA); Amgen(Amgen); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Eli Lilly(Eli Lilly); Celgene(Bristol-Myers SquibbCelgene Corporation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Dr. Ritchlin reports receiving consulting fees from AbbVie, Novartis Pharmaceuticals, Sun Pharmaceutical Industries, and Pfizer and grant support from UCB Pharmaceuticals, Amgen, Janssen Pharmaceuticals, and AbbVie; Dr. Colbert, being a principal investigator on a Cooperative Research and Development Agreement (CRADA) between his institute and Eli Lilly; and Dr. Gladman, receiving honoraria from AbbVie, Amgen, Celgene, Janssen Pharmaceuticals, Novartis Pharmaceuticals, UCB Pharmaceuticals, and Bristol-Myers Squibb, consulting fees from Eli Lilly, and grant support from Pfizer, AbbVie, Celgene, Janssen Pharmaceuticals, Novartis Pharmaceuticals, and UCB Pharmaceuticals. No other potential conflict of interest relevant to this article was reported.	Adamopoulos IE, 2011, J IMMUNOL, V187, P951, DOI 10.4049/jimmunol.1003986; Anandarajah AP, 2008, ANN RHEUM DIS, V67, P296, DOI 10.1136/ard.2007.076091; Anandarajah AP, 2009, NAT REV RHEUMATOL, V5, P634, DOI 10.1038/nrrheum.2009.210; Araujo EG, 2015, ANN RHEUM DIS, V74, P655, DOI 10.1136/annrheumdis-2013-204229; Arumugam R, 2012, J RHEUMATOL, V39, P32, DOI 10.3899/jrheum.120239; Baeten D, 2000, ANN RHEUM DIS, V59, P945, DOI 10.1136/ard.59.12.945; Benham H, 2014, ARTHRITIS RHEUMATOL, V66, P1755, DOI 10.1002/art.38638; Beukelman T, 2011, ARTHRIT CARE RES, V63, P465, DOI 10.1002/acr.20460; Bowes J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7046; Brockbank JE, 2005, ANN RHEUM DIS, V64, P188, DOI 10.1136/ard.2003.018184; Buckley C, 2010, J RHEUMATOL, V37, P2141, DOI 10.3899/jrheum.100034; BUSKILA D, 1992, J RHEUMATOL, V19, P1115; Chandran V, 2009, ANN RHEUM DIS, V68, P664, DOI 10.1136/ard.2008.089367; Coates LC, 2013, BRIT J DERMATOL, V168, P802, DOI 10.1111/bjd.12190; Coates L, 2015, RHEUM DIS CLIN N AM, V41, P699, DOI 10.1016/j.rdc.2015.07.009; Coates LC, 2016, ARTHRITIS RHEUMATOL, V68, P1060, DOI 10.1002/art.39573; Coates LC, 2010, ARTHRIT CARE RES, V62, P965, DOI 10.1002/acr.20155; Colbert RA, 2010, NAT REV RHEUMATOL, V6, P477, DOI 10.1038/nrrheum.2010.103; Danning CL, 2000, ARTHRITIS RHEUM-US, V43, P1244, DOI 10.1002/1529-0131(200006)43:6<1244::AID-ANR7>3.0.CO;2-2; Dominguez-Rosado I, 2016, J AM COLL SURGEONS, V222, P961, DOI 10.1016/j.jamcollsurg.2016.01.049; Eder L, 2016, ARTHRITIS RHEUMATOL, V68, P915, DOI 10.1002/art.39494; FitzGerald O, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0640-3; FitzGerald O, 2014, ARTHRITIS RHEUMATOL, V66, P1077, DOI 10.1002/art.38370; Gladman DD, 2007, J RHEUMATOL, V34, P1740; Gladman DD, 2013, J RHEUMATOL, V40, P1357, DOI 10.3899/jrheum.130163; Gladman DD, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3049; GLADMAN DD, 1995, J RHEUMATOL, V22, P675; GLADMAN DD, 1987, Q J MED, V62, P127; Gladman DD, 2001, J RHEUMATOL, V28, P1045; GLADMAN DD, 1990, J RHEUMATOL, V17, P809; GLADMAN DD, 1993, CLIN INVEST MED, V16, P1; Gossec L, 2016, ANN RHEUM DIS, V75, P499, DOI 10.1136/annrheumdis-2015-208337; Harden JL, 2015, J AUTOIMMUN, V64, P66, DOI 10.1016/j.jaut.2015.07.008; Kaltwasser JP, 2004, ARTHRITIS RHEUM-US, V50, P1939, DOI 10.1002/art.20253; Kane D, 2003, RHEUMATOLOGY, V42, P1460, DOI 10.1093/rheumatology/keg384; Kavanaugh A, 2014, ANN RHEUM DIS, V73, P1020, DOI 10.1136/annrheumdis-2013-205056; Kavanaugh AF, 2006, J RHEUMATOL, V33, P1417; Kehl AS, 2016, ARTHRITIS RHEUMATOL, V68, P312, DOI 10.1002/art.39458; Khan M, 2003, J RHEUMATOL, V30, P1022; Kingsley GH, 2012, RHEUMATOLOGY, V51, P1368, DOI 10.1093/rheumatology/kes001; Kotsis K, 2012, ARTHRIT CARE RES, V64, P1593, DOI 10.1002/acr.21725; Leijten EFA, 2015, ARTHRITIS RHEUMATOL, V67, P2673, DOI 10.1002/art.39261; Lories RJ, 2014, BEST PRACT RES CL RH, V28, P765, DOI 10.1016/j.berh.2014.10.008; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Lubrano E, 2016, J RHEUMATOL, V43, P1541, DOI 10.3899/jrheum.160363; McGonagle D, 1998, LANCET, V352, P1137, DOI 10.1016/S0140-6736(97)12004-9; McHugh NJ, 2003, RHEUMATOLOGY, V42, P778, DOI 10.1093/rheumatology/keg217; McInnes IB, 2014, ANN RHEUM DIS, V73, P349, DOI 10.1136/annrheumdis-2012-202646; Mease P, 2011, ARTHRITIS RHEUM-US, V63, P939, DOI 10.1002/art.30176; Mease PJ, 2017, ANN RHEUM DIS, V76, P79, DOI 10.1136/annrheumdis-2016-209709; Mease PJ, 2015, RHEUM DIS CLIN N AM, V41, P723, DOI 10.1016/j.rdc.2015.07.010; Mease PJ, 2014, NEW ENGL J MED, V370, P2295, DOI 10.1056/NEJMoa1315231; Menon B, 2014, ARTHRITIS RHEUMATOL, V66, P1272, DOI 10.1002/art.38376; Michelsen B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123582; MOLL J M H, 1973, Seminars in Arthritis and Rheumatism, V3, P55, DOI 10.1016/0049-0172(73)90035-8; MOLL JMH, 1974, MEDICINE, V53, P343, DOI 10.1097/00005792-197409000-00002; Nash P, 2005, ANN RHEUM DIS, V64, P74, DOI 10.1136/ard.2004.030783; Ogdie A, 2015, RHEUM DIS CLIN N AM, V41, P545, DOI 10.1016/j.rdc.2015.07.001; Ogdie A, 2015, CURR OPIN RHEUMATOL, V27, P118, DOI 10.1097/BOR.0000000000000152; Ogdie A, 2010, ARCH DERMATOL, V146, P785, DOI 10.1001/archdermatol.2010.136; Ono T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10928; Paine A, 2016, CURR OPIN RHEUMATOL, V28, P66, DOI 10.1097/BOR.0000000000000232; Poggenborg RP, 2015, RHEUM DIS CLIN N AM, V41, P593, DOI 10.1016/j.rdc.2015.07.007; Poggenborg RP, 2011, THER ADV MUSCULOSKEL, V3, P42, DOI 10.1177/1759720X10394031; Reinhardt A, 2016, ARTHRITIS RHEUMATOL, V68, P2476, DOI 10.1002/art.39732; Ringold S, 2013, J RHEUMATOL, V40, P936, DOI 10.3899/jrheum.121147; Ritchlin CT, 2003, J CLIN INVEST, V111, P821, DOI 10.1172/JCI200316069; Ruutu M, 2012, ARTHRITIS RHEUM-US, V64, P2211, DOI 10.1002/art.34423; Scarpa R, 2000, J RHEUMATOL, V27, P1241; Scher JU, 2015, ARTHRITIS RHEUMATOL, V67, P128, DOI 10.1002/art.38892; Sherlock JP, 2012, NAT MED, V18, P1069, DOI 10.1038/nm.2817; Stoll ML, 2006, ARTHRITIS RHEUM, V54, P3564, DOI 10.1002/art.22173; Stuart PE, 2015, AM J HUM GENET, V97, P816, DOI 10.1016/j.ajhg.2015.10.019; Taurog JD, 2016, NEW ENGL J MED, V374, P2563, DOI 10.1056/NEJMra1406182; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Thorarensen SM, 2016, ANN RHEUM DIS; Tillett W, 2015, RHEUMATOLOGY, V54, P157, DOI 10.1093/rheumatology/keu264; Villani AP, 2015, J AM ACAD DERMATOL, V73, P242, DOI 10.1016/j.jaad.2015.05.001; Weitz JE, 2014, EXPERT OPIN BIOL TH, V14, P515, DOI 10.1517/14712598.2014.890587; WRIGHT V, 1961, ANN RHEUM DIS, V20, P123, DOI 10.1136/ard.20.2.123; Yeremenko N, 2014, CURR OPIN RHEUMATOL, V26, P361, DOI 10.1097/BOR.0000000000000069; Zias J, 1996, AM J PHYS ANTHROPOL, V101, P491	82	372	379	2	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2017	376	10					957	970		10.1056/NEJMra1505557	http://dx.doi.org/10.1056/NEJMra1505557			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JA	28273019				2022-12-28	WOS:000395626500012
J	Wang, S; Hassold, T; Hunt, P; White, MA; Zickler, D; Kleckner, N; Zhang, LR				Wang, Shunxin; Hassold, Terry; Hunt, Patricia; White, Martin A.; Zickler, Denise; Kleckner, Nancy; Zhang, Liangran			Inefficient Crossover Maturation Underlies Elevated Aneuploidy in Human Female Meiosis	CELL			English	Article							SYNAPTONEMAL COMPLEX LENGTH; MEIOTIC RECOMBINATION; HUMAN MALES; INDIVIDUAL CHROMOSOMES; HUMAN OOCYTES; MATERNAL AGE; CHIASMA FORMATION; INTERFERENCE; PATTERNS; SEGREGATION	Meiosis is the cellular program that underlies gamete formation. For this program, crossovers between homologous chromosomes play an essential mechanical role to ensure regular segregation. We present a detailed study of crossover formation in human male and female meiosis, enabled by modeling analysis. Results suggest that recombination in the two sexes proceeds analogously and efficiently throughmost stages. However, specifically in female (but not male), similar to 25% of the intermediates that should mature into crossover products actually fail to do so. Further, this "female-specific crossover maturation inefficiency'' is inferred to make major contributions to the high level of chromosome mis-segregation and resultant aneuploidy that uniquely afflicts human female oocytes (e.g., giving Down syndrome). Additionally, crossover levels on different chromosomes in the same nucleus tend to co-vary, an effect attributable to global per-nucleus modulation of chromatin loop size. Maturation inefficiency could potentially reflect an evolutionary advantage of increased aneuploidy for human females.	[Wang, Shunxin; Zhang, Liangran] Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China; [Wang, Shunxin; White, Martin A.; Kleckner, Nancy] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Hassold, Terry; Hunt, Patricia] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Hassold, Terry; Hunt, Patricia] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA; [Zickler, Denise] Univ Paris Saclay, Univ Paris Sud, CNRS, I2BC,CEA, F-91198 Gif Sur Yvette, France	Shandong University; Harvard University; Washington State University; Washington State University; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Zhang, LR (corresponding author), Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China.; Kleckner, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	kleckner@fas.harvard.edu; zhangliangran@sdu.edu.cn		zhang, liangran/0000-0002-8550-6742; White, Martin/0000-0001-6482-8462	NIH [NIH RO1 GM044794, R37 HD03141, RO1 ES 013527]; Centre National de la Recherche Scientifique [UMR 9198]; 1000-talents Plan for young researchers; Qilu Scholar of Shandong University; National Natural Science Foundation of China [31671293]; Shandong Provincial Natural Science Foundation, China [JQ201605]; Human Frontiers Science Program [LT000927/2013]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD021341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044794] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); 1000-talents Plan for young researchers; Qilu Scholar of Shandong University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province); Human Frontiers Science Program(Human Frontier Science Program); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Cohen for kindly provided RPA, MSH4/5 and MLH1 foci data at different stages of prophase I. We are very grateful to Beth Weiner for help in manuscript preparation. This work, S.W., L.Z., M.A.W. and N.K. were supported by a grant to N.K. from the NIH (NIH RO1 GM044794) and to D.Z. from the Centre National de la Recherche Scientifique (UMR 9198). S.W. and L.Z. were also funded by the 1000-talents Plan for young researchers, Qilu Scholar of Shandong University, National Natural Science Foundation of China (project 31671293) and Shandong Provincial Natural Science Foundation, China (Project JQ201605). M.A.W. was also funded by a long-term fellowship from the Human Frontiers Science Program (LT000927/2013). T.H. was supported by grant NIH R37 HD03141, and P.H. was supported by grant NIH RO1 ES 013527.	Bennabi I, 2016, J CELL BIOL, V215, P611, DOI 10.1083/jcb.201607062; BOJKO M, 1983, CARLSBERG RES COMMUN, V48, P457, DOI 10.1007/BF02911920; BOJKO M, 1985, CARLSBERG RES COMMUN, V50, P43, DOI 10.1007/BF02907137; Campbell CL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7260; Cheng EY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000661; Chiang T, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094367; Codina-Pascual M, 2006, MOL HUM REPROD, V12, P123, DOI 10.1093/molehr/gal007; Cole F, 2012, NAT CELL BIOL, V14, P424, DOI 10.1038/ncb2451; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Fieller E., 1940, J ROYAL STAT SOC S, V7, P1, DOI [10.2307/2983630, DOI 10.2307/2983630]; Franasiak JM, 2014, J ASSIST REPROD GEN, V31, P1501, DOI 10.1007/s10815-014-0333-x; Gray S, 2016, ANNU REV GENET, V50, P175, DOI 10.1146/annurev-genet-120215-035111; Gruhn JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085075; Handyside AH, 2012, BBA-MOL BASIS DIS, V1822, P1913, DOI 10.1016/j.bbadis.2012.07.007; Hassold T, 2004, CYTOGENET GENOME RES, V107, P249, DOI 10.1159/000080602; HASSOLD T, 1995, AM J HUM GENET, V57, P867; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; HUGERAT Y, 1993, GENETICS, V135, P297; Hunter N, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016618; Jessberger R, 2012, EMBO REP, V13, P539, DOI 10.1038/embor.2012.54; Jones GH, 2006, CELL, V126, P246, DOI 10.1016/j.cell.2006.07.010; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; Kleckner N, 2003, TRENDS GENET, V19, P623, DOI 10.1016/j.tig.2003.09.004; Kleckner N., 2015, COLD SPRING HARB PER, V7, P7; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Lenzi ML, 2005, AM J HUM GENET, V76, P112, DOI 10.1086/427268; Lu SJ, 2012, SCIENCE, V338, P1627, DOI 10.1126/science.1229112; Lynn A, 2002, SCIENCE, V296, P2222, DOI 10.1126/science.1071220; Middlebrooks CD, 2014, HUM MOL GENET, V23, P408, DOI 10.1093/hmg/ddt433; Nagaoka SI, 2012, NAT REV GENET, V13, P493, DOI 10.1038/nrg3245; Novak I, 2008, J CELL BIOL, V180, P83, DOI 10.1083/jcb.200706136; Oliver TR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099560; Oliver TR, 2012, HUM GENET, V131, P1039, DOI 10.1007/s00439-011-1121-7; Oliver-Bonet M, 2005, MOL HUM REPROD, V11, P517, DOI 10.1093/molehr/gah193; Oliver-Bonet M, 2007, MOL HUM REPROD, V13, P837, DOI 10.1093/molehr/gam076; Ottolini CS, 2015, NAT GENET, V47, P727, DOI 10.1038/ng.3306; Pan ZZ, 2012, AM J MED GENET A, V158A, P581, DOI 10.1002/ajmg.a.35222; Storlazzi A, 2008, GENE DEV, V22, P796, DOI 10.1101/gad.459308; Storlazzi A, 2010, CELL, V141, P94, DOI 10.1016/j.cell.2010.02.041; Sun F, 2008, MOL HUM REPROD, V14, P399, DOI 10.1093/molehr/gan030; Sun F, 2004, AM J HUM GENET, V74, P521, DOI 10.1086/382138; Sun F, 2006, HUM MOL GENET, V15, P2376, DOI 10.1093/hmg/ddl162; Tanaka TU, 2010, EMBO J, V29, P4070, DOI 10.1038/emboj.2010.294; Tease C, 2004, CYTOGENET GENOME RES, V107, P208, DOI 10.1159/000080599; Tease C, 2002, AM J HUM GENET, V70, P1469, DOI 10.1086/340734; [汪鹏 Wang Peng], 2013, [中国卫生统计, Chinese Journal of Health Statistics], V30, P317; Wang SX, 2015, CELL CYCLE, V14, P305, DOI 10.4161/15384101.2014.991185; WARBURTON D, 1987, NEW ENGL J MED, V316, P158, DOI 10.1056/NEJM198701153160308; Watanabe Y, 2012, NAT REV MOL CELL BIO, V13, P370, DOI 10.1038/nrm3349; White MA, 2017, METHODS MOL BIOL, V1471, P305, DOI 10.1007/978-1-4939-6340-9_18; Wolstenholme J, 2000, CHROMOSOMA, V109, P435, DOI 10.1007/s004120000088; Zhang LR, 2014, P NATL ACAD SCI USA, V111, pE5059, DOI 10.1073/pnas.1416411111; Zhang LR, 2014, NATURE, V511, P551, DOI 10.1038/nature13442; Zhang LR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004042; Zielinska AP, 2015, ELIFE, V4, DOI 10.7554/eLife.11389	56	80	82	0	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2017	168	6					977	+		10.1016/j.cell.2017.02.002	http://dx.doi.org/10.1016/j.cell.2017.02.002			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8ZF	28262352	Green Accepted, Bronze			2022-12-28	WOS:000396287900007
J	Zhang, J; Hess, PW; Kyprianidis, A; Becker, P; Lee, A; Smith, J; Pagano, G; Potirniche, ID; Potter, AC; Vishwanath, A; Yao, NY; Monroe, C				Zhang, J.; Hess, P. W.; Kyprianidis, A.; Becker, P.; Lee, A.; Smith, J.; Pagano, G.; Potirniche, I. -D.; Potter, A. C.; Vishwanath, A.; Yao, N. Y.; Monroe, C.			Observation of a discrete time crystal	NATURE			English	Article							MANY-BODY LOCALIZATION	Spontaneous symmetry breaking is a fundamental concept in many areas of physics, including cosmology, particle physics and condensed matter(1). An example is the breaking of spatial translational symmetry, which underlies the formation of crystals and the phase transition from liquid to solid. Using the analogy of crystals in space, the breaking of translational symmetry in time and the emergence of a 'time crystal' was recently proposed(2,3), but was later shown to be forbidden in thermal equilibrium(4-6). However, non-equilibrium Floquet systems, which are subject to a periodic drive, can exhibit persistent time correlations at an emergent subharmonic frequency(7-10). This new phase of matter has been dubbed a 'discrete time crystal'(10). Here we present the experimental observation of a discrete time crystal, in an interacting spin chain of trapped atomic ions. We apply a periodic Hamiltonian to the system under many-body localization conditions, and observe a subharmonic temporal response that is robust to external perturbations. The observation of such a time crystal opens the door to the study of systems with long-range spatio-temporal correlations and novel phases of matter that emerge under intrinsically nonequilibrium conditions(7).	[Zhang, J.; Hess, P. W.; Kyprianidis, A.; Becker, P.; Lee, A.; Smith, J.; Pagano, G.; Monroe, C.] Univ Maryland, Dept Phys, Joint Quantum Inst, College Pk, MD 20742 USA; [Zhang, J.; Hess, P. W.; Kyprianidis, A.; Becker, P.; Lee, A.; Smith, J.; Pagano, G.; Monroe, C.] NIST, College Pk, MD 20742 USA; [Potirniche, I. -D.; Vishwanath, A.; Yao, N. Y.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Potter, A. C.] Univ Texas Austin, Dept Phys, Austin, TX 78712 USA; [Vishwanath, A.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Monroe, C.] IonQ Inc, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; National Institute of Standards & Technology (NIST) - USA; University of California System; University of California Berkeley; University of Texas System; University of Texas Austin; Harvard University	Zhang, J (corresponding author), Univ Maryland, Dept Phys, Joint Quantum Inst, College Pk, MD 20742 USA.; Zhang, J (corresponding author), NIST, College Pk, MD 20742 USA.	jiehang.zhang@gmail.com	Pagano, Guido/B-1750-2018; Potter, Andrew/AAM-1480-2020; Pagano, Guido/ACJ-0744-2022; Monroe, Christopher R/G-8105-2011; Vishwanath, Ashvin/AAO-6878-2020; Yao, Norman/A-3929-2009	Pagano, Guido/0000-0002-6760-4015; Pagano, Guido/0000-0002-6760-4015; Yao, Norman/0000-0003-0194-7266; Potter, Andrew/0000-0001-5048-1269; Hess, Paul/0000-0003-2985-4221; Becker, Patrick/0000-0002-7786-9447	ARO Atomic and Molecular Physics Program; AFOSR MURI on Quantum Measurement and Verification; IARPA LogiQ program; IC Postdoctoral Research Fellowship Program; NSF Physics Frontier Center at JQI; Miller Institute for Basic Research in Science; AFOSR MURI grant [FA9550- 14-1-0035]; Simons Investigator Program; LDRD Program of LBNL under US DOE [DE-AC02-05CH11231]; Direct For Mathematical & Physical Scien [1430094] Funding Source: National Science Foundation	ARO Atomic and Molecular Physics Program; AFOSR MURI on Quantum Measurement and Verification; IARPA LogiQ program; IC Postdoctoral Research Fellowship Program; NSF Physics Frontier Center at JQI(National Science Foundation (NSF)); Miller Institute for Basic Research in Science; AFOSR MURI grant; Simons Investigator Program; LDRD Program of LBNL under US DOE; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge discussions with M. Zaletel and D. Stamper-Kurn. This work was supported by the ARO Atomic and Molecular Physics Program, the AFOSR MURI on Quantum Measurement and Verification, the IARPA LogiQ program, the IC Postdoctoral Research Fellowship Program, the NSF Physics Frontier Center at JQI (and the PFC Seed Grant), and the Miller Institute for Basic Research in Science. A.V. was supported by the AFOSR MURI grant FA9550- 14-1-0035 and the Simons Investigator Program. N.Y.Y. acknowledges support from the LDRD Program of LBNL under US DOE Contract No. DE-AC02-05CH11231.	[Anonymous], 2016, PREPRINT; Bordia P., 2016, PREPRINT; Brown KR, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.052318; Bruno P, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.118901; Burin AL, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.104428; Chaikin P. M., 1995, PRINCIPLES CONDENSED, V1; D'Alessio L, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041048; Else DV, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.090402; Else DV, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.201103; Hayes D, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.140501; Jotzu G, 2014, NATURE, V515, P237, DOI 10.1038/nature13915; Khemani V, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.250401; Kim K, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.120502; Lazarides A, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.012110; Li TC, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.163001; Nandkishore R, 2015, ANNU REV CONDEN MA P, V6, P15, DOI 10.1146/annurev-conmatphys-031214-014726; Olmschenk S, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.052314; Ponte P, 2015, ANN PHYS-NEW YORK, V353, P196, DOI 10.1016/j.aop.2014.11.008; Porras D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.207901; Potter AC, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.041001; Sacha K, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.033617; Sachdev S., 1999, QUANTUM PHASE TRANSI; Smith J, 2016, NAT PHYS, V12, P907, DOI [10.1038/nphys3783, 10.1038/NPHYS3783]; von Keyserlingk CW, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.085112; von Keyserlingk CW, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.245145; Wilczek F, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.250402; Wilczek F, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.160401; Yao NY, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.030401; Yao NY, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.243002	33	605	609	14	223	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2017	543	7644					217	+		10.1038/nature21413	http://dx.doi.org/10.1038/nature21413			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0GQ	28277505	Green Submitted			2022-12-28	WOS:000395688700033
J	Moonen, B; Shiff, C				Moonen, Bruno; Shiff, Clive			Should we commit to eradicating malaria worldwide?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Moonen, Bruno] Bill & Melinda Gates Fdn, Global Hlth Program, Malaria, Seattle, WA 98109 USA; [Shiff, Clive] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Bill & Melinda Gates Foundation; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Moonen, B (corresponding author), Bill & Melinda Gates Fdn, Global Hlth Program, Malaria, Seattle, WA 98109 USA.; Shiff, C (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.	Bruno.Moonen@gatesfoundation.org; cshiff1@jhu.edu						African Union, CAT FRAM END AIDS TD; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364; CAsia Pacific Leaders Malaria Alliance, MAL EL ROADM SAV MO; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Consejo de Ministros de Salud de Centroamericana y Rca. Dominicana (COMISCA), PLAN ESTR EL MAL CEN; Draper C, 1972, T R SOC TROP MED HYG, V356, P342; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Gates Melinda, COMMUNICATION; Hemingway J, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002380; Mastbaum O., 1957, Journal of Tropical Medicine and Hygiene, V60, P119; Mnzava AP, 2014, T ROY SOC TROP MED H, V108, P550, DOI 10.1093/trstmh/tru101; Molyneux DH, 1980, THE GARKI PROJECT; Najera J. A., 2001, Parassitologia (Rome), V43, P1; Neiderud Carl-Johan, 2015, Infection Ecology & Epidemiology, V5, P27060, DOI 10.3402/iee.v5.27060; Ortiz-Ospina E, 2016, WORLD POVERTY; Roll Back Malaria, ACT INV DEF MAL 2016; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Senaratne R, 2016, LANCET, V388, P1038, DOI 10.1016/S0140-6736(16)31572-0; Shiff C, 2002, CLIN MICROBIOL REV, V15, P278, DOI 10.1128/CMR.15.2.278-293.2002; Smith DL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0145; Stamps TJ, 1992, MED RES COUNCIL ZIMB, V356, P5; UN, 2014, WORLD URB PROSP 2014; United Nations, SUST DEV GOALS; Whitty CJM, 2014, CLIN MED, V14, P419, DOI 10.7861/clinmedicine.14-4-419; WHO, 2013, WORLD MALARIA REPORT 2013, P1; World Health Organization, 1969, REEX GLOB STRAT MAL; World Health Organization, 2021, GLOB TECHN STRAT MAL	28	3	3	2	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2017	356								j916	10.1136/bmj.j916	http://dx.doi.org/10.1136/bmj.j916			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JW	28255004				2022-12-28	WOS:000395628700017
J	Wailoo, K				Wailoo, Keith			Sickle Cell Disease - A History of Progress and Peril	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wailoo, Keith] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA	Princeton University	Wailoo, K (corresponding author), Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA.							[Anonymous], 1959, TIME, P42; GRAY GW, 1951, SCI AM, V185, P56; Wailoo Keith., 2015, PAIN POLITICAL HIST; Wailoo Keith, 2001, DYING CITY BLUES SIC; Wailoo Keith, 2007, TROUBLED DREAM GENET	5	14	15	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2017	376	9					805	807		10.1056/NEJMp1700101	http://dx.doi.org/10.1056/NEJMp1700101			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9JK	28249142				2022-12-28	WOS:000395627500001
J	Abbasi, J				Abbasi, Jennifer			For Health Disparities, Don't Ignore the Microbiome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2017	317	8					797	797		10.1001/jama.2017.0447	http://dx.doi.org/10.1001/jama.2017.0447			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM7PW	28245306				2022-12-28	WOS:000395505600004
J	Green, A; Phiri, P				Green, Andrew; Phiri, Patrick			Frontline: Responding to Malawi's health needs	LANCET			English	Editorial Material									[Phiri, Patrick] Malawi Red Cross, Lilongwe, Malawi		Phiri, P (corresponding author), Malawi Red Cross, Lilongwe, Malawi.								0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 25	2017	389	10071					788	788		10.1016/S0140-6736(17)30583-4	http://dx.doi.org/10.1016/S0140-6736(17)30583-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9UU	28248166				2022-12-28	WOS:000394966400018
J	Voelker, R				Voelker, Rebecca			Inspections Turn up Insects, Mold in Drug Compounding Facilities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2017	317	7					688	688		10.1001/jama.2017.0453	http://dx.doi.org/10.1001/jama.2017.0453			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8WR	28241339				2022-12-28	WOS:000394901600008
J	Rosenbaum, L				Rosenbaum, Lisa			Resisting the Suppression of Science	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Baker James A., 2017, CONSERVATIVE CASE CA; Kahan DM, 2017, J RISK RES, V20, P1, DOI 10.1080/13669877.2016.1260631; Kahan DM, 2015, POLIT PSYCHOL, V36, P1, DOI 10.1111/pops.12244; Nyhan B, 2014, PEDIATRICS, V133, pE835, DOI 10.1542/peds.2013-2365; Sunstein CR, 2012, NY TIMES	5	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 27	2017	376	17					1607	1609		10.1056/NEJMp1702362	http://dx.doi.org/10.1056/NEJMp1702362			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET2AY	28248549				2022-12-28	WOS:000400071900002
J	Reardon, S				Reardon, Sara			How Trump's travel ban is affecting science	NATURE			English	News Item																			0	3	3	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2017	543	7644					157	158		10.1038/nature.2017.21579	http://dx.doi.org/10.1038/nature.2017.21579			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0GQ	28277525	Bronze			2022-12-28	WOS:000395688700005
J	Woolley, AE; Montgomery, MW; Savage, WJ; Achebe, MO; Dunford, K; Villeda, S; Maguire, JH; Marty, FM				Woolley, Ann E.; Montgomery, Mary W.; Savage, William J.; Achebe, Maureen O.; Dunford, Kathleen; Villeda, Sarah; Maguire, James H.; Marty, Francisco M.			Post-Babesiosis Warm Autoimmune Hemolytic Anemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								BACKGROUND Babesiosis, a tickborne zoonotic disease caused by intraerythrocytic protozoa of the genus babesia, is characterized by nonimmune hemolytic anemia that resolves with antimicrobial treatment and clearance of parasitemia. The development of warm-antibody autoimmune hemolytic anemia (also known as warm autoimmune hemolytic anemia [WAHA]) in patients with babesiosis has not previously been well described. METHODS After the observation of sporadic cases of WAHA that occurred after treatment of patients for babesiosis, we conducted a retrospective cohort study of all the patients with babesiosis who were cared for at our center from January 2009 through June 2016. Data on covariates of interest were extracted from the medical records, including any hematologic complications that occurred within 3 months after the diagnosis and treatment of babesiosis. RESULTS A total of 86 patients received a diagnosis of babesiosis during the 7.5-year study period; 18 of these patients were asplenic. WAHA developed in 6 patients 2 to 4 weeks after the diagnosis of babesiosis, by which time all the patients had had clinical and laboratory responses to antimicrobial treatment of babesiosis, including clearance of Babesia microti parasitemia. All 6 patients were asplenic (P < 0.001) and had positive direct antiglobulin tests for IgG and complement component 3; warm autoantibodies were identified in all these patients. No alternative explanation for clinical hemolysis was found. WAHA required immunosuppressive treatment in 4 of the 6 patients. CONCLUSIONS We documented post-babesiosis WAHA in patients who did not have a history of autoimmunity; asplenic patients appeared to be particularly at risk.	[Woolley, Ann E.; Montgomery, Mary W.; Dunford, Kathleen; Villeda, Sarah; Maguire, James H.; Marty, Francisco M.] Harvard Med Sch, Brigham & Womens Hosp, Div Infect Dis, Boston, MA USA; [Savage, William J.] Harvard Med Sch, Brigham & Womens Hosp, Div Transfus Med, Boston, MA USA; [Achebe, Maureen O.] Harvard Med Sch, Brigham & Womens Hosp, Div Hematol, Boston, MA USA; [Woolley, Ann E.; Montgomery, Mary W.; Savage, William J.; Achebe, Maureen O.; Maguire, James H.; Marty, Francisco M.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA; [Woolley, Ann E.; Achebe, Maureen O.; Marty, Francisco M.] Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Woolley, AE (corresponding author), Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.	awoolley@bwh.harvard.edu	Marty, Francisco M./H-7088-2019	Marty, Francisco M./0000-0002-3708-8734				ABDALLA S, 1982, BRIT J HAEMATOL, V51, P415, DOI 10.1111/j.1365-2141.1982.tb02797.x; Berentsen S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/363278; Evenson DA, 1998, J CLIN APHERESIS, V13, P32, DOI 10.1002/(SICI)1098-1101(1998)13:1<32::AID-JCA7>3.3.CO;2-1; Gehrs BC, 2002, AM J HEMATOL, V69, P258, DOI 10.1002/ajh.10062; Hatcher JC, 2001, CLIN INFECT DIS, V32, P1117, DOI 10.1086/319742; Herman JH, 2010, J CLIN APHERESIS, V25, P358, DOI 10.1002/jca.20262; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Johnson ST, 2007, TRANSFUSION, V47, P697, DOI 10.1111/j.1537-2995.2007.01173.x; King KE, 2005, SEMIN HEMATOL, V42, P131, DOI 10.1053/j.seminhematol.2005.04.003; Krause PJ, 2008, CLIN INFECT DIS, V46, P370, DOI 10.1086/525852; Krause PJ, 2003, AM J TROP MED HYG, V68, P431, DOI 10.4269/ajtmh.2003.68.431; Petz LD, 2004, IMMUNE HEMOLYTIC ANE; Raffray L, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-398; ROSNER F, 1984, AM J MED, V76, P696, DOI 10.1016/0002-9343(84)90298-5; Sharma Vishnu, 2012, J Assoc Physicians India, V60, P129; Shatzel JJ, 2015, TRANSFUSION, V55, P661, DOI 10.1111/trf.12901; Sonani Rajesh, 2013, Asian J Transfus Sci, V7, P151, DOI 10.4103/0973-6247.115581; Teal AE, 2012, J CLIN MICROBIOL, V50, P903, DOI 10.1128/JCM.05848-11; TELEN MJ, 1990, J ACQ IMMUN DEF SYND, V3, P933; Vannier E, 2008, INFECT DIS CLIN N AM, V22, P469, DOI 10.1016/j.idc.2008.03.010; Vannier E, 2012, NEW ENGL J MED, V366, P2397, DOI 10.1056/NEJMra1202018; White DJ, 1998, ARCH INTERN MED, V158, P2149, DOI 10.1001/archinte.158.19.2149; WOLF CFW, 1982, TRANSFUSION, V22, P538, DOI 10.1046/j.1537-2995.1982.22683068624.x	23	25	26	1	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2017	376	10					939	946		10.1056/NEJMoa1612165	http://dx.doi.org/10.1056/NEJMoa1612165			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JA	28273010				2022-12-28	WOS:000395626500010
J	Greene, MI; Moore, JS				Greene, Mark I.; Moore, Jonni S.			Peter C. Nowell (1928-2016)	SCIENCE			English	Biographical-Item									[Greene, Mark I.; Moore, Jonni S.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Greene, MI (corresponding author), Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA.	moorej@mail.med.upenn.edu							0	0	0	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					913	913		10.1126/science.aam9738	http://dx.doi.org/10.1126/science.aam9738			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2YM	28254903				2022-12-28	WOS:000395181700024
J	Weiss, KR				Weiss, Kenneth R.			Can deep reefs rescue shallow ones?	SCIENCE			English	Editorial Material																			0	5	5	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					903	903		10.1126/science.355.6328.903	http://dx.doi.org/10.1126/science.355.6328.903			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM2YM	28254897				2022-12-28	WOS:000395181700018
J	Lynch, M; Ali, F; Mallipeddi, R				Lynch, Magnus; Ali, Faisal; Mallipeddi, Raj			CASE REVIEW A pedunculated nasal nodule	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lynch, Magnus] Guys & St Thomas NHS Fdn Trust, St Johns Inst Dermatol, Dermatol Surg & Laser Unit, Dermatol, London, England; [Ali, Faisal] Guys & St Thomas NHS Fdn Trust, St Johns Inst Dermatol, Dermatol Surg & Laser Unit, Dermatol Surg, London, England; [Mallipeddi, Raj] Guys & St Thomas NHS Fdn Trust, St Johns Inst Dermatol, Dermatol Surg & Laser Unit, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Mallipeddi, R (corresponding author), Guys & St Thomas NHS Fdn Trust, St Johns Inst Dermatol, Dermatol Surg & Laser Unit, London, England.	raj.mallipeddi@gstt.nhs.uk		Lynch, Magnus/0000-0001-7586-4338				Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Mc Loone NM, 2006, J EUR ACAD DERMATOL, V20, P698, DOI 10.1111/j.1468-3083.2006.01576.x; Roewert-Huber J, 2007, BRIT J DERMATOL, V157, P47, DOI 10.1111/j.1365-2133.2007.08273.x; Sekulic A, 2015, J AM ACAD DERMATOL, V72, P1021, DOI 10.1016/j.jaad.2015.03.021; Shriner DL, 1998, J AM ACAD DERMATOL, V39, P79, DOI 10.1016/S0190-9622(98)70405-0; Telfer NR, 2008, BRIT J DERMATOL, V159, P35, DOI 10.1111/j.1365-2133.2008.08666.x; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201	8	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2017	356								j763	10.1136/bmj.j763	http://dx.doi.org/10.1136/bmj.j763			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JW	28254755				2022-12-28	WOS:000395628700016
J	Levitt, L				Levitt, Larry			What Might an ACA Replacement Plan Look Like?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Levitt, Larry] Kaiser Family Fdn, Special Initiat, Oakland, CA USA; [Levitt, Larry] Kaiser Initiat Hlth Reform & Private Insurance, Oakland, CA USA		Levitt, L (corresponding author), Kaiser Family Fdn, Special Initiat, Oakland, CA USA.; Levitt, L (corresponding author), Kaiser Initiat Hlth Reform & Private Insurance, Oakland, CA USA.	llevitt@kff.org							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2017	317	8					795	796		10.1001/jama.2017.0661	http://dx.doi.org/10.1001/jama.2017.0661			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM7PW	28245310	Bronze			2022-12-28	WOS:000395505600003
J	Garcia-Borreguero, D; Cano-Pumarega, I				Garcia-Borreguero, Diego; Cano-Pumarega, Irene			New concepts in the management of restless legs syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PERIODIC LIMB MOVEMENTS; QUALITY-OF-LIFE; LONG-TERM TREATMENT; RELEASE OXYCODONE-NALOXONE; PLACEBO-CONTROLLED TRIAL; SLEEP BEHAVIOR DISORDER; JOINT TASK-FORCE; DOUBLE-BLIND; EKBOM DISEASE; SYNDROME RLS	Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED) is a neurological condition with an overall prevalence in adults of 5-10% in Europe and North America. It is characterised by strong feelings of restlessness and distressing paraesthesia-like sensations in the lower legs, particularly when at rest. The symptoms vary considerably in severity and frequency. RLS/WED has a variable clinical expression influenced by genetic, environmental, and medical factors. Research into the pathophysiology of RLS/WED has found that various genetic markers and existing dysfunctions in dopaminergic mechanisms and iron mechanisms play a central role. Until recently, the first line treatment of RLS/WED was with low dose dopamine agonists, with three drugs having been approved by the US Food and Drug Administration and the European Medicines Agency. However, the occurrence of dopaminergic augmentation and an overall increase in severity of symptoms during long term treatment with dopamine agonists is leading to a shift towards non-dopaminergic alternatives as initial treatments, and particularly to alpha 2 delta ligands. Recent international guidelines recommend, whenever possible, to start treatment with these drugs (alpha 2 delta ligands) to avoid augmentation from the start. Other (eg, glutamatergic or adenosine) neurotransmitters might also play an important role in causing RLS/WED and might thus lead to new treatments.	[Garcia-Borreguero, Diego; Cano-Pumarega, Irene] Sleep Res Inst, Madrid 28036, Spain		Garcia-Borreguero, D (corresponding author), Sleep Res Inst, Madrid 28036, Spain.	dgb@iis.es	Cano-Pumarega, Irene/P-1717-2019	Cano-Pumarega, Irene/0000-0003-1543-7187; Garcia-Borreguerro, Diego/0000-0003-1083-9654	UCB; Xenoport	UCB(UCB Pharma SA); Xenoport	We have read and understood the BMJ policy on declaration of interests and declare the following interests: DGB has received research grants from UCB and Xenoport.	Abetz L, 2004, CLIN THER, V26, P925, DOI 10.1016/S0149-2918(04)90136-1; Allen RP, 2002, SLEEP MED, V3, pS3, DOI 10.1016/S1389-9457(02)00140-5; Allen RP, 2000, SLEEP MED, V1, P11, DOI 10.1016/S1389-9457(99)00012-X; Allen RP, 2014, SLEEP MED, V15, P860, DOI 10.1016/j.sleep.2014.03.025; Allen RP, 2014, NEW ENGL J MED, V370, P621, DOI 10.1056/NEJMoa1303646; Allen RP, 2013, NEUROLOGY, V80, P2028, DOI 10.1212/WNL.0b013e318294b3f6; Allen RP, 2013, AM J HEMATOL, V88, P261, DOI 10.1002/ajh.23397; Allen RP, 2011, SLEEP MED, V12, P431, DOI 10.1016/j.sleep.2011.03.003; Allen RP, 2011, MOVEMENT DISORD, V26, P114, DOI 10.1002/mds.23430; Allen RP, 2009, SLEEP MED, V10, P1097, DOI 10.1016/j.sleep.2008.10.007; Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Allen RP, 2005, ARCH INTERN MED, V165, P1286, DOI 10.1001/archinte.165.11.1286; Allen RP, 2001, J CLIN NEUROPHYSIOL, V18, P128, DOI 10.1097/00004691-200103000-00004; Allen RP, 1996, SLEEP, V19, P205, DOI 10.1093/sleep/19.3.205; Allen RP, 2002, NEUROLOGY, V59, P639, DOI 10.1212/WNL.59.4.639; Allen RP, 2001, NEUROLOGY, V56, P263, DOI 10.1212/WNL.56.2.263; Allen RP, 2012, 16 INT C PARK DIS MO; Aurora RN, 2012, SLEEP, V35, P1039, DOI 10.5665/sleep.1988; Bassetti CL, 2001, EUR NEUROL, V45, P67, DOI 10.1159/000052098; Benediktsdottir B, 2010, SLEEP MED, V11, P1043, DOI 10.1016/j.sleep.2010.08.006; Bogan RK, 2010, MAYO CLIN PROC, V85, P512, DOI 10.4065/mcp.2009.0700; Bombois S, 2010, J NUTR HEALTH AGING, V14, P212, DOI 10.1007/s12603-010-0052-7; Bonati MT, 2003, BRAIN, V126, P1485, DOI 10.1093/brain/awg137; Buchfuhrer MJ, 2008, SLEEP MED, V9, P188, DOI 10.1016/j.sleep.2007.02.013; Budhiraja P, 2012, J CLIN SLEEP MED, V8, P119, DOI 10.5664/jcsm.1756; Burtscher C, 2014, J NEUROL SCI, V346, P121, DOI 10.1016/j.jns.2014.08.007; Chen NH, 2010, PSYCHIAT CLIN NEUROS, V64, P170, DOI 10.1111/j.1440-1819.2010.02067.x; Chen SH, 2004, AM J HUM GENET, V74, P876, DOI 10.1086/420772; Cho YW, 2008, SLEEP, V31, P219, DOI 10.1093/sleep/31.2.219; Chokroverty S, 2015, SLEEP MED CLIN, V10, P249, DOI 10.1016/j.jsmc.2015.05.021; Cippa MAT, 2013, J SLEEP RES, V22, P589, DOI 10.1111/jsr.12053; Claman DM, 2006, J CLIN SLEEP MED, V2, P438; Connor JR, 2004, NEUROLOGY, V62, P1563, DOI 10.1212/01.WNL.0000123251.60485.AC; Connor JR, 2003, NEUROLOGY, V61, P304, DOI 10.1212/01.WNL.0000078887.16593.12; Cook JD, 1999, AM J MED SCI, V318, P269, DOI 10.1097/00000441-199910000-00006; Cornelius JR, 2010, SLEEP, V33, P81; Cosentino FII, 2012, ACTA NEUROL SCAND, V125, P319, DOI 10.1111/j.1600-0404.2011.01563.x; Daubian-Nose P, 2014, SLEEP SCI, V7, P234, DOI 10.1016/j.slsci.2014.10.002; Dauvilliers Y, 2007, SLEEP, V30, P844, DOI 10.1093/sleep/30.7.844; Desai AV, 2004, TWIN RES, V7, P589, DOI 10.1375/1369052042663841; Desautels A, 2001, AM J HUM GENET, V69, P1266, DOI 10.1086/324649; Durgin T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140632; Earley CJ, 2011, SLEEP, V34, P341, DOI 10.1093/sleep/34.3.341; Earley CJ, 2010, SLEEP MED, V11, P807, DOI 10.1016/j.sleep.2010.07.007; Earley CJ, 2009, SLEEP MED, V10, P1155, DOI 10.1016/j.sleep.2009.01.006; Earley CJ, 2005, SLEEP MED, V6, P301, DOI 10.1016/j.sleep.2005.01.008; Fantini ML, 2002, NEUROLOGY, V59, P1889, DOI 10.1212/01.WNL.0000038348.94399.F6; Ferre S, 2016, SLEEP MED; Ferri R, 2016, SLEEP MED, V26, P86, DOI 10.1016/j.sleep.2016.10.010; Ferri R, 2007, CLIN NEUROPHYSIOL, V118, P438, DOI 10.1016/j.clinph.2006.10.007; Ferri R, 2016, SLEEP, V39, P413, DOI 10.5665/sleep.5454; FERRO AM, 1975, BIOCHIM BIOPHYS ACTA, V410, P285, DOI 10.1016/0005-2744(75)90231-4; Frauscher B, 2009, SLEEP MED, V10, P611, DOI 10.1016/j.sleep.2008.09.007; Fulda S, 2012, CLIN NEUROPHYSIOL, V123, pe104, DOI DOI 10.1016/J.CLINPH.2012.03.056; Fulda S, 2008, BRAIN, V131, P902, DOI 10.1093/brain/awm244; Gamaldo C, 2009, SLEEP MED, V10, P134, DOI 10.1016/j.sleep.2007.11.024; Garcia-Borreguero D., 2015, SLEEP MED CLIN, V10, pxiii, DOI [10.1016/j.jsmc.2015.05.020pmid:26329438., DOI 10.1016/J.JSMC.2015.05.020PMID:26329438]; Garcia-Borreguero D, 2007, SLEEP MED, V8, P742, DOI 10.1016/j.sleep.2006.09.009; Garcia-Borreguero D, 2007, SLEEP MED, V8, P520, DOI 10.1016/j.sleep.2007.03.022; Garcia-Borreguero D, 2016, SLEEP MED, V21, P1, DOI 10.1016/j.sleep.2016.01.017; Garcia-Borreguero D, 2015, SLEEP MED CLIN, V10, P287, DOI 10.1016/j.jsmc.2015.05.020; Garcia-Borreguero D, 2014, SLEEP, V37, P635, DOI 10.5665/sleep.3558; Garcia-Borreguero D, 2013, SLEEP MED, V14, P675, DOI 10.1016/j.sleep.2013.05.016; Garcia-Borreguero D, 2013, SLEEP, V36, P1101, DOI 10.5665/sleep.2820; Garcia-Borreguero D, 2012, EUR J NEUROL, V19, P1385, DOI 10.1111/j.1468-1331.2012.03853.x; Garcia-Borreguero D, 2012, MOVEMENT DISORD, V27, P277, DOI 10.1002/mds.24889; Gemignani F, 1999, NEUROLOGY, V52, P1064, DOI 10.1212/WNL.52.5.1064; Giannaki CD, 2013, J CLIN SLEEP MED, V9, P147, DOI 10.5664/jcsm.2412; Happe S, 2009, SLEEP MED, V10, P295, DOI 10.1016/j.sleep.2008.01.002; Heim B, 2016, NEUROLOGY, V87, P36, DOI 10.1212/WNL.0000000000002803; Hening WA, 1999, SLEEP, V22, P901, DOI 10.1093/sleep/22.7.901; Hening WA, 2010, MOVEMENT DISORD, V25, P1675, DOI 10.1002/mds.23157; Hening WA, 2009, SLEEP MED, V10, P976, DOI 10.1016/j.sleep.2008.09.015; Hogl B, 2011, SLEEP MED, V12, P351, DOI 10.1016/j.sleep.2010.12.007; Hogl B, 2005, NEUROLOGY, V64, P1920, DOI 10.1212/01.WNL.0000163996.64461.A3; Holmes R, 2007, J NEURAL TRANSM, V114, P929, DOI 10.1007/s00702-006-0614-3; Hoque R, 2010, J CLIN SLEEP MED, V6, P79; Hornyak M, 2007, SLEEP, V30, P861, DOI 10.1093/sleep/30.7.861; Hornyak M, 2007, CLIN NEUROPHYSIOL, V118, P1532, DOI 10.1016/j.clinph.2007.04.001; Hornyak Magdolna, 2002, Sleep Med, V3, P457, DOI 10.1016/S1389-9457(02)00080-1; Hornyak M, 2014, SLEEP MED REV, V18, P153, DOI 10.1016/j.smrv.2013.03.004; IANNACCONE S, 1995, MOVEMENT DISORD, V10, P2, DOI 10.1002/mds.870100103; Innes KE, 2013, J CLIN SLEEP MED, V9, P1065, DOI 10.5664/jcsm.3084; Innes KE, 2011, SLEEP MED, V12, P623, DOI 10.1016/j.sleep.2010.12.018; Inoue Y, 2013, CURR MED RES OPIN, V29, P13, DOI 10.1185/03007995.2012.746217; Iranzo A, 2007, MOVEMENT DISORD, V22, pS424, DOI 10.1002/mds.21600; Israel S, 2011, CIRCULATION, V124, P1223; Kagimura T, 2011, SLEEP MED, V12, P821, DOI 10.1016/j.sleep.2011.04.012; Karroum EG, 2012, J NEUROL SCI, V320, P26, DOI 10.1016/j.jns.2012.05.051; Kemlink D, 2008, NEUROGENETICS, V9, P75, DOI 10.1007/s10048-007-0113-1; Kushida CA, 2009, NEUROLOGY, V72, P439, DOI 10.1212/01.wnl.0000341770.91926.cc; Kushida C, 2007, QUAL LIFE RES, V16, P617, DOI 10.1007/s11136-006-9142-8; Kushida CA, 2009, SLEEP, V32, P159, DOI 10.1093/sleep/32.2.159; Lal R, 2012, CLIN NEUROPHARMACOL, V35, P165, DOI 10.1097/WNF.0b013e318259eac8; Lee DO, 2011, J CLIN SLEEP MED, V7, P279, DOI 10.5664/JCSM.1074; Levchenko A, 2006, NEUROLOGY, V67, P900, DOI 10.1212/01.wnl.0000233991.20410.b6; Levchenko A, 2009, MOVEMENT DISORD, V24, P40, DOI 10.1002/mds.22263; Lipford MC, 2012, SLEEP MED, V13, P1280, DOI 10.1016/j.sleep.2012.08.004; Mackie S, 2015, CNS DRUGS, V29, P351, DOI 10.1007/s40263-015-0250-2; Michaud M, 2000, MOVEMENT DISORD, V15, P289, DOI 10.1002/1531-8257(200003)15:2<289::AID-MDS1012>3.0.CO;2-E; Michaud M, 2002, EUR NEUROL, V48, P108, DOI 10.1159/000062996; Michaud M, 2002, MOVEMENT DISORD, V17, P112, DOI 10.1002/mds.10004; Mitterling T, 2015, SLEEP MED, V16, P1252, DOI 10.1016/j.sleep.2015.05.028; Mitterling T, 2014, SLEEP MED, V15, P1231, DOI 10.1016/j.sleep.2014.05.023; Molnar MZ, 2005, AM J KIDNEY DIS, V45, P388, DOI 10.1053/j.ajkd.2004.10.007; Montplaisir J, 1997, MOVEMENT DISORD, V12, P61, DOI 10.1002/mds.870120111; Montplaisir J, 1998, MOVEMENT DISORD, V13, P324, DOI 10.1002/mds.870130220; Oboshi Y, 2012, J CEREBR BLOOD F MET, V32, P654, DOI 10.1038/jcbfm.2011.201; Ohayon MM, 2012, SLEEP MED REV, V16, P283, DOI 10.1016/j.smrv.2011.05.002; Ondo W, 2004, ARCH NEUROL-CHICAGO, V61, P1393, DOI 10.1001/archneur.61.9.1393; Ondo W, 1996, NEUROLOGY, V47, P1435, DOI 10.1212/WNL.47.6.1435; Ondo WG, 2005, MOVEMENT DISORD, V20, P345, DOI 10.1002/mds.20359; Ondo WG, 2000, NEUROLOGY, V55, P1404, DOI 10.1212/WNL.55.9.1404; Pedroso JL, 2011, ARQ NEURO-PSIQUIAT, V69, P253, DOI 10.1590/S0004-282X2011000200021; Pennestri MH, 2007, NEUROLOGY, V68, P1213, DOI 10.1212/01.wnl.0000259036.89411.52; Pennestri MH, 2006, SLEEP, V29, P1183, DOI 10.1093/sleep/29.9.1183; Picchietti D, 2007, PEDIATRICS, V120, P253, DOI 10.1542/peds.2006-2767; Picchietti DL, 2015, SLEEP MED REV, V22, P64, DOI 10.1016/j.smrv.2014.10.009; Pichler I, 2006, AM J HUM GENET, V79, P716, DOI 10.1086/507875; Plazzi G, 2010, SLEEP, V33, P689, DOI 10.1093/sleep/33.5.689; Provini F, 2015, SLEEP MED CLIN, V10, P215, DOI 10.1016/j.jsmc.2015.05.006; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Robinson MR, 2014, TRENDS GENET, V30, P124, DOI 10.1016/j.tig.2014.02.003; Salas RE, 2012, AM J MANAG CARE, V18, pS207; Saletu B, 2002, SLEEP MED, V3, pS35, DOI 10.1016/S1389-9457(02)00147-8; Sawanyawisuth K, 2013, J CLIN SLEEP MED, V9, P47, DOI 10.5664/jcsm.2338; Schormair B, 2008, NAT GENET, V40, P946, DOI 10.1038/ng.190; Sforza E, 2002, CLIN NEUROPHYSIOL, V113, P883, DOI 10.1016/S1388-2457(02)00066-4; Sforza E, 2003, CLIN NEUROPHYSIOL, V114, P1116, DOI 10.1016/S1388-2457(03)00077-4; Sforza E, 2007, SLEEP, V30, P43, DOI 10.1093/sleep/30.1.43; Shi YB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121215; Siddiqui F, 2007, CLIN NEUROPHYSIOL, V118, P1923, DOI 10.1016/j.clinph.2007.05.006; Silver N, 2011, SLEEP MED, V12, P440, DOI 10.1016/j.sleep.2010.11.002; Stefansson H, 2007, NEW ENGL J MED, V357, P639, DOI 10.1056/NEJMoa072743; Stevens MS, 2015, SLEEP MED CLIN, V10, P369, DOI 10.1016/j.jsmc.2015.05.017; Stiasny-Kolster K, 2004, BRAIN, V127, P773, DOI 10.1093/brain/awh079; Szentkiralyi A, 2013, J SLEEP RES, V22, P434, DOI 10.1111/jsr.12040; Szentkiralyi A, 2011, SLEEP MED, V12, P815, DOI 10.1016/j.sleep.2011.06.016; Trenkwalder C, 2016, SLEEP MED; Trenkwalder C, 2015, SLEEP MED; Trenkwalder C, 2008, MOVEMENT DISORD, V23, P2267, DOI 10.1002/mds.22254; Trenkwalder C, 2008, SLEEP MED, V9, P572, DOI 10.1016/j.sleep.2007.07.020; Trenkwalder C, 2008, LANCET NEUROL, V7, P595, DOI 10.1016/S1474-4422(08)70112-1; Trenkwalder C, 2016, NEUROLOGY, V86, P1336, DOI 10.1212/WNL.0000000000002542; Trenkwalder C, 2015, LANCET NEUROL, V14, P1161, DOI 10.1016/S1474-4422(15)00243-4; Trenkwalder C, 2013, LANCET NEUROL, V12, P1141, DOI 10.1016/S1474-4422(13)70239-4; Walters AS, 2014, J CLIN SLEEP MED, V10, P1343, DOI 10.5664/jcsm.4298; Walters AS, 2010, SLEEP, V33, P287, DOI 10.1093/sleep/33.3.287; Walters AS, 2009, CLIN NEUROPHARMACOL, V32, P311, DOI 10.1097/WNF.0b013e3181b3ab16; Walters AS, 1996, NEUROLOGY, V46, P92, DOI 10.1212/WNL.46.1.92; Wijemanne S, 2015, SLEEP MED, V16, P678, DOI 10.1016/j.sleep.2015.03.002; Winkelman J, 2003, SLEEP MED, V4, P261, DOI 10.1016/S1389-9457(03)00066-2; Winkelman JW, 2006, EUR J NEUROL, V13, P8, DOI 10.1111/j.1468-1331.2006.01586.x; Winkelman JW, 2008, NEUROLOGY, V70, P35, DOI 10.1212/01.wnl.0000287072.93277.c9; Winkelman JW, 2006, SLEEP MED, V7, P545, DOI 10.1016/j.sleep.2006.01.004; Winkelman JW, 2016, NEUROLOGY, V87, P2585, DOI 10.1212/WNL.0000000000003388; Winkelman JW, 2013, SLEEP MED, V14, P934, DOI 10.1016/j.sleep.2013.05.017; Winkelman JW, 2009, SLEEP, V32, P772, DOI 10.1093/sleep/32.6.772; Winkelman JW, 1999, SLEEP, V22, P575, DOI 10.1093/sleep/22.5.575; Winkelmann J, 2000, SLEEP, V23, P597; Winkelmann J, 2016, SLEEP MED IN PRESS; Winkelmann J, 2007, NAT GENET, V39, P1000, DOI 10.1038/ng2099; Winkelmann J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002171; Xiong L, 2007, NEUROLOGY, V68, P1631, DOI 10.1212/01.wnl.0000261016.90374.fd; Xiong L, 2010, ARCH NEUROL-CHICAGO, V67, P617, DOI 10.1001/archneurol.2010.67; Yang C, 2005, BIOL PSYCHIAT, V58, P510, DOI 10.1016/j.biopsych.2005.04.022; Zhang JH, 2014, J PSYCHOSOM RES, V76, P158, DOI 10.1016/j.jpsychores.2013.11.017; Zhao HR, 2007, J NEUROSCI RES, V85, P1065, DOI 10.1002/jnr.21207	168	42	46	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 27	2017	356								j104	10.1136/bmj.j104	http://dx.doi.org/10.1136/bmj.j104			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JP	28242627				2022-12-28	WOS:000395628000006
J	Molyneux, M				Molyneux, Malcolm			Ombudsman's annual report for 2016	LANCET			English	Editorial Material									[Molyneux, Malcolm] The Lancet, London EC2Y 5AS, England		Molyneux, M (corresponding author), The Lancet, London EC2Y 5AS, England.	ombudsman@lancet.com						[Anonymous], 2016, LANCET INFECT DIS, V16, P619; The Lancet, 2016, LANCET, V387, P417	2	2	4	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 25	2017	389	10071					783	783		10.1016/S0140-6736(17)30400-2	http://dx.doi.org/10.1016/S0140-6736(17)30400-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9UU	28248162				2022-12-28	WOS:000394966400014
J	Glukhova, A; Thal, DM; Nguyen, AT; Vecchio, EA; Jorg, M; Scammells, PJ; May, LT; Sexton, PM; Christopoulos, A				Glukhova, Alisa; Thal, David M.; Nguyen, Anh T.; Vecchio, Elizabeth A.; Jorg, Manuela; Scammells, Peter J.; May, Lauren T.; Sexton, Patrick M.; Christopoulos, Arthur			Structure of the Adenosine A(1) Receptor Reveals the Basis for Subtype Selectivity	CELL			English	Article							PROTEIN-COUPLED RECEPTOR; 2ND EXTRACELLULAR LOOP; ACUTE HEART-FAILURE; A(2A) RECEPTOR; ALLOSTERIC MODULATION; MOLECULAR-DYNAMICS; ADENOSINE-A1-RECEPTOR BINDING; CRYSTAL-STRUCTURES; FORCE-FIELDS; DRUG DESIGN	The adenosine A(1) receptor (A(1)-AR) is a G-proteincoupled receptor that plays a vital role in cardiac, renal, and neuronal processes but remains poorly targeted by current drugs. We determined a 3.2 angstrom crystal structure of the A(1)-AR bound to the selective covalent antagonist, DU172, and identified striking differences to the previously solved adenosine A(2A) receptor (A(2A)-AR) structure. Mutational and computational analysis of A(1)-AR revealed a distinct conformation of the second extracellular loop and a wider extracellular cavity with a secondary binding pocket that can accommodate orthosteric and allosteric ligands. We propose that conformational differences in these regions, rather than amino-acid divergence, underlie drug selectivity between these adenosine receptor subtypes. Our findings provide a molecular basis for AR subtype selectivity with implications for understanding the mechanisms governing allosteric modulation of these receptors, allowing the design of more selective agents for the treatment of ischemia-reperfusion injury, renal pathologies, and neuropathic pain.	[Glukhova, Alisa; Thal, David M.; Nguyen, Anh T.; Vecchio, Elizabeth A.; May, Lauren T.; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia; [Jorg, Manuela; Scammells, Peter J.] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic 3052, Australia	Monash University; Monash University	Sexton, PM; Christopoulos, A (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia.	patrick.sexton@monash.edu; arthur.christopoulos@monash.edu	Nguyen, Anh/GPK-4377-2022; Christopoulos, Arthur/B-6207-2013; Sexton, Patrick M/B-1319-2008; Nguyen, Anh/GQQ-3393-2022; Thal, David/GXH-4911-2022	Nguyen, Anh/0000-0002-6385-0585; Christopoulos, Arthur/0000-0003-4442-3294; Sexton, Patrick M/0000-0001-8902-2473; Vecchio, Elizabeth/0000-0002-2172-2083; Joerg, Manuela/0000-0002-3116-373X; Thal, David/0000-0002-0325-2524; May, Lauren/0000-0002-4412-1707; Glukhova, Alisa/0000-0003-4146-965X; Scammells, Peter/0000-0003-2930-895X	National Health and Medical Research Council of Australia (NHMRC) [APP1055134, APP1084246]; Australian Endeavour Scholarship and Fellowship; Australian Research Council (ARC) Discovery Early Career Researcher Award (DECRA); Australian Postgraduate Award; Australian Cancer Therapeutics scholarship	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Endeavour Scholarship and Fellowship(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Research Council (ARC) Discovery Early Career Researcher Award (DECRA)(Australian Research Council); Australian Postgraduate Award(Australian Government); Australian Cancer Therapeutics scholarship	Data collection was undertaken at the MX2 beamline at the Australian synchrotron. This work was funded by the National Health and Medical Research Council of Australia (NHMRC) Program Grant APP1055134 and Project Grant APP1084246. A.T.N. is a recipient of an Australian Endeavour Scholarship and Fellowship. L.T.M. is a recipient of an Australian Research Council (ARC) Discovery Early Career Researcher Award (DECRA), A.C. is a Senior Principal Research Fellow, and P.M.S. is a Principal Research Fellow, of the NHMRC. E.A.V. holds an Australian Postgraduate Award and an Australian Cancer Therapeutics scholarship. We thank Prof. Brian Kobilka for helpful discussions.	Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; Aurelio L, 2009, J MED CHEM, V52, P4543, DOI 10.1021/jm9002582; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Baltos JA, 2016, BIOCHEM PHARMACOL, V99, P101, DOI 10.1016/j.bcp.2015.11.013; Beauglehole AR, 2000, J MED CHEM, V43, P4973, DOI 10.1021/jm000181f; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Braunwald E, 2011, J CARDIOVASC PHARM T, V16, P349, DOI 10.1177/1074248411407637; BRUNS RF, 1990, MOL PHARMACOL, V38, P950; BRUNS RF, 1990, MOL PHARMACOL, V38, P939; Carpenter B, 2016, NATURE, V538, DOI 10.1038/nature19803; Changeux JP, 2016, CELL, V166, P1084, DOI 10.1016/j.cell.2016.08.015; Chen JF, 2013, NAT REV DRUG DISCOV, V12, P265, DOI 10.1038/nrd3955; Congreve M, 2012, J MED CHEM, V55, P1898, DOI 10.1021/jm201376w; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Dore AS, 2011, STRUCTURE, V19, P1283, DOI 10.1016/j.str.2011.06.014; Dror RO, 2013, NATURE, V503, P295, DOI 10.1038/nature12595; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Ferguson GN, 2008, J MED CHEM, V51, P6165, DOI 10.1021/jm800557d; Foadi J, 2013, ACTA CRYSTALLOGR D, V69, P1617, DOI 10.1107/S0907444913012274; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Goblyos A, 2011, BBA-BIOMEMBRANES, V1808, P1309, DOI 10.1016/j.bbamem.2010.06.013; Gracia E, 2013, NEUROPHARMACOLOGY, V71, P56, DOI 10.1016/j.neuropharm.2013.03.005; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Guo D, 2017, CHEM REV, V117, P38, DOI 10.1021/acs.chemrev.6b00025; Guo D, 2016, MOL PHARMACOL, V89, P485, DOI 10.1124/mol.115.102657; Gutierrez-de-Teran H, 2017, CURR TOP MED CHEM, V17, P40, DOI 10.2174/1568026616666160719164207; Hino T, 2012, NATURE, V482, P237, DOI 10.1038/nature10750; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Jazayeri A, 2015, J BIOL CHEM, V290, P19489, DOI 10.1074/jbc.R115.668251; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kennedy DP, 2014, MOL PHARMACOL, V85, P301, DOI 10.1124/mol.113.088682; Kloner RA, 2006, EUR HEART J, V27, P2400, DOI 10.1093/eurheartj/ehl094; Kourounakis AP, 2000, DRUG DEVELOP RES, V49, P227, DOI 10.1002/1098-2299(200004)49:4<227::AID-DDR1>3.0.CO;2-1; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Lebon G, 2015, MOL PHARMACOL, V87, P907, DOI 10.1124/mol.114.097360; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Leone RD, 2015, COMPUT STRUCT BIOTEC, V13, P265, DOI 10.1016/j.csbj.2015.03.008; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Massie BM, 2010, NEW ENGL J MED, V363, P1419, DOI 10.1056/NEJMoa0912613; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller CE, 2011, BBA-BIOMEMBRANES, V1808, P1290, DOI 10.1016/j.bbamem.2010.12.017; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Mustafa S Jamal, 2009, Handb Exp Pharmacol, P161, DOI 10.1007/978-3-540-89615-9_6; Neves MAC, 2012, J COMPUT AID MOL DES, V26, P675, DOI 10.1007/s10822-012-9547-0; Nguyen ATN, 2016, MOL PHARMACOL, V90, P703, DOI 10.1124/mol.116.105007; Nguyen ATN, 2016, MOL PHARMACOL, V90, P715, DOI 10.1124/mol.116.105015; Peeters MC, 2012, BIOCHEM PHARMACOL, V84, P76, DOI 10.1016/j.bcp.2012.03.008; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pinna A, 2014, CNS DRUGS, V28, P455, DOI 10.1007/s40263-014-0161-7; Savinainen JR, 2003, BRIT J PHARMACOL, V140, P1451, DOI 10.1038/sj.bjp.0705577; Segala E, 2016, J MED CHEM, V59, P6470, DOI 10.1021/acs.jmedchem.6b00653; Teerlink JR, 2012, DRUG SAFETY, V35, P233, DOI 10.2165/11594680-000000000-00000; Thal DM, 2016, NATURE, V531, P335, DOI 10.1038/nature17188; Totrov M, 1997, PROTEINS, P215; TUCKER AL, 1994, J BIOL CHEM, V269, P27900; Valant C, 2014, P NATL ACAD SCI USA, V111, P4614, DOI 10.1073/pnas.1320962111; van der Klein PAM, 1999, J MED CHEM, V42, P3629, DOI 10.1021/jm991051d; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793	68	175	178	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2017	168	5					867	+		10.1016/j.cell.2017.01.042	http://dx.doi.org/10.1016/j.cell.2017.01.042			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8YB	28235198	Bronze			2022-12-28	WOS:000396284800015
J	Paules, CI; Fauci, AS				Paules, Catharine I.; Fauci, Anthony S.			Yellow Fever - Once Again on the Radar Screen in the Americas	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							THREAT		[Paules, Catharine I.; Fauci, Anthony S.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Paules, CI (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.			Paules, Catharine/0000-0002-9064-6678				Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Gardner CL, 2010, CLIN LAB MED, V30, P237, DOI 10.1016/j.cll.2010.01.001; Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030; Wu JT, 2016, LANCET, V388, P2904, DOI 10.1016/S0140-6736(16)31838-4	4	87	88	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 13	2017	376	15					1397	1399		10.1056/NEJMp1702172	http://dx.doi.org/10.1056/NEJMp1702172			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ER6EX	28273000	Bronze			2022-12-28	WOS:000398899200001
J	Herzlinger, RE; Richman, BD; Boxer, RJ				Herzlinger, Regina E.; Richman, Barak D.; Boxer, Richard J.			Achieving Universal Coverage Without Turning to a Single Payer Lessons From 3 Other Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Herzlinger, Regina E.] Harvard Sch Business, Boston, MA USA; [Richman, Barak D.] Duke Univ, Durham, NC USA; [Boxer, Richard J.] Univ Calif Los Angeles, David Geffen Sch Med, 1143 Linda Flora Dr, Los Angeles, CA 90049 USA	Harvard University; Duke University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Boxer, RJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, 1143 Linda Flora Dr, Los Angeles, CA 90049 USA.	rboxer@mednet.ucla.edu						Blumel M, 2015, 2015 INT PROFILES HL, P69; Claxton G, 2016, PREEXISTING CONDITIO; Herman B, 2016, MODERN HEALTHCARE; Mitchell EM, 2016, CONCENTRATION HLTH E; National Institute for Health Care Management, 2012, CONC HLTH CAR SPEND; Rae M, 2015, COST INDIVIDUAL MAND; Riley T, 2017, HIGH RISK POOLS DEJA; Senate Republican Finance Committee Staff, 2015 MED SOC SEC TRU; Suderman P., 2017, MAJOR BLOW OBAMACARE	9	6	6	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2017	317	14					1409	1410		10.1001/jama.2017.1475	http://dx.doi.org/10.1001/jama.2017.1475			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER6FQ	28241203				2022-12-28	WOS:000398901200010
J	Kontis, V; Bennett, JE; Mathers, CD; Li, GQ; Foreman, K; Ezzati, M				Kontis, Vasilis; Bennett, James E.; Mathers, Colin D.; Li, Guangquan; Foreman, Kyle; Ezzati, Majid			Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble	LANCET			English	Article							NONCOMMUNICABLE DISEASES; UNITED-STATES; MORTALITY; INCOME; LIMITS; INEQUALITY; DEMOGRAPHY; PROSPECTS; HEALTH	Background Projections of future mortality and life expectancy are needed to plan for health and social services and pensions. Our aim was to forecast national age-specific mortality and life expectancy using an approach that takes into account the uncertainty related to the choice of forecasting model. Methods We developed an ensemble of 21 forecasting models, all of which probabilistically contributed towards the final projections. We applied this approach to project age-specific mortality to 2030 in 35 industrialised countries with high-quality vital statistics data. We used age-specific death rates to calculate life expectancy at birth and at age 65 years, and probability of dying before age 70 years, with life table methods. Findings Life expectancy is projected to increase in all 35 countries with a probability of at least 65% for women and 85% for men. There is a 90% probability that life expectancy at birth among South Korean women in 2030 will be higher than 86.7 years, the same as the highest worldwide life expectancy in 2012, and a 57% probability that it will be higher than 90 years. Projected female life expectancy in South Korea is followed by those in France, Spain, and Japan. There is a greater than 95% probability that life expectancy at birth among men in South Korea, Australia, and Switzerland will surpass 80 years in 2030, and a greater than 27% probability that it will surpass 85 years. Of the countries studied, the USA, Japan, Sweden, Greece, Macedonia, and Serbia have some of the lowest projected life expectancy gains for both men and women. The female life expectancy advantage over men is likely to shrink by 2030 in every country except Mexico, where female life expectancy is predicted to increase more than male life expectancy, and in Chile, France, and Greece where the two sexes will see similar gains. More than half of the projected gains in life expectancy at birth in women will be due to enhanced longevity above age 65 years. Interpretation There is more than a 50% probability that by 2030, national female life expectancy will break the 90 year barrier, a level that was deemed unattainable by some at the turn of the 21st century. Our projections show continued increases in longevity, and the need for careful planning for health and social services and pensions. Copyright (C) The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license.	[Kontis, Vasilis; Bennett, James E.; Li, Guangquan; Foreman, Kyle; Ezzati, Majid] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Kontis, Vasilis; Bennett, James E.; Foreman, Kyle; Ezzati, Majid] Imperial Coll London, MRC PHE Ctr Environm & Hlth, London, England; [Mathers, Colin D.] World Hlth Org, Dept Informat Evidence & Res, Geneva, Switzerland; [Li, Guangquan] Northumbria Univ, Dept Math Phys & Elect Engn, Newcastle Upon Tyne, Tyne & Wear, England; [Foreman, Kyle] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Ezzati, Majid] Imperial Coll London, WHO Collaborating Ctr NCD Surveillance & Epidemio, London, England	Imperial College London; Imperial College London; World Health Organization; Northumbria University; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Imperial College London	Ezzati, M (corresponding author), Imperial Coll London, London W2 1PG, England.	majid.ezzati@imperial.ac.uk	Li, Guangquan/AAW-6920-2021	Li, Guangquan/0000-0002-8736-5349; Kontis, Vasilis/0000-0002-0485-1561; Bennett, James Elston/0000-0002-9616-6878; Mathers, Colin/0000-0002-0617-6731	UK Medical Research Council; US Environmental Protection Agency; MRC [MR/L01341X/1, MR/K005901/1] Funding Source: UKRI; Medical Research Council [MR/L01341X/1, MR/K005901/1] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US Environmental Protection Agency(United States Environmental Protection Agency); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	UK Medical Research Council and US Environmental Protection Agency.	Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; [Anonymous], 2014, LANCET, DOI DOI 10.1016/S0140-6736(14)60616-4; Babones SJ, 2008, SOC SCI MED, V66, P1614, DOI 10.1016/j.socscimed.2007.12.012; Beltran-Sanchez H, 2015, P NATL ACAD SCI USA, V112, P8993, DOI 10.1073/pnas.1421942112; Bentham J, 2016, ELIFE, V5, DOI 10.7554/eLife.13410.001; Booth H, 2008, ANN ACTUAR SCI, V3, P3, DOI 10.1017/S1748499500000440; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Deaton A, 2003, J ECON LIT, V41, P113, DOI 10.1257/002205103321544710; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Ezzati M, 2008, PLOS MED, V5, P557, DOI 10.1371/journal.pmed.0050066; Ezzati M, 2012, SCIENCE, V337, P1482, DOI 10.1126/science.1227001; Grinshteyn E, 2016, AM J MED, V129, P266, DOI 10.1016/j.amjmed.2015.10.025; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Ikeda N, 2011, LANCET, V378, P1094, DOI 10.1016/S0140-6736(11)61055-6; Indicators OE., 2015, HLTH GLANC 2011, DOI [10.1787/health_glance-2015-en, DOI 10.1787/HEALTH_GLANCE-2015-EN]; Khang YH, 2016, EUR J PUBLIC HEALTH, V26, P242, DOI 10.1093/eurpub/ckv128; MANTON KG, 1991, POPUL DEV REV, V17, P603, DOI 10.2307/1973599; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; OLSHANSKY SJ, 1990, SCIENCE, V250, P634, DOI 10.1126/science.2237414; Olshansky SJ, 2001, SCIENCE, V291, P1491, DOI 10.1126/science.291.5508.1491; Parr N, 2016, POP STUD-J DEMOG, V70, P181, DOI 10.1080/00324728.2016.1190029; Riley J. C., 2007, LOW INCOME SOCIAL GR; Sen A., 2001, POVERTY INEQUALITY H; United Nations Department of Economic and Social Affairs, 2015, WORLD POPULATION PRO; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; World Health Organisation, 2015, WORLD REP AG HLTH GE; Yang S, 2010, AM J PUBLIC HEALTH, V100, P896, DOI 10.2105/AJPH.2009.160341; You DZ, 2015, LANCET, V386, P2275, DOI 10.1016/S0140-6736(15)00120-8; Zhou B, 2017, LANCET, V389, P37, DOI 10.1016/S0140-6736(16)31919-5	32	618	628	6	100	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 1	2017	389	10076					1323	1335		10.1016/S0140-6736(16)32381-9	http://dx.doi.org/10.1016/S0140-6736(16)32381-9			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EQ2OF	28236464	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000397908700025
J	Sipp, D; McCabe, C; Rasko, JEJ				Sipp, Douglas; McCabe, Christopher; Rasko, John E. J.			Show drugs work before selling them	NATURE			English	Editorial Material									[Sipp, Douglas] RIKEN, Ctr Dev Biol, Kobe, Hyogo, Japan; [Sipp, Douglas] Keio Univ, Sch Med, Tokyo, Japan; [Sipp, Douglas] Global Res Inst, Tokyo, Japan; [McCabe, Christopher] Univ Alberta, Edmonton, AB, Canada; [Rasko, John E. J.] Royal Prince Alfred Hosp, Dept Cell & Mol Therapies, Sydney, NSW, Australia	RIKEN; Keio University; University of Alberta; University of Sydney	Sipp, D (corresponding author), RIKEN, Ctr Dev Biol, Kobe, Hyogo, Japan.; Sipp, D (corresponding author), Keio Univ, Sch Med, Tokyo, Japan.; Sipp, D (corresponding author), Global Res Inst, Tokyo, Japan.	sipp@cdb.riken.jp	Sipp, Douglas/C-9218-2017	Sipp, Douglas/0000-0002-5979-0938; rasko, John/0000-0003-2975-807X				Bothwell LE, 2016, NEW ENGL J MED, V374, P2175, DOI 10.1056/NEJMms1604593; da Silva EMK, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008185.pub4; Henderson D. R., 2009, FORBES; Junod Suzanne White, 2008, QUICK GUIDE CLIN TRI, P25; Moore TJ, 2014, JAMA INTERN MED, V174, P90, DOI 10.1001/jamainternmed.2013.11813; Siramshetty VB, 2016, NUCLEIC ACIDS RES, V44, pD1080, DOI 10.1093/nar/gkv1192	6	8	8	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2017	543	7644					174	175		10.1038/543174a	http://dx.doi.org/10.1038/543174a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN0GQ	28277530	Bronze			2022-12-28	WOS:000395688700013
J	Furler, J; O'Neal, D; Speight, J; Manski-Nankervis, JA; Gorelik, A; Holmes-Truscott, E; Ginnivan, L; Young, D; Best, J; Patterson, E; Liew, D; Segal, L; May, C; Blackberry, I				Furler, John; O'Neal, David; Speight, Jane; Manski-Nankervis, Jo-Anne; Gorelik, Alexandra; Holmes-Truscott, Elizabeth; Ginnivan, Louise; Young, Doris; Best, James; Patterson, Elizabeth; Liew, Danny; Segal, Leonie; May, Carl; Blackberry, Irene			Supporting insulin initiation in type 2 diabetes in primary care: results of the Stepping Up pragmatic cluster randomised controlled clinical trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GLYCEMIC CONTROL; MANAGEMENT; THERAPY; QUALITY; INTENSIFICATION; HYPERGLYCEMIA; HYPOGLYCEMIA; INTEGRATION; COMMUNITY; BARRIERS	OBJECTIVE To compare the effectiveness of a novel model of care ("Stepping Up") with usual primary care in normalising insulin initiation for type 2 diabetes, leading to improved glycated haemoglobin (HbA1c) levels. DESIGN Cluster randomised controlled trial. SETTING Primary care practices in Victoria, Australia, with a practice nurse and at least one consenting eligible patient (HbA1c >= 7.5% with maximal oral treatment). PARTICIPANTS 266 patients with type 2 diabetes and 74 practices (mean cluster size 4 (range 1-8) patients), followed up for 12 months. INTERVENTION The Stepping Up model of care intervention involved theory based change in practice systems and reorientation of the roles of health professionals in the primary care diabetes team. The core components were an enhanced role for the practice nurse in leading insulin initiation and mentoring by a registered nurse with diabetes educator credentials. MAIN OUTCOME MEASURES The primary endpoint was change in HbA1c. Secondary endpoints included the proportion of participants who transitioned to insulin, proportion who achieved target HbA1c, and a change in depressive symptoms (patient health questionnaire, PHQ-9), diabetes specific distress (problem areas in diabetes scale, PAID), and generic health status (assessment of quality of life instrument, AQoL-8D). RESULTS HbA1c improved in both arms, with a clinically significant between arm difference (mean difference -0.6%, 95% confidence interval -0.9% to -0.3%), favouring the intervention. At 12 months, in intervention practices, 105/151 (70%) of participants had started insulin, compared with 25/115 (22%) in control practices (odds ratio 8.3, 95% confidence interval 4.5 to 15.4, P<0.001). Target HbA1c (<= 7% (53 mmol/mol)) was achieved by 54 (36%) intervention participants and 22 (19%)control participants (odds ratio 2.2, 1.2 to 4.3, P=0.02). Depressive symptoms did not worsen at 12 months (PHQ-9: -1.1 (3.5) v-0.1 (2.9), P=0.05). A statistically significant difference was found between arms in the mean change in mental health (AQoL mental component summary: 0.04 (SD 0.16) v-0.002 (0.13), mean difference 0.04 (95% confidence interval 0.002 to 0.08), P=0.04), favouring the intervention, but no significant difference in physical health (AQoL physical component summary: 0.03 (0.15) v 0.02 (0.13)) nor diabetes specific distress (5.6 (15.5) v-2.4 (15.4)). No severe hypoglycaemia events were reported. CONCLUSIONS The Stepping Up model of care was associated with increased insulin initiation rates in primary care, and improvements in glycated haemoglobin without worsening emotional wellbeing. TRIAL REGISTRATION Australian and New Zealand Clinical Trials Registry ACTRN12612001028897.	[Furler, John; Manski-Nankervis, Jo-Anne; Young, Doris] Univ Melbourne, Dept Gen Practice, Melbourne, Vic 3053, Australia; [O'Neal, David] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia; [Speight, Jane; Holmes-Truscott, Elizabeth; Ginnivan, Louise] Deakin Univ, Sch Psychol, Geelong, Vic 3217, Australia; [Speight, Jane; Holmes-Truscott, Elizabeth] Australian Ctr Behav Res Diabet, Diabet Victoria, Melbourne, Vic, Australia; [Gorelik, Alexandra] Univ Melbourne, Melbourne EpiCtr, Melbourne, Vic, Australia; [Young, Doris] Univ Melbourne, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia; [Best, James] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Patterson, Elizabeth] Univ Melbourne, Sch Nursing, Melbourne, Vic, Australia; [Liew, Danny] Monash Univ, Sch Publ Hlth & Prevent Med, Clayton, Vic, Australia; [Segal, Leonie] Univ South Australia, Div Hlth Sci, Hlth Econ & Social Policy Grp, Adelaide, SA, Australia; [May, Carl] Univ Southampton, Fac Hlth Sci, Southampton, Hants, England; [Blackberry, Irene] La Trobe Univ, Coll Sci Hlth & Engn, Australian Inst Primary Care & Ageing, John Richards Initiat, Melbourne, Vic, Australia	University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; Deakin University; University of Melbourne; University of Melbourne; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Melbourne; Monash University; University of South Australia; University of Southampton; La Trobe University	Furler, J (corresponding author), Univ Melbourne, Dept Gen Practice, Melbourne, Vic 3053, Australia.	j.furler@unimelb.edu.au	Gorelik, Alexandra/Z-6361-2019; Speight, Jane/AES-0292-2022	Gorelik, Alexandra/0000-0003-1032-0457; Holmes-Truscott, Elizabeth/0000-0001-9139-4663; Speight, Jane/0000-0002-1204-6896; Best, James/0000-0002-5239-9274; May, Carl/0000-0002-0451-2690	Australian National Health and Medical Research Council [1023738]; Roche Diagnostics Australia	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Roche Diagnostics Australia	The study was funded by the Australian National Health and Medical Research Council (ID 1023738) and was supported by an educational/research grant by Roche Diagnostics Australia.	American Diabetes Association, 2016, Clin Diabetes, V34, P3, DOI 10.2337/diaclin.34.1.3; Blackberry ID, 2014, DIABETES RES CLIN PR, V106, P247, DOI 10.1016/j.diabres.2014.08.011; Blackberry ID, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5272; Blak BT, 2012, DIABETIC MED, V29, pE191, DOI 10.1111/j.1464-5491.2012.03694.x; Curtis Bradley, 2014, J Med Econ, V17, P21, DOI 10.3111/13696998.2013.862538; Dale J, 2010, PRIM CARE DIABETES, V4, P85, DOI 10.1016/j.pcd.2010.03.001; Davis TME, 2006, MED J AUSTRALIA, V184, P325, DOI 10.5694/j.1326-5377.2006.tb00264.x; Dzida G, 2015, PRIM CARE DIABETES, V9, P346, DOI 10.1016/j.pcd.2015.01.002; Elliott L, 2016, DIABETES THER, V7, P45, DOI 10.1007/s13300-016-0157-z; Frier BM, 2016, DIABETIC MED, V33, P1125, DOI 10.1111/dme.12878; Furler J, 2011, AUST FAM PHYSICIAN, V40, P617; Furler JS, 2014, FAM PRACT, V31, P349, DOI 10.1093/fampra/cmt085; Furler JS, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-20; Giraudeau B, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000065; Gucciardi E, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0407-1; Hajos TRS, 2011, DIABETIC MED, V28, P1096, DOI 10.1111/j.1464-5491.2011.03329.x; Harris SB, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-71; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Khunti K, 2012, DIABETES OBES METAB, V14, P654, DOI 10.1111/j.1463-1326.2012.01602.x; Khunti S, 2015, BRIT J DIABETES VASC, V15, P65, DOI 10.15277/bjdvd.2015.019; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kunt T, 2009, INT J CLIN PRACT, V63, P6, DOI 10.1111/j.1742-1241.2009.02176.x; May CR, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-29; McGuire H, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1575; Nathan DM, 2008, DIABETES CARE, V31, P173, DOI [10.2337/dc08-9016, 10.2337/dc08-0545]; O'Connor PJ, 2013, CURR DIABETES REP, V13, P172, DOI 10.1007/s11892-012-0350-z; Phillips LS, 2001, ANN INTERN MED, V135, P825, DOI 10.7326/0003-4819-135-9-200111060-00012; Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543; Polonsky WH, 2011, DIABETES CARE, V34, P262, DOI 10.2337/dc10-1732; Pouwer F, 2009, DIABETES-METAB RES, V25, pS4, DOI 10.1002/dmrr.981; Richardson J, 2014, PATIENT, V7, P85, DOI 10.1007/s40271-013-0036-x; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18]; Shah BR, 2005, DIABETES CARE, V28, P600, DOI 10.2337/diacare.28.3.600; Speight J, 2011, DIABETES MILES AUSTR; The Royal Australian College of General Practitioners and Diabetes Australia, 2014, GENERAL PRACTICE MAN; Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760; Zimmet PZ, 2014, LANCET DIABETES ENDO, V2, P56, DOI 10.1016/S2213-8587(13)70112-8	38	32	32	1	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2017	356								j783	10.1136/bmj.j783	http://dx.doi.org/10.1136/bmj.j783			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BS	28274941	Green Published, hybrid, Green Submitted, Green Accepted			2022-12-28	WOS:000396433200013
J	Singer, M; Bulled, N; Ostrach, B; Mendenhall, E				Singer, Merrill; Bulled, Nicola; Ostrach, Bayla; Mendenhall, Emily			Syndemics and the biosocial conception of health	LANCET			English	Article							SUBSTANCE-ABUSE; BACTERIOPHAGE THERAPY; HIV; VIOLENCE; TUBERCULOSIS; COINFECTION; HIV/AIDS; DISEASE; VIRUS; EPIDEMIOLOGY	The syndemics model of health focuses on the biosocial complex, which consists of interacting, co-present, or sequential diseases and the social and environmental factors that promote and enhance the negative effects of disease interaction. This emergent approach to health conception and clinical practice reconfigures conventional historical understanding of diseases as distinct entities in nature, separate from other diseases and independent of the social contexts in which they are found. Rather, all of these factors tend to interact synergistically in various and consequential ways, having a substantial impact on the health of individuals and whole populations. Specifically, a syndemics approach examines why certain diseases cluster (ie, multiple diseases affecting individuals and groups); the pathways through which they interact biologically in individuals and within populations, and thereby multiply their overall disease burden, and the ways in which social environments, especially conditions of social inequality and injustice, contribute to disease clustering and interaction as well as to vulnerability. In this Series, the contributions of the syndemics approach for understanding both interacting chronic diseases in social context, and the implications of a syndemics orientation to the issue of health rights, are examined.	[Singer, Merrill] Univ Connecticut, Dept Anthropol, Storrs, CT 06269 USA; [Singer, Merrill] Univ Connecticut, Dept Community Med, Storrs, CT USA; [Bulled, Nicola] Worcester Polytech Inst, Div Interdisciplinary & Global Studies, Worcester, MA 01609 USA; [Ostrach, Bayla] Boston Univ, Sch Med, Boston, MA 02118 USA; [Mendenhall, Emily] Georgetown Univ, Sch Foreign Serv, Washington, DC 20057 USA	University of Connecticut; University of Connecticut; Worcester Polytechnic Institute; Boston University; Georgetown University	Singer, M (corresponding author), Univ Connecticut, Dept Anthropol, Storrs, CT 06269 USA.	Merrill.Singer@uconn.edu	Ostrach, Bayla/AAJ-3391-2021	Ostrach, Bayla/0000-0003-2803-3747; Bulled, Nicola/0000-0002-9699-3937				Ahmed S., 2007, NAT REV IMMUNOL; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Beliles K, 1998, PSYCHOSOMATICS, V39, pS2, DOI 10.1016/S0033-3182(98)71339-8; Billingsley R, 2013, LESSONS LESOTHO JOI; Blanton LS, 2014, VECTOR-BORNE ZOONOT, V14, P557, DOI 10.1089/vbz.2014.1575; Bonds MH, 2010, P ROY SOC B-BIOL SCI, V277, P1185, DOI 10.1098/rspb.2009.1778; Bourgois Philippe, 1995, SEARCH RESPECT SELLI; Clougherty JE, 2007, ENVIRON HEALTH PERSP, V115, P1140, DOI 10.1289/ehp.9863; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; de Noronha ALL, 2008, PATHOL RES PRACT, V204, P155, DOI 10.1016/j.prp.2007.10.008; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; Earnshaw VA, 2009, AIDS BEHAV, V13, P1160, DOI 10.1007/s10461-009-9593-3; Ellison G, 2003, LEARNING HIV AIDS; Farmer P, 2001, B WORLD HEALTH ORGAN, V79, P1145; Farmer Paul, 2008, Health Hum Rights, V10, P5; Farmer PE, 2006, PLOS MED, V3, P1686, DOI 10.1371/journal.pmed.0030449; Fortin M, 2006, ANN FAM MED, V4, P104, DOI 10.1370/afm.516; Gilbert L, 2015, JAIDS-J ACQ IMM DEF, V69, pS118, DOI 10.1097/QAI.0000000000000626; Gonzalez-Guarda R. M., 2009, HISPANIC HLTH CARE I, V7, P114, DOI [10.1891/1540-4153.7.3.114, DOI 10.1891/1540-4153.7.3.114]; Goodrich Suzanne, 2013, Confl Health, V7, P25, DOI 10.1186/1752-1505-7-25; Griffiths EC, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2286; Harries AD, 2011, INT J TUBERC LUNG D, V15, P1436, DOI 10.5588/ijtld.11.0503; Hatzenbuehler ML, 2009, PSYCHOL BULL, V135, P707, DOI 10.1037/a0016441; Hebert-Dufresne L, 2015, P NATL ACAD SCI USA, V112, P10551, DOI 10.1073/pnas.1507820112; Himmelgreen D, 2010, ENVIRONMENT, V52, P6, DOI 10.1080/00139157.2010.493106; Himmelgreen DA, 2009, AJAR-AFR J AIDS RES, V8, P401, DOI 10.2989/AJAR.2009.8.4.4.1041; Inui TS, 2007, J GEN INTERN MED, V22, P1745, DOI 10.1007/s11606-007-0437-4; Jefferys RJ, 2015, P NATL ACAD SCI USA, V112, pE2118, DOI 10.1073/pnas.1502380112; Kijak Gustavo H, 2005, Curr Infect Dis Rep, V7, P480, DOI 10.1007/s11908-005-0051-8; Kilmarx PH, 2001, SEX TRANSM DIS, V28, P347, DOI 10.1097/00007435-200106000-00008; Kjetland EF, 2006, AIDS, V20, P593, DOI 10.1097/01.aids.0000210614.45212.0a; Krieger N, 2001, INT J EPIDEMIOL, V30, P668, DOI 10.1093/ije/30.4.668; Latkin C, 2010, DRUG ALCOHOL DEPEN, V110, P221, DOI 10.1016/j.drugalcdep.2010.03.004; Leatherman TL, 1997, AM J PHYS ANTHROPOL, V102, P1; Littleton J, 2009, SOC SCI MED, V69, P1674, DOI 10.1016/j.socscimed.2009.08.042; Lu TK, 2011, CURR OPIN MICROBIOL, V14, P524, DOI 10.1016/j.mib.2011.07.028; McClelland RS, 2005, J INFECT DIS, V191, P333, DOI 10.1086/427262; Mehle A, 2012, J VIROL, V86, P1750, DOI 10.1128/JVI.06203-11; Mendenhall Emily, 2013, SYNDEMIC SUFFERING S; Merabishvili M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004944; Mok H, 2002, B CAN PSYCHIAT A DEC, P25; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; NICHTER M, 2009, GLOBAL HLTH WHY CULT; Ostrach B, 2012, HLTH SOCIOL REV, V21, P1532; Pawslowski A, 2012, PLOS PATHOG, V8; Puett C, 2014, COST EFFECT RESOUR A, V12, DOI 10.1186/1478-7547-12-11; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Rasella D, 2013, LANCET, V382, P57, DOI 10.1016/S0140-6736(13)60715-1; Reddy M, 2007, JAMA-J AM MED ASSOC, V298, P1911, DOI 10.1001/jama.298.16.1911; Rousseau CM, 2007, J VIROL, V81, P4492, DOI 10.1128/JVI.02050-06; Rye David B., 2003, Curr Treat Options Neurol, V5, P231, DOI 10.1007/s11940-003-0014-z; Serrano E, 2014, EPIDEMIOL INFECT, V142, P1533, DOI 10.1017/S0950268813002100; Shaikh MA, 2003, SAUDI MED J, V24, P278; Sheth PM, 2008, J INFECT DIS, V197, P1394, DOI 10.1086/587697; Singer M., 2009, INTRO SYNDEMICS CRIT; Singer M., 1996, FREE INQ CREAT SOCIO, V24, P99, DOI [10.1093/jn/nxaa361, DOI 10.1093/jn/nxaa361]; Singer M, 2012, ANN ANTHROPL PRACT, V36, P205, DOI 10.1111/napa.12000; Singer Merrill, 2016, COMPANION ANTHR ENV; Stall R, 2003, AM J PUBLIC HEALTH, V93, P939, DOI 10.2105/AJPH.93.6.939; Stall Ron, 2007, UNEQUAL OPPORTUNITY; Strickland GT, 2006, HEPATOLOGY, V43, P915, DOI 10.1002/hep.21173; Sullivan KA, 2015, AIDS PATIENT CARE ST, V29, pS42, DOI 10.1089/apc.2014.0278; Summers WC, 2001, ANNU REV MICROBIOL, V55, P437, DOI 10.1146/annurev.micro.55.1.437; Tesh S.N., 1988, HIDDEN ARGUMENTS POL; Tsai AC, 2015, SOC SCI MED, V139, P26, DOI 10.1016/j.socscimed.2015.06.024; Tscherne DM, 2011, J CLIN INVEST, V121, P6, DOI 10.1172/JCI44947; US Department of Health and Human Services Centers for Disease Control and Prevention, 2010, CDCPS1010175 DIS CON; WALLACE R, 1990, SOC SCI MED, V31, P801, DOI 10.1016/0277-9536(90)90175-R; Waterson A., 1993, STREET ADDICTS POLIT; Weiser SD, 2007, PLOS MED, V4, P1589, DOI 10.1371/journal.pmed.0040260; Weiser SD, 2011, AM J CLIN NUTR, V94, p1729S, DOI 10.3945/ajcn.111.012070; Wongsrichanalai C, 2003, AM J TROP MED HYG, V68, P583, DOI 10.4269/ajtmh.2003.68.583; Wright A, 2009, CLIN OTOLARYNGOL, V34, P349, DOI 10.1111/j.1749-4486.2009.01973.x; Wright RJ, 2001, ENVIRON HEALTH PERSP, V109, P1085, DOI 10.2307/3454965	74	544	560	2	55	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 4	2017	389	10072					941	950		10.1016/s0140-6736(17)30003-x	http://dx.doi.org/10.1016/s0140-6736(17)30003-x			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM4DL	28271845				2022-12-28	WOS:000395263400034
J	Willen, SS; Knipper, M; Abadia-Barrero, CE; Davidovitch, N				Willen, Sarah S.; Knipper, Michael; Abadia-Barrero, Cesar E.; Davidovitch, Nadav			Syndemic vulnerability and the right to health	LANCET			English	Article							SOCIAL DETERMINANTS; PUBLIC-HEALTH; MENTAL-HEALTH; MIGRATION; IMMIGRATION; DETENTION; REFUGEES; DISEASE; EQUITY; EXPERIENCES	Investigators working both in syndemics, a field of applied health research with roots in medical anthropology, and in the field of health and human rights recognise that upstream social, political, and structural determinants contribute more to health inequities than do biological factors or personal choices. Syndemics investigates synergistic, often deleterious interactions among comorbid health conditions, especially under circumstances of structural and political adversity. Health and human rights research draws on international law to argue that all people deserve access not only to health care, but also to the underlying determinants of good health. Taking the urgent matter of migrant health as an empirical focus, we juxtapose the fields of syndemics and health and human rights, identify their complementarities, and advocate for a combined approach. By melding insights from these fields, the combined syndemics/health and human rights approach advanced here can provide clinicians and other key stakeholders with concrete insights, tools, and strategies to tackle the health inequities that affect migrants and other vulnerable groups by: (1) mapping the effect of social, political, and structural determinants on health; (2) identifying opportunities for upstream intervention; and (3) working collaboratively to tackle the structures, institutions, and processes that cause and exacerbate health inequities. Undergirding this approach is an egalitarian interpretation of the right to health that differs from narrow legalistic and individual interpretations by insisting that all people are equal in worth and, as a result, equally deserving of protection from syndemic vulnerability.	[Willen, Sarah S.] Univ Connecticut, Dept Anthropol, Storrs, CT 06269 USA; [Abadia-Barrero, Cesar E.] Univ Connecticut, Human Rights Inst, Storrs, CT USA; [Knipper, Michael] Justus Liebig Univ Giessen, Inst Hist Med, Giessen, Germany; [Davidovitch, Nadav] Ben Gurion Univ Negev, Dept Hlth Syst Management, Beer Sheva, Israel	University of Connecticut; University of Connecticut; Justus Liebig University Giessen; Ben Gurion University	Willen, SS (corresponding author), Univ Connecticut, Dept Anthropol, Storrs, CT 06269 USA.	sarah.willen@uconn.edu	Abadia, Cesar/K-6074-2019	Knipper, Michael/0000-0002-8469-7575				Andorno R, 2009, J MED PHILOS, V34, P223, DOI 10.1093/jmp/jhp023; [Anonymous], 2015, LANCET, V386, P1013, DOI 10.1016/S0140-6736(15)00190-7; [Anonymous], HIGH LEV M REF MIGR; Australian Human Rights Commission, 2014, FORG CHILDR NAT INQ; Ayres JR, 2010, ROUTLEDGE HDB GLOBAL; BAfF-Zentren, GES BAG MANG GES FLU; Bisserbe N, 2016, WALL STREET J; Bisson JI, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6161; BMZ, 2009, GES MENSCH; BOCHENEK, 2016, HUMAN RIGHTS WATCH; Bouchard L, 2015, SOC SCI MED, V141, P100, DOI 10.1016/j.socscimed.2015.07.022; BRANDT AM, 1978, HASTINGS CENT REP, V8, P21, DOI 10.2307/3561468; Braveman P, 2003, J EPIDEMIOL COMMUN H, V57, P254, DOI 10.1136/jech.57.4.254; Braveman Paula, 2010, Health Hum Rights, V12, P31; British Medical Association (BMA), 2011, SOC DET HLTH WHAT DO; Castaneda H, 2015, ANNU REV PUBL HEALTH, V36, P375, DOI 10.1146/annurev-publhealth-032013-182419; Centers for Disease Control and Prevention, 2009, PROGR COLL SERV INT; Chapman AR, 2011, J HUM RIGHTS, V10, P132, DOI 10.1080/14754835.2011.568914; Chapman AR, 2009, BIOETHICS, V23, P97, DOI 10.1111/j.1467-8519.2008.00716.x; Chapman Audrey R., 2016, HUMAN RIGHTS GLOBAL; Chrisafis A, 2015, GUARDIAN; Cohen J., 2007, PUBLIC HLTH HUMAN RI, P362; Committee on Economic Social and Cultural Rights, 2000, EC1220004 UN COMM EC; DANIELS N, 1985, JUST HLTH CARE; Daniels N, 2006, HASTINGS CENT REP, V36, P22, DOI 10.1353/hcr.2006.0058; Daniels Norman, 2009, COMPANION BIOETHICS, P362; Daynes L., 2015, FOREWORD ENV HLTH AS; Drozdek B, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-148; European Commission, 2015, MOR RESP MAN REF CRI; Farmer PE, 2006, PLOS MED, V3, P1686, DOI 10.1371/journal.pmed.0030449; Filc D, 2016, INT J HEALTH SERV, V46, P734, DOI 10.1177/0020731415594601; Fleischman Y, 2015, SOC SCI MED, V147, P89, DOI 10.1016/j.socscimed.2015.10.046; Gable L, 2007, J LAW MED ETHICS, V35, P534, DOI 10.1111/j.1748-720X.2007.00178.x; Garcia-Garcia CR, 2016, LIFE SCI, V145, P274, DOI 10.1016/j.lfs.2015.10.013; Gawande A, 2011, NEW YORKER, V24, P2011; Pointer Mildred A, 2012, Int J Hypertens, V2012, P268013, DOI [10.1155/2012/453465, 10.1155/2012/268013]; Greenhouse S, 2014, NY TIMES; Grodin M., 2013, HLTH HUMAN RIGHTS CH; Grodin MA, 1996, JAMA-J AM MED ASSOC, V276, P1682, DOI 10.1001/jama.276.20.1682; Hanewald B, 2015, PSYCHIAT PRAX, V43, P165; Hessler K, 2002, MED SOCIAL JUSTICE; Holmes Seth, 2013, FRESH FRUIT BROKEN B; Horton R, 2008, LANCET, V371, P2213, DOI 10.1016/S0140-6736(08)60956-3; Horton R, 2013, LANCET, V382, P3, DOI 10.1016/S0140-6736(13)61181-2; Horton S., 2016, LEAVE THEIR KIDNEYS; Innis M., 2016, NY TIMES; Isakjee A., 2015, ENV HLTH ASSESSMENT; Kickbusch I., 2010, IMPLEMENTING HLTH AL; Kickbusch I, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h81; Kirmayer LJ, CAN MED ASS J, V183, pe959; Kluge U, 2016, NERVENHEILKUNDE, V35, P385; Kranzler Y, 2013, ISR J HEALTH POLICY, V2, DOI 10.1186/2045-4015-2-16; Krieger N, 2008, AM J PUBLIC HEALTH, V98, P221, DOI 10.2105/AJPH.2007.111278; Lamkaddem M, 2015, EUR J PUBLIC HEALTH, V25, P917, DOI 10.1093/eurpub/ckv061; Langlois EV, 2016, LANCET, V387, P319, DOI 10.1016/S0140-6736(16)00101-X; London L, 2011, RIGHTS BASED APPROAC; London L., 2008, HLTH HUMAN RIGHTS, V10, P65; Luna Florencia., 2009, INT J FEM APPROACHES, V2, P121, DOI [10.3138/ijfab.2.1.121, DOI 10.3138/IJFAB.2.1.121]; MacNaughton G., 2012, NE U LAW J, V4, P365; MacNaughton G, 2015, HEALTH HUM RIGHTS, V17, P63, DOI 10.2307/healhumarigh.17.1.63; MANN J, 1993, AM J INFECT CONTROL, V21, P317, DOI 10.1016/0196-6553(93)90389-L; Mann JM, 1996, AIDS EDUCATION, P1; Mann JM, 1996, BMJ-BRIT MED J, V312, P924; Mares S, 2004, AUST NZ J PUBL HEAL, V28, P520, DOI 10.1111/j.1467-842X.2004.tb00041.x; Mares S, 2015, J PAEDIATR CHILD H, V51, P663, DOI 10.1111/jpc.12954; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Martin PL, 2013, MIGR LETT, V10, P159; McClure HH, 2015, J IMMIGR MINOR HEALT, V17, P1518, DOI 10.1007/s10903-014-0066-z; McCoy HV, 2016, J IMMIGR MINOR HEALT, V18, P710, DOI 10.1007/s10903-015-0265-2; McKeown T., 1979, MED HIST, DOI DOI 10.1515/9781400854622; Mendenhall E., 2015, MED ANTHROPOL Q, DOI 10.1111/maq.12215; Mendenhall E., 2012, SYNDEMIC SUFFERING S, DOI DOI 10.4324/9781315419459; Mendenhall E, 2017, LANCET, V389, P951, DOI 10.1016/S0140-6736(17)30402-6; Mental Health and Psychosocial Support Network, MENT HLTH PSYCH SUPP; Muiznieks N., REPORT COMMISSIONER; Newman LK, 2008, REFUG SURV Q, V27, P110, DOI 10.1093/rsq/hdn034; Nichter M., 2008, GLOBAL HLTH WHY CULT; Nutting PA, 2009, ANN FAM MED, V7, P254, DOI 10.1370/afm.1002; Ottersen OP, 2014, LANCET, V383, P630, DOI 10.1016/S0140-6736(13)62407-1; Quandt SA, 2013, AM J PUBLIC HEALTH, V103, pE24, DOI 10.2105/AJPH.2012.301135; Quesada J, 2011, MED ANTHROPOL, V30, P339, DOI 10.1080/01459740.2011.576725; Rechel B, 2013, LANCET, V381, P1235, DOI 10.1016/S0140-6736(12)62086-8; Reverby SM, 2011, LANCET, V377, P1646, DOI 10.1016/S0140-6736(11)60663-6; Ruger JP, 2010, HLTH SOCIAL JUSTICE; Save the Children (Australia) and UNICEF (Australia), 2016, SAV CHILDR AUSTR UNI; Scheffler S, 2003, PHILOS PUBLIC AFF, V31, P5, DOI 10.1111/j.1088-4963.2003.00005.x; Schmidt H, 2015, LANCET, V386, P928, DOI 10.1016/S0140-6736(15)60244-6; Sen A., 1985, MORALITY OBJECTIVITY, P130; Silberhorn T, 2015, HEALTH HUM RIGHTS, V17, P21; Silove Derrick, 2007, Transcult Psychiatry, V44, P359, DOI 10.1177/1363461507081637; Singer M, 2003, MED ANTHROPOL Q, V17, P423, DOI 10.1525/maq.2003.17.4.423; Singer M., 2009, INTRO SYNDEMICS CRIT; Singer M, 2012, ANN ANTHROPL PRACT, V36, P205, DOI 10.1111/napa.12000; Smedley B.D, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Stall R., 2008, UNEQUAL OPPORTUNITY; Steel Z, 2011, SOC SCI MED, V72, P1149, DOI 10.1016/j.socscimed.2011.02.007; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Teodorescu Dinu-Stefan, 2015, BMC Psychol, V3, P7, DOI 10.1186/s40359-015-0064-5; The Lancet, 2008, LANCET, V372; Tsai AC, 2017, LANCET, V389, P978, DOI 10.1016/S0140-6736(17)30403-8; Tsai AC, 2015, SOC SCI MED, V139, P26, DOI 10.1016/j.socscimed.2015.06.024; United Nations Department of Economic and Social Affairs Population Division, 2016, STESASERA375 UN DEP; United Nations Office of the High Commissioner for Human Rights, 1976, INT COV EC SOC CULT; Unnithan M, 2015, HEALTH HUM RIGHTS, V17, P45; Vela XF, 2014, MEDICC REV, V16, P55, DOI 10.37757/MR2014.V16.N2.9; Venkatapuram Sridhar, 2010, Health Hum Rights, V12, P3; Virchow R., 1848, MEDICINISCHE REFORM, V18, P125; Viruell-Fuentes EA, 2012, SOC SCI MED, V75, P2099, DOI 10.1016/j.socscimed.2011.12.037; Walker, 2016, GUARDIAN; Willen SS, 2012, SOC SCI MED, V74, P805, DOI 10.1016/j.socscimed.2011.10.041; Willen SS, 2011, MED ANTHROPOL Q, V25, P303, DOI 10.1111/j.1548-1387.2011.01163.x; Willen Sarah S., 2016, HDB MIGRATION HLTH; Woodhead M., BMJ, V350, ph3008; Yamin A., 2015, POWER SUFFERING STRU; Yamin AE, 2014, J HUM RIGHTS PRACT, V6, P451, DOI 10.1093/jhuman/huu019; Zimmerman C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001034; Zwi KJ, 2003, MED J AUSTRALIA, V179, P319, DOI 10.5694/j.1326-5377.2003.tb05558.x	117	90	94	3	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 4	2017	389	10072					964	977						14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM4DL	28271847				2022-12-28	WOS:000395263400036
J	Wang, GL; Valent, B				Wang, Guo-Liang; Valent, Barbara			Durable resistance to rice blast	SCIENCE			English	Editorial Material							MAGNAPORTHE-ORYZAE; WHEAT BLAST; BANGLADESH; PATHOTYPE; TRITICUM; IMMUNITY		[Wang, Guo-Liang] Chinese Acad Agr Sci, Inst Plant Protect, State Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Wang, Guo-Liang] Ohio State Univ, Dept Plant Pathol, Columbus, OH 43210 USA; [Valent, Barbara] Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; University System of Ohio; Ohio State University; Kansas State University	Wang, GL (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.; Wang, GL (corresponding author), Ohio State Univ, Dept Plant Pathol, Columbus, OH 43210 USA.	wang.620@osu.edu; bvalent@ksu.edu		Valent, Barbara/0000-0002-5088-3345; Wang, Guo-Liang/0000-0001-8877-3064				Cruz CD, 2016, CROP SCI, V56, P990, DOI 10.2135/cropsci2015.07.0410; Deng YW, 2017, SCIENCE, V355, P962, DOI 10.1126/science.aai8898; Giraldo MC, 2013, NAT REV MICROBIOL, V11, P800, DOI 10.1038/nrmicro3119; Islam MT, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0309-7; Li X, 2015, CURR OPIN IMMUNOL, V32, P114, DOI 10.1016/j.coi.2015.01.014; Liu WD, 2016, NATL SCI REV, V3, P295, DOI 10.1093/nsr/nww015; Malaker PK, 2016, PLANT DIS, V100, P2330, DOI 10.1094/PDIS-05-16-0666-PDN; Pennisi E, 2010, SCIENCE, V327, P804, DOI 10.1126/science.327.5967.804; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Qu SH, 2006, GENETICS, V172, P1901, DOI 10.1534/genetics.105.044891; Vos IA, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00639; Zhou B, 2006, MOL PLANT MICROBE IN, V19, P1216, DOI 10.1094/MPMI-19-1216	12	35	41	3	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					906	907		10.1126/science.aam9517	http://dx.doi.org/10.1126/science.aam9517			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM2YM	28254898				2022-12-28	WOS:000395181700019
J	Dammin, JT				Dammin, John T.			Case 39-2016: A Man with a History of Prostate Cancer and Recent Rectal Bleeding	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Dammin, John T.] Boston Univ, Sch Med, Boston, MA 02118 USA	Boston University	Dammin, JT (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.	tristramdammin@comcast.net						[Anonymous], 2016, NEW ENGL J MED, V375, P2481, DOI [10.1056/NEJMc1700703, DOI 10.1056/NEJMC1700703]	1	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2017	376	9					897	898		10.1056/NEJMc1700703	http://dx.doi.org/10.1056/NEJMc1700703			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JK	28249149				2022-12-28	WOS:000395627500031
J	Denk, F				Denk, Franziska			Don't let useful data go to waste	NATURE			English	Editorial Material									[Denk, Franziska] Kings Coll London, Neurosci Res Lab, London WC2R 2LS, England	University of London; King's College London	Denk, F (corresponding author), Kings Coll London, Neurosci Res Lab, London WC2R 2LS, England.	franziska.denk@kcl.ac.uk	Denk, Franziska/A-4212-2010	Denk, Franziska/0000-0003-4883-4234					0	9	9	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2017	543	7643					7	7		10.1038/543007a	http://dx.doi.org/10.1038/543007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN0AA	28252084	Green Submitted, Bronze			2022-12-28	WOS:000395671500004
J	Ivashkin, V; Zharkova, M				Ivashkin, Vladimir; Zharkova, Maria			Cholesteryl Ester Crystals in Lysosomal Acid Lipase Deficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ivashkin, Vladimir; Zharkova, Maria] First Moscow State Med Univ, Moscow, Russia	Sechenov First Moscow State Medical University	Zharkova, M (corresponding author), First Moscow State Med Univ, Moscow, Russia.	zharkovamaria@mail.ru		Ivashkin, Vladimir T./0000-0002-6815-6015					0	5	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2017	376	9					E14	E14		10.1056/NEJMicm1610060	http://dx.doi.org/10.1056/NEJMicm1610060			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9JK	28249129				2022-12-28	WOS:000395627500011
J	Muth, CC				Muth, Christopher C.			Rembrandt's Senses Lessons in "Perceiving" the Patient	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												christopher.muth@jamanetwork.org						Dixon L., 2010, HEKTOEN INT J, V2; Fresia CJ, 2011, DUTCH ART ENCY, P309; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, pVII	3	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2017	317	8					790	792		10.1001/jama.2017.0553	http://dx.doi.org/10.1001/jama.2017.0553			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM7PW	28245301				2022-12-28	WOS:000395505600001
J	O'Connor, S				O'Connor, Simon			In stable COPD with moderate desaturation, long-term supplemental oxygen did not reduce deaths or hospitalizations	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[O'Connor, Simon] Tamworth Rural Referral Hosp, Tamworth, NSW, Australia		O'Connor, S (corresponding author), Tamworth Rural Referral Hosp, Tamworth, NSW, Australia.							[Anonymous], 1980, Ann Intern Med, V93, P391; FLENLEY DC, 1981, LANCET, V1, P681	2	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2017	166	4					JC17	JC17		10.7326/ACPJC-2017-166-4-017	http://dx.doi.org/10.7326/ACPJC-2017-166-4-017			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7FO	28241290				2022-12-28	WOS:000394786700005
J	Voelker, R				Voelker, Rebecca			Novel Drugs Passed Muster in 2016	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2017	317	7					688	688		10.1001/jama.2017.0312	http://dx.doi.org/10.1001/jama.2017.0312			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8WR	28241338				2022-12-28	WOS:000394901600007
J	[Anonymous]				[Anonymous]			Communication and the Journals (Reprinted from JAMA., 199, pg 577-578, 1967)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		ABELSON PH, 1966, SCIENCE, V154, P727, DOI 10.1126/science.154.3750.727; [Anonymous], 1966, VISUAL MED, V1, p2A; FOX T, 1965, CRISIS COMMUNICATION; 1967, JAMA, V199, P577	4	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2017	317	7					774	774		10.1001/jama.2016.20843	http://dx.doi.org/10.1001/jama.2016.20843			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8WR	28241345				2022-12-28	WOS:000394901600033
J	Roerink, ME; Bredie, SJH; Heijnen, M; Dinarello, CA; Knoop, H; Van der Meer, JWM				Roerink, Megan E.; Bredie, Sebastian J. H.; Heijnen, Michael; Dinarello, Charles A.; Knoop, Hans; Van der Meer, Jos W. M.			Cytokine Inhibition in Patients With Chronic Fatigue Syndrome A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; BLOCKING INTERLEUKIN-1; INFLAMMATION; ANAKINRA; PREVENTION; SICKNESS; BEHAVIOR; DISEASE; PLASMA; SAFETY	Background: Interleukin-1 (IL-1), an important proinflammatory cytokine, is suspected to play a role in chronic fatigue syndrome (CFS). Objective: To evaluate the effect of subcutaneous anakinra versus placebo on fatigue severity in female patients with CFS. Design: Randomized, placebo-controlled trial from July 2014 to May 2016. Patients, providers, and researchers were blinded to treatment assignment. (ClinicalTrials.gov: NCT02108210) Setting: University hospital in the Netherlands. Patients: 50 women aged 18 to 59 years with CFS and severe fatigue leading to functional impairment. Intervention: Participants were randomly assigned to daily subcutaneous anakinra, 100 mg (n = 25), or placebo (n = 25) for 4 weeks and were followed for an additional 20 weeks after treatment (n = 50). Measurements: The primary outcome was fatigue severity, measured by the Checklist Individual Strength subscale (CIS-fatigue) at 4 weeks. Secondary outcomes were level of impairment, physical and social functioning, psychological distress, and pain severity at 4 and 24 weeks. Results: At 4 weeks, 8% (2 of 25) of anakinra recipients and 20% (5 of 25) of placebo recipients reached a fatigue level within the range reported by healthy persons. There were no clinically important or statistically significant differences between groups in CIS-fatigue score at 4 weeks (mean difference, 1.5 points [95% Cl, -4.1 to 7.2 points]) or the end of follow-up. No statistically significant between-group differences were seen for any secondary outcome at 4 weeks or the end of follow-up. One patient in the anakinra group discontinued treatment because of an adverse event. Patients in the anakinra group had more injection site reactions (68% [17 of 25] vs. 4% [1 of 25]). Limitation: Small sample size and wide variability in symptom duration; inclusion was not limited to patients with postinfectious symptoms. Conclusion: Peripheral IL-1 inhibition using anakinra for 4 weeks does not result in a clinically significant reduction in fatigue severity in women with CFS and severe fatigue.	[Roerink, Megan E.; Bredie, Sebastian J. H.; Heijnen, Michael; Van der Meer, Jos W. M.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Geert Grotepl Zuid 8,POB 9101, NL-6500 HB Nijmegen, Netherlands; [Knoop, Hans] Univ Amsterdam, Dept Med Psychol, AMC, Postbox 22660 J3 209, NL-1100 DD Amsterdam, Netherlands; [Dinarello, Charles A.] Univ Colorado, Med Ctr, 12700 East 19th Ave,B168, Aurora, CO 80045 USA	Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; University of Colorado System; University of Colorado Anschutz Medical Campus	Roerink, ME (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Geert Grotepl Zuid 8,POB 9101, NL-6500 HB Nijmegen, Netherlands.	Megan.Roerink@radboudumc.nl	Knoop, Hans/D-3264-2009; Dinarello, Charles/C-8524-2013; Bredie, Sebastian JH/L-4226-2015; van der Meer, Jos W.M./C-8521-2013	Knoop, Hans/0000-0001-7763-3517; Bredie, Sebastian JH/0000-0002-6973-7540; van der Meer, Jos W.M./0000-0001-5120-3690	Interleukin Foundation	Interleukin Foundation	Interleukin Foundation and an independent donor who wishes to remain anonymous.	Blundell S, 2015, BRAIN BEHAV IMMUN, V50, P186, DOI 10.1016/j.bbi.2015.07.004; Bonsall DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140678; Cattaneo A, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw045; Cavelti-Weder Claudia, 2011, Diabetes Care, V34, pe158, DOI 10.2337/dc11-1196; Cho HJ, 2005, PSYCHOSOM MED, V67, P301, DOI 10.1097/01.psy.0000156969.76986.e0; Clark SR, 2008, J CEREBR BLOOD F MET, V28, P387, DOI 10.1038/sj.jcbfm.9600537; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; de Jager W, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-52; Derogatis L., 2010, CORSINI ENCY PSYCHOL, P1, DOI [DOI 10.1002/9780470479216.CORPSY0970, 10.1002/9780470479216.corpsy0970]; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dinarello CA, 2013, SEMIN IMMUNOL, V25, P469, DOI 10.1016/j.smim.2013.10.008; Felger JC, 2012, FRONT NEUROENDOCRIN, V33, P315, DOI 10.1016/j.yfrne.2012.09.003; Fletcher MA, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-96; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Goldbach-Mansky R, 2009, ANN NY ACAD SCI, V1182, P111, DOI 10.1111/j.1749-6632.2009.05159.x; Greaney AJ, 2016, J LEUKOCYTE BIOL, V99, P189, DOI 10.1189/jlb.3A0415-155RR; Greenhalgh AD, 2010, BRIT J PHARMACOL, V160, P153, DOI 10.1111/j.1476-5381.2010.00684.x; Gueorguieva I, 2008, BRIT J CLIN PHARMACO, V65, P317, DOI 10.1111/j.1365-2125.2007.03026.x; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; Hornig M, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400121; Jacobs H M, 1990, Ned Tijdschr Geneeskd, V134, P1950; Kim J, 2014, CLIN ORTHOP SURG, V6, P103, DOI 10.4055/cios.2014.6.1.103; Knoop H, 2008, BRIT J PSYCHIAT, V193, P340, DOI 10.1192/bjp.bp.108.051292; Kullenberg T, 2016, RHEUMATOLOGY, V55, P1499, DOI 10.1093/rheumatology/kew208; Lachmann HJ, 2009, J EXP MED, V206, P1029, DOI 10.1084/jem.20082481; Larun L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003200.pub3; LINDE A, 1992, J INFECT DIS, V165, P994, DOI 10.1093/infdis/165.6.994; Neu D, 2014, EUR J APPL PHYSIOL, V114, P1841, DOI 10.1007/s00421-014-2910-1; Norheim KB, 2012, PLOS ONE, V7, P429, DOI 10.1371/journal.pone.0030123; Nunes EJ, 2014, PSYCHOPHARMACOLOGY, V231, P727, DOI 10.1007/s00213-013-3285-4; Ogungbenro K, 2016, J PHARMACOKINET PHAR, V43, P1, DOI 10.1007/s10928-015-9450-0; Omdal R, 2005, RHEUMATOL INT, V25, P481, DOI 10.1007/s00296-004-0463-z; Price JR, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001027.pub2; Reeves WC, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-25; Rinehart J, 1997, CANCER INVEST, V15, P403, DOI 10.3109/07357909709047578; Roerink ME, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0796-7; Roerink ME, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0971-z; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Singh K, 2014, P NATL ACAD SCI USA, V111, P15550, DOI 10.1073/pnas.1416940111; Smith MEB, 2015, ANN INTERN MED, V162, P841, DOI 10.7326/M15-0114; Swanink CMA, 1996, J INFECT DIS, V173, P460, DOI 10.1093/infdis/173.2.460; The GKH, 2010, J CLIN PSYCHIAT, V71, P528, DOI 10.4088/JCP.08m04719whi; Tummers M, 2010, J CONSULT CLIN PSYCH, V78, P724, DOI 10.1037/a0020052; Tzanetakou V, 2016, JAMA DERMATOL, V152, P52, DOI 10.1001/jamadermatol.2015.3903; van Asseldonk EJP, 2011, J CLIN ENDOCR METAB, V96, P2119, DOI 10.1210/jc.2010-2992; Vercoulen J., 1999, GEDRAGSTHERAPIE, V32, P131; VERCOULEN JHMM, 1994, J PSYCHOSOM RES, V38, P383, DOI 10.1016/0022-3999(94)90099-X; Vollmer-Conna U, 2004, PSYCHOL MED, V34, P1289, DOI 10.1017/S0033291704001953; Vollmer-Conna U, 2007, CLIN INFECT DIS, V45, P732, DOI 10.1086/520990; WALSH CE, 1992, BRIT J HAEMATOL, V80, P106, DOI 10.1111/j.1365-2141.1992.tb06408.x; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WEISDORF D, 1994, BLOOD, V84, P2044; Whiting P, 2001, JAMA-J AM MED ASSOC, V286, P1360, DOI 10.1001/jama.286.11.1360; Wiborg JF, 2015, PSYCHOTHER PSYCHOSOM, V84, P368, DOI 10.1159/000438867; Woodlock TJ, 1999, J IMMUNOTHER, V22, P251, DOI 10.1097/00002371-199905000-00008	56	25	26	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 18	2017	166	8					557	+		10.7326/M16-2391	http://dx.doi.org/10.7326/M16-2391			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ES1RF	28265678				2022-12-28	WOS:000399304000015
J	Page, KR; Polk, S				Page, Kathleen R.; Polk, Sarah			Chilling Effect? Post-Election Health Care Use by Undocumented and Mixed-Status Families	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Page, Kathleen R.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; [Polk, Sarah] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Page, KR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA.							Constable P, 2007, WASHINGTON POST; Obama BH, 2017, NEW ENGL J MED, V376, P297, DOI 10.1056/NEJMp1616577; Sommers BD, 2015, JAMA-J AM MED ASSOC, V314, P366, DOI 10.1001/jama.2015.8421; Watson Tara, 2010, 16278 NBER	4	48	48	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2017	376	12							e20	10.1056/NEJMp1700829	http://dx.doi.org/10.1056/NEJMp1700829			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO9NB	28273008				2022-12-28	WOS:000397014300001
J	Baker, DW				Baker, David W.			History of The Joint Commission's Pain Standards Lessons for Today's Prescription Opioid Epidemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Baker, David W.] Joint Commiss, Div Healthcare Qual Evaluat, Oak Brook Terrace, IL 60181 USA		Baker, DW (corresponding author), Joint Commiss, Div Healthcare Qual Evaluat, Oak Brook Terrace, IL 60181 USA.	dbaker@jointcommission.org						Apfelbaum JL, 2003, ANESTH ANALG, V97, P534, DOI 10.1213/01.ANE.0000068822.10113.9E; Frasco PE, 2005, ANESTH ANALG, V100, P162, DOI 10.1213/01.ANE.0000139354.26208.1C; Institute for Safe Medication Practices, 2002, PAIR SCAL DONT WEIGH; MAX MB, 1990, ANN INTERN MED, V113, P885, DOI 10.7326/0003-4819-113-11-885; Osterweis M., 1987, PAIN DISABILITY CLIN; PORTER J, 1980, NEW ENGL J MED, V302, P123; Puntillo Kathleen, 2003, Pain Manag Nurs, V4, P171, DOI 10.1016/S1524-9042(03)00033-X; Vila H, 2005, ANESTH ANALG, V101, P474, DOI 10.1213/01.ANE.0000155970.45321.A8	8	168	171	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2017	317	11					1117	1118		10.1001/jama.2017.0935	http://dx.doi.org/10.1001/jama.2017.0935			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9CQ	28241189				2022-12-28	WOS:000396987200013
J	Zarocostas, J				Zarocostas, John			Interim leader appointed as Global Fund election restarts	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 11	2017	389	10073					996	996		10.1016/S0140-6736(17)30692-X	http://dx.doi.org/10.1016/S0140-6736(17)30692-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EN9UN	28283285				2022-12-28	WOS:000396345200007
J	Lee, JY; Rosenbaum, DM				Lee, Jyh-Yeuan; Rosenbaum, Daniel M.			Transporters Revealed	CELL			English	Editorial Material							CRYSTAL-STRUCTURE; P-GLYCOPROTEIN; BINDING	The subfamily C ATP-binding cassette (ABCC) transporters mediate multidrug resistance and ion conductance regulation. Recent atomic or near-atomic resolution structures of three physiologically significant ABCC transporters (MRP1, SUR1, and CFTR), determined by using single-particle cryo-electron microscopy (cryo-EM), reveal structural details that help explain the wide functional diversity of this ABC transporter subfamily.	[Lee, Jyh-Yeuan] Univ Texas Southwestern Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Rosenbaum, Daniel M.] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Rosenbaum, DM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA.	dan.rosenbaum@utsouthwestern.edu	Lee, Jyh-Yeuan/ACA-2717-2022	Lee, Jyh-Yeuan/0000-0003-1799-2416				Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Johnson ZL, 2017, CELL, V168, P1075, DOI 10.1016/j.cell.2017.01.041; Lee JY, 2016, NATURE, V533, P561, DOI 10.1038/nature17666; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Li NN, 2017, CELL, V168, P101, DOI 10.1016/j.cell.2016.12.028; Locher KP, 2016, NAT STRUCT MOL BIOL, V23, P487, DOI 10.1038/nsmb.3216; Martin GM., 2017, ELIFE; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Zhang Z, 2016, CELL, V167, P1586, DOI 10.1016/j.cell.2016.11.014	10	12	12	4	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2017	168	6					951	953		10.1016/j.cell.2017.02.033	http://dx.doi.org/10.1016/j.cell.2017.02.033			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8ZF	28283067	Bronze			2022-12-28	WOS:000396287900003
J	Shad, N; Haq, M; Barnes, DJ				Shad, Nadia; Haq, Masud; Barnes, Dennis J.			CASE REVIEW A postpartum eruption	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Shad, Nadia] Univ Hosp Lewisham, London, England; [Haq, Masud; Barnes, Dennis J.] Tunbridge Wells Hosp, Tunbridge Wells, England	University of London; King's College London	Shad, N (corresponding author), Univ Hosp Lewisham, London, England.	Nadia.shad@nhs.net						Ambros-Rudolph CM, 2006, J AM ACAD DERMATOL, V54, P395, DOI 10.1016/j.jaad.2005.12.012; Castro LA, 2006, J AM ACAD DERMATOL, V55, P823, DOI 10.1016/j.jaad.2006.07.015; Huilaja L, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0136-2; Intong LRA, 2011, DERMATOL CLIN, V29, P447, DOI 10.1016/j.det.2011.03.002; Laugel V, 2001, ARCH PEDIATRIE, V8, P1071, DOI 10.1016/S0929-693X(01)00585-1; Lipozencic J, 2012, CLIN DERMATOL, V30, P51, DOI 10.1016/j.clindermatol.2011.03.009; Lo Schiavo A, 2013, CLIN DERMATOL, V31, P391, DOI 10.1016/j.clindermatol.2013.01.006; Rudolph CM, 2006, BRIT J DERMATOL, V154, P54, DOI 10.1111/j.1365-2133.2005.06856.x; SHORNICK JK, 1983, J AM ACAD DERMATOL, V8, P214, DOI 10.1016/S0190-9622(83)70027-7; Valeyrie L, 2001, ANN DERMATOL VENER, V128, P638	10	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2017	356								j968	10.1136/bmj.j968	http://dx.doi.org/10.1136/bmj.j968			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BU	28280104				2022-12-28	WOS:000396433400015
J	Grant, BR; Grant, PR				Grant, B. Rosemary; Grant, Peter R.			Watching speciation in action	SCIENCE			English	Editorial Material							EVOLUTION		[Grant, B. Rosemary; Grant, Peter R.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Princeton University	Grant, BR (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	rgrant@princeton.edu; prgrant@princeton.edu	Grant, Peter/HIR-3733-2022					Brawand D, 2014, NATURE, V513, P375, DOI 10.1038/nature13726; Darwin Charles, 1859, ORIGIN SPECIES, P490; Fontaine MC, 2015, SCIENCE, V347, DOI 10.1126/science.1258524; Grant P.R., 2014, 40 YEARS EVOLUTION; Huerta-Sanchez E, 2014, NATURE, V512, P194, DOI 10.1038/nature13408; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kronforst MR, 2015, GENETICS, V200, P1, DOI 10.1534/genetics.114.172387; Lamichhaney S, 2016, SCIENCE, V352, P470, DOI 10.1126/science.aad8786; Lamichhaney S, 2016, NAT GENET, V48, P84, DOI 10.1038/ng.3430; McKenna DD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1088-8; Natarajan C, 2016, SCIENCE, V354, P336, DOI 10.1126/science.aaf9070; Rausher MD, 2015, EVOLUTION, V69, P1655, DOI 10.1111/evo.12687; Rieseberg LH, 2003, PHILOS T R SOC B, V358, P1141, DOI 10.1098/rstb.2003.1283; Rohner N, 2013, SCIENCE, V342, P1372, DOI 10.1126/science.1240276; Song Y, 2011, CURR BIOL, V21, P1296, DOI 10.1016/j.cub.2011.06.043; van't Hof AE, 2016, NATURE, V534, P102, DOI 10.1038/nature17951; [No title captured]	17	18	19	3	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					910	911		10.1126/science.aam6411	http://dx.doi.org/10.1126/science.aam6411			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM2YM	28254901				2022-12-28	WOS:000395181700022
J	Leonard, J; Morales, A; Zupancic, P; Esslinger, T; Donner, T				Leonard, Julian; Morales, Andrea; Zupancic, Philip; Esslinger, Tilman; Donner, Tobias			Supersolid formation in a quantum gas breaking a continuous translational symmetry	NATURE			English	Article							PHASE-TRANSITION; CAVITY; SUPERFLUID; LATTICE	The concept of a supersolid state combines the crystallization of a many-body system with dissipationless flow of the atoms from which it is built. This quantum phase requires the breaking of two continuous symmetries: the phase invariance of a superfluid and the continuous translational invariance to form the crystal(1,2). Despite having been proposed for helium almost 50 years ago(3,4), experimental verification of supersolidity remains elusive(5,6). A variant with only discrete translational symmetry breaking on a preimposed lattice structure-the 'lattice supersolid'(7)-has been realized, based on self-organization of a Bose-Einstein condensate(8,9). However, lattice supersolids do not feature the continuous ground-state degeneracy that characterizes the supersolid state as originally proposed. Here we report the realization of a supersolid with continuous translational symmetry breaking along one direction in a quantum gas. The continuous symmetry that is broken emerges from two discrete spatial symmetries by symmetrically coupling a Bose-Einstein condensate to the modes of two optical cavities. We establish the phase coherence of the supersolid and find a high ground-state degeneracy by measuring the crystal position over many realizations through the light fields that leak from the cavities. These light fields are also used to monitor the position fluctuations in real time. Our concept provides a route to creating and studying glassy many-body systems with controllably lifted ground-state degeneracies, such as supersolids in the presence of disorder.	[Leonard, Julian; Morales, Andrea; Zupancic, Philip; Esslinger, Tilman; Donner, Tobias] Swiss Fed Inst Technol, Inst Quantum Elect, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Esslinger, T (corresponding author), Swiss Fed Inst Technol, Inst Quantum Elect, CH-8093 Zurich, Switzerland.	esslinger@phys.ethz.ch	Donner, Tobias/A-2845-2011; Esslinger, Tilman/M-9022-2016	Donner, Tobias/0000-0001-7016-587X; Esslinger, Tilman/0000-0002-8333-107X; Zupancic, Philip/0000-0002-4698-2818; Morales, Andrea/0000-0003-1222-6333	Synthetic Quantum Many-Body Systems (European Research Council); EU Collaborative Project TherMiQ [618074]; SBFI; SNF	Synthetic Quantum Many-Body Systems (European Research Council)(European Research Council (ERC)); EU Collaborative Project TherMiQ; SBFI; SNF	We thank E. Demler, J. Larson and B. P. Venkatesh for discussions on U(1) symmetries in optical cavities and M. Lee for contributions in the building stage of the experimental apparatus. We acknowledge funding from Synthetic Quantum Many-Body Systems (European Research Council advanced grant) and the EU Collaborative Project TherMiQ (Grant Agreement 618074), and also SBFI support for Horizon2020 project QUIC and SNF support for NCCR QSIT and DACH project 'Quantum Crystals of Matter and Light'.	ANDREEV AF, 1969, SOV PHYS JETP-USSR, V29, P1107; Asboth JK, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.013414; Baksic A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.173601; Baumann K, 2010, NATURE, V464, P1301, DOI 10.1038/nature09009; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Boninsegni M, 2012, REV MOD PHYS, V84, P759, DOI 10.1103/RevModPhys.84.759; Brennecke F, 2013, P NATL ACAD SCI USA, V110, P11763, DOI 10.1073/pnas.1306993110; Chan MHW, 2013, J LOW TEMP PHYS, V172, P317, DOI 10.1007/s10909-013-0882-x; Eichhorn A, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042141; Emary C, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.066203; Fan JT, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.023812; GOLDMAN N, 2014, Patent No. 77126401; Gopalakrishnan S, 2009, NAT PHYS, V5, P845, DOI 10.1038/NPHYS1403; Hayn M, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.053856; Kadau H, 2016, NATURE, V530, P194, DOI 10.1038/nature16485; Kim DY, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.155301; Kim E, 2004, NATURE, V427, P225, DOI 10.1038/nature02220; Kollar A. J., 2016, SUPERMODE DENSITY WA; Labeyrie G, 2014, NAT PHOTONICS, V8, P321, DOI [10.1038/NPHOTON.2014.52, 10.1038/nphoton.2014.52]; Lahaye T, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/12/126401; Lemoine M., 2008, INFLATIONARY COSMOLO; Leonard J, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/9/093028; Li J, 2016, PHYS REV LETT, V117; MATSUDA H, 1970, SUP PROG THEOR PHYS, P411, DOI 10.1143/PTPS.46.411; Moses SA, 2015, SCIENCE, V350, P659, DOI 10.1126/science.aac6400; Mottl R, 2012, SCIENCE, V336, P1570, DOI 10.1126/science.1220314; Nagy D, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.043637; Ostermann S, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.021026; Ritsch H, 2013, REV MOD PHYS, V85, P553, DOI 10.1103/RevModPhys.85.553; Safaei S, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.043810; Strack P, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.277202; THOULESS DJ, 1969, ANN PHYS-NEW YORK, V52, P403, DOI 10.1016/0003-4916(69)90286-3; Zeiher J, 2016, NAT PHYS, V12, P1095, DOI [10.1038/NPHYS3835, 10.1038/nphys3835]	33	252	254	7	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2017	543	7643					87	+		10.1038/nature21067	http://dx.doi.org/10.1038/nature21067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0AA	28252072	Green Submitted			2022-12-28	WOS:000395671500037
J	Scholfield, DW; Ram, AD				Scholfield, Daniel W.; Ram, Ashok Daya			CASE REVIEW The importance of recording first passage of meconium in neonates	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Scholfield, Daniel W.] Charing Cross Hosp, London, England; [Ram, Ashok Daya] Norwich Univ Hosp, Norwich, Norfolk, England	Imperial College London	Scholfield, DW (corresponding author), Charing Cross Hosp, London, England.	danwscholfield@doctors.org.uk						Chen Y, 2013, J PEDIATR SURG, V48, P642, DOI 10.1016/j.jpedsurg.2012.12.036; Coran A., 2012, PEDIAT SURG, P1265; De la Torre-Mondragon L, 1998, J PEDIATR SURG, V33, P1283, DOI 10.1016/S0022-3468(98)90169-5; Duhamel B, 1973, Acta Paediatr Belg, V27, P103; Frykman PK, 2012, SEMIN PEDIATR SURG, V21, P328, DOI 10.1053/j.sempedsurg.2012.07.007; Gosemann JH, 2013, EUR J PEDIATR SURG, V23, P94, DOI 10.1055/s-0033-1343085; Gunnarsdottir A, 2010, J PEDIATR GASTR NUTR, V51, P160, DOI 10.1097/MPG.0b013e3181cac1b6; Langer JC, 2011, FUNDAMENTALS OF PEDIATRIC SURGERY, P475, DOI 10.1007/978-1-4419-6643-8_61; Levitt MA, 2009, J PEDIATR SURG, V44, P271, DOI 10.1016/j.jpedsurg.2008.10.053; Nah SA, 2012, J PEDIATR SURG, V47, P308, DOI 10.1016/j.jpedsurg.2011.11.025; ROSENFIELD NS, 1984, RADIOLOGY, V150, P393, DOI 10.1148/radiology.150.2.6691093; Ruttenstock E, 2010, PEDIATR SURG INT, V26, P1101, DOI 10.1007/s00383-010-2695-1; SMITH GHH, 1991, PEDIATR SURG INT, V6, P318; SOAVE F, 1964, SURGERY, V56, P1007; SWENSON O, 1948, SURGERY, V24, P212; Tjaden NEB, 2013, TRANSL RES, V162, P1, DOI 10.1016/j.trsl.2013.03.001	16	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2017	356								j711	10.1136/bmj.j711	http://dx.doi.org/10.1136/bmj.j711			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JW	28254949				2022-12-28	WOS:000395628700015
J	Welsch, ME; Kaplan, A; Chambers, JM; Stokes, ME; Bos, PH; Zask, A; Zhang, Y; Sanchez-Martin, M; Badgley, MA; Huang, CS; Tran, TH; Akkiraju, H; Brown, LM; Nandakumar, R; Cremers, S; Yang, WS; Tong, L; Olive, KP; Ferrando, A; Stockwell, BR				Welsch, Matthew E.; Kaplan, Anna; Chambers, Jennifer M.; Stokes, Michael E.; Bos, Pieter H.; Zask, Arie; Zhang, Yan; Sanchez-Martin, Marta; Badgley, Michael A.; Huang, Christine S.; Tran, Timothy H.; Akkiraju, Hemanth; Brown, Lewis M.; Nandakumar, Renu; Cremers, Serge; Yang, Wan Seok; Tong, Liang; Olive, Kenneth P.; Ferrando, Adolfo; Stockwell, Brent R.			Multivalent Small-Molecule Pan-RAS Inhibitors	CELL			English	Article							MEDIATED NUCLEOTIDE EXCHANGE; PROTEIN-PROTEIN INTERACTIONS; K-RAS; STRUCTURAL BASIS; CANCER-THERAPY; TARGETING RAS; CELLS; ACTIVATION; DISCOVERY; ONCOGENES	Design of small molecules that disrupt protein-protein interactions, including the interaction of RAS proteins and their effectors, may provide chemical probes and therapeutic agents. We describe here the synthesis and testing of potential small-molecule pan-RAS ligands, which were designed to interact with adjacent sites on the surface of oncogenic KRAS. One compound, termed 3144, was found to bind to RAS proteins using microscale thermophoresis, nuclear magnetic resonance spectroscopy, and isothermal titration calorimetry and to exhibit lethality in cells partially dependent on expression of RAS proteins. This compound was metabolically stable in liver microsomes and displayed anti-tumor activity in xenograft mouse cancer models. These findings suggest that pan-RAS inhibition may be an effective therapeutic strategy for some cancers and that structure-based design of small molecules targeting multiple adjacent sites to create multivalent inhibitors may be effective for some proteins.	[Welsch, Matthew E.; Zhang, Yan; Stockwell, Brent R.] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Kaplan, Anna; Chambers, Jennifer M.; Stokes, Michael E.; Bos, Pieter H.; Zask, Arie; Huang, Christine S.; Tran, Timothy H.; Akkiraju, Hemanth; Brown, Lewis M.; Tong, Liang; Stockwell, Brent R.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Sanchez-Martin, Marta; Ferrando, Adolfo] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA; [Stokes, Michael E.; Cremers, Serge; Olive, Kenneth P.; Ferrando, Adolfo] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; [Badgley, Michael A.; Olive, Kenneth P.] Columbia Univ, Dept Med, Med Ctr, Div Digest & Liver Dis, New York, NY 10032 USA; [Akkiraju, Hemanth; Brown, Lewis M.] Columbia Univ, Quantitat Prote & Metabol Ctr, New York, NY 10027 USA; [Nandakumar, Renu; Cremers, Serge] Columbia Univ, Med Ctr, Irving Inst Clin & Translat Res, New York, NY 10032 USA; [Yang, Wan Seok] St Johns Univ, Dept Biol Sci, Queens, NY 11439 USA; [Ferrando, Adolfo] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Saint John's University; Columbia University	Stockwell, BR (corresponding author), Columbia Univ, Dept Chem, New York, NY 10027 USA.	bstockwell@columbia.edu	Zhang, Yan/AAC-7222-2020; Stockwell, Brent R/AAE-7200-2019	Zhang, Yan/0000-0002-8659-6321; Stockwell, Brent R/0000-0002-3532-3868; Olive, Kenneth/0000-0002-3392-8994; Tong, Liang/0000-0002-0563-6468; Huang, Christine/0000-0003-4082-3880; Badgley, Michael/0000-0002-2745-696X; Bos, Pieter/0000-0002-8710-4771; Zask, Arie/0000-0002-1991-1328	NIH [S10OD012018, 5R01CA097061, 5R01GM085081, R01CA161061, 1S10RR025431-01A1]; NSF [CHE 0840451]; NYSTAR; Training Program in Molecular Biophysics [T32GM008281]; New York State Stem Cell Science Board (NYSTEM) [C029159]; NHMRC CJ Martin Biomedical Fellowship; NATIONAL CANCER INSTITUTE [R01CA172398, R01CA097061, R35CA210065, R01CA161061, R35CA209896] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085081, P41GM111244, T32GM008281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA040582] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012018] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NYSTAR; Training Program in Molecular Biophysics; New York State Stem Cell Science Board (NYSTEM); NHMRC CJ Martin Biomedical Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Neil Whalen, Stuart Myers, and Howard Robinson for setting up the X29 beamline at the NSLS. The in-house X-ray diffraction instrument was purchased with an NIH grant to L.T. (S10OD012018). This research was supported by grants to BRS (NIH 5R01CA097061, 5R01GM085081, and R01CA161061). We thank John Decatur and the Columbia Chemistry NMR core facility (NSF grant CHE 0840451 and NIH grant 1S10RR025431-01A1) for assistance in compound characterization, Michael Gaschler for providing the RHEB protein used for microscale thermophoresis, and Michael Goger from New York Structural Biology Center (NYSBC) for assistance with 3D-NMR data acquisition. B.R.S. is a member of the New York Structural Biology Center. The data collected at NYSBC was made possible by a grant from NYSTAR. A.K. was supported by the Training Program in Molecular Biophysics T32GM008281. We thank the New York State Stem Cell Science Board (NYSTEM) for support under contract #C029159 (L.M.B.). B.R.S. is a founder, consultant, and shareholder of Kyras Therapeutics, which has licensed intellectual property described in this manuscript; B.R.S. and M.E.W. are recipients of royalty payments from this license. All animal studies were approved by the Columbia University IACUC. J.M.C. was supported by an NHMRC CJ Martin Biomedical Fellowship.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Arkin MR, 2014, CHEM BIOL, V21, P1102, DOI 10.1016/j.chembiol.2014.09.001; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Block C, 1996, NAT STRUCT BIOL, V3, P244, DOI 10.1038/nsb0396-244; Burns MC, 2014, P NATL ACAD SCI USA, V111, P3401, DOI 10.1073/pnas.1315798111; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Colletti LM, 2008, ANAL BIOCHEM, V383, P186, DOI 10.1016/j.ab.2008.08.012; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Gysin Stephan, 2011, Genes Cancer, V2, P359, DOI 10.1177/1947601911412376; Hall BE, 2002, P NATL ACAD SCI USA, V99, P12138, DOI 10.1073/pnas.192453199; Hewitt SH, 2016, CHEM COMMUN, V52, P9745, DOI 10.1039/c6cc03457h; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Huang L, 1997, NAT STRUCT BIOL, V4, P609, DOI 10.1038/nsb0897-609; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Jahnke W, 2006, FRAGMENT BASED APPRO; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; McCormick F, 2011, J SURG ONCOL, V103, P464, DOI 10.1002/jso.21749; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oberstein PE, 2013, THER ADV GASTROENTER, V6, P321, DOI 10.1177/1756283X13478680; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Ostrem JML, 2016, NAT REV DRUG DISCOV, V15, P771, DOI 10.1038/nrd.2016.139; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Piovan E, 2013, CANCER CELL, V24, P766, DOI 10.1016/j.ccr.2013.10.022; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Prior IA, 2012, SEMIN CELL DEV BIOL, V23, P145, DOI 10.1016/j.semcdb.2011.09.002; Sastra Stephen A, 2014, Cold Spring Harb Protoc, V2014, P47, DOI 10.1101/pdb.prot077834; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shima F, 2013, P NATL ACAD SCI USA, V110, P8182, DOI 10.1073/pnas.1217730110; Spiegel J, 2014, NAT CHEM BIOL, V10, P613, DOI 10.1038/nchembio.1560; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Sun Q, 2014, J BIOMOL NMR, V60, P11, DOI 10.1007/s10858-014-9849-8; Sun Q, 2012, ANGEW CHEM INT EDIT, V51, P6140, DOI 10.1002/anie.201201358; Tanaka T, 2010, ONCOGENE, V29, P6064, DOI 10.1038/onc.2010.346; Tsutsumi K, 2009, CELL SIGNAL, V21, P1672, DOI 10.1016/j.cellsig.2009.07.004; Urosevic J, 2009, MOL CARCINOGEN, V48, P1038, DOI 10.1002/mc.20555; van Hattum H, 2014, CHEM BIOL, V21, P1185, DOI 10.1016/j.chembiol.2014.08.001; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Vo U, 2013, BIOMOL NMR ASSIGN, V7, P215, DOI 10.1007/s12104-012-9413-y; Walker K, 2005, CURR OPIN GENET DEV, V15, P62, DOI 10.1016/j.gde.2004.11.001; Wang WR, 2012, BIOORG MED CHEM LETT, V22, P5766, DOI 10.1016/j.bmcl.2012.07.082; Ward AF, 2012, BLOOD, V120, P3397, DOI 10.1182/blood-2012-05-378596; Weiwer M, 2012, BIOORG MED CHEM LETT, V22, P1822, DOI 10.1016/j.bmcl.2011.09.047; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010	55	149	156	1	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2017	168	5					878	+		10.1016/j.cell.2017.02.006	http://dx.doi.org/10.1016/j.cell.2017.02.006			41	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8YB	28235199	Green Accepted, Bronze			2022-12-28	WOS:000396284800016
J	Gilbody, S; Lewis, H; Adamson, J; Atherton, K; Bailey, D; Birtwistle, J; Bosanquet, K; Clare, E; Delgadillo, J; Ekers, D; Foster, D; Gabe, R; Gascoyne, S; Haley, L; Hamilton, J; Hargate, R; Hewitt, C; Holmes, J; Keding, A; Lilley-Kelly, A; Meer, S; Mitchell, N; Overend, K; Pasterfield, M; Pervin, J; Richards, DA; Spilsbury, K; Traviss-Turner, G; Trepel, D; Woodhouse, R; Ziegler, F; McMillan, D				Gilbody, Simon; Lewis, Helen; Adamson, Joy; Atherton, Katie; Bailey, Della; Birtwistle, Jacqueline; Bosanquet, Katharine; Clare, Emily; Delgadillo, Jaime; Ekers, David; Foster, Deborah; Gabe, Rhian; Gascoyne, Samantha; Haley, Lesley; Hamilton, Jahnese; Hargate, Rebecca; Hewitt, Catherine; Holmes, John; Keding, Ada; Lilley-Kelly, Amanda; Meer, Shaista; Mitchell, Natasha; Overend, Karen; Pasterfield, Madeline; Pervin, Jodi; Richards, David A.; Spilsbury, Karen; Traviss-Turner, Gemma; Trepel, Dominic; Woodhouse, Rebecca; Ziegler, Friederike; McMillan, Dean			Effect of Collaborative Care vs Usual Care on Depressive Symptoms in Older Adults With Subthreshold Depression The CASPER Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MAJOR DEPRESSION; HEALTH; PHQ-9; LIFE; INTERVENTIONS; MANAGEMENT; DISORDERS; SEVERITY	IMPORTANCE There is little evidence to guide management of depressive symptoms in older people. OBJECTIVE To evaluate whether a collaborative care intervention can reduce depressive symptoms and prevent more severe depression in older people. DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial conducted from May 24, 2011, to November 14, 2014, in 32 primary care centers in the United Kingdom among 705 participants aged 65 years or older with Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) subthreshold depression; participants were followed up for 12 months. INTERVENTIONS Collaborative care (n=344) was coordinated by a case manager who assessed functional impairments relating to mood symptoms. Participants were offered behavioral activation and completed an average of 6 weekly sessions. The control group received usual primary care (n=361). MAIN OUTCOMES AND MEASURES The primary outcome was self-reported depression severity at 4-month follow-up on the 9-item Patient Health Questionnaire (PHQ-9; score range, 0-27). Included among 10 prespecified secondary outcomes were the PHQ-9 score at 12-month follow-up and the proportion meeting criteria for depressive disorder (PHQ-9 score >= 10) at 4- and 12-month follow-up. RESULTS The 705 participants were 58% female with a mean age of 77 (SD, 7.1) years. Four-month retention was 83%, with higher loss to follow-up in collaborative care (82/344 [24%]) vs usual care (37/361 [10%]). Collaborative care resulted in lower PHQ-9 scores vs usual care at 4-month follow-up. The proportions of participants meeting criteria for depression at 4-month follow-up were 17.2%(45/262) vs 23.5%(76/324), respectively (difference, -6.3%[95% CI, -12.8% to 0.2%]; relative risk, 0.83 [95% CI, 0.61-1.27]; P = .25) and at 12-month follow-up were 15.7%(37/235) vs 27.8%(79/284) (difference, -12.1% [95% CI, -19.1% to -5.1%]; relative risk, 0.65 [95% CI, 0.46-0.91]; P = .01). [GRAPHICS] CONCLUSIONS AND RELEVANCE Among older adults with subthreshold depression, collaborative care compared with usual care resulted in a statistically significant difference in depressive symptoms at 4-month follow-up, of uncertain clinical importance. Although differences persisted through 12 months, findings are limited by attrition, and further research is needed to assess longer-term efficacy.	[Gilbody, Simon; Lewis, Helen; Adamson, Joy; Bailey, Della; Bosanquet, Katharine; Foster, Deborah; Gabe, Rhian; Gascoyne, Samantha; Hewitt, Catherine; Keding, Ada; Mitchell, Natasha; Overend, Karen; Pervin, Jodi; Trepel, Dominic; Woodhouse, Rebecca; McMillan, Dean] Univ York, Dept Hlth Sci, Heslington, England; [Gilbody, Simon; McMillan, Dean] Univ York, Hull York Med Sch, Heslington, England; [Atherton, Katie; Hargate, Rebecca; Lilley-Kelly, Amanda; Pasterfield, Madeline] Leeds & York Partnership NHS Fdn Trust, Leeds, W Yorkshire, England; [Birtwistle, Jacqueline; Holmes, John; Meer, Shaista; Traviss-Turner, Gemma] Univ Leeds, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England; [Clare, Emily; Hamilton, Jahnese] Northumberland Tyne & Wear NHS Fdn Trust, NIHR Clin Res Network Mental Hlth North East & No, Acad Psychiat, Wolfson Res Ctr, Campus Ageing & Vital, Newcastle Upon Tyne, Tyne & Wear, England; [Delgadillo, Jaime] Leeds Community Healthcare NHS Trust, Leeds, W Yorkshire, England; [Ekers, David] Univ Durham, Mental Hlth Res Grp, Durham, England; [Ekers, David; Haley, Lesley] Tees Esk & Wear Valleys NHS Fdn Trust, NIHR Clin Res Network North East & North Cumbria, Dept Res & Dev, Middlesbrough, Cleveland, England; [Richards, David A.] Univ Exeter, Inst Hlth Res, Sch Med, Exeter, Devon, England; [Spilsbury, Karen] Univ Leeds, Sch Healthcare, Fac Med & Hlth, Leeds, W Yorkshire, England; [Ziegler, Friederike] Univ Sheffield, Dept Urban Studies & Planning, Sheffield, S Yorkshire, England	University of York - UK; University of Hull; University of York - UK; University of Leeds; Newcastle University - UK; Durham University; University of Exeter; University of Leeds; University of Sheffield	Gilbody, S (corresponding author), Univ York, Hlth Sci, York YO10 5DD, N Yorkshire, England.	simon.gilbody@york.ac.uk	Gilbody, Simon/AAY-3720-2021; Mitchell, Natasha/GXH-2160-2022; Trépel, Dominic/J-9292-2014; Hamilton, Jahnese/L-8510-2019; Bosanquet, Katharine/P-8859-2015; Richards, David/B-4807-2009	Gilbody, Simon/0000-0002-8236-6983; Trépel, Dominic/0000-0002-1421-2966; Hamilton, Jahnese/0000-0003-1783-5648; Delgadillo, Jaime/0000-0001-5349-230X; Traviss-Turner, Gemma/0000-0002-1770-6216; Bosanquet, Katharine/0000-0002-6241-9734; Gabe, Rhian/0000-0002-0273-3094; Richards, David/0000-0002-8821-5027; Spilsbury, Karen/0000-0002-6908-0032; Ekers, David/0000-0003-3898-3340; Adamson, Joy/0000-0002-9860-0850; Hargate, Rebecca/0000-0001-6532-2375; Birtwistle, Jacqueline/0000-0002-6083-589X; Hewitt, Catherine Elizabeth/0000-0002-0415-3536; Ziegler, Friederike/0000-0001-5529-0146	UK National Institute of Health Research Health Technology Assessment Programme [08/19/04]; Medical Research Council [G0701013] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10037, 08/19/04, NF-SI-0611-10203] Funding Source: researchfish; MRC [G0701013] Funding Source: UKRI	UK National Institute of Health Research Health Technology Assessment Programme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was funded by the UK National Institute of Health Research Health Technology Assessment Programme (project number 08/19/04).	Archer J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006525.pub2; Baldwin RC, 2003, INT J GERIATR PSYCH, V18, P829, DOI 10.1002/gps.940; Buntrock C, 2016, JAMA-J AM MED ASSOC, V315, P1854, DOI 10.1001/jama.2016.4326; Chachamovich E, 2008, GERONTOLOGIST, V48, P593, DOI 10.1093/geront/48.5.593; Chew-Graham C, 2004, BMJ-BRIT MED J, V329, P181, DOI 10.1136/bmj.329.7459.181; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cuijpers P, 2008, AM J PSYCHIAT, V165, P1272, DOI 10.1176/appi.ajp.2008.07091422; Ekers D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100100; Gilbody S, 2003, JAMA-J AM MED ASSOC, V289, P3145, DOI 10.1001/jama.289.23.3145; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Gunn J, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-88; Jacobson NS, 1996, J CONSULT CLIN PSYCH, V64, P295, DOI 10.1037/0022-006X.64.2.295; Judd LL, 1998, ARCH GEN PSYCHIAT, V55, P694, DOI 10.1001/archpsyc.55.8.694; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; McMillan D, 2010, J AFFECT DISORDERS, V127, P122, DOI 10.1016/j.jad.2010.04.030; Moriarty AS, 2015, GEN HOSP PSYCHIAT, V37, P567, DOI 10.1016/j.genhosppsych.2015.06.012; National Institute for Health and Clinical Excellence, 2009, DEPR AD TREATM MAN D; Pasterfield M, 2014, COGN BEH THER, V7, DOI 10.1017/S1754470X14000038; RAPP SR, 1988, J CONSULT CLIN PSYCH, V56, P851, DOI 10.1037/0022-006X.56.6.851; Reed SJ, 2016, JAMA INTERN MED, V176, P691, DOI 10.1001/jamainternmed.2016.0804; Samad Z, 2011, INT J GERIATR PSYCH, V26, P1211, DOI 10.1002/gps.2680; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18]; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Vaishnavi S, 2007, PSYCHIAT RES, V152, P293, DOI 10.1016/j.psychres.2007.01.006; Ware J.E., 1995, SF 12 SCORE SF 12 PH; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	31	71	72	2	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2017	317	7					728	737		10.1001/jama.2017.0130	http://dx.doi.org/10.1001/jama.2017.0130			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL8WR	28241357	Green Accepted, Bronze			2022-12-28	WOS:000394901600020
J	McDermott, M; Kibbe, MR				McDermott, MaryMcGrae; Kibbe, Melina R.			Improving Lower Extremity Functioning in Peripheral Artery Disease Exercise, Endovascular Revascularization, or Both?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CLINICAL-TRIAL; INTERMITTENT CLAUDICATION; SUPERVISED EXERCISE; ANGIOPLASTY; OUTCOMES		[McDermott, MaryMcGrae] Northwestern Univ, Dept Med & Prevent Med, Feinberg Sch Med, 750 N Lake Shore Dr,Tenth Floor, Chicago, IL 60611 USA; [Kibbe, Melina R.] Univ North Carolina Chapel Hill, Dept Surg, Chapel Hill, NC USA	Northwestern University; Feinberg School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	McDermott, M (corresponding author), Northwestern Univ, Dept Med & Prevent Med, Feinberg Sch Med, 750 N Lake Shore Dr,Tenth Floor, Chicago, IL 60611 USA.	mdm608@northwestern.edu			Patient-Centered Outcomes Research Institute [CER-1306-02719]; National Heart, Lung, and Blood Institute [R01-HL122846, R01-HL126117]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122846, R01HL126117] Funding Source: NIH RePORTER	Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded in part by the Patient-Centered Outcomes Research Institute (CER-1306-02719) and by the National Heart, Lung, and Blood Institute (R01-HL122846 and R01-HL126117).	Fakhry F, 2015, JAMA-J AM MED ASSOC, V314, P1936, DOI 10.1001/jama.2015.14851; Fakhry F, 2012, J VASC SURG, V56, P1132, DOI 10.1016/j.jvs.2012.04.046; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Gerhard-Herman MD, 2016, J AM COLL CARDIOL; Harwood AE, 2016, ANN VASC SURG, V34, P280, DOI 10.1016/j.avsg.2016.02.009; Jones DW, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000345; Mazari FAK, 2012, BRIT J SURG, V99, P39, DOI 10.1002/bjs.7710; McDermott MM, 2009, J AM COLL CARDIOL, V53, P1056, DOI 10.1016/j.jacc.2008.09.063; Murphy TP, 2012, CIRCULATION, V125, P130, DOI 10.1161/CIRCULATIONAHA.111.075770; Sachs T, 2011, J VASC SURG, V54, P1021, DOI 10.1016/j.jvs.2011.03.281	10	22	24	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2017	317	7					689	690		10.1001/jama.2016.20673	http://dx.doi.org/10.1001/jama.2016.20673			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8WR	28241363				2022-12-28	WOS:000394901600010
J	Grosser, T; Woolf, CJ; FitzGerald, GA				Grosser, Tilo; Woolf, Clifford J.; FitzGerald, Garret A.			Time for nonaddictive relief of pain	SCIENCE			English	Editorial Material							OPIOID EPIDEMIC; UNITED-STATES; ABUSE; HEALTH		[Grosser, Tilo; FitzGerald, Garret A.] Univ Penn, Inst Translat Med & Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA; [Woolf, Clifford J.] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA USA; [Woolf, Clifford J.] Harvard Med Sch, Boston, MA USA	University of Pennsylvania; Pennsylvania Medicine; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	FitzGerald, GA (corresponding author), Univ Penn, Inst Translat Med & Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA.	garret@upenn.edu	Grosser, Tilo/A-1057-2007; Woolf, Clifford/A-9784-2010	Grosser, Tilo/0000-0001-8569-8396; 	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL117798] Funding Source: NIH RePORTER; NHLBI NIH HHS [U54 HL117798] Funding Source: Medline; NICHD NIH HHS [U54 HD090255] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bruchas MR, 2016, TRENDS PHARMACOL SCI, V37, P279, DOI 10.1016/j.tips.2016.01.001; Chen LH, 2014, P NATL ACAD SCI USA, V111, P6828, DOI 10.1073/pnas.1401797111; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Florence CS, 2016, MED CARE, V54, P901, DOI 10.1097/MLR.0000000000000625; Hauser W, 2016, PAIN MANAG, V6, P249, DOI 10.2217/pmt.16.5; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; Levy-Cooperman N, 2016, J PHARMACOL EXP THER, V359, P471, DOI 10.1124/jpet.116.236547; Murthy VH, 2017, JAMA-J AM MED ASSOC, V317, P133, DOI 10.1001/jama.2016.18215; Nahin RL, 2016, MAYO CLIN PROC, V91, P1292, DOI 10.1016/j.mayocp.2016.06.007; Skolnick P, 2016, NEURON, V92, P294, DOI 10.1016/j.neuron.2016.09.051; Smith-Edwards KM, 2016, ELIFE, V5, DOI 10.7554/eLife.20527; Tetreault P, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002570; Trost Z, 2015, PAIN, V156, P514, DOI 10.1097/01.j.pain.0000460326.02891.fc; Volkow ND, 2016, NEW ENGL J MED, V374, P1253, DOI 10.1056/NEJMra1507771; Winslow D., 2016, ESQUIRE MAGAZIN 0809	15	42	42	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI		1026	1027		10.1126/science.aan0088	http://dx.doi.org/10.1126/science.aan0088			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9VY	28280170				2022-12-28	WOS:000396348900019
J	Kim, AR; Ulirsch, JC; Wilmes, S; Unal, E; Moraga, I; Karakukcu, M; Yuan, D; Kazerounian, S; Abdulhay, NJ; King, DS; Gupta, N; Gabriel, SB; Lander, ES; Patiroglu, T; Ozcan, A; Ozdemir, MA; Garcia, KC; Piehler, J; Gazda, HT; Klein, DE; Sankaran, VG				Kim, Ah Ram; Ulirsch, Jacob C.; Wilmes, Stephan; Unal, Ekrem; Moraga, Ignacio; Karakukcu, Musa; Yuan, Daniel; Kazerounian, Shideh; Abdulhay, Nour J.; King, David S.; Gupta, Namrata; Gabriel, Stacey B.; Lander, Eric S.; Patiroglu, Turkan; Ozcan, Alper; Ozdemir, Mehmet Akif; Garcia, K. Christopher; Piehler, Jacob; Gazda, Hanna T.; Klein, Daryl E.; Sankaran, Vijay G.			Functional Selectivity in Cytokine Signaling Revealed Through a Pathogenic EPO Mutation	CELL			English	Article							DIAMOND-BLACKFAN ANEMIA; MYELOPROLIFERATIVE NEOPLASMS; GENETIC-VARIATION; ERYTHROPOIETIN RECEPTOR; BIASED AGONISM; TYROSINE; IDENTIFICATION; PHOSPHATASE; INHIBITOR; PROTEINS	Cytokines are classically thought to stimulate downstream signaling pathways through monotonic activation of receptors. We describe a severe anemia resulting from a homozygous mutation (R150Q) in the cytokine erythropoietin (EPO). Surprisingly, the EPO R150Q mutant shows only a mild reduction in affinity for its receptor but has altered binding kinetics. The EPO mutant is less effective at stimulating erythroid cell proliferation and differentiation, even at maximally potent concentrations. While the EPO mutant can stimulate effectors such as STAT5 to a similar extent as the wild-type ligand, there is reduced JAK2-mediated phosphorylation of select downstream targets. This impairment in downstream signaling mechanistically arises from altered receptor dimerization dynamics due to extracellular binding changes. These results demonstrate how variation in a single cytokine can lead to biased downstream signaling and can thereby cause human disease. Moreover, we have defined a distinct treatable form of anemia through mutation identification and functional studies.	[Kim, Ah Ram; Ulirsch, Jacob C.; Abdulhay, Nour J.; Sankaran, Vijay G.] Harvard Med Sch, Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Hematol Oncol, Boston, MA 02115 USA; [Kim, Ah Ram; Ulirsch, Jacob C.; Abdulhay, Nour J.; Sankaran, Vijay G.] Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Kim, Ah Ram; Ulirsch, Jacob C.; Abdulhay, Nour J.; Gupta, Namrata; Gabriel, Stacey B.; Lander, Eric S.; Gazda, Hanna T.; Sankaran, Vijay G.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Wilmes, Stephan; Piehler, Jacob] Univ Osnabruck, Dept Biol, Div Biophys, D-49076 Osnabruck, Germany; [Unal, Ekrem; Karakukcu, Musa; Patiroglu, Turkan; Ozcan, Alper; Ozdemir, Mehmet Akif] Erciyes Univ, Fac Med, Div Pediat Hematol & Oncol, Dept Pediat, TR-38039 Kayseri, Turkey; [Moraga, Ignacio; Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Yuan, Daniel; Kazerounian, Shideh; Gazda, Hanna T.] Harvard Med Sch, Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Genet & Genom, Boston, MA 02115 USA; [King, David S.] Univ Calif Berkeley, Howard Hughes Med Inst, Mass Spectrometry Lab, Berkeley, CA 94720 USA; [Klein, Daryl E.] Yale Univ, Sch Med, Dept Pharmacol, Canc Biol Inst, West Haven, CT 06516 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University Osnabruck; Erciyes University; Howard Hughes Medical Institute; Stanford University; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Yale University	Sankaran, VG (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Hematol Oncol, Boston, MA 02115 USA.; Sankaran, VG (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.; Sankaran, VG (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Klein, DE (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, Canc Biol Inst, West Haven, CT 06516 USA.	daryl.klein@yale.edu; sankaran@broadinstitute.org	Özcan, Alper/GSE-7300-2022; Karakukcu, M/AAT-4574-2021; Unal, Ekrem/A-5099-2019	Özcan, Alper/0000-0002-6100-1205; Karakukcu, M/0000-0003-2015-3541; Unal, Ekrem/0000-0002-2691-4826; Ulirsch, Jacob/0000-0002-7947-0827; Abdulhay, Nour/0000-0002-2794-3776; Klein, Daryl/0000-0002-7188-0450; Wilmes, Stephan/0000-0002-4112-710X; Moraga, Ignacio/0000-0001-9909-0701	NIH [R01DK103794, R33HL120791, R01HL107558, K02HL111156, U54HG003067]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL111156, R33HL120791, R01HL107558] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI051321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103794] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to the family described in this paper for their willingness to participate in this study. We thank M. Lemmon, S. Harrison, H. Lodish, F. Bunn, J. Casanova, D. Nathan, S. Orkin, D. Ginsburg, and members of the Sankaran laboratory for valuable comments and advice on this work. We thank S. Ozcan for assistance with aspirate imaging. This work was funded by NIH grants R01DK103794 and R33HL120791 (V.G.S.), R01HL107558 and K02HL111156 (H.T.G), and U54HG003067 (S.B.G. and E.S.L.).	Bunn HF, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011619; Casanova JL, 2014, J EXP MED, V211, P2137, DOI 10.1084/jem.20140520; Chen LW, 2006, MOL PHARMACOL, V70, P562, DOI 10.1124/mol.106.025536; Chen Y, 2003, J BIOL CHEM, V278, P16520, DOI 10.1074/jbc.M210572200; Danilova N, 2015, DIS MODEL MECH, V8, P1013, DOI 10.1242/dmm.020529; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Doherty L, 2010, AM J HUM GENET, V86, P222, DOI 10.1016/j.ajhg.2009.12.015; Elliott S, 1997, BLOOD, V89, P493, DOI 10.1182/blood.V89.2.493; Flygare J, 2011, BLOOD, V117, P3435, DOI 10.1182/blood-2010-07-295550; Giani FC, 2016, CELL STEM CELL, V18, P73, DOI 10.1016/j.stem.2015.09.015; Halupa A, 2005, BLOOD, V105, P552, DOI 10.1182/blood-2003-09-3237; Herenbrink CK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10842; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Jenni S, 2015, MOL CELL, V60, P941, DOI 10.1016/j.molcel.2015.10.026; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kirito K, 1997, J BIOL CHEM, V272, P16507, DOI 10.1074/jbc.272.26.16507; Kirito K, 2002, BLOOD, V99, P102, DOI 10.1182/blood.V99.1.102; Knapp DJHF, 2017, BLOOD, V129, P307, DOI 10.1182/blood-2016-09-740654; Kovacs E, 2015, ANNU REV BIOCHEM, V84, P739, DOI 10.1146/annurev-biochem-060614-034402; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; Kuhrt D, 2015, BLOOD, V125, P3536, DOI 10.1182/blood-2014-11-575357; Landowski M, 2013, HUM GENET, V132, P1265, DOI 10.1007/s00439-013-1326-z; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lemmon MA, 2016, CELL, V164, P1172, DOI 10.1016/j.cell.2016.02.047; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Ludwig LS, 2014, NAT MED, V20, P748, DOI 10.1038/nm.3557; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Meyer SC, 2015, CANCER CELL, V28, P15, DOI 10.1016/j.ccell.2015.06.006; Moraga I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab2677; Moraga I, 2015, CELL, V160, P1196, DOI 10.1016/j.cell.2015.02.011; Narla A, 2011, SEMIN HEMATOL, V48, P117, DOI 10.1053/j.seminhematol.2011.01.004; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quintas-Cardama A, 2010, BLOOD, V115, P3109, DOI 10.1182/blood-2009-04-214957; Rajagopal S, 2011, MOL PHARMACOL, V80, P367, DOI 10.1124/mol.111.072801; Roder F, 2014, ACS CHEM BIOL, V9, P2479, DOI 10.1021/cb5005806; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Roy V, 2005, BIOL BLOOD MARROW TR, V11, P600, DOI 10.1016/j.bbmt.2005.05.005; Sander J, 1998, DATA MIN KNOWL DISC, V2, P169, DOI 10.1023/A:1009745219419; Sankaran VG, 2015, J CLIN INVEST, V125, P1665, DOI 10.1172/JCI78619; Sankaran VG, 2013, AM J HEMATOL, V88, P930, DOI 10.1002/ajh.23573; Sankaran VG, 2012, J CLIN INVEST, V122, P2439, DOI 10.1172/JCI63597; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; Silvennoinen O, 2015, BLOOD, V125, P3388, DOI 10.1182/blood-2015-01-621110; Spangler JB, 2015, ANNU REV IMMUNOL, V33, P139, DOI 10.1146/annurev-immunol-032713-120211; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; Tarailo-Graovac M, 2016, NEW ENGL J MED, V374, P2246, DOI 10.1056/NEJMoa1515792; Tefferi A, 2012, BLOOD, V119, P2721, DOI 10.1182/blood-2011-11-395228; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Ulirsch JC, 2016, CELL, V165, P1530, DOI 10.1016/j.cell.2016.04.048; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518; WEN DY, 1994, J BIOL CHEM, V269, P22839; Wilmes S, 2015, J CELL BIOL, V209, P579, DOI 10.1083/jcb.201412049; Wisler JW, 2014, CURR OPIN CELL BIOL, V27, P18, DOI 10.1016/j.ceb.2013.10.008; Wu TR, 2002, J BIOL CHEM, V277, P47572, DOI 10.1074/jbc.M207536200; Yin J, 2005, P NATL ACAD SCI USA, V102, P15815, DOI 10.1073/pnas.0507705102; You CJ, 2014, ANAL CHEM, V86, P8593, DOI 10.1021/ac501127r; Yu CL, 2000, J BIOL CHEM, V275, P599, DOI 10.1074/jbc.275.1.599	62	71	72	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2017	168	6					1053	+		10.1016/j.cell.2017.02.026	http://dx.doi.org/10.1016/j.cell.2017.02.026			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8ZF	28283061	Bronze, Green Accepted			2022-12-28	WOS:000396287900013
J	Detsky, AS; Gropper, MA				Detsky, Allan S.; Gropper, Michael A.			Why Physician Leaders of Health Care Organizations Should Participate in Direct Patient Care RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Detsky, Allan S.] Univ Toronto, Toronto, ON, Canada; [Gropper, Michael A.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of Toronto; University of California System; University of California San Francisco	Detsky, AS (corresponding author), Univ Toronto, Toronto, ON, Canada.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2017	166	5					376	377		10.7326/L16-0624	http://dx.doi.org/10.7326/L16-0624			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BO	28265660				2022-12-28	WOS:000396432800016
J	Clery, D				Clery, Daniel			ASTRONOMY Global telescope gears up to image black holes	SCIENCE			English	News Item														Clery, Daniel/0000-0002-8742-3596					0	0	0	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					893	894		10.1126/science.355.6328.893	http://dx.doi.org/10.1126/science.355.6328.893			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2YM	28254890				2022-12-28	WOS:000395181700011
J	Debelle, G				Debelle, Geoff			Why the Children and Social Work Bill needs to be amended	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Debelle, Geoff] Royal Coll Paediat & Child Hlth, Child Protect, London, England		Debelle, G (corresponding author), Royal Coll Paediat & Child Hlth, Child Protect, London, England.	geoff.debelle@bch.nhs.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 28	2017	356								j999	10.1136/bmj.j999	http://dx.doi.org/10.1136/bmj.j999			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JQ	28246101				2022-12-28	WOS:000395628100019
J	Kyrgiou, M; Kalliala, I; Markozannes, G; Gunter, MJ; Paraskevaidis, E; Gabra, H; Martin-Hirsch, P; Tsilidis, KK				Kyrgiou, Maria; Kalliala, Ilkka; Markozannes, Georgios; Gunter, Marc J.; Paraskevaidis, Evangelos; Gabra, Hani; Martin-Hirsch, Pierre; Tsilidis, Konstantinos K.			Adiposity and cancer at major anatomical sites: umbrella review of the literature	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BODY-MASS INDEX; DOSE-RESPONSE METAANALYSIS; HORMONE REPLACEMENT THERAPY; ENVIRONMENTAL RISK-FACTORS; PRIMARY LIVER-CANCER; BREAST-CANCER; ENDOMETRIAL CANCER; COLORECTAL-CANCER; BARIATRIC SURGERY; PROSTATE-CANCER	OBJECTIVE To evaluate the strength and validity of the evidence for the association between adiposity and risk of developing or dying from cancer. DESIGN Umbrella review of systematic reviews and meta-analyses. DATA SOURCES PubMed, Embase, Cochrane Database of Systematic Reviews, and manual screening of retrieved references. ELIGIBILITY CRITERIA Systematic reviews or meta-analyses of observational studies that evaluated the association between indices of adiposity and risk of developing or dying from cancer. Data synthesis Primary analysis focused on cohort studies exploring associations for continuous measures of adiposity. The evidence was graded into strong, highly suggestive, suggestive, or weak after applying criteria that included the statistical significance of the random effects summary estimate and of the largest study in a meta-analysis, the number of cancer cases, heterogeneity between studies, 95% prediction intervals, small study effects, excess significance bias, and sensitivity analysis with credibility ceilings. RESULTS 204 meta-analyses investigated associations between seven indices of adiposity and developing or dying from 36 primary cancers and their subtypes. Of the 95 meta-analyses that included cohort studies and used a continuous scale to measure adiposity, only 12 (13%) associations for nine cancers were supported by strong evidence. An increase in body mass index was associated with a higher risk of developing oesophageal adenocarcinoma; colon and rectal cancer in men; biliary tract system and pancreatic cancer; endometrial cancer in premenopausal women; kidney cancer; and multiple myeloma. Weight gain and waist to hip circumference ratio were associated with higher risks of postmenopausal breast cancer in women who have never used hormone replacement therapy and endometrial cancer, respectively. The increase in the risk of developing cancer for every 5 kg/m(2) increase in body mass index ranged from 9% (relative risk 1.09, 95% confidence interval 1.06 to 1.13) for rectal cancer among men to 56% (1.56, 1.34 to 1.81) for biliary tract system cancer. The risk of postmenopausal breast cancer among women who have never used HRT increased by 11% for each 5 kg of weight gain in adulthood (1.11, 1.09 to 1.13), and the risk of endometrial cancer increased by 21% for each 0.1 increase in waist to hip ratio (1.21, 1.13 to 1.29). Five additional associations were supported by strong evidence when categorical measures of adiposity were included: weight gain with colorectal cancer; body mass index with gallbladder, gastric cardia, and ovarian cancer; and multiple myeloma mortality. CONCLUSIONS Although the association of adiposity with cancer risk has been extensively studied, associations for only 11 cancers (oesophageal adenocarcinoma, multiple myeloma, and cancers of the gastric cardia, colon, rectum, biliary tract system, pancreas, breast, endometrium, ovary, and kidney) were supported by strong evidence. Other associations could be genuine, but substantial uncertainty remains. Obesity is becoming one of the biggest problems in public health; evidence on the strength of the associated risks may allow finer selection of those at higher risk of cancer, who could be targeted for personalised prevention strategies.	[Kyrgiou, Maria; Kalliala, Ilkka; Gabra, Hani] Imperial Coll London, Inst Reprod & Dev Biol, Dept Surg & Canc, Fac Med, London W12 0NN, England; [Kyrgiou, Maria; Gabra, Hani] Imperial Healthcare NHS Trust, West London Gynaecol Canc Ctr, Queen Charlottes & Chelsea Hosp, Hammersmith Hosp, London, England; [Markozannes, Georgios; Tsilidis, Konstantinos K.] Univ Ioannina, Dept Hyg & Epidemiol, Sch Med, Ioannina, Greece; [Gunter, Marc J.] Int Agcy Res Canc, Sect Nutr & Metab, Lyon, France; [Paraskevaidis, Evangelos] Univ Ioannina, Dept Obstet & Gynaecol, Ioannina, Greece; [Martin-Hirsch, Pierre] Lancashire Teaching Hosp, Dept Gynaecol Oncol, Preston, Lancs, England; [Martin-Hirsch, Pierre] Univ Lancaster, Dept Biophys, Lancaster, England; [Tsilidis, Konstantinos K.] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England	Imperial College London; Imperial College London; University of Ioannina; World Health Organization; International Agency for Research on Cancer (IARC); University of Ioannina; Lancaster University; Imperial College London	Kyrgiou, M (corresponding author), Imperial Coll London, Inst Reprod & Dev Biol, Dept Surg & Canc, Fac Med, London W12 0NN, England.; Kyrgiou, M (corresponding author), Imperial Healthcare NHS Trust, West London Gynaecol Canc Ctr, Queen Charlottes & Chelsea Hosp, Hammersmith Hosp, London, England.	m.kyrgiou@imperial.ac.uk	Markozannes, Georgios/GXM-3556-2022; Markozannes, Georgios/AAS-7269-2020; Gunter, Marc/AAP-8621-2020; Paraskevaidis, Evangelos/ABH-4990-2020; Kalliala, Ilkka/ABC-9253-2021	Markozannes, Georgios/0000-0001-8481-579X; Markozannes, Georgios/0000-0001-8481-579X; Kalliala, Ilkka/0000-0002-7664-0587; Gabra, Hani/0000-0002-3322-4399; Tsilidis, Konstantinos/0000-0002-8452-8472; Gunter, Marc/0000-0001-5472-6761	Genesis Research Trust (Garfield Weston Foundation) [P63522]; Sigrid Juselius Fellowship [P52483]; World Cancer Research Fund International Regular Grant Programme [2014/1180]; Ovarian Cancer Action [PS5827, PSA601]; Imperial Experimental Cancer Medicine Centre; Cancer Research UK Imperial Centre; Imperial Healthcare NHS Trust NIHR BRC [P45272]	Genesis Research Trust (Garfield Weston Foundation); Sigrid Juselius Fellowship(Sigrid Juselius Foundation); World Cancer Research Fund International Regular Grant Programme; Ovarian Cancer Action(Ovarian Cancer Action); Imperial Experimental Cancer Medicine Centre; Cancer Research UK Imperial Centre; Imperial Healthcare NHS Trust NIHR BRC	This work was supported by Genesis Research Trust (Garfield Weston Foundation, P63522 to MK); Sigrid Juselius Fellowship (P52483 to IK and MK); World Cancer Research Fund International Regular Grant Programme (2014/1180 to KKT); Ovarian Cancer Action (PS5827 and PSA601 to MG and MK); the Imperial Experimental Cancer Medicine Centre, the Cancer Research UK Imperial Centre, Imperial Healthcare NHS Trust NIHR BRC (P45272:MK). None of the funders had any influence on the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Alsamarrai A, 2014, CLIN GASTROENTEROL H, V12, P1635, DOI 10.1016/j.cgh.2014.01.038; Amadou A, 2013, OBES REV, V14, P665, DOI 10.1111/obr.12028; Aune D, 2015, ANN ONCOL, V26, P1635, DOI 10.1093/annonc/mdv142; Aune D, 2012, ANN ONCOL, V23, P843, DOI 10.1093/annonc/mdr398; Aune D, 2015, INT J CANCER, V136, P1888, DOI 10.1002/ijc.29207; Baer HJ, 2010, AM J EPIDEMIOL, V171, P1183, DOI 10.1093/aje/kwq045; Baer HJ, 2005, BREAST CANCER RES, V7, pR314, DOI 10.1186/bcr998; Belbasis L, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0692-5; Belbasis L, 2015, LANCET NEUROL, V14, P263, DOI 10.1016/S1474-4422(14)70267-4; Bellou V, 2016, ALZHEIMERS DEMENT; Bellou V, 2016, PARKINSONISM RELAT D, V23, P1, DOI 10.1016/j.parkreldis.2015.12.008; Boffetta P, 2008, JNCI-J NATL CANCER I, V100, P988, DOI 10.1093/jnci/djn191; Cao Y, 2011, CANCER PREV RES, V4, P486, DOI 10.1158/1940-6207.CAPR-10-0229; Carreras-Torres R, 2016, SCI REP-UK, V6, DOI 10.1038/srep31121; Casagrande DS, 2014, OBES SURG, V24, P1499, DOI 10.1007/s11695-014-1276-0; Castillo JJ, 2014, CL LYMPH MYELOM LEUK, V14, P122, DOI 10.1016/j.clml.2013.10.005; Castillo JJ, 2012, LEUKEMIA RES, V36, P868, DOI 10.1016/j.leukres.2011.12.020; Chen Y, 2012, EUR J CANCER, V48, P2137, DOI 10.1016/j.ejca.2012.02.063; Cheraghi Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051446; Chlebowski RT, 2004, NEW ENGL J MED, V350, P991, DOI 10.1056/NEJMoa032071; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Connolly BS, 2002, NUTR CANCER, V44, P127, DOI 10.1207/S15327914NC4402_02; Crosbie EJ, 2010, CANCER EPIDEM BIOMAR, V19, P3119, DOI 10.1158/1055-9965.EPI-10-0832; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Discacciati A, 2012, ANN ONCOL, V23, P1665, DOI 10.1093/annonc/mdr603; Dixon JB, 2010, MOL CELL ENDOCRINOL, V316, P104, DOI 10.1016/j.mce.2009.07.008; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Freedman ND, 2007, AM J EPIDEMIOL, V165, P1424, DOI 10.1093/aje/kwm051; Gao C, 2016, INT J EPIDEMIOL, V45, P896, DOI 10.1093/ije/dyw129; Geer EB, 2009, GENDER MED, V6, P60, DOI 10.1016/j.genm.2009.02.002; Guo Y, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002105; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Harriss DJ, 2009, COLORECTAL DIS, V11, P547, DOI 10.1111/j.1463-1318.2009.01766.x; Harvie M, 2003, Obes Rev, V4, P157, DOI 10.1046/j.1467-789X.2003.00108.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Ioannidis JPA, 2007, CLIN TRIALS, V4, P245, DOI 10.1177/1740774507079441; Ioannidis JPA, 2013, J MATH PSYCHOL, V57, P184, DOI 10.1016/j.jmp.2013.03.002; Ioannidis JPA, 2011, EPIDEMIOLOGY, V22, P450, DOI 10.1097/EDE.0b013e31821b506e; Ioannidis JPA, 2009, CAN MED ASSOC J, V181, P488, DOI 10.1503/cmaj.081086; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Johnson VE, 2013, P NATL ACAD SCI USA, V110, P19313, DOI 10.1073/pnas.1313476110; Kaaks R, 2002, CANCER EPIDEM BIOMAR, V11, P1531; Keum N, 2015, JNCI-J NATL CANCER I, V107, DOI [10.1093/jnci/dju428, 10.1093/jnci/djv088]; Lahmann PH, 2004, INT J CANCER, V111, P762, DOI 10.1002/ijc.20315; Larsson SC, 2007, BRIT J CANCER, V96, P1457, DOI 10.1038/sj.bjc.6603703; Larsson SC, 2008, INT J CANCER, V122, P1418, DOI 10.1002/ijc.23176; Larsson SC, 2007, AM J CLIN NUTR, V86, P556, DOI 10.1093/ajcn/86.3.556; Larsson SC, 2007, INT J CANCER, V121, P1564, DOI 10.1002/ijc.22762; Larsson SC, 2011, EUR J CANCER, V47, P2422, DOI 10.1016/j.ejca.2011.06.029; Lauby-Secretan B, 2016, NEW ENGL J MED, V375, P794, DOI 10.1056/NEJMsr1606602; Li J, 2014, LECT NOTES COMPUT SC, V8881, P184, DOI 10.1007/978-3-319-12691-3_15; Lin XJ, 2014, JPN J CLIN ONCOL, V44, P783, DOI 10.1093/jjco/hyu082; Ma J, 2015, MED SCI MONITOR, V21, P283, DOI 10.12659/MSM.892035; Ma YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053916; MacInnis RJ, 2006, CANCER CAUSE CONTROL, V17, P989, DOI 10.1007/s10552-006-0049-z; Markozannes G, 2016, EUR J CANCER, V69, P61, DOI 10.1016/j.ejca.2016.09.026; Marmot M., 2007, FOOD NUTR PHYS ACT P; McCullough ML, 2008, CANCER EPIDEM BIOMAR, V17, P73, DOI 10.1158/1055-9965.EPI-07-2567; Moghaddam AA, 2007, CANCER EPIDEM BIOMAR, V16, P2533, DOI 10.1158/1055-9965.EPI-07-0708; Murphy N, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv210; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Papatheodorou SI, 2015, J CLIN EPIDEMIOL, V68, P163, DOI 10.1016/j.jclinepi.2014.09.004; Park M, 2014, PREV MED, V65, P13, DOI 10.1016/j.ypmed.2014.03.027; Pierobon M, 2013, BREAST CANCER RES TR, V137, P307, DOI 10.1007/s10549-012-2339-3; Poorolajal J, 2016, EUR J CANCER PREV, V25, P232, DOI 10.1097/CEJ.0000000000000164; Poorolajal J, 2014, ASIAN PAC J CANCER P, V15, P7665, DOI 10.7314/APJCP.2014.15.18.7665; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Ritte R, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3186; Robsahm TE, 2013, EUR J CANCER PREV, V22, P492, DOI 10.1097/CEJ.0b013e328360f434; Salanti G, 2009, J CLIN EPIDEMIOL, V62, P115, DOI 10.1016/j.jclinepi.2008.05.014; Sandholt CH, 2014, OBESITY, V22, P901, DOI 10.1002/oby.20540; Schlesinger S, 2015, OBES REV, V16, P607, DOI 10.1111/obr.12286; Sergentanis TN, 2013, EUR J CANCER, V49, P642, DOI 10.1016/j.ejca.2012.08.028; Shao C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090167; Singh S, 2013, CLIN GASTROENTEROL H, V11, P1399, DOI 10.1016/j.cgh.2013.05.009; StataCorp, 2013, STATA STAT SOFTW REL; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Stevens GA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-22; Sun JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119313; Suzuki R, 2009, INT J CANCER, V124, P698, DOI 10.1002/ijc.23943; Theodoratou E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2035; Thrift AP, 2015, CANCER EPIDEM BIOMAR, V24, P1024, DOI 10.1158/1055-9965.EPI-14-1309; Thrift AP, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju252; Tsilidis KK, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7607; Tsilidis KK, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001609; Tsilidis KK, 2012, JNCI-J NATL CANCER I, V104, P1867, DOI 10.1093/jnci/djs437; Turati F, 2013, ANN ONCOL, V24, P609, DOI 10.1093/annonc/mds244; Upala S, 2015, SURG OBES RELAT DIS, V11, P949, DOI 10.1016/j.soard.2014.09.024; Wallin A, 2011, EUR J CANCER, V47, P1606, DOI 10.1016/j.ejca.2011.01.020; Wang FR, 2014, INT J CANCER, V135, P1673, DOI 10.1002/ijc.28813; Wang YQ, 2012, ONCOLOGIST, V17, P1461, DOI 10.1634/theoncologist.2012-0066; White KK, 2012, INT J CANCER, V131, pE705, DOI 10.1002/ijc.27373; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Cancer Research Fund International, 2013, DIET NUTR PHYS ACT E; World Cancer Research Fund International/American Institute for Cancer Research Continuous Update Project Report, 2010, DIET NUTR PHYS ACT B; World Cancer Research Fund International/American Institute for Cancer Research CUPR, 2016, DIET NUTR PHYS ACT O; Yang XW, 2015, MED SCI MONITOR, V21, P1350, DOI 10.12659/MSM.893553; Yang Y, 2013, INT J CANCER, V132, P1162, DOI 10.1002/ijc.27719; Zhang XY, 2015, ONCOL LETT, V9, P1307, DOI 10.3892/ol.2014.2841; Zhang YY, 2014, INT J BIOL MARKER, V29, pE21, DOI 10.5301/jbm.5000047	107	379	388	11	73	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 28	2017	356								j477	10.1136/bmj.j477	http://dx.doi.org/10.1136/bmj.j477			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JQ	28246088	Green Accepted, Green Published, Green Submitted, hybrid			2022-12-28	WOS:000395628100014
J	Grantham, HJ; Stocken, DD; Reynolds, NJ				Grantham, Henry J.; Stocken, Deborah D.; Reynolds, Nick J.			Doxycycline: a first-line treatment for bullous pemphigoid?	LANCET			English	Editorial Material							TOPICAL CORTICOSTEROIDS		[Grantham, Henry J.; Reynolds, Nick J.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Grantham, Henry J.; Reynolds, Nick J.] Newcastle Hosp NHS Fdn Trust, Newcastle Dermatol, Royal Victoria Infirm, Newcastle Upon Tyne, Tyne & Wear, England; [Stocken, Deborah D.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK	Reynolds, NJ (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Reynolds, NJ (corresponding author), Newcastle Hosp NHS Fdn Trust, Newcastle Dermatol, Royal Victoria Infirm, Newcastle Upon Tyne, Tyne & Wear, England.	nick.reynolds@ncl.ac.uk		Grantham, Henry/0000-0002-3197-4823; Stocken, Deborah/0000-0001-8031-1738; Reynolds, Nick/0000-0002-6484-825X	NIHR-Newcastle Biomedical Research Centre; Medical Research Council [MR/N005872/1] Funding Source: researchfish; MRC [MR/N005872/1] Funding Source: UKRI	NIHR-Newcastle Biomedical Research Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	HJG is an academic foundation doctor based at Newcastle University and the Newcastle upon Tyne Hospitals NHS Foundation Trust. NJR's laboratory and research is supported by the NIHR-Newcastle Biomedical Research Centre. NJR is chair of the UK Translational Research Network in Dermatology which collaborates with the UK Dermatology Clinical Trials Network and director of the Medical Research Council/Engineering and Physical Sciences Research Council (MRC/EPSRC) Newcastle Molecular Pathology Node. DDS declares no competing interests.	Bratton DJ, 2012, CLIN TRIALS, V9, P605, DOI 10.1177/1740774512453220; FIVENSON DP, 1994, ARCH DERMATOL, V130, P753, DOI 10.1001/archderm.130.6.753; Joly P, 2002, NEW ENGL J MED, V346, P321, DOI 10.1056/NEJMoa011592; Joly P, 2009, J INVEST DERMATOL, V129, P1681, DOI 10.1038/jid.2008.412; Langan SM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a180; Perret LJ, 2014, AUSTRALAS J DERMATOL, V55, P111, DOI 10.1111/ajd.12075; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; Rehal S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012594; Ren Z, 2017, BRIT J DERMATOL, V176, P87, DOI 10.1111/bjd.14821; Schmidt E, 2013, LANCET, V381, P320, DOI 10.1016/S0140-6736(12)61140-4; Taghipour K, 2013, CLIN EXP DERMATOL, V38, P311, DOI 10.1111/ced.12042; Williams HC, 2017, LANCET	12	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 22	2017	389	10079					1586	1588		10.1016/S0140-6736(17)30549-4	http://dx.doi.org/10.1016/S0140-6736(17)30549-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ES5EK	28279483	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000399560000006
J	Hodge, JG; Gostin, LO				Hodge, James G., Jr.; Gostin, Lawrence O.			Revamping the US Federal Common Rule Modernizing Human Participant Research Regulations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hodge, James G., Jr.] Arizona State Univ, Sandra Day OConnor Coll Law, Publ Hlth Law & Policy Program, Phoenix, AZ USA; [Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Global & Natl Hlth Law, Law Ctr, Washington, DC USA	Arizona State University; Arizona State University-Downtown Phoenix; Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Law Ctr, 600 New Jersey Ave NW,McDonough 568, Washington, DC 20001 USA.	gostin@law.georgetown.edu						Akbar F., 2017, OBSERVER; [Anonymous], PREC MED IN; Department of Homeland Security, 2017, Fed Regist, V82, P7149; Hornyak T., 2016, NAT INDEX; Hudson KL, 2015, NEW ENGL J MED, V373, P2293, DOI 10.1056/NEJMp1512205; U.S. Department of Health and Human Services, FED POL PROT HUM SUB	6	13	14	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2017	317	15					1521	1522		10.1001/jama.2017.1633	http://dx.doi.org/10.1001/jama.2017.1633			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ES2YN	28241195				2022-12-28	WOS:000399393900006
J	Bhandari, M; Devereaux, PJ; Guyatt, G; Thabane, L; Walter, SD; Heetveld, MJ; Jeray, KJ; Liew, S; Schemitsch, EH; Tornetta, P; Della Rocca, GJ; McCormack, R; Oliver, TM; Segers, MJM; Rangan, A; Richardson, M; Sprague, S; Slobogean, GP; Scott, T; Garibaldi, A; Zhou, Q; Heels-Ansdell, D; Viveiros, H; Zielinski, SM; Van Lieshout, EMM; Johal, H; Hanusch, BC; Swiontkowski, M				Bhandari, Mohit; Devereaux, P. J.; Guyatt, Gordon; Thabane, Lehana; Walter, Stephen D.; Heetveld, Martin J.; Jeray, Kyle J.; Liew, Susan; Schemitsch, Emil H.; Tornetta, Paul, III; Della Rocca, Gregory J.; McCormack, Robert; Oliver, Todd M.; Segers, Michiel J. M.; Rangan, Amar; Richardson, Martin; Sprague, Sheila; Slobogean, Gerard P.; Scott, Taryn; Garibaldi, Alisha; Zhou, Qi; Heels-Ansdell, Diane; Viveiros, Helena; Zielinski, Stephanie M.; Van Lieshout, Esther M. M.; Johal, Herman; Hanusch, Birgit C.; Swiontkowski, Marc			Fracture fixation in the operative management of hip fractures (FAITH): an international, multicentre, randomised controlled trial	LANCET			English	Article							FEMORAL-NECK FRACTURES; SLIDING SCREW PLATE; ELDERLY-PATIENTS; NECROSIS; SMOKING; RISK; HEAD	Background Reoperation rates are high after surgery for hip fractures. We investigated the effect of a sliding hip screw versus cancellous screws on the risk of reoperation and other key outcomes. Methods For this international, multicentre, allocation concealed randomised controlled trial, we enrolled patients aged 50 years or older with a low-energy hip fracture requiring fracture fixation from 81 clinical centres in eight countries. Patients were assigned by minimisation with a centralised computer system to receive a single large-diameter screw with a side-plate (sliding hip screw) or the present standard of care, multiple small-diameter cancellous screws. Surgeons and patients were not blinded but the data analyst, while doing the analyses, remained blinded to treatment groups. The primary outcome was hip reoperation within 24 months after initial surgery to promote fracture healing, relieve pain, treat infection, or improve function. Analyses followed the intention-to-treat principle. This study was registered with ClinicalTrials.gov, number NCT00761813. Findings Between March 3, 2008, and March 31, 2014, we randomly assigned 1108 patients to receive a sliding hip screw (n=557) or cancellous screws (n=551). Reoperations within 24 months did not differ by type of surgical fixation in those included in the primary analysis: 107 (20%) of 542 patients in the sliding hip screw group versus 117 (22%) of 537 patients in the cancellous screws group (hazard ratio [HR] 0.83, 95% CI 0.63-1.09; p=0.18). Avascular necrosis was more common in the sliding hip screw group than in the cancellous screws group (50 patients [9%] vs 28 patients [5%]; HR 1.91, 1.06-3.44; p=0.0319). However, no significant difference was found between the number of medically related adverse events between groups (p=0.82; appendix); these events included pulmonary embolism (two patients [<1%] vs four [1%] patients; p=0.41) and sepsis (seven [1%] vs six [1%]; p=0.79). Interpretation In terms of reoperation rates the sliding hip screw shows no advantage, but some groups of patients (smokers and those with displaced or base of neck fractures) might do better with a sliding hip screw than with cancellous screws.	[Bhandari, Mohit] McMaster Univ, Dept Surg, Div Orthopaed Surg, Hamilton, ON L8L 8E7, Canada	McMaster University	Bhandari, M (corresponding author), McMaster Univ, Dept Surg, Div Orthopaed Surg, Hamilton, ON L8L 8E7, Canada.	bhandam@mcmaster.ca	Devereaux, PJ/AAF-2862-2019; Johal, Herman/AAR-1935-2021; Hanusch, Birgit/AAZ-3292-2020; Schreurs, B.W./L-4639-2015; Zhou, Qi/GSM-9583-2022; Sprague, Sheila/AAQ-4232-2021; Bhandari, Mohit/AAQ-1675-2021; Edwards, M.J.R./H-8026-2014; Schemitsch, Emil/G-5706-2017; Nanda, Rajesh/AAN-6307-2021; Walter, Stephen/AAB-5548-2022; Devereaux, PJ/AAY-1757-2021; Tan, Edward C.T.H./L-4681-2015; Della Rocca, Gregory/AAM-5281-2021	Johal, Herman/0000-0003-0643-534X; Sprague, Sheila/0000-0003-1466-8063; Schemitsch, Emil/0000-0002-6435-9069; Walter, Stephen/0000-0003-4157-8928; Tan, Edward C.T.H./0000-0002-9978-249X; Nauth, Aaron/0000-0002-9186-7747; Reed, Michael/0000-0002-6309-2710; Frihagen, Frede/0000-0002-4811-669X; Schmidt, Andrew/0000-0002-9740-4049; Kottam, Lucksy/0000-0002-7976-2416; Vallier, Heather/0000-0003-3881-6518; Coles, Chad/0000-0003-0454-3507; Kamali Moaveni, Afshin/0000-0003-4933-1700; Dunbar, MD FRCSC PhD FCAHS, Michael/0000-0003-3629-498X; van Wessem, Karlijn/0000-0002-1166-0990; Tannoury, Chadi/0000-0002-2369-432X; Lorenzo, Melissa/0000-0002-8203-2799; Switzer, Julie/0000-0002-4834-1643; Rangan, Amar/0000-0002-5452-8578; /0000-0001-6570-3290; Cole, Peter/0000-0001-6217-5103; Horan, Annamarie/0000-0003-3000-5841; Tetsworth, Kevin/0000-0002-3069-4141; Swiontkowski, Marc/0000-0001-7036-1782; Pape, Hans-Christoph/0000-0002-2059-4980	National Institutes of Health; Canadian Institutes of Health Research; Stichting NutsOhra; Netherlands Organisation for Health Research and Development; Physicians' Services Incorporated; Canadian Institutes of Health Research [MOP-106630, MCT-87771]; National Institutes of Health [1R01AR055267-01A1]; Stichting NutsOhra [SNO-T-0602-43]; Netherlands Organisation for Health Research and Development [80-82310-97-11032]; Stryker GmBH; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [R01AR055267-01A1]; County Durham & Tees Valley Comprehensive Local Research Network; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055267] Funding Source: NIH RePORTER; Alberta Innovates [201500090] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Stichting NutsOhra; Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Physicians' Services Incorporated; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stichting NutsOhra; Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Stryker GmBH; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); County Durham & Tees Valley Comprehensive Local Research Network; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Alberta Innovates	National Institutes of Health, Canadian Institutes of Health Research, Stichting NutsOhra, Netherlands Organisation for Health Research and Development, Physicians' Services Incorporated.; This study was funded by research grants from the Canadian Institutes of Health Research (MOP-106630 and MCT-87771), National Institutes of Health (1R01AR055267-01A1), Stichting NutsOhra (SNO-T-0602-43), The Netherlands Organisation for Health Research and Development (80-82310-97-11032), Physicians' Services Incorporated, and Stryker GmBH. MB was also funded, in part, through the Early Research Award Program, which provided funding for the present study, and by a Canada research chair in musculoskeletal trauma, which is unrelated to the present study (McMaster University, Hamilton, ON, Canada). Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number R01AR055267-01A1. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Research reported in this publication was also supported by The County Durham & Tees Valley Comprehensive Local Research Network, which operates as part of the National Institute for Health Research Comprehensive Clinical Research Network in England.	BARNES R, 1976, J BONE JOINT SURG BR, V58, P2, DOI 10.1302/0301-620X.58B1.1270491; Bartonicek J, 2001, J ORTHOP TRAUMA, V15, P358, DOI 10.1097/00005131-200106000-00009; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Benterud JG, 1997, ANN CHIR GYNAECOL FE, V86, P338; Bhandari M, 2005, J BONE JOINT SURG AM, V87A, P2122, DOI 10.2106/JBJS.E.00535; Bhandari M, 2003, J BONE JOINT SURG AM, V85A, P1673, DOI 10.2106/00004623-200309000-00004; BLAIR B, 1994, CLIN ORTHOP RELAT R, P256; BRODETTI A, 1960, J BONE JOINT SURG BR, V42, P794; Brooks R., 2003, MEASUREMENT VALUATIO; Castillo RC, 2005, J ORTHOP TRAUMA, V19, P151, DOI 10.1097/00005131-200503000-00001; Collett D, 1994, MODELLING SURVIVAL D; Deneka DA, 1997, J ORTHOP TRAUMA, V11, P337, DOI 10.1097/00005131-199707000-00007; GARDEN RS, 1961, J BONE JOINT SURG BR, V43, P647, DOI 10.1302/0301-620X.43B4.647; Gullberg B, 1997, OSTEOPOROSIS INT, V7, P407, DOI 10.1007/PL00004148; Harper WM, 1994, THESIS; Hoshino CM, 2015, INJURY, V46, P474, DOI 10.1016/j.injury.2014.12.008; Kuokkanen H, 1991, Acta Orthop Belg, V57, P53; Law MR, 1997, BMJ-BRIT MED J, V315, P841, DOI 10.1136/bmj.315.7112.841; LINDE F, 1986, INJURY, V17, P159, DOI 10.1016/0020-1383(86)90322-0; MADSEN F, 1987, ACTA ORTHOP SCAND, V58, P212, DOI 10.3109/17453678709146468; McCormack R, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-219; MCHORNEY CA, 1992, MED CARE, V30, pMS253, DOI 10.1097/00005650-199205001-00025; Mundi S, 2014, ACTA ORTHOP, V85, P54, DOI 10.3109/17453674.2013.878831; Nikolopoulos KE, 2003, INJURY, V34, P525, DOI 10.1016/S0020-1383(02)00367-4; Parker M, 2006, BMJ-BRIT MED J, V333, P27, DOI 10.1136/bmj.333.7557.27; Parker MJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000093.pub5; Parker MJ., 2001, COCHRANE DB SYST REV, V4, P1467; Paus A, 1986, J Oslo City Hosp, V36, P55; Pauwels F., 1935, SCHENKELHALSBRUCH ME; Scott NW, 2002, CONTROL CLIN TRIALS, V23, P662, DOI 10.1016/S0197-2456(02)00242-8; SORENSEN JL, 1992, ACTA ORTHOP SCAND, V63, P288, DOI 10.3109/17453679209154784; Study to Prospectively Evaluate Reamed Intramedullary Nails in Tibial Fractures (SPRINT) Investigators, 2011, J Bone Joint Surg Am, V93, pe8, DOI 10.2106/JBJS.I.01555; Sun X, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1553; SWIONTKOWSKI MF, 1994, J BONE JOINT SURG AM, V76A, P129, DOI 10.2106/00004623-199401000-00019; Watson A, 2013, ANZ J SURG, V83, P679, DOI 10.1111/j.1445-2197.2012.06256.x; Zielinski SM, 2014, OSTEOPOROSIS INT, V25, P875, DOI 10.1007/s00198-013-2487-2	36	112	122	2	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 15	2017	389	10078					1519	1527		10.1016/S0140-6736(17)30066-1	http://dx.doi.org/10.1016/S0140-6736(17)30066-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER7OP	28262269	Green Submitted, Green Accepted			2022-12-28	WOS:000399002900025
J	Gaynor, M; Mostashari, F; Ginsburg, PB				Gaynor, Martin; Mostashari, Farzad; Ginsburg, Paul B.			Making Health Care Markets Work Competition Policy for Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gaynor, Martin] Carnegie Mellon Univ, 5000 Forbes Ave, Pittsburgh, PA 15213 USA; [Mostashari, Farzad] Aledade Inc, Bethesda, MD USA; [Ginsburg, Paul B.] Brookings Inst, Washington, DC 20036 USA; [Ginsburg, Paul B.] Univ South Calif, Los Angeles, CA USA	Carnegie Mellon University; Brookings Institution; University of Southern California	Gaynor, M (corresponding author), Carnegie Mellon Univ, H John Heinz Coll 3, 5000 Forbes Ave, Pittsburgh, PA 15213 USA.	mgaynor@cmu.edu			Robert Wood Johnson Foundation; American Academy of Ophthalmology; Blue Cross Blue Shield Association; Summa Health; Bipartisan Policy Center; Maine Medical Center; Indiana Primary Care Association; American College of Chest Physicians	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); American Academy of Ophthalmology; Blue Cross Blue Shield Association; Summa Health; Bipartisan Policy Center; Maine Medical Center; Indiana Primary Care Association; American College of Chest Physicians(General Electric)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Gaynor reports receipt of grant funding support from the Robert Wood Johnson Foundation and provision of uncompensated consultancy services to the Federal Trade Commission. Dr Ginsburg reports receipt of personal fees for public trustee services from the American Academy of Ophthalmology; advisory board services from the National Institute for Health Care Management; consultancy fees from Blue Cross Blue Shield Association, Summa Health, and the Bipartisan Policy Center outside the submitted work. Dr Mostashari reports receipt of personal fees from Maine Medical Center, the Indiana Primary Care Association, and the American College of Chest Physicians outside the submitted work.	American Hospital Association, 2016, CHART 2 9 ANN HOSP M; Cutler DM, 2013, JAMA-J AM MED ASSOC, V310, P1964, DOI 10.1001/jama.2013.281675; Frakt AB, 2015, JAMA-J AM MED ASSOC, V314, P547, DOI 10.1001/jama.2015.9195; Gaynor M, 2016, HLTH AFFAIRS BLOG; Jha AK, 2017, JAMA-J AM MED ASSOC, V317, P125, DOI 10.1001/jama.2016.17772; Kane CK., NEW DATA PHYS PRACTI; McWilliams JM, 2016, JAMA-J AM MED ASSOC, V316, P1711, DOI 10.1001/jama.2016.12049	7	30	30	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2017	317	13					1313	1314		10.1001/jama.2017.1173	http://dx.doi.org/10.1001/jama.2017.1173			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ9VR	28253376				2022-12-28	WOS:000398434200012
J	Doukky, R; Diemer, G; Medina, A; Winchester, DE; Murthy, VL; Phillips, LM; Flood, K; Giering, L; Hearn, G; Schwartz, RG; Russell, R; Wolinsky, D				Doukky, Rami; Diemer, Gretchen; Medina, Andria; Winchester, David E.; Murthy, Venkatesh L.; Phillips, Lawrence M.; Flood, Kathleen; Giering, Linda; Hearn, Georgia; Schwartz, Ronald G.; Russell, Raymond; Wolinsky, David			Promoting Appropriate Use of Cardiac Imaging: No Longer an Academic Exercise	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARDIOVASCULAR MAGNETIC-RESONANCE; COMPUTED-TOMOGRAPHY; USE CRITERIA; IMPACT; MULTICENTER; ECHOCARDIOGRAPHY; ANGIOGRAPHY; DISEASE; RISK		Cook Cty Hlth & Hosp Syst, Chicago, IL USA; [Diemer, Gretchen] Thomas Jefferson Univ, Sidney Kimmel Med Coll, 1025 Walnut St,100 Coll Bldg, Philadelphia, PA 19107 USA; [Medina, Andria] Univ Oklahoma, Hlth Sci Ctr, Internal Med, OU Phys Bldg,Suite 4E,825 NE 10th St, Oklahoma City, OK 73104 USA; [Winchester, David E.] Univ Florida, Coll Med, 1600 SW Archer Rd,Box 100277, Gainesville, FL 32610 USA; [Murthy, Venkatesh L.] Univ Michigan, Cardiovasc Ctr 1338, 1500 East Med Ctr Dr,SPC 5873, Ann Arbor, MI 48109 USA; [Phillips, Lawrence M.] NYU, Langone Med Ctr, 530 First Ave, New York, NY 10016 USA; [Flood, Kathleen; Giering, Linda; Hearn, Georgia] Amer Soc Nucl Cardiol, 4340 East West Highway,Suite 1120, Bethesda, MD 20814 USA; [Schwartz, Ronald G.] Univ Rochester, Med Ctr, 601 Elmwood Ave,Box 679-N, Rochester, NY 14642 USA; Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Wolinsky, David] Cleveland Clin Florida, 2950 Cleveland Clin Blvd, Weston, FL 33331 USA; [Doukky, Rami] John H Stroger Jr Hosp Cook Cty, Div Cardiol, 1901 West Harrison St,Suite 3620, Chicago, IL 60612 USA; [Russell, Raymond] Rhode Isl Hosp, Cardiovasc Inst, 593 Eddy St,Floor 5, Providence, RI 02903 USA	John H Stroger Junior Hospital Cook County; Jefferson University; University of Oklahoma System; University of Oklahoma Health Sciences Center; State University System of Florida; University of Florida; University of Michigan System; University of Michigan; New York University; NYU Langone Medical Center; University of Rochester; Brown University; Cleveland Clinic Foundation; John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Lifespan Health Rhode Island; Rhode Island Hospital	Doukky, R (corresponding author), John H Stroger Jr Hosp Cook Cty, Div Cardiol, 1901 West Harrison St,Suite 3620, Chicago, IL 60612 USA.	rdoukky@cookcountyhhs.org	Murthy, Venkatesh L./B-3448-2013; Schwartz, Ronald/R-8576-2019; Winchester, David/AAR-5536-2020	Murthy, Venkatesh L./0000-0002-7901-1321; Winchester, David/0000-0002-5224-2891; Diemer, Gretchen/0000-0002-5243-9256				Bhatia RS, 2013, JACC-CARDIOVASC IMAG, V6, P545, DOI 10.1016/j.jcmg.2013.01.010; Chinnaiyan KM, 2012, J AM COLL CARDIOL, V60, P1185, DOI 10.1016/j.jacc.2012.06.008; Doukky R, 2016, J NUCL MED, V57, P1251, DOI 10.2967/jnumed.115.167205; Fonseca R, 2015, J AM COLL CARDIOL, V65, P763, DOI 10.1016/j.jacc.2014.11.057; Hendel RC, 2010, J AM COLL CARDIOL, V55, P156, DOI 10.1016/j.jacc.2009.11.004; Lin FY, 2013, J AM COLL CARDIOL, V62, P308, DOI 10.1016/j.jacc.2013.04.059; McGraw S, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0137-x; Saifi S, 2013, JACC-CARDIOVASC IMAG, V6, P823, DOI 10.1016/j.jcmg.2013.01.012; Willens HJ, 2013, JACC-CARDIOVASC IMAG, V6, P297, DOI 10.1016/j.jcmg.2012.11.009; Wolk MJ, 2014, J AM COLL CARDIOL, V63, P380, DOI 10.1016/j.jacc.2013.11.009	10	7	7	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2017	166	6					438	+		10.7326/M16-2673	http://dx.doi.org/10.7326/M16-2673			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9RM	28241267				2022-12-28	WOS:000397025800019
J	Millini, R				Millini, Roberto			Beyond trial and error for zeolite catalysts	SCIENCE			English	Editorial Material							PERSPECTIVES		[Millini, Roberto] Eni SpA, Res & Technol Innovat Dept, R&D Program Energy Transit, Via F Maritano 26, I-20097 San Donato Milanese, Italy	Eni SpA	Millini, R (corresponding author), Eni SpA, Res & Technol Innovat Dept, R&D Program Energy Transit, Via F Maritano 26, I-20097 San Donato Milanese, Italy.	roberto.millini@eni.com						Broach R.W., 2010, ZEOLITES IND SEPARAT; Cejka J., 2010, ZEOLITES CATALYSIS S, V2; Cejka J, 2012, CATAL TODAY, V179, P2, DOI 10.1016/j.cattod.2011.10.006; Eliasova P, 2015, CHEM SOC REV, V44, P7177, DOI 10.1039/c5cs00045a; HEILMANN J, 1994, ANGEW CHEM INT EDIT, V33, P471, DOI 10.1002/anie.199404711; Li JY, 2015, CHEM SOC REV, V44, P7112, DOI 10.1039/c5cs00023h; Li S., 2016, MOL IMPRINTED CATALY; Gallego EM, 2017, SCIENCE, V355, DOI 10.1126/science.aal0121; Millini R, 2003, J CATAL, V217, P298, DOI 10.1016/S0021-9517(03)00071-X; Pinar AB, 2009, J CATAL, V263, P258, DOI 10.1016/j.jcat.2009.02.017; Roth WJ, 2014, CHEM REV, V114, P4807, DOI 10.1021/cr400600f	11	2	2	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI		1028	1028		10.1126/science.aam8037	http://dx.doi.org/10.1126/science.aam8037			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9VY	28280171				2022-12-28	WOS:000396348900020
J	West, JG				West, Julian G.			Fortune favors the well read	SCIENCE			English	Editorial Material									[West, Julian G.] Princeton Univ, Princeton, NJ 08544 USA	Princeton University	West, JG (corresponding author), Princeton Univ, Princeton, NJ 08544 USA.			West, Julian/0000-0002-3715-7883					0	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI					10.1126/science.355.6329.1090	http://dx.doi.org/10.1126/science.355.6329.1090			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9VY	28280208				2022-12-28	WOS:000396348900047
J	Yu, YQ; Barry, DM; Hao, Y; Liu, XT; Chen, ZF				Yu, Yao-Qing; Barry, Devin M.; Hao, Yan; Liu, Xue-Ting; Chen, Zhou-Feng			Molecular and neural basis of contagious itch behavior in mice	SCIENCE			English	Article							GASTRIN-RELEASING-PEPTIDE; SUPRACHIASMATIC NUCLEUS; SENSATION; RECEPTOR; RHYTHMS; EMPATHY; NEURONS; MOUSE; LIGHT	Socially contagious itch is ubiquitous in human society, but whether it exists in rodents is unclear. Using a behavioral paradigm that does not entail prior training or reward, we found that mice scratched after observing a conspecific scratching. Molecular mapping showed increased neuronal activity in the suprachiasmatic nucleus (SCN) of the hypothalamus of mice that displayed contagious scratching. Ablation of gastrin-releasing peptide receptor (GRPR) or GRPR neurons in the SCN abolished contagious scratching behavior, which was recapitulated by chemogenetic inhibition of SCN GRP neurons. Activation of SCN GRP/GRPR neurons evoked scratching behavior. These data demonstrate that GRP-GRPR signaling is necessary and sufficient for transmitting contagious itch information in the SCN. The findings may have implications for our understanding of neural circuits that control socially contagious behaviors.	[Yu, Yao-Qing; Barry, Devin M.; Hao, Yan; Liu, Xue-Ting; Chen, Zhou-Feng] Washington Univ, Sch Med, Ctr Study Itch, St Louis, MO 63110 USA; [Yu, Yao-Qing; Barry, Devin M.; Hao, Yan; Liu, Xue-Ting; Chen, Zhou-Feng] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Yu, Yao-Qing] Fourth Mil Med Univ, Tangdu Hosp, Inst Biomed Sci Pain, Xian 710038, Shaanxi, Peoples R China; [Chen, Zhou-Feng] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Chen, Zhou-Feng] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Hao, Yan] Huazhong Univ Sci & Technol, Dept Pediat, Tongji Hosp, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China; [Liu, Xue-Ting] Guangzhou Med Univ, Affiliated Hosp 2, Guangdong Prov Key Lab Allergy & Clin Immunol, State Key Lab Resp Dis, Guangzhou 510260, Guangdong, Peoples R China	Washington University (WUSTL); Washington University (WUSTL); Air Force Military Medical University; Washington University (WUSTL); Washington University (WUSTL); Huazhong University of Science & Technology; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Chen, ZF (corresponding author), Washington Univ, Sch Med, Ctr Study Itch, St Louis, MO 63110 USA.; Chen, ZF (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.; Chen, ZF (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.; Chen, ZF (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA.	chenz@wustl.edu	Liu, Xueting/GPP-2573-2022; Yu, Yao-Qing/D-6163-2017	Liu, Xueting/0000-0001-5419-198X; Yu, Yao-Qing/0000-0002-8047-9714; Barry, Devin/0000-0002-3140-6121	NIH-NIDA T32 training grant [5T32DA007261-23]; W. M. Keck Fellowship; NIH [1R01AR056318-06, R21 NS088861-01A1, R01NS094344, R01 DA037261-01A1, R56 AR064294-01A1]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056318, R56AR064294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS088861, R01NS094344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007261, R01DA037261] Funding Source: NIH RePORTER	NIH-NIDA T32 training grant; W. M. Keck Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Yin for technical support and N. Shah for discussion. AAV5-EF1a-DIO-h4MDi-mCherry virus was kindly provided as a gift from M. R. Bruchas' lab. Virus preparation was performed by M. Li of the Hope Center Viral Vectors Core at Washington University School of Medicine. The data reported in this manuscript are tabulated in the main paper and in the supplementary materials. Supported by NIH-NIDA T32 training grant 5T32DA007261-23 and the W. M. Keck Fellowship (D.M.B.) and by NIH grants 1R01AR056318-06, R21 NS088861-01A1, R01NS094344, R01 DA037261-01A1, and R56 AR064294-01A1 (Z.-F.C.). Author contributions: Y.-Q.Y., D.M.B., Y.H., and X.-T.L. participated in experimental design, performed tests, and analyzed the data; Z.-F.C. conceived and supervised the project; Z.-F.C. wrote the manuscript; and D.M.B. and Y.-Q.Y. contributed to the writing.	Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Barry DM, 2016, MOL PAIN, V12, DOI 10.1177/1744806916643724; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Galef B.G. Jr, 1988, P3; Gamble KL, 2007, J NEUROSCI, V27, P12078, DOI 10.1523/JNEUROSCI.1109-07.2007; Herzog ED, 2007, NAT REV NEUROSCI, V8, P790, DOI 10.1038/nrn2215; HEYES CM, 1993, ANIM BEHAV, V46, P999, DOI 10.1006/anbe.1993.1281; Karatsoreos IN, 2006, EUR J NEUROSCI, V23, P1047, DOI 10.1111/j.1460-9568.2006.04633.x; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; LeGates TA, 2014, NAT REV NEUROSCI, V15, P443, DOI 10.1038/nrn3743; Morgan C.L., 1896, HABIT AND INSTINCT; Panksepp JB, 2011, NEUROSCI BIOBEHAV R, V35, P1864, DOI 10.1016/j.neubiorev.2011.05.013; Provine RR, 2014, BEHAV BRAIN SCI, V37, P216, DOI 10.1017/S0140525X13002458; Schut C, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00057; SHINOHARA K, 1993, J NEUROSCI, V13, P793; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Thorpe W. H, 1963, LEARNING INSTINCT AN; WHITEN A, 1992, ADV STUD BEHAV, V21, P239, DOI 10.1016/S0065-3454(08)60146-1; Zentall TR, 2006, ANIM COGN, V9, P335, DOI 10.1007/s10071-006-0039-2; Zhao ZQ, 2014, J NEUROSCI, V34, P12402, DOI 10.1523/JNEUROSCI.1709-14.2014; Zhao ZQ, 2013, J CLIN INVEST, V123, P4769, DOI 10.1172/JCI70528	22	62	65	5	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI					10.1126/science.aak9748	http://dx.doi.org/10.1126/science.aak9748			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9VY	28280205	Green Accepted			2022-12-28	WOS:000396348900044
J	Hon, CC; Ramilowski, JA; Harshbarger, J; Bertin, N; Rackham, OJL; Gough, J; Denisenko, E; Schmeier, S; Poulsen, TM; Severin, J; Lizio, M; Kawaji, H; Kasukawa, T; Itoh, M; Burroughs, AM; Noma, S; Djebali, S; Alam, T; Medvedeva, YA; Testa, AC; Lipovich, L; Yip, CW; Abugessaisa, I; Mendez, M; Hasegawa, A; Tang, D; Lassmann, T; Heutink, P; Babina, M; Wells, CA; Kojima, S; Nakamura, Y; Suzuki, H; Daub, CO; de Hoon, MJL; Arner, E; Hayashizaki, Y; Carninci, P; Forrest, ARR				Hon, Chung-Chau; Ramilowski, Jordan A.; Harshbarger, Jayson; Bertin, Nicolas; Rackham, Owen J. L.; Gough, Julian; Denisenko, Elena; Schmeier, Sebastian; Poulsen, Thomas M.; Severin, Jessica; Lizio, Marina; Kawaji, Hideya; Kasukawa, Takeya; Itoh, Masayoshi; Burroughs, A. Maxwell; Noma, Shohei; Djebali, Sarah; Alam, Tanvir; Medvedeva, Yulia A.; Testa, Alison C.; Lipovich, Leonard; Yip, Chi-Wai; Abugessaisa, Imad; Mendez, Mickael; Hasegawa, Akira; Tang, Dave; Lassmann, Timo; Heutink, Peter; Babina, Magda; Wells, Christine A.; Kojima, Soichi; Nakamura, Yukio; Suzuki, Harukazu; Daub, Carsten O.; de Hoon, Michiel J. L.; Arner, Erik; Hayashizaki, Yoshihide; Carninci, Piero; Forrest, Alistair R. R.			An atlas of human long non-coding RNAs with accurate 5 ' ends	NATURE			English	Article							GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; TRANSCRIPTION; ARCHITECTURE; ANNOTATION; LANDSCAPE; EVOLUTION; DATABASE; LNCRNA; QUANTIFICATION	Long non-coding RNAs (lncRNAs) are largely heterogeneous and functionally uncharacterized. Here, using FANTOM5 cap analysis of gene expression (CAGE) data, we integrate multiple transcript collections to generate a comprehensive atlas of 27,919 human lncRNA genes with high-confidence 5' ends and expression profiles across 1,829 samples from the major human primary cell types and tissues. Genomic and epigenomic classification of these lncRNAs reveals that most intergenic lncRNAs originate from enhancers rather than from promoters. Incorporating genetic and expression data, we show that lncRNAs overlapping trait-associated single nucleotide polymorphisms are specifically expressed in cell types relevant to the traits, implicating these lncRNAs in multiple diseases. We further demonstrate that lncRNAs overlapping expression quantitative trait loci (eQTL)-associated single nucleotide polymorphisms of messenger RNAs are co-expressed with the corresponding messenger RNAs, suggesting their potential roles in transcriptional regulation. Combining these findings with conservation data, we identify 19,175 potentially functional lncRNAs in the human genome.	[Hon, Chung-Chau; Ramilowski, Jordan A.; Harshbarger, Jayson; Severin, Jessica; Lizio, Marina; Kawaji, Hideya; Kasukawa, Takeya; Itoh, Masayoshi; Burroughs, A. Maxwell; Noma, Shohei; Yip, Chi-Wai; Abugessaisa, Imad; Mendez, Mickael; Hasegawa, Akira; Tang, Dave; Lassmann, Timo; Heutink, Peter; Suzuki, Harukazu; Daub, Carsten O.; de Hoon, Michiel J. L.; Arner, Erik; Carninci, Piero; Forrest, Alistair R. R.] RIKEN, Ctr Life Sci Technol, Div Gen Technol, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan; [Ramilowski, Jordan A.; Harshbarger, Jayson; Bertin, Nicolas; Severin, Jessica; Lizio, Marina; Kawaji, Hideya; Itoh, Masayoshi; Burroughs, A. Maxwell; Noma, Shohei; Mendez, Mickael; Hasegawa, Akira; Tang, Dave; Lassmann, Timo; Suzuki, Harukazu; Daub, Carsten O.; de Hoon, Michiel J. L.; Arner, Erik; Hayashizaki, Yoshihide; Carninci, Piero; Forrest, Alistair R. R.] RIKEN, Omics Sci Ctr, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan; [Bertin, Nicolas] Natl Univ Singapore, Ctr Translat Med, Canc Sci Inst Singapore, 14 Med Dr 12-01, Singapore 117599, Singapore; [Rackham, Owen J. L.; Gough, Julian] Univ Bristol, Dept Comp Sci, Life Sci Bldg,24 Tyndall Ave, Bristol BS8 1TQ, Avon, England; [Rackham, Owen J. L.] Duke NUS Med Sch, Program Cardiovasc & Metab Disorders, 8 Coll Rd, Singapore 169857, Singapore; [Denisenko, Elena; Schmeier, Sebastian] Massey Univ Auckland, Inst Nat & Math Sci, Albany 0632, New Zealand; [Poulsen, Thomas M.] Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery BRD, Tsukuba Cent 2,1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan; [Kawaji, Hideya; Itoh, Masayoshi; Hayashizaki, Yoshihide] RIKEN, Prevent Med & Diag Innovat Program, 2-1 Hirosawa, Wako, Saitama 3510198, Japan; [Burroughs, A. Maxwell] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; [Djebali, Sarah] Barcelona Inst Sci & Technol, Ctr Gen Regulat CRG, Dr Aiguader 88, Barcelona 08003, Spain; [Djebali, Sarah] UPF, Barcelona Biomed Res Pk PRBB, Dr Aiguader 88, Barcelona 08003, Spain; [Alam, Tanvir] KAUST, Computat Biosci Res Ctr, Comp Elect & Math Sci & Engn Div, Thuwal 239556900, Saudi Arabia; [Medvedeva, Yulia A.] RAS, Biotechnol Res Ctr, Inst Bioengn, Moscow 119071, Russia; [Medvedeva, Yulia A.] RAS, Vavilov Inst Gen Genet, Moscow 119991, Russia; [Testa, Alison C.; Forrest, Alistair R. R.] Univ Western Australia, QEII Med Ctr, Harry Perkins Inst Med Res, Nedlands, WA 6009, Australia; [Testa, Alison C.; Forrest, Alistair R. R.] Univ Western Australia, Med Res Ctr, Nedlands, WA 6009, Australia; [Lipovich, Leonard] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Lipovich, Leonard] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; [Tang, Dave; Lassmann, Timo] Univ Western Australia, Telethon Kids Inst, 100 Roberts Rd, Subiaco, WA 6008, Australia; [Heutink, Peter] German Ctr Neurodegenerat Dis DZNE, D-72076 Tubingen, Germany; [Babina, Magda] Charite, Dept Dermatol & Allergy, D-10117 Berlin, Germany; [Wells, Christine A.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia; [Wells, Christine A.] Univ Melbourne, Fac Med, Dept Anat & Neurosci, Melbourne, Vic 3010, Australia; [Kojima, Soichi] RIKEN, CLST Div Biofunct Dynam Imaging, Wako, Saitama 3510198, Japan; [Nakamura, Yukio] RIKEN, BioResource Ctr, Cell Engn Div, Tsukuba, Ibaraki 3050074, Japan; [Nakamura, Yukio] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki 3058577, Japan; [Daub, Carsten O.] Karolinska Inst, Dept Biosci & Nutr, S-14183 Huddinge, Sweden; [Bertin, Nicolas] Human Longev Singapore Pte Ltd, Singapore, Singapore; [Djebali, Sarah] Univ Toulouse, INRA, INPT, ENVT,GenPhySE, Castanet Tolosan, France; [Mendez, Mickael] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada	RIKEN; RIKEN; National University of Singapore; University of Bristol; National University of Singapore; Massey University; National Institute of Advanced Industrial Science & Technology (AIST); RIKEN; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; King Abdullah University of Science & Technology; Research Center of Biotechnology RAS; Russian Academy of Sciences; Russian Academy of Sciences; Vavilov Institute of General Genetics; Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia; Wayne State University; Wayne State University; Telethon Kids Institute; University of Western Australia; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Queensland; University of Melbourne; RIKEN; RIKEN; University of Tsukuba; Karolinska Institutet; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; University of Toronto	Carninci, P; Forrest, ARR (corresponding author), RIKEN, Ctr Life Sci Technol, Div Gen Technol, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.; Carninci, P; Forrest, ARR (corresponding author), RIKEN, Omics Sci Ctr, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.; Forrest, ARR (corresponding author), Univ Western Australia, QEII Med Ctr, Harry Perkins Inst Med Res, Nedlands, WA 6009, Australia.; Forrest, ARR (corresponding author), Univ Western Australia, Med Res Ctr, Nedlands, WA 6009, Australia.	carninci@riken.jp; alistair.forrest@gmail.com	Itoh, Masayoshi/N-5363-2015; Kasukawa, Takeya/N-5070-2015; Rackham, Owen/AAM-3108-2021; Denisenko, Elena/AAG-1101-2021; Lipovich, Leonard/B-2355-2019; Severin, Jessica/AAQ-2723-2020; Lassmann, Timo/HCH-4313-2022; Djebali, Sarah/O-9817-2014; Abugessaisa, Imad/S-9275-2018; Medvedva, Yulia A/H-5947-2016; Tang, Dave/G-9670-2014; Nakamura, Yukio/A-5263-2016; Ramilowski, Jordan A./Z-3103-2019; Bertin, Nicolas/O-9602-2019; Carninci, Piero/K-1568-2014; Daub, Carsten O/A-7436-2010; Schmeier, Sebastian/D-4731-2011; Wells, Christine/A-5071-2010; Kawaji, Hideya/N-5116-2015; Bertin, Nicolas/C-3025-2008	Itoh, Masayoshi/0000-0002-1772-318X; Kasukawa, Takeya/0000-0001-5085-0802; Rackham, Owen/0000-0002-4390-0872; Denisenko, Elena/0000-0001-6358-526X; Lipovich, Leonard/0000-0002-0531-3570; Severin, Jessica/0000-0003-1274-208X; Lassmann, Timo/0000-0002-0138-2691; Djebali, Sarah/0000-0002-0599-1267; Abugessaisa, Imad/0000-0001-7458-801X; Medvedva, Yulia A/0000-0002-7587-1666; Tang, Dave/0000-0002-4790-9014; Nakamura, Yukio/0000-0001-8056-4946; Ramilowski, Jordan A./0000-0002-3156-6416; Carninci, Piero/0000-0001-7202-7243; Daub, Carsten O/0000-0002-3295-8729; Schmeier, Sebastian/0000-0002-3947-8226; Burroughs, A. Max/0000-0002-2229-8771; Heutink, Peter/0000-0001-5218-1737; Wells, Christine/0000-0003-3133-3628; Hon, Chung-Chau/0000-0002-3741-7577; Alam, Tanvir/0000-0001-7033-3693; Forrest, Alistair/0000-0003-4543-1675; Babina, Magda/0000-0002-4500-7615; Kawaji, Hideya/0000-0002-0575-0308; Alam, Tanvir/0000-0003-4844-0171; de Hoon, Michiel/0000-0003-0489-2352; Bertin, Nicolas/0000-0002-9835-9606	MEXT; MEXT, Japan; Cancer Research Trust; MACA Ride to Conquer Cancer; Australian Research Council [DP160101960]; National Human Genome Research Institute of the National Institutes of Health [U54HG007004]; Ministry of Economy and Competitiveness (MINECO) [BIO2011-26205]; Spanish Ministry of Economy and Competitiveness [SEV-2012-0208]; Russian Science Foundation [15-14-30002]; Biotechnology and Biological Sciences Research Council [BB/G022771/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA022453] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG007004] Funding Source: NIH RePORTER; BBSRC [BB/G022771/1] Funding Source: UKRI	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Cancer Research Trust; MACA Ride to Conquer Cancer; Australian Research Council(Australian Research Council); National Human Genome Research Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Ministry of Economy and Competitiveness (MINECO)(Spanish Government); Spanish Ministry of Economy and Competitiveness(Spanish Government); Russian Science Foundation(Russian Science Foundation (RSF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	FANTOM5 was made possible by research grants for the RIKEN Omics Science Center and the Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from the MEXT to Y.H. It was also supported by research grants for the RIKEN Preventive Medicine and Diagnosis Innovation Program (RIKEN PMI) to Y.H. and the RIKEN Centre for Life Science Technologies, Division of Genomic Technologies (RIKEN CLST (DGT)) from the MEXT, Japan. A.R.R.F. is supported by a Senior Cancer Research Fellowship from the Cancer Research Trust, the MACA Ride to Conquer Cancer and the Australian Research Council's Discovery Projects funding scheme (DP160101960). S.D. is supported by award number U54HG007004 from the National Human Genome Research Institute of the National Institutes of Health, funding from the Ministry of Economy and Competitiveness (MINECO) under grant number BIO2011-26205, and SEV-2012-0208 from the Spanish Ministry of Economy and Competitiveness. Y.A.M. is supported by the Russian Science Foundation, grant 15-14-30002. We thank RIKEN GeNAS for generation of the CAGE and RNA-seq libraries, the Netherlands Brain Bank for brain materials, the RIKEN BioResource Centre for providing cell lines and all members of the FANTOM5 consortium for discussions, in particular H. Ashoor, M. Frith, R. Guigo, A. Tanzer, E. Wood, H. Jia, K. Bailie, J. Harrow, E. Valen, R. Andersson, K. Vitting-Seerup, A. Sandelin, M. Taylor, J. Shin, R. Mori, C. Mungall and T. Meehan.	Abugessaisa I, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw105; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andersson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6336; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; Batut P, 2013, GENOME RES, V23, P169, DOI 10.1101/gr.139618.112; Bostock M, 2011, IEEE T VIS COMPUT GR, V17, P2301, DOI 10.1109/TVCG.2011.185; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Clark MB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000625; Core LJ, 2014, NAT GENET, V46, P1311, DOI 10.1038/ng.3142; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hasegawa A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-144; Holm H, 2010, NAT GENET, V42, P117, DOI 10.1038/ng.511; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kapusta A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003470; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Li MJ, 2016, NUCLEIC ACIDS RES, V44, pD869, DOI 10.1093/nar/gkv1317; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Meehan TF, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-6; Mungall CJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r5; Ng SY, 2012, EMBO J, V31, P522, DOI 10.1038/emboj.2011.459; Olexiouk V, 2016, NUCLEIC ACIDS RES, V44, pD324, DOI 10.1093/nar/gkv1175; Palazzo AF, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00002; Paralkar VR, 2016, MOL CELL, V62, P104, DOI 10.1016/j.molcel.2016.02.029; Patro R, 2014, NAT BIOTECHNOL, V32, P462, DOI 10.1038/nbt.2862; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Quek XC, 2015, NUCLEIC ACIDS RES, V43, pD168, DOI 10.1093/nar/gku988; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sakharkar Meena Kishore, 2004, In Silico Biology, V4, P387; Schmidt LH, 2011, J THORAC ONCOL, V6, P1984, DOI 10.1097/JTO.0b013e3182307eac; Severin J, 2014, NAT BIOTECHNOL, V32, P217, DOI 10.1038/nbt.2840; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Sloan CA, 2016, NUCLEIC ACIDS RES, V44, pD726, DOI 10.1093/nar/gkv1160; Smith JG, 2009, HEART RHYTHM, V6, P634, DOI 10.1016/j.hrthm.2009.02.022; Steijger T, 2013, NAT METHODS, V10, P1177, DOI [10.1038/nmeth.2714, 10.1038/NMETH.2714]; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Ulitsky I, 2016, NAT REV GENET, V17, P601, DOI 10.1038/nrg.2016.85; Villar D, 2015, CELL, V160, P554, DOI 10.1016/j.cell.2015.01.006; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Washietl S, 2011, RNA, V17, P578, DOI 10.1261/rna.2536111; Wheeler TJ, 2013, BIOINFORMATICS, V29, P2487, DOI 10.1093/bioinformatics/btt403; Wheeler TJ, 2013, NUCLEIC ACIDS RES, V41, pD70, DOI 10.1093/nar/gks1265; Xiang JF, 2014, CELL RES, V24, P513, DOI 10.1038/cr.2014.35	68	563	586	6	198	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2017	543	7644					199	+		10.1038/nature21374	http://dx.doi.org/10.1038/nature21374			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0GQ	28241135	Green Accepted, Green Submitted			2022-12-28	WOS:000395688700030
J	Nielsen, S; Larance, B; Lintzeris, N				Nielsen, Suzanne; Larance, Briony; Lintzeris, Nicholas			Opioid Agonist Treatment for Patients With Dependence on Prescription Opioids	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; GUIDELINE	CLINICAL QUESTION Are different opioid agonist treatments (eg, methadone vs buprenorphine) associated with differences in efficacy for treating prescription opioid dependence, and is long-term maintenance of opioid agonist treatment associated with differences in efficacy compared with opioid taper or psychological treatments alone? BOTTOM LINE For patients who are dependent on prescription opioids, long-term maintenance of opioid agonists is associated with less prescription opioid use and better adherence to medication and psychological therapies for opioid dependence compared with opioid taper or psychological treatments alone. Methadone maintenance was not associated with differences in therapeutic efficacy compared with buprenorphine maintenance treatment. Evidence quality was low to moderate.	[Nielsen, Suzanne; Larance, Briony] Univ New South Wales, Natl Drug & Alcohol Ctr, Sydney, NSW, Australia; [Lintzeris, Nicholas] Univ Sydney, Discipline Addict Med, Sydney, NSW, Australia	University of New South Wales Sydney; University of Sydney	Nielsen, S (corresponding author), Univ New South Wales, Natl Drug & Alcohol Res Ctr, 22-32 King St, Randwick, NSW 2031, Australia.	suzanne.nielsen@unsw.edu.au			Reckitt Benckiser (Indivior); Mundipharma	Reckitt Benckiser (Indivior); Mundipharma	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Nielsen, Larance, and Lintzeris have received grant funding from Reckitt Benckiser (Indivior), which had no conditions on the work or the way the findings were reported. Drs Larance and Lintzeris reported receiving grant funding from Mundipharma for postmarketing surveillance studies of reformulated OxyContin. Dr Lintzeris reported receiving honoraria from Pharmacomedia.	Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Han B, 2015, JAMA-J AM MED ASSOC, V314, P1468, DOI 10.1001/jama.2015.11859; Kampman K, 2015, J ADDICT MED, V9, P358, DOI 10.1097/ADM.0000000000000166; Nielsen S, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011117.pub2; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; US Center for Substance Abuse Treatment, 2004, CLIN GUID US BUPR TR, V40; Wood EA, GUIDELINE CLIN MANAG	7	44	44	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2017	317	9					967	968		10.1001/jama.2017.0001	http://dx.doi.org/10.1001/jama.2017.0001			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM8DM	28267837	Green Published			2022-12-28	WOS:000395541500016
J	Horton, R				Horton, Richard			Offline: Global health security-smart strategy or naive tactics?	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 4	2017	389	10072					892	892						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM4DL	28271828	Bronze			2022-12-28	WOS:000395263400010
J	Masters, K				Masters, Kate			PERSONAL VIEW My mum's care means that decisions not to resuscitate must now be discussed with patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												katemasters67@sky.com							0	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2017	356								j1084	10.1136/bmj.j1084	http://dx.doi.org/10.1136/bmj.j1084			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JW	28254811				2022-12-28	WOS:000395628700008
J	Chan, M; Elias, C; Fauci, A; Lake, A; Berkley, S				Chan, Margaret; Elias, Chris; Fauci, Anthony; Lake, Anthony; Berkley, Seth			Reaching everyone, everywhere with life-saving vaccines	LANCET			English	Editorial Material									[Chan, Margaret] WHO, Geneva, Switzerland; [Elias, Chris] Bill & Melinda Gates Fdn, Seattle, WA 98109 USA; [Fauci, Anthony] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Lake, Anthony] United Nations Childrens Fund, New York, NY USA; [Berkley, Seth] Gavi, Geneva, Switzerland	World Health Organization; Bill & Melinda Gates Foundation; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); UNICEF	Elias, C (corresponding author), Bill & Melinda Gates Fdn, Seattle, WA 98109 USA.				World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Ozawa S, 2016, HEALTH AFFAIR, V35, P199, DOI 10.1377/hlthaff.2015.1086; UNICEF WHO & World Bank Group., 2021, LEVELS TRENDS CHILD; WHO, 2016, 2016 MIDT REV GLOB V; WHO, 2010, GLOB HLTH LEAD LAUNC; WHO, 2016, WHO WELC GLOB HLTH F; WHO Regional Office for South-East Asia, 2016, WHO S E AS REG EL MA; World Health Organization, 2013, GLOB VACC ACT PLAN M; You DZ, 2010, LANCET, V376, P931, DOI 10.1016/S0140-6736(10)61429-8	8	9	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 25	2017	389	10071					777	779		10.1016/S0140-6736(17)30554-8	http://dx.doi.org/10.1016/S0140-6736(17)30554-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9UU	28248159				2022-12-28	WOS:000394966400011
J	Albert, N				Albert, Nikolai			Five years of specialised early intervention versus two years of specialised early intervention followed by three years of standard treatment for patients with a first episode psychosis: randomised, superiority, parallel group trial in Denmark (OPUS II) (vol 356, i6681, 2017)	BMJ-BRITISH MEDICAL JOURNAL			English	Correction													Albert, Nikolai/G-3452-2018	Albert, Nikolai/0000-0002-0685-9647				Albert N, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1015	1	17	19	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2017	356								j1015	10.1136/bmj.j1015	http://dx.doi.org/10.1136/bmj.j1015			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KZ	28235902	Green Published, hybrid			2022-12-28	WOS:000395631800004
J	Sharfstein, JM; Stebbins, M				Sharfstein, Joshua M.; Stebbins, Michael			Enhancing Transparency at the US Food and Drug Administration Moving Beyond the 21st Century Cures Act	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FDA		[Sharfstein, Joshua M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Stebbins, Michael] Laura & John Arnold Fdn, Houston, TX USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sharfstein, JM (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 615 N Wolfe St,W1033F, Baltimore, MD 21205 USA.	joshua.sharfstein@jhu.edu		Stebbins, Michael/0000-0003-0941-2805	Laura and John Arnold Foundation	Laura and John Arnold Foundation	The Blueprint for Transparency at the US Food and Drug Administration is supported by a grant from the Laura and John Arnold Foundation.	Davis AL, 2017, JAMA-J AM MED ASSOC, V317, P905, DOI 10.1001/jama.2017.0918; Kesselheim AS, 2017, JAMA-J AM MED ASSOC, V317, P581, DOI 10.1001/jama.2016.20640; Kesselheim AS, 2016, JAMA-J AM MED ASSOC, V316, P2357, DOI 10.1001/jama.2016.16437; Lurie P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2758; Pharmaceutical Research and Manufacturers of America (PhRMA), 2009, COMM FOOD DRUG ADM T; Sharfstein JM, FDA TRANSPARENCYWORK; Sharfstein JM, 2016, JAMA-J AM MED ASSOC, V315, P984, DOI 10.1001/jama.2016.1461	7	8	8	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2017	317	16					1621	1622		10.1001/jama.2017.2481	http://dx.doi.org/10.1001/jama.2017.2481			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET1FW	28288264				2022-12-28	WOS:000400014000008
J	Cao, C; Suttmeier, RP				Cao, Cong; Suttmeier, Richard P.			Challenges of S&T system reform in China	SCIENCE			English	Editorial Material									[Cao, Cong] Univ Nottingham Ningbo China, Fac Humanities & Social Sci, Ningbo 315100, Zhejiang, Peoples R China; [Cao, Cong] East China Normal Univ, Inst Innovat & Strateg Studies, Shanghai 200062, Peoples R China; [Suttmeier, Richard P.] Univ Oregon, Polit Sci, Eugene, OR 97403 USA	University of Nottingham Ningbo China; East China Normal University; University of Oregon	Suttmeier, RP (corresponding author), Univ Oregon, Polit Sci, Eugene, OR 97403 USA.	petesutt@uoregon.edu	Cao, Cong/U-1847-2019					Bai C. L., 2014, REFORM RES I WHICH W; Cao C, 2013, SCIENCE, V341, P460, DOI 10.1126/science.1234206; Cheung T.M, 2016, PLANNING INNOVATION; Ministry of Science and Technology P. R. China, 2016, OUTL NAT INN DRIV DE; Ministry of Science and Technology P. R. China, 2016, ZHONGH RENM GONGH CU; Neal Homer A., 2008, SPUTNIK US SCI POLIC, P25; Pokrovsky Vladimir, 2016, SCIENCEINSIDER; Poo MM, 2016, NATL SCI REV, V3, P382, DOI 10.1093/nsr/nww057; Springut M., 2011, CHINAS PROGRAMS SCI; Suttmeier RP, 2006, SCIENCE, V312, P58, DOI 10.1126/science.1122280; Sutton R. S., 2015, J DIALECT NAT, V17, P1; The State Science and Technology Commission International Development Research Center, 1997, DEC REF SCI TECHN PO; Xi J., 2015, CENTR PART MASS ORG	13	19	21	3	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI		1019	1021		10.1126/science.aal2515	http://dx.doi.org/10.1126/science.aal2515			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9VY	28280166				2022-12-28	WOS:000396348900015
J	Johnson, TE; Brown, M; Gardiner, NJ; Kirkland, CL; Smithies, RH				Johnson, Tim E.; Brown, Michael; Gardiner, Nicholas J.; Kirkland, Christopher L.; Smithies, R. Hugh			Earth's first stable continents did not form by subduction	NATURE			English	Article							MINERAL EQUILIBRIA CALCULATIONS; ARCHEAN CRUST; SYSTEM K2O-FEO-MGO-AL2O3-SIO2-H2O-TIO2-FE2O3; MANTLE; DELAMINATION; LITHOSPHERE; GENESIS; GROWTH; AMPHIBOLITE; AUSTRALIA	The geodynamic environment in which Earth's first continents formed and were stabilized remains controversial(1). Most exposed continental crust that can be dated back to the Archaean eon (4 billion to 2.5 billion years ago) comprises tonalite-trondhjemite-granodiorite rocks (TTGs) that were formed through partial melting of hydrated low-magnesium basaltic rocks(2); notably, these TTGs have 'arc-like' signatures of trace elements and thus resemble the continental crust produced in modern subduction settings(3). In the East Pilbara Terrane, Western Australia, low-magnesium basalts of the Coucal Formation at the base of the Pilbara Supergroup have trace-element compositions that are consistent with these being source rocks for TTGs. These basalts may be the remnants of a thick (more than 35 kilometres thick), ancient (more than 3.5 billion years old) basaltic crust(4,5) that is predicted to have existed if Archaean mantle temperatures were much hotter than today's(6-8). Here, using phase equilibria modelling of the Coucal basalts, we confirm their suitability as TTG 'parents', and suggest that TTGs were produced by around 20 per cent to 30 per cent melting of the Coucal basalts along high geothermal gradients (of more than 700 degrees Celsius per gigapascal). We also analyse the trace-element composition of the Coucal basalts, and propose that these rocks were themselves derived from an earlier generation of high-magnesium basaltic rocks, suggesting that the arc-like signature in Archaean TTGs was inherited from an ancestral source lineage. This protracted, multistage process for the production and stabilization of the first continents-coupled with the high geothermal gradients-is incompatible with modern-style plate tectonics, and favours instead the formation of TTGs near the base of thick, plateau-like basaltic crust(9). Thus subduction was not required to produce TTGs in the early Archaean eon.	[Johnson, Tim E.; Gardiner, Nicholas J.; Kirkland, Christopher L.] Curtin Univ, Dept Appl Geol, Inst Geosci Res TIGeR, Ctr Explorat Targeting Curtin Node,Australian Res, GPO Box U1987, Perth, WA 6845, Australia; [Brown, Michael] Univ Maryland, Dept Geol, Lab Crustal Petrol, College Pk, MD 20742 USA; [Smithies, R. Hugh] Geol Survey Western Australia, 100 Plain St, East Perth, WA 6004, Australia	Curtin University; University System of Maryland; University of Maryland College Park; Geological Survey of Western Australia	Johnson, TE (corresponding author), Curtin Univ, Dept Appl Geol, Inst Geosci Res TIGeR, Ctr Explorat Targeting Curtin Node,Australian Res, GPO Box U1987, Perth, WA 6845, Australia.	tim.johnson@curtin.edu.au	Johnson, Tim/M-6009-2017; Kirkland, Christopher/S-3305-2016	Johnson, Tim/0000-0001-8704-4396; Kirkland, Christopher/0000-0003-3367-8961; Gardiner, Nicholas/0000-0003-3465-9295	Institute of Geoscience Research (TIGeR) at Curtin University	Institute of Geoscience Research (TIGeR) at Curtin University	We acknowledge financial support from The Institute of Geoscience Research (TIGeR) at Curtin University. R.H.S. publishes with the permission of the Executive Director, Geological Survey of Western Australia.	Bedard JH, 2006, GEOCHIM COSMOCHIM AC, V70, P1188, DOI 10.1016/j.gca.2005.11.008; Berry AJ, 2008, NATURE, V455, P960, DOI 10.1038/nature07377; Boehnke P, 2013, CHEM GEOL, V351, P324, DOI 10.1016/j.chemgeo.2013.05.028; Brown M, 2014, GEOSCI FRONT, V5, P553, DOI 10.1016/j.gsf.2014.02.005; Condie K. C., 2008, DID PLATE TECTONICS; Condie KC, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000333; Foley S, 2002, NATURE, V417, P837, DOI 10.1038/nature00799; Green ECR, 2016, J METAMORPH GEOL, V34, P845, DOI 10.1111/jmg.12211; Herzberg C, 2012, LITHOS, V149, P4, DOI 10.1016/j.lithos.2012.01.010; Herzberg C, 2010, EARTH PLANET SC LETT, V292, P79, DOI 10.1016/j.epsl.2010.01.022; Holland T, 2003, CONTRIB MINERAL PETR, V145, P492, DOI 10.1007/s00410-003-0464-z; Holland TJB, 2011, J METAMORPH GEOL, V29, P333, DOI 10.1111/j.1525-1314.2010.00923.x; Johnson TE, 2014, NAT GEOSCI, V7, P47, DOI [10.1038/NGEO2019, 10.1038/ngeo2019]; Kerrich R, 1999, LITHOS, V46, P163, DOI 10.1016/S0024-4937(98)00059-0; Korenaga J, 2008, REV GEOPHYS, V46, DOI 10.1029/2007RG000241; Martin H, 2002, GEOLOGY, V30, P319, DOI 10.1130/0091-7613(2002)030<0319:SCITTG>2.0.CO;2; Martin H., 1994, DEV PRECAMBRIAN GEOL, P205, DOI [10.1016/S0166-2635(08)70224-X, DOI 10.1016/S0166-2635(08)70224-X, DOI 10.1016/50166-2635]; MCKENZIE D, 1991, J PETROL, V32, P1021, DOI 10.1093/petrology/32.5.1021; Moyen JF, 2006, GEOPHYS MONOGR SER, V164, P149, DOI 10.1029/164GM11; Moyen JF, 2011, LITHOS, V123, P21, DOI 10.1016/j.lithos.2010.09.015; POWELL R, 1988, J METAMORPH GEOL, V6, P173, DOI 10.1111/j.1525-1314.1988.tb00415.x; Rapp RP, 2003, NATURE, V425, P605, DOI 10.1038/nature02031; RAPP RP, 1995, J PETROL, V36, P891, DOI 10.1093/petrology/36.4.891; Sizova E, 2015, PRECAMBRIAN RES, V271, P198, DOI 10.1016/j.precamres.2015.10.005; Smithies RH, 2009, EARTH PLANET SC LETT, V281, P298, DOI 10.1016/j.epsl.2009.03.003; Smithies RH, 2000, EARTH PLANET SC LETT, V182, P115, DOI 10.1016/S0012-821X(00)00236-3; STIMAC J, 1994, CHEM GEOL, V117, P313, DOI 10.1016/0009-2541(94)90134-1; Sun S.-S., 1989, GEOLOGICAL SOC LONDO, V42, P323, DOI [10.1144/GSL.SP.1989.042.01.19, DOI 10.1144/GSL.SP.1989.042.01.19]; Van Kranendonk MJ, 2015, GEOL SOC SPEC PUBL, V389, P83, DOI 10.1144/SP389.12; Van Kranendonk MJ, 2002, ECON GEOL BULL SOC, V97, P695; White RW, 2014, J METAMORPH GEOL, V32, P261, DOI 10.1111/jmg.12071; White RW, 2000, J METAMORPH GEOL, V18, P497, DOI 10.1046/j.1525-1314.2000.00269.x; White RW, 2002, J METAMORPH GEOL, V20, P41, DOI 10.1046/j.0263-4929.2001.00349.x; Willbold M, 2009, EARTH PLANET SC LETT, V279, P44, DOI 10.1016/j.epsl.2008.12.029; Xiong XL, 2011, GEOCHIM COSMOCHIM AC, V75, P1673, DOI 10.1016/j.gca.2010.06.039; Zegers TE, 2001, GEOLOGY, V29, P1083, DOI 10.1130/0091-7613(2001)029<1083:MACFBC>2.0.CO;2	36	227	233	4	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2017	543	7644					239	+		10.1038/nature21383	http://dx.doi.org/10.1038/nature21383			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0GQ	28241147				2022-12-28	WOS:000395688700038
J	Guirguis-Blake, JM; Henderson, JT; Perdue, LA				Guirguis-Blake, Janelle M.; Henderson, Jillian T.; Perdue, Leslie A.			Periodic Screening Pelvic Examination Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-PRACTICE GUIDELINE; RISK ADULT WOMEN; OVARIAN-CANCER; BACTERIAL VAGINOSIS; ASYMPTOMATIC WOMEN; RECOMMENDATION STATEMENT; BIMANUAL EXAMINATION; VAGINAL EXAMINATION; AMERICAN-COLLEGE; SEXUAL VIOLENCE	IMPORTANCE Recent changes in the periodicity of cervical cancer screening have led to questions about the role of screening pelvic examinations among asymptomatic women. OBJECTIVE To systematically review literature on health benefits, accuracy, and harms of the screening pelvic examination for gynecologic conditions for the US Preventive Services Task Force (USPSTF). DATA SOURCES MEDLINE, PubMed, and Cochrane Central Register of Controlled Trials for relevant English-language studies published through January 13, 2016, with surveillance through August 3, 2016. STUDY SELECTION Two reviewers independently screened abstracts and studies. The search yielded 8678 unique citations; 316 full-text articles were reviewed, and 9 studies including 27 630 patients met inclusion criteria. DATA EXTRACTION AND SYNTHESIS Two reviewers rated study quality using USPSTF criteria. MAIN OUTCOMES AND MEASURES Morbidity; mortality; diagnostic accuracy for any gynecologic cancer or condition except cervical cancer, gonorrhea, and chlamydia, which are covered by other USPSTF screening recommendations; harms (false-positive rates, false-negative rates, surgery rates). RESULTS No trials examined the effectiveness of the pelvic examination in reducing all-cause mortality, reducing cancer-and disease-specific morbidity and mortality, or improving quality of life. Eight studies reported accuracy for the screening pelvic examination: ovarian cancer (4 studies; n = 26 432), bacterial vaginosis (2 studies; n = 930), trichomoniasis (1 study; n = 779), and genital herpes (1 study; n = 779). In the 4 ovarian cancer screening studies, low prevalence of ovarian cancer consistently resulted in low positive predictive values (PPVs) and false-positive rates, with a lack of precision in accuracy estimates (sensitivity range, 0%-100%; specificity range, 91%-99%; PPV range, 0%-3.6%; negative predictive value [NPV] range, >= 99%). Each diagnostic accuracy study for bacterial vaginosis, trichomoniasis, and genital herpes was performed in a high-prevalence population with substantial proportions of symptomatic patients and reported accuracy characteristics for individual physical examination findings (bacterial vaginosis, homogeneous discharge: sensitivity range, 69%-79%; specificity range, 54%-97%; PPV range, 52%-95%; NPV range, 79%-80%; herpes simplex virus, vulvar ulcerations: sensitivity, 20%; specificity, 98%; PPV, 88%; NPV, 57%; trichomoniasis, colpitis macularis: sensitivity, 2%; specificity, 100%; PPV, 100%; NPV, 85%). Surgery rates resulting from an abnormal screening pelvic examination for ovarian cancer ranged from 5% to 36% at 1 year, with the largest study reporting an 11% surgery rate and 1% complication rate within 1 year of a screening pelvic examination with abnormal findings. CONCLUSIONS AND RELEVANCE No direct evidence was identified for overall benefits and harms of the pelvic examination as a 1-time or periodic screening test. Limited evidence was identified regarding the diagnostic accuracy and harms of routine screening pelvic examinations in asymptomatic primary care populations.	[Guirguis-Blake, Janelle M.] Univ Washington, Dept Family Med, Tacoma, WA USA; [Guirguis-Blake, Janelle M.; Henderson, Jillian T.; Perdue, Leslie A.] Kaiser Permanente, Ctr Hlth Res, Kaiser Permanente Res Affiliates Evidence Based P, Portland, OR USA	University of Washington; University of Washington Tacoma; Kaiser Permanente	Guirguis-Blake, JM (corresponding author), Univ Washington, Dept Family Med, Kaiser Permanente Res Affiliates EPC, 521 Martin Luther King Jr Way, Tacoma, WA 98405 USA.	jguirgui@u.washington.edu			Agency for Healthcare Research and Quality (AHRQ)	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This research was funded by the Agency for Healthcare Research and Quality (AHRQ) under a contract to support the USPSTF.	Adonakis GL, 1996, EUR J OBSTET GYN R B, V65, P221, DOI 10.1016/0301-2115(95)02369-0; [Anonymous], 2009, Obstet Gynecol, V114, P1409, DOI 10.1097/AOG.0b013e3181c6f8a4; [Anonymous], 2011, CLIN PREV SERV WOM C; Bates C, 2014, ANN INTERN MED, V161, P925, DOI 10.7326/L14-5035-2; Bloomfield HE, 2014, ANN INTERN MED, V161, P46, DOI 10.7326/M13-2881; Bump RC, 2013, AM J OBSTET GYNECOL, V208, P91, DOI 10.1016/j.ajog.2012.11.018; Burns RB, 2015, ANN INTERN MED, V163, P537, DOI 10.7326/M15-1220; Buys SS, 2005, AM J OBSTET GYNECOL, V193, P1630, DOI 10.1016/j.ajog.2005.05.005; CLANCY CM, 1992, JAMA-J AM MED ASSOC, V268, P1918, DOI 10.1001/jama.268.14.1918; Committee on Practice BulletinsGynecology, 2012, Obstet Gynecol, V120, P1222, DOI http://10.1097/AOG.0b013e318277c92a; Conry JA, 2015, OBSTET GYNECOL, V126, P697, DOI 10.1097/AOG.0000000000001055; Doroudi M, 2017, J MED SCREEN, V24, P220, DOI 10.1177/0969141316680381; Ebell MH, 2015, AM J PREV MED, V48, P350, DOI 10.1016/j.amepre.2014.10.007; ESCHENBACH DA, 1988, AM J OBSTET GYNECOL, V158, P819, DOI 10.1016/0002-9378(88)90078-6; GROVER S, 1995, INT J GYNECOL CANCER, V5, P291, DOI 10.1046/j.1525-1438.1995.05040291.x; Gutman RE, 2005, OBSTET GYNECOL, V105, P551, DOI 10.1097/01.AOG.0000145752.97999.67; Harper C, 2001, FAM PLANN PERSPECT, V33, P13, DOI 10.2307/2673737; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Henderson JT, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.015; Henderson JT, 2005, MED CARE, V43, P826, DOI 10.1097/01.mlr.0000170422.73033.eb; Henderson JT, 2002, WOMEN HEALTH ISS, V12, P138, DOI 10.1016/S1049-3867(02)00134-2; Herman Cheryl, 2006, Virtual Mentor, V8, P34, DOI 10.1001/virtualmentor.2006.8.1.cprl1-0601; Herman CR, 2002, AM J ROENTGENOL, V179, P825, DOI 10.2214/ajr.179.4.1790825; Howlader N, 2015, SEER CANC STAT REV 1; JACOBS I, 1988, LANCET, V1, P268; Jennings JC, 2014, ANN INTERN MED, V161, P924, DOI [10.7326/L14-5034, 10.7326/L14-5034-2]; KOUTSKY LA, 1992, NEW ENGL J MED, V326, P1533, DOI 10.1056/NEJM199206043262305; LeFevre ML, 2014, ANN INTERN MED, V161, P902, DOI 10.7326/M14-1981; Metz S, 2014, ANN INTERN MED, V161, P925, DOI 10.7326/L14-5035; Miller JW, 2014, PREV MED, V69, P37, DOI 10.1016/j.ypmed.2014.07.009; Moyer VA, 2013, ANN INTERN MED, V159, P856, DOI 10.7326/0003-4819-159-12-201312170-00016; Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424; Padilla LA, 2000, OBSTET GYNECOL, V96, P593, DOI 10.1016/S0029-7844(00)00970-4; Padilla LA, 2005, INT J GYNECOL OBSTET, V88, P84, DOI 10.1016/j.ijgo.2004.09.015; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Qaseem A, 2014, ANN INTERN MED, V161, P67, DOI 10.7326/M14-0701; Saraiya Mona, 2015, Evid Based Med, V20, P31, DOI 10.1136/ebmed-2014-110081; Sawaya GF, 2014, ANN INTERN MED, V161, P78, DOI 10.7326/M14-1205; Sawaya GF, 2011, ARCH INTERN MED, V171, P2054, DOI 10.1001/archinternmed.2011.567; SPIEGEL CA, 1983, J CLIN MICROBIOL, V18, P170, DOI 10.1128/JCM.18.1.170-177.1983; Stormo AR, 2014, JAMA INTERN MED, V174, P1512, DOI 10.1001/jamainternmed.2014.3003; Stormo AR, 2012, PREV MED, V54, P415, DOI 10.1016/j.ypmed.2012.03.012; Swahnberg K, 2011, EUR J OBSTET GYN R B, V157, P200, DOI 10.1016/j.ejogrb.2011.02.025; Tayal VS, 2008, J ULTRAS MED, V27, P1171, DOI 10.7863/jum.2008.27.8.1171; Tiemstra JD, 2011, J AM BOARD FAM MED, V24, P290, DOI 10.3122/jabfm.2011.03.100209; Trikalinos, 2012, 2 ACM SIGHIT INT HLT, P819, DOI [DOI 10.1145/2110363, DOI 10.1145/2110363.2110464]; Ueland FR, 2005, GYNECOL ONCOL, V99, P400, DOI 10.1016/j.ygyno.2005.06.030; Weitlauf JC, 2010, J WOMENS HEALTH, V19, P1271, DOI 10.1089/jwh.2009.1673; Weitlauf JC, 2008, OBSTET GYNECOL, V112, P1343, DOI 10.1097/AOG.0b013e31818e4678; Wells G., NEWCASTLE OTTAWA SCA; Westhoff CL, 2011, J WOMENS HEALTH, V20, P5, DOI 10.1089/jwh.2010.2349; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; WOLNERHANSSEN P, 1989, JAMA-J AM MED ASSOC, V261, P571	54	17	18	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2017	317	9					954	966		10.1001/jama.2016.12819	http://dx.doi.org/10.1001/jama.2016.12819			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM8DM	28267861				2022-12-28	WOS:000395541500015
J	Grady, C; Cummings, SR; Rowbotham, MC; McConnell, MV; Ashley, EA; Kang, G				Grady, Christine; Cummings, Steven R.; Rowbotham, Michael C.; McConnell, Michael V.; Ashley, Euan A.; Kang, Gagandeep			The Changing Face of Informed Consent	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PERSONAL HEALTH INFORMATION; BIOLOGICAL SAMPLES; CLINICAL-TRIALS; RESEARCH PARTICIPANTS; PRECISION MEDICINE; PUBLIC-ATTITUDES; RESEARCH ETHICS; BIG DATA; BIOBANK; MULTIMEDIA		[Grady, Christine; Cummings, Steven R.; Rowbotham, Michael C.; McConnell, Michael V.; Ashley, Euan A.; Kang, Gagandeep] NIH, Dept Bioeth, Ctr Clin, Bldg 10,1C118, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Grady, C (corresponding author), NIH, Dept Bioeth, Ctr Clin, Bldg 10,1C118, Bethesda, MD 20892 USA.	cgrady@nih.gov	Rowbotham, Michael/AAA-3606-2019	McConnell, Michael/0000-0001-8743-0932				[Anonymous], SOP AUD VIS REC INF; [Anonymous], ALL RES PROGR; [Anonymous], 2015, GUID IND US EL INF C; Antman EM, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002810; Ashley EA, 2015, JAMA-J AM MED ASSOC, V313, P2119, DOI 10.1001/jama.2015.3595; Bakos Y, 2014, J LEGAL STUD, V43, P1, DOI 10.1086/674424; Ballantyne A, 2015, AM J BIOETHICS, V15, P65, DOI 10.1080/15265161.2015.1062171; Bent S, 2014, J AM ACAD CHILD PSY, V53, P658, DOI 10.1016/j.jaac.2014.01.018; Bhattacharjee Y, 2013, SCIENCE, V341, P327, DOI 10.1126/science.341.6144.327; Boren Zachary Davies, 2014, INDEPENDENT; Botkin JR, 2014, J COMMUN GENET, V5, P205, DOI 10.1007/s12687-013-0175-8; Boutin NT, 2016, J PERS MED, V6, DOI 10.3390/jpm6020017; Boyd D, 2012, INFORM COMMUN SOC, V15, P662, DOI 10.1080/1369118X.2012.678878; Brooks GC, 2015, CIRC-HEART FAIL, V8, P905, DOI 10.1161/CIRCHEARTFAILURE.115.002062; Brothers KB, 2011, AM J MED GENET A, V155A, P2982, DOI 10.1002/ajmg.a.34304; CDSCO, 2014, GUID AUD VIS REC INF; Chauhan Ramesh Chand, 2015, Perspect Clin Res, V6, P159, DOI 10.4103/2229-3485.159941; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Dorsey ER, 2017, ACAD MED, V92, P157, DOI 10.1097/ACM.0000000000001205; Dorsey ER, 2015, JAMA NEUROL, V72, P582, DOI 10.1001/jamaneurol.2014.4524; El Emam K, 2013, AM J BIOETHICS, V13, P42, DOI 10.1080/15265161.2013.767958; ERICSSON, 2016, ERICSSON MOBILITY RE; Faden R., 1986, HIST THEORY INFORM C; Faden RR, 2013, HASTINGS CENT REP, V43, pS16, DOI 10.1002/hast.134; FDA, 2016, US EL INF CONS CLIN; FDA, 2015, MOB MED APPL GUID IN; FDA, 2016, GEN WELLN POL LOW RI; Festinger DS, 2010, ETHICS BEHAV, V20, P387, DOI 10.1080/10508422.2010.491767; Filkins BL, 2016, AM J TRANSL RES, V8, P1560; Flory J, 2004, JAMA-J AM MED ASSOC, V292, P1593, DOI 10.1001/jama.292.13.1593; Goel V, 2014, NY TIMES; Grady C, 2015, AM J BIOETHICS, V15, P34, DOI 10.1080/15265161.2015.1062162; Grady C, 2015, NEW ENGL J MED, V372, P855, DOI 10.1056/NEJMra1411250; Grande D, 2014, ANN INTERN MED, V161, P855, DOI 10.7326/M14-1118; Hockley WE, 2008, MEM COGNITION, V36, P1351, DOI 10.3758/MC.36.7.1351; International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 1996, GUID GOOD CLIN PRACT; Jacobs BP, 2005, MEDICINE, V84, P197, DOI 10.1097/01.md.0000172299.72364.95; Karlson EW, 2016, J PERS MED, V6, DOI 10.3390/jpm6010002; Kaufman D, 2012, GENET MED, V14, P787, DOI 10.1038/gim.2012.45; Kaye J, 2015, EUR J HUM GENET, V23, P141, DOI 10.1038/ejhg.2014.71; Kim SYH, 2014, NEW ENGL J MED, V370, P769, DOI 10.1056/NEJMhle1312508; Kulkarni Niranjan G, 2014, Perspect Clin Res, V5, P6, DOI 10.4103/2229-3485.124547; Lentz J, 2016, CONTEMP CLIN TRIALS, V49, P65, DOI 10.1016/j.cct.2016.06.005; Lo B, 2016, NEW ENGL J MED, V374, P1205, DOI 10.1056/NEJMp1600511; Lynch HF, 2016, HASTINGS CENT REP, V46, P4, DOI 10.1002/hast.528; Mascalzoni D, 2015, EUR J HUM GENET, V23, P721, DOI 10.1038/ejhg.2014.197; McCaughey T, 2016, CELL STEM CELL, V18, P307, DOI 10.1016/j.stem.2016.02.006; McConnell MV, 2017, JAMA CARDIOL, V2, P67, DOI 10.1001/jamacardio.2016.4395; McKinney RE, 2015, CLIN TRIALS, V12, P494, DOI 10.1177/1740774515597688; Meeker M., 2016, INT TRENDS 2016 COD; Mega JL, 2014, JAMA-J AM MED ASSOC, V312, P1969, DOI 10.1001/jama.2014.15224; Meslin EM, 2013, INT J MED INFORM, V82, P1136, DOI 10.1016/j.ijmedinf.2013.08.010; Mikal J, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0105-5; Miller F., 2010, ETHICS CONSENT THEOR; Miller FG, 2011, KENNEDY INST ETHIC J, V21, P201, DOI 10.1353/ken.2011.0013; Moodley K, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-4; Mostert M, 2016, EUR J HUM GENET, V24, P956, DOI 10.1038/ejhg.2015.239; Newport F., 2015, MOST US SMARTPHONE; Nishimura A, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-28; Orri M, 2014, CONTEMP CLIN TRIALS, V38, P190, DOI 10.1016/j.cct.2014.04.009; Plaut VC, 2012, LAW HUMAN BEHAV, V36, P293, DOI 10.1037/h0093969; Pullman D, 2012, GENET MED, V14, P229, DOI [10.1038/GIM.0b013e31822e578f, 10.1038/gim.0b013e31822e578f]; Regalado, 2016, MIT TECHNOL REV; Riordan F, 2015, INT J MED INFORM, V84, P237, DOI 10.1016/j.ijmedinf.2015.01.008; Rothstein MA, 2015, J LAW MED ETHICS, V43, P897, DOI 10.1111/jlme.12327; Rothwell E, 2014, J EMPIR RES HUM RES, V9, P1, DOI 10.1177/1556264614552627; Rowbotham MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058603; Sage Bionetworks, PART CTR CONS TOOLK; Schreiner MS, 2014, NEW ENGL J MED, V370, P1958, DOI 10.1056/NEJMc1403310; Simon CM, 2016, GENET MED, V18, P57, DOI 10.1038/gim.2015.33; Simon CM, 2014, BIOPRESERV BIOBANK, V12, P423, DOI 10.1089/bio.2014.0045; Simon CM, 2011, GENET MED, V13, P821, DOI 10.1097/GIM.0b013e31821d2f88; Simon JR, 2014, ANN INTERN MED, V161, P917, DOI 10.7326/M14-1669; Tait AR, 2015, JAMA-J AM MED ASSOC, V313, P463, DOI 10.1001/jama.2014.17122; Tanner CM, 2014, MOVEMENT DISORD, V29, P743, DOI 10.1002/mds.25814; Tomlinson T, 2015, JAMA-J AM MED ASSOC, V313, P417, DOI 10.1001/jama.2014.16363; Treweek S, 2009, J HEALTH SERV RES PO, V14, P13, DOI 10.1258/jhsrp.2008.008016; Trinidad Susan Brown, 2012, AJOB Prim Res, V3, P3; Vanaken H, 2016, ECONSENT STUDY PROVI; Vayena E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004798; Verma IM, 2014, P NATL ACAD SCI USA, V111, P10779, DOI 10.1073/pnas.1412469111; Warriner AH, 2016, CONT CLIN TRIAL COMM, V3, P32, DOI 10.1016/j.conctc.2016.02.003; Wee R, 2013, J PRIM HEALTH CARE, V5, P341, DOI 10.1071/HC13341; Wendler D, 2006, BMJ-BRIT MED J, V332, P544, DOI 10.1136/bmj.332.7540.544; Wilson LS, 2015, HEALTHC INFORM RES, V21, P213, DOI 10.4258/hir.2015.21.4.213; Zimmer M., 2016, WIRED	86	106	111	1	72	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2017	376	9					856	867		10.1056/NEJMra1603773	http://dx.doi.org/10.1056/NEJMra1603773			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9JK	28249147				2022-12-28	WOS:000395627500009
J	Abbasi, J				Abbasi, Jennifer			VHA Initiative Reduces Risky Opioid Prescribing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2017	317	8					797	797		10.1001/jama.2017.1087	http://dx.doi.org/10.1001/jama.2017.1087			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM7PW	28245307				2022-12-28	WOS:000395505600005
J	Quigley, A; Godfrey, E				Quigley, Andrea; Godfrey, Edmund			Kenneth Michael Mackenzie OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2017	356								j957	10.1136/bmj.j957	http://dx.doi.org/10.1136/bmj.j957			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KZ	28235770				2022-12-28	WOS:000395631800013
J	Barr, J				Barr, Justin			Battle of the Bulge: Aortic Aneurysm Management From Early Modernity to the Present	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							COMPLETE OCCLUSION; BLOOD-VESSELS; SURGERY; REPAIR	For centuries, physicians have recognized aortic aneurysms as an acute threat to life. Therapeutic approaches to the disease began in the 18th century when leading physicians, such as Rene Laennec and Antonio Valsalva, applied research on circulation and blood coagulation to devise whole-body fasting and bleeding regimens to prevent rupture. After John Hunter's success in ligating arteries to treat peripheral aneurysms, surgeons attempted analogous operations on the aorta, but even the renowned Sir Astley Cooper and William Halsted met with disastrous results. Other clinicians tried various methods of creating intraluminal clots, including the application of such new technologies as electricity and plastic. Vessel repair techniques, pioneered by Alexis Carrel and others in the 20th century, eventually provided a reliably effective treatment. In the past few decades, minimally invasive methods that approach aneurysms endovascularly through small groin incisions have been adopted. A successful 2005 congressional campaign to fund screening for aortic aneurysms brought the disease to national attention and symbolizes current confidence in curing it. Drawing on various published and unpublished sources, this paper elucidates the development of specific treatments for aortic aneurysms over time and more broadly addresses how medicine and surgery apply the knowledge and technology available in particular eras to treat a specific, identifiable, and lethal disease. Examining the evolution of these therapeutic efforts unveils broader trends in the history of medicine. This allows aortic aneurysms to serve as a case study for exploring shifting philosophies in medical history.	[Barr, Justin] Duke Univ, Med Ctr, 10 Duke Med Circle,POB 3443, Durham, NC 27710 USA	Duke University	Barr, J (corresponding author), Duke Univ, Med Ctr, 10 Duke Med Circle,POB 3443, Durham, NC 27710 USA.	justin.barr@duke.edu			Yale University; U.S. Army Heritage and Education Center; Society for the History of Navy Medicine; ABC-CLIO; National Library of Medicine	Yale University; U.S. Army Heritage and Education Center; Society for the History of Navy Medicine; ABC-CLIO; National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Dr. Barr reports grants from Yale University, U.S. Army Heritage and Education Center, The Society for the History of Navy Medicine, and ABC-CLIO; other (honorarium for lecture) from Kansas University Medical Center; and applications for grants from National Library of Medicine during the conduct of the study. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?ms Num=M16-2081.	Anderson OW, 1975, BLUE CROSS 1929 ACCO; Bacilli G., 1878, B ACAD MED, P18; Barr J., 2014, SURG REPAIR ARTERIES; Barr J, 2014, J VASC SURG, V60, P260, DOI 10.1016/j.jvs.2014.04.056; Bean WB, 1950, W OSLER APHORISMS HI; Bellingham OB, 1852, MED PRESS, V27, P81; BLAKEMORE AH, 1954, ANN SURG, V140, P324, DOI 10.1097/00000658-195409000-00008; Bowman A. K., 1942, LIFE TEACHING W MACE; Brandt AM., 2007, CIGARETTE CENTURY RI; Bud Robert, 2007, PENICILLIN TRIUMPH T; Bylebyl J J, 1979, Henry E Sigerist Suppl Bull Hist Med, P28; Bylebyl JJ, 1972, B HIST MED, V47, P427; Carrel A, 1907, B JOHNS HOPKINS HOSP, V18, P18; Cartwright FF, 1968, DEV MODERN SURG; Castro JC, 2011, GAC MED MEX, V147, P74; CHILD CG, 1953, SURG GYNECOL OBSTET, V96, P375; Cooper A., 1818, SURG ESSAYS, P111; Cooper A, 1827, LECT A COOPER PRINCI; CREECH O, 1966, ANN SURG, V164, P935, DOI 10.1097/00000658-196612000-00001; DETAKATS G, 1952, AMA ARCH SURG, V64, P307, DOI 10.1001/archsurg.1952.01260010321006; Dua A, 2014, J VASC SURG, V59, P1512, DOI 10.1016/j.jvs.2014.01.007; DUBOST C, 1952, AMA ARCH SURG, V64, P405, DOI 10.1001/archsurg.1952.01260010419018; Duffin Jacalyn, 1998, SEE BETTER EYE LIFE; Eck NV, 1877, VOEN MED J, V130, P1; Elkin DC, 1940, ANN SURG, V112, P895, DOI 10.1097/00000658-194011000-00004; Erichsen JE, 1844, OBSERVATIONS ANEURIS; ESTES JE, 1950, CIRCULATION, V2, P258, DOI 10.1161/01.CIR.2.2.258; Finney JMT, 1912, ANN SURG, V55, P661, DOI 10.1097/00000658-191205000-00002; Futcher TB, 1900, J AMER MED ASSOC, V34, P204; Fye, 2015, CARING HEART MAYO CL; Garland HG, 1932, J PATHOL BACTERIOL, V35, P333, DOI 10.1002/path.1700350304; Ghaliongui P, 1987, EBERS PAPYRUS NEW EN; GROSS RE, 1951, ANN SURG, V134, P753, DOI 10.1097/00000658-195113440-00020; Halsted W., 1905, B JOHNS HOPKINS HOSP, V16, P346; Halsted WS, 1909, J EXP MED, V11, P373, DOI 10.1084/jem.11.2.373; Halsted WS, 1906, J AMER MED ASSOC, V47, P2147; Harris C.R.S., 1973, HEART VASCULAR SYSTE; Harvey WA, 1978, EXERCITATIO ANATOMIC; Home E, 1793, T SOC IMPROVEMENT ME, P143; Hunner GL, 1900, B JOHNS HOPKINS HOSP, V11, P263; Jassinowsky A, 1891, ARCH KLIN CHIR, V42, P816; Lancisi GM, 1952, ANEURYSMATIBUS OPUS; Lucke B, 1921, J AMER MED ASSOC, V77, P935; Ludmerer KM., 2015, LET ME HEAL OPPORTUN; Macewen W, 1890, Br Med J, V2, P1164; Macewen W, 1890, LANCET, V2, P1086; Malas MB, 2010, SEMIN VASC SURG, V23, P165, DOI 10.1053/j.semvascsurg.2010.05.009; Matas R, 1900, T S SURG ASS, V13, P272; McGinigle KL, 2015, J VASC SURG, V61, p122S, DOI 10.1016/j.jvs.2015.04.234; Moore C H, 1864, Med Chir Trans, V47, P129; Morus Iwan Rhys, 1998, FRANKENSTEINS CHILDR; Murphy J., 1897, MED REC, V51, P73; Olszewski TM., 2008, THESIS; OUDOT J, 1951, PRESSE MED, V59, P234; Phillips B, 1832, SERIES EXPT PERFORME; Rankin G, 1903, Med Chir Trans, V86, P377; Rothstein WG., 1992, AM PHYS 19 CENTURY S; Shumacker J, 1984, SOC VASCULAR SURG HI; Society for Vascular Surgery, 2016, COMMUNICATION; Starr P, 1982, SOCIAL TRANSFORMATIO; Stevens Rosemary, 1989, SICKNESS WEALTH AM H; Tufnell J, 1874, Med Chir Trans, V57, P83; van Bochove CA, 2016, J VASC SURG, V63, P827, DOI 10.1016/j.jvs.2015.10.055; Vesalius A, 2014, FABRIC HUMAN BODY 7; Warner John Harley, 1998, SPIRIT SYSTEM FRENCH; Watts SH, 1907, B JOHNS HOPKINS HOSP, V18, P153; Weir RF, 1892, N Y MED J, V55, P510; Welch WH, 1920, PAPERS ADDRESSES W H, P110	68	1	2	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2017	166	4					291	+		10.7326/M16-2081	http://dx.doi.org/10.7326/M16-2081			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7FO	28241301				2022-12-28	WOS:000394786700019
J	Lye, DC; Archuleta, S; Syed-Omar, SF; Low, JG; Oh, HM; Wei, Y; Fisher, D; Ponnampalavanar, SSL; Wijaya, L; Lee, LK; Ooi, EE; Kamarulzaman, A; Lum, LC; Tambyah, PA; Leo, YS				Lye, David C.; Archuleta, Sophia; Syed-Omar, Sharifah F.; Low, Jenny G.; Oh, Helen M.; Wei, Yuan; Fisher, Dale; Ponnampalavanar, Sasheela S. L.; Wijaya, Limin; Lee, Linda K.; Ooi, Eng-Eong; Kamarulzaman, Adeeba; Lum, Lucy C.; Tambyah, Paul A.; Leo, Yee-Sin			Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trial	LANCET			English	Article							GLOBAL DISTRIBUTION; HEMORRHAGIC-FEVER; INFECTION; INDIA	Background Dengue is the commonest vector-borne infection worldwide. It is often associated with thrombocytopenia, and prophylactic platelet transfusion is widely used despite the dearth of robust evidence. We aimed to assess the efficacy and safety of prophylactic platelet transfusion in the prevention of bleeding in adults with dengue and thrombocytopenia. Methods We did an open-label, randomised, superiority trial in five hospitals in Singapore and Malaysia. We recruited patients aged at least 21 years who had laboratory-confirmed dengue (confirmed or probable) and thrombocytopenia (<= 20 000 platelets per mu L), without persistent mild bleeding or any severe bleeding. Patients were assigned (1: 1), with randomly permuted block sizes of four or six and stratified by centre, to receive prophylactic platelet transfusion in addition to supportive care (transfusion group) or supportive care alone (control group). In the transfusion group, 4 units of pooled platelets were given each day when platelet count was 20 000 per mu L or lower; supportive care consisted of bed rest, fluid therapy, and fever and pain medications. The primary endpoint was clinical bleeding (excluding petechiae) by study day 7 or hospital discharge (whichever was earlier), analysed by intention to treat. Safety outcomes were analysed according to the actual treatment received. This study was registered with ClinicalTrials.gov, number NCT01030211, and is completed. Findings Between April 29, 2010, and Dec 9, 2014, we randomly assigned 372 patients to the transfusion group (n=188) or the control group (n=184). The intention-to-treat analysis included 187 patients in the transfusion group (one patient was withdrawn immediately) and 182 in the control group (one was withdrawn immediately and one did not have confirmed or probable dengue). Clinical bleeding by day 7 or hospital discharge occurred in 40 (21%) patients in the transfusion group and 48 (26%) patients in the control group (risk difference -4.98% [95% CI -15.08 to 5.34]; relative risk 0.81 [95% CI 0.56 to 1.17]; p=0.16). 13 adverse events occurred in the transfusion group and two occurred in the control group (5.81% [-4.42 to 16.01]; 6.26 [1.43 to 27.34]; p=0.0064). Adverse events that were possibly, probably, or definitely related to transfusion included three cases of urticaria, one maculopapular rash, one pruritus, and one chest pain, as well as one case each of anaphylaxis, transfusion-related acute lung injury, and fluid overload that resulted in serious adverse events. No death was reported. Interpretation In adult patients with dengue and thrombocytopenia, prophylactic platelet transfusion was not superior to supportive care in preventing bleeding, and might be associated with adverse events.	[Lye, David C.; Lee, Linda K.; Leo, Yee-Sin] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore; [Lye, David C.; Archuleta, Sophia; Fisher, Dale; Tambyah, Paul A.; Leo, Yee-Sin] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Leo, Yee-Sin] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Archuleta, Sophia; Fisher, Dale; Tambyah, Paul A.] Natl Univ Hlth Syst, Natl Univ Hosp, Div Infect Dis, Singapore, Singapore; [Syed-Omar, Sharifah F.; Ponnampalavanar, Sasheela S. L.; Kamarulzaman, Adeeba; Lum, Lucy C.] Univ Malaya, Med Ctr, Kuala Lumpur, Malaysia; [Low, Jenny G.; Wijaya, Limin] Singapore Gen Hosp, Singapore, Singapore; [Low, Jenny G.; Ooi, Eng-Eong] Duke NUS Med Sch, Singapore, Singapore; [Oh, Helen M.] Changi Gen Hosp, Singapore, Singapore; [Wei, Yuan] Singapore Clin Res Inst, Singapore, Singapore; [Leo, Yee-Sin] Lee Kong Chian Sch Med, Singapore, Singapore	Tan Tock Seng Hospital; National University of Singapore; National University of Singapore; National University of Singapore; Universiti Malaya; Singapore General Hospital; National University of Singapore; Changi General Hospital; Singapore Clinical Research Institute; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Lye, DC (corresponding author), Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	david_lye@ttsh.com.sg	Lum, Lucy/Q-9871-2017; Lye, David/ABF-4402-2021; OMAR, SHARIFAH FARIDAH SFSO SYED/B-9752-2010; LA SRI PONNAMPALAVANAR, SASHEELA SRI/B-9703-2010	Lum, Lucy/0000-0002-7452-4208; Archuleta, Sophia/0000-0002-8414-6327; Syed Omar, Sharifah Faridah/0000-0002-4947-4878; Ooi, Eng Eong/0000-0002-0520-1544; Lye, David/0000-0003-0324-0205; sri la sri ponnampalavanar, sasheela/0000-0002-4506-1304	National Medical Research Council, Singapore; National Medical Research Council, Singapore (STOP dengue grant) [NMRC/TCR/005/2008]	National Medical Research Council, Singapore(National Medical Research Council, Singapore); National Medical Research Council, Singapore (STOP dengue grant)(National Medical Research Council, Singapore)	National Medical Research Council, Singapore.; We thank all the doctors and research staff whose enthusiasm and work have made this clinical trial possible. This study was funded by the National Medical Research Council, Singapore (STOP dengue grant NMRC/TCR/005/2008).	Adalja AA, 2012, EMERG INFECT DIS, V18, P608, DOI 10.3201/eid1804.110968; Assir MZK, 2013, TRANSFUS MED HEMOTH, V40, P362, DOI 10.1159/000354837; Bhaskar E, 2015, J INFECT DEV COUNTR, V9, P105, DOI 10.3855/jidc.5031; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Cardier JE, 2006, CYTOKINE, V34, P155, DOI 10.1016/j.cyto.2006.04.002; Chamnanchanunt S, 2012, SE ASIAN J TROP MED, V43, P890; Chaudhary R, 2006, TRANSFUS APHER SCI, V35, P239, DOI 10.1016/j.transci.2006.08.007; Chaurasia R, 2015, TRANSFUS MED HEMOTH, V42, P227, DOI 10.1159/000371500; Chuansumrit A, 2014, THROMB RES, V133, P10, DOI 10.1016/j.thromres.2013.09.028; Chuansumrit Ampaiwan, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P10; Delaflor-Weiss E, 2000, TRANSFUS MED REV, V14, P180, DOI 10.1016/S0887-7963(00)80007-3; Fujimoto Denys Eiti, 2014, Rev. Bras. Hematol. Hemoter., V36, P115, DOI 10.5581/1516-8484.20140027; Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; Kutsuna S, 2015, EMERG INFECT DIS, V21, P517, DOI [10.3201/eid2103.141662, 10.3201/eid2103/141662]; Lee Min-Sheng, 2006, Journal of Microbiology Immunology and Infection, V39, P121; Lee TH, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004576; Lum LCS, 2003, J PEDIATR-US, V143, P682, DOI 10.1067/S0022-3476(03)00503-1; Lum LCSL, 2002, J PEDIATR-US, V140, P629, DOI 10.1067/mpd.2002.123665; Lye DC, 2009, CLIN INFECT DIS, V48, P1262, DOI 10.1086/597773; Sang SW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003808; Sharma A, 2012, AM J TROP MED HYG, V86, P531, DOI 10.4269/ajtmh.2012.10-0209; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Slichter SJ, 2010, NEW ENGL J MED, V362, P600, DOI 10.1056/NEJMoa0904084; Suaya JA, 2009, AM J TROP MED HYG, V80, P846, DOI 10.4269/ajtmh.2009.80.846; Teo D, 2009, TRANSFUSION MED, V19, P66, DOI 10.1111/j.1365-3148.2009.00916.x; Wang SF, 2016, AM J TROP MED HYG, V94, P193, DOI 10.4269/ajtmh.15-0422; Whitehorn J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001716; WHO, 1997, DENG HAEM FEV DIAGN; World Health Organization, 2009, DENG GUID TREATM PRE	30	40	46	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 22	2017	389	10079					1611	1618		10.1016/S0140-6736(17)30269-6	http://dx.doi.org/10.1016/S0140-6736(17)30269-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ES5EK	28283286				2022-12-28	WOS:000399560000028
J	Zhao, C; Cai, S; Shin, K; Lim, A; Kalisky, T; Lu, WJ; Clarke, MF; Beachy, PA				Zhao, Chen; Cai, Shang; Shin, Kunyoo; Lim, Agnes; Kalisky, Tomer; Lu, Wan-Jin; Clarke, Michael F.; Beachy, Philip A.			Stromal Gli2 activity coordinates a niche signaling program for mammary epithelial stem cells	SCIENCE			English	Article							GROWTH-FACTOR-I; GLAND DEVELOPMENT; TRANSCRIPTION FACTOR; HORMONE DEFICIENCY; IGF-I; MOUSE; HEDGEHOG; DIFFERENTIATION; EXPRESSION; RECEPTOR	The stem cell niche is a complex local signaling microenvironment that sustains stem cell activity during organ maintenance and regeneration. The mammary gland niche must support its associated stem cells while also responding to systemic hormonal regulation that triggers pubertal changes. We find that Gli2, the major Hedgehog pathway transcriptional effector, acts within mouse mammary stromal cells to direct a hormone-responsive niche signaling program by activating expression of factors that regulate epithelial stem cells as well as receptors for the mammatrophic hormones estrogen and growth hormone. Whereas prior studies implicate stem cell defects in human disease, this work shows that niche dysfunction may also cause disease, with possible relevance for human disorders and in particular the breast growth pathogenesis associated with combined pituitary hormone deficiency.	[Zhao, Chen; Cai, Shang; Shin, Kunyoo; Lim, Agnes; Lu, Wan-Jin; Clarke, Michael F.; Beachy, Philip A.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Zhao, Chen; Shin, Kunyoo; Lu, Wan-Jin; Beachy, Philip A.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Shin, Kunyoo] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 37673, Gyumgbuk, South Korea; [Lim, Agnes; Beachy, Philip A.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Kalisky, Tomer] Bar Ilan Univ, Fac Engn, IL-52900 Ramat Gan, Israel; [Kalisky, Tomer] Bar Ilan Univ, Inst Nanotechnol & Adv Mat, IL-52900 Ramat Gan, Israel; [Beachy, Philip A.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Pohang University of Science & Technology (POSTECH); Stanford University; Bar Ilan University; Bar Ilan University; Howard Hughes Medical Institute; Stanford University	Beachy, PA (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.; Beachy, PA (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.; Beachy, PA (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.; Beachy, PA (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	pbeachy@stanford.edu		Shin, Kunyoo/0000-0002-1519-9839; Cai, Shang/0000-0003-0630-7719; Lim, Agnes/0000-0002-6618-2500; Lu, Wan-Jin/0000-0002-2186-9800	Susan G. Komen fellowship; U.S. Department of Defense; Breast Cancer Research Foundation; Ludwig Institute for Cancer Research; NIH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER	Susan G. Komen fellowship(Susan G. Komen Breast Cancer Foundation); U.S. Department of Defense(United States Department of Defense); Breast Cancer Research Foundation; Ludwig Institute for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a Susan G. Komen fellowship to C.Z. and funding from the U.S. Department of Defense, the Breast Cancer Research Foundation, and the Ludwig Institute for Cancer Research. The cell imaging core of Stanford Neuroscience Microscopy Service and the FACS core of Stanford Institute for Stem Cell Biology and Regenerative Medicine were supported by NIH core grants. We are grateful to K. M. Loh and J. Sage for critical reading and helpful discussion of this manuscript. P.A.B. is an investigator of the Howard Hughes Medical Institute.	Asselin-Labat ML, 2006, J NATL CANCER I, V98, P1011, DOI 10.1093/jnci/djj267; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Bai CYB, 2001, DEVELOPMENT, V128, P5161; Bai LX, 2010, GENE DEV, V24, P1882, DOI 10.1101/gad.1932810; Bonnette SG, 2001, ENDOCRINOLOGY, V142, P4937, DOI 10.1210/en.142.11.4937; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Brisken C, 2007, STEM CELL REV, V3, P147, DOI 10.1007/s12015-007-0019-1; Cohen ED, 2009, J CLIN INVEST, V119, P2538, DOI 10.1172/JCI38079; Corrales JD, 2006, DEVELOPMENT, V133, P1811, DOI 10.1242/dev.02351; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Darendeliler F, 2011, HORM RES PAEDIAT, V76, P42, DOI 10.1159/000329161; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Franca MM, 2013, CLIN ENDOCRINOL, V78, P551, DOI 10.1111/cen.12044; Franca MM, 2010, J CLIN ENDOCR METAB, V95, pE384, DOI 10.1210/jc.2010-1050; Gouon-Evans V, 2000, DEVELOPMENT, V127, P2269; Guerquin MJ, 2013, J CLIN INVEST, V123, P3564, DOI 10.1172/JCI67521; Hatsell SJ, 2006, DEVELOPMENT, V133, P3661, DOI 10.1242/dev.02542; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kenney Nicholas J., 2001, Journal of Biomedicine and Biotechnology, V1, P133, DOI 10.1155/S1110724301000304; Kundakovic M, 2013, P NATL ACAD SCI USA, V110, P9956, DOI 10.1073/pnas.1214056110; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lee MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029758; Lee M, 2013, J MAMMARY GLAND BIOL, V18, P133, DOI 10.1007/s10911-013-9291-7; Lewis MT, 2001, DEV BIOL, V238, P133, DOI 10.1006/dbio.2001.0410; Lim A, 2014, NAT CELL BIOL, V16, P1135, DOI 10.1038/ncb3057; Maghnie M, 2006, J CLIN ENDOCR METAB, V91, P2900, DOI 10.1210/jc.2006-0050; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Moses H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003277; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; PERTZELAN A, 1982, CLIN ENDOCRINOL, V16, P359, DOI 10.1111/j.1365-2265.1982.tb00728.x; ROBINSON SD, 1991, DEVELOPMENT, V113, P867; Roessler E, 2005, HUM MOL GENET, V14, P2181, DOI 10.1093/hmg/ddi222; Ruan WF, 1999, ENDOCRINOLOGY, V140, P5075, DOI 10.1210/en.140.11.5075; RUAN WF, 1992, P NATL ACAD SCI USA, V89, P10872, DOI 10.1073/pnas.89.22.10872; RUAN WF, 1995, ENDOCRINOLOGY, V136, P1296, DOI 10.1210/en.136.3.1296; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; Smith GH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1856; Sternlicht MD, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1368; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taylor CR, 1996, BIOTECH HISTOCHEM, V71, P263, DOI 10.3109/10520299609117171; Veltmaat JM, 2006, DEVELOPMENT, V133, P2325, DOI 10.1242/dev.02394; Visvader JE, 2014, GENE DEV, V28, P1143, DOI 10.1101/gad.242511.114; Visvader JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004879; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Whyte JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076883; Wood GA, 2007, REPRODUCTION, V133, P1035, DOI 10.1530/REP-06-0302; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020	52	68	68	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2017	356	6335							eaal3485	10.1126/science.aal3485	http://dx.doi.org/10.1126/science.aal3485			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES4XQ	28280246	Green Submitted			2022-12-28	WOS:000399540100053
J	Imbeault, M; Helleboid, PY; Trono, D				Imbeault, Michael; Helleboid, Pierre-Yves; Trono, Didier			KRAB zinc-finger proteins contribute to the evolution of gene regulatory networks	NATURE			English	Article							EMBRYONIC STEM-CELLS; ENDOGENOUS RETROVIRUSES; TRANSPOSABLE ELEMENTS; DNA METHYLATION; METHYLTRANSFERASE; EXPRESSION; ALIGNMENT; INSIGHTS	The human genome encodes some 350 Kruppel-associated box (KRAB) domain-containing zinc-finger proteins (KZFPs), the products of a rapidly evolving gene family that has been traced back to early tetrapods(1,2). The function of most KZFPs is unknown, but a few have been demonstrated to repress transposable elements in embryonic stem (ES) cells by recruiting the transcriptional regulator TRIM28 and associated mediators of histone H3 Lys9 trimethylation (H3K9me3)-dependent heterochromatin formation and DNA methylation(3-9). Depletion of TRIM28 in human or mouse ES cells triggers the upregulation of a broad range of transposable elements(4,10,11), and recent data based on a few specific examples have pointed to an arms race between hosts and transposable elements as an important driver of KZFP gene selection(5). Here, to obtain a global view of this phenomenon, we combined phylogenetic and genomic studies to investigate the evolutionary emergence of KZFP genes in vertebrates and to identify their targets in the human genome. First, we unexpectedly reassigned the root of the family to a common ancestor of coelacanths and tetrapods. Second, although we confirmed that the majority of KZFPs bind transposable elements and pinpoint cases of ongoing co-evolution, we found that most of their transposable element targets have lost all transposition potential. Third, by examining the interplay between human KZFPs and other transcriptional modulators, we obtained evidence that KZFPs exploit evolutionarily conserved fragments of transposable elements as regulatory platforms long after the arms race against these genetic invaders has ended. Together, our results demonstrate that KZFPs partner with transposable elements to build a largely species-restricted layer of epigenetic regulation.	[Imbeault, Michael; Helleboid, Pierre-Yves; Trono, Didier] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Trono, D (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland.	didier.trono@epfl.ch		Imbeault, Michael/0000-0002-0073-0922	Swiss National Science Foundation; European Research Council [ERC 268721]; Fonds de la Recherche en Sante du Quebec	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	We thank the University of Lausanne Genomic Technologies Facility for sequencing, J. Marquis, S. Offner and C. Raclot for technical assistance and Vital-IT for computing resources. This work was financed through grants from the Swiss National Science Foundation and the European Research Council (ERC 268721) to D.T., and a fellowship from the Fonds de la Recherche en Sante du Quebec to M.I.	Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Castro-Diaz N, 2014, GENE DEV, V28, P1397, DOI 10.1101/gad.241661.114; Chikina MD, 2012, BIOINFORMATICS, V28, P607, DOI 10.1093/bioinformatics/bts009; Chuong EB, 2017, NAT REV GENET, V18, P71, DOI 10.1038/nrg.2016.139; Chuong EB, 2016, SCIENCE, V351, P1083, DOI 10.1126/science.aad5497; Dale RK, 2011, BIOINFORMATICS, V27, P3423, DOI 10.1093/bioinformatics/btr539; Dreos R, 2013, NUCLEIC ACIDS RES, V41, pD157, DOI 10.1093/nar/gks1233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ecco G, 2016, DEV CELL, V36, P611, DOI 10.1016/j.devcel.2016.02.024; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Jacobs FMJ, 2014, NATURE, V516, P242, DOI 10.1038/nature13760; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liu H, 2014, GENOME BIOL EVOL, V6, P510, DOI 10.1093/gbe/evu030; Lizio M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0560-6; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Quenneville S, 2012, CELL REP, V2, P766, DOI 10.1016/j.celrep.2012.08.043; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Turelli P, 2014, GENOME RES, V24, P1260, DOI 10.1101/gr.172833.114; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	30	234	244	5	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2017	543	7646					550	+		10.1038/nature21683	http://dx.doi.org/10.1038/nature21683			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO9OM	28273063				2022-12-28	WOS:000397018000051
J	Koyama, M; Zhang, Z; Wang, MM; Ponge, D; Raabe, D; Tsuzaki, K; Noguchi, H; Tasan, CC				Koyama, Motomichi; Zhang, Zhao; Wang, Meimei; Ponge, Dirk; Raabe, Dierk; Tsuzaki, Kaneaki; Noguchi, Hiroshi; Tasan, Cemal Cem			Bone-like crack resistance in hierarchical metastable nanolaminate steels	SCIENCE			English	Article							TRANSFORMATION-INDUCED PLASTICITY; FULLY PEARLITIC STEELS; HIGH-CYCLE FATIGUE; MICROSTRUCTURE; GROWTH; FRACTURE; PROPAGATION; AUSTENITE; STRENGTH; BEHAVIOR	Fatigue failures create enormous risks for all engineered structures, as well as for human lives, motivating large safety factors in design and, thus, inefficient use of resources. Inspired by the excellent fracture toughness of bone, we explored the fatigue resistance in metastability-assisted multiphase steels. We show here that when steel microstructures are hierarchical and laminated, similar to the substructure of bone, superior crack resistance can be realized. Our results reveal that tuning the interface structure, distribution, and phase stability to simultaneously activate multiple micromechanisms that resist crack propagation is key for the observed leap in mechanical response. The exceptional properties enabled by this strategy provide guidance for all fatigue-resistant alloy design efforts.	[Koyama, Motomichi; Zhang, Zhao; Tsuzaki, Kaneaki; Noguchi, Hiroshi] Kyushu Univ, Motooka 744, Fukuoka 8190395, Japan; [Wang, Meimei; Ponge, Dirk; Raabe, Dierk] Max Planck Inst Eisenforsch GmbH, Max Planck Str 1, D-40237 Dusseldorf, Germany; [Wang, Meimei; Tasan, Cemal Cem] MIT, Dept Mat Sci & Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Kyushu University; Max Planck Society; Massachusetts Institute of Technology (MIT)	Koyama, M (corresponding author), Kyushu Univ, Motooka 744, Fukuoka 8190395, Japan.; Wang, MM (corresponding author), Max Planck Inst Eisenforsch GmbH, Max Planck Str 1, D-40237 Dusseldorf, Germany.; Wang, MM; Tasan, CC (corresponding author), MIT, Dept Mat Sci & Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	koyama@mech.kyushu-u.ac.jp; mm_wang@mit.edu; tasan@mit.edu	Raabe, Dierk/A-6470-2009; koyama, motomichi/T-7044-2017	Raabe, Dierk/0000-0003-0194-6124; koyama, motomichi/0000-0002-5006-9976; Noguchi, Hiroshi/0000-0002-9439-7226	KAKENHI (from the Japan Society for the Promotion of Science) [15K18235, 16H06365]; European Research Council (ERC) under the European Union's 7th Framework Programme (FP7, ERC Advanced Grant) [290998]; Department of Materials Science and Engineering of the Massachusetts Institute of Technology	KAKENHI (from the Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); European Research Council (ERC) under the European Union's 7th Framework Programme (FP7, ERC Advanced Grant); Department of Materials Science and Engineering of the Massachusetts Institute of Technology	This work was financially supported by KAKENHI (Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science; 15K18235 and 16H06365), the European Research Council (ERC) under the European Union's 7th Framework Programme (FP7/2007-2013, ERC Advanced Grant agreement 290998), and the Department of Materials Science and Engineering of the Massachusetts Institute of Technology. C.C.T. and M.K. designed the research; Z.Z. and M.W. were the lead experimental scientists; and M.K. and C.C.T. wrote the paper. All authors discussed the results and commented on the manuscript. The authors declare no conflicts of interest.	Abareshi M, 2011, MATER DESIGN, V32, P5099, DOI 10.1016/j.matdes.2011.06.018; ARAN A, 1990, J MATER SCI LETT, V9, P1407, DOI 10.1007/BF00721598; CAI XL, 1985, METALL TRANS A, V16, P1405, DOI 10.1007/BF02658673; Chandran KSR, 2005, NAT MATER, V4, P303, DOI 10.1038/nmat1351; DAEUBLER MA, 1990, METALL TRANS A, V21, P925, DOI 10.1007/BF02656577; Fujisawa T, 2014, INT J FRACTURE, V185, P17, DOI 10.1007/s10704-013-9895-3; Gludovatz B, 2014, SCIENCE, V345, P1153, DOI 10.1126/science.1254581; GRAY GT, 1985, METALL TRANS A, V16, P753, DOI 10.1007/BF02814826; GRAY GT, 1983, METALL TRANS A, V14, P421, DOI 10.1007/BF02644220; Haidemenopoulos GN, 2013, MAT SCI ENG A-STRUCT, V573, P7, DOI 10.1016/j.msea.2013.02.015; Hu ZG, 2010, MATER DESIGN, V31, P2884, DOI 10.1016/j.matdes.2009.12.034; Ju YB, 2016, ACTA MATER, V112, P326, DOI 10.1016/j.actamat.2016.04.042; KEMSLEY DS, 1956, NATURE, V178, P653, DOI 10.1038/178653a0; Kimura Y, 2008, SCIENCE, V320, P1057, DOI 10.1126/science.1156084; Li LL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4536; Li LL, 2014, SCI REP-UK, V4, DOI 10.1038/srep03744; Ma ZW, 2016, SCI REP-UK, V6, DOI 10.1038/srep22156; MAYER HR, 1995, FATIGUE FRACT ENG M, V18, P935, DOI 10.1111/j.1460-2695.1995.tb00918.x; MEI Z, 1991, ENG FRACT MECH, V39, P569, DOI 10.1016/0013-7944(91)90068-C; Mughrabi H, 2013, ACTA MATER, V61, P1197, DOI 10.1016/j.actamat.2012.10.029; MURAKAMI Y, 1989, INT J FATIGUE, V11, P291, DOI 10.1016/0142-1123(89)90054-6; Nalla RK, 2003, NAT MATER, V2, P164, DOI 10.1038/nmat832; Peterlik H, 2006, NAT MATER, V5, P52, DOI 10.1038/nmat1545; PINEAU AG, 1974, METALL TRANS, V5, P1103, DOI 10.1007/BF02644322; Pineau A, 2016, ACTA MATER, V107, P484, DOI 10.1016/j.actamat.2015.05.050; RITCHIE RO, 1988, MAT SCI ENG A-STRUCT, V103, P15, DOI 10.1016/0025-5416(88)90547-2; Ritchie RO, 2011, NAT MATER, V10, P817, DOI [10.1038/nmat3115, 10.1038/NMAT3115]; Sonsino CM, 2007, INT J FATIGUE, V29, P2246, DOI 10.1016/j.ijfatigue.2006.11.015; Suresh S., 1984, International Metals Reviews, V29, P445; Timoshenko SP., 1953, HIST STRENGTH MAT BR; VERPOEST I, 1985, INT J FATIGUE, V7, P199, DOI 10.1016/0142-1123(85)90051-9; Wang MM, 2015, ACTA MATER, V85, P216, DOI 10.1016/j.actamat.2014.11.010; Wang MM, 2014, ACTA MATER, V79, P268, DOI 10.1016/j.actamat.2014.07.020; Wang YD, 2003, NAT MATER, V2, P101, DOI 10.1038/nmat812; WASYNCZUK JA, 1984, MATER SCI ENG, V62, P79, DOI 10.1016/0025-5416(84)90269-6	35	226	232	21	317	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI					10.1126/science.aal2766	http://dx.doi.org/10.1126/science.aal2766			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9VY	28280201				2022-12-28	WOS:000396348900039
J	Pennisi, E				Pennisi, Elizabeth			MAKING WAVES	SCIENCE			English	Editorial Material																			0	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI		1006	1009		10.1126/science.355.6329.1006	http://dx.doi.org/10.1126/science.355.6329.1006			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9VY	28280162				2022-12-28	WOS:000396348900012
J	Hochhaus, A; Larson, RA; Guilhot, F; Radich, JP; Branford, S; Hughes, TP; Baccarani, M; Deininger, MW; Cervantes, F; Fujihara, S; Ortmann, CE; Menssen, HD; Kantarjian, H; O'Brien, SG; Druker, BJ				Hochhaus, Andreas; Larson, Richard A.; Guilhot, Francois; Radich, Jerald P.; Branford, Susan; Hughes, Timothy P.; Baccarani, Michele; Deininger, Michael W.; Cervantes, Francisco; Fujihara, Satoko; Ortmann, Christine-Elke; Menssen, Hans D.; Kantarjian, Hagop; O'Brien, Stephen G.; Druker, Brian J.		IRIS Investigators	Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; ALPHA PLUS CYTARABINE; PATIENTS RECEIVING IMATINIB; FOLLOW-UP; MOLECULAR RESPONSE; RANDOMIZED CML; SURVIVAL; INTERFERON; DASATINIB; NILOTINIB	BACKGROUND Imatinib, a selective BCR-ABL1 kinase inhibitor, improved the prognosis for patients with chronic myeloid leukemia (CML). We conducted efficacy and safety analyses on the basis of more than 10 years of follow-up in patients with CML who were treated with imatinib as initial therapy. METHODS In this open-label, multicenter trial with crossover design, we randomly assigned patients with newly diagnosed CML in the chronic phase to receive either imatinib or interferon alfa plus cytarabine. Long-term analyses included overall survival, response to treatment, and serious adverse events. RESULTS The median follow-up was 10.9 years. Given the high rate of crossover among patients who had been randomly assigned to receive interferon alfa plus cytarabine (65.6%) and the short duration of therapy before crossover in these patients (median, 0.8 years), the current analyses focused on patients who had been randomly assigned to receive imatinib. Among the patients in the imatinib group, the estimated overall survival rate at 10 years was 83.3%. Approximately half the patients (48.3%) who had been randomly assigned to imatinib completed study treatment with imatinib, and 82.8% had a complete cytogenetic response. Serious adverse events that were considered by the investigators to be related to imatinib were uncommon and most frequently occurred during the first year of treatment. CONCLUSIONS Almost 11 years of follow-up showed that the efficacy of imatinib persisted over time and that long-term administration of imatinib was not associated with unacceptable cumulative or late toxic effects. (Funded by Novartis Pharmaceuticals; IRIS ClinicalTrials.gov numbers, NCT00006343 and NCT00333840.)	[Hochhaus, Andreas] Univ Klinikum Jena, Abt Hamatol Onkol, Jena, Germany; [Larson, Richard A.] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Guilhot, Francois] Ctr Hosp Univ Poitiers, INSERM, Ctr Invest Clin 1402, Poitiers, France; [Radich, Jerald P.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Branford, Susan] Univ South Australia, Ctr Canc Biol, SA Pathol, Adelaide, SA, Australia; [Branford, Susan; Hughes, Timothy P.] Univ Adelaide, Adelaide, SA, Australia; [Hughes, Timothy P.] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Baccarani, Michele] Univ Bologna, Bologna, Italy; [Deininger, Michael W.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Cervantes, Francisco] Univ Barcelona, Dept Hematol, Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Fujihara, Satoko; Ortmann, Christine-Elke; Menssen, Hans D.] Novartis, Basel, Switzerland; [Menssen, Hans D.] Anderson Canc Ctr, Houston, TX USA; [O'Brien, Stephen G.] Univ Newcastle, Newcastle, NSW, Australia; [Druker, Brian J.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Druker, Brian J.] Howard Hughes Med Inst, Portland, OR USA	Friedrich Schiller University of Jena; University of Chicago; CHU Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Fred Hutchinson Cancer Center; Centre for Cancer Biology; SA Pathology; University of South Australia; University of Adelaide; South Australian Health & Medical Research Institute (SAHMRI); University of Bologna; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Texas System; UTMD Anderson Cancer Center; University of Newcastle; Oregon Health & Science University; Howard Hughes Medical Institute	Hochhaus, A (corresponding author), Univ Klinikum Jena, Abt Hamatol Onkol, Klin Innere Med 2, Klinikum 1, D-07740 Jena, Germany.	andreas.hochhaus@med.uni-jena.de	Kovacs, Michael/G-3315-2011; Branford, Susan/X-7733-2019; Seymour, John/K-7326-2019; Hughes, Tim/AAO-9975-2021; Blaise, Didier/R-2483-2016	Seymour, John/0000-0003-2188-6835; Blaise, Didier/0000-0002-5684-9447; Agha, Mounzer/0000-0002-2275-7544; Branford, Susan/0000-0002-5095-7981; Druker, Brian/0000-0001-8331-8206; Hughes, Timothy/0000-0002-0910-3730; Guilhot, Francois/0000-0001-7222-487X; Hernandez-Boluda, Juan Carlos/0000-0002-4289-3113	Novartis Pharmaceuticals; NATIONAL CANCER INSTITUTE [P50CA100632, P30CA016672] Funding Source: NIH RePORTER	Novartis Pharmaceuticals(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Novartis Pharmaceuticals; IRIS ClinicalTrials.gov numbers, NCT00006343 and NCT00333840.	[Anonymous], 2016, FAST STATS INTERACTI; Baccarani M, 2006, BLOOD, V108, P1809, DOI 10.1182/blood-2006-02-005686; Baccarani M, 2013, BLOOD, V122, P872, DOI 10.1182/blood-2013-05-501569; Bower H, 2016, J CLIN ONCOL, V34, P2851, DOI 10.1200/JCO.2015.66.2866; Chihara D, 2012, ONCOLOGIST, V17, P1547, DOI 10.1634/theoncologist.2012-0197; Cohen MH, 2002, CLIN CANCER RES, V8, P935; Cortes JE, 2013, NEW ENGL J MED, V369, P1783, DOI 10.1056/NEJMoa1306494; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Gambacorti-Passerini C, 2014, AM J HEMATOL, V89, P732, DOI 10.1002/ajh.23728; Gambacorti-Passerini C, 2011, JNCI-J NATL CANCER I, V103, P553, DOI 10.1093/jnci/djr060; Giles FJ, 2013, LEUKEMIA, V27, P107, DOI 10.1038/leu.2012.181; Gratwohl A, 2016, LEUKEMIA, V30, P562, DOI 10.1038/leu.2015.281; Guilhot F, 2009, HAEMATOL-HEMATOL J, V94, P1669, DOI 10.3324/haematol.2009.010629; Guilhot J, 2012, BLOOD, V119, P5963, DOI 10.1182/blood-2011-10-383711; Hasford J, 1998, JNCI-J NATL CANCER I, V90, P850, DOI 10.1093/jnci/90.11.850; Hasford J, 2011, BLOOD, V118, P686, DOI 10.1182/blood-2010-12-319038; Hehlmann R, 2007, BLOOD, V109, P4686, DOI 10.1182/blood-2006-11-055186; Hehlmann R, 2014, J CLIN ONCOL, V32, P415, DOI 10.1200/JCO.2013.49.9020; Hochhaus A, 2016, LEUKEMIA, V30, P1044, DOI 10.1038/leu.2016.5; Hochhaus A, 2016, LEUKEMIA, V30, P57, DOI 10.1038/leu.2015.270; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Hochhaus A., 2015, BLOOD ASH ANN M ABST, V126, P2781, DOI [10.1182/blood.V126.23.2781.2781, DOI 10.1182/BLOOD.V126.23.2781.2781]; Hughes TP, 2010, BLOOD, V116, P3758, DOI 10.1182/blood-2010-03-273979; Hughes TP, 2003, NEW ENGL J MED, V349, P1423, DOI 10.1056/NEJMoa030513; Jabbour E, 2014, BLOOD, V123, P494, DOI 10.1182/blood-2013-06-511592; Kalmanti L, 2015, LEUKEMIA, V29, P1123, DOI 10.1038/leu.2015.36; Kantarjian H, 2012, BLOOD, V119, P1981, DOI 10.1182/blood-2011-08-358135; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Pfirrmann M, 2016, LEUKEMIA, V30, P48, DOI 10.1038/leu.2015.261; Roy L, 2006, BLOOD, V108, P1478, DOI 10.1182/blood-2006-02-001495; Rumpold H, 2011, CURR CANCER DRUG TAR, V11, P3, DOI 10.2174/156800911793743619; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Saussele S, 2016, LEUKEMIA, V30, P1638, DOI 10.1038/leu.2016.115; Saussele S, 2015, BLOOD, V126, P42, DOI 10.1182/blood-2015-01-617993; Shah NP, 2014, BLOOD, V123, P2317, DOI 10.1182/blood-2013-10-532341; SOKAL JE, 1984, BLOOD, V63, P789, DOI 10.1182/blood.V63.4.789.789; Westin JR, 2012, MOL CANCER THER, V11, P2549, DOI 10.1158/1535-7163.MCT-12-0473	38	637	663	7	103	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2017	376	10					917	927		10.1056/NEJMoa1609324	http://dx.doi.org/10.1056/NEJMoa1609324			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JA	28273028	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000395626500008
J	Spinney, L				Spinney, Laura			THE SHARED PAST THAT WASN'T	NATURE			English	News Item							MEMORIES											Coman A, 2016, P NATL ACAD SCI USA, V113, P8171, DOI 10.1073/pnas.1525569113; Coman A, 2015, J EXP PSYCHOL GEN, V144, P717, DOI 10.1037/xge0000077; Coman A, 2012, J EXP PSYCHOL GEN, V141, P321, DOI 10.1037/a0025247; Edelson M, 2011, SCIENCE, V333, P108, DOI 10.1126/science.1203557; Edelson MG, 2014, J NEUROSCI, V34, P7744, DOI 10.1523/JNEUROSCI.4720-13.2014; Gottfried J., 2016, NEWS USE SOCIAL MEDI; Licata L, 2010, INT J CONFL VIOLENCE, V4, P45; Mana A., 2015, MIND SOC, V14, P57, DOI 10.1007/s11299- 014-0159-3; Morin R, 2016, AM NAME 10 MOST SIGN; Roediger HL, 2014, SCIENCE, V346, P1106, DOI 10.1126/science.1259627; Svob C, 2016, MEM COGNITION, V44, P846, DOI 10.3758/s13421-016-0607-x	11	13	13	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2017	543	7644					168	170		10.1038/543168a	http://dx.doi.org/10.1038/543168a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN0GQ	28277522				2022-12-28	WOS:000395688700010
J	Davis, AL; Miller, JD				Davis, Anna L.; Miller, James Dabney			The European Medicines Agency and Publication of Clinical Study Reports A Challenge for the US FDA	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OSELTAMIVIR; INFLUENZA; ADULTS		[Davis, Anna L.; Miller, James Dabney] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Miller, JD (corresponding author), 4110 Greenway, Baltimore, MD 21218 USA.	jmill165@jhu.edu			Laura and John Arnold Foundation	Laura and John Arnold Foundation	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Ms Davis and Mr Miller reported receiving grant funding from the Laura and John Arnold Foundation.	Dobson J, 2015, LANCET, V385, P1729, DOI 10.1016/S0140-6736(14)62449-1; Doshi P, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1194-7; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2545	3	8	8	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2017	317	9					905	906		10.1001/jama.2017.0918	http://dx.doi.org/10.1001/jama.2017.0918			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM8DM	28241281				2022-12-28	WOS:000395541500007
J	Samanta, D; Klajn, R				Samanta, Dipak; Klajn, Rafal			Clathrates grow up	SCIENCE			English	Editorial Material							BINARY NANOPARTICLE SUPERLATTICES		[Samanta, Dipak; Klajn, Rafal] Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Klajn, R (corresponding author), Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel.	rafal.klajn@weizmann.ac.il	Samanta, Dipak/AAC-6635-2019	Samanta, Dipak/0000-0002-3474-3588				BAKER W, 1956, J CHEM SOC, P2010, DOI 10.1039/jr9560002010; KVENVOLDEN KA, 1988, CHEM GEOL, V71, P41, DOI 10.1016/0009-2541(88)90104-0; Lin HX, 2017, SCIENCE, V355, P931, DOI 10.1126/science.aal3919; Momma K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1196; O'Brien MN, 2015, NAT MATER, V14, P833, DOI [10.1038/NMAT4293, 10.1038/nmat4293]; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; Singh G, 2014, SCIENCE, V345, P1149, DOI 10.1126/science.1254132; Talapin DV, 2009, NATURE, V461, P964, DOI 10.1038/nature08439; Zhang C, 2013, NAT MATER, V12, P741, DOI [10.1038/NMAT3647, 10.1038/nmat3647]; Zhao H, 2016, NAT NANOTECHNOL, V11, P82, DOI [10.1038/NNANO.2015.256, 10.1038/nnano.2015.256]	10	2	2	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					912	912		10.1126/science.aam7927	http://dx.doi.org/10.1126/science.aam7927			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM2YM	28254902				2022-12-28	WOS:000395181700023
J	Dodd, MS; Papineau, D; Grenne, T; Slack, JF; Rittner, M; Pirajno, F; O'Neil, J; Little, CTS				Dodd, Matthew S.; Papineau, Dominic; Grenne, Tor; Slack, John F.; Rittner, Martin; Pirajno, Franco; O'Neil, Jonathan; Little, Crispin T. S.			Evidence for early life in Earth's oldest hydrothermal vent precipitates	NATURE			English	Article							NUVVUAGITTUQ SUPRACRUSTAL BELT; CHEMICAL SEDIMENTARY PROTOLITHS; IRON FORMATIONS; QUEBEC; GRAPHITE; TEXTURES; ZIRCON; PRESERVATION; MICROFOSSILS; BIOGENICITY	Although it is not known when or where life on Earth began, some of the earliest habitable environments may have been submarine-hydrothermal vents. Here we describe putative fossilized microorganisms that are at least 3,770 million and possibly 4,280 million years old in ferruginous sedimentary rocks, interpreted as seafloor-hydrothermal vent-related precipitates, from the Nuvvuagittuq belt in Quebec, Canada. These structures occur as micrometre-scale haematite tubes and filaments with morphologies and mineral assemblages similar to those of filamentous microorganisms from modern hydrothermal vent precipitates and analogous microfossils in younger rocks. The Nuvvuagittuq rocks contain isotopically light carbon in carbonate and carbonaceous material, which occurs as graphitic inclusions in diagenetic carbonate rosettes, apatite blades intergrown among carbonate rosettes and magnetite-haematite granules, and is associated with carbonate in direct contact with the putative microfossils. Collectively, these observations are consistent with an oxidized biomass and provide evidence for biological activity in submarine-hydrothermal environments more than 3,770 million years ago.	[Dodd, Matthew S.; Papineau, Dominic] London Ctr Nanotechnol, 17-19 Gordon St, London WC1H 0AH, England; [Dodd, Matthew S.; Papineau, Dominic; Rittner, Martin] UCL, Dept Earth Sci, London WC1E 6BT, England; [Grenne, Tor] Geol Survey Norway, Leiv Eirikssons Vei 39, N-7040 Trondheim, Norway; [Slack, John F.] US Geol Survey, Natl Ctr, MS 954, Reston, VA 20192 USA; [Pirajno, Franco] Univ Western Australia, Ctr Explorat Targeting, 35 Stirling Highway, Crawley, WA 6009, Australia; [O'Neil, Jonathan] Univ Ottawa, Dept Earth & Environm Sci, Ottawa, ON K1N 6N5, Canada; [Little, Crispin T. S.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England	University of London; University College London; University of London; University College London; Geological Survey of Norway; United States Department of the Interior; United States Geological Survey; University of Western Australia; University of Ottawa; University of Leeds	Papineau, D (corresponding author), London Ctr Nanotechnol, 17-19 Gordon St, London WC1H 0AH, England.; Papineau, D (corresponding author), UCL, Dept Earth Sci, London WC1E 6BT, England.	d.papineau@ucl.ac.uk	Rittner, Martin/B-2963-2012; Papineau, Dominic/AAD-6366-2019; Pirajno, Franco/B-3643-2013	Rittner, Martin/0000-0002-2289-1903; Papineau, Dominic/0000-0003-0063-7514; Dodd, Matthew/0000-0003-4470-933X; Little, Crispin/0000-0002-1917-4460	UCL; LCN; DTG from EPSRC, UK; NASA Astrobiology Institute [NNA04CC09A]; Carnegie Institution of Washington; Carnegie of Canada	UCL; LCN; DTG from EPSRC, UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NASA Astrobiology Institute; Carnegie Institution of Washington; Carnegie of Canada	M.S.D. and D.P. acknowledge support from UCL and the LCN, and a DTG from EPSRC, UK. D.P. also thanks the NASA Astrobiology Institute (grant no. NNA04CC09A), the Carnegie Institution of Washington and Carnegie of Canada for funding, and the Geological Survey of Western Australia for access and support in the core library. We thank the municipality of Inukjuak, Quebec, and the Pituvik Landholding Corporation for permission to work on their territory; M. Carroll for logistical support; J. Davy and A. Beard for assistance with sample preparation and SEM and EPMA analyses; S. Huo for help with FIB nano-fabrication; G. and Y. Shields-Zhou and P. Pogge Von Strandmann for comments on the manuscript; and K. Konhauser for review.	Ayupova NR, 2013, LITHOL MINER RESOUR+, V48, P438, DOI 10.1134/S0024490213030024; Ayupova NR, 2016, BIOGENIC-ABIOGENIC INTERACTIONS IN NATURAL AND ANTHROPOGENIC SYSTEMS, P109, DOI 10.1007/978-3-319-24987-2_10; Bernard S, 2014, ELEMENTS, V10, P435, DOI 10.2113/gselements.10.6.435; Beyssac O, 2002, J METAMORPH GEOL, V20, P859, DOI 10.1046/j.1525-1314.2002.00408.x; Bolhar R, 2004, EARTH PLANET SC LETT, V222, P43, DOI 10.1016/j.epsl.2004.02.016; Boyd T D, 2001, PAPUA NEW GUINEA GEO, V2, P45, DOI DOI 10.1039/B105277M; Brasier AT, 2015, ASTROBIOLOGY, V15, P883, DOI 10.1089/ast.2015.1293; Campbell KA, 2015, ASTROBIOLOGY, V15, P858, DOI 10.1089/ast.2015.1307; Cates NL, 2009, CHEM GEOL, V261, P98, DOI 10.1016/j.chemgeo.2009.01.023; Cates NL, 2013, EARTH PLANET SC LETT, V362, P283, DOI 10.1016/j.epsl.2012.11.054; Chew DM, 2011, CHEM GEOL, V280, P200, DOI 10.1016/j.chemgeo.2010.11.010; Darling JR, 2013, AM J SCI, V313, P844, DOI 10.2475/09.2013.02; Dauphas N, 2007, EARTH PLANET SC LETT, V254, P358, DOI 10.1016/j.epsl.2006.11.042; DUHIG NC, 1992, ECON GEOL BULL SOC, V87, P764, DOI 10.2113/gsecongeo.87.3.764; Edwards KJ, 2011, ISME J, V5, P1748, DOI 10.1038/ismej.2011.48; Emerson D, 2002, APPL ENVIRON MICROB, V68, P3085, DOI 10.1128/AEM.68.6.3085-3093.2002; Fru EC, 2015, GEOBIOLOGY, V13, P225, DOI 10.1111/gbi.12128; Grenne T, 2003, MINER DEPOSITA, V38, P625, DOI 10.1007/s00126-003-0346-3; Griffin W.L., 2008, LASER ABLATION ICP M, P308; HEANEY PJ, 1991, PRECAMBRIAN RES, V49, P355, DOI 10.1016/0301-9268(91)90041-8; Heimann A, 2010, EARTH PLANET SC LETT, V294, P8, DOI 10.1016/j.epsl.2010.02.015; Hein J, 2008, MAR GEORESOUR GEOTEC, V26, P317, DOI 10.1080/10641190802430986; Jackson SE, 2004, CHEM GEOL, V211, P47, DOI 10.1016/j.chemgeo.2004.06.017; Jochum KP, 2011, GEOSTAND GEOANAL RES, V35, P397, DOI 10.1111/j.1751-908X.2011.00120.x; JUNIPER SK, 1988, CAN MINERAL, V26, P859; Kohler I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2770; Krepski ST, 2013, GEOBIOLOGY, V11, P457, DOI 10.1111/gbi.12043; Lepland A, 2011, GEOBIOLOGY, V9, P2, DOI 10.1111/j.1472-4669.2010.00261.x; Li JT, 2012, FEMS MICROBIOL ECOL, V81, P205, DOI 10.1111/j.1574-6941.2012.01367.x; Little CTS, 2004, GEOMICROBIOL J, V21, P415, DOI 10.1080/01490450490485845; Little CTS, 1999, GEOLOGY, V27, P167, DOI 10.1130/0091-7613(1999)027<0167:EJHVCF>2.3.CO;2; Ludwig K. R., 2008, BERKELEY GEOCHRONOLO, V76; McCollom TM, 2007, CHEM REV, V107, P382, DOI 10.1021/cr0503660; Mloszewska AM, 2013, GONDWANA RES, V23, P574, DOI 10.1016/j.gr.2012.11.005; Mloszewska AM, 2012, EARTH PLANET SC LETT, V317, P331, DOI 10.1016/j.epsl.2011.11.020; Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0; O'Neil J, 2007, DEV PREC G, V15, P219, DOI 10.1016/S0166-2635(07)15034-9; O'Neil J, 2008, SCIENCE, V321, P1828, DOI 10.1126/science.1161925; O'Neil J, 2012, PRECAMBRIAN RES, V220, P23, DOI 10.1016/j.precamres.2012.07.009; O'Neil J, 2011, J PETROL, V52, P985, DOI 10.1093/petrology/egr014; Ohtomo Y, 2014, NAT GEOSCI, V7, P25, DOI [10.1038/NGEO2025, 10.1038/ngeo2025]; Papineau D, 2016, GEOBIOLOGY, V14, P3, DOI 10.1111/gbi.12164; Papineau D, 2011, NAT GEOSCI, V4, P376, DOI [10.1038/ngeo1155, 10.1038/NGEO1155]; Papineau D, 2010, GEOCHIM COSMOCHIM AC, V74, P5862, DOI 10.1016/j.gca.2010.05.025; Papineau D, 2010, GEOCHIM COSMOCHIM AC, V74, P5884, DOI 10.1016/j.gca.2010.07.002; Parenteau MN, 2010, PALAIOS, V25, P97, DOI 10.2110/palo.2008.p08-133r; Picard A, 2016, GEOBIOLOGY, V14, P276, DOI 10.1111/gbi.12171; Reed W. P., 1992, TECH REP; Rosing MT, 1999, SCIENCE, V283, P674, DOI 10.1126/science.283.5402.674; Smith A. J. B., 2012, GOLDSCHMIDT, P2384; Sun Z., 2012, AM MINERAL, V98, P85; Sun ZL, 2015, J GEOPHYS RES-BIOGEO, V120, P187, DOI 10.1002/2014JG002764; Thompson K. J., 2014, 2014 GSA ANN M, V46, P401; van Zuilen MA, 2002, NATURE, V418, P627, DOI 10.1038/nature00934; VANCAPPELLEN P, 1988, AM J SCI, V288, P289, DOI 10.2475/ajs.288.4.289; WALTER MR, 1976, NATURE, V261, P221, DOI 10.1038/261221a0; Wirth R, 2009, CHEM GEOL, V261, P217, DOI 10.1016/j.chemgeo.2008.05.019; ZAIKIN AN, 1970, NATURE, V225, P535, DOI 10.1038/225535b0; Zega TJ, 2007, METEORIT PLANET SCI, V42, P1	59	300	311	26	341	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2017	543	7643					60	+		10.1038/nature21377	http://dx.doi.org/10.1038/nature21377			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0AA	28252057	Bronze			2022-12-28	WOS:000395671500032
J	Marris, E				Marris, Emma			How to kill wild animals humanely for conservation	NATURE			English	News Item																		Dubois S, 2017, CONSERV BIOL, V31, P753, DOI 10.1111/cobi.12896	1	2	3	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2017	543	7643					18	+		10.1038/nature.2017.21536	http://dx.doi.org/10.1038/nature.2017.21536			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0AA	28252082	Bronze			2022-12-28	WOS:000395671500010
J	Parker, R				Parker, Rebecca			Out-of-Network Emergency-Physician Bills	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Parker, Rebecca] Amer Coll Emergency Phys, Washington, DC 20037 USA		Parker, R (corresponding author), Amer Coll Emergency Phys, Washington, DC 20037 USA.	rparker@acep.org						American College of Emergency Physicians, 2016, FLOR DAT SUGG BAL BI; Cooper Z, 2016, NEW ENGL J MED, V375, P1915, DOI 10.1056/NEJMp1608571; Department for Education, 2022, SUMMARY CO2 MONITORS; International Committee of Medical Journal Editors, ICMJE DISCL POT CONF	4	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2017	376	9					898	899		10.1056/NEJMc1700368	http://dx.doi.org/10.1056/NEJMc1700368			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JK	28249144				2022-12-28	WOS:000395627500033
J	Allen, D				Allen, David			Moving the Needle on Recovery From Breast Cancer The Healing Role of Postmastectomy Tattoos	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Allen, David] David Allen Tattoo, Chicago, IL USA		Allen, D (corresponding author), David Allen Tattoo, Chicago, IL USA.	david@allentattoo.com							0	9	9	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2017	317	7					672	674		10.1001/jama.2017.047	http://dx.doi.org/10.1001/jama.2017.047			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8WR	28241334				2022-12-28	WOS:000394901600001
J	Bates, ER				Bates, Eric R.			In left main CAD, PCI with everolimuseluting stents was noninferior to CABG for death, MI, or stroke at 3 years	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Bates, Eric R.] Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bates, ER (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.							Fihn SD, 2014, J AM COLL CARDIOL, V64, P1929, DOI 10.1016/j.jacc.2014.07.017; Lee PH, 2016, J AM COLL CARDIOL, V68, P1233, DOI 10.1016/j.jacc.2016.05.089; Nerlekar N, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.116.004729; Xu B, 2016, JACC-CARDIOVASC INTE, V9, P2086, DOI 10.1016/j.jcin.2016.08.011	4	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2017	166	4					JC21	JC21		10.7326/ACPJC-2017-166-4-021	http://dx.doi.org/10.7326/ACPJC-2017-166-4-021			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7FO	28241294				2022-12-28	WOS:000394786700009
J	Luca, VC; Kim, BC; Ge, C; Kakuda, S; Di, W; Roein-Peikar, M; Haltiwanger, RS; Zhu, C; Ha, T; Garcia, KC				Luca, Vincent C.; Kim, Byoung Choul; Ge, Chenghao; Kakuda, Shinako; Wu, Di; Roein-Peikar, Mehdi; Haltiwanger, Robert S.; Zhu, Cheng; Ha, Taekjip; Garcia, K. Christopher			SIGNAL TRANSDUCTION Notch-Jagged complex structure implicates a catch bond in tuning ligand sensitivity	SCIENCE			English	Article							DELTA; BINDING; ACTIVATION; DOMAIN; ENDOCYTOSIS; REGIONS; FUCOSE; SITES	Notch receptor activation initiates cell fate decisions and is distinctive in its reliance on mechanical force and protein glycosylation. The 2.5-angstrom-resolution crystal structure of the extracellular interacting region of Notch1 complexed with an engineered, high-affinity variant of Jagged1 (Jag1) reveals a binding interface that extends similar to 120 angstroms along five consecutive domains of each protein. O-Linked fucose modifications on Notch1 epidermal growth factor-like (EGF) domains 8 and 12 engage the EGF3 and C2 domains of Jag1, respectively, and different Notch1 domains are favored in binding to Jag1 than those that bind to the Delta-like 4 ligand. Jag1 undergoes conformational changes upon Notch binding, exhibiting catch bond behavior that prolongs interactions in the range of forces required for Notch activation. This mechanism enables cellular forces to regulate binding, discriminate among Notch ligands, and potentiate Notch signaling.	[Luca, Vincent C.; Wu, Di; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Luca, Vincent C.; Wu, Di; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Luca, Vincent C.; Wu, Di; Garcia, K. Christopher] Howard Hughes Med Inst, Stanford, CA 94305 USA; [Kim, Byoung Choul; Roein-Peikar, Mehdi; Ha, Taekjip] Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Kim, Byoung Choul; Roein-Peikar, Mehdi; Ha, Taekjip] Johns Hopkins Univ Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Ge, Chenghao; Zhu, Cheng] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Kakuda, Shinako; Haltiwanger, Robert S.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Roein-Peikar, Mehdi; Ha, Taekjip] Johns Hopkins Univ Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Zhu, Cheng] Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Ha, Taekjip] Johns Hopkins Univ, Dept Biophys, Baltimore, MD 21218 USA; [Haltiwanger, Robert S.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Johns Hopkins University; University System of Georgia; Georgia Institute of Technology; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Johns Hopkins University; University System of Georgia; Georgia Institute of Technology; Johns Hopkins University; University System of Georgia; University of Georgia	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.; Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.; Garcia, KC (corresponding author), Howard Hughes Med Inst, Stanford, CA 94305 USA.	kcgarcia@stanford.edu	Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258; Ge, Chenghao/0000-0002-1386-3177; Zhu, Cheng/0000-0002-1718-565X	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; NIH [R01-GM097015, K99-CA204738, R01-AI044902, R01-GM061126]; Howard Hughes Medical Institute; NSF Physics Frontier Center [PHY 1430124]; Cancer Research Institute; NATIONAL CANCER INSTITUTE [R00CA204738, K99CA204738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061126, R01GM097015] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NSF Physics Frontier Center(National Science Foundation (NSF)); Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Velasco, K. Jude, B. Bell, and S. Fischer for assistance; M. Elowitz for providing Notch reporter cells; T. Lohman for biotinylated tandem tetramer SSB; the Advanced Photon Source staff for support and access to the 23-ID-B beamline; and the staff of the Stanford Synchrotron Radiation Lightsource, which is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-76SF00515. This work was supported by NIH grant R01-GM097015, a gift from the Mathers Fund, and the Ludwig Cancer Foundation (K.C.G.); the Howard Hughes Medical Institute (K.C.G., T.H., and B.C.K.); a NSF Physics Frontier Center grant (PHY 1430124) (T.H.); an Irvington Postdoctoral Fellowship from the Cancer Research Institute and NIH grant K99-CA204738 (V.C.L); NIH grant R01-AI044902 (C.Z. and C.G); and NIH grant R01-GM061126 (S.K. and R.S.H.). Coordinates and structure factors of the Notch1-Jag1<INF>JV1</INF> complex have been deposited in the Protein Data Bank with accession code 5UK5.	Andrawes MB, 2013, J BIOL CHEM, V288, P25477, DOI 10.1074/jbc.M113.454850; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Chakrabarti S, 2014, P NATL ACAD SCI USA, V111, P9048, DOI 10.1073/pnas.1405384111; Chapman G, 2016, BBA-MOL CELL RES, V1863, P166, DOI 10.1016/j.bbamcr.2015.10.021; Chen W, 2010, J BIOL CHEM, V285, P35967, DOI 10.1074/jbc.M110.155770; Chillakuri CR, 2013, CELL REP, V5, P861, DOI 10.1016/j.celrep.2013.10.029; Chowdhury F, 2016, NANO LETT, V16, P3892, DOI 10.1021/acs.nanolett.6b01403; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Gordon WR, 2015, DEV CELL, V33, P729, DOI 10.1016/j.devcel.2015.05.004; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Kakuda S, 2017, DEV CELL, V40, P193, DOI 10.1016/j.devcel.2016.12.013; Kershaw NJ, 2015, BIOCHEM J, V468, P159, DOI 10.1042/BJ20150010; Luca VC, 2015, SCIENCE, V347, P847, DOI 10.1126/science.1261093; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Parks AL, 2000, DEVELOPMENT, V127, P1373; Rampal R, 2005, J BIOL CHEM, V280, P32133, DOI 10.1074/jbc.M506104200; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Taylor P, 2014, P NATL ACAD SCI USA, V111, P7290, DOI 10.1073/pnas.1319683111; Thomas W, 2006, J CELL BIOL, V174, P911, DOI 10.1083/jcb.200609029; Wang XF, 2013, SCIENCE, V340, P991, DOI 10.1126/science.1231041; Weisshuhn PC, 2016, STRUCTURE, V24, P555, DOI 10.1016/j.str.2016.02.010; Xu AG, 2005, J BIOL CHEM, V280, P30158, DOI 10.1074/jbc.M505569200; Yamamoto S, 2012, SCIENCE, V338, P1229, DOI 10.1126/science.1228745	30	157	158	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1320	+		10.1126/science.aaf9739	http://dx.doi.org/10.1126/science.aaf9739			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28254785	Green Submitted, Green Accepted			2022-12-28	WOS:000397082900041
J	Gao, X; Wang, KL				Gao, Xiang; Wang, Kelin			Rheological separation of the megathrust seismogenic zone and episodic tremor and slip	NATURE			English	Article							SAN-ANDREAS-FAULT; LOW-FREQUENCY EARTHQUAKES; HIKURANGI SUBDUCTION ZONE; 1944 TONANKAI EARTHQUAKE; TERM SLOW SLIP; NEW-ZEALAND; HEAT-FLOW; ACCRETIONARY PRISM; CRUSTAL STRUCTURE; SOUTHWEST JAPAN	Episodic tremor and accompanying slow slip, together called ETS, is most often observed in subduction zones of young and warm subducting slabs(1-3). ETS should help us to understand the mechanics of subduction megathrusts(3,4), but its mechanism is still unclear. It is commonly assumed that ETS represents a transition from seismic to aseismic behaviour of the megathrust with increasing depth, but this assumption is in contradiction with an observed spatial separation between the seismogenic zone and the ETS zone(5-8). Here we propose a unifying model for the necessary geological condition of ETS that explains the relationship between the two zones. By developing numerical thermal models, we examine the governing role of thermopetrologically controlled fault zone rheology (frictional versus viscous shear). High temperatures in the warm-slab environment(9) cause the megathrust seismogenic zone to terminate before reaching the depth of the intersection of the continental Mohorovicic discontinuity (Moho) and the subduction interface, called the mantle wedge corner. High pore-fluid pressures around the mantle wedge corner(10) give rise to an isolated friction zone responsible for ETS. Separating the two zones is a segment of semi-frictional or viscous behaviour. The new model reconciles a wide range of seemingly disparate observations and defines a conceptual framework for the study of slip behaviour and the seismogenesis of major faults.	[Gao, Xiang] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Geol & Environm, 7 Nanhai Rd, Qingdao 266071, Peoples R China; [Gao, Xiang] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Geol, 1 Wenhai Rd, Qingdao 266061, Peoples R China; [Wang, Kelin] Nat Resources Canada, Geol Survey Canada, Pacific Geosci Ctr, 9860 West Saanich Rd, Sidney, BC V8L 4B2, Canada; [Wang, Kelin] Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8P 5C2, Canada	Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao National Laboratory for Marine Science & Technology; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; University of Victoria	Wang, KL (corresponding author), Nat Resources Canada, Geol Survey Canada, Pacific Geosci Ctr, 9860 West Saanich Rd, Sidney, BC V8L 4B2, Canada.; Wang, KL (corresponding author), Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8P 5C2, Canada.	kelin.wang@canada.ca			Chinese Academy of Sciences' Strategic Priority Research Program [XDA11030102]; National Natural Science Foundation of China [41406063]; Geological Survey of Canada; Natural Sciences and Engineering Research Council of Canada through the University of Victoria	Chinese Academy of Sciences' Strategic Priority Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Geological Survey of Canada(Natural Resources Canada); Natural Sciences and Engineering Research Council of Canada through the University of Victoria	We thank J. He for developing the computer code PGCtherm2D employed in this work. X.G. was supported by the Chinese Academy of Sciences' Strategic Priority Research Program (grant XDA11030102) and the National Natural Science Foundation of China (grant 41406063). K.W. was supported by Geological Survey of Canada core funding and Discovery Grant from Natural Sciences and Engineering Research Council of Canada through the University of Victoria. This is Geological Survey of Canada contribution 20160265.	Altamimi Z, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2007JB004949; Angiboust S, 2015, GEOCHEM GEOPHY GEOSY, V16, P1905, DOI 10.1002/2015GC005776; [Anonymous], 2010, J SEISMOL SOC JPN, DOI DOI 10.4294/ZISIN.63.97; Audet P, 2016, TECTONOPHYSICS, V670, P1, DOI 10.1016/j.tecto.2016.01.005; Audet P, 2014, NATURE, V510, P389, DOI 10.1038/nature13391; Audet P, 2009, NATURE, V457, P76, DOI 10.1038/nature07650; Baba T, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022320; Baba T, 2006, TECTONOPHYSICS, V426, P119, DOI 10.1016/j.tecto.2006.02.015; Bachmann R, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005927; Bannister S, 2007, GEOPHYS J INT, V169, P602, DOI 10.1111/j.1365-246X.2007.03345.x; Bannister S, 2004, GEOPHYS J INT, V159, P291, DOI 10.1111/j.1365-246X.2004.02384.x; Becken M, 2011, NATURE, V480, P87, DOI 10.1038/nature10609; Beeler NM, 2013, J GEOPHYS RES-SOL EA, V118, P5976, DOI 10.1002/2013JB010118; Bostock MG, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004391; Bostock MG, 2002, NATURE, V417, P536, DOI 10.1038/417536a; Cavalie O, 2013, EARTH PLANET SC LETT, V367, P52, DOI 10.1016/j.epsl.2013.02.020; Daub EG, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046866; DAVIS EE, 1990, J GEOPHYS RES-SOLID, V95, P8869, DOI 10.1029/JB095iB06p08869; DeMets C, 2010, GEOPHYS J INT, V181, P1, DOI 10.1111/j.1365-246X.2009.04491.x; Dempsey DE, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009218; Di Toro G, 2011, NATURE, V471, P494, DOI 10.1038/nature09838; Dragert H, 2001, SCIENCE, V292, P1525, DOI 10.1126/science.1060152; Dragert H, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008609; Eberhart-Phillips D, 2015, GEOPHYS J INT, V201, P838, DOI 10.1093/gji/ggv057; Frank WB, 2014, J GEOPHYS RES-SOL EA, V119, P7686, DOI 10.1002/2014JB011457; Frank WB, 2013, GEOPHYS RES LETT, V40, P2661, DOI 10.1002/grl.50561; Fry B, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048319; Fulton PM, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006087; Fulton PM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019378; Gao X, 2014, SCIENCE, V345, P1038, DOI 10.1126/science.1255487; Giger SB, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004828; Hayes GP, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008524; Hirauchi K, 2013, GEOLOGY, V41, P75, DOI 10.1130/G33552.1; Hirose H, 2010, SCIENCE, V330, P1502, DOI 10.1126/science.1197102; Husker AL, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003916; Hyndman RD, 2015, J GEOPHYS RES-SOL EA, V120, P4344, DOI 10.1002/2015JB011920; Ichinose GA, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2003JB002393; Ide S., 2016, J GEOPHYS RES, V121, P1; Ide S, 2007, NATURE, V447, P76, DOI 10.1038/nature05780; Ide S, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008840; Igarashi T, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001920; Iinuma T, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009186; Ito Y, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025270; Jodicke H, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003739; Johnson KM, 2013, GEOPHYS RES LETT, V40, DOI 10.1002/grl.50216; Kao H, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006046; Kato A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043723; Kim Y, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006942; Kim Y, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004033; Kirby SH, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-67; Kobayashi A, 2012, J SEISMOL SOC JPN, V64, P63, DOI DOI 10.4294/ZISIN.64.63; Kobayashi A, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-9; Kodaira S, 2004, SCIENCE, V304, P1295, DOI 10.1126/science.1096535; KOSTOGLODOV V, 1995, J GEOPHYS RES-SOL EA, V100, P17977, DOI 10.1029/95JB01484; Kostoglodov V., 1999, CIEN ANOS SISMICIDAD; Kostoglodov V, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045424; Larson KM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029912; Liu YJ, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006142; Loveless JP, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2008JB006248; Lowry A. R., 2005, GEOPHYS J INT, V200, P1; Matsuzawa T, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007566; Maury J, 2016, J GEOPHYS RES-SOL EA, V121, P5136, DOI 10.1002/2016JB013027; McCrory PA, 2016, GEOCHEM GEOPHY GEOSY, V17, P2434, DOI 10.1002/2015GC006198; Muller RD, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001743; Murray J, 2006, B SEISMOL SOC AM, V96, pS283, DOI 10.1785/0120050820; Nadeau RM, 2005, SCIENCE, V307, P389, DOI 10.1126/science.1107142; Nadeau RM, 2009, SCIENCE, V325, P191, DOI 10.1126/science.1174155; Nakajima J, 2002, PHYS EARTH PLANET IN, V130, P31, DOI 10.1016/S0031-9201(01)00307-7; Nakamura W., 2016, J GEOPHYS RES, V121, P1; Nakanishi A, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000424; Obara K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020848; Obara K, 2002, SCIENCE, V296, P1679, DOI 10.1126/science.1070378; Obara K, 2011, J GEODYN, V52, P229, DOI 10.1016/j.jog.2011.04.002; OKINO K, 1994, J GEOMAGN GEOELECTR, V46, P463, DOI 10.5636/jgg.46.463; Ozawa S, 2013, EARTH PLANETS SPACE, V65, P67, DOI 10.5047/eps.2012.06.009; Payero JS, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032877; Peacock SM, 2011, GEOLOGY, V39, P471, DOI 10.1130/G31649.1; Peng ZG, 2010, NAT GEOSCI, V3, P599, DOI 10.1038/NGEO940; Peng ZG, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006049; Rogers G, 2003, SCIENCE, V300, P1942, DOI 10.1126/science.1084783; Royer AA, 2014, EARTH PLANET SC LETT, V402, P247, DOI 10.1016/j.epsl.2013.08.040; Saffer DM, 2015, NAT GEOSCI, V8, P594, DOI [10.1038/ngeo2490, 10.1038/NGEO2490]; Sass JH, 1997, J GEOPHYS RES-SOL EA, V102, P27575, DOI 10.1029/97JB02350-B; Schwartz SY, 2007, REV GEOPHYS, V45, DOI 10.1029/2006RG000208; Sekine S, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2008JB006059; Shelly DR, 2006, NATURE, V442, P188, DOI 10.1038/nature04931; Shelly DR, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043672; Shimamoto T, 2014, J GEOPHYS RES-SOL EA, V119, P8089, DOI 10.1002/2014JB011170; Song TRA, 2009, SCIENCE, V324, P502, DOI 10.1126/science.1167595; Takagi R, 2016, GEOPHYS RES LETT, V43, P1066, DOI 10.1002/2015GL066987; Thomas AM, 2009, NATURE, V462, P1048, DOI 10.1038/nature08654; Tietze K, 2013, GEOPHYS J INT, V195, P130, DOI 10.1093/gji/ggt234; Tsuji T, 2013, EARTH PLANET SC LETT, V364, P44, DOI 10.1016/j.epsl.2012.12.038; Wada I, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005190; Wada I, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002570; Waldhauser F, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005479; Wallace LM, 2013, GEOPHYS RES LETT, V40, P5393, DOI 10.1002/2013GL057682; Wallace LM, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007717; Wallace LM, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002610; Wang KL, 2016, J GEODYN, V98, P1, DOI 10.1016/j.jog.2016.03.010; Wang KL, 2014, TECTONOPHYSICS, V610, P1, DOI 10.1016/j.tecto.2013.11.024; Wang KL, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002888; Wang P.-L., 2013, J GEOPHYS RES, V118, P1; Wannamaker PE, 2014, GEOCHEM GEOPHY GEOSY, V15, P4230, DOI 10.1002/2014GC005509; Wech AG, 2011, NAT GEOSCI, V4, P624, DOI 10.1038/ngeo1215; Williams CF, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019352; Williams CA, 2013, SEISMOL RES LETT, V84, P1066, DOI 10.1785/0220130035; WILSON DS, 1988, J GEOPHYS RES-SOLID, V93, P11863, DOI 10.1029/JB093iB10p11863; Wu CQ, 2013, EARTH PLANET SC LETT, V368, P144, DOI 10.1016/j.epsl.2013.03.007; Yamanaka Y, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002683; Zeng XF, 2016, GEOPHYS J INT, V206, P1574, DOI 10.1093/gji/ggw217; Zhu LP, 2000, EARTH PLANET SC LETT, V179, P183, DOI 10.1016/S0012-821X(00)00101-1	112	133	140	7	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2017	543	7645					416	+		10.1038/nature21389	http://dx.doi.org/10.1038/nature21389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9RN	28264194				2022-12-28	WOS:000396337400049
J	Rodriguez-Colman, MJ; Schewe, M; Meerlo, M; Stigter, E; Gerrits, J; Pras-Raves, M; Sacchetti, A; Hornsveld, M; Oost, KC; Snippert, HJ; Verhoeven-Duif, N; Fodde, R; Burgering, BMT				Rodriguez-Colman, Maria J.; Schewe, Matthias; Meerlo, Maaike; Stigter, Edwin; Gerrits, Johan; Pras-Raves, Mia; Sacchetti, Andrea; Hornsveld, Marten; Oost, Koen C.; Snippert, Hugo J.; Verhoeven-Duif, Nanda; Fodde, Riccardo; Burgering, Boudewijn M. T.			Interplay between metabolic identities in the intestinal crypt supports stem cell function	NATURE			English	Article							CANCER-CELLS; NUCLEAR-DNA; P38 MAPK; COLON; PROGENITORS; DICHLOROACETATE; DIFFERENTIATION; IDENTIFICATION	The small intestinal epithelium self-renews every four or five days. Intestinal stem cells (Lgr5(+) crypt base columnar cells (CBCs)) sustain this renewal and reside between terminally differentiated Paneth cells at the bottom of the intestinal crypt(1). Whereas the signalling requirements for maintaining stem cell function and crypt homeostasis have been well studied, little is known about how metabolism contributes to epithelial homeostasis. Here we show that freshly isolated Lgr5(+) CBCs and Paneth cells from the mouse small intestine display different metabolic programs. Compared to Paneth cells, Lgr5(+) CBCs display high mitochondrial activity. Inhibition of mitochondrial activity in Lgr5(+) CBCs or inhibition of glycolysis in Paneth cells strongly affects stem cell function, as indicated by impaired organoid formation. In addition, Paneth cells support stem cell function by providing lactate to sustain the enhanced mitochondrial oxidative phosphorylation in the Lgr5(+) CBCs. Mechanistically, we show that oxidative phosphorylation stimulates p38 MAPK activation by mitochondrial reactive oxygen species signalling, thereby establishing the mature crypt phenotype. Together, our results reveal a critical role for the metabolic identity of Lgr5(+) CBCs and Paneth cells in supporting optimal stem cell function, and we identify mitochondria and reactive oxygen species signalling as a driving force of cellular differentiation.	[Rodriguez-Colman, Maria J.; Meerlo, Maaike; Stigter, Edwin; Hornsveld, Marten; Oost, Koen C.; Snippert, Hugo J.; Burgering, Boudewijn M. T.] Univ Med Ctr Utrecht, Ctr Mol Med, Mol Canc Res, Heidelberglaan 100, NL-3584 CG Utrecht, Netherlands; [Schewe, Matthias; Sacchetti, Andrea; Fodde, Riccardo] Erasmus Univ, Med Ctr, Erasmus MC Canc Inst, Dept Pathol, Rotterdam, Netherlands; [Gerrits, Johan; Pras-Raves, Mia; Verhoeven-Duif, Nanda] Dept Genet, Lundlaan 6, NL-3584 EA Utrecht, Netherlands; [Gerrits, Johan; Pras-Raves, Mia; Verhoeven-Duif, Nanda] Ctr Mol Med, Lundlaan 6, NL-3584 EA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	Burgering, BMT (corresponding author), Univ Med Ctr Utrecht, Ctr Mol Med, Mol Canc Res, Heidelberglaan 100, NL-3584 CG Utrecht, Netherlands.	b.m.t.burgering@umcutrecht.nl	Fodde, Riccardo/AAW-9394-2021; Sacchetti, Andrea/H-8763-2019	Fodde, Riccardo/0000-0001-9839-4324; Rodriguez-Colman, Maria J./0000-0001-8382-5128; Oost, Koen/0000-0002-5162-9939	CGC.nl; Utrecht Life Sciences; Dutch Cancer Society [EMCR 2012-5473, UU 2013-6070]; Netherlands Institute of Regenerative Medicine	CGC.nl; Utrecht Life Sciences; Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Institute of Regenerative Medicine	This work was financially supported by CGC.nl (M.J.R.-C., H.J.S.), Utrecht Life Sciences (M.M.), Dutch Cancer Society ((KWF), EMCR 2012-5473 (M.S.), and UU 2013-6070 (K.C.O.)) and from the Netherlands Institute of Regenerative Medicine (R.F.). We thank H. Bos, T. Dansen and S. van Mil for helpful discussions and proofreading; F. de Sauvage (Genentech) for providing DTR-LGR5-GFP mice; T. Dick (DKFZ) for mtGrx1-roGFP and I. Verlaan (UMC Utrecht) for R-spondin/Wnt3a-conditioned medium.	Aguer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028536; Baker K, 1998, J PHARMACOL EXP THER, V284, P215; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Chambers MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050679; Cleaver JE, 2014, P NATL ACAD SCI USA, V111, P13487, DOI 10.1073/pnas.1414135111; Fordham RP, 2013, CELL STEM CELL, V13, P734, DOI 10.1016/j.stem.2013.09.015; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; Hamanaka RB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003638; Hoffmann S, 2004, FREE RADICAL BIO MED, V36, P765, DOI 10.1016/j.freeradbiomed.2003.12.019; Kankotia S, 2014, BBA-REV CANCER, V1846, P617, DOI 10.1016/j.bbcan.2014.08.005; Liang R, 2014, ANTIOXID REDOX SIGN, V20, P1902, DOI 10.1089/ars.2013.5300; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Morgan B, 2011, FREE RADICAL BIO MED, V51, P1943, DOI 10.1016/j.freeradbiomed.2011.08.035; Mustata RC, 2013, CELL REP, V5, P421, DOI 10.1016/j.celrep.2013.09.005; Otsuka M, 2010, GASTROENTEROLOGY, V138, P1255, DOI 10.1053/j.gastro.2010.01.005; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Regot S, 2014, CELL, V157, P1724, DOI 10.1016/j.cell.2014.04.039; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schewe M, 2016, CELL STEM CELL, V19, P38, DOI 10.1016/j.stem.2016.05.023; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Song IS, 2015, GASTROENTEROLOGY, V149, P1006, DOI 10.1053/j.gastro.2015.06.007; Tormos AM, 2013, FREE RADICAL RES, V47, P905, DOI 10.3109/10715762.2013.821200; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; Vermeulen J. L., 2015, J VIS EXP; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Yin XL, 2016, CELL STEM CELL, V18, P25, DOI 10.1016/j.stem.2015.12.005; Yin XL, 2014, NAT METHODS, V11, P106, DOI 10.1038/nmeth.2737; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zhdanov AV, 2014, BBA-BIOENERGETICS, V1837, P51, DOI 10.1016/j.bbabio.2013.07.008	36	246	252	11	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2017	543	7645					424	+		10.1038/nature21673	http://dx.doi.org/10.1038/nature21673			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9RN	28273069				2022-12-28	WOS:000396337400051
J	Matsui, EC; Perzanowski, M; Peng, RD; Wise, RA; Balcer-Whaley, S; Newman, M; Cunningham, A; Divjan, A; Bollinger, ME; Zhai, SY; Chew, G; Miller, RL; Phipatanakul, W				Matsui, Elizabeth C.; Perzanowski, Matthew; Peng, Roger D.; Wise, Robert A.; Balcer-Whaley, Susan; Newman, Michelle; Cunningham, Amparito; Divjan, Adnan; Bollinger, Mary E.; Zhai, Shuyan; Chew, Ginger; Miller, Rachel L.; Phipatanakul, Wanda			Effect of an Integrated Pest Management Intervention on Asthma Symptoms Among Mouse-Sensitized Children and Adolescents With Asthma A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INNER-CITY CHILDREN; ENVIRONMENTAL INTERVENTION; ALLERGEN EXPOSURE; HOMES; SCHOOLS; HEALTH; AIR	IMPORTANCE Professionally delivered integrated pest management (IPM) interventions can reduce home mouse allergen concentrations, but whether they reduce asthma morbidity among mouse-sensitized and exposed children and adolescents is unknown. OBJECTIVE To determine the effect of an IPM intervention on asthma morbidity among mouse-sensitized and exposed children and adolescents with asthma. DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial conducted in Baltimore, Maryland, and Boston, Massachusetts. Participants were mouse-sensitized and exposed children and adolescents (aged 5-17 years) with asthma randomized to receive professionally delivered IPM plus pest management education or pest management education alone. Enrollment occurred between May 2010 and August 2014; the final follow-up visit occurred on September 25, 2015. INTERVENTIONS Integrated pest management consisted of application of rodenticide, sealing of holes that could serve as entry points for mice, trap placement, targeted cleaning, allergen-proof mattress and pillow encasements, and portable air purifiers. Infestation was assessed every 3 months, and if infestation persisted or recurred, additional treatments were delivered. All participants received pest management education, which consisted of written material and demonstration of the materials needed to set traps and seal holes. MAIN OUTCOMES AND MEASURES The primary outcome was maximal symptom days defined as the highest number of days of symptoms in the previous 2 weeks among 3 types of symptoms (days of slowed activity due to asthma; number of nights of waking with asthma symptoms; and days of coughing, wheezing, or chest tightness) across 6, 9, and 12 months. RESULTS Of 361 children and adolescents who were randomized (mean [SD] age, 9.8 [3.2] years; 38% female; 181 in IPM plus pest management education group and 180 in pest management education alone group), 334 were included in the primary analysis. For the primary outcome, there was no statistically significant between-group difference for maximal symptom days across 6, 9, and 12 months with a median of 2.0 (interquartile range, 0.7-4.7) maximal symptom days in the IPM plus pest management education group and 2.7 (interquartile range, 1.3-5.0) maximal symptom days in the pest management education alone group (P = .16) and a ratio of symptom frequencies of 0.86 (95% CI, 0.69-1.06). CONCLUSIONS AND RELEVANCE Among mouse-sensitized and exposed children and adolescents with asthma, an intensive year-long integrated pest management intervention plus pest management education vs pest management education alone resulted in no significant difference in maximal symptom days from 6 to 12 months.	[Matsui, Elizabeth C.; Balcer-Whaley, Susan; Newman, Michelle; Zhai, Shuyan] Johns Hopkins Univ, Sch Med, Div Pediat Allergy Immunol, Baltimore, MD USA; [Perzanowski, Matthew; Divjan, Adnan; Chew, Ginger; Miller, Rachel L.] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY USA; [Peng, Roger D.] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Wise, Robert A.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA; [Cunningham, Amparito; Phipatanakul, Wanda] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Pediat Allergy Immunol, Boston, MA USA; [Bollinger, Mary E.] Univ Maryland, Sch Med, Div Pulm Allergy & Immunol, Baltimore, MD 21201 USA; [Miller, Rachel L.] Columbia Univ, Coll Phys & Surg, Div Pulm Allergy & Crit Care Med, New York, NY USA; [Miller, Rachel L.] Columbia Univ, Coll Phys & Surg, Div Pediat Allergy Immunol & Rheumatol, New York, NY USA	Johns Hopkins University; Columbia University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Harvard University; Boston Children's Hospital; Harvard Medical School; University System of Maryland; University of Maryland Baltimore; Columbia University; Columbia University	Matsui, EC (corresponding author), Johns Hopkins Univ Hosp, 600 N Wolfe St,CMSC 1102, Baltimore, MD 21287 USA.	ematsui@jhmi.edu		Matsui, Elizabeth/0000-0001-8134-5593; Divjan, Adnan/0000-0002-8895-5965; Wise, Robert/0000-0002-8353-2349	National Institute of Allergy and Infectious Diseases [U01Al083238, K24 AI114769, K24 AI106822]; National Institute of Environmental Health Sciences [R01 ES023447, R01 ES026170]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI114769, R34AI074928, R01AI070630, K24AI106822, U01AI083238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES023447, R01ES026170, P30ES009089] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants U01Al083238, K24 AI114769, and K24 AI106822 from the National Institute of Allergy and Infectious Diseases and grants R01 ES023447 and R01 ES026170 from the National Institute of Environmental Health Sciences. The 3M Corporation donated air purifiers and CleanBrands LLC donated allergen-proof mattress and pillow encasements for the study.	Ahluwalia SK, 2013, J ALLERGY CLIN IMMUN, V132, P830, DOI 10.1016/j.jaci.2013.05.005; Chew GL, 2005, INDOOR AIR, V15, P228, DOI 10.1111/j.1600-0668.2005.00363.x; Chew GL, 2003, ENVIRON HEALTH PERSP, V111, P1348, DOI 10.1289/ehp.6124; DiMango E, 2016, J ALLER CL IMM-PRACT, V4, P671, DOI 10.1016/j.jaip.2016.01.016; Eggleston PA, 2016, J ALLER CL IMM-PRACT, V4, P680, DOI 10.1016/j.jaip.2016.04.017; Matsui EC, 2005, J ALLERGY CLIN IMMUN, V115, P358, DOI 10.1016/j.jaci.2004.11.007; Matsui EC, 2006, ANN ALLERG ASTHMA IM, V97, P514, DOI 10.1016/S1081-1206(10)60943-X; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; Paulson JA, 2006, ENVIRON HEALTH PERSP, V114, P1603, DOI 10.1289/ehp.9000; Permaul P, 2012, PEDIAT ALLERG IMM-UK, V23, P543, DOI 10.1111/j.1399-3038.2012.01327.x; Perry TT, 2008, ANN ALLERG ASTHMA IM, V100, P358, DOI 10.1016/S1081-1206(10)60599-6; Phipatanakul W, 2004, ANN ALLERG ASTHMA IM, V92, P420, DOI 10.1016/S1081-1206(10)61777-2; Phipatanakul W, 2000, J ALLERGY CLIN IMMUN, V106, P1070, DOI 10.1067/mai.2000.110796; Pongracic JA, 2008, ANN ALLERG ASTHMA IM, V101, P35, DOI 10.1016/S1081-1206(10)60832-0; Szefler S, 2000, NEW ENGL J MED, V343, P1054; Wildfire JJ, 2012, J ALLERGY CLIN IMMUN, V129, P694, DOI 10.1016/j.jaci.2011.12.962	16	70	70	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2017	317	10					1027	1036		10.1001/jama.2016.21048	http://dx.doi.org/10.1001/jama.2016.21048			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO5DO	28264080	Green Accepted			2022-12-28	WOS:000396713400015
J	Cardis, MA; Pasieka, HB				Cardis, Michael A.; Pasieka, Helena B.			Grouped Pustules on an Erythematous Base	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cardis, Michael A.; Pasieka, Helena B.] MedStar Georgetown Univ Hosp, Washington, DC 20007 USA	Georgetown University	Pasieka, HB (corresponding author), MedStar Georgetown Univ Hosp, Washington, DC 20007 USA.	helena.b.pasieka@medstar.net	Cardis, Michael/V-6223-2019	Cardis, Michael/0000-0003-4547-101X					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2017	376	10					971	971		10.1056/NEJMicm1609042	http://dx.doi.org/10.1056/NEJMicm1609042			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9JA	28273013				2022-12-28	WOS:000395626500013
J	Drane, P; Brault, ME; Cui, GF; Meghani, K; Chaubey, S; Detappe, A; Parnandi, N; He, YZ; Zheng, XF; Botuyan, MV; Kalousi, A; Yewdell, WT; Munch, C; Harper, JW; Chaudhuri, J; Soutoglou, E; Mer, G; Chowdhury, D				Drane, Pascal; Brault, Marie-Eve; Cui, Gaofeng; Meghani, Khyati; Chaubey, Shweta; Detappe, Alexandre; Parnandi, Nishita; He, Yizhou; Zheng, Xiao-Feng; Botuyan, Maria Victoria; Kalousi, Alkmini; Yewdell, William T.; Muench, Christian; Harper, J. Wade; Chaudhuri, Jayanta; Soutoglou, Evi; Mer, Georges; Chowdhury, Dipanjan			TIRR regulates 53BP1 by masking its histone methyl-lysine binding function	NATURE			English	Article							STRAND BREAK REPAIR; DNA BREAKS; CYTOPLASMIC DOMAIN; PROTEIN; RECRUITMENT; INHIBITORS; SYNDECAN-4; RESECTION; SYNDESMOS; SITES	P53-binding protein 1 (53BP1) is a multi-functional double-strand break repair protein that is essential for class switch recombination in B lymphocytes and for sensitizing BRCA1-deficient tumours to poly-ADP-ribose polymerase-1 (PARP) inhibitors. Central to all 53BP1 activities is its recruitment to double-strand breaks via the interaction of the tandem Tudor domain with dimethylated lysine 20 of histone H4 (H4K20me2). Here we identify an uncharacterized protein, Tudor interacting repair regulator (TIRR), that directly binds the tandem Tudor domain and masks its H4K20me2 binding motif. Upon DNA damage, the protein kinase ataxia-telangiectasia mutated (ATM) phosphorylates 53BP1 and recruits RAP1-interacting factor 1 (RIF1) to dissociate the 53BP1-TIRR complex. However, overexpression of TIRR impedes 53BP1 function by blocking its localization to double-strand breaks. Depletion of TIRR destabilizes 53BP1 in the nuclear-soluble fraction and alters the double-strand break-induced protein complex centring 53BP1. These findings identify TIRR as a new factor that influences double-strand break repair using a unique mechanism of masking the histone methyl-lysine binding function of 53BP1.	[Drane, Pascal; Brault, Marie-Eve; Meghani, Khyati; Chaubey, Shweta; Detappe, Alexandre; Parnandi, Nishita; He, Yizhou; Zheng, Xiao-Feng; Chowdhury, Dipanjan] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Cui, Gaofeng; Botuyan, Maria Victoria; Mer, Georges] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Kalousi, Alkmini; Soutoglou, Evi] IGBMC, F-67404 Illkirch Graffenstaden, France; [Yewdell, William T.; Chaudhuri, Jayanta] Mem Sloan Kettering Canc Ctr, Gerstner Sloan Kettering Grad Sch, Immunol Program, New York, NY 10065 USA; [Muench, Christian; Harper, J. Wade] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Chaudhuri, Jayanta] Weill Cornell Med Sch, Immunol & Microbial Pathogenesis Program, New York, NY 10065 USA; [Chowdhury, Dipanjan] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Chowdhury, Dipanjan] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Muench, Christian] Goethe Univ, Sch Med, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany	Harvard University; Dana-Farber Cancer Institute; Mayo Clinic; Institut National de la Sante et de la Recherche Medicale (Inserm); Memorial Sloan Kettering Cancer Center; Harvard University; Harvard Medical School; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Goethe University Frankfurt	Chowdhury, D (corresponding author), Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA.; Chowdhury, D (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Chowdhury, D (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	dipanjan_chowdhury@dfci.harvard.edu	Detappe, Alexandre/HGC-4905-2022; Mer, Georges/AAT-4946-2021; Munch, Christian/AAW-7256-2020; cui, gaofeng/A-1107-2013	Mer, Georges/0000-0002-1900-1578; Soutoglou, Evi/0000-0002-3724-5613; cui, gaofeng/0000-0001-5267-9033; Zheng, Xiao-Feng/0000-0001-8769-4604; Munch, Christian/0000-0003-3832-090X; Detappe, Alexandre/0000-0001-9364-1621; Parnandi, Nishita/0000-0003-2903-3773; Botuyan, Maria Victoria/0000-0002-6466-7432; He, Yizhou/0000-0002-1396-7275; Harper, Jeffrey/0000-0002-6944-7236	National Institute of Allergy and Infectious Diseases [R01 AI101897-01]; National Cancer Institute [R01CA142698-07, 4T32CA009149-40]; Leukemia and Lymphoma Society Scholar Grant; Claudia Adams Barr Program for Innovative Cancer Research; Department of Defense Ovarian Cancer Award; Breast SPORE Pilot Award; Robert and Deborah First Fund Award; National Institutes of Health [R01 CA132878, R01 GM116829]; Mayo Clinic Brain Cancer SPORE Program Pilot Award [P50 CA108961]; National Institutes of Health/National Institute of Allergy and Infectious Disease grants [1RO1AI072194, 1RO1AI124186]; National Cancer Institute Cancer Center Support grant [P30CA008748];  [AG011085]; NATIONAL CANCER INSTITUTE [T32CA009149, R01CA142698, P50CA108961, R01CA132878, P30CA008748, T32CA009361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101897, R01AI124186, R01AI072194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116829] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society Scholar Grant(Leukemia and Lymphoma Society); Claudia Adams Barr Program for Innovative Cancer Research; Department of Defense Ovarian Cancer Award(United States Department of Defense); Breast SPORE Pilot Award; Robert and Deborah First Fund Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Brain Cancer SPORE Program Pilot Award; National Institutes of Health/National Institute of Allergy and Infectious Disease grants; National Cancer Institute Cancer Center Support grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to L. Xu for RIF1 antibody and S. Boulton for RIF1<SUP>-/-</SUP> MEFs. D.C. is supported by R01 AI101897-01 (National Institute of Allergy and Infectious Diseases) and R01CA142698-07 (National Cancer Institute), a Leukemia and Lymphoma Society Scholar Grant, the Claudia Adams Barr Program for Innovative Cancer Research, a Department of Defense Ovarian Cancer Award, a Breast SPORE Pilot Award, and a Robert and Deborah First Fund Award. G.M. is supported by National Institutes of Health grants R01 CA132878 and R01 GM116829, and a Mayo Clinic Brain Cancer SPORE Program Pilot Award (P50 CA108961). J.W.H. is supported by AG011085. J.C. is supported by National Institutes of Health/National Institute of Allergy and Infectious Disease grants (1RO1AI072194 and 1RO1AI124186) and a National Cancer Institute Cancer Center Support grant (P30CA008748). W.T.Y. is supported by a training grant from the National Cancer Institute (4T32CA009149-40).	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; Baciu PC, 2000, J CELL SCI, V113, P315; Bothmer A, 2013, J EXP MED, V210, P115, DOI 10.1084/jem.20121975; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Chapman JR, 2012, J CELL SCI, V125, P3529, DOI 10.1242/jcs.105353; Charier G, 2004, STRUCTURE, V12, P1551, DOI 10.1016/j.str.2004.06.014; Cui GF, 2009, BIOCHEMISTRY-US, V48, P3798, DOI 10.1021/bi900348z; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denhez F, 2002, J BIOL CHEM, V277, P12270, DOI 10.1074/jbc.M110291200; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Dong JC, 2015, NATURE, V525, P134, DOI 10.1038/nature14970; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Feng L, 2013, J BIOL CHEM, V288, P11135, DOI 10.1074/jbc.M113.457440; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Hartlerode AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049211; Iwabuchi K, 2003, J BIOL CHEM, V278, P36487, DOI 10.1074/jbc.M304066200; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jowsey P, 2007, DNA REPAIR, V6, P1536, DOI 10.1016/j.dnarep.2007.04.011; Kim H, 2015, BIOCHEM BIOPH RES CO, V463, P762, DOI 10.1016/j.bbrc.2015.06.010; Lee DH, 2014, MOL CELL, V54, P512, DOI 10.1016/j.molcel.2014.03.020; Lemaitre C, 2012, ONCOGENE, V31, P4803, DOI 10.1038/onc.2011.638; Lord CJ, 2013, NAT MED, V19, P1381, DOI 10.1038/nm.3369; Lu R, 2013, TRENDS BIOCHEM SCI, V38, P546, DOI 10.1016/j.tibs.2013.08.002; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Macnaughtan MA, 2005, J AM CHEM SOC, V127, P17626, DOI 10.1021/ja056977r; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Orthwein A, 2014, SCIENCE, V344, P189, DOI 10.1126/science.1248024; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Sandhu SK, 2011, CURR DRUG TARGETS, V12, P2034; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Tang JB, 2013, NAT STRUCT MOL BIOL, V20, P317, DOI 10.1038/nsmb.2499; Taylor MJ, 2008, NUCLEIC ACIDS RES, V36, P6021, DOI 10.1093/nar/gkn605; Wagner T, 2014, CHEMMEDCHEM, V9, P466, DOI 10.1002/cmdc.201300422; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Yap TA, 2011, CA-CANCER J CLIN, V61, P31, DOI 10.3322/caac.20095; Zimmerman M, 2014, TRENDS CELL BIOL, V24, P108, DOI 10.1016/j.tcb.2013.09.003; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573; Zong DL, 2015, NUCLEIC ACIDS RES, V43, P4950, DOI 10.1093/nar/gkv336	51	71	77	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2017	543	7644					211	+		10.1038/nature21358	http://dx.doi.org/10.1038/nature21358			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0GQ	28241136	Green Accepted			2022-12-28	WOS:000395688700032
J	Gibney, E				Gibney, Elizabeth			A MATTER OF TIME	NATURE			English	News Item																		Else DV, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.090402; Khemani V, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.250401; Wilczek F, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.160401	6	7	8	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2017	543	7644					164	166		10.1038/543164a	http://dx.doi.org/10.1038/543164a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0GQ	28277535				2022-12-28	WOS:000395688700009
J	Natterer, FD; Yang, K; Paul, W; Willke, P; Choi, TY; Greber, T; Heinrich, AJ; Lutz, CP				Natterer, Fabian D.; Yang, Kai; Paul, William; Willke, Philip; Choi, Taeyoung; Greber, Thomas; Heinrich, Andreas J.; Lutz, Christopher P.			Reading and writing single-atom magnets	NATURE			English	Article							MOLECULE MAGNETS; ANISOTROPY; SCALE	The single-atom bit represents the ultimate limit of the classical approach to high-density magnetic storage media. So far, the smallest individually addressable bistable magnetic bits have consisted of 3-12 atoms(1-3). Long magnetic relaxation times have been demonstrated for single lanthanide atoms in molecular magnets(4-12), for lanthanides diluted in bulk crystals(13), and recently for ensembles of holmium (Ho) atoms supported on magnesium oxide (MgO)(14). These experiments suggest a path towards data storage at the atomic limit, but the way in which individual magnetic centres are accessed remains unclear. Here we demonstrate the reading and writing of the magnetism of individual Ho atoms on MgO, and show that they independently retain their magnetic information over many hours. We read the Ho states using tunnel magnetoresistance(15,16) and write the states with current pulses using a scanning tunnelling microscope. The magnetic origin of the long-lived states is confirmed by single-atom electron spin resonance(17) on a nearby iron sensor atom, which also shows that Ho has a large out-of-plane moment of 10.1 +/- 0.1 Bohr magnetons on this surface. To demonstrate independent reading and writing, we built an atomic-scale structure with two Ho bits, to which we write the four possible states and which we read out both magnetoresistively and remotely by electron spin resonance. The high magnetic stability combined with electrical reading and writing shows that single-atom magnetic memory is indeed possible.	[Natterer, Fabian D.; Yang, Kai; Paul, William; Willke, Philip; Choi, Taeyoung; Greber, Thomas; Lutz, Christopher P.] IBM Almaden Res Ctr, San Jose, CA 95120 USA; [Natterer, Fabian D.] Ecole Polytech Fed Lausanne, Inst Phys, CH-1015 Lausanne, Switzerland; [Yang, Kai] Univ Chinese Acad Sci, Sch Phys Sci, Beijing 100049, Peoples R China; [Yang, Kai] Univ Chinese Acad Sci, Key Lab Vacuum Phys, Beijing 100049, Peoples R China; [Willke, Philip] Univ Gottingen, Phys Inst 4, Friedrich Hund Pl 1, D-37077 Gottingen, Germany; [Greber, Thomas] Univ Zurich, Inst Phys, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Heinrich, Andreas J.] Ctr Quantum Nanosci, Inst Basic Sci, Seoul, South Korea; [Heinrich, Andreas J.] Ewha Womans Univ, Dept Phys, Seoul, South Korea	International Business Machines (IBM); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Gottingen; University of Zurich; Institute for Basic Science - Korea (IBS); Ewha Womans University	Natterer, FD; Lutz, CP (corresponding author), IBM Almaden Res Ctr, San Jose, CA 95120 USA.; Natterer, FD (corresponding author), Ecole Polytech Fed Lausanne, Inst Phys, CH-1015 Lausanne, Switzerland.; Heinrich, AJ (corresponding author), Ctr Quantum Nanosci, Inst Basic Sci, Seoul, South Korea.; Heinrich, AJ (corresponding author), Ewha Womans Univ, Dept Phys, Seoul, South Korea.	fabian.natterer@epfl.ch; heinrich@ewha.ac.kr; cplutz@us.ibm.com	Natterer, Fabian Donat/Y-6493-2019; Willke, Philip/Q-3441-2018; Yang, Kai/H-8288-2013; Greber, Thomas/D-9509-2015; Natterer, Fabian Donat/I-4016-2012	Willke, Philip/0000-0002-7215-8419; Yang, Kai/0000-0002-5863-3666; Greber, Thomas/0000-0002-5234-1937; Cador, Olivier/0000-0003-2064-6223; Natterer, Fabian Donat/0000-0002-2488-5988	Office of Naval Research; Swiss National Science Foundation [P300P2_158468, PZ00P2_167965]; National Natural Science Foundation of China [61471337]; Natural Sciences and Engineering Research Council of Canada; German academic exchange service	Office of Naval Research(Office of Naval Research); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); German academic exchange service(Deutscher Akademischer Austausch Dienst (DAAD))	We thank B. Melior for technical assistance and F. Donati for discussions. We acknowledge financial support from the Office of Naval Research. F.D.N. appreciates support from the Swiss National Science Foundation under project numbers P300P2_158468 and PZ00P2_167965, and help from A. Natterer. K.Y. acknowledges support from National Natural Science Foundation of China (grant number 61471337). W.P. thanks the Natural Sciences and Engineering Research Council of Canada for fellowship support. P.W. acknowledges financial support from the German academic exchange service. T.G. thanks B. Delley for discussions and IBM Research for its hospitality.	Baumann S, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.237202; Baumann S, 2015, SCIENCE, V350, P417, DOI 10.1126/science.aac8703; Bogani L, 2008, NAT MATER, V7, P179, DOI 10.1038/nmat2133; Choi T., 2017, NAT NANOTECHNOL; Coffey D, 2015, SCI REP-UK, V5, DOI 10.1038/srep13709; Donati F, 2016, SCIENCE, V352, P318, DOI 10.1126/science.aad9898; Donati F, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.237201; Donati F, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.177201; Gambardella P, 2003, SCIENCE, V300, P1130, DOI 10.1126/science.1082857; Gatteschi D., 2011, MOL NANOMAGNETS; Giraud R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.057203; Ishikawa N, 2003, J AM CHEM SOC, V125, P8694, DOI 10.1021/ja029629n; Khajetoorians AA, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.157204; Khajetoorians AA, 2016, SCIENCE, V352, P296, DOI 10.1126/science.aaf2481; Khajetoorians AA, 2013, SCIENCE, V339, P55, DOI 10.1126/science.1228519; Kyatskaya S, 2009, J AM CHEM SOC, V131, P15143, DOI 10.1021/ja906165e; Lacroix C, 2011, INTRO FRUSTRATED MAG; Layfield RA, 2014, ORGANOMETALLICS, V33, P1084, DOI 10.1021/om401107f; Liddle ST, 2015, CHEM SOC REV, V44, P6655, DOI 10.1039/c5cs00222b; Loth S, 2012, SCIENCE, V335, P196, DOI 10.1126/science.1214131; Loth S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/125021; MESERVEY R, 1980, PHYS REV B, V22, P1331, DOI 10.1103/PhysRevB.22.1331; Miyamachi T, 2013, NATURE, V503, P242, DOI 10.1038/nature12759; Pal J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.126102; Paul W., 2016, NAT PHYS; Paul W, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4955446; Rinehart JD, 2011, CHEM SCI, V2, P2078, DOI 10.1039/c1sc00513h; Schintke S, 2004, J PHYS-CONDENS MAT, V16, pR49, DOI 10.1088/0953-8984/16/4/R02; Steinbrecher M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10454; Vincent R, 2012, NATURE, V488, P357, DOI 10.1038/nature11341; Wackerlin C, 2016, ADV MATER, V28, P5195, DOI [10.1002/adma.201506305, 10.1002/adma.201670180]; Westerstrom R, 2012, J AM CHEM SOC, V134, P9840, DOI 10.1021/ja301044p; Wiesendanger R, 2009, REV MOD PHYS, V81, P1495, DOI 10.1103/RevModPhys.81.1495	33	237	240	16	446	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2017	543	7644					226	+		10.1038/nature21371	http://dx.doi.org/10.1038/nature21371			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0GQ	28277519	Green Accepted, Green Submitted			2022-12-28	WOS:000395688700035
J	Hampton, T				Hampton, Tracy			Technique Monitors T Cells as They Target Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2017	317	9					899	899		10.1001/jama.2017.1388	http://dx.doi.org/10.1001/jama.2017.1388			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4NM	28267845				2022-12-28	WOS:000426801600003
J	Iacobucci, G				Iacobucci, Gareth			Five minutes with ... Harry Burns	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2017	356								j1183	10.1136/bmj.j1183	http://dx.doi.org/10.1136/bmj.j1183			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BP	28270421				2022-12-28	WOS:000396432900002
J	Micha, R; Penalvo, JL; Cudhea, F; Imamura, F; Rehm, CD; Mozaffarian, D				Micha, Renata; Penalvo, Jose L.; Cudhea, Frederick; Imamura, Fumiaki; Rehm, Colin D.; Mozaffarian, Dariush			Association Between Dietary Factors and Mortality From Heart Disease, Stroke, and Type 2 Diabetes in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR-DISEASE; CONSUMPTION; ENVIRONMENT; PREVENTION; STANDARDS; NUTRITION; BURDEN; IMPACT; POLICY; RISK	IMPORTANCE In the United States, national associations of individual dietary factors with specific cardiometabolic diseases are not well established. OBJECTIVE To estimate associations of intake of 10 specific dietary factors with mortality due to heart disease, stroke, and type 2 diabetes (cardiometabolic mortality) among US adults. DESIGN, SETTING, AND PARTICIPANTS A comparative risk assessment model incorporated data and corresponding uncertainty on population demographics and dietary habits from National Health and Nutrition Examination Surveys (1999-2002: n = 8104; 2009-2012: n = 8516); estimated associations of diet and disease from meta-analyses of prospective studies and clinical trials with validity analyses to assess potential bias; and estimated disease-specific national mortality from the National Center for Health Statistics. EXPOSURES Consumption of 10 foods/nutrients associated with cardiometabolic diseases: fruits, vegetables, nuts/seeds, whole grains, unprocessed red meats, processed meats, sugar-sweetened beverages (SSBs), polyunsaturated fats, seafood omega-3 fats, and sodium. MAIN OUTCOMES AND MEASURES Estimated absolute and percentage mortality due to heart disease, stroke, and type 2 diabetes in 2012. Disease-specific and demographic-specific (age, sex, race, and education) mortality and trends between 2002 and 2012 were also evaluated. RESULTS In 2012, 702 308 cardiometabolic deaths occurred in US adults, including 506 100 from heart disease (371 266 coronary heart disease, 35 019 hypertensive heart disease, and 99 815 other cardiovascular disease), 128 294 from stroke (16 125 ischemic, 32 591 hemorrhagic, and 79 578 other), and 67 914 from type 2 diabetes. Of these, an estimated 318 656 (95% uncertainty interval [UI], 306 064-329 755; 45.4%) cardiometabolic deaths per year were associated with suboptimal intakes-48.6%(95% UI, 46.2%-50.9%) of cardiometabolic deaths in men and 41.8%(95% UI, 39.3%-44.2%) in women; 64.2%(95% UI, 60.6%-67.9%) at younger ages (25-34 years) and 35.7%(95% UI, 33.1%-38.1%) at older ages (>= 75 years); 53.1%(95% UI, 51.6%-54.8%) among blacks, 50.0%(95% UI, 48.2%-51.8%) among Hispanics, and 42.8%(95% UI, 40.9%-44.5%) among whites; and 46.8%(95% UI, 44.9%-48.7%) among lower-, 45.7%(95% UI, 44.2%-47.4%) among medium-, and 39.1%(95% UI, 37.2%-41.2%) among higher-educated individuals. The largest numbers of estimated diet-related cardiometabolic deaths were related to high sodium (66 508 deaths in 2012; 9.5% of all cardiometabolic deaths), low nuts/seeds (59 374; 8.5%), high processed meats (57 766; 8.2%), low seafood omega-3 fats (54 626; 7.8%), low vegetables (53 410; 7.6%), low fruits (52 547; 7.5%), and high SSBs (51 694; 7.4%). Between 2002 and 2012, population-adjusted US cardiometabolic deaths per year decreased by 26.5%. The greatest decline was associated with insufficient polyunsaturated fats (-20.8% relative change [95% UI, -18.5% to -22.8%]), nuts/seeds (-18.0%[95% UI, -14.6% to -21.0%]), and excess SSBs (-14.5%[95% UI, -12.0% to -16.9%]). The greatest increase was associated with unprocessed red meats (+ 14.4%[95% UI, 9.1%-19.5%]). CONCLUSIONS AND RELEVANCE Dietary factors were estimated to be associated with a substantial proportion of deaths from heart disease, stroke, and type 2 diabetes. These results should help identify priorities, guide public health planning, and inform strategies to alter dietary habits and improve health.	[Micha, Renata; Penalvo, Jose L.; Cudhea, Frederick; Mozaffarian, Dariush] Tufts Friedman Sch Nutr Sci & Policy, 150 Harrison Ave, Boston, MA 02111 USA; [Imamura, Fumiaki] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England; [Rehm, Colin D.] Montefiore Med Ctr, Off Community & Populat Hlth, 111 E 210th St, Bronx, NY 10467 USA	University of Cambridge; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Micha, R (corresponding author), Tufts Friedman Sch Nutr Sci & Policy, 150 Harrison Ave, Boston, MA 02111 USA.	renata.micha@tufts.edu	Mozaffarian, Dariush/ABC-2822-2020; REHM, COLIN D./J-1215-2019; Imamura, Fumiaki/J-1038-2019; Penalvo, Jose L./AAA-9210-2020	REHM, COLIN D./0000-0002-7644-0040; Imamura, Fumiaki/0000-0002-6841-8396; Penalvo, Jose L./0000-0003-0096-6238	National Institutes of Health; National Heart, Lung, and Blood Institute [R01 HL130735, R01 HL115189]; Bunge Fellowship in Global Nutrition; MRC [MC_UU_12015/5] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115189, R01HL130735] Funding Source: NIH RePORTER; Medical Research Council [MC_UU_12015/5] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Bunge Fellowship in Global Nutrition; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by the National Institutes of Health and the National Heart, Lung, and Blood Institute (grant R01 HL130735 to Dr Micha and grant R01 HL115189 to Dr Mozaffarian). Dr Penalvo was partly supported by a Bunge Fellowship in Global Nutrition.	Afshin A, 2014, HDB GLOBAL HLTH POLI, DOI DOI 10.1002/9781118509623.CH9; Afshin A, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0658-9; Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; Colchero MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6704; Belluz J, 2016, DEVASTATING BLOW BEV; Bodenheimer Thomas, 2005, Dis Manag, V8, P319, DOI 10.1089/dis.2005.8.319; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Ezzati M., 2004, COMP QUANTIFICATION, V1; Falbe J, 2016, AM J PUBLIC HEALTH, V106, P1865, DOI 10.2105/AJPH.2016.303362; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Harnack L, 2016, JAMA INTERN MED, V176, P1610, DOI 10.1001/jamainternmed.2016.5633; Henney JE, 2010, STRATEGIES REDUCE SO; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Kopel E, 2013, NEW ENGL J MED, V369, P672, DOI 10.1056/NEJMc1306659; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Micha R, 2012, EUR J CLIN NUTR, V66, P119, DOI 10.1038/ejcn.2011.147; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127; Mozaffarian D, 2012, CIRCULATION, V126, P1514, DOI 10.1161/CIR.0b013e318260a20b; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; National Commission on Hunger, 2015, FREED HUNG ACH GOAL; Rehm CD, 2016, JAMA-J AM MED ASSOC, V315, P2542, DOI 10.1001/jama.2016.7491; Shulkin ML, 2016, CIRCULATION, V133; Singh GP, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064893, 10.1371/journal.pone.0065174]; Singh GM, 2015, CIRCULATION, V132, P639, DOI 10.1161/CIRCULATIONAHA.114.010636; US Department of Agriculture and US Department of Health and Human Services, 2015, 2015 2020 DIET GUID; US Food and Drug Administration, 2016, GUID IND VO IN PRESS; Webb M, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6699; Willett W, 2013, NUTR EPIDEMIOLOGY, P287; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organization, 2003, DIET NUTR PREV CHRON, V916, pi; Wyness LA, 2012, PUBLIC HEALTH NUTR, V15, P254, DOI 10.1017/S1368980011000966	35	532	549	9	267	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2017	317	9					912	924		10.1001/jama.2017.0947	http://dx.doi.org/10.1001/jama.2017.0947			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM8DM	28267855	Green Accepted			2022-12-28	WOS:000395541500011
J	Tsai, AC; Mendenhall, E; Trostle, JA; Kawachi, I				Tsai, Alexander C.; Mendenhall, Emily; Trostle, James A.; Kawachi, Ichiro			Co-occurring epidemics, syndemics, and population health	LANCET			English	Editorial Material							SUFFICIENT CAUSE INTERACTIONS; EDUCATIONAL-ATTAINMENT; PARTNER VIOLENCE; LIFE EXPECTANCY; HIV RISK; CONTEXT; WOMEN; DISEASE; AIDS; INTERVENTIONS		[Tsai, Alexander C.] Massachusetts Gen Hosp, Chester M Pierce MD Div Global Psychiat, Boston, MA 02114 USA; [Tsai, Alexander C.; Kawachi, Ichiro] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA; [Tsai, Alexander C.; Kawachi, Ichiro] Harvard Univ, Harvard Ctr Populat & Dev Studies, Boston, MA 02115 USA; [Kawachi, Ichiro] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Tsai, Alexander C.] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Mendenhall, Emily] Georgetown Univ, Edmund A Walsh Sch Foreign Serv, Washington, DC USA; [Trostle, James A.] Trinity Coll, Dept Anthropol, Hartford, CT 06106 USA; [Trostle, James A.] Univ Chile, Fac Med, Sch Publ Hlth, Santiago, Chile	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Mbarara University of Science & Technology; Georgetown University; Trinity College; Universidad de Chile	Tsai, AC (corresponding author), Massachusetts Gen Hosp, MGH Global Hlth, Boston, MA 02114 USA.	actsai@partners.org	Tsai, Alexander C./F-4247-2015	Tsai, Alexander C./0000-0001-6397-7917; Trostle, James/0000-0002-6045-9521	US National Institutes of Health [K23MH096620]; US National Science Foundation [EAR-1360330]; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH096620] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank, without implicating, Brian T Chan, Jessica F Magidson, Mark J Siedner, and Atheendar S Venkataramani for their helpful comments on drafts of this manuscript. ACT acknowledges salary support from the US National Institutes of Health (K23MH096620). JAT acknowledges grant support from the US National Science Foundation (EAR-1360330). The funders had no role in the analysis or interpretation of the evidence, in writing the manuscript, or in the decision to submit the manuscript for publication.	Aizer A, 2010, AM ECON REV, V100, P1847, DOI 10.1257/aer.100.4.1847; Beaman L, 2012, SCIENCE, V335, P582, DOI 10.1126/science.1212382; Beaman L, 2009, Q J ECON, V124, P1497, DOI 10.1162/qjec.2009.124.4.1497; BRISCOE J, 1984, AM J EPIDEMIOL, V120, P449, DOI 10.1093/oxfordjournals.aje.a113909; Chakrapani V, 2017, GLOB PUBLIC HEALTH, V12, P250, DOI 10.1080/17441692.2015.1091024; Conroy AA, 2016, AIDS BEHAV, V20, P2045, DOI 10.1007/s10461-016-1385-y; Curtis V, 2000, TROP MED INT HEALTH, V5, P22, DOI 10.1046/j.1365-3156.2000.00512.x; Diez-Roux AV, 1998, AM J PUBLIC HEALTH, V88, P216, DOI 10.2105/AJPH.88.2.216; Dow WH, 1999, AM ECON REV, V89, P1358, DOI 10.1257/aer.89.5.1358; Eisenberg JNS, 2007, AM J PUBLIC HEALTH, V97, P846, DOI 10.2105/AJPH.2006.086207; FARMER P, 1993, CULT MED PSYCHIAT, V17, P387, DOI 10.1007/BF01379306; FARMER P, 1989, DAEDALUS, V118, P135; Farmer P, 1996, EMERG INFECT DIS, V2, P259, DOI 10.3201/eid0204.960402; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Ganz ML, 2000, AM J PUBLIC HEALTH, V90, P367, DOI 10.2105/AJPH.90.3.367; Hatcher AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049821; Heise LL, 2015, LANCET GLOB HEALTH, V3, pE332, DOI 10.1016/S2214-109X(15)00013-3; Jewkes R, 2002, LANCET, V359, P1423, DOI 10.1016/S0140-6736(02)08357-5; Johnson RC, 2009, J LAW ECON, V52, P251, DOI 10.1086/597102; Li R, 2016, HEALTH PSYCHOL, V35, P148, DOI 10.1037/hea0000265; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Lutfey K, 2005, AM J SOCIOL, V110, P1326, DOI 10.1086/428914; Montez JK, 2014, DEMOGRAPHY, V51, P413, DOI 10.1007/s13524-013-0261-x; Operario D, 2010, JAIDS-J ACQ IMM DEF, V55, pS91, DOI 10.1097/QAI.0b013e3181fbc9ec; Papachristos AV, 2015, SOC SCI MED, V125, P139, DOI 10.1016/j.socscimed.2014.01.056; Phelan JC, 2010, J HEALTH SOC BEHAV, V51, pS28, DOI 10.1177/0022146510383498; Riley MW, 1963, SOCIOLOGICAL RES, P700; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Rose G., 1992, STRATEGY PREVENTIVE; ROTHMAN KJ, 1974, AM J EPIDEMIOL, V99, P385, DOI 10.1093/oxfordjournals.aje.a121626; SAMEROFF AJ, 1987, PEDIATRICS, V79, P343; Shannon K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028739; Sharkey P, 2008, AM J SOCIOL, V113, P931, DOI 10.1086/522804; Sharkey P, 2010, P NATL ACAD SCI USA, V107, P11733, DOI 10.1073/pnas.1000690107; Sharkey PT, 2012, AM J PUBLIC HEALTH, V102, P2287, DOI 10.2105/AJPH.2012.300789; Singer M, 2003, MED ANTHROPOL Q, V17, P423, DOI 10.1525/maq.2003.17.4.423; Singer M., 1996, FREE INQ CREAT SOCIO, V24, P99, DOI [10.1093/jn/nxaa361, DOI 10.1093/jn/nxaa361]; Singer M, 2011, ANN ANTHROPL PRACT, V35, P8, DOI 10.1111/j.2153-9588.2011.01064.x; Singer Merrill, 2006, FREE INQUIRY CREATIV, V34, P39; Tsai AC, 2016, AIDS BEHAV, V20, P423, DOI 10.1007/s10461-015-1260-2; Tsai AC, 2015, SOC SCI MED, V139, P26, DOI 10.1016/j.socscimed.2015.06.024; Tsai AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123182; Tsai AC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001440; Tsai AC, 2012, AIDS, V26, P381, DOI 10.1097/QAD.0b013e32834e1ccb; Turner RJ, 1995, J HEALTH SOC BEHAV, V36, P360, DOI 10.2307/2137325; VANDERSLICE J, 1995, AM J EPIDEMIOL, V141, P135, DOI 10.1093/oxfordjournals.aje.a117401; Vanderweele TJ, 2008, BIOMETRIKA, V95, P49, DOI 10.1093/biomet/asm090; VanderWeele TJ, 2009, EPIDEMIOLOGY, V20, P6, DOI 10.1097/EDE.0b013e31818f69e7; Venkataramani AS, 2016, LANCET PUBLIC HEALTH, V1, pE18, DOI 10.1016/S2468-2667(16)30005-6; Venkataramani AS, 2016, AM J PUBLIC HEALTH, V106, P478, DOI 10.2105/AJPH.2015.302941; WAGNER E G, 1958, Monogr Ser World Health Organ, V39, P1; WALLACE R, 1988, ENVIRON RES, V47, P1, DOI 10.1016/S0013-9351(88)80018-5; Wildeman C, 2009, DEMOGRAPHY, V46, P265, DOI 10.1353/dem.0.0052; Wilson M, 1997, BRIT MED J, V314, P1271, DOI 10.1136/bmj.314.7089.1271	54	136	137	2	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 4	2017	389	10072					978	982		10.1016/S0140-6736(17)30403-8	http://dx.doi.org/10.1016/S0140-6736(17)30403-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM4DL	28271848	Green Accepted, Bronze			2022-12-28	WOS:000395263400037
J	Usher, AD				Usher, Ann Danaiya			Swedish global health institute established with Gates grant	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 4	2017	389	10072					893	893						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM4DL	28271829				2022-12-28	WOS:000395263400011
J	Yu, VWC; Yusuf, RZ; Oki, T; Wu, J; Saez, B; Wang, X; Cook, C; Baryawno, N; Ziller, MJ; Lee, E; Gu, HC; Meissner, A; Lin, CP; Kharchenko, PV; Scadden, DT				Yu, Vionnie W. C.; Yusuf, Rushdia Z.; Oki, Toshihiko; Wu, Juwell; Saez, Borja; Wang, Xin; Cook, Colleen; Baryawno, Ninib; Ziller, Michael J.; Lee, Eunjung; Gu, Hongcang; Meissner, Alexander; Lin, Charles P.; Kharchenko, Peter V.; Scadden, David T.			Epigenetic Memory Underlies Cell-Autonomous Heterogeneous Behavior of Hematopoietic Stem Cells (vol 167, pg 1310, 2016)	CELL			English	Correction												peter.kharchenko@post.harvard.edu; david_scadden@harvard.edu	Wang, Xin/A-1130-2012	Wang, Xin/0000-0002-5122-2418; Baryawno, Ninib/0000-0001-6054-4163	NCI NIH HHS [U54 CA193461] Funding Source: Medline; NHLBI NIH HHS [R21 HL126070, P01 HL131477] Funding Source: Medline; NIA NIH HHS [K25 AG037596] Funding Source: Medline; NIDDK NIH HHS [R24 DK103074] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U54CA193461] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL126070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK103074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K25AG037596] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		VIONNIE WC, 2016, CELL, V167, P1310	1	51	53	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2017	168	5					944	945		10.1016/j.cell.2017.02.010	http://dx.doi.org/10.1016/j.cell.2017.02.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8YB	28235203	Bronze, Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000396284800022
J	Resnick, SM; Matsumoto, AM; Stephens-Shields, AJ; Ellenberg, SS; Gill, TM; Shumaker, SA; Pleasants, DD; Barrett-Connor, E; Bhasin, S; Cauley, JA; Cella, D; Crandall, JP; Cunningham, GR; Ensrud, KE; Farrar, JT; Lewis, CE; Molitch, ME; Pahor, M; Swerdloff, RS; Cifelli, D; Anton, S; Basaria, S; Diem, SJ; Wang, C; Hou, XL; Snyder, PJ				Resnick, Susan M.; Matsumoto, Alvin M.; Stephens-Shields, Alisa J.; Ellenberg, Susan S.; Gill, Thomas M.; Shumaker, Sally A.; Pleasants, Debbie D.; Barrett-Connor, Elizabeth; Bhasin, Shalender; Cauley, Jane A.; Cella, David; Crandall, Jill P.; Cunningham, Glenn R.; Ensrud, Kristine E.; Farrar, John T.; Lewis, Cora E.; Molitch, Mark E.; Pahor, Marco; Swerdloff, Ronald S.; Cifelli, Denise; Anton, Stephen; Basaria, Shehzad; Diem, Susan J.; Wang, Christina; Hou, Xiaoling; Snyder, Peter J.			Testosterone Treatment and Cognitive Function in Older Men With Low Testosterone and Age-Associated Memory Impairment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SERUM TESTOSTERONE; SEX-HORMONES; ALZHEIMER-DISEASE; VERBAL MEMORY; ELDERLY-MEN; SUPPLEMENTATION; TRIAL; PERFORMANCE; DEPRESSION	IMPORTANCE Most cognitive functions decline with age. Prior studies suggest that testosterone treatment may improve these functions. OBJECTIVE To determine if testosterone treatment compared with placebo is associated with improved verbal memory and other cognitive functions in older men with low testosterone and age-associated memory impairment (AAMI). DESIGN, SETTING, AND PARTICIPANTS The Testosterone Trials (TTrials) were 7 trials to assess the efficacy of testosterone treatment in older men with low testosterone levels. The Cognitive Function Trial evaluated cognitive function in all TTrials participants. In 12 US academic medical centers, 788 men who were 65 years or older with a serum testosterone level less than 275 ng/mL and impaired sexual function, physical function, or vitality were allocated to testosterone treatment (n = 394) or placebo (n = 394). A subgroup of 493 men met criteria for AAMI based on baseline subjective memory complaints and objective memory performance. Enrollment in the TTrials began June 24, 2010; the final participant completed treatment and assessment in June 2014. INTERVENTIONS Testosterone gel (adjusted to maintain the testosterone level within the normal range for young men) or placebo gel for 1 year. MAIN OUTCOMES AND MEASURES The primary outcome was the mean change from baseline to 6 months and 12 months for delayed paragraph recall (score range, 0 to 50) among men with AAMI. Secondary outcomes were mean changes in visual memory (Benton Visual Retention Test; score range, 0 to -26), executive function (Trail-Making Test B minus A; range, -290 to 290), and spatial ability (Card Rotation Test; score range, -80 to 80) among men with AAMI. Tests were administered at baseline, 6 months, and 12 months. RESULTS Among the 493 men with AAMI (mean age, 72.3 years [SD, 5.8]; mean baseline testosterone, 234 ng/dL [SD, 65.1]), 247were assigned to receive testosterone and 246 to receive placebo. Of these groups, 247 men in the testosterone group and 245 men in the placebo completed the memory study. There was no significant mean change from baseline to 6 and 12 months in delayed paragraph recall score among men with AAMI in the testosterone and placebo groups (adjusted estimated difference, -0.07 [95% CI, -0.92 to 0.79]; P = .88). Mean scores for delayed paragraph recall were 14.0 at baseline, 16.0 at 6 months, and 16.2 at 12 months in the testosterone group and 14.4 at baseline, 16.0 at 6 months, and 16.5 at 12 months in the placebo group. Testosterone was also not associated with significant differences in visual memory (-0.28 [95% CI, -0.76 to 0.19]; P = .24), executive function (-5.51 [95% CI, -12.91 to 1.88]; P = .14), or spatial ability (-0.12 [95% CI, -1.89 to 1.65]; P = .89). CONCLUSIONS AND RELEVANCE Among older men with low testosterone and age-associated memory impairment, treatment with testosterone for 1 year compared with placebo was not associated with improved memory or other cognitive functions.	[Snyder, Peter J.] Univ Penn, Div Endocrinol Diabet & Metab, Perelman Sch Med, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Resnick, Susan M.] NIA, Lab Behav Neurosci, NIH, Baltimore, MD 21224 USA; [Matsumoto, Alvin M.] Dept Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA USA; [Matsumoto, Alvin M.] Univ Washington, Sch Med, Dept Internal Med, Div Gerontol & Geriatr Med, Seattle, WA USA; [Stephens-Shields, Alisa J.; Ellenberg, Susan S.; Hou, Xiaoling] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Gill, Thomas M.] Yale Sch Med, Div Geriatr Med, New Haven, CT USA; [Shumaker, Sally A.; Pleasants, Debbie D.; Basaria, Shehzad] Wake Forest Sch Med, Winston Salem, NC USA; [Barrett-Connor, Elizabeth] Univ Calif San Diego, Sch Med, Dept Internal Med, La Jolla, CA 92093 USA; [Barrett-Connor, Elizabeth] Univ Calif San Diego, Sch Med, Div Epidemiol, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Bhasin, Shalender] Harvard Med Sch, Brigham & Womens Hosp, Res Program Mens Hlth Aging & Metab, Boston, MA USA; [Cauley, Jane A.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Cella, David] Northwestern Univ, Dept Med Social Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [Crandall, Jill P.] Albert Einstein Coll Med, Div Endocrinol, Bronx, NY 10467 USA; [Crandall, Jill P.] Albert Einstein Coll Med, Div Geriatr, Bronx, NY 10467 USA; [Cunningham, Glenn R.] Baylor Coll Med, Dept Med, Div Diabet Endocrinol & Metab, Houston, TX 77030 USA; [Cunningham, Glenn R.] Baylor Coll Med, Dept Mol & Cellular Biol, Div Diabet Endocrinol & Metab, Houston, TX 77030 USA; [Cunningham, Glenn R.] Baylor St Lukes Med Ctr, Houston, TX USA; [Cunningham, Glenn R.; Ensrud, Kristine E.; Diem, Susan J.] Univ Minnesota, Dept Med, Div Epidemiol & Community Hlth, Box 736 UMHC, Minneapolis, MN 55455 USA; [Ensrud, Kristine E.] Minneapolis Vet Affairs Hlth Care Syst, Minneapolis, MN USA; [Farrar, John T.; Cifelli, Denise] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Lewis, Cora E.] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA; [Molitch, Mark E.] Northwestern Univ, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Pahor, Marco; Anton, Stephen] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL USA; [Swerdloff, Ronald S.; Wang, Christina] Harbor Univ Calif Los Angeles Med Ctr, Div Endocrinol, Torrance, CA USA; [Swerdloff, Ronald S.; Wang, Christina] Los Angeles Biomed Res Inst, Torrance, CA USA	University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Geriatric Research Education & Clinical Center; University of Washington; University of Washington Seattle; University of Pennsylvania; Pennsylvania Medicine; Yale University; Wake Forest University; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University; Feinberg School of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Pennsylvania; Pennsylvania Medicine; University of Alabama System; University of Alabama Birmingham; Northwestern University; Feinberg School of Medicine; State University System of Florida; University of Florida; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute	Snyder, PJ (corresponding author), Univ Penn, Div Endocrinol Diabet & Metab, Perelman Sch Med, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	pjs@mail.med.upenn.edu	Farrar, John T/AAP-4788-2021; Gill, Thomas M./H-7043-2019; Matsumoto, Alvin/AAH-6096-2020	Farrar, John T/0000-0001-8656-5157; Gill, Thomas M./0000-0002-6450-0368; Ensrud, Kristine/0000-0002-9069-3036; Basaria, Shehzad/0000-0003-1749-8549	NIA/NIH [U01 AG030644, R01 AG37679]; National Heart, Lung, and Blood Institute; National Institute of Neurological Disorders and Stroke; National Institute of Child Health and Human Development; AndroGel; placebo gel; Claude D. Pepper Older Americans Independence Center (OAIC) [P30-AG013679]; Claude D. Pepper OAIC [P30AG021342]; Yale Clinical and Translational Science Award [UL1TR000142]; Department of Veterans Affairs Puget Sound Health Care System; NIA [K07AG043587]; Intramural Research Program of NIA/NIH; National Institute for Diabetes and Digestive and Kidney Diseases of NIH [DK079626]; Boston Claude D. Pepper OAIC [5P30AG031679]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK079626, P30DK020541, P30DK079626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037679, P30AG031679, K07AG043587, U01AG030644, P30AG028740, P30AG021342] Funding Source: NIH RePORTER	NIA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); AndroGel; placebo gel; Claude D. Pepper Older Americans Independence Center (OAIC); Claude D. Pepper OAIC; Yale Clinical and Translational Science Award; Department of Veterans Affairs Puget Sound Health Care System; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural Research Program of NIA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute for Diabetes and Digestive and Kidney Diseases of NIH; Boston Claude D. Pepper OAIC; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Testosterone Trials were supported by grant U01 AG030644 from the NIA/NIH, supplemented by funds from the National Heart, Lung, and Blood Institute; National Institute of Neurological Disorders and Stroke; and National Institute of Child Health and Human Development. AbbVie provided funding, AndroGel, and placebo gel. The Boston site was partially supported by grant P30-AG013679 from the Claude D. Pepper Older Americans Independence Center (OAIC). The Yale Field Center was partially supported by grant P30AG021342 from the Claude D. Pepper OAIC and grant UL1TR000142 from the Yale Clinical and Translational Science Award. Additional support was from the Department of Veterans Affairs Puget Sound Health Care System (Dr Matsumoto); the Academic Leadership Award (K07AG043587) from the NIA (Dr Gill); the Intramural Research Program of NIA/NIH (Dr Resnick); grant DK079626 from the National Institute for Diabetes and Digestive and Kidney Diseases of NIH to the University of Alabama at Birmingham Diabetes Research and Training Center (Dr Lewis); grant R01 AG37679 from NIA/NIH (Dr Cauley); and grant 5P30AG031679 from the Boston Claude D. Pepper OAIC (Dr Bhasin).	Almeida OP, 2004, PSYCHONEUROENDOCRINO, V29, P1071, DOI 10.1016/j.psyneuen.2003.11.002; Barrett-Connor E, 1999, J CLIN ENDOCR METAB, V84, P3681, DOI 10.1210/jc.84.10.3681; Benton A.L., 1974, REVISED VISUAL RETEN; Bilgel M, 2014, ALZHEIMERS DEMENT, V10, P735, DOI 10.1016/j.jalz.2014.04.520; Bussiere JR, 2005, BEHAV NEUROSCI, V119, P1429, DOI 10.1037/0735-7044.119.6.1429; Cherrier MM, 2007, PSYCHONEUROENDOCRINO, V32, P72, DOI 10.1016/j.psyneuen.2006.10.008; Cherrier MM, 2005, NEUROLOGY, V64, P290, DOI 10.1212/01.WNL.0000149639.25136.CA; Cherrier MM, 2001, NEUROLOGY, V57, P80, DOI 10.1212/WNL.57.1.80; Cherrier MM, 2003, J ANDROL, V24, P568; Cherrier MM, 2002, J CLIN ENDOCR METAB, V87, P3090, DOI 10.1210/jc.87.7.3090; Crook T H 3rd, 1992, Int Psychogeriatr, V4, P165, DOI 10.1017/S1041610292000991; Crook T, 1986, DEV NEUROPSYCHOL, V2, P261, DOI 10.1080/87565648609540348; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; Goldman WP, 2001, ALZ DIS ASSOC DIS, V15, P72, DOI 10.1097/00002093-200104000-00006; Green HJ, 2002, BJU INT, V90, P427, DOI 10.1046/j.1464-410X.2002.02917.x; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Janowsky JS, 2006, NEUROSCIENCE, V138, P1015, DOI 10.1016/j.neuroscience.2005.09.007; Liverman CT, 2004, TESTOSTERONE AGING C; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Moffat SD, 2002, J CLIN ENDOCR METAB, V87, P5001, DOI 10.1210/jc.2002-020419; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Price L, 2004, J CLIN EXP NEUROPSYC, V26, P531, DOI 10.1080/13803390490496678; Resnick Susan M, 2004, Clin Trials, V1, P440, DOI 10.1191/1740774504cn040oa; SCHAIE KW, 1993, PSYCHOL AGING, V8, P44, DOI 10.1037/0882-7974.8.1.44; Shumaker SA, 1998, CONTROL CLIN TRIALS, V19, P604, DOI 10.1016/S0197-2456(98)00038-5; SMITH G, 1991, PSYCHOL AGING, V6, P551; Snyder PJ, 2016, NEW ENGL J MED, V374, P611, DOI 10.1056/NEJMoa1506119; Snyder PJ, 2014, CLIN TRIALS, V11, P362, DOI 10.1177/1740774514524032; Sperling RA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007941; TAVES DR, 1974, CLIN PHARMACOL THER, V15, P443; Thilers PP, 2006, PSYCHONEUROENDOCRINO, V31, P565, DOI 10.1016/j.psyneuen.2005.12.005; Tierney MC, 2005, NEUROLOGY, V64, P1853, DOI 10.1212/01.WNL.0000163773.21794.0B; TOHGI H, 1995, BRAIN RES, V700, P245, DOI 10.1016/0006-8993(95)00971-R; Vaughan C, 2007, J ANDROL, V28, P875, DOI 10.2164/jandrol.107.002931; Wechsler D., 1945, WECHSLER MEMORY SCAL; Yaffe K, 2002, J AM GERIATR SOC, V50, P707, DOI 10.1046/j.1532-5415.2002.50166.x	37	120	124	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2017	317	7					717	727		10.1001/jama.2016.21044	http://dx.doi.org/10.1001/jama.2016.21044			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL8WR	28241356	Green Accepted			2022-12-28	WOS:000394901600019
J	Sonuga-Barke, EJS; Kennedy, M; Kumsta, R; Knights, N; Golm, D; Rutter, M; Maughan, B; Schlotz, W; Kreppner, J				Sonuga-Barke, Edmund J. S.; Kennedy, Mark; Kumsta, Robert; Knights, Nicky; Golm, Dennis; Rutter, Michael; Maughan, Barbara; Schlotz, Wolff; Kreppner, Jana			Child-to-adult neurodevelopmental and mental health trajectories after early life deprivation: the young adult follow-up of the longitudinal English and Romanian Adoptees study	LANCET			English	Article							EARLY INSTITUTIONAL DEPRIVATION; EARLY ADOLESCENCE; PSYCHOLOGICAL PATTERNS; CLINICAL PRESENTATION; ATTACHMENT; DIFFICULTIES; DISORDER; SYMPTOMS; PARENT; CARE	Background Time-limited, early-life exposures to institutional deprivation are associated with disorders in childhood, but it is unknown whether effects persist into adulthood. We used data from the English and Romanian Adoptees study to assess whether deprivation-associated adverse neurodevelopmental and mental health outcomes persist into young adulthood. Methods The English and Romanian Adoptees study is a longitudinal, natural experiment investigation into the long-term outcomes of individuals who spent from soon after birth to up to 43 months in severe deprivation in Romanian institutions before being adopted into the UK. We used developmentally appropriate standard questionnaires, interviews completed by parents and adoptees, and direct measures of IQ to measure symptoms of autism spectrum disorder, inattention and overactivity, disinhibited social engagement, conduct or emotional problems, and cognitive impairment (IQ score <80) during childhood (ages 6, 11, and 15 years) and in young adulthood (22-25 years). For analysis, Romanian adoptees were split into those who spent less than 6 months in an institution and those who spent more than 6 months in an institution. We used a comparison group of UK adoptees who did not experience deprivation. We used mixed-effects regression models for ordered-categorical outcome variables to compare symptom levels and trends between groups. Findings Romanian adoptees who experienced less than 6 months in an institution (n=67 at ages 6 years; n=50 at young adulthood) and UK controls (n=52 at age 6 years; n=39 at young adulthood) had similarly low levels of symptoms across most ages and outcomes. By contrast, Romanian adoptees exposed to more than 6 months in an institution (n=98 at ages 6 years; n=72 at young adulthood) had persistently higher rates than UK controls of symptoms of autism spectrum disorder, disinhibited social engagement, and inattention and overactivity through to young adulthood (pooled p<0.0001 for all). Cognitive impairment in the group who spent more than 6 months in an institution remitted from markedly higher rates at ages 6 years (p=0.0001) and 11 years (p=0.0016) compared with UK controls, to normal rates at young adulthood (p=0.76). By contrast, self-rated emotional symptoms showed a lateonset pattern with minimal differences versus UK controls at ages 11 years (p=0.0449) and 15 years (p=0.17), and then marked increases by young adulthood (p=0.0005), with similar effects seen for parent ratings. The high deprivation group also had a higher proportion of people with low educational achievement (p=0.0195), unemployment (p=0.0124), and mental health service use (p=0.0120, p=0.0032, and p=0.0003 for use when aged <11 years, 11-14 years, and 15-23 years, respectively) than the UK control group. A fifth (n=15) of individuals who spent more than 6 months in an institution were problem-free at all assessments. Interpretation Notwithstanding the resilience shown by some adoptees and the adult remission of cognitive impairment, extended early deprivation was associated with long-term deleterious effects on wellbeing that seem insusceptible to years of nurturance and support in adoptive families.	[Sonuga-Barke, Edmund J. S.; Kennedy, Mark; Golm, Dennis; Kreppner, Jana] Univ Southampton, Dept Psychol, Dev Brain Behaviour Lab, Southampton, Hants, England; [Sonuga-Barke, Edmund J. S.] Dept Child & Adolescent Psychiat, Southampton, Hants, England; [Rutter, Michael; Maughan, Barbara] MRC Social, Genet Dev Psychiat, Southampton, Hants, England; [Rutter, Michael; Maughan, Barbara] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Kumsta, Robert] Ruhr Univ Bochum, Fac Psychol, Dept Genet Psychol, Bochum, Germany; [Knights, Nicky] Amy Winehouse Fdn, London, England; [Schlotz, Wolff] Max Planck Inst Empir Aesthet, Frankfurt, Germany	University of Southampton; University of London; King's College London; Ruhr University Bochum	Sonuga-Barke, EJS (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neuros, Dept Child & Adolescent Psychiat, London SE5 8AF, England.	edmund.sonuga-barke@kcl.ac.uk	Sonuga-Barke, Edmund j/D-9137-2011; Kumsta, Robert/P-9641-2016; Schlotz, Wolff/AAI-9549-2020; Kreppner, Jana/N-1444-2015	Kumsta, Robert/0000-0001-6006-6958; Schlotz, Wolff/0000-0003-2356-7766; Rutter, Michael Llewellyn/0000-0003-1577-7405; Maughan, Barbara/0000-0002-8887-3484; Sonuga-Barke, Edmund/0000-0002-6996-3935; Kreppner, Jana/0000-0003-3527-9083; Golm, Dennis/0000-0002-2950-7935	Economic and Social Research Council; Medical Research Council; Department of Health; Jacobs Foundation; Nuffield Foundation; Economic and Social Research Council [RES-062-23-3300]; Department of Health [3700295]; National Institute for Health Research Central Commissioning Facility [3700295]; Nuffield Foundation [OPD/00248/G]; ESRC [ES/I037970/1] Funding Source: UKRI; Economic and Social Research Council [ES/I037970/1] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; Jacobs Foundation; Nuffield Foundation; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department of Health; National Institute for Health Research Central Commissioning Facility; Nuffield Foundation; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Economic and Social Research Council, Medical Research Council, Department of Health, Jacobs Foundation, Nuffield Foundation.; The Economic and Social Research Council funded the young adult follow-up of the English and Romanian Adoptees (ERA) study (RES-062-23-3300). The ERA received funding from the Department of Health (age 4, 6, and 11 years assessments; reference number 3700295; Jan 1, 1993, to Dec 31, 1997); National Institute for Health Research Central Commissioning Facility (age 15 years follow-up; 3700295; Sept 1, 2003, to March 31, 2009), the Medical Research Council, Jacobs Foundation (Oct 1, 2003, to Sept 30, 2009), and the Nuffield Foundation (OPD/00248/G; Oct 1, 2003, to Sept 30, 2007). We would like to express our sincere gratitude to all the families and young people who have participated in this study over the many years it has been running. Without them this work would not be possible. We are also grateful for comments from Graeme Fairchild (University of Bath, UK) during initial planning meetings and to Victoria Hayter and Helen Loader (University of Southampton, UK) for their support. We thank all previous researchers on the project, especially Tom O'Connor (University of Rochester Medical Center, Rochester, NY, USA), Celia Beckett (Bournemouth University, UK), Jenny Castle (King's College London, UK), Suzanne Stevens (University of Auckland, New Zealand), Emma Colvert (King's College London, UK), Christine Groothues (retired), and Amanda Hawkins who were involved in the collection of data during the mid-adolescent phase of the project. We thank our advisory board for all their useful suggestions, especially Megan Gunnar (University of Minnesota, MN, USA), Jonathan Hill (University of Reading, UK), Trevor Robbins (University of Cambridge, UK), and John Simmonds (CoramBAAF Adoption and Fostering Academy, London, UK).	ARMSDEN GC, 1987, J YOUTH ADOLESCENCE, V16, P427, DOI 10.1007/BF02202939; Beckett C, 2006, CHILD DEV, V77, P696, DOI 10.1111/j.1467-8624.2006.00898.x; BENNETT EL, 1964, SCIENCE, V146, P610, DOI 10.1126/science.146.3644.610; Colvert E, 2008, DEV PSYCHOPATHOL, V20, P547, DOI 10.1017/S0954579408000278; Conners CK, 2011, CONNERS COMPREHENSIV, DOI [10.1007/978-0-387-79948-3_1534, DOI 10.1007/978-0-387-79948-3_1534]; Elander J, 1996, INT J METHOD PSYCH, V6, P63, DOI 10.1002/(SICI)1234-988X(199607)6:2<63::AID-MPR151>3.3.CO;2-M; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Harrington R., 2002, CHILD ADOLESCENT PSY, P463; Hartung CM, 2005, J PSYCHOPATHOL BEHAV, V27, P159, DOI 10.1007/s10862-005-0632-8; Kay CL, 2016, DEV PSYCHOPATHOL, V28, P73, DOI 10.1017/S0954579415000292; Kennedy M, 2016, J CHILD PSYCHOL PSYC, V57, P1113, DOI 10.1111/jcpp.12576; KENNY ME, 1987, J YOUTH ADOLESCENCE, V16, P17, DOI 10.1007/BF02141544; Kreppner J, 2010, MONOGR SOC RES CHILD, V75, P79, DOI 10.1111/j.1540-5834.2010.00551.x; Kreppner JM, 2007, DEV PSYCHOL, V43, P931, DOI 10.1037/0012-1649.43.4.931; Kumsta R, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.95; Kumsta R, 2015, EUR PSYCHOL, V20, P138, DOI 10.1027/1016-9040/a000227; Kumsta R, 2010, J CHILD PSYCHOL PSYC, V51, P755, DOI 10.1111/j.1469-7610.2010.02249.x; Kumsta R, 2010, MONOGR SOC RES CHILD, V75, P48, DOI 10.1111/j.1540-5834.2010.00550.x; Levin AR, 2015, J AM ACAD CHILD PSY, V54, P108, DOI 10.1016/j.jaac.2014.11.011; McCarthy D, 1972, MCCARTHY SCALES CHIL; Mela V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137283; Merz EC, 2010, J ABNORM CHILD PSYCH, V38, P459, DOI 10.1007/s10802-009-9383-4; Morrison L, 2004, J FAM HIST, V29, P168, DOI 10.1177/0363199004264899; Radford L., 2011, CHILD ABUSE NEGLECT; Rushton A, 2013, J CHILD PSYCHOL PSYC, V54, P1215, DOI 10.1111/jcpp.12088; RUTTER M, 1985, BRIT J PSYCHIAT, V147, P598, DOI 10.1192/bjp.147.6.598; Rutter M, 1999, J CHILD PSYCHOL PSYC, V40, P537, DOI 10.1017/S0021963099003935; Rutter M., 2003, SOCIAL COMMUNICATION; Rutter M, 2012, J AM ACAD CHILD PSY, V51, P762, DOI 10.1016/j.jaac.2012.05.011; Schlotz W, 2009, BRAIN BEHAV IMMUN, V23, P905, DOI 10.1016/j.bbi.2009.02.001; Sonuga-Barke EJS, 2010, MONOGR SOC RES CHILD, V75, P102, DOI 10.1111/j.1540-5834.2010.00552.x; Wechsler D., 2007, WASI 2 WECHSLER ABBR; Wechsler D., 1992, MANUAL WECHSLER INTE; Wiik KL, 2011, J CHILD PSYCHOL PSYC, V52, P56, DOI 10.1111/j.1469-7610.2010.02294.x; Zeanah CH, 2015, J CHILD PSYCHOL PSYC, V56, P207, DOI 10.1111/jcpp.12347; Zeanah CH, 2011, MONOGR SOC RES CHILD, V76, P147, DOI 10.1111/j.1540-5834.2011.00631.x	37	164	164	1	61	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 15	2017	389	10078					1539	1548		10.1016/S0140-6736(17)30045-4	http://dx.doi.org/10.1016/S0140-6736(17)30045-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ER7OP	28237264	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000399002900027
J	Atkin, W; Wooldrage, K; Parkin, DM; Kralj-Hans, I; MacRae, E; Shah, U; Duffy, S; Cross, AJ				Atkin, Wendy; Wooldrage, Kate; Parkin, D. Maxwell; Kralj-Hans, Ines; MacRae, Eilidh; Shah, Urvi; Duffy, Stephen; Cross, Amanda J.			Long-term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK Flexible Sigmoidoscopy Screening randomised controlled trial	LANCET			English	Article							COLORECTAL-CANCER INCIDENCE; COMMITTEE; MORTALITY; RATES	Background Colorectal cancer is the third most common cancer worldwide. Previous analyses have only reported follow-up after flexible sigmoidoscopy for a maximum of 12 years. We aimed to examine colorectal cancer incidence and mortality after a single flexible sigmoidoscopy screening and 17 years of follow-up. Methods In this multicentre randomised trial (UK Flexible Sigmoidoscopy Screening Trial), done between Nov 14, 1994, and March 30, 1999, 170 432 eligible men and women, who had indicated on a previous questionnaire that they would probably attend screening if invited, were randomly assigned (1: 2) to an intervention group (offered flexible sigmoidoscopy screening) or a control group (not contacted). Randomisation was done centrally in blocks of 12, and stratified by trial centre, general practice, and household type. The nature of the intervention did not allow the staff to be masked to arm of the trial; however, randomisation was done in batches so that the control group and participants not yet randomised were unaware of their allocation status. The primary outcomes were incidence and mortality of colorectal cancer. Hazard ratios (HRs) and 95% CIs for colorectal cancer incidence and mortality were estimated for intention-to-treat and per-protocol analyses. The trial is registered with ISRCTN, number 28352761. Findings Our cohort analysis included 170 034 people: 112 936 in the control group and 57 098 in the intervention group, 40 621 (71%) of whom were screened and 16 477 (29%) were not screened. During screening and a median of 17.1 years' follow-up, colorectal cancer was diagnosed in 1230 individuals in the intervention group and 3253 in the control group, and 353 individuals in the intervention group versus 996 individuals in the control group died from colorectal cancer. In intention-to-treat analyses, colorectal cancer incidence was reduced by 26% (HR 0.74 [95% CI 0.70-0.80]; p < 0.0001) in the intervention group versus the control group and colorectal cancer mortality was reduced by 30% (0.70 [0.62-0.79]; p < 0.0001) in the intervention group versus the control group. In per-protocol analyses, adjusted for non-compliance, colorectal cancer incidence and mortality were 35% (HR 0.65 [95% CI 0.59-0.71]) and 41% (0.59 [0.49-0.70]) lower in the screened group. Interpretation A single flexible sigmoidoscopy continues to provide substantial protection from colorectal cancer diagnosis and death, with protection lasting at least 17 years. Copyright (C) The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license.	[Atkin, Wendy; Wooldrage, Kate; Kralj-Hans, Ines; MacRae, Eilidh; Shah, Urvi; Cross, Amanda J.] Imperial Coll London, Dept Surg & Canc, Canc Screening & Prevent Res Grp, St Marys Campus,Norfolk Pl, London W2 1PG, England; [Parkin, D. Maxwell] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England; [Duffy, Stephen] Queen Mary Univ, Wolfson Inst Prevent Med, Ctr Canc Prevent, London, England	Imperial College London; University of Oxford; University of London; Queen Mary University London	Atkin, W (corresponding author), Imperial Coll London, Dept Surg & Canc, Canc Screening & Prevent Res Grp, St Marys Campus,Norfolk Pl, London W2 1PG, England.	w.atkin@imperial.ac.uk		Wooldrage, Kate/0000-0001-8209-3113	National Institute for Health Research Efficacy and Mechanism Evaluation; MRC [G9615910] Funding Source: UKRI; Cancer Research UK [16894] Funding Source: researchfish; Medical Research Council [G9615910] Funding Source: researchfish; National Institute for Health Research [16/65/01, NF-SI-0513-10092] Funding Source: researchfish	National Institute for Health Research Efficacy and Mechanism Evaluation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	National Institute for Health Research Efficacy and Mechanism Evaluation.	Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Atkin WS, 2002, LANCET, V359, P1291, DOI 10.1016/s0140-6736(02)08268-5; ATKIN WS, 1993, LANCET, V341, P736, DOI 10.1016/0140-6736(93)90499-7; Atkin WS, 2001, J MED SCREEN, V8, P137, DOI 10.1136/jms.8.3.137; Cuzick J, 1997, STAT MED, V16, P1017, DOI 10.1002/(SICI)1097-0258(19970515)16:9<1017::AID-SIM508>3.0.CO;2-V; Cuzick J, 2007, J MED SCREEN, V14, P178, DOI 10.1258/096914107782912059; Hirai HW, 2016, ALIMENT PHARM THER, V43, P755, DOI 10.1111/apt.13556; Holme O, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6673; Holme O, 2014, JAMA-J AM MED ASSOC, V312, P606, DOI 10.1001/jama.2014.8266; Mayor S, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2325; National Cancer Intelligence Network, 2014, OLD PEOPL CANC; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Office for National Statistics, 1998, CANC REG STAT ENG 19; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Segnan N, 2011, J NATL CANCER I, V103, P1310, DOI 10.1093/jnci/djr284; Siegel RL, 2012, CANCER EPIDEM BIOMAR, V21, P411, DOI 10.1158/1055-9965.EPI-11-1020; Souverijn JHM, 2014, NEW ENGL J MED, V371, P187, DOI 10.1056/NEJMc1405215; Tabar L, 2004, J MED SCREEN, V11, P126, DOI 10.1258/0969141041732175; Troy Brown RN, 2014, FDA PAN REC NEW COL; Turner EL, 2016, BRIT J CANCER, V115, P90, DOI 10.1038/bjc.2016.162	20	188	200	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 1	2017	389	10076					1299	1311		10.1016/S0140-6736(17)30396-3	http://dx.doi.org/10.1016/S0140-6736(17)30396-3			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ2OF	28236467	hybrid, Green Published			2022-12-28	WOS:000397908700023
J	Allen, SE; Hug, I; Pabian, S; Rzeszutek, I; Hoehener, C; Nowacki, M				Allen, Sarah E.; Hug, Iris; Pabian, Sylwia; Rzeszutek, Iwona; Hoehener, Cristina; Nowacki, Mariusz			Circular Concatemers of Ultra-Short DNA Segments Produce Regulatory RNAs	CELL			English	Article							CILIATE PARAMECIUM-TETRAURELIA; GENOME; REARRANGEMENTS; TRANSCRIPTION; ELIMINATION; TETRAHYMENA	In the ciliated protozoan Paramecium tetraurelia, Piwi-associated small RNAs are generated upon the elimination of tens of thousands of short transposon-derived DNA segments as part of development. These RNAs then target complementary DNA for elimination in a positive feedback process, contributing to germline defense and genome stability. In this work, we investigate the formation of these RNAs, which we show to be transcribed directly from the short (length mode 27 bp) excised DNA segments. Our data support a mechanism whereby the concatenation and circularization of excised DNA segments provides a template for RNA production. This process allows the generation of a doublestranded RNA for Dicer-like protein cleavage to give rise to a population of small regulatory RNAs that precisely match the excised DNA sequences.	[Allen, Sarah E.; Hug, Iris; Pabian, Sylwia; Rzeszutek, Iwona; Hoehener, Cristina; Nowacki, Mariusz] Univ Bern, Inst Cell Biol, Baltzerstr 4, CH-3012 Bern, Switzerland	University of Bern	Nowacki, M (corresponding author), Univ Bern, Inst Cell Biol, Baltzerstr 4, CH-3012 Bern, Switzerland.	mariusz.nowacki@izb.unibe.ch	Nowacki, Mariusz/E-4485-2011	Nowacki, Mariusz/0000-0003-4894-2905; Rzeszutek, Iwona/0000-0001-6016-868X	European Research Council (ERC) [260358, 681178]; Swiss National Science Foundation [31003A_146257, 31003A_166407]; National Center of Competence in Research (NCCR) RNA and Disease	European Research Council (ERC)(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research (NCCR) RNA and Disease(Swiss National Science Foundation (SNSF))	We would like to thank Eric Meyer for inspiring discussions regarding the experiments and Nasikhat Stahlberger for technical support. This research was supported by grants from the European Research Council (ERC) (260358 "EPIGENOME" and 681178 "G-EDIT"), the Swiss National Science Foundation (31003A_146257 and 31003A_166407), and the National Center of Competence in Research (NCCR) RNA and Disease.	Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Arnaiz O, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002984; Arnaiz O, 2011, NUCLEIC ACIDS RES, V39, pD632, DOI 10.1093/nar/gkq918; Aronica L, 2008, GENE DEV, V22, P2228, DOI 10.1101/gad.481908; Baudry C, 2009, GENE DEV, V23, P2478, DOI 10.1101/gad.547309; Beisson J., 2010, COLD SPRING HARB PRO, V2010; BRABANT F, 1995, J VIROL, V69, P4423, DOI 10.1128/JVI.69.7.4423-4430.1995; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Czech B, 2016, TRENDS BIOCHEM SCI, V41, P324, DOI 10.1016/j.tibs.2015.12.008; Dudley D.D., 2005, ADV IMMUNOL, P43; Gratias A, 2003, MOL CELL BIOL, V23, P7152, DOI 10.1128/MCB.23.20.7152-7162.2003; Gratias A, 2008, NUCLEIC ACIDS RES, V36, P3244, DOI 10.1093/nar/gkn154; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Jahn CL, 2002, ANNU REV MICROBIOL, V56, P489, DOI 10.1146/annurev.micro.56.012302.160916; Kapusta A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002049; Kawaji H, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040022; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Mochizuki K, 2004, EUKARYOT CELL, V3, P1233, DOI 10.1128/EC.3.5.1233-1240.2004; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Sandoval PY, 2014, DEV CELL, V28, P174, DOI 10.1016/j.devcel.2013.12.010; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Singh DP, 2014, NATURE, V509, P447, DOI 10.1038/nature13318; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Swart EC, 2014, NUCLEIC ACIDS RES, V42, P8970, DOI 10.1093/nar/gku619; Wang JB, 2014, CURR OPIN GENET DEV, V27, P26, DOI 10.1016/j.gde.2014.03.012; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002	29	27	27	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2017	168	6					990	+		10.1016/j.cell.2017.02.020	http://dx.doi.org/10.1016/j.cell.2017.02.020			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8ZF	28283070	hybrid, Green Published			2022-12-28	WOS:000396287900008
J	Goldford, JE; Hartman, H; Smith, TF; Segre, D				Goldford, Joshua E.; Hartman, Hyman; Smith, Temple F.; Segre, Daniel			Remnants of an Ancient Metabolism without Phosphate	CELL			English	Article							TRANSITION-METAL SULFIDES; COMMON ANCESTOR; GENE-TRANSFER; AMINO-ACIDS; EVOLUTION; ORIGIN; PHOSPHORUS; NETWORKS; LIFE	Phosphate is essential for all living systems, serving as a building block of genetic and metabolic machinery. However, it is unclear how phosphate could have assumed these central roles on primordial Earth, given its poor geochemical accessibility. We used systems biology approaches to explore the alternative hypothesis that a protometabolism could have emerged prior to the incorporation of phosphate. Surprisingly, weidentified a cryptic phosphate-independent core metabolism producible from simple prebiotic compounds. This network is predicted to support the biosynthesis of a broad category of key biomolecules. Its enrichment for enzymes utilizing iron-sulfur clusters, and the fact that thermodynamic bottlenecks are more readily overcome by thioester rather than phosphate couplings, suggest that this network may constitute a "metabolic fossil'' of an early phosphate-free nonenzymatic biochemistry. Our results corroborate and expand previous proposals that a putative thioester-based metabolism could have predated the incorporation of phosphate and an RNA-based genetic system.	[Goldford, Joshua E.; Smith, Temple F.; Segre, Daniel] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Hartman, Hyman] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Smith, Temple F.; Segre, Daniel] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Segre, Daniel] Boston Univ, Dept Phys, Dept Biol, 590 Commonwealth Ave, Boston, MA 02215 USA	Boston University; Massachusetts Institute of Technology (MIT); Boston University; Boston University	Segre, D (corresponding author), Boston Univ, Bioinformat Program, Boston, MA 02215 USA.; Segre, D (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.; Segre, D (corresponding author), Boston Univ, Dept Phys, Dept Biol, 590 Commonwealth Ave, Boston, MA 02215 USA.	dsegre@bu.edu	Hartman, Hyman/N-7363-2019; Segre, Daniel/A-1993-2009	Segre, Daniel/0000-0003-4859-1914; Goldford, Joshua/0000-0001-7315-8018	NSF [DEB-1457695, NSFOCE-BSF-1635070]; US DOE [DE-SC0012627]; Human Frontier Science Program; National Institute of General Medical Sciences of the National Institutes of Health [T32GM100842]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM100842] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); US DOE(United States Department of Energy (DOE)); Human Frontier Science Program(Human Frontier Science Program); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful for the helpful feedback from Pankaj Mehta, Jennifer Talbot, Kirill Korolev, Jeff Gore, and all members of the Segre lab. We are also very grateful for the helpful insights provided by anonymous reviewers. This work was partially funded by the NSF under grants DEB-1457695 and NSFOCE-BSF-1635070, by US DOE grant DE-SC0012627, by the Human Frontier Science Program and by the National Institute of General Medical Sciences of the National Institutes of Health under award number T32GM100842.	Adcock CT, 2013, NAT GEOSCI, V6, P824, DOI [10.1038/NGEO1923, 10.1038/ngeo1923]; Bar-Even A, 2012, BBA-BIOENERGETICS, V1817, P1646, DOI 10.1016/j.bbabio.2012.05.002; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; Cody GD, 2004, GEOCHIM COSMOCHIM AC, V68, P2185, DOI 10.1016/j.gca.2003.11.020; Cody GD, 2000, SCIENCE, V289, P1337, DOI 10.1126/science.289.5483.1337; Cody GD, 2004, ANNU REV EARTH PL SC, V32, P569, DOI 10.1146/annurev.earth.32.101802.120225; David LA, 2011, NATURE, V469, P93, DOI 10.1038/nature09649; de Duve C, 1991, BLUEPRINT CELL NATUR; Deamer D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004929; Delaye L, 2005, ORIGINS LIFE EVOL B, V35, P537, DOI 10.1007/s11084-005-5760-3; EAKIN RE, 1963, P NATL ACAD SCI USA, V49, P360, DOI 10.1073/pnas.49.3.360; Ebenhoh Oliver, 2004, Genome Inform, V15, P35; ECK RV, 1966, SCIENCE, V152, P363, DOI 10.1126/science.152.3720.363; Flamholz A, 2012, NUCLEIC ACIDS RES, V40, pD770, DOI 10.1093/nar/gkr874; Goldman AD, 2013, NUCLEIC ACIDS RES, V41, pD1079, DOI 10.1093/nar/gks1217; Gorlero M, 2009, FEBS LETT, V583, P153, DOI 10.1016/j.febslet.2008.11.052; HALL DO, 1971, NATURE, V233, P136, DOI 10.1038/233136a0; Halmann M., 1974, ORIGIN LIFE EVOLUTIO, P169; Handorf T, 2005, J MOL EVOL, V61, P498, DOI 10.1007/s00239-005-0027-1; HARTMAN H, 1992, PHOTOSYNTH RES, V33, P171, DOI 10.1007/BF00039179; HARTMAN H, 1975, J MOL EVOL, V4, P359, DOI 10.1007/BF01732537; Hazen RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002162; Hemavathi K, 2010, J APPL CRYSTALLOGR, V43, P196, DOI 10.1107/S002188980903982X; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Keefe AD, 1995, J MOL EVOL, V41, P693; KEEFE AD, 1995, NATURE, V373, P683, DOI 10.1038/373683a0; Keller MA, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.20145228; Khomyakova M, 2011, SCIENCE, V331, P334, DOI 10.1126/science.1196544; KING GAM, 1980, BIOSYSTEMS, V13, P23, DOI 10.1016/0303-2647(80)90003-9; Lang SQ, 2010, GEOCHIM COSMOCHIM AC, V74, P941, DOI 10.1016/j.gca.2009.10.045; LASZLO P, 1987, SCIENCE, V235, P1473, DOI 10.1126/science.235.4795.1473; Martin ACR, 2005, BIOINFORMATICS, V21, P4297, DOI 10.1093/bioinformatics/bti694; Martin W, 2007, PHILOS T R SOC B, V362, P1887, DOI 10.1098/rstb.2006.1881; Milner-White EJ, 2011, GENES-BASEL, V2, P671, DOI 10.3390/genes2040671; Mirkin BG, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-2; Morowitz HJ, 2010, BIOL BULL-US, V219, P1; Morowitz HJ, 2000, P NATL ACAD SCI USA, V97, P7704, DOI 10.1073/pnas.110153997; Nelson D.L., 2005, LEHNINGER PRINCIPLES, DOI DOI 10.1002/BMB.2005.494033010419; Nitschke W, 2013, BBA-BIOENERGETICS, V1827, P871, DOI 10.1016/j.bbabio.2013.02.008; Noor E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003098; Novikov Y, 2013, P NATL ACAD SCI USA, V110, P13283, DOI 10.1073/pnas.1304923110; O'Brien EJ, 2015, CELL, V161, P971, DOI 10.1016/j.cell.2015.05.019; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Parker ET, 2011, P NATL ACAD SCI USA, V108, P5526, DOI 10.1073/pnas.1019191108; Pasek MA, 2008, P NATL ACAD SCI USA, V105, P853, DOI 10.1073/pnas.0708205105; Pasek MA, 2013, P NATL ACAD SCI USA, V110, P10089, DOI 10.1073/pnas.1303904110; Pizzarello S, 2004, SCIENCE, V303, P1151, DOI 10.1126/science.1093057; Plata G, 2015, NATURE, V517, P369, DOI 10.1038/nature13827; Rauchfuss H, 2008, CHEMICAL EVOLUTION AND THE ORIGIN OF LIFE, P1; Raymond J, 2006, SCIENCE, V311, P1764, DOI 10.1126/science.1118439; Russell MJ, 2010, GEOBIOLOGY, V8, P355, DOI 10.1111/j.1472-4669.2010.00249.x; Schwartz AW, 2006, PHILOS T R SOC B, V361, P1743, DOI 10.1098/rstb.2006.1901; Semenov SN, 2016, NATURE, V537, P656, DOI 10.1038/nature19776; Smith E, 2004, P NATL ACAD SCI USA, V101, P13168, DOI 10.1073/pnas.0404922101; Smith E, 2016, ORIGIN NATURE LIFE E; Sousa FL, 2014, BBA-BIOENERGETICS, V1837, P964, DOI 10.1016/j.bbabio.2014.02.001; Sousa FL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0088; Srinivasan V, 2009, BIOL BULL-US, V216, P126; Vetsigian K, 2006, P NATL ACAD SCI USA, V103, P10696, DOI 10.1073/pnas.0603780103; WACHTERSHAUSER G, 1990, P NATL ACAD SCI USA, V87, P200, DOI 10.1073/pnas.87.1.200; Wang M, 2007, GENOME RES, V17, P1572, DOI 10.1101/gr.6454307; Weiss MC, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.116, 10.1038/nmicrobiol.2016.116]	63	113	114	4	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2017	168	6					1126	+		10.1016/j.cell.2017.02.001	http://dx.doi.org/10.1016/j.cell.2017.02.001			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8ZF	28262353	hybrid			2022-12-28	WOS:000396287900019
J	[Anonymous]				[Anonymous]			Relief for Chronic Constipation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2017	317	9					900	900		10.1001/jama.2017.1065	http://dx.doi.org/10.1001/jama.2017.1065			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4NM	28267840				2022-12-28	WOS:000426801600005
J	Mohammadi, D				Mohammadi, Dara			Growing older with HIV in the UK	LANCET			English	Editorial Material																			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 4	2017	389	10072					894	895						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM4DL	28271830				2022-12-28	WOS:000395263400012
J	Morgan, J				Morgan, Jules			Disability-a neglected issue in Greece's refugee camps	LANCET			English	Editorial Material																			0	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 4	2017	389	10072					896	896						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM4DL	28271831				2022-12-28	WOS:000395263400013
J	Siepielski, AM; Morrissey, MB; Buoro, M; Carlson, SM; Caruso, CM; Clegg, SM; Coulson, T; DiBattista, J; Gotanda, KM; Francis, CD; Hereford, J; Kingsolver, JG; Augustine, KE; Kruuk, LEB; Martin, RA; Sheldon, BC; Sletvold, N; Svensson, EI; Wade, MJ; MacColl, ADC				Siepielski, Adam M.; Morrissey, Michael B.; Buoro, Mathieu; Carlson, Stephanie M.; Caruso, Christina M.; Clegg, Sonya M.; Coulson, Tim; DiBattista, Joseph; Gotanda, Kiyoko M.; Francis, Clinton D.; Hereford, Joe; Kingsolver, Joel G.; Augustine, Kate E.; Kruuk, Loeske E. B.; Martin, Ryan A.; Sheldon, Ben C.; Sletvold, Nina; Svensson, Erik I.; Wade, Michael J.; MacColl, Andrew D. C.			Precipitation drives global variation in natural selection	SCIENCE			English	Article							CLIMATE-CHANGE; ADAPTATION; EXTINCTION; IMPACTS; INDEXES; EVOLUTION	Climate change has the potential to affect the ecology and evolution of every species on Earth. Although the ecological consequences of climate change are increasingly well documented, the effects of climate on the key evolutionary process driving adaptation-natural selection-are largely unknown. We report that aspects of precipitation and potential evapotranspiration, along with the North Atlantic Oscillation, predicted variation in selection across plant and animal populations throughout many terrestrial biomes, whereas temperature explained little variation. By showing that selection was influenced by climate variation, our results indicate that climate change may cause widespread alterations in selection regimes, potentially shifting evolutionary trajectories at a global scale.	[Siepielski, Adam M.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA; [Morrissey, Michael B.] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland; [Buoro, Mathieu; Carlson, Stephanie M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Caruso, Christina M.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Clegg, Sonya M.; Sheldon, Ben C.] Univ Oxford, Edward Grey Inst, Dept Zool, Oxford, England; [Clegg, Sonya M.] Griffith Univ, Environm Futures Res Inst, 170 Kessels Rd, Nathan, Qld, Australia; [Coulson, Tim; Gotanda, Kiyoko M.] Univ Oxford, Dept Zool, Oxford, England; [DiBattista, Joseph] Curtin Univ, Dept Environm & Agr, Perth, WA 6845, Australia; [Gotanda, Kiyoko M.] McGill Univ, Redpath Museum, Montreal, PQ, Canada; [Gotanda, Kiyoko M.] McGill Univ, Dept Biol, Montreal, PQ, Canada; [Francis, Clinton D.] Calif Polytech State Univ San Luis Obispo, Dept Biol Sci, San Luis Obispo, CA 93407 USA; [Hereford, Joe] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Kingsolver, Joel G.; Augustine, Kate E.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Kruuk, Loeske E. B.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Martin, Ryan A.] Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA; [Sletvold, Nina] Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden; [Svensson, Erik I.] Lund Univ, Dept Biol, Lund, Sweden; [Wade, Michael J.] Indiana Univ, Dept Biol, Bloomington, IN USA; [MacColl, Andrew D. C.] Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England	University of Arkansas System; University of Arkansas Fayetteville; University of St Andrews; University of California System; University of California Berkeley; University of Guelph; University of Oxford; Griffith University; University of Oxford; Curtin University; McGill University; McGill University; California State University System; California Polytechnic State University San Luis Obispo; University of California System; University of California Davis; University of North Carolina; University of North Carolina Chapel Hill; Australian National University; Case Western Reserve University; Uppsala University; Lund University; Indiana University System; Indiana University Bloomington; University of Nottingham	Siepielski, AM (corresponding author), Univ Pau & Pays Adour, INRA, St Pee Sur Nivelle, France.	amsiepie@uark.edu	Sheldon, Ben C/A-8056-2010; Siepielski, Adam/AAE-4806-2021; Svensson, Erik/E-8324-2010; Martin, Ryan/AAF-1314-2019; Gotanda, Kiyoko/A-4119-2013; Kruuk, Loeske/AAB-8714-2019; Kruuk, Loeske E. B./J-3295-2012; Coulson, Tim/AAL-8148-2021; MacColl, Andrew/B-7090-2014; Morrissey, Michael/F-3226-2010	Sheldon, Ben C/0000-0002-5240-7828; Svensson, Erik/0000-0001-9006-016X; Martin, Ryan/0000-0002-7448-5907; Gotanda, Kiyoko/0000-0002-3666-0700; Kruuk, Loeske/0000-0001-8588-1123; Kruuk, Loeske E. B./0000-0001-8588-1123; Coulson, Tim/0000-0001-9371-9003; MacColl, Andrew/0000-0003-2102-6130; Buoro, Mathieu/0000-0001-7053-3767; Morrissey, Michael/0000-0001-6209-0177; Carlson, Stephanie/0000-0003-3055-6483	NSF [EF-0905606, DEB1620046, DBI 1300426]; Natural Sciences and Engineering Research Council of Canada (NSERC); Australian Research Council; Div Of Biological Infrastructure [1300426] Funding Source: National Science Foundation; NERC [NE/M003035/1] Funding Source: UKRI; Natural Environment Research Council [NE/M003035/1, NE/L00688X/1] Funding Source: researchfish	NSF(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Australian Research Council(Australian Research Council); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the many field biologists whose efforts allowed us to perform this analysis and C. Benkman, A. Hendry, and M. McPeek for comments. This work originated from a National Evolutionary Synthesis Center (NESCent) working group (NSF grant EF-0905606). A.M.S acknowledges the NSF (grant DEB1620046); B.C.S is a Wolfson Research Merit Award holder; R.A.M was supported by the NSF (grant DBI 1300426); K.M.G was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC); and L.E.B.K. was supported by the Australian Research Council. The data reported in this paper are available at datadryad.org (doi: 10.5061/dryad.52650) and as supplementary materials.	Bell G, 2008, EVOL APPL, V1, P3, DOI 10.1111/j.1752-4571.2007.00011.x; Bonebrake TC, 2010, P NATL ACAD SCI USA, V107, P12581, DOI 10.1073/pnas.0911841107; Bumpus HC., 1899, BIOL LECTURES MARINE, P209; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; Donat MG, 2013, J GEOPHYS RES-ATMOS, V118, P2098, DOI 10.1002/jgrd.50150; Donat MG, 2016, NAT CLIM CHANGE, V6, P508, DOI [10.1038/NCLIMATE2941, 10.1038/nclimate2941]; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; GOMULKIEWICZ R, 1995, EVOLUTION, V49, P201, DOI 10.1111/j.1558-5646.1995.tb05971.x; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Hallett TB, 2004, NATURE, V430, P71, DOI 10.1038/nature02708; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Husby A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000585; Karl TR, 2003, SCIENCE, V302, P1719, DOI 10.1126/science.1090228; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.2307/2408842; Rahmstorf S, 2011, P NATL ACAD SCI USA, V108, P17905, DOI 10.1073/pnas.1101766108; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; Urban MC, 2015, SCIENCE, V348, P571, DOI 10.1126/science.aaa4984; Vazquez DP, 2017, BIOL REV, V92, P22, DOI 10.1111/brv.12216	23	196	201	11	283	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					959	+		10.1126/science.aag2773	http://dx.doi.org/10.1126/science.aag2773			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2YM	28254943	Green Accepted, Green Submitted			2022-12-28	WOS:000395181700041
J	[Anonymous]				[Anonymous]			HUMAN MIGRATION	NATURE			English	Editorial Material																			0	0	0	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2017	543	7463					21	21		10.1038/543021a	http://dx.doi.org/10.1038/543021a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY4NR	28252097	Bronze			2022-12-28	WOS:000426802200001
J	Slomski, A				Slomski, Anita			Improving Shared Decision Making in Management of Dementia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2017	317	8					798	798		10.1001/jama.2017.1135	http://dx.doi.org/10.1001/jama.2017.1135			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM7PW	28245321				2022-12-28	WOS:000395505600009
J	Stafford, N				Stafford, Ned			Herman Vanden Berghe Helped establish human genetics in Belgium	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												ns@europefn.de							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 28	2017	356								j1056	10.1136/bmj.j1056	http://dx.doi.org/10.1136/bmj.j1056			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JQ	28246089				2022-12-28	WOS:000395628100009
J	van Weel, C; Kassai, R				van Weel, Chris; Kassai, Ryuki			Expanding primary care in South and East Asia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[van Weel, Chris] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, Gen Practice, Nijmegen, Netherlands; [van Weel, Chris] Australian Natl Univ, Dept Hlth Serv Res & Policy, Gen Practice, Canberra, ACT, Australia; [Kassai, Ryuki] Fukushima Med Univ, Dept Community & Family Med, Family Med, Fukushima, Japan	Radboud University Nijmegen; Australian National University; Fukushima Medical University	van Weel, C (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, Gen Practice, Nijmegen, Netherlands.; van Weel, C (corresponding author), Australian Natl Univ, Dept Hlth Serv Res & Policy, Gen Practice, Canberra, ACT, Australia.	chris.vanweel@radboudumc.nl	van Weel, Chris/D-4375-2009	van Weel, Chris/0000-0003-3653-4701				[Anonymous], 2012, J AM BOARD FAM ME S1, V356; Eklund K, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-76; Frank C, 2015, CAN FAM PHYSICIAN, V61, P601; Hansen J, 2015, HEALTH AFFAIR, V34, P1531, DOI 10.1377/hlthaff.2015.0582; Javanparast S, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-36; Jha A, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2216; Kassai R, 2014, JPN J HLTH EC POLICY, V26, P3; Kidd M, 2013, CONTRIBUTION FAMILY; Kringos D., 2012, THESIS; Macinko J, 2003, HEALTH SERV RES, V38, P831, DOI 10.1111/1475-6773.00149; Reeve J, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-112; STARFIELD B, 1994, LANCET, V344, P1129, DOI 10.1016/S0140-6736(94)90634-3; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Stigler F, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30315-4; Turner G, 2014, AGE AGEING, V43, P744, DOI 10.1093/ageing/afu138; van Weel C, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000057; van Weel C, 2016, BRIT J GEN PRACT, V66, pE451, DOI 10.3399/bjgp16X685513; van Weel C, 2015, ANN FAM MED, V13, P86, DOI 10.1370/afm.1751; WHO, 2008, WORLD HLTH REPORT 20; WHO South East Asia Region, 2015, SEARC682015 WHO S E; WONCA Europe, EUR DEF GEN PRACT FA; World Bank, 2016, LIV LONG PROSP AG E	22	17	18	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 27	2017	356								j634	10.1136/bmj.j634	http://dx.doi.org/10.1136/bmj.j634			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JP	28242604	Green Submitted			2022-12-28	WOS:000395628000007
J	Simon, H				Simon, Howard			Unloading Shoes for Self-management of Knee Osteoarthritis	ANNALS OF INTERNAL MEDICINE			English	Letter									[Simon, Howard] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University	Simon, H (corresponding author), Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA.							D'Aout K, 2009, FOOTWEAR SCI, V1, P81, DOI 10.1080/19424280903386411; Hinman RS, 2016, ANN INTERN MED, V165, P381, DOI 10.7326/M16-0453; Hoffmann P., 1905, J BONE JT SURG AM, V2, P105; Shakoor N, 2006, ARTHRITIS RHEUM, V54, P2923, DOI 10.1002/art.22123	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2017	166	4					311	311		10.7326/L16-0631	http://dx.doi.org/10.7326/L16-0631			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7FO	28241299				2022-12-28	WOS:000394786700027
J	Horton, R				Horton, Richard			Offline: The Bedouin predicament	LANCET			English	Editorial Material												richard.horton@lancet.com							0	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2016	387	10027					1498	1498		10.1016/S0140-6736(16)30166-0	http://dx.doi.org/10.1016/S0140-6736(16)30166-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DI8HH	28236415	Bronze			2022-12-28	WOS:000373741600012
J	Jha, V; Martin, DE; Bargman, JM; Davies, S; Feehally, J; Finkelstein, F; Harris, D; Misra, M; Remuzzi, G; Levin, A				Jha, Vivekanand; Martin, Dominique E.; Bargman, Joanne M.; Davies, Simon; Feehally, John; Finkelstein, Fred; Harris, David; Misra, Madhukar; Remuzzi, Giuseppe; Levin, Adeera		Int Soc Nephrology Ethical Dialysi	Ethical issues in dialysis therapy	LANCET			English	Article							KIDNEY-DISEASE; DECISION-MAKING; CARE; ACCESS; TRANSPLANTATION; HEMODIALYSIS; COST; ESRD	Treatment for end-stage kidney disease is a major economic challenge and a public health concern worldwide. Renal-replacement therapy poses several practical and ethical dilemmas of global relevance for patients, clinicians, and policy makers. These include how to: promote patients' best interests; increase access to dialysis while maintaining procedural and distributive justice; minimise the influence of financial incentives and competing interests; ensure quality of care in service delivery and access to non-dialytic supportive care when needed; minimise the financial burden on patients and health-care system; and protect the interests of vulnerable groups during crisis situations. These issues have received comparatively little attention, and there is scant ethical analysis and guidance available to decision makers. In this Health Policy, we provide an overview of the major ethical issues related to dialysis provision worldwide, identify priorities for further investigation and management, and present preliminary recommendations to guide practice and policy.	[Jha, Vivekanand] George Inst Global Hlth, New Delhi 110025, India; [Jha, Vivekanand] Univ Oxford, Oxford, England; [Martin, Dominique E.] Deakin Univ, Sch Med, Melbourne, Vic, Australia; [Bargman, Joanne M.] Univ Toronto, Toronto, ON, Canada; [Davies, Simon] Keele Univ, Inst Appl Clin Sci, Keele, Staffs, England; [Feehally, John] Univ Leicester, Leicester, Leics, England; [Finkelstein, Fred] Yale Univ, New Haven, CT USA; [Harris, David] Univ Sydney, Sydney, NSW, Australia; [Misra, Madhukar] Univ Missouri, Columbia, MO USA; [Remuzzi, Giuseppe] Ist Ric Farmacol Mario Negri, Bergamo, Italy; [Levin, Adeera] Univ British Columbia, Vancouver, BC, Canada	University of Oxford; Deakin University; University of Toronto; Keele University; University of Leicester; Yale University; University of Sydney; University of Missouri System; University of Missouri Columbia; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of British Columbia	Jha, V (corresponding author), George Inst Global Hlth, New Delhi 110025, India.	vivek.jha@georgeinstitute.ox.ac.uk	Harris, David/W-4786-2019; Remuzzi, Giuseppe/V-9766-2017	Jha, Vivekanand/0000-0002-8015-9470; Martin, Dominique/0000-0001-9363-0770; Remuzzi, Giuseppe/0000-0002-6194-3446	Baxter Healthcare; GlaxoSmithKline; NephroPlus; Fresenius Medical Care	Baxter Healthcare; GlaxoSmithKline(GlaxoSmithKline); NephroPlus; Fresenius Medical Care	VJ reports grants from Baxter Healthcare and GlaxoSmithKline and personal fees from NephroPlus; NephroPlus is a dialysis provider. DEM reports personal fees from WHO, outside the submitted work. SD reports grants and personal fees from Baxter Healthcare and Fresenius Medical Care; both are dialysis providers. JMB reports institutional support from Baxter Healthcare for education in home dialysis. DH reports personal fees from Roche Myanmar, outside the submitted work. JF, FF, MM, GR, and AL declare no competing interests.	[Anonymous], 2010, B WORLD HEALTH ORGAN, V88, P81; Chou SH, 2006, CLIN J AM SOC NEPHRO, V1, P58, DOI 10.2215/CJN.00560705; Collins A, 2006, KIDNEY INT, V69, P781, DOI 10.1038/sj.ki.5000250; Collins A, 2014, AM J KIDNEY DIS, V63, pE1; Combs SA, 2015, AM J KIDNEY DIS, V65, P233, DOI 10.1053/j.ajkd.2014.07.018; Davison SN, 2015, KIDNEY INT, V88, P447, DOI 10.1038/ki.2015.110; Etheredge H, 2015, DEV WORLD BIOETH, V15, P233, DOI 10.1111/dewb.12067; Evans NG, 2015, CLIN J AM SOC NEPHRO, V10, P2263, DOI 10.2215/CJN.03730415; Hussain JA, 2015, CLIN J AM SOC NEPHRO, V10, P1201, DOI 10.2215/CJN.11091114; Jensen CE, 2014, DAN MED J, V61; Jha V, 1996, NEPHROLOGY, V2, P65, DOI 10.1111/j.1440-1797.1996.tb00068.x; Jha V, 2015, CLIN NEPHROL, V83, pS7, DOI 10.5414/CNP83S007; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Just PM, 2008, NEPHROL DIAL TRANSPL, V23, P2365, DOI 10.1093/ndt/gfm939; Karopadi AN, 2013, NEPHROL DIAL TRANSPL, V28, P2553, DOI 10.1093/ndt/gft214; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; Morton RL, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c112; Moss AH, 2010, CLIN J AM SOC NEPHRO, V5, P2380, DOI 10.2215/CJN.07170810; Murray MA, 2009, PATIENT EDUC COUNS, V76, P149, DOI 10.1016/j.pec.2008.12.010; Operations and Business Environment, ANN REPORT; Ozar DT, 2013, CLIN J AM SOC NEPHRO, V8, P840, DOI 10.2215/CJN.08490812; Parker JC, 2011, SEMIN DIALYSIS, V24, P5, DOI 10.1111/j.1525-139X.2010.00806.x; Ramachandran R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067812; Rinehart A, 2013, CLIN J AM SOC NEPHRO, V8, P2000, DOI 10.2215/CJN.12191212; Rodriguez RA, 2015, ADV CHRONIC KIDNEY D, V22, P60, DOI 10.1053/j.ackd.2014.07.003; Saran R, 2016, AM J KIDNEY DIS, V67, pS1, DOI 10.1053/j.ajkd.2015.12.014; Saunders MR, 2014, J RACIAL ETHN HEALTH, V1, P291, DOI 10.1007/s40615-014-0036-0; SINGER P, 1995, J MED ETHICS, V21, P144, DOI 10.1136/jme.21.3.144; Thompson AK, 2006, BMC MED ETHICS, V7, P12, DOI [10.1186/1472-6939-7-12, DOI 10.1186/1472-6939-7-12]; Tonelli M, 2011, AM J TRANSPLANT, V11, P2093, DOI 10.1111/j.1600-6143.2011.03686.x	30	30	31	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2017	389	10081					1851	1856		10.1016/S0140-6736(16)32408-4	http://dx.doi.org/10.1016/S0140-6736(16)32408-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET8KW	28238456	Green Submitted			2022-12-28	WOS:000400549300034
J	Riback, JA; Katanski, CD; Kear-Scott, JL; Pilipenko, EV; Rojek, AE; Sosnick, TR; Drummond, DA				Riback, Joshua A.; Katanski, Christopher D.; Kear-Scott, Jamie L.; Pilipenko, Evgeny V.; Rojek, Alexandra E.; Sosnick, Tobin R.; Drummond, D. Allan			Stress-Triggered Phase Separation Is an Adaptive, Evolutionarily Tuned Response	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; DISORDERED PROTEINS; LIQUID DROPLETS; MESSENGER-RNAS; HEAT-STRESS; GRANULES; SEQUENCE; BINDING; TRANSITIONS; TEMPERATURE	In eukaryotic cells, diverse stresses trigger coalescence of RNA-binding proteins into stress granules. In vitro, stress-granule-associated proteins can demix to form liquids, hydrogels, and other assemblies lacking fixed stoichiometry. Observing these phenomena has generally required conditions far removed from physiological stresses. We show that poly(A)-binding protein (Pab1 in yeast), a defining marker of stress granules, phase separates and forms hydrogels in vitro upon exposure to physiological stress conditions. Other RNA-binding proteins depend upon low-complexity regions (LCRs) or RNA for phase separation, whereas Pab1' s LCR is not required for demixing, and RNA inhibits it. Based on unique evolutionary patterns, we create LCR mutations, which systematically tune its biophysical properties and Pab1 phase separation in vitro and in vivo. Mutations that impede phase separation reduce organism fitness during prolonged stress. Poly(A)-binding protein thus acts as a physiological stress sensor, exploiting phase separation to precisely mark stress onset, a broadly generalizable mechanism.	[Riback, Joshua A.] Univ Chicago, Grad Program Biophys Sci, Chicago, IL 60673 USA; [Katanski, Christopher D.; Kear-Scott, Jamie L.; Pilipenko, Evgeny V.; Rojek, Alexandra E.; Sosnick, Tobin R.; Drummond, D. Allan] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60673 USA; [Sosnick, Tobin R.] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60673 USA; [Sosnick, Tobin R.] Univ Chicago, Inst Mol Engn, Chicago, IL 60673 USA; [Drummond, D. Allan] Univ Chicago, Dept Human Genet, Chicago, IL 60673 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Drummond, DA (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60673 USA.; Drummond, DA (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60673 USA.	dadrummond@uchicago.edu	Freed, Karl F/J-7764-2018; Drummond, D. Allan/A-1250-2015	Freed, Karl F/0000-0001-6240-2599; Drummond, D. Allan/0000-0001-7018-7059; Riback, Joshua/0000-0002-1516-4484; Katanski, Christopher/0000-0002-1707-081X	Pew Charitable Trusts; NIH via the Protein Translation Research Network [GM105816, GM55694, T32 EB009412-07, T32 GM007183]; NSF [GRF DGE-1144082]; US Army Research Office Multidisciplinary University Research Initiative [W911NF-14-1-0411]; big Ideas Generator seed grant; DOE [DEAC02-06CH11357]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622, R29GM055694, U54GM105816, R01GM055694, T32GM007183] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018090] Funding Source: NIH RePORTER	Pew Charitable Trusts; NIH via the Protein Translation Research Network; NSF(National Science Foundation (NSF)); US Army Research Office Multidisciplinary University Research Initiative(MURI); big Ideas Generator seed grant; DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to E. Wallace and members of the Drummond and Sosnick labs for helpful discussions, and we thank I. Gagnon for protein purification, S. Chakravarthy and A. Zmyslowski for assistance in SAXS measurements, and E. Nieweglowska for plasmid construction. Imaging was performed at the University of Chicago Integrated Light Microscopy Facility; we thank V. Bindokas, S. Bond, and C. Labno for their help. D.A.D. is a Pew Scholar in the Biomedical Sciences. This work was funded in part by grants from the Pew Charitable Trusts; the NIH, GM105816 via the Protein Translation Research Network (D.A.D.), GM55694 and T32 EB009412-07 (T.R.S.), and T32 GM007183 (C.D.K.); the NSF, GRF DGE-1144082 (J.A.R.); the US Army Research Office Multidisciplinary University Research Initiative Awards W911NF-14-1-0411; and a big Ideas Generator seed grant. Use of the Advanced Photon Source, an Office of Science User Facility, operated for the Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the DOE under Contract No. DEAC02-06CH11357.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; [Anonymous], 2021, LANG ENV STAT COMP; Boke E, 2016, CELL, V166, P637, DOI 10.1016/j.cell.2016.06.051; Borzova VA, 2015, INT J BIOL MACROMOL, V80, P130, DOI 10.1016/j.ijbiomac.2015.06.040; Brachmann CB, 1998, YEAST, V14, P115; Brangwynne CP, 2015, NAT PHYS, V11, P899, DOI [10.1038/NPHYS3532, 10.1038/nphys3532]; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Buchan JR, 2011, J CELL SCI, V124, P228, DOI 10.1242/jcs.078444; Cherkasov V, 2013, CURR BIOL, V23, P2452, DOI 10.1016/j.cub.2013.09.058; Csardi G, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005206; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; EDELSTEIN SJ, 1980, BIOPHYS J, V32, P347, DOI 10.1016/S0006-3495(80)84961-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engel SR, 2014, G3-GENES GENOM GENET, V4, P389, DOI 10.1534/g3.113.008995; Farny NG, 2009, RNA, V15, P1814, DOI 10.1261/rna.1684009; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Hofmann H, 2012, P NATL ACAD SCI USA, V109, P16155, DOI 10.1073/pnas.1207719109; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Kang KJ, 2012, NATURE, V481, P76, DOI 10.1038/nature10715; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kini HK, 2016, RNA, V22, P61, DOI 10.1261/rna.053447.115; Kroschwald S, 2015, ELIFE, V4, DOI 10.7554/eLife.06807; Lee CH, 2015, J CELL BIOL, V208, P533, DOI 10.1083/jcb.201407105; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; LINDQUIST S, 1990, ENZYME, V44, P147, DOI 10.1159/000468754; Maupetit J, 2006, NUCLEIC ACIDS RES, V34, pW147, DOI 10.1093/nar/gkl289; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; Mugler CF, 2016, ELIFE, V5, DOI 10.7554/eLife.18746; Munder MC, 2016, ELIFE, V5, DOI 10.7554/eLife.09347; Pak CW, 2016, MOL CELL, V63, P72, DOI 10.1016/j.molcel.2016.05.042; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; SACHS AB, 1987, MOL CELL BIOL, V7, P3268, DOI 10.1128/MCB.7.9.3268; Sengupta P, 2013, CURR BIOL, V23, pR304, DOI 10.1016/j.cub.2013.03.009; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Skinner JJ, 2014, P NATL ACAD SCI USA, V111, P15975, DOI 10.1073/pnas.1404213111; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390; Wallace EWJ, 2015, CELL, V162, P1286, DOI 10.1016/j.cell.2015.08.041; Weigert C, 2009, APPL ENVIRON MICROB, V75, P5615, DOI 10.1128/AEM.00650-09; Wuttke R, 2014, P NATL ACAD SCI USA, V111, P5213, DOI 10.1073/pnas.1313006111; Yang XX, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004763; Yao G, 2007, MOL CELL BIOL, V27, P6243, DOI 10.1128/MCB.00734-07; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017	48	407	411	22	165	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2017	168	6					1028	+		10.1016/j.cell.2017.02.027	http://dx.doi.org/10.1016/j.cell.2017.02.027			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8ZF	28283059	Bronze, Green Accepted			2022-12-28	WOS:000396287900011
J	George, DR; de Boer, C; Green, MJ				George, Daniel R.; de Boer, Claire; Green, Michael J.			"That Landscape Is Where I'd Like to Be ..." Offering Patients With Cancer a Choice of Artwork	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[George, Daniel R.; de Boer, Claire; Green, Michael J.] Penn State Coll Med, Dept Humanities, Hershey, PA 17033 USA; [de Boer, Claire] Penn State Milton S Hershey Med Ctr, Hershey, PA 17033 USA; [Green, Michael J.] Penn State Coll Med, Dept Med, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	de Boer, C (corresponding author), Penn State Coll Med, Dept Humanities, Hershey, PA 17033 USA.; de Boer, C (corresponding author), Penn State Milton S Hershey Med Ctr, Hershey, PA 17033 USA.	cdeboer@pennstatehealth.psu.edu	Green, Martin A/H-7567-2012	Green, Martin A/0000-0002-8860-396X; Green, Michael/0000-0002-4828-4749	National Endowment for the Arts [14-3800-7008]	National Endowment for the Arts	This work was supported by funding from the National Endowment for the Arts (grant 14-3800-7008).	Moss H, 2014, LANCET, V383, P1032, DOI 10.1016/S0140-6736(14)60507-9; Sehgal NL, 2010, J HOSP MED, V5, P234, DOI 10.1002/jhm.638; Young RK, 2016, JAMA-J AM MED ASSOC, V316, P1365, DOI 10.1001/jama.2016.14822	3	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2017	317	9					890	892		10.1001/jama.2017.1233	http://dx.doi.org/10.1001/jama.2017.1233			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM8DM	28267834				2022-12-28	WOS:000395541500001
J	Erlich, Y; Zielinski, D				Erlich, Yaniv; Zielinski, Dina			DNA Fountain enables a robust and efficient storage architecture	SCIENCE			English	Article							DIGITAL INFORMATION; ERROR	DNA is an attractive medium to store digital information. Here we report a storage strategy, called DNA Fountain, that is highly robust and approaches the information capacity per nucleotide. Using our approach, we stored a full computer operating system, movie, and other files with a total of 2.14 x 10(6) bytes in DNA oligonucleotides and perfectly retrieved the information from a sequencing coverage equivalent to a single tile of Illumina sequencing. We also tested a process that can allow 2.18 x 10(15) retrievals using the original DNA sample and were able to perfectly decode the data. Finally, we explored the limit of our architecture in terms of bytes per molecule and obtained a perfect retrieval from a density of 215 petabytes per gram of DNA, orders of magnitude higher than previous reports.	[Erlich, Yaniv; Zielinski, Dina] New York Genome Ctr, New York, NY 10013 USA; [Erlich, Yaniv] Columbia Univ, Fu Fdn Sch Engn, Dept Comp Sci, New York, NY 10027 USA; [Erlich, Yaniv] Columbia Univ, Ctr Computat Biol & Bioinformat C2B2, Dept Syst Biol, New York, NY 10027 USA	Columbia University; Columbia University	Erlich, Y (corresponding author), New York Genome Ctr, New York, NY 10013 USA.; Erlich, Y (corresponding author), Columbia Univ, Fu Fdn Sch Engn, Dept Comp Sci, New York, NY 10027 USA.; Erlich, Y (corresponding author), Columbia Univ, Ctr Computat Biol & Bioinformat C2B2, Dept Syst Biol, New York, NY 10027 USA.	yaniv@cs.columbia.edu		Zielinski, Dina/0000-0002-6188-9590	Burroughs Wellcome Fund	Burroughs Wellcome Fund(Burroughs Wellcome Fund)	Y.E. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund. This study was supported by a gift from A. Heafy and P. Heafy to the Erlich lab. We thank P. Smibert and M. Stoeckius for technical assistance with oligo design, N. Abe and S. Pescatore for sequencing operations, A. Gordon for creating the movie and the DNA Fountain website, and S. Zaaijer and N. Sanjana for comments and discussions. Code is available at https://github.com/TeamErlich/dnafountain. Sequencing data are available at www.ebi.ac.uk/ena/data/view/PRJEB19305 and www.ebi.ac.uk/ena/data/view/PRJEB19307.	Agbavwe C, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-57; Bancroft C, 2001, SCIENCE, V293, P1763; Blawat M, 2016, PROCEDIA COMPUT SCI, V80, P1011, DOI 10.1016/j.procs.2016.05.398; Bornhol J, 2016, ACM SIGPLAN NOTICES, V51, P637, DOI [10.1145/2872362.2872397, 10.1145/2954679.2872397]; Byers JW, 2002, IEEE J SEL AREA COMM, V20, P1528, DOI 10.1109/JSAC.2002.803996; Church GM, 2012, SCIENCE, V337, P1628, DOI 10.1126/science.1226355; Demir U, 2006, ISCN '06: PROCEEDINGS OF THE 7TH INTERNATIONAL SYMPOSIUM ON COMPUTER NETWORKS, P264; Erlich Y, 2009, GENOME RES, V19, P1243, DOI 10.1101/gr.092957.109; Goldman N, 2013, NATURE, V494, P77, DOI 10.1038/nature11875; Grass RN, 2015, ANGEW CHEM INT EDIT, V54, P2552, DOI 10.1002/anie.201411378; Kosuri S, 2014, NAT METHODS, V11, P499, DOI [10.1038/NMETH.2918, 10.1038/nmeth.2918]; Luby M, 2002, ANN IEEE SYMP FOUND, P271, DOI 10.1109/SFCS.2002.1181950; MacKay D. J. C., 2002, INFORM THEORY INFERE; MacKay DJC, 2005, IEE P-COMMUN, V152, P1062, DOI 10.1049/ip-com:20050237; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Schwartz JJ, 2012, NAT METHODS, V9, P913, DOI 10.1038/nmeth.2137; Shannon C.E., 1949, MATH THEORY COMMUNIC; Stockhammer T, 2008, INTERNET COMMUN, P239; WALLACE MR, 1978, KYBERNETES, V7, P265, DOI 10.1108/eb005489; Yazdi S. H. T., 2015, IEEE T MOL BIOL MULT, V1, P230; Yazdi SMHT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14138	21	299	345	36	334	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					950	953		10.1126/science.aaj2038	http://dx.doi.org/10.1126/science.aaj2038			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2YM	28254941	Green Submitted			2022-12-28	WOS:000395181700039
J	Moran, GJ; Talan, DA				Moran, Gregory J.; Talan, David A.			Cellulitis Commonly Misdiagnosed or Just Misunderstood?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SKIN		[Moran, Gregory J.; Talan, David A.] Olive View UCLA Med Ctr, Dept Emergency Med, Div Infect Dis, 14445 Olive View Dr, Sylmar, CA 91342 USA	University of California System; University of California Los Angeles	Moran, GJ (corresponding author), Olive View UCLA Med Ctr, Dept Emergency Med, Div Infect Dis, 14445 Olive View Dr, Sylmar, CA 91342 USA.	gmoran@ucla.edu			Allergan; Cempra	Allergan(AbbVieAllergan); Cempra	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Moran reported receiving grants and consulting fees from Allergan; and grants from Cempra. Dr Talan reported receiving grants and consulting fees from Allergan.	Arakaki RY, 2014, JAMA DERMATOL, V150, P1056, DOI 10.1001/jamadermatol.2014.1085; Crisp JG, 2015, CLIN INFECT DIS, V61, P1679, DOI 10.1093/cid/civ655; Eron Lawrence J., 2003, Journal of Antimicrobial Chemotherapy, V52, pi3; Levell NJ, 2011, BRIT J DERMATOL, V164, P1326, DOI 10.1111/j.1365-2133.2011.10275.x; Raff AB, 2016, JAMA-J AM MED ASSOC, V316, P325, DOI 10.1001/jama.2016.8825; Talan DA, 2015, WEST J EMERG MED, V16, P89, DOI 10.5811/westjem.2014.11.24133; Weng QY, 2017, JAMA DERMATOL, V153, P141, DOI 10.1001/jamadermatol.2016.3816	7	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2017	317	7					760	761		10.1001/jama.2016.15921	http://dx.doi.org/10.1001/jama.2016.15921			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8WR	28241341				2022-12-28	WOS:000394901600023
J	Voils, CI; Olsen, MK; Gierisch, JM; Mcvay, MA; Grubber, JM; Gaillard, L; Bolton, J; Maciejewski, ML; Strawbridge, E; Yancy, WS				Voils, Corrine I.; Olsen, Maren K.; Gierisch, Jennifer M.; Mcvay, Megan A.; Grubber, Janet M.; Gaillard, Leslie; Bolton, Jamiyla; Maciejewski, Matthew L.; Strawbridge, Elizabeth; Yancy, William S., Jr.			Maintenance of Weight Loss After Initiation of Nutrition Training A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							LONG-TERM MANAGEMENT; LOW-FAT DIET; LOW-CARBOHYDRATE; PROGRAMS; OBESITY; ADULTS; MOVE	Background: Weight regain after successful weight loss interventions is common. Objective: To establish the efficacy of a weight loss maintenance program compared with usual care in obese adults. Design: 2-group, parallel, randomized trial stratified by initial weight loss (< 10 kg vs. >= 10 kg), conducted from 20 August 2012 to 18 December 2015. Outcome assessors were blinded to treatment assignment. (ClinicalTrials. gov: NCT01357551) Setting: 3 primary care clinics at the Veterans Affairs Medical Center in Durham and Raleigh, North Carolina. Patients: Obese outpatients (body mass index >= 30 kg/m(2)) who lost 4 kg or more of body weight during a 16-week, group-based weight loss program. Intervention: The maintenance intervention, delivered primarily by telephone, addressed satisfaction with outcomes, relapseprevention planning, self-monitoring, and social support. Usual care involved no contact except for study measurements. Measurements: Primary outcome was mean weight regain at week 56. Secondary outcomes included self-reported caloric intake, walking, and moderate physical activity. Results: Of 504 patients in the initial program, 222 lost at least 4 kg of body weight and were randomly assigned to maintenance (n = 110) or usual care (n = 112). Retention was 85%. Most patients were middle-aged white men. Mean weight loss during initiation was 7.2 kg (SD, 3.1); mean weight at randomization was 103.6 kg (SD, 20.4). Estimated mean weight regain was statistically significantly lower in the intervention (0.75 kg) than the usual care (2.36 kg) group (estimated mean difference, 1.60 kg [ 95% CI, 0.07 to 3.13 kg]; P = 0.040). No statistically significant differences in secondary outcomes were seen at 56 weeks. No adverse events directly attributable to the intervention were observed. Limitations: Results may not generalize to other settings or populations. Dietary intake and physical activity were selfreported. Duration was limited to 56 weeks. Conclusion: An intervention focused on maintenance-specific strategies and delivered in a resource-conserving way modestly slowed the rate of weight regain in obese adults.	Duke Univ, Durham Vet Affairs Med Ctr, Durham, NC USA; [Yancy, William S., Jr.] Duke Univ, Diet & Fitness Ctr, 501 Douglas St, Durham, NC 27705 USA; [Voils, Corrine I.] Clin Sci Ctr K6 100, 600 Highland Ave, Madison, WI 53792 USA; [Olsen, Maren K.; Gierisch, Jennifer M.; Grubber, Janet M.; Gaillard, Leslie; Bolton, Jamiyla; Maciejewski, Matthew L.; Strawbridge, Elizabeth] Durham Vet Affairs Med Ctr, 508 Fulton St 152, Durham, NC 27705 USA; [Mcvay, Megan A.] Duke Univ, Med Ctr, Box 3862, Durham, NC 27710 USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University	Voils, CI (corresponding author), Clin Sci Ctr K6 100, 600 Highland Ave, Madison, WI 53792 USA.	voils@surgery.wisc.edu; maren.olsen@va.gov	Gierisch, Jennifer/GLU-1269-2022		Veterans Affairs Health Services Research and Development Service; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL127334] Funding Source: NIH RePORTER; Veterans Affairs [I01HX000690] Funding Source: NIH RePORTER	Veterans Affairs Health Services Research and Development Service(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	Veterans Affairs Health Services Research and Development Service.	Balding DJ, 2004, APPL LONGITUDINAL AN; Borm GF, 2007, J CLIN EPIDEMIOL, V60, P1234, DOI 10.1016/j.jclinepi.2007.02.006; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Dombrowski S U, 2014, BMJ, V348, pg2646, DOI 10.1136/bmj.g2646; Foster GD, 2010, ANN INTERN MED, V153, P147, DOI 10.7326/0003-4819-153-3-201008030-00005; Jeffery RW, 2009, PREV MED, V49, P384, DOI 10.1016/j.ypmed.2009.08.004; Jensen MD, 2014, J AM COLL CARDIOL, V63, P2985, DOI 10.1016/j.jacc.2013.11.004; Kahwati LC, 2011, TRANSL BEHAV MED, V1, P551, DOI 10.1007/s13142-011-0077-4; Keppel G, 1991, DESIGN ANAL RES HDB; Kiernan M, 2013, J CONSULT CLIN PSYCH, V81, P336, DOI 10.1037/a0030544; MacLean PS, 2015, OBESITY, V23, P7, DOI 10.1002/oby.20967; Olsen MK, 2012, SLEEP MED, V13, P123, DOI 10.1016/j.sleep.2011.09.007; Pekkarinen T, 2015, J OBES, V2015, DOI 10.1155/2015/651460; PERRI MG, 1988, J CONSULT CLIN PSYCH, V56, P529, DOI 10.1037/0022-006X.56.4.529; Perri MG, 2001, J CONSULT CLIN PSYCH, V69, P722, DOI 10.1037/0022-006X.69.4.722; PERRI MG, 1987, J CONSULT CLIN PSYCH, V55, P615, DOI 10.1037/0022-006X.55.4.615; Perri MG, 2008, ARCH INTERN MED, V168, P2347, DOI 10.1001/archinte.168.21.2347; Rothman AJ, 2000, HEALTH PSYCHOL, V19, P64, DOI 10.1037/0278-6133.19.Suppl1.64; Rothman AJ, 2009, ANN BEHAV MED, V38, pS4, DOI 10.1007/s12160-009-9118-3; Sherwood NE, 2013, PREV MED, V56, P171, DOI 10.1016/j.ypmed.2012.12.014; Svetkey LP, 2008, JAMA-J AM MED ASSOC, V299, P1139, DOI 10.1001/jama.299.10.1139; Voils CI, 2016, OBES SCI PRACT, V2, P355, DOI 10.1002/osp4.58; Voils CI, 2014, CONTEMP CLIN TRIALS, V39, P95, DOI 10.1016/j.cct.2014.08.002; Voils CI, 2014, HEALTH EDUC BEHAV, V41, P325, DOI 10.1177/1090198113515242; Wadden TA, 2005, NEW ENGL J MED, V353, P2111, DOI 10.1056/NEJMoa050156; West DS, 2011, INT J OBESITY, V35, P259, DOI 10.1038/ijo.2010.138; Wing RR, 2006, NEW ENGL J MED, V355, P1563, DOI 10.1056/NEJMoa061883; Yancy WS, 2015, ANN INTERN MED, V162, P805, DOI 10.7326/M14-2358; Yancy WS, 2010, ARCH INTERN MED, V170, P136, DOI 10.1001/archinternmed.2009.492	29	34	35	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 4	2017	166	7					463	+		10.7326/M16-2160	http://dx.doi.org/10.7326/M16-2160			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EQ4PT	28241185	Green Accepted			2022-12-28	WOS:000398061100008
J	Blancon, JC; Tsai, H; Nie, W; Stoumpos, CC; Pedesseau, L; Katan, C; Kepenekian, M; Soe, CMM; Appavoo, K; Sfeir, MY; Tretiak, S; Ajayan, PM; Kanatzidis, MG; Even, J; Crochet, JJ; Mohite, AD				Blancon, J. -C.; Tsai, H.; Nie, W.; Stoumpos, C. C.; Pedesseau, L.; Katan, C.; Kepenekian, M.; Soe, C. M. M.; Appavoo, K.; Sfeir, M. Y.; Tretiak, S.; Ajayan, P. M.; Kanatzidis, M. G.; Even, J.; Crochet, J. J.; Mohite, A. D.			PEROVSKITE PHYSICS Extremely efficient internal exciton dissociation through edge states in layered 2D perovskites	SCIENCE			English	Article							QUANTUM CONFINEMENT; ENERGIES; DYNAMICS	Understanding and controlling charge and energy flow in state-of-the-art semiconductor quantum wells has enabled high-efficiency optoelectronic devices. Two-dimensional (2D) Ruddlesden-Popper perovskites are solution-processed quantum wells wherein the band gap can be tuned by varying the perovskite-layer thickness, which modulates the effective electron-hole confinement. We report that, counterintuitive to classical quantum-confined systems where photogenerated electrons and holes are strongly bound by Coulomb interactions or excitons, the photophysics of thin films made of Ruddlesden-Popper perovskites with a thickness exceeding two perovskite-crystal units (>1.3 nanometers) is dominated by lower-energy states associated with the local intrinsic electronic structure of the edges of the perovskite layers. These states provide a direct pathway for dissociating excitons into longer-lived free carriers that substantially improve the performance of optoelectronic devices.	[Blancon, J. -C.; Tsai, H.; Nie, W.; Tretiak, S.; Crochet, J. J.; Mohite, A. D.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Tsai, H.; Ajayan, P. M.] Rice Univ, Dept Mat Sci & Nanoengn, Houston, TX 77005 USA; [Stoumpos, C. C.; Soe, C. M. M.; Kanatzidis, M. G.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Pedesseau, L.; Even, J.] CNRS, INSA, FOTON, UMR 6082, F-35708 Rennes, France; [Katan, C.; Kepenekian, M.] Univ Rennes 1, CNRS, ISCR, UMR 6226, F-35042 Rennes, France; [Appavoo, K.; Sfeir, M. Y.] Ctr Funct Nanomat, Brookhaven Natl Lab, Upton, NY 11973 USA; [Kanatzidis, M. G.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; Rice University; Northwestern University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Rennes; United States Department of Energy (DOE); Brookhaven National Laboratory; Northwestern University	Crochet, JJ; Mohite, AD (corresponding author), Los Alamos Natl Lab, Los Alamos, NM 87545 USA.	jcrochet@lanl.gov; amohite@lanl.gov	Tsai, Hsinhan/AAN-7850-2020; Jacky, EVEN/C-6212-2008; Pedesseau, Laurent/G-5198-2014; Mohite, Aditya D./AAF-2908-2019; Claudine, KATAN/I-9446-2012; Nie, Wanyi/AAC-5354-2019; Tretiak, Sergei/B-5556-2009; Blancon, Jean-Christophe/Q-7950-2017; Sfeir, Matthew/AAE-7390-2019; Stoumpos, Constantinos C./P-6677-2016	Jacky, EVEN/0000-0002-4607-3390; Pedesseau, Laurent/0000-0001-9414-8644; Claudine, KATAN/0000-0002-2017-5823; Tretiak, Sergei/0000-0001-5547-3647; Blancon, Jean-Christophe/0000-0002-3833-5792; Sfeir, Matthew/0000-0001-5619-5722; Stoumpos, Constantinos C./0000-0001-8396-9578				Abdel-Baki K, 2016, J APPL PHYS, V119, DOI 10.1063/1.4941345; Bartnik AC, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.195313; Blancon JC, 2016, ADV FUNCT MATER, V26, P4283, DOI 10.1002/adfm.201505324; Blancon JC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3542; Cao DH, 2015, J AM CHEM SOC, V137, P7843, DOI 10.1021/jacs.5b03796; deQuilettes DW, 2015, SCIENCE, V348, P683, DOI 10.1126/science.aaa5333; Even J, 2014, CHEMPHYSCHEM, V15, P3733, DOI 10.1002/cphc.201402428; Gauthron K, 2010, OPT EXPRESS, V18, P5912, DOI 10.1364/OE.18.005912; Guo Z, 2016, ACS NANO, V10, P9992, DOI 10.1021/acsnano.6b04265; Herz LM, 2016, ANNU REV PHYS CHEM, V67, P65, DOI 10.1146/annurev-physchem-040215-112222; ISHIHARA T, 1990, PHYS REV B, V42, P11099, DOI 10.1103/PhysRevB.42.11099; Jasieniak J, 2011, ACS NANO, V5, P5888, DOI 10.1021/nn201681s; Kagan CR, 1999, SCIENCE, V286, P945, DOI 10.1126/science.286.5441.945; Kitazawa N, 2011, J PHYS CHEM SOLIDS, V72, P1467, DOI 10.1016/j.jpcs.2011.08.029; Lin YX, 2014, NANO LETT, V14, P5569, DOI 10.1021/nl501988y; Miller OD, 2012, IEEE J PHOTOVOLT, V2, P303, DOI 10.1109/JPHOTOV.2012.2198434; Mitzi DB, 2001, IBM J RES DEV, V45, P29, DOI 10.1147/rd.451.0029; Nie WY, 2015, SCIENCE, V347, P522, DOI 10.1126/science.aaa0472; Pedesseau L, 2016, ACS NANO, V10, P9776, DOI 10.1021/acsnano.6b05944; Richter JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13941; RUDDLESDEN SN, 1958, ACTA CRYSTALLOGR, V11, P54, DOI 10.1107/S0365110X58000128; RUDDLESDEN SN, 1957, ACTA CRYSTALLOGR, V10, P538, DOI 10.1107/S0365110X57001929; Sapori D, 2016, NANOSCALE, V8, P6369, DOI 10.1039/c5nr07175e; Smith IC, 2014, ANGEW CHEM INT EDIT, V53, P11232, DOI 10.1002/anie.201406466; Stoumpos CC, 2016, CHEM MATER, V28, P2852, DOI 10.1021/acs.chemmater.6b00847; Straus DB, 2016, J AM CHEM SOC, V138, P13798, DOI 10.1021/jacs.6b08175; Tanaka K, 2005, JPN J APPL PHYS 1, V44, P5923, DOI 10.1143/JJAP.44.5923; Tanaka K, 2003, SCI TECHNOL ADV MAT, V4, P599, DOI 10.1016/j.stam.2003.09.019; Tsai HH, 2016, NATURE, V536, P312, DOI 10.1038/nature18306; Wang H, 2015, J PHYS CHEM C, V119, P19590, DOI 10.1021/acs.jpcc.5b04403; Wu XX, 2015, J AM CHEM SOC, V137, P2089, DOI 10.1021/ja512833n; Yaffe O, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.045414; Yang J, 2015, J PHYS CHEM C, V119, P26809, DOI 10.1021/acs.jpcc.5b08207	33	689	691	47	821	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1288	1291		10.1126/science.aal4211	http://dx.doi.org/10.1126/science.aal4211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28280250	Green Submitted			2022-12-28	WOS:000397082900033
J	Samet, JM; Burke, TA; Goldstein, BD				Samet, Jonathan M.; Burke, Thomas A.; Goldstein, Bernard D.			The Trump Administration and the Environment - Heed the Science	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							AIR-POLLUTION		[Samet, Jonathan M.] Univ Southern Calif, Keck Sch Med USC, Dept Prevent Med, Los Angeles, CA USA; [Burke, Thomas A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Burke, Thomas A.] Johns Hopkins Bloomberg Sch Publ Hlth, Risk Sci & Publ Policy Inst, Baltimore, MD USA; [Goldstein, Bernard D.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA USA	University of Southern California; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Samet, JM (corresponding author), Univ Southern Calif, Keck Sch Med USC, Dept Prevent Med, Los Angeles, CA USA.							Adgate JL, 2014, ENVIRON SCI TECHNOL, V48, P8307, DOI 10.1021/es404621d; [Anonymous], 2017, CLEAN POW PLAN EX PO; [Anonymous], 2013, FIN REP INT SCI ASS; [Anonymous], 2007, TOXICITY TESTING 21; [Anonymous], 2009, FIN REP INT SCI ASS; [Anonymous], 2005, NAT AC PREC ASS PROG; [Anonymous], 2017, PROGR CLEAN AIR IMPR; [Anonymous], 2017, US 21 CENT SCI IMPR; BUTLER S, 1984, MANDATE LEADERSHIP 2; Chen JC, 2015, ANN NEUROL, V78, P466, DOI 10.1002/ana.24460; Clinton W. J., 1994, FED REG; Environmental Protection Agency, 2011, BEN COSTS CLEAN AIR; Gauderman WJ, 2015, NEW ENGL J MED, V372, P905, DOI 10.1056/NEJMoa1414123; Goldstein BD, 2017, ENVIRON SCI POLICY, V68, P28, DOI 10.1016/j.envsci.2016.11.012; Goldstein BD, 2011, NEW ENGL J MED, V364, P1334, DOI 10.1056/NEJMra1007197; National Research Council, 2012, EXP SCI 21 CENT VIS; National Research Council, 2009, SCI DEC ADV RISK ASS; National Research Council Committee on the Institutional Means for Assessment of Risks to Public Health Commission on Life Sciences, 1983, RISK ASS FED GOV MAN; National Resource Council, 2011, SUST US EPA; Otto S., 2016, THE WAR ON SCI; Pope CA, 2009, NEW ENGL J MED, V360, P376, DOI 10.1056/NEJMsa0805646	21	30	30	2	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2017	376	12					1182	1188		10.1056/NEJMms1615242	http://dx.doi.org/10.1056/NEJMms1615242			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO9NB	28249122				2022-12-28	WOS:000397014300019
J	Lenzer, J				Lenzer, Jeanne			Do doctors have a "duty to warn" if they believe a leader is dangerously mentally ill?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jlenzer@bmj.com						Frances A., EMINENT PSYCHIATRIST; Friedman RA, 2011, NY TIMES; Friedman RA, 2017, NY TIMES; Hamblin J, 2016, ATLANTIC; Lenzer J, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6775; National Conference of State Legislatures, 2015, MENT HLTH PROF DUT W; Resnick B., 2017, THE PSYCHIATRIST WHO	7	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2017	356								j1087	10.1136/bmj.j1087	http://dx.doi.org/10.1136/bmj.j1087			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BU	28280055				2022-12-28	WOS:000396433400002
J	Mountjoy, L; Kollmorgen, D				Mountjoy, Luke; Kollmorgen, Daniel			Glucagonoma-Associated Rash	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mountjoy, Luke; Kollmorgen, Daniel] Iowa Methodist Med Ctr, Des Moines, IA 50309 USA	Iowa Methodist Medical Center	Mountjoy, L (corresponding author), Iowa Methodist Med Ctr, Des Moines, IA 50309 USA.	lukemountjoy@gmail.com							0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2017	376	10					E18	E18		10.1056/NEJMicm1603135	http://dx.doi.org/10.1056/NEJMicm1603135			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9JA	28273025				2022-12-28	WOS:000395626500014
J	Schmidt, M; Mansfield, KE; Bhaskaran, K; Nitsch, D; Sorensen, HT; Smeeth, L; Tomlinson, LA				Schmidt, Morten; Mansfield, Kathryn E.; Bhaskaran, Krishnan; Nitsch, Dorothea; Sorensen, Henrik Toft; Smeeth, Liam; Tomlinson, Laurie A.			Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							KIDNEY-DISEASE; RENAL-FUNCTION; EFFICACY; OUTCOMES; CANCERS; TRIAL; CKD	OBJECTIVE To examine long term cardiorenal outcomes associated with increased concentrations of creatinine after the start of angiotensin converting enzyme inhibitor/angiotensin receptor blocker treatment. DESIGN Population based cohort study using electronic health records from the Clinical Practice Research Datalink and Hospital Episode Statistics. SETTING UK primary care, 1997-2014. PARTICIPANTS Patients starting treatment with angiotensin converting enzyme inhibitors or angiotensin receptor blockers (n=122 363). MAIN OUTCOME MEASURES Poisson regression was used to compare rates of end stage renal disease, myocardial infarction, heart failure, and death among patients with creatinine increases of 30% or more after starting treatment against those without such increases, and for each 10% increase in creatinine. Analyses were adjusted for age, sex, calendar period, socioeconomic status, lifestyle factors, chronic kidney disease, diabetes, cardiovascular comorbidities, and use of other antihypertensive drugs and non-steroidal anti-inflammatory drugs. RESULTS Among the 2078 (1.7%) patients with creatinine increases of 30% or more, a higher proportion were female, were elderly, had cardiorenal comorbidity, and used non-steroidal anti-inflammatory drugs, loop diuretics, or potassium sparing diuretics. Creatinine increases of 30% or more were associated with an increased adjusted incidence rate ratio for all outcomes, compared with increases of less than 30%: 3.43 (95% confidence interval 2.40 to 4.91) for end stage renal disease, 1.46 (1.16 to 1.84) for myocardial infarction, 1.37 (1.14 to 1.65) for heart failure, and 1.84 (1.65 to 2.05) for death. The detailed categorisation of increases in creatinine concentrations (<10%, 10-19%, 20-29%, 30-39%, and >= 40%) showed a graduated relation for all outcomes (all P values for trends < 0.001). Notably, creatinine increases of less than 30% were also associated with increased incidence rate ratios for all outcomes, including death (1.15 (1.09 to 1.22) for increases of 10-19% and 1.35 (1.23 to 1.49) for increases of 20-29%, using < 10% as reference). Results were consistent across calendar periods, across subgroups of patients, and among continuing users. CONCLUSIONS Increases in creatinine after the start of angiotensin converting enzyme inhibitor/angiotensin receptor blocker treatment were associated with adverse cardiorenal outcomes in a graduated relation, even below the guideline recommended threshold of a 30% increase for stopping treatment.	[Schmidt, Morten; Mansfield, Kathryn E.; Bhaskaran, Krishnan; Nitsch, Dorothea; Smeeth, Liam; Tomlinson, Laurie A.] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London, England; [Schmidt, Morten; Sorensen, Henrik Toft] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Schmidt, Morten] Reg Hosp Randers, Dept Internal Med, Randers, Denmark	University of London; London School of Hygiene & Tropical Medicine; Aarhus University	Schmidt, M (corresponding author), London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London, England.; Schmidt, M (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark.; Schmidt, M (corresponding author), Reg Hosp Randers, Dept Internal Med, Randers, Denmark.	morten.schmidt@clin.au.dk	Sorensen, Henrik Toft/Z-6181-2019; Smeeth, Liam/X-5862-2018	Sorensen, Henrik Toft/0000-0003-4299-7040; Tomlinson, Laurie/0000-0001-8848-9493; Smeeth, Liam/0000-0002-9168-6022; Bhaskaran, Krishnan/0000-0001-5364-8757; Nitsch, Dorothea/0000-0001-5767-248X; Schmidt, Morten/0000-0002-4935-4059	Aarhus University Hospital; A.P. Moller Foundation for the Advancement of Medical Science; Snedkermester Sophus Jacobsen and Hustru Astrid Jacobsens Fond; Christian og Ottilia Brorsons Rejselegat for yngre videnskabsmaend og -kvinder; Program for Clinical Research Infrastructure (PROCRIN); Wellcome Trust [107731/Z/15/Z, 101143/Z/13/Z]; Royal Society [107731/Z/15/Z]; Lundbeck Foundation [R155-2014-2647] Funding Source: researchfish; Novo Nordisk Fonden [NNF14SA0015794] Funding Source: researchfish	Aarhus University Hospital; A.P. Moller Foundation for the Advancement of Medical Science; Snedkermester Sophus Jacobsen and Hustru Astrid Jacobsens Fond; Christian og Ottilia Brorsons Rejselegat for yngre videnskabsmaend og -kvinder; Program for Clinical Research Infrastructure (PROCRIN); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	MS was supported by Aarhus University Hospital, the A.P. Moller Foundation for the Advancement of Medical Science, Snedkermester Sophus Jacobsen and Hustru Astrid Jacobsens Fond, and Christian og Ottilia Brorsons Rejselegat for yngre videnskabsmaend og -kvinder. HTS was supported by the Program for Clinical Research Infrastructure (PROCRIN) established by the Lundbeck Foundation and the Novo Nordisk Foundation. KB holds a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (grant number 107731/Z/15/Z). LAT and KEM are funded by a Wellcome Trust intermediate clinical fellowship (101143/Z/13/Z). None of these funding sources had a role in the design, conduct, analysis, or reporting of the study.	Ahmed AK, 2010, NEPHROL DIAL TRANSPL, V25, P3977, DOI 10.1093/ndt/gfp511; Andersen PK, 2012, INT J EPIDEMIOL, V41, P861, DOI 10.1093/ije/dyr213; Bakris GL, 2000, ARCH INTERN MED, V160, P685, DOI 10.1001/archinte.160.5.685; Bangalore S, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i438; Barbour SJ, 2010, NEPHROL DIAL TRANSPL, V25, P2422, DOI 10.1093/ndt/gfq283; Bhandari S, 2016, NEPHROL DIAL TRANSPL, V31, P255, DOI 10.1093/ndt/gfv346; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Bhaskaran K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003389; Bhaskaran K, 2013, EUR UROL, V64, pE86, DOI 10.1016/j.eururo.2013.07.004; Charytan D, 2006, KIDNEY INT, V70, P2021, DOI 10.1038/sj.ki.5001934; Clark H, 2014, EUR J HEART FAIL, V16, P41, DOI 10.1002/ejhf.13; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Doran T, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3590; Hammad TA, 2008, PHARMACOEPIDEM DR S, V17, P1197, DOI 10.1002/pds.1672; Health and Social Care Information Centre, HOSPITAL EPISODE STA; Herrett E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2350; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Lesogor A, 2013, EUR J HEART FAIL, V15, P1236, DOI 10.1093/eurjhf/hft089; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; McDonald HI, 2015, AM J KIDNEY DIS, V66, P60, DOI 10.1053/j.ajkd.2014.11.027; National Institute for Health and Care Excellence, 2016, HYP AD DIAGN MAN; Palmer SC, 2015, LANCET, V385, P2047, DOI 10.1016/S0140-6736(14)62459-4; Pitt B, 1997, LANCET, V349, P747, DOI 10.1016/S0140-6736(97)01187-2; Schmidt M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012818; Sharma P, 2011, COCHRANE DB SYST REV, V10; Vinogradova Y, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f114	28	83	83	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2017	356								j791	10.1136/bmj.j791	http://dx.doi.org/10.1136/bmj.j791			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BU	28279964	hybrid, Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000396433400013
J	Verma, S				Verma, Shyam			Steroid modified tinea	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Verma, Shyam] Nirvan Skin Clin, Makarpura Rd, Vadodara 390009, India		Verma, S (corresponding author), Nirvan Skin Clin, Makarpura Rd, Vadodara 390009, India.	skindiaverma@gmail.com						Ansar Akram, 2011, Med Mycol J, V52, P25, DOI 10.3314/jjmm.52.25; Dogra Sunil, 2016, Indian Dermatol Online J, V7, P73, DOI 10.4103/2229-5178.178100; Havlickova B, 2008, MYCOSES, V51, P2, DOI 10.1111/j.1439-0507.2008.01606.x; Kim WJ, 2013, J KOREAN MED SCI, V28, P145, DOI 10.3346/jkms.2013.28.1.145; Lahiri K, 2016, INDIAN J DERMATOL, V61, P265, DOI 10.4103/0019-5154.182417; Romano C, 2006, MYCOSES, V49, P383, DOI 10.1111/j.1439-0507.2006.01251.x; Sahoo Alok Kumar, 2016, Indian Dermatol Online J, V7, P77, DOI 10.4103/2229-5178.178099; Stollery Nigel, 2016, Practitioner, V260, P32; Verma S, 2015, INT J DERMATOL, V54, pE192, DOI 10.1111/ijd.12734; Verma SB, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6079	10	11	11	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2017	356								j973	10.1136/bmj.j973	http://dx.doi.org/10.1136/bmj.j973			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BS	28274995				2022-12-28	WOS:000396433200014
J	Sharma, A; Baweja, P				Sharma, Akshit; Baweja, Paramdeep			Medical Identity Theft: A Case Report	ANNALS OF INTERNAL MEDICINE			English	Letter							HEPATIC MYELOPATHY; LIVER-TRANSPLANTATION; PORTOSYSTEMIC SHUNT; PORTACAVAL-SHUNT; CIRRHOSIS; COMPLICATION; DEGENERATION		[Sharma, Akshit; Baweja, Paramdeep] Univ Missouri, Sch Med, Kansas City, MO 64108 USA	University of Missouri System; University of Missouri Kansas City	Sharma, A (corresponding author), Univ Missouri, Sch Med, Kansas City, MO 64108 USA.							Baccarani U, 2010, LIVER TRANSPLANT, V16, P1336, DOI 10.1002/lt.22149; BECHAR M, 1970, J NEUROL SCI, V11, P101, DOI 10.1016/0022-510X(70)90120-6; Conde C., 2009, TEX MED, V105, P43; Counsell C, 1996, J NEUROL NEUROSUR PS, V60, P590, DOI 10.1136/jnnp.60.5.590; Davis N, 2005, J AHIMA, V76; GIANGASPERO F, 1985, VIRCHOWS ARCH A, V406, P475, DOI 10.1007/BF00710238; Koo Ja Eun, 2008, Korean J Hepatol, V14, P89, DOI 10.3350/kjhep.2008.14.1.89; LEBOVICS E, 1985, ARCH INTERN MED, V145, P1921, DOI 10.1001/archinte.145.10.1921; Mancini M, 2014, WEST J EMERG MED, V15, P899, DOI 10.5811/westjem.2014.8.22438; MENDOZA G, 1994, EUR NEUROL, V34, P209, DOI 10.1159/000117040; Nardone R, 2006, J NEUROL, V253, P81, DOI 10.1007/s00415-005-0930-9; Pinarbasi B, 2009, J CLIN GASTROENTEROL, V43, P176, DOI 10.1097/MCG.0b013e318150d399; Ponemon Institute, 2015, 4 ANN STUD MED ID TH; Premkumar Madhumita, 2012, Case Reports Hepatol, V2012, P735906, DOI 10.1155/2012/735906; Qu B, 2009, TRANSPL P, V41, P1987, DOI 10.1016/j.transproceed.2009.01.105; ROBINSON CE, 1978, PARAPLEGIA, V16, P3, DOI 10.1038/sc.1978.2; SCOBIE BA, 1964, ARCH INTERN MED, V113, P805, DOI 10.1001/archinte.1964.00280120005002; SOBUKAWA E, 1994, INTERNAL MED, V33, P718, DOI 10.2169/internalmedicine.33.718; Troisi R, 1999, NEW ENGL J MED, V340, P151, DOI 10.1056/NEJM199901143400216; Weissenborn K, 2003, GASTROENTEROLOGY, V124, P346, DOI 10.1053/gast.2003.50062	20	2	2	1	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2017	166	5					380	+		10.7326/L16-0360	http://dx.doi.org/10.7326/L16-0360			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BO	28265656				2022-12-28	WOS:000396432800021
J	Loewenberg, S				Loewenberg, Sam			Rebecca Richards-Kortum: bioengineering for global health	LANCET			English	Biographical-Item																			0	0	0	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 4	2017	389	10072					899	899						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM4DL	28271833				2022-12-28	WOS:000395263400015
J	Diercks, CS; Yaghi, OM				Diercks, Christian S.; Yaghi, Omar M.			The atom, the molecule, and the covalent organic framework	SCIENCE			English	Review							RETICULAR CHEMISTRY; DESIGNED SYNTHESIS; CRYSTALLINE; CONSTRUCTION; FUNCTIONALIZATION; TAXONOMY; PORES; NETS	Just over a century ago, Lewis published his seminal work on what became known as the covalent bond, which has since occupied a central role in the theory of making organic molecules. With the advent of covalent organic frameworks (COFs), the chemistry of the covalent bond was extended to two-and three-dimensional frameworks. Here, organic molecules are linked by covalent bonds to yield crystalline, porous COFs from light elements (boron, carbon, nitrogen, oxygen, and silicon) that are characterized by high architectural and chemical robustness. This discovery paved the way for carrying out chemistry on frameworks without losing their porosity or crystallinity, and in turn achieving designed properties in materials. The recent union of the covalent and the mechanical bond in the COF provides the opportunity for making woven structures that incorporate flexibility and dynamics into frameworks.	[Yaghi, Omar M.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA; Berkeley Global Sci Inst, Berkeley, CA 94720 USA; King Abdulaziz City Sci & Technol, Riyadh 11442, Saudi Arabia	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; King Abdulaziz City for Science & Technology	Yaghi, OM (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	yaghi@berkeley.edu	Yaghi, Omar M/C-6749-2013	Yaghi, Omar/0000-0002-5611-3325	BASF SE (Ludwigshafen, Germany); Army Research Office for the Multidisciplinary University Research Initiatives [WG11NF-15-1-0047]; King Abdulaziz Center for Science and Technology	BASF SE (Ludwigshafen, Germany)(BASF); Army Research Office for the Multidisciplinary University Research Initiatives; King Abdulaziz Center for Science and Technology	We thank K. E. Cordova, M. J. Kalmutzki, E. A. Kapustin, Z. Ji, and Y. Liu of the Yaghi research group for valuable discussions and helpful comments. Supported by BASF SE (Ludwigshafen, Germany), Army Research Office for the Multidisciplinary University Research Initiatives award WG11NF-15-1-0047, and the King Abdulaziz Center for Science and Technology.	ASHTON PR, 1989, ANGEW CHEM INT EDIT, V28, P1396, DOI 10.1002/anie.198913961; Ayme JF, 2012, NAT CHEM, V4, P15, DOI 10.1038/nchem.1193; Barnes JC, 2013, SCIENCE, V339, P429, DOI 10.1126/science.1228429; Carlucci L, 2003, COORDIN CHEM REV, V246, P247, DOI 10.1016/S0010-8545(03)00126-7; CESARIO M, 1985, J CHEM SOC CHEM COMM, P244, DOI 10.1039/c39850000244; Chichak KS, 2004, SCIENCE, V304, P1308, DOI 10.1126/science.1096914; Colson JW, 2011, SCIENCE, V332, P228, DOI 10.1126/science.1202747; COREY EJ, 1988, CHEM SOC REV, V17, P111, DOI 10.1039/cs9881700111; Cote AP, 2005, SCIENCE, V310, P1166, DOI 10.1126/science.1120411; Cram D.J., 1997, CONTAINER MOLECULES; Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328; Dalapati S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8786; DeBlase CR, 2013, J AM CHEM SOC, V135, P16821, DOI 10.1021/ja409421d; Delgado-Friedrichs O, 2007, PHYS CHEM CHEM PHYS, V9, P1035, DOI 10.1039/b615006c; DIETRICH B, 1973, TETRAHEDRON, V29, P1629, DOI 10.1016/S0040-4020(01)83409-8; DIETRICHBUCHECKER CO, 1983, TETRAHEDRON LETT, V24, P5095, DOI 10.1016/S0040-4039(00)94050-4; Ding SY, 2011, J AM CHEM SOC, V133, P19816, DOI 10.1021/ja206846p; Ding XS, 2011, ANGEW CHEM INT EDIT, V50, P1289, DOI 10.1002/anie.201005919; Du Y., 2016, ANGEW CHEM, V128, P1769, DOI [10.1002/ange.201509014, DOI 10.1002/ANGE.201509014]; El-Kaderi HM, 2007, SCIENCE, V316, P268, DOI 10.1126/science.1139915; Fang QR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5503; FRISCH HL, 1961, J AM CHEM SOC, V83, P3789, DOI 10.1021/ja01479a015; Gilday LC, 2013, ANGEW CHEM INT EDIT, V52, P4356, DOI 10.1002/anie.201300464; Guo J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3736; HOFFMANN R, 1993, SCI AM, V268, P66, DOI 10.1038/scientificamerican0293-66; Huang N, 2015, J AM CHEM SOC, V137, P7079, DOI 10.1021/jacs.5b04300; Hunt JR, 2008, J AM CHEM SOC, V130, P11872, DOI 10.1021/ja805064f; Jackson KT, 2012, CHEM COMMUN, V48, P8823, DOI 10.1039/c2cc33583b; Jiang JC, 2016, J AM CHEM SOC, V138, P3255, DOI 10.1021/jacs.5b10666; Kandambeth S., 2013, ANGEW CHEM, V125, P13290, DOI [10.1002/ange.201306775, DOI 10.1002/ANGE.201306775]; Kandambeth S, 2012, J AM CHEM SOC, V134, P19524, DOI 10.1021/ja308278w; Kuhn P, 2008, ANGEW CHEM INT EDIT, V47, P3450, DOI 10.1002/anie.200705710; Lehn JM, 2002, P NATL ACAD SCI USA, V99, P4763, DOI 10.1073/pnas.072065599; Lehn JM, 1999, CHEM-EUR J, V5, P2455; Leigh DA, 2014, NAT CHEM, V6, P978, DOI [10.1038/NCHEM.2056, 10.1038/nchem.2056]; Lewis GN, 1916, J AM CHEM SOC, V38, P762, DOI 10.1021/ja02261a002; Lin GQ, 2016, J AM CHEM SOC, V138, P3302, DOI 10.1021/jacs.6b00652; Lin S, 2015, SCIENCE, V349, P1208, DOI 10.1126/science.aac8343; Liu YZ, 2016, SCIENCE, V351, P365, DOI 10.1126/science.aad4011; Mastalerz M, 2010, ANGEW CHEM INT EDIT, V49, P5042, DOI 10.1002/anie.201000443; Nagai A, 2013, ANGEW CHEM INT EDIT, V52, P3770, DOI 10.1002/anie.201300256; Nagai A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1542; Nath B, 2016, CRYSTENGCOMM, V18, P4259, DOI 10.1039/c6ce00168h; O'Keeffe M, 2012, CHEM REV, V112, P675, DOI 10.1021/cr200205j; O'Keeffe M, 2008, ACCOUNTS CHEM RES, V41, P1782, DOI 10.1021/ar800124u; Ockwig NW, 2005, ACCOUNTS CHEM RES, V38, P176, DOI 10.1021/ar020022l; PEDERSEN CJ, 1967, J AM CHEM SOC, V89, P7017, DOI 10.1021/ja01002a035; Rowan SJ, 2002, ANGEW CHEM INT EDIT, V41, P898, DOI 10.1002/1521-3773(20020315)41:6<898::AID-ANIE898>3.0.CO;2-E; SCHILL G, 1964, ANGEW CHEM INT EDIT, V3, P546, DOI 10.1002/anie.196405461; Spitler EL, 2011, J AM CHEM SOC, V133, P19416, DOI 10.1021/ja206242v; Staudinger H, 1920, BER DTSCH CHEM GES, V53, P1073, DOI 10.1002/cber.19200530627; Stegbauer L, 2015, CHEM MATER, V27, P7874, DOI 10.1021/acs.chemmater.5b02151; Stegbauer L, 2014, CHEM SCI, V5, P2789, DOI 10.1039/c4sc00016a; Tilford RW, 2008, ADV MATER, V20, P2741, DOI 10.1002/adma.200800030; Tozawa T, 2009, NAT MATER, V8, P973, DOI [10.1038/nmat2545, 10.1038/NMAT2545]; Uribe-Romo FJ, 2011, J AM CHEM SOC, V133, P11478, DOI 10.1021/ja204728y; Uribe-Romo FJ, 2009, J AM CHEM SOC, V131, P4570, DOI 10.1021/ja8096256; VOGTLE F, 1992, ANGEW CHEM INT EDIT, V31, P1619, DOI 10.1002/anie.199216191; Waller PJ, 2016, J AM CHEM SOC, V138, P15519, DOI 10.1021/jacs.6b08377; Wan S., 2009, ANGEW CHEM, V121, P5547, DOI DOI 10.1002/ANGE.200900881; Wan S, 2008, ANGEW CHEM INT EDIT, V47, P8826, DOI 10.1002/anie.200803826; Wan S, 2011, CHEM MATER, V23, P4094, DOI 10.1021/cm201140r; WASSERMAN E, 1960, J AM CHEM SOC, V82, P4433, DOI 10.1021/ja01501a082; Wells AF., 2012, STRUCTURAL INORGANIC; WOODWARD R B, 1973, Pure and Applied Chemistry, V33, P145, DOI 10.1351/pac197333010145; Wu Y, 2015, CHEM COMMUN, V51, P10096, DOI 10.1039/c5cc03457d; Xu H, 2016, NAT MATER, V15, P722, DOI [10.1038/nmat4611, 10.1038/NMAT4611]; Xu H, 2015, NAT CHEM, V7, P905, DOI [10.1038/NCHEM.2352, 10.1038/nchem.2352]; Xu H, 2014, CHEM COMMUN, V50, P1292, DOI 10.1039/c3cc48813f; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650; Zhang YB, 2013, J AM CHEM SOC, V135, P16336, DOI 10.1021/ja409033p; Zhao S, 2016, RSC ADV, V6, P38774, DOI 10.1039/c6ra04859e; Zhou TY, 2014, J AM CHEM SOC, V136, P15885, DOI 10.1021/ja5092936; Zhuang XD, 2016, POLYM CHEM-UK, V7, P4176, DOI 10.1039/c6py00561f	74	1372	1386	296	3489	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328							eaal1585	10.1126/science.aal1585	http://dx.doi.org/10.1126/science.aal1585			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2YM	28254887				2022-12-28	WOS:000395181700031
J	Kumar, S				Kumar, Sanjay			SCIENTIFIC COMMUNITY Critics assail India's attempt to 'validate' folk remedy	SCIENCE			English	News Item																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					898	898		10.1126/science.355.6328.898	http://dx.doi.org/10.1126/science.355.6328.898			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2YM	28254894				2022-12-28	WOS:000395181700015
J	Li, ZY; Wu, XJ; Zhou, LP; Liu, W; Gao, X; Nian, XM; Trinkaus, E				Li, Zhan-Yang; Wu, Xiu-Jie; Zhou, Li-Ping; Liu, Wu; Gao, Xing; Nian, Xiao-Mei; Trinkaus, Erik			Late Pleistocene archaic human crania from Xuchang, China	SCIENCE			English	Article							REMAINS; BRAIN; HOMO	Two early Late Pleistocene (similar to 105,000- to 125,000- year-old) crania from Lingjing, Xuchang, China, exhibit a morphological mosaic with differences from and similarities to their western contemporaries. They share pan-Old World trends in encephalization and in supraorbital, neurocranial vault, and nuchal gracilization. They reflect eastern Eurasian ancestry in having low, sagittally flat, and inferiorly broad neurocrania. They share occipital (suprainiac and nuchal torus) and temporal labyrinthine ( semicircular canal) morphology with the Neandertals. This morphological combination reflects Pleistocene human evolutionary patterns in general biology, as well as both regional continuity and interregional population dynamics.	[Li, Zhan-Yang; Wu, Xiu-Jie; Liu, Wu; Gao, Xing] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China; [Li, Zhan-Yang] Henan Prov Inst Cultural Relics & Archaeol, Zhengzhou 450000, Peoples R China; [Zhou, Li-Ping; Nian, Xiao-Mei] Peking Univ, Dept Geog, Lab Earth Surface Proc, Beijing 100871, Peoples R China; [Gao, Xing] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Nian, Xiao-Mei] East China Normal Univ, State Key Lab Estuarine & Coastal Res, 3663 North Zhongshan Rd, Shanghai 200062, Peoples R China; [Trinkaus, Erik] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Peking University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; East China Normal University; Washington University (WUSTL)	Wu, XJ (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China.; Trinkaus, E (corresponding author), Washington Univ, Dept Anthropol, St Louis, MO 63130 USA.	wuxiujie@ivpp.ac.cn; trinkaus@wustl.edu	wu, xiujie/S-5516-2016	wu, xiujie/0000-0002-2893-9699; Trinkaus, Erik/0000-0002-5175-1651; Nian, Xiaomei/0000-0002-3164-9254	National Natural Science Foundation of China [41672020, 41630102, 41672024]; Chinese Academy of Sciences [132311KYSB20160004, 2016DB001]; 111Project [111-2-09]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); 111Project(Ministry of Education, China - 111 Project)	This work was supported by the National Natural Science Foundation of China (grants 41672020, 41630102, and 41672024), the Chinese Academy of Sciences (grant 132311KYSB20160004), 111Project (grant 111-2-09), and the Chinese Academy of Sciences President's International Fellowship Initiative (award 2016DB001). We are grateful to X. M. Sun, L. M. Jia, Q. B. Zhao, S. Q. Zhang, W. Dong, Z. Y. Zhao, Q. M. Fu, J. T. Qin, R. L. Holloway, M. H. Wolpoff, L. L. Shackelford, and J. C. Willman for their help in the excavations, sharing comparative data, and/or manuscript preparation. We are also grateful to the administrative departments of the Xuchang County Cultural Relics for their help with the excavations. The data reported in this paper are tabulated in the supplementary materials. The human fossils are in the Henan Provincial Institute of Cultural Relics and Archeology, Zhengzhou, China. Z.-Y. L. directed the Lingjing research project, organized fieldwork, and conducted the geological studies of the Lingjing site. X.-J.W. and E.T. performed the anthropological study of the Xuchang human fossils. L.-P.Z. designed the OSL dating analysis. L.-P.Z. and X.-M.N. undertook the fieldwork and OSL analysis. X.-J.W., W.L., X.G., L.-P.Z., X.-M.N., and E.T. analyzed the data and prepared the paper.	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Balzeau A, 2010, J HUM EVOL, V58, P1, DOI 10.1016/j.jhevol.2009.05.016; Cartmill Matt., 2009, THE HUMAN LINEAGE; DAY MH, 1969, NATURE, V222, P1135, DOI 10.1038/2221135a0; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; [高星 Gao Xing], 2014, [人类学学报, Acta Anthropologica Sinica], V33, P237; Klein R., 2009, HUMAN CAREER; Li Z. Y., 2010, ACTA ARCHAEOLOGICA S, V1, P73; Liu W., 2014, HUMAN FOSSILS CHINA; Liu W., 2010, CHINA QUAT INT, V211, P29; Liu W, 2011, VERTEBR PALEOBIOL PA, P77, DOI 10.1007/978-94-007-0492-3_7; Liu W, 2010, P NATL ACAD SCI USA, V107, P19201, DOI 10.1073/pnas.1014386107; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Ruff CB, 1997, NATURE, V387, P173, DOI 10.1038/387173a0; Sherwood CC, 2008, J ANAT, V212, P426, DOI 10.1111/j.1469-7580.2008.00868.x; Spoor F, 2003, J HUM EVOL, V44, P141, DOI 10.1016/S0047-2484(02)00166-5; Trinkaus E, 2005, ANNU REV ANTHROPOL, V34, P207, DOI 10.1146/annurev.anthro.34.030905.154913; Trinkaus E, 2004, AM J PHYS ANTHROPOL, V124, P28, DOI 10.1002/ajpa.10336; Trinkaus E., 2014, PEOPLE SUNGHIR; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669; Wu XJ, 2016, AM J PHYS ANTHROPOL, V160, P633, DOI 10.1002/ajpa.22974; Wu XJ, 2014, P NATL ACAD SCI USA, V111, P10509, DOI 10.1073/pnas.1410735111	22	99	138	3	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					969	972		10.1126/science.aal2482	http://dx.doi.org/10.1126/science.aal2482			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM2YM	28254945				2022-12-28	WOS:000395181700044
J	Dijstelbloem, H				Dijstelbloem, Huub			Migration tracking is a mess	NATURE			English	Editorial Material									[Dijstelbloem, Huub] Netherlands Sci Council Govt Policy, The Hague, Netherlands; [Dijstelbloem, Huub] Univ Amsterdam, Philosophy Sci & Polit, NL-1012 WX Amsterdam, Netherlands	University of Amsterdam	Dijstelbloem, H (corresponding author), Netherlands Sci Council Govt Policy, The Hague, Netherlands.; Dijstelbloem, H (corresponding author), Univ Amsterdam, Philosophy Sci & Polit, NL-1012 WX Amsterdam, Netherlands.	h.o.dijstelbloem@uva.nl						Amoore Louise, 2013, POLITICS POSSIBILITY; Broeders D., 2016, DIGITIZING IDENTITIE, P242, DOI DOI 10.4324/9781315756400-13; Hasian Jr Marouf, 2016, FORENSIC RHETORICS S; Walters W., 2016, COMP EUR POLIT	4	12	12	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2017	543	7643					31	33		10.1038/543032a	http://dx.doi.org/10.1038/543032a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN0AA	28252099	Green Submitted, Bronze			2022-12-28	WOS:000395671500015
J	Murray, SA; Kendall, M; Mitchell, G; Moine, S; Amblas-Novellas, J; Boyd, K				Murray, Scott A.; Kendall, M.; Mitchell, G.; Moine, S.; Amblas-Novellas, J.; Boyd, K.			Palliative care from diagnosis to death	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CANCER; END; PEOPLE; LIFE; UNCERTAINTY; DISEASES; FAILURE; FRAILTY; TOOLS; NEEDS		[Murray, Scott A.; Kendall, M.; Boyd, K.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Primary Palliat Care Res Grp, Edinburgh, Midlothian, Scotland; [Mitchell, G.] Univ Queensland, Fac Med & Biomed Sci, Gen Practice & Palliat Care, Brisbane, Qld, Australia; [Moine, S.] Amiens Univ Hosp, Hlth Educ & Practices Lab, Amiens, France; [Amblas-Novellas, J.] Univ Vic, Geriatr & Palliat Care Dept, Barcelona, Spain	University of Edinburgh; University of Queensland; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC)	Murray, SA (corresponding author), Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Primary Palliat Care Res Grp, Edinburgh, Midlothian, Scotland.	Scott.Murray@ed.ac.uk	Amblàs-Novellas, Jordi/AAB-4651-2019	Amblàs-Novellas, Jordi/0000-0002-2338-3054; Boyd, Kirsty/0000-0002-5526-1078; Murray, Scott A/0000-0002-6649-9428; MOINE, Sebastien/0000-0003-3960-9422				Amblas-Novellas J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012340; Back AL, 2005, CA-CANCER J CLIN, V55, P164, DOI 10.3322/canjclin.55.3.164; Bacon J., 2012, PALLIATIVE APPROACH; Beernaert K, 2016, EUR J CANCER CARE, V25, P534, DOI 10.1111/ecc.12522; British Medical Association, 2016, END OF LIF CAR PHYS, V3; Caprio AJ, 2016, CAN MED ASSOC J, V188, P711, DOI 10.1503/cmaj.160206; Cavers D, 2012, CAN MED ASSOC J, V184, pE373, DOI 10.1503/cmaj.111622; Detering KM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1345; Gamondi C., 2013, EUROPEAN J PALLIATIV, V20, P86; Gomez-Batiste X, 2016, J PAIN SYMPTOM MANAG; Higginson IJ, 2014, LANCET RESP MED, V2, P979, DOI 10.1016/S2213-2600(14)70226-7; Hui D, 2016, NAT REV CLIN ONCOL, V13, P159, DOI 10.1038/nrclinonc.2015.201; Jackson VA, 2013, J PALLIAT MED, V16, P894, DOI 10.1089/jpm.2012.0547; Kendall M, 2015, J PAIN SYMPTOM MANAG, V50, P216, DOI 10.1016/j.jpainsymman.2015.02.017; Kimbell B, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3802; Lloyd A, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0350-y; Maas EAT, 2013, BMJ SUPPORT PALLIAT, V3, P444, DOI 10.1136/bmjspcare-2013-000527; Mason B, 2016, BMJ SUPPORT PALLIAT, V6, P60, DOI 10.1136/bmjspcare-2013-000639; Masso M, 2015, PALLIATIVE MED, V29, P22, DOI 10.1177/0269216314551814; Mitchell G, 2014, BMC PALLIAT CARE, V13, DOI 10.1186/1472-684X-13-24; Murray SA, 2008, BRIT MED J, V336, P958, DOI 10.1136/bmj.39535.491238.94; Murtagh FEM, 2014, PALLIATIVE MED, V28, P49, DOI 10.1177/0269216313489367; Parry R, 2014, BMJ SUPPORT PALLIAT, V4, P331, DOI 10.1136/bmjspcare-2014-000649; Rocker G, 2016, CAN MED ASSOC J, V188, pE493, DOI 10.1503/cmaj.151454; Smith AK, 2013, NEW ENGL J MED, V368, P2448, DOI 10.1056/NEJMp1303295; Tapsfield J, 2019, BMJ SUPPORT PALLIAT, V9, DOI 10.1136/bmjspcare-2015-001014; Tassinari D, 2016, REV RECENT CLIN TRIA, V11, P63, DOI 10.2174/1574887110666151014141650; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Temel JS, 2016, J CLIN ONCOL, V3; Walsh RI, 2015, J PALLIAT CARE, V31, P118, DOI 10.1177/082585971503100208; World Health Assembly, 2014, 134 SESS WORLD HLTH; Zimmermann C, 2016, CAN MED ASSOC J, V188, pE217, DOI 10.1503/cmaj.151171	32	100	99	2	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 27	2017	356								j878	10.1136/bmj.j878	http://dx.doi.org/10.1136/bmj.j878			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JP	28242747	Green Submitted			2022-12-28	WOS:000395628000008
J	Baird, JK				Baird, J. Kevin			Telling the human story of Asia's invisible malaria burden	LANCET			English	Editorial Material									[Baird, J. Kevin] Univ Oxford, Eijkman Oxford Clin Res Unit, Eijkman Inst Mol Biol, Jakarta, Indonesia; [Baird, J. Kevin] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford OX3 7LF, England	Eijkman Institute; University of Oxford; University of Oxford	Baird, JK (corresponding author), Univ Oxford, Eijkman Oxford Clin Res Unit, Eijkman Inst Mol Biol, Jakarta, Indonesia.; Baird, JK (corresponding author), Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford OX3 7LF, England.	kevin.baird@ndm.ox.ac.uk			Wellcome Trust's Major Overseas Programme Vietnam	Wellcome Trust's Major Overseas Programme Vietnam	I am Head of Oxford University's Eijkman-Oxford Clinical Research Unit within the Eijkman Institute of Molecular Biology in Jakarta, Indonesia. Public engagement funding from the Wellcome Trust's Major Overseas Programme Vietnam supported the photographic work of Pearl Gan. Laurent Renia (Singapore), Francois Nosten and Suphak Nosten (Thailand), Arjen Dondorp (Thailand), Tom Peto (Cambodia), Sara Canavati (Cambodia), Lenny Ekawati (Indonesia), and Mary Chambers (Vietnam) all contributed to the See Malaria in Asia Project. I declare no other competing interests.	Baird JK, 2016, INT J PARASITOL; Butler D, 2010, NATURE, V467, P1015, DOI 10.1038/4671015a; Cibulskis RE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001142; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Gan P, 2017, LANCET, V389, P789, DOI 10.1016/S0140-6736(17)30516-0; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Hay SI, 2010, LANCET, V376, P1716, DOI 10.1016/S0140-6736(10)61084-7; Millar SB, 2015, CLIN MICROBIOL INFEC, V21, P640, DOI 10.1016/j.cmi.2015.03.017; PATH Malaria Vaccine Initiative, 2011, STAYING COURS MAL RE; Pigott DM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-246; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; WHO, 2016, WORLD MAL REP 2016; Woodrow CJ, 2017, FEMS MICROBIOL REV, V41, P34, DOI 10.1093/femsre/fuw037	14	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 25	2017	389	10071					781	782		10.1016/S0140-6736(17)30556-1	http://dx.doi.org/10.1016/S0140-6736(17)30556-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9UU	28248161	Green Submitted			2022-12-28	WOS:000394966400013
J	Agoritsas, T; Merglen, A; Shah, ND; O'Donnell, M; Guyatt, GH				Agoritsas, Thomas; Merglen, Arnaud; Shah, Nilay D.; O'Donnell, Martin; Guyatt, Gordon H.			Adjusted Analyses in Studies Addressing Therapy and Harm Users' Guides to the Medical Literature	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PROPENSITY-SCORE METHODS; INSTRUMENTAL VARIABLE ANALYSES; ACUTE CORONARY SYNDROMES; TREATMENT-SELECTION BIAS; LOGISTIC-REGRESSION; OBSERVATIONAL DATA; RANDOMIZED-TRIALS; OUTCOMES RESEARCH; RISK ADJUSTMENT; CARE	Observational studies almost always have bias because prognostic factors are unequally distributed between patients exposed or not exposed to an intervention. The standard approach to dealing with this problem is adjusted or stratified analysis. Its principle is to use measurement of risk factors to create prognostically homogeneous groups and to combine effect estimates across groups. The purpose of this Users' Guide is to introduce readers to fundamental concepts underlying adjustment as a way of dealing with prognostic imbalance and to the basic principles and relative trustworthiness of various adjustment strategies. One alternative to the standard approach is propensity analysis, in which groups are matched according to the likelihood of membership in exposed or unexposed groups. Propensity methods can deal with multiple prognostic factors, even if there are relatively few patients having outcome events. However, propensity methods do not address other limitations of traditional adjustment: investigators may not have measured all relevant prognostic factors ( or not accurately), and unknown factors may bias the results. A second approach, instrumental variable analysis, relies on identifying a variable associated with the likelihood of receiving the intervention but not associated with any prognostic factor or with the outcome ( other than through the intervention); this could mimic randomization. However, as with assumptions of other adjustment approaches, it is never certain if an instrumental variable analysis eliminates bias. Although all these approaches can reduce the risk of bias in observational studies, none replace the balance of both known and unknown prognostic factors offered by randomization.	[Agoritsas, Thomas] Univ Hosp Geneva, Div Clin Epidemiol, Geneva, Switzerland; [Agoritsas, Thomas] Univ Hosp Geneva, Div Gen Internal Med, Geneva, Switzerland; [Agoritsas, Thomas; Merglen, Arnaud; Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol & Biostat, Fac Hlth Sci, Hamilton, ON, Canada; [Merglen, Arnaud] Univ Geneva, Univ Hosp Geneva, Div Gen Pediat, Geneva, Switzerland; [Merglen, Arnaud] Univ Geneva, Fac Med, Geneva, Switzerland; [Merglen, Arnaud] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Pediat Med,PORT, Toronto, ON, Canada; [Shah, Nilay D.] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN USA; [O'Donnell, Martin] NUI Galway, HRB Clin Res Facil, Galway, Ireland	University of Geneva; University of Geneva; McMaster University; University of Geneva; University of Geneva; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Mayo Clinic; Health Research Board - Ireland; Ollscoil na Gaillimhe-University of Galway	Agoritsas, T (corresponding author), Univ Hosp Geneva, Dept Internal Med Rehabil & Geriatr DMIRG, Div Clin Epidemiol, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland.; Agoritsas, T (corresponding author), Univ Hosp Geneva, Dept Internal Med Rehabil & Geriatr DMIRG, Div Gen Internal Med, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland.	thomas.agoritsas@gmail.com	O'Donnell, Martin/ABE-7459-2020; Agoritsas, Thomas/F-4321-2014	O'Donnell, Martin/0000-0002-7347-7761; Agoritsas, Thomas/0000-0002-6182-9969	Swiss National Science Foundation [P3SMP3-155290/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Dr Agoritsas was financially supported by the Fellowship for Prospective Researchers grant P3SMP3-155290/1 from the Swiss National Science Foundation.	Ali MS, 2015, J CLIN EPIDEMIOL, V68, P122, DOI 10.1016/j.jclinepi.2014.08.011; Austin PC, 2007, J THORAC CARDIOV SUR, V134, P1128, DOI 10.1016/j.jtcvs.2007.07.021; Austin PC, 2017, STAT METHODS MED RES, V26, P1654, DOI 10.1177/0962280215584401; Austin PC, 2015, J CLIN EPIDEMIOL, V68, P627, DOI 10.1016/j.jclinepi.2014.12.014; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Austin PC, 2010, STAT MED, V29, P2137, DOI 10.1002/sim.3854; Biondi-Zoccai G, 2011, CONTEMP CLIN TRIALS, V32, P731, DOI 10.1016/j.cct.2011.05.006; Bjelakovic G, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007176.pub2, 10.1590/1516-3180.20151332T1]; Bjelakovic G, 2013, JAMA-J AM MED ASSOC, V310, P1178, DOI 10.1001/jama.2013.277028; Blais L, 2000, ARCH INTERN MED, V160, P2363, DOI 10.1001/archinte.160.15.2363; Brignardello-Petersen R, 2015, USERS GUIDES MED LIT; Brookhart MA, 2010, PHARMACOEPIDEM DR S, V19, P537, DOI 10.1002/pds.1908; Brookhart M Alan, 2007, Int J Biostat, V3, P14; Cepeda MS, 2003, AM J EPIDEMIOL, V158, P280, DOI 10.1093/aje/kwg115; Chen Y, 2011, J CLIN EPIDEMIOL, V64, P687, DOI 10.1016/j.jclinepi.2010.09.006; Concato J, 2010, AM J MED, V123, pE16, DOI 10.1016/j.amjmed.2010.10.004; Courvoisier DS, 2011, J CLIN EPIDEMIOL, V64, P993, DOI 10.1016/j.jclinepi.2010.11.012; Crown WH, 2014, APPL HEALTH ECON HEA, V12, P7, DOI 10.1007/s40258-013-0075-4; Crown WH, 2011, VALUE HEALTH, V14, P1078, DOI 10.1016/j.jval.2011.06.009; D'Agostino RB, 2007, JAMA-J AM MED ASSOC, V297, P314, DOI 10.1001/jama.297.3.314; Dahabreh IJ, 2014, JAMA-J AM MED ASSOC, V312, P129, DOI 10.1001/jama.2014.4364; Dahabreh IJ, 2012, EUR HEART J, V33, P1893, DOI 10.1093/eurheartj/ehs114; Dale KM, 2006, JAMA-J AM MED ASSOC, V295, P74, DOI 10.1001/jama.295.1.74; Davies NM, 2013, EPIDEMIOLOGY, V24, P363, DOI 10.1097/EDE.0b013e31828abafb; Del Fiol G, 2014, JAMA INTERN MED, V174, P710, DOI 10.1001/jamainternmed.2014.368; DeMaria AN, 2009, J AM COLL CARDIOL, V53, P973, DOI 10.1016/j.jacc.2009.02.010; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Ebrahim S, 2015, USERS GUIDES MED LIT; Fang G, 2012, AM J EPIDEMIOL, V175, P1142, DOI 10.1093/aje/kwr448; Fang G, 2012, AM J EPIDEMIOL, V175, P60, DOI 10.1093/aje/kwr283; FINUCANE FF, 1993, ARCH INTERN MED, V153, P73, DOI 10.1001/archinte.153.1.73; Guyatt G., 2006, CLIN EPIDEMIOLOGY DO; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hemkens LG, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i493; Hochman M, 2010, JAMA-J AM MED ASSOC, V303, P951, DOI 10.1001/jama.2010.240; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V286, P821, DOI 10.1001/jama.286.7.821; Kennedy CC, 2008, J GEN INTERN MED, V23, P337, DOI 10.1007/s11606-007-0391-1; Kern LM, 2013, ANN INTERN MED, V158, P77, DOI 10.7326/0003-4819-158-2-201301150-00001; Kleinbaum DG, 2012, STAT BIOL HEALTH, P1, DOI 10.1007/978-1-4419-6646-9; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; Kuss O, 2013, J CLIN EPIDEMIOL, V66, P1302, DOI 10.1016/j.jclinepi.2013.06.001; Lalani T, 2010, CIRCULATION, V121, P1005, DOI 10.1161/CIRCULATIONAHA.109.864488; Lee CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050163; LEVINE M, 1994, JAMA-J AM MED ASSOC, V271, P1615, DOI 10.1001/jama.271.20.1615; Luo Zhehui, 2010, Med Care Res Rev, V67, P528, DOI 10.1177/1077558710361486; Martens EP, 2008, INT J EPIDEMIOL, V37, P1142, DOI 10.1093/ije/dyn079; Martens EP, 2006, EPIDEMIOLOGY, V17, P260, DOI 10.1097/01.ede.0000215160.88317.cb; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; Pirracchio R, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-132; Rassen JA, 2011, AM J EPIDEMIOL, V173, P1404, DOI 10.1093/aje/kwr001; Rathore SS, 2005, JAMA-J AM MED ASSOC, V293, P1383, DOI 10.1001/jama.293.11.1383; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Saquib N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4313; Shah BR, 2005, J CLIN EPIDEMIOL, V58, P550, DOI 10.1016/j.jclinepi.2004.10.016; Stanner SA, 2004, PUBLIC HEALTH NUTR, V7, P407, DOI 10.1079/PHN2003543; Stukel TA, 2005, JAMA-J AM MED ASSOC, V293, P1329, DOI 10.1001/jama.293.11.1329; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Sullivan P, 2011, JAMA-J AM MED ASSOC, V305, P400, DOI 10.1001/jama.2011.12; Swanson SA, 2015, AM J EPIDEMIOL, V181, P191, DOI 10.1093/aje/kwu284; Swanson SA, 2014, STAT SCI, V29, P371, DOI 10.1214/14-STS491; Swanson SA, 2013, EPIDEMIOLOGY, V24, P370, DOI 10.1097/EDE.0b013e31828d0590; Tan HJ, 2012, JAMA-J AM MED ASSOC, V307, P1629, DOI 10.1001/jama.2012.475; Walsh M, 2015, USERS GUIDES MED LIT; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673; Willcox JK, 2004, CRIT REV FOOD SCI, V44, P275, DOI 10.1080/10408690490468489; Zhang ZH, 2014, J CLIN EPIDEMIOL, V67, P932, DOI 10.1016/j.jclinepi.2014.02.018	70	90	94	2	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2017	317	7					748	759		10.1001/jama.2016.20029	http://dx.doi.org/10.1001/jama.2016.20029			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8WR	28241362				2022-12-28	WOS:000394901600022
J	Friedrich, MJ				Friedrich, M. J.			Ebola Vaccine Found Highly Protective	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2017	317	7					687	687		10.1001/jama.2017.0633	http://dx.doi.org/10.1001/jama.2017.0633			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8WR	28241366				2022-12-28	WOS:000394901600005
J	Friedrich, MJ				Friedrich, M. J.			Uneven Progress in Preventing and Treating HIV Infections Worldwide	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2017	317	7					687	687		10.1001/jama.2017.0635	http://dx.doi.org/10.1001/jama.2017.0635			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8WR	28241367				2022-12-28	WOS:000394901600006
J	Steinberg, D; Bennett, GG; Svetkey, L				Steinberg, Dori; Bennett, Gary G.; Svetkey, Laura			The DASH Diet, 20 Years Later	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BLOOD-PRESSURE; HEART-DISEASE; HYPERTENSION; TRIAL		[Steinberg, Dori; Bennett, Gary G.] Duke Univ, Duke Global Hlth Inst, Duke Global Digital Hlth Sci Ctr, 310 Trent Dr,POB 90519, Durham, NC 27708 USA; [Bennett, Gary G.] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA; [Svetkey, Laura] Duke Univ, Med Ctr, Dept Med, Div Nephrol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Steinberg, D (corresponding author), Duke Univ, Duke Global Hlth Inst, Duke Global Digital Hlth Sci Ctr, 310 Trent Dr,POB 90519, Durham, NC 27708 USA.	dori.steinberg@duke.edu		Steinberg, Dori/0000-0001-7588-4216	National Institutes of Health [K12HD043446]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Dr Steinberg was supported by the Building Interdisciplinary Research Careers in Women's Health Career Development Award K12HD043446 from the National Institutes of Health.	Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Bell RA, 2008, PATIENT EDUC COUNS, V72, P115, DOI 10.1016/j.pec.2008.01.021; Burke LE, 2012, AM J PREV MED, V43, P20, DOI 10.1016/j.amepre.2012.03.016; Erlinger TP, 2003, PREV MED, V37, P327, DOI 10.1016/S0091-7435(03)00140-3; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kim Hyun, 2016, Prev Med Rep, V4, P525; Mellen PB, 2008, ARCH INTERN MED, V168, P308, DOI 10.1001/archinternmed.2007.119; Mozaffarian D, 2016, CIRCULATION, V133, P447, DOI 10.1161/CIR.0000000000000366; Pew Research Center, MOB FACT SHEET; Young CM, 2008, J CLIN HYPERTENS, V10, P603, DOI 10.1111/j.1751-7176.2008.08199.x	10	52	54	1	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2017	317	15					1529	1530		10.1001/jama.2017.1628	http://dx.doi.org/10.1001/jama.2017.1628			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ES2YN	28278326	Green Accepted			2022-12-28	WOS:000399393900010
J	Eltorai, AEM; Eltorai, MI				Eltorai, Adam E. M.; Eltorai, Mahmoud I.			The Risk of Expanding the Uninsured Population by Repealing the Affordable Care Act	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Eltorai, Adam E. M.] Brown Univ, Warren Alpert Med Sch, 222 Richmond St,Box G-9999, Providence, RI 02912 USA	Brown University	Eltorai, AEM (corresponding author), Brown Univ, Warren Alpert Med Sch, 222 Richmond St,Box G-9999, Providence, RI 02912 USA.	adam_eltorai@brown.edu						Congressional Budget Office, 2017, REP PORT AFF CAR ACT; Kaiser Family Foundation, 2016, EST 52 MILL AD HAV P; Levitt L., 2017, JAMA FORUM WHAT MIGH; Levitt L, 2016, LOS ANGELES TIMES; Rudowitz Robin, 2016, WHAT COVERAGE FINANC; Tolbert J., 2020, KEY FACTS UN POP	6	7	7	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2017	317	14					1407	1408		10.1001/jama.2017.2042	http://dx.doi.org/10.1001/jama.2017.2042			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER6FQ	28241204				2022-12-28	WOS:000398901200009
J	le Roux, CW; Astrup, A; Fujioka, K; Greenway, F; Lau, DCW; Van Gaal, L; Ortiz, RV; Wilding, JPH; Skjoth, TV; Manning, LS; Pi-Sunyer, X				le Roux, Carel W.; Astrup, Arne; Fujioka, Ken; Greenway, Frank; Lau, David C. W.; Van Gaal, Luc; Ortiz, Rafael Violante; Wilding, John P. H.; Skjoth, Trine V.; Manning, Linda Shapiro; Pi-Sunyer, Xavier		SCALE Obesity & Prediabet NN8022	3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial	LANCET			English	Article							NORMAL GLUCOSE REGULATION; LIFE-STYLE; OBESE SUBJECTS; 3.0 MG; PREVENTION; REGRESSION; EXENATIDE	Background Liraglutide 3 . 0 mg was shown to reduce bodyweight and improve glucose metabolism after the 56-week period of this trial, one of four trials in the SCALE programme. In the 3-year assessment of the SCALE Obesity and Prediabetes trial we aimed to evaluate the proportion of individuals with prediabetes who were diagnosed with type 2 diabetes. Methods In this randomised, double-blind, placebo-controlled trial, adults with prediabetes and a body-mass index of at least 30 kg/m(2), or at least 27 kg/m(2) with comorbidities, were randomised 2: 1, using a telephone or web-based system, to once-daily subcutaneous liraglutide 3 . 0 mg or matched placebo, as an adjunct to a reduced-calorie diet and increased physical activity. Time to diabetes onset by 160 weeks was the primary outcome, evaluated in all randomised treated individuals with at least one post-baseline assessment. The trial was conducted at 191 clinical research sites in 27 countries and is registered with ClinicalTrials.gov, number NCT01272219. Findings The study ran between June 1, 2011, and March 2, 2015. We randomly assigned 2254 patients to receive liraglutide (n=1505) or placebo (n=749). 1128 (50%) participants completed the study up to week 160, after withdrawal of 714 (47%) participants in the liraglutide group and 412 (55%) participants in the placebo group. By week 160, 26 (2%) of 1472 individuals in the liraglutide group versus 46 (6%) of 738 in the placebo group were diagnosed with diabetes while on treatment. The mean time from randomisation to diagnosis was 99 (SD 47) weeks for the 26 individuals in the liraglutide group versus 87 (47) weeks for the 46 individuals in the placebo group. Taking the different diagnosis frequencies between the treatment groups into account, the time to onset of diabetes over 160 weeks among all randomised individuals was 2 . 7 times longer with liraglutide than with placebo (95% CI 1 . 9 to 3 . 9, p<0.0001), corresponding with a hazard ratio of 0 . 21 (95% CI 0.13-0.34). Liraglutide induced greater weight loss than placebo at week 160 (-6.1 [SD 7 . 3] vs -1.9% [6 . 3]; estimated treatment difference -4.3%, 95% CI -4.9 to -3.7, p<0.0001). Serious adverse events were reported by 227 (15%) of 1501 randomised treated individuals in the liraglutide group versus 96 (13%) of 747 individuals in the placebo group. Interpretation In this trial, we provide results for 3 years of treatment, with the limitation that withdrawn individuals were not followed up after discontinuation. Liraglutide 3 . 0 mg might provide health benefits in terms of reduced risk of diabetes in individuals with obesity and prediabetes.	[le Roux, Carel W.] Univ Coll Dublin, Conway Inst, Diabet Complicat Res Ctr, Dublin 4, Ireland; [le Roux, Carel W.] Imperial Coll London, Investigat Sci, London, England; [Astrup, Arne] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Fujioka, Ken] Scripps Clin, Div Endocrinol, Dept Nutr & Metab Res, La Jolla, CA 92037 USA; [Greenway, Frank] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, CA USA; [Lau, David C. W.] Univ Calgary, Dept Med & Biochem & Mol Biol, Calgary, AB, Canada; [Van Gaal, Luc] Univ Antwerp Hosp, Dept Endocrinol Diabetol & Metab Dis, Antwerp, Belgium; [Ortiz, Rafael Violante] Inst Mexicano Seguro Social, Dept Endocrinol, Ciudad Madero, Mexico; [Wilding, John P. H.] Univ Liverpool, Dept Obes & Endocrinol, Liverpool, Merseyside, England; [Skjoth, Trine V.; Manning, Linda Shapiro] Novo Nordisk AS, Soborg, Denmark; [Pi-Sunyer, Xavier] Columbia Univ, Div Endocrinol, New York, NY USA; [Pi-Sunyer, Xavier] Columbia Univ, Obes Res Ctr, New York, NY USA	University College Dublin; Imperial College London; University of Copenhagen; Scripps Research Institute; Louisiana State University System; University of Calgary; University of Antwerp; Instituto Mexicano del Seguro Social; University of Liverpool; Novo Nordisk; Columbia University; Columbia University	le Roux, CW (corresponding author), Univ Coll Dublin, Conway Inst, Diabet Complicat Res Ctr, Dublin 4, Ireland.	carel.leroux@ucd.ie	Prins, Johannes B/M-5884-2013; Finucane, Francis/G-6031-2012; Buscemi, Silvio/K-9662-2016; Carmen, Team1/Y-7382-2019; Lyudmila, Suplotova A/J-3596-2014; Santini, Ferruccio/J-9272-2018; Gurieva, Irina/AAQ-2052-2021; Wilding, John/ABB-6443-2020; Wilding, John PH/A-7106-2008; Geloneze, Bruno/F-4231-2010; Astrup, Arne/B-1407-2015; Padwal, Raj/G-6903-2016	Prins, Johannes B/0000-0001-9497-927X; Finucane, Francis/0000-0002-5374-7090; Buscemi, Silvio/0000-0003-0730-7649; Carmen, Team1/0000-0003-4234-1746; Lyudmila, Suplotova A/0000-0001-9253-8075; Santini, Ferruccio/0000-0002-1706-0822; Gurieva, Irina/0000-0003-2284-2893; Wilding, John/0000-0003-2839-8404; Wilding, John PH/0000-0003-2839-8404; Geloneze, Bruno/0000-0002-0557-4578; Ekaterina, Troshina/0000-0002-8520-8702; Bilz, Stefan/0000-0002-7716-2791; McGowan, Barbara/0000-0003-2015-726X; O'Neil, Patrick/0000-0002-0388-4046; Klemsdal, Tor Ole/0000-0001-5442-9134; Wittert, Gary/0000-0001-6818-6065; Marchesini, Giulio/0000-0003-2407-9860; Krempf, Michel/0000-0002-4353-9511; Shapiro Manning, Linda/0000-0001-8229-381X; Le Roux, Carel/0000-0001-5521-5445; Astrup, Arne/0000-0001-8968-8996; Tytus, Richard/0000-0001-8247-8523; Sathyapalan, Thozhukat/0000-0003-3544-2231; Madsbad, Sten/0000-0002-5017-1815; Lab, Carmen/0000-0002-5935-3236; Padwal, Raj/0000-0003-3541-2817; Carraro, Raffaele/0000-0002-5874-8076	Novo Nordisk, Denmark	Novo Nordisk, Denmark(Novo Nordisk)	Novo Nordisk, Denmark.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053; Astrup A, 2012, INT J OBESITY, V36, P843, DOI 10.1038/ijo.2011.158; Astrup A, 2009, LANCET, V374, P1606, DOI 10.1016/S0140-6736(09)61375-1; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Blackman A, 2016, INT J OBESITY, V40, P1310, DOI 10.1038/ijo.2016.52; Brod M, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-19; Chaudhuri A, 2012, J CLIN ENDOCR METAB, V97, P198, DOI 10.1210/jc.2011-1508; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Davies MJ, 2015, JAMA-J AM MED ASSOC, V314, P687, DOI 10.1001/jama.2015.9676; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; Erlinger S, 2000, EUR J GASTROEN HEPAT, V12, P1347, DOI 10.1097/00042737-200012120-00015; Garvey WT, 2014, DIABETES CARE, V37, P912, DOI 10.2337/dc13-1518; International Conference on Harmonisation, ICH HARM TRIP GUID G, VE6; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kolotkin RL, 2001, OBES RES, V9, P102, DOI 10.1038/oby.2001.13; Mainous AG, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005002; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; McEvoy BW, 2016, J BIOPHARM STAT, V26, P30, DOI 10.1080/10543406.2015.1094814; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Perreault L, 2014, DIABETES CARE, V37, P2622, DOI 10.2337/dc14-0656; Perreault L, 2012, LANCET, V379, P2243, DOI 10.1016/S0140-6736(12)60525-X; Pi-Sunyer X, 2015, NEW ENGL J MED, V373, P11, DOI 10.1056/NEJMoa1411892; Pyke C, 2014, ENDOCRINOLOGY, V155, P1280, DOI 10.1210/en.2013-1934; Rosenstock J, 2010, DIABETES CARE, V33, P1173, DOI 10.2337/dc09-1203; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; TENNER S, 1994, AM J GASTROENTEROL, V89, P1863; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; van Can J, 2014, INT J OBESITY, V38, P784, DOI 10.1038/ijo.2013.162; Viswanathan Prabhakar, 2007, Endocr Pract, V13, P444; Wadden TA, 2013, INT J OBESITY, V37, P1443, DOI 10.1038/ijo.2013.120; Ware JE, 2000, 3 SF 36 HLTH SURVEY	33	326	340	5	94	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 8	2017	389	10077					1399	1409		10.1016/S0140-6736(17)30069-7	http://dx.doi.org/10.1016/S0140-6736(17)30069-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ8OJ	28237263	Green Accepted			2022-12-28	WOS:000398345100032
J	Mervis, J				Mervis, Jeffrey			Federal share of basic research hits new low	SCIENCE			English	News Item																			0	17	17	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI		1005	1005		10.1126/science.355.6329.1005	http://dx.doi.org/10.1126/science.355.6329.1005			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9VY	28280161				2022-12-28	WOS:000396348900011
J	Erb, MA; Scott, TG; Li, BE; Xie, HF; Paulk, J; Seo, HS; Souza, A; Roberts, JM; Dastjerdi, S; Buckley, DL; Sanjana, NE; Shalem, O; Nabet, B; Zeid, R; Offei-Addo, NK; Dhe-Paganon, S; Zhang, F; Orkin, SH; Winter, GE; Bradner, JE				Erb, Michael A.; Scott, Thomas G.; Li, Bin E.; Xie, Huafeng; Paulk, Joshiawa; Seo, Hyuk-Soo; Souza, Amanda; Roberts, Justin M.; Dastjerdi, Shiva; Buckley, Dennis L.; Sanjana, Neville E.; Shalem, Ophir; Nabet, Behnam; Zeid, Rhamy; Offei-Addo, Nana K.; Dhe-Paganon, Sirano; Zhang, Feng; Orkin, Stuart H.; Winter, Georg E.; Bradner, James E.			Transcription control by the ENL YEATS domain in acute leukaemia	NATURE			English	Article							BET BROMODOMAIN INHIBITION; MIXED-LINEAGE LEUKEMIA; H3K79 METHYLATION; HISTONE CROTONYLATION; ESSENTIAL GENES; IN-VIVO; C-MYC; CHROMATIN; CELLS; PROTEIN	Recurrent chromosomal translocations producing a chimaeric MLL oncogene give rise to a highly aggressive acute leukaemia associated with poor clinical outcome(1). The preferential involvement of chromatin-associated factors as MLL fusion partners belies a dependency on transcription control(2). Despite recent progress made in targeting chromatin regulators in cancer(3), available therapies for this well-characterized disease remain inadequate, prompting the need to identify new targets for therapeutic intervention. Here, using unbiased CRISPR-Cas9 technology to perform a genome-scale loss-of-function screen in an MLL-AF4-positive acute leukaemia cell line, we identify ENL as an unrecognized gene that is specifically required for proliferation in vitro and in vivo. To explain the mechanistic role of ENL in leukaemia pathogenesis and dynamic transcription control, a chemical genetic strategy was developed to achieve targeted protein degradation. Acute loss of ENL suppressed the initiation and elongation of RNA polymerase II at active genes genome-wide, with pronounced effects at genes featuring a disproportionate ENL load. Notably, an intact YEATS chromatin-reader domain was essential for ENL-dependent leukaemic growth. Overall, these findings identify a dependency factor in acute leukaemia and suggest a mechanistic rationale for disrupting the YEATS domain in disease.	[Erb, Michael A.; Scott, Thomas G.; Paulk, Joshiawa; Souza, Amanda; Roberts, Justin M.; Dastjerdi, Shiva; Buckley, Dennis L.; Nabet, Behnam; Zeid, Rhamy; Winter, Georg E.; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Li, Bin E.; Xie, Huafeng; Orkin, Stuart H.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Li, Bin E.; Xie, Huafeng; Orkin, Stuart H.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Li, Bin E.; Xie, Huafeng; Orkin, Stuart H.] Harvard Med Sch, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Seo, Hyuk-Soo; Offei-Addo, Nana K.; Dhe-Paganon, Sirano] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Sanjana, Neville E.; Shalem, Ophir; Zhang, Feng] Broad Inst, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Sanjana, Neville E.; Shalem, Ophir] MIT, McGovern Inst Brain Res, Dept Biol Engn, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Orkin, Stuart H.] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Bradner, James E.] Harvard Med Sch, Dept Med, Boston, MA USA; [Winter, Georg E.] Austrian Acad Sci, Res Ctr Mol Med, A-1090 Vienna, Austria; [Bradner, James E.] Novartis Inst BioMed Res, Cambridge, MA 02139 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Austrian Academy of Sciences; Novartis	Bradner, JE (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Bradner, JE (corresponding author), Harvard Med Sch, Dept Med, Boston, MA USA.	james.bradner@novartis.com	Macrae, Rhiannon/AAX-1536-2020; Nabet, Behnam/AAZ-4987-2020	Nabet, Behnam/0000-0002-6738-4200; Scott, Thomas/0000-0003-4743-2786; Erb, Michael/0000-0001-9993-3481; Roberts, Justin/0000-0001-6112-7476; Shalem, Ophir/0000-0002-2267-0801	NIH [R01-CA176745, P01-CA109901]; EMBO long-term fellowship; Pathway to Independence Award from the NHGRI [R00-HG008171]; NATIONAL CANCER INSTITUTE [R01CA176745, P01CA109901] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R00HG008171] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Pathway to Independence Award from the NHGRI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors thank S. A. Armstrong, C. D. Allis, and X. Shi for transparent and supportive dialogue. We also thank J. A. Perry for editing the manuscript and N. S. Gray and C. J. Ott for suggestions. Quantitative proteomics studies were performed by R. Kunz. This research was supported by philanthropic gifts from K. Lubin and E. Woods, as well as NIH grants (R01-CA176745 and P01-CA109901 to J.E.B.). G.E.W. was supported by an EMBO long-term fellowship. D.L.B. is a Merck Fellow of the Damon Runyon Cancer Research Foundation (DRG-2196-14). N. E. S. is supported by a Pathway to Independence Award (R00-HG008171) from the NHGRI.	Andrews FH, 2016, NAT CHEM BIOL, V12, P396, DOI 10.1038/nchembio.2065; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Cai SF, 2015, MOL CELL, V60, P561, DOI 10.1016/j.molcel.2015.10.042; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Daigle SR, 2013, BLOOD, V122, P1017, DOI 10.1182/blood-2013-04-497644; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Guenther MG, 2008, GENE DEV, V22, P3403, DOI 10.1101/gad.1741408; He NH, 2011, P NATL ACAD SCI USA, V108, pE636, DOI 10.1073/pnas.1107107108; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Levis M, 2002, BLOOD, V99, P3885, DOI 10.1182/blood.V99.11.3885; Li YY, 2016, MOL CELL, V62, P181, DOI 10.1016/j.molcel.2016.03.028; Li YY, 2014, CELL, V159, P558, DOI 10.1016/j.cell.2014.09.049; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mueller D, 2007, BLOOD, V110, P4445, DOI 10.1182/blood-2007-05-090514; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Ott CJ, 2012, BLOOD, V120, P2843, DOI 10.1182/blood-2012-02-413021; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Rathert P, 2015, NATURE, V525, P543, DOI 10.1038/nature14898; RUBNITZ JE, 1994, BLOOD, V84, P1747; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shanle EK, 2015, GENE DEV, V29, P1795, DOI 10.1101/gad.269977.115; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Slany RK, 2005, HEMATOL ONCOL, V23, P1, DOI 10.1002/hon.739; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wilkinson AC, 2013, CELL REP, V3, P116, DOI 10.1016/j.celrep.2012.12.016; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; Zeisig DT, 2005, ONCOGENE, V24, P5525, DOI 10.1038/sj.onc.1208699; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	31	158	161	4	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2017	543	7644					270	+		10.1038/nature21688	http://dx.doi.org/10.1038/nature21688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0GQ	28241139	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000395688700045
J	Turner, R				Turner, Robert			Peter Mansfield (1933-2017) Physicist who developed MRI, revolutionizing medicine OBITUARY	NATURE			English	Biographical-Item									[Turner, Robert] Max Planck Inst, Human Cognit & Brain Sci, Neurophys, Leipzig, Germany	Max Planck Society	Turner, R (corresponding author), Max Planck Inst, Human Cognit & Brain Sci, Neurophys, Leipzig, Germany.	turner@cbs.mpg.de						MANSFIELD P, PUBLICATION LIST	1	2	2	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2017	543	7644					180	180		10.1038/543180a	http://dx.doi.org/10.1038/543180a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0GQ	28277517	Bronze			2022-12-28	WOS:000395688700021
J	Wan, LL; Wen, H; Li, YY; Lyu, J; Xi, YX; Hoshii, T; Joseph, JK; Wang, XL; Loh, YHE; Erb, MA; Souza, AL; Bradner, JE; Shen, L; Li, W; Li, HT; Allis, CD; Armstrong, SA; Shi, XB				Wan, Liling; Wen, Hong; Li, Yuanyuan; Lyu, Jie; Xi, Yuanxin; Hoshii, Takayuki; Joseph, Julia K.; Wang, Xiaolu; Loh, Yong-Hwee E.; Erb, Michael A.; Souza, Amanda L.; Bradner, James E.; Shen, Li; Li, Wei; Li, Haitao; Allis, C. David; Armstrong, Scott A.; Shi, Xiaobing			ENL links histone acetylation to oncogenic gene expression in acute myeloid leukaemia	NATURE			English	Article							RNA-POLYMERASE-II; ELONGATION COMPLEX; TRANSCRIPTION ELONGATION; CHROMATIN; INHIBITION; RESISTANCE; COMPONENT; TEFB	Cancer cells are characterized by aberrant epigenetic landscapes and often exploit chromatin machinery to activate oncogenic gene expression programs(1). Recognition of modified histones by 'reader' proteins constitutes a key mechanism underlying these processes; therefore, targeting such pathways holds clinical promise, as exemplified by the development of bromodomain and extra-terminal (BET) inhibitors(2,3). We recently identified the YEATS domain as an acetyl-lysine-binding module(4), but its functional importance in human cancer remains unknown. Here we show that the YEATS domain-containing protein ENL, but not its paralogue AF9, is required for disease maintenance in acute myeloid leukaemia. CRISPR-Cas9-mediated depletion of ENL led to anti-leukaemic effects, including increased terminal myeloid differentiation and suppression of leukaemia growth in vitro and in vivo. Biochemical and crystal structural studies and chromatin-immunoprecipitation followed by sequencing analyses revealed that ENL binds to acetylated histone H3, and co-localizes with H3K27ac and H3K9ac on the promoters of actively transcribed genes that are essential for leukaemia. Disrupting the interaction between the YEATS domain and histone acetylation via structure-based mutagenesis reduced the recruitment of RNA polymerase II to ENL-target genes, leading to the suppression of oncogenic gene expression programs. Notably, disrupting the functionality of ENL further sensitized leukaemia cells to BET inhibitors. Together, our data identify ENL as a histone acetylation reader that regulates oncogenic transcriptional programs in acute myeloid leukaemia, and suggest that displacement of ENL from chromatin may be a promising epigenetic therapy, alone or in combination with BET inhibitors, for aggressive leukaemia.	[Wan, Liling; Joseph, Julia K.; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Wan, Liling; Hoshii, Takayuki; Armstrong, Scott A.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Wan, Liling; Hoshii, Takayuki; Armstrong, Scott A.] Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Wen, Hong; Wang, Xiaolu; Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA; [Wen, Hong; Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Houston, TX 77030 USA; [Li, Yuanyuan; Li, Haitao] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Sch Med, Dept Basic Med Sci,MOE Key Lab Prot Sci, Beijing 100084, Peoples R China; [Li, Yuanyuan; Li, Haitao] Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China; [Lyu, Jie; Xi, Yuanxin; Li, Wei] Baylor Coll Med, Dan L Duncan Canc Ctr, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Loh, Yong-Hwee E.; Shen, Li] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA; [Loh, Yong-Hwee E.; Shen, Li] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Erb, Michael A.; Souza, Amanda L.; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA; [Bradner, James E.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Shi, Xiaobing] Univ Texas Houston, Grad Sch Biomed Sci, Genes & Dev & Epigenet & Mol Carcinogenesis Grad, Houston, TX 77030 USA; [Souza, Amanda L.; Bradner, James E.] Novartis Inst BioMed Res, Cambridge, MA 02139 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Tsinghua University; Tsinghua University; Baylor College of Medicine; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Texas System; University of Texas Health Science Center Houston; Novartis	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA.; Armstrong, SA (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.; Armstrong, SA (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA.; Shi, XB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA.; Shi, XB (corresponding author), Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Houston, TX 77030 USA.; Shi, XB (corresponding author), Univ Texas Houston, Grad Sch Biomed Sci, Genes & Dev & Epigenet & Mol Carcinogenesis Grad, Houston, TX 77030 USA.	alliscd@rockefeller.edu; scott_armstrong@dfci.harvard.edu; xbshi@mdanderson.org	Li, Haitao/B-2668-2012; Lyu, Jie/AAP-4077-2020	Li, Haitao/0000-0001-6741-293X; Lyu, Jie/0000-0002-6530-5257; Shi, Xiaobing/0000-0001-5242-8189; Erb, Michael/0000-0001-9993-3481; Wen, Hong/0000-0001-8739-4572	NIH [1R01CA204639-01, CA66996, CA140575, R01HG007538, R01CA193466]; Leukaemia and Lymphoma Society [LLS-SCOR 7006-13]; Rockefeller University; NIH/NCI [1R01CA204020-01]; Cancer Prevention and Research Institute of Texas [RP160237, RP170285]; Welch Foundation [G1719]; Major State Basic Research Development Program in China [2016YFA0500700, 2015CB910503]; Tsinghua University Initiative Scientific Research Program; NATIONAL CANCER INSTITUTE [R01CA204020, R01CA176745, P30CA016672, P01CA066996, R01CA140575, P30CA008748, R01CA193466, R01CA204639] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007538] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukaemia and Lymphoma Society; Rockefeller University; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Prevention and Research Institute of Texas; Welch Foundation(The Welch Foundation); Major State Basic Research Development Program in China(National Basic Research Program of China); Tsinghua University Initiative Scientific Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank H. Li, M. Armstrong, C.-W. Chen, M. Yu, H. Chu, K. Tanaka, D. Peng and T. Scott for discussions and technical supports. We are grateful to The Rockefeller University Genomic Resource Center, Flow Cytometry Resource Center, The MD Anderson Science Park Next-Generation Sequencing Facility (CPRIT RP120348), The Sequencing and Microarray Facility and The Flow Cytometry and Cellular Imaging Core Facility (NIH/NCI P30CA016672), The Shanghai Synchrotron Radiation Facility BL17U beamline, and The China National Center for Protein Sciences Beijing for facility supports. The research was supported by funds from NIH (1R01CA204639-01), the Leukaemia and Lymphoma Society (LLS-SCOR 7006-13), and The Rockefeller University to C.D.A.; NIH grants (CA66996 and CA140575) and the Leukaemia and Lymphoma Society to S.A.A.; grants from NIH/NCI (1R01CA204020-01), Cancer Prevention and Research Institute of Texas (RP160237 and RP170285) and Welch Foundation (G1719) to X.S.; grants from the Major State Basic Research Development Program in China (2016YFA0500700 and 2015CB910503), and the Tsinghua University Initiative Scientific Research Program to H.L.; and grants from NIH (R01HG007538 and R01CA193466) to W.L. X.S. is a recipient of a Leukaemia & Lymphoma Society Career Development Award and an R. Lee Clark Fellow and Faculty Scholar of MD Anderson Cancer Center. L.W. is a fellow of the Jane Coffin Childs Memorial Fund. Y.L. is a Tsinghua Advanced Innovation fellow.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Deshpande AJ, 2012, TRENDS IMMUNOL, V33, P563, DOI 10.1016/j.it.2012.06.002; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fong CY, 2015, NATURE, V525, P538, DOI 10.1038/nature14888; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Guenther MG, 2008, GENE DEV, V22, P3403, DOI 10.1101/gad.1741408; He NH, 2011, P NATL ACAD SCI USA, V108, pE636, DOI 10.1073/pnas.1107107108; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Kawahara M, 2012, CANCER CELL, V22, P194, DOI 10.1016/j.ccr.2012.06.027; Li YY, 2014, CELL, V159, P558, DOI 10.1016/j.cell.2014.09.049; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo ZJ, 2012, MOL CELL BIOL, V32, P2608, DOI 10.1128/MCB.00182-12; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Perlman EJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10013; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Rathert P, 2015, NATURE, V525, P543, DOI 10.1038/nature14898; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wen H, 2014, NATURE, V508, P263, DOI 10.1038/nature13045; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	27	134	137	3	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2017	543	7644					265	+		10.1038/nature21687	http://dx.doi.org/10.1038/nature21687			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0GQ	28241141	Green Accepted, Green Submitted			2022-12-28	WOS:000395688700044
J	Yuste, R; Bargmann, C				Yuste, Rafael; Bargmann, Cori			Toward a Global BRAIN Initiative	CELL			English	Editorial Material								Neuroscience is entering a collaborative era in which powerful new technologies, generated by large scientific projects in many countries, will have a dramatic impact on science, medicine, and society. Coordinating these international initiatives and ensuring broad distribution of novel technologies and open accessibility of the generated data will multiply their value, while tapping creativity and expertise from every source.	[Yuste, Rafael] Columbia Univ, Neurotechnol Ctr, Kavli Inst Brain Sci, Dept Biol Sci & Neurosci, New York, NY 10027 USA; [Bargmann, Cori] Chan Zuckerberg Initiat, Palo Alto, CA 94301 USA; [Bargmann, Cori] Rockefeller Univ, Lulu & Anthony Wang Lab Neural Circuits & Behav, New York, NY 10065 USA	Columbia University; Rockefeller University	Yuste, R (corresponding author), Columbia Univ, Neurotechnol Ctr, Kavli Inst Brain Sci, Dept Biol Sci & Neurosci, New York, NY 10027 USA.; Bargmann, C (corresponding author), Chan Zuckerberg Initiat, Palo Alto, CA 94301 USA.; Bargmann, C (corresponding author), Rockefeller Univ, Lulu & Anthony Wang Lab Neural Circuits & Behav, New York, NY 10065 USA.	rmy5@columbia.edu; cori@mail.rockefeller.edu			National Science Foundation [DBI 1644405]; Kavli Foundation	National Science Foundation(National Science Foundation (NSF)); Kavli Foundation	We thank the National Science Foundation (Grant DBI 1644405) and the Kavli Foundation for support.	Alivisatos AP, 2015, NEURON, V88, P445, DOI 10.1016/j.neuron.2015.10.015; Alivisatos AP, 2012, NEURON, V74, P970, DOI 10.1016/j.neuron.2012.06.006; Goering S, 2016, CELL, V167, P882, DOI 10.1016/j.cell.2016.10.029; Jorgenson LA, 2015, PHILOS T R SOC B, V370, P8, DOI 10.1098/rstb.2014.0164; Koch C, 2012, NATURE, V483, P397, DOI 10.1038/483397a; Mainen ZF, 2016, NATURE, V539, P159, DOI 10.1038/539159a; Vogelstein JT, 2016, NEURON, V92, P622, DOI 10.1016/j.neuron.2016.10.033	7	28	32	1	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2017	168	6					956	959		10.1016/j.cell.2017.02.023	http://dx.doi.org/10.1016/j.cell.2017.02.023			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8ZF	28256259	Bronze			2022-12-28	WOS:000396287900005
J	Martinez-Gonzalez, MA; Estruch, R; Corella, D; Ros, E; Fito, M; Schwingshackl, L; Salas-Salvado, J				Martinez-Gonzalez, Miguel A.; Estruch, Ramon; Corella, Dolores; Ros, Emilio; Fito, Montse; Schwingshackl, Lukas; Salas-Salvado, Jordi			Effects on Health Outcomes of a Mediterranean Diet With No Restriction on Fat Intake	ANNALS OF INTERNAL MEDICINE			English	Letter									[Martinez-Gonzalez, Miguel A.] Univ Navarra, Pamplona, Spain; [Estruch, Ramon] Hosp Clin Barcelona, Barcelona, Spain; [Corella, Dolores] Univ Valencia, Valencia, Spain; [Ros, Emilio] Ctr Invest Red Fisiopatol Obesidad & Nutr, Madrid, Spain; [Fito, Montse] Inst Municipal Invest Med, Barcelona, Spain; [Schwingshackl, Lukas] German Inst Human Nutr, Potsdam, Germany; [Salas-Salvado, Jordi] Univ Rovira Virgili, Reus, Tarragona, Spain	University of Navarra; University of Barcelona; Hospital Clinic de Barcelona; University of Valencia; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Universitat Rovira i Virgili	Martinez-Gonzalez, MA (corresponding author), Univ Navarra, Pamplona, Spain.		Martinez-Gonzalez, Miguel A./AAE-7669-2019; Salas-Salvado, Jordi/C-7229-2017; Schwingshackl, Lukas/AAC-4119-2019; Estruch, Ramon/AAZ-3723-2020	Salas-Salvado, Jordi/0000-0003-2700-7459; Schwingshackl, Lukas/0000-0003-3407-7594; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808				Bloomfield HE, 2016, ANN INTERN MED, V165, P491, DOI 10.7326/M16-0361; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Martinez-Gonzalez MA, 2016, CURR OPIN CLIN NUTR, V19, P401, DOI 10.1097/MCO.0000000000000316; Schwingshackl L, 2015, J ACAD NUTR DIET, V115, P780, DOI 10.1016/j.jand.2014.12.009; Sofi F, 2014, PUBLIC HEALTH NUTR, V17, P2769, DOI 10.1017/S1368980013003169	5	2	2	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2017	166	5					378	378		10.7326/L16-0589	http://dx.doi.org/10.7326/L16-0589			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BO	28265657				2022-12-28	WOS:000396432800018
J	Villamor, E; Tedroff, K; Peterson, M; Johansson, S; Neovius, M; Petersson, G; Cnattingius, S				Villamor, Eduardo; Tedroff, Kristina; Peterson, Mark; Johansson, Stefan; Neovius, Martin; Petersson, Gunnar; Cnattingius, Sven			Association Between Maternal Body Mass Index in Early Pregnancy and Incidence of Cerebral Palsy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTERPREGNANCY WEIGHT CHANGE; MEDIATION ANALYSIS; OBESITY; RISK; POPULATION; BORN; ANTECEDENTS; PREVALENCE; OVERWEIGHT; EXPOSURE	IMPORTANCE Maternal overweight and obesity are associated with increased risks of preterm delivery, asphyxia-related neonatal complications, and congenital malformations, which in turn are associated with increased risks of cerebral palsy. It is uncertain whether risk of cerebral palsy in offspring increases with maternal overweight and obesity severity and what could be possible mechanisms. OBJECTIVE To study the associations between early pregnancy body mass index (BMI) and rates of cerebral palsy by gestational age and to identify potential mediators of these associations. DESIGN, SETTING, AND PARTICIPANTS Population-based retrospective cohort study of women with singleton children born in Sweden from 1997 through 2011. Using national registries, children were followed for a cerebral palsy diagnosis through 2012. EXPOSURES Early pregnancy BMI. MAIN OUTCOMES AND MEASURES Incidence rates of cerebral palsy and hazard ratios (HRs) with 95% CIs, adjusted for maternal age, country of origin, education level, cohabitation with a partner, height, smoking during pregnancy, and year of delivery. RESULTS Of 1 423 929 children included (mean gestational age, 39.8 weeks [SD, 1.8]; 51.4% male), 3029 were diagnosed with cerebral palsy over a median 7.8 years of follow-up (risk, 2.13 per 1000 live births; rate, 2.63/10 000 child-years). The percentages of mothers in BMI categories were 2.4% at BMI less than 18.5 (underweight), 61.8% at BMI of 18.5 to 24.9 (normal weight), 24.8% at BMI of 25 to 29.9 (overweight), 7.8% at BMI of 30 to 34.9 (obesity grade 1), 2.4% at BMI of 35 to 39.9 (obesity grade 2), and 0.8% at BMI 40 or greater (obesity grade 3). The number of cerebral palsy cases in each BMI category was 64, 1487, 728, 239, 88, and 38; and the rates per 10 000 child-years were 2.58, 2.35, 2.92, 3.15, 4.00, and 5.19, respectively. Compared with children of normal-weight mothers, adjusted HR of cerebral palsy were 1.22 (95% CI, 1.11-1.33) for overweight, 1.28 (95% CI, 1.11-1.47) for obesity grade 1, 1.54 (95% CI, 1.24, 1.93) for obesity grade 2, and 2.02 (95% CI, 1.46-2.79) for obesity grade 3. Results were statistically significant for children born at full term, who comprised 71% of all children with cerebral palsy, but not for preterm infants. An estimated 45% of the association between maternal BMI and rates of cerebral palsy in full-term children was mediated through asphyxia-related neonatal morbidity. CONCLUSIONS AND RELEVANCE Among Swedishwomen with singleton children, maternal overweight and obesity were significantly associated with the rate of cerebral palsy. The association was limited to children born at full term and was partly mediated through asphyxia-related neonatal complications.	[Villamor, Eduardo] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, 1420 Washington Hts, Ann Arbor, MI 48109 USA; [Villamor, Eduardo; Johansson, Stefan; Neovius, Martin; Petersson, Gunnar; Cnattingius, Sven] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; [Tedroff, Kristina] Karolinska Inst, Dept Womens & Childrens Hlth, Neuropediat Unit, Stockholm, Sweden; [Peterson, Mark] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Johansson, Stefan] Karolinska Inst, Sodersjukhuset, Dept Clin Sci & Educ, Stockholm, Sweden	University of Michigan System; University of Michigan; Karolinska Institutet; Karolinska Institutet; University of Michigan System; University of Michigan; Karolinska Institutet; Sodersjukhuset Hospital	Villamor, E (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, 1420 Washington Hts, Ann Arbor, MI 48109 USA.	villamor@umich.edu	Peterson, Mark/ABD-3853-2020; Tedroff, Kristina/AAD-7620-2022	Peterson, Mark/0000-0002-9861-4275; Tedroff, Kristina/0000-0002-0456-8029; Neovius, Martin/0000-0003-2300-3055; Johansson, Stefan/0000-0001-8832-6918	Swedish Research Council for Health, Working Life, and Welfare [2014-0073]; Karolinska Institutet	Swedish Research Council for Health, Working Life, and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Karolinska Institutet(Karolinska Institutet)	The study was supported by grant 2014-0073 from the Swedish Research Council for Health, Working Life, and Welfare and an unrestricted grant from Karolinska Institutet (Dr Cnattingius).	Ahlin K, 2016, ACTA OBSTET GYN SCAN, V95, P793, DOI 10.1111/aogs.12885; Andersen GL, 2008, EUR J PAEDIATR NEURO, V12, P4, DOI 10.1016/j.ejpn.2007.05.001; Branum Amy M, 2016, Natl Vital Stat Rep, V65, P1; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; CARTER BS, 1993, CLIN PERINATOL, V20, P287, DOI 10.1016/S0095-5108(18)30394-4; Christensen D, 2014, DEV MED CHILD NEUROL, V56, P59, DOI 10.1111/dmcn.12268; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Edlow AG, 2016, BJOG-INT J OBSTET GY, V123, P180, DOI 10.1111/1471-0528.13795; Ellenberg JH, 2013, DEV MED CHILD NEUROL, V55, P210, DOI 10.1111/dmcn.12016; Forthun I, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0874; George L, 2006, ACTA OBSTET GYN SCAN, V85, P1331, DOI 10.1080/00016340600935433; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Himmelmann K, 2007, DEV MED CHILD NEUROL, V49, P246, DOI 10.1111/j.1469-8749.2007.00246.x; Himmelmann K, 2014, ACTA PAEDIATR, V103, P618, DOI 10.1111/apa.12614; HOFFMANN AL, 1991, EUR J OBSTET GYN R B, V38, P97, DOI 10.1016/0028-2243(91)90184-M; Hogberg U, 1997, ACTA OBSTET GYN SCAN, V76, P907, DOI 10.3109/00016349709034900; Janik MDC, 2013, J PEDIATR-US, V163, P1307, DOI 10.1016/j.jpeds.2013.06.062; Johansson S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6572; Kruse M, 2009, DEV MED CHILD NEUROL, V51, P622, DOI 10.1111/j.1469-8749.2008.03190.x; Li MY, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2206; Ludvigsson JF, 2016, EUR J EPIDEMIOL, V31, P125, DOI 10.1007/s10654-016-0117-y; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Martinez-Biarge M, 2013, PEDIATRICS, V132, pE952, DOI 10.1542/peds.2013-0511; Metzger BE, 2010, BJOG-INT J OBSTET GY, V117, P575, DOI 10.1111/j.1471-0528.2009.02486.x; Nelson KB, 2015, NEW ENGL J MED, V373, P946, DOI 10.1056/NEJMra1505261; Ovesen P, 2011, OBSTET GYNECOL, V118, P305, DOI 10.1097/AOG.0b013e3182245d49; Pan C, 2014, J CHILD NEUROL, V29, pNP196, DOI 10.1177/0883073813510971; Persson M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001648; Peterson MD, 2015, JAMA-J AM MED ASSOC, V314, P2303, DOI 10.1001/jama.2015.11025; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Sturm R, 2013, INT J OBESITY, V37, P889, DOI 10.1038/ijo.2012.159; Valeri L, 2015, EPIDEMIOLOGY, V26, pE23, DOI 10.1097/EDE.0000000000000253; Valeri L, 2013, PSYCHOL METHODS, V18, P137, DOI 10.1037/a0031034; Villamor E, 2006, LANCET, V368, P1164, DOI 10.1016/S0140-6736(06)69473-7; Villamor E, 2016, OBESITY, V24, P727, DOI 10.1002/oby.21384; Villamor E, 2015, ANN HUM BIOL, V42, P507, DOI 10.3109/03014460.2014.969488; Walstab J, 2002, AUST NZ J OBSTET GYN, V42, P138, DOI 10.1111/j.0004-8666.2002.00138.x	41	52	54	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2017	317	9					925	936		10.1001/jama.2017.0945	http://dx.doi.org/10.1001/jama.2017.0945			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM8DM	28267854	Bronze			2022-12-28	WOS:000395541500012
J	Nembhard, WN; Tang, XY; Hu, ZP; MacLeod, S; Stowe, Z; Webber, D				Nembhard, Wendy N.; Tang, Xinyu; Hu, Zhuopei; MacLeod, Stewart; Stowe, Zachary; Webber, Daniel			Maternal and infant genetic variants, maternal periconceptional use of selective serotonin reuptake inhibitors, and risk of congenital heart defects in offspring: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MTHFR C677T POLYMORPHISM; FOLATE METABOLISM GENES; ONE-CARBON METABOLISM; NEURAL-TUBE DEFECTS; BIRTH-DEFECTS; EARLY-PREGNANCY; FOLIC-ACID; THYMIDYLATE SYNTHASE; DEPRESSIVE SYMPTOMS; ANTIDEPRESSANT USE	OBJECTIVE To evaluate whether the association between maternal periconceptional use of selective serotonin reuptake inhibitors (SSRIs) and increased risk of congenital heart defects in offspring is modified by maternal or infant genetic variants in folate, homocysteine, or transsulfuration pathways. DESIGN Population based study. DNA from mothers, fathers, and infants was genotyped with an Illumina GoldenGate custom single nucleotide polymorphism panel. A hybrid design based on a log linear model was used to calculate relative risks and Bayesian false discovery probabilities (BFDP) to identify polymorphisms associated with congenital heart defects modified by SSRI use. DATA SOURCES Data from the US National Birth Defects Prevention Study on 1180 liveborn infants with congenital heart defects and 1644 controls, born 1997-2008. MAIN OUTCOME MEASURES Cases included infants with selected congenital heart defects and control infants had no major defects. SSRI use was obtained from telephone interviews with mothers. RESULTS For women who reported taking SSRIs periconceptionally, maternal SHMT1 (rs9909104) GG and AG genotypes were associated with a 5.9 and 2.4 increased risk of select congenital heart defects in offspring, respectively, versus the AA genotype (BFDP= 0.69). Compared with the AA genotype, BHMT (rs492842 and rs542852) GG and AG genotypes were associated with twice the risk of congenital heart defects (BFDP= 0.74 and 0.79, respectively). MGST1 (rs2075237) CC and AC genotypes were associated with an increased risk compared with the GG genotype (8.0 and 2.8, respectively; BFDP= 0.79). Single nucleotide polymorphism in infant genes in the folate (MTHFS rs12438477), homocysteine (TRDMT1 rs6602178 and GNMT rs11752813) and transsulfuration (GSTP1 rs7941395 and MGST1 rs7294985) pathways were also associated with an increased risk of congenital heart defects. CONCLUSIONS Common maternal or infant genetic variants in folate, homocysteine, or transsulfuration pathways are associated with an increased risk of certain congenital heart defects among children of women taking SSRIs during cardiogenesis.	[Nembhard, Wendy N.; MacLeod, Stewart; Webber, Daniel] Univ Arkansas Med Sci, Coll Med, Dept Pediat, Div Birth Defects Res, Little Rock, AR 72202 USA; [Nembhard, Wendy N.; MacLeod, Stewart; Webber, Daniel] Arkansas Childrens Res Inst, Little Rock, AR 72202 USA; [Tang, Xinyu; Hu, Zhuopei] Univ Arkansas Med Sci, Coll Med, Dept Pediat, Arkansas Childrens Res Inst,Div Biostat, Little Rock, AR 72202 USA; [Stowe, Zachary] Univ Arkansas Med Sci, Coll Med, Dept Psychiat, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Nembhard, WN (corresponding author), Univ Arkansas Med Sci, Coll Med, Dept Pediat, Div Birth Defects Res, Little Rock, AR 72202 USA.; Nembhard, WN (corresponding author), Arkansas Childrens Res Inst, Little Rock, AR 72202 USA.	wnnembhard@uams.edu			Eunice Kennedy Shriver National Institute of Child Health and Human Development [5R01HD039054-12]; CDC National Center on Birth Defects and Developmental Disabilities [5U01DD000491-05]; Arkansas Biosciences Institute	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); CDC National Center on Birth Defects and Developmental Disabilities; Arkansas Biosciences Institute	The study received funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (#5R01HD039054-12), the CDC National Center on Birth Defects and Developmental Disabilities (#5U01DD000491-05), and the Arkansas Biosciences Institute. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention. The study funders played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. The researchers are independent from the funders, and all authors, external and internal, had full access to all of the data (including statistical reports and tables) in the study and can take responsibility for the integrity of the data and the accuracy of the data analysis.	Abarinov EV, 2013, J NUTR, V143, P1028, DOI 10.3945/jn.113.174417; Alwan S, 2007, NEW ENGL J MED, V356, P2684, DOI 10.1056/NEJMoa066584; Alwan S, 2011, J CLIN PHARMACOL, V51, P264, DOI 10.1177/0091270010373928; Ban L, 2014, BJOG-INT J OBSTET GY, V121, P1471, DOI 10.1111/1471-0528.12682; Beaudin AE, 2011, AM J CLIN NUTR, V93, P789, DOI 10.3945/ajcn.110.002766; Beydoun MA, 2010, PSYCHOSOM MED, V72, P862, DOI 10.1097/PSY.0b013e3181f61863; Blomberg MI, 2010, BIRTH DEFECTS RES A, V88, P35, DOI 10.1002/bdra.20620; Botto LD, 1996, PEDIATRICS, V98, P911; Botto LD, 2003, AM J MED GENET A, V121A, P95, DOI 10.1002/ajmg.a.20132; Botto LD, 2007, BIRTH DEFECTS RES A, V79, P714, DOI 10.1002/bdra.20403; Castro R, 2006, J INHERIT METAB DIS, V29, P3, DOI 10.1007/s10545-006-0106-5; Caton AR, 2009, HYPERTENSION, V54, P63, DOI 10.1161/HYPERTENSIONAHA.109.129098; Chapman ALP, 2013, J BIOL CHEM, V288, P6465, DOI 10.1074/jbc.M112.418970; Chowdhury S, 2012, MOL GENET METAB, V107, P596, DOI 10.1016/j.ymgme.2012.09.022; Christensen KE, 2013, CARDIOL YOUNG, V23, P89, DOI 10.1017/S1047951112000431; Cole JA, 2007, PHARMACOEPIDEM DR S, V16, P1075, DOI 10.1002/pds.1463; Colvin L, 2011, BIRTH DEFECTS RES A, V91, P142, DOI 10.1002/bdra.20773; Crabtree MJ, 2009, J BIOL CHEM, V284, P28128, DOI 10.1074/jbc.M109.041483; Cunningham JM, 2008, CANCER EPIDEM BIOMAR, V17, P1781, DOI 10.1158/1055-9965.EPI-07-2849; Czeizel AE, 1998, EUR J OBSTET GYN R B, V78, P151, DOI 10.1016/S0301-2115(98)00061-X; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; Czeizel AE, 2013, NUTRIENTS, V5, P4760, DOI 10.3390/nu5114760; Davis RL, 2007, PHARMACOEPIDEM DR S, V16, P1086, DOI 10.1002/pds.1462; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dennery Phyllis A., 2007, Birth Defects Research, V81, P155, DOI 10.1002/bdrc.20098; Diav-Citrin O, 2008, BRIT J CLIN PHARMACO, V66, P695, DOI 10.1111/j.1365-2125.2008.03261.x; Druschel C, 1996, PUBLIC HEALTH REP, V111, P359; Einarson A, 2001, AM J PSYCHIAT, V158, P1728, DOI 10.1176/appi.ajp.158.10.1728; Erickson SW, J STAT SOFTW, DOI 10.18637/jss.v071.c02; Etheredge AJ, 2012, AM J MED GENET A, V158A, P2439, DOI 10.1002/ajmg.a.35552; Evans J, 2001, BRIT MED J, V323, P257, DOI 10.1136/bmj.323.7307.257; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; Fava M, 2007, J CLIN PSYCHIAT, V68, P4; Field Martha S., 2011, Frontiers in Genetics, V2, P36, DOI 10.3389/fgene.2011.00036; Furu K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1798; Gilboa SM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.08.005; Gilbody S, 2007, AM J EPIDEMIOL, V165, P1, DOI 10.1093/aje/kwj347; Grewal J, 2008, BIRTH DEFECTS RES A, V82, P519, DOI 10.1002/bdra.20461; Grigoriadis Sophie, 2007, Ann Clin Psychiatry, V19, P247, DOI 10.1080/10401230701653294; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE293, DOI 10.4088/JCP.12r07966; Grillo MA, 2008, AMINO ACIDS, V34, P187, DOI 10.1007/s00726-007-0500-9; Hackshaw A, 2011, HUM REPROD UPDATE, V17, P589, DOI 10.1093/humupd/dmr022; HARDY LW, 1987, SCIENCE, V235, P448, DOI 10.1126/science.3099389; Hayes RM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.04.028; Heil SG, 2000, MOL GENET METAB, V71, P511, DOI 10.1006/mgme.2000.3078; Hobbs CA, 2005, AM J CLIN NUTR, V82, P598, DOI 10.1093/ajcn/82.3.598; Hobbs CA, 2005, AM J CLIN NUTR, V81, P147; Hobbs CA, 2014, BIRTH DEFECTS RES A, V100, P116, DOI 10.1002/bdra.23225; Hobbs CA, 2010, OBSTET GYNECOL, V116, P316, DOI 10.1097/AOG.0b013e3181e80979; Huybrechts KF, 2014, NEW ENGL J MED, V370, P2397, DOI 10.1056/NEJMoa1312828; Huybrechts KF, 2013, GEN HOSP PSYCHIAT, V35, P265, DOI 10.1016/j.genhosppsych.2012.12.010; Jimenez-Solem E, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001148; Junker R, 2001, CARDIOVASC RES, V51, P251, DOI 10.1016/S0008-6363(01)00286-3; Kalhan SC, 2012, REV ENDOCR METAB DIS, V13, P109, DOI 10.1007/s11154-012-9215-7; Kallen K, 2007, BIRTH-ISS PERINAT C, V34, P99, DOI 10.1111/j.1523-536X.2006.00155_1.x; Kapusta L, 1999, J PEDIATR-US, V135, P773, DOI 10.1016/S0022-3476(99)70102-2; Kelemen LE, 2008, CANCER RES, V68, P2498, DOI 10.1158/0008-5472.CAN-07-5165; Kelly CB, 2004, J PSYCHOPHARMACOL, V18, P567, DOI 10.1177/0269881104047285; Knudsen TM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-333; Kornum Jette B, 2010, Clin Epidemiol, V2, P29; Kulin NA, 1998, JAMA-J AM MED ASSOC, V279, P609, DOI 10.1001/jama.279.8.609; Lee K, 2001, OBSTET GYNECOL, V98, P620, DOI 10.1016/S0029-7844(01)01507-1; Lennestal R, 2009, EUR J CLIN PHARMACOL, V65, P615, DOI 10.1007/s00228-009-0620-0; LEVITT AJ, 1989, BIOL PSYCHIAT, V25, P867, DOI 10.1016/0006-3223(89)90266-7; Li M, 2014, HUM GENET, V133, P1127, DOI 10.1007/s00439-014-1453-1; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Long J, 2011, BIRTH DEFECTS RES A, V91, P879, DOI 10.1002/bdra.22849; Louik C, 2007, NEW ENGL J MED, V356, P2675, DOI 10.1056/NEJMoa067407; LYNBERG M C, 1991, Teratology, V43, P449; MacDorman ME, 2007, BIRTH-ISS PERINAT C, V34, P101, DOI 10.1111/j.1523-536X.2006.00155_3.x; MAKER HS, 1981, J NEUROCHEM, V36, P589, DOI 10.1111/j.1471-4159.1981.tb01631.x; Malik S, 2008, PEDIATRICS, V121, pE810, DOI 10.1542/peds.2007-1519; Malm H, 2011, OBSTET GYNECOL, V118, P111, DOI 10.1097/AOG.0b013e318220edcc; Mamasoula C, 2013, CIRC-CARDIOVASC GENE, V6, P347, DOI 10.1161/CIRCGENETICS.113.000191; Miller AL, 2008, ALTERN MED REV, V13, P216; MILLER E, 1981, NEW ENGL J MED, V304, P1331, DOI 10.1056/NEJM198105283042204; Miriam-Webster, 2016, MEDICAL DICTIONARY; Mitchell AA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.029; Mitchell LE, 2010, BIRTH DEFECTS RES A, V88, P48, DOI 10.1002/bdra.20622; Myles N, 2013, AUST NZ J PSYCHIAT, V47, P1002, DOI 10.1177/0004867413492219; Nembhard WN, 2001, TERATOLOGY, V64, P267, DOI 10.1002/tera.1073; Nie Y, 2011, CLIN CHEM LAB MED, V49, P2101, DOI 10.1515/CCLM.2011.673; Nikfar S, 2012, DARU, V20, DOI 10.1186/2008-2231-20-75; Oh SS, 2010, INT J CANCER, V127, P2169, DOI 10.1002/ijc.25214; Ori M, 2013, INT J DEV BIOL, V57, P707, DOI 10.1387/ijdb.130204mo; Oster ME, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000256; Papakostas GI, 2012, AM J PSYCHIAT, V169, P1267, DOI 10.1176/appi.ajp.2012.11071114; Papakostas GI, 2004, J CLIN PSYCHIAT, V65, P1096; Park SL, 2010, CARCINOGENESIS, V31, P1264, DOI 10.1093/carcin/bgq096; Patel SS, 2012, AM J MED GENET A, V158A, P2447, DOI 10.1002/ajmg.a.35555; Pedersen LH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3569; Polen KND, 2013, BIRTH DEFECTS RES A, V97, P28, DOI 10.1002/bdra.23096; Rasmussen SA, 2002, TERATOLOGY, V66, P177, DOI 10.1002/tera.10086; Reefhuis J, 2015, BIRTH DEFECTS RES A, V103, P656, DOI 10.1002/bdra.23384; Reefhuis J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3190; Reis M, 2010, PSYCHOL MED, V40, P1723, DOI 10.1017/S0033291709992194; Sadler TW, 2011, REPROD TOXICOL, V32, P484, DOI 10.1016/j.reprotox.2011.09.004; Sadler TW, 2010, AM J MED GENET A, V152A, P2426, DOI 10.1002/ajmg.a.33636; Shelton Richard C, 2013, Prim Care Companion CNS Disord, V15, DOI 10.4088/PCC.13m01520; Simon GE, 2002, AM J PSYCHIAT, V159, P2055, DOI 10.1176/appi.ajp.159.12.2055; Sivojelezova A, 2005, AM J OBSTET GYNECOL, V193, P2004, DOI 10.1016/j.ajog.2005.05.012; Stahl SM, 2007, CNS SPECTRUMS, V12, P739, DOI 10.1017/S1092852900015418; Stoller JZ, 2005, SEMIN CELL DEV BIOL, V16, P704, DOI 10.1016/j.semcdb.2005.06.004; Tang XY, 2015, AM J MED GENET A, V167, P1231, DOI 10.1002/ajmg.a.36867; Tolmunen T, 2003, J NUTR, V133, P3233, DOI 10.1093/jn/133.10.3233; TOWNER D, 1995, DIABETES CARE, V18, P1446, DOI 10.2337/diacare.18.11.1446; Tuorto F, 2012, NAT STRUCT MOL BIOL, V19, P900, DOI 10.1038/nsmb.2357; Tyagi N, 2005, AM J PHYSIOL-HEART C, V289, pH2649, DOI 10.1152/ajpheart.00548.2005; Vandenberg LN, 2013, DIS MODEL MECH, V6, P261, DOI 10.1242/dmm.010256; Verkleij-Hagoort AC, 2006, BJOG-INT J OBSTET GY, V113, P1412, DOI 10.1111/j.1471-0528.2006.01109.x; Vermunt JK, 1996, LOG LINEAR EVENT HIS; Vermunt JK, 1997, LOG LINEAR MODELS FO; Vermunt JK, 1997, LEM A GENERAL PROGRA; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; Wang BJ, 2013, J MATERN-FETAL NEO M, V26, P1768, DOI 10.3109/14767058.2013.799648; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058041; Watkins ML, 2001, EPIDEMIOLOGY, V12, P439, DOI 10.1097/00001648-200107000-00014; Weinberg CR, 2005, AM J HUM GENET, V77, P627, DOI 10.1086/496900; Wenstrom KD, 2001, AM J OBSTET GYNECOL, V184, P806, DOI 10.1067/mob.2001.113845; Wisner KL, 2009, AM J PSYCHIAT, V166, P557, DOI 10.1176/appi.ajp.2008.08081170; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; Wu XD, 2003, J HYPERTENS, V21, P1847, DOI 10.1097/00004872-200310000-00011; Wu YL, 2013, PROG NEURO-PSYCHOPH, V46, P78, DOI 10.1016/j.pnpbp.2013.06.015; Wurst KE, 2010, BIRTH DEFECTS RES A, V88, P159, DOI 10.1002/bdra.20627; Yonkers KA, 2014, ANNU REV CLIN PSYCHO, V10, P369, DOI 10.1146/annurev-clinpsy-032813-153626; Yoon PW, 2001, PUBLIC HEALTH REP, V116, P32, DOI 10.1093/phr/116.S1.32; Zhu HP, 2012, AM J MED GENET A, V158A, P2194, DOI 10.1002/ajmg.a.35310; Zhu HP, 2012, AM J MED GENET A, V158A, P1124, DOI 10.1002/ajmg.a.35313	130	17	17	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2017	356								j832	10.1136/bmj.j832	http://dx.doi.org/10.1136/bmj.j832			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO1BH	28264803	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000396432100008
J	Cassidy, MC; Bruno, A; Rubbert, S; Irfan, M; Kammhuber, J; Schouten, RN; Akhmerov, AR; Kouwenhoven, LP				Cassidy, M. C.; Bruno, A.; Rubbert, S.; Irfan, M.; Kammhuber, J.; Schouten, R. N.; Akhmerov, A. R.; Kouwenhoven, L. P.			Demonstration of an ac Josephson junction laser	SCIENCE			English	Article							RADIATION; EMISSION; ARRAYS; NOISE	Superconducting electronic devices have reemerged as contenders for both classical and quantum computing due to their fast operation speeds, low dissipation, and long coherence times. An ultimate demonstration of coherence is lasing. We use one of the fundamental aspects of superconductivity, the ac Josephson effect, to demonstrate a laser made from a Josephson junction strongly coupled to a multimode superconducting cavity. A dc voltage bias applied across the junction provides a source of microwave photons, and the circuit's nonlinearity allows for efficient down-conversion of higher-order Josephson frequencies to the cavity's fundamental mode. The simple fabrication and operation allows for easy integration with a range of quantum devices, allowing for efficient on-chip generation of coherent microwave photons at low temperatures.	[Cassidy, M. C.; Bruno, A.; Kammhuber, J.; Schouten, R. N.; Kouwenhoven, L. P.] Delft Univ Technol, QuTech, POB 5046, NL-2600 GA Delft, Netherlands; [Rubbert, S.; Irfan, M.; Schouten, R. N.; Akhmerov, A. R.; Kouwenhoven, L. P.] Delft Univ Technol, Kavli Inst Nanosci, POB 5046, NL-2600 GA Delft, Netherlands	Delft University of Technology; Delft University of Technology	Kouwenhoven, LP (corresponding author), Delft Univ Technol, QuTech, POB 5046, NL-2600 GA Delft, Netherlands.; Kouwenhoven, LP (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, POB 5046, NL-2600 GA Delft, Netherlands.	l.p.kouwenhoven@tudelft.nl	Irfan, Muhammad/M-4967-2017	Irfan, Muhammad/0000-0002-2924-8451; Akhmerov, Anton/0000-0001-8031-1340; Bruno, Alessandro/0000-0002-7821-5082; Cassidy, Maja/0000-0002-7780-1549	Netherlands Organisation for Scientific Research (NWO/OCW), as part of the Frontiers of Nanoscience program; Foundation for Fundamental Research on Matter (FOM); European Research Council (ERC); Microsoft Corporation Station Q	Netherlands Organisation for Scientific Research (NWO/OCW), as part of the Frontiers of Nanoscience program; Foundation for Fundamental Research on Matter (FOM)(FOM (The Netherlands)); European Research Council (ERC)(European Research Council (ERC)European Commission); Microsoft Corporation Station Q(Microsoft)	We thank D. J. van Woerkom, W. Uilhoorn, and D. de Jong for experimental assistance and C. Eichler, Y. M. Blanter, F. Hassler, J. E. Mooij, and Y. V. Nazarov for helpful discussions. This work has been supported by the Netherlands Organisation for Scientific Research (NWO/OCW), as part of the Frontiers of Nanoscience program, Foundation for Fundamental Research on Matter (FOM), European Research Council (ERC), and Microsoft Corporation Station Q. M.C.C. and L.P.K. have filed a provisional patent application that relates to the Josephson junction laser.	ADLER R, 1946, P IRE, V34, P351, DOI 10.1109/JRPROC.1946.229930; Astafiev O, 2007, NATURE, V449, P588, DOI 10.1038/nature06141; Barbara P, 1999, PHYS REV LETT, V82, P1963, DOI 10.1103/PhysRevLett.82.1963; Chen F, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.020506; Chen F, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3573824; DEVORET MH, 1990, PHYS REV LETT, V64, P1824, DOI 10.1103/PhysRevLett.64.1824; Erickson RP, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.187002; Hofheinz M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.217005; Liu YY, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.053802; Liu YY, 2015, SCIENCE, V347, P285, DOI 10.1126/science.aaa2501; Meister S, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.174532; Ozyuzer L, 2007, SCIENCE, V318, P1291, DOI 10.1126/science.1149802; PEDERSEN NF, 1976, APPL PHYS LETT, V28, P562, DOI 10.1063/1.88824; Rogovin D., 1976, Physics Reports. Physics Letters Section C, V25c, P175, DOI 10.1016/0370-1573(76)90011-9; Siddiqi I, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.207002; Solinas P, 2015, SCI REP-UK, V5, DOI 10.1038/srep12260; STOVER HL, 1966, APPL PHYS LETT, V8, P91, DOI 10.1063/1.1754502; TILLEY DR, 1970, PHYS LETT A, VA 33, P205, DOI 10.1016/0375-9601(70)90735-8; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Wang ZL, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4802893; WELLSTOOD FC, 1987, APPL PHYS LETT, V50, P772, DOI 10.1063/1.98041; YURKE B, 1988, PHYS REV LETT, V60, P764, DOI 10.1103/PhysRevLett.60.764	22	59	62	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					939	+		10.1126/science.aah6640	http://dx.doi.org/10.1126/science.aah6640			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2YM	28254938	Green Submitted			2022-12-28	WOS:000395181700036
J	Li, JR; Lee, J; Huang, W; Burchesky, S; Shteynas, B; Top, FC; Jamison, AO; Ketterle, W				Li, Jun-Ru; Lee, Jeongwon; Huang, Wujie; Burchesky, Sean; Shteynas, Boris; Top, Furkan Cagri; Jamison, Alan O.; Ketterle, Wolfgang			A stripe phase with supersolid properties in spin-orbit-coupled Bose-Einstein condensates	NATURE			English	Article							GAS	Supersolidity combines superfluid flow with long-range spatial periodicity of solids(1), two properties that are often mutually exclusive. The original discussion of quantum crystals(2) and supersolidity focused on solid He-4 and triggered extensive experimental efforts(3,4) that, instead of supersolidity, revealed exotic phenomena including quantum plasticity and mass supertransport(4). The concept of supersolidity was then generalized from quantum crystals to other superfluid systems that break continuous translational symmetry. Bose-Einstein condensates with spin-orbit coupling are predicted to possess a stripe phase(5-7) with supersolid properties(8,9). Despite several recent studies of the miscibility of the spin components of such a condensate(10-12), the presence of stripes has not been detected. Here we observe the predicted density modulation of this stripe phase using Bragg reflection (which provides evidence for spontaneous long-range order in one direction) while maintaining a sharp momentum distribution (the hallmark of superfluid Bose-Einstein condensates). Our work thus establishes a system with continuous symmetry-breaking properties, associated collective excitations and superfluid behaviour.	[Li, Jun-Ru; Lee, Jeongwon; Huang, Wujie; Burchesky, Sean; Shteynas, Boris; Top, Furkan Cagri; Jamison, Alan O.; Ketterle, Wolfgang] MIT, Harvard Ctr Ultracold Atoms, Dept Phys, Cambridge, MA 02139 USA; [Li, Jun-Ru; Lee, Jeongwon; Huang, Wujie; Burchesky, Sean; Shteynas, Boris; Top, Furkan Cagri; Jamison, Alan O.; Ketterle, Wolfgang] MIT, Res Lab Eelct, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Li, JR (corresponding author), MIT, Harvard Ctr Ultracold Atoms, Dept Phys, Cambridge, MA 02139 USA.; Li, JR (corresponding author), MIT, Res Lab Eelct, Cambridge, MA 02139 USA.	junruli@mit.edu	Li, Junru/B-9217-2017; Li, Junru/Q-4232-2019	Li, Junru/0000-0001-6155-9463; Li, Junru/0000-0001-6155-9463; Burchesky, Sean/0000-0002-6740-3977; Lee, Jeongwon/0000-0003-3932-0063	NSF through the Center for Ultracold Atoms; ARO-MURI Non-equilibrium Many-body Dynamics [W911NF-14-1-0003]; AFOSR-MURI Quantum Phases of Matter [FA9550-14-1- 0035];  [1506369]	NSF through the Center for Ultracold Atoms; ARO-MURI Non-equilibrium Many-body Dynamics; AFOSR-MURI Quantum Phases of Matter; 	We thank S. Stringari for discussions and W. C. Burton for reading the manuscript. We acknowledge support from the NSF through the Center for Ultracold Atoms and from award 1506369, from ARO-MURI Non-equilibrium Many-body Dynamics (grant W911NF-14-1-0003) and from AFOSR-MURI Quantum Phases of Matter (grant FA9550-14-1- 0035).	Baumann K, 2010, NATURE, V464, P1301, DOI 10.1038/nature09009; Boninsegni M, 2012, REV MOD PHYS, V84, P759, DOI 10.1103/RevModPhys.84.759; Bulgac A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.215301; Burdick NQ, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.031022; Chen Y, 2012, J LOW TEMP PHYS, V169, P149, DOI 10.1007/s10909-012-0657-9; CHESTER GV, 1970, PHYS REV A, V2, P256, DOI 10.1103/PhysRevA.2.256; Cheuk LW, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.095302; Giovanazzi S, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.130402; Han W, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.013607; Henkel N, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.195302; Ho TL, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.150403; Ji SC, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.105301; Ji SC, 2014, NAT PHYS, V10, P314, DOI [10.1038/NPHYS2905, 10.1038/nphys2905]; Kim E, 2004, NATURE, V427, P225, DOI 10.1038/nature02220; Kuklov AB, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.184508; Leonard J., 2017, NATURE; Li J, 2016, PHYS REV LETT, V117; Li Y, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.235302; Li Y, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.225301; Lin YJ, 2011, NATURE, V471, P83, DOI 10.1038/nature09887; Martone GI, 2015, EUR PHYS J-SPEC TOP, V224, P553, DOI 10.1140/epjst/e2015-02386-x; Miyake H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.175302; Ostermann S, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.021026; Stanescu TD, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.023616; Sun Q, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.033619; Wang CJ, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.160403; Wang PJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.095301; Wessel S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.127205; ZHAI H, 2015, Patent No. 78026001	30	302	304	3	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2017	543	7643					91	+		10.1038/nature21431	http://dx.doi.org/10.1038/nature21431			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0AA	28252062	Green Submitted			2022-12-28	WOS:000395671500038
J	Abbasi, J				Abbasi, Jennifer			Public-Private Partnership Speeds Investigator Access to Cancer Drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2017	317	8					797	797		10.1001/jama.2017.1089	http://dx.doi.org/10.1001/jama.2017.1089			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM7PW	28245308				2022-12-28	WOS:000395505600006
J	Gaist, D; Rodriguez, LAG; Hellfritzsch, M; Poulsen, FR; Halle, B; Hallas, J; Pottegard, A				Gaist, David; Garcia Rodriguez, Luis Alberto; Hellfritzsch, Maja; Poulsen, Frantz Rom; Halle, Bo; Hallas, Jesper; Pottegard, Anton			Association of Antithrombotic Drug Use With Subdural Hematoma Risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CLINICAL-TRIALS; ATRIAL-FIBRILLATION; INTRACRANIAL HEMORRHAGE; PATIENT REGISTER; METAANALYSIS; WARFARIN; THERAPY; ANTICOAGULATION; INJURIES; ASPIRIN	IMPORTANCE Incidence of subdural hematoma has been reported to be increasing. To what extent this is related to increasing use of antithrombotic drugs is unknown. OBJECTIVES To estimate the association between use of antithrombotic drugs and subdural hematoma risk and determine trends in subdural hematoma incidence and antithrombotic drug use in the general population. DESIGN, SETTING, AND PARTICIPANTS Case-control study of 10 010 patients aged 20 to 89 years with a first-ever subdural hematoma principal discharge diagnosis from 2000 to 2015 matched by age, sex, and calendar year to 400 380 individuals from the general population (controls). Subdural hematoma incidence and antithrombotic drug use was identified using population-based regional data (population: 484 346) and national data (population: 5.2 million) from Denmark. Conditional logistic regression models were used to estimate odds ratios (ORs) that were adjusted for comorbidity, education level, and income level. EXPOSURES Use of low-dose aspirin, clopidogrel, a vitamin K antagonist (VKA), a direct oral anticoagulant, and combined antithrombotic drug treatment. MAIN OUTCOMES AND MEASURES Association of subdural hematoma with antithrombotic drug use, subdural hematoma incidence rate, and annual prevalence of treatment with antithrombotic drugs. RESULTS Among 10 010 patients with subdural hematoma (mean age, 69.2 years; 3462 women [34.6%]), 47.3% were taking antithrombotic medications. Current use of low-dose aspirin (cases: 26.7%, controls: 22.4%; adjusted OR, 1.24 [95% CI, 1.15-1.33]), clopidogrel (cases: 5.0%, controls: 2.2%; adjusted OR, 1.87 [95% CI, 1.57-2.24]), a direct oral anticoagulant (cases: 1.0%, controls: 0.6%; adjusted OR, 1.73 [95% CI, 1.31-2.28]), and a VKA (cases: 14.3%, controls: 4.9%; adjusted OR, 3.69 [95% CI, 3.38-4.03]) were associated with higher risk of subdural hematoma. The risk of subdural hematoma was highest when a VKA was used concurrently with an antiplatelet drug (low-dose aspirin and a VKA: 3.6% of cases and 1.1% of controls; adjusted OR, 4.00 [95% CI, 3.40-4.70]; clopidogrel and a VKA: 0.3% of cases and 0.04% of controls; adjusted OR, 7.93 [95% CI, 4.49-14.02]). The prevalence of antithrombotic drug use increased from 31.0 per 1000 individuals from the general population in 2000 to 76.9 per 1000 individuals in 2015 (P < .001 for trend). The overall subdural hematoma incidence rate increased from 10.9 per 100 000 person-years in 2000 to 19.0 per 100 000 person-years in 2015 (P < .001 for trend). The largest increase was among older patients (> 75 years; n = 4441) who experienced an increase from 55.1 per 100 000 person-years to 99.7 per 100 000 person-years (P < .001 for trend). CONCLUSIONS AND RELEVANCE In Denmark, antithrombotic drug use was associated with higher risk of subdural hematoma; and the highest odds of subdural hematoma was associated with combined use of a VKA and an antiplatelet drug. The increased incidence of subdural hematoma from 2000 to 2015 appears to be associated with the increased use of antithrombotic drugs, particularly use of a VKA among older patients.	[Gaist, David] Odense Univ Hosp, Dept Neurol, Odense, Denmark; [Gaist, David; Poulsen, Frantz Rom] Univ Southern Denmark, Fac Hlth Sci, Dept Clin Res, Odense, Denmark; [Garcia Rodriguez, Luis Alberto] Ctr Espanol Invest Farmacoepidemiol, Madrid, Spain; [Hellfritzsch, Maja; Hallas, Jesper; Pottegard, Anton] Univ Southern Denmark, Dept Publ Hlth, Clin Pharmacol, Odense, Denmark; [Poulsen, Frantz Rom; Halle, Bo] Odense Univ Hosp, Dept Neurosurg, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; Odense University Hospital	Gaist, D (corresponding author), Univ Southern Denmark, Odense Univ Hosp, Dept Neurol, Odense, Denmark.	dgaist@health.sdu.dk	Gaist, David/I-4397-2014	Gaist, David/0000-0001-5205-7007; Pottegard, Anton/0000-0001-9314-5679; Poulsen, Frantz Rom/0000-0001-5715-6901	Boehringer-Ingelheim; Bayer Pharma AG (Germany); Astra Zeneca (Sweden)	Boehringer-Ingelheim(Boehringer Ingelheim); Bayer Pharma AG (Germany); Astra Zeneca (Sweden)(AstraZeneca)	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Gaist reported receiving honoraria from AstraZeneca (Sweden) for participation as a coinvestigator on a research project. Dr Garcia Rodriguez reported receiving institutional research grants from Bayer Pharma AG (Germany) and Astra Zeneca (Sweden); and serving as on an advisory board for Bayer Pharma AG. Dr Hellfritzsch reported receiving speaker honorarium from Bristol-Myers Squibb and Pfizer outside the submitted work. Dr Pottegard reported receiving institutional research grants from Boehringer-Ingelheim. No other disclosures were reported.	Adelborg K, 2016, HEART, V102, P1883, DOI 10.1136/heartjnl-2016-309402; Adhiyaman V, 2002, POSTGRAD MED J, V78, P71, DOI 10.1136/pmj.78.916.71; Baechli H, 2004, NEUROSURG REV, V27, P263, DOI 10.1007/s10143-004-0337-6; Balser D, 2015, J NEUROSURG, V123, P1209, DOI 10.3171/2014.9.JNS141550; BARRITT DW, 1960, LANCET, V1, P1309; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Connolly BJ, 2014, STROKE, V45, P1672, DOI 10.1161/STROKEAHA.114.005430; Connolly BJ, 2013, J STROKE CEREBROVASC, V22, P444, DOI 10.1016/j.jstrokecerebrovasdis.2013.01.007; De Bonis P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068732; Fang MC, 2007, AM J MED, V120, P700, DOI 10.1016/j.amjmed.2006.07.034; Gaist D, 1997, DAN MED BULL, V44, P445; Hallas J, 2006, BMJ-BRIT MED J, V333, P726, DOI 10.1136/bmj.38947.697558.AE; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hart RG, 2012, STROKE, V43, P1511, DOI 10.1161/STROKEAHA.112.650614; HYLEK EM, 1994, ANN INTERN MED, V120, P897, DOI 10.7326/0003-4819-120-11-199406010-00001; Jensen VM, 2011, SCAND J PUBLIC HEALT, V39, P91, DOI 10.1177/1403494810394715; Larsen TB, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3189; Lindvall P, 2009, J CLIN NEUROSCI, V16, P1287, DOI 10.1016/j.jocn.2009.01.001; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pedersen K, 2015, NEUROEPIDEMIOLOGY, V45, P20, DOI 10.1159/000381780; Poulsen FR, 2016, PHARMACOEPIDEM DR S, V25, P1253, DOI 10.1002/pds.4058; REYMOND MA, 1992, NEUROSURG REV, V15, P21, DOI 10.1007/BF02352062; ROTHMAN KJ, 2008, EPIDEMIOLOGY; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Rust T, 2006, J CLIN NEUROSCI, V13, P823, DOI 10.1016/j.jocn.2004.12.013; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P12, DOI 10.1177/1403494811399956	27	78	78	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2017	317	8					836	846		10.1001/jama.2017.0639	http://dx.doi.org/10.1001/jama.2017.0639			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM7PW	28245322	Green Published			2022-12-28	WOS:000395505600021
J	McCoy, RC; Wakefield, J; Akey, JM				McCoy, Rajiv C.; Wakefield, Jon; Akey, Joshua M.			Impacts of Neanderthal-Introgressed Sequences on the Landscape of Human Gene Expression	CELL			English	Article							ALLELE-SPECIFIC EXPRESSION; GENOME-WIDE PATTERNS; FALSE DISCOVERY RATE; RAPID EVOLUTION; NTRK2; ASSOCIATION; IDENTIFICATION; CEREBELLUM; HAPLOTYPES; ADMIXTURE	Regulatory variation influencing gene expression is a key contributor to phenotypic diversity, both within and between species. Unfortunately, RNA degrades too rapidly to be recovered from fossil remains, limiting functional genomic insights about our extinct hominin relatives. Many Neanderthal sequences survive in modern humans due to ancient hybridization, providing an opportunity to assess their contributions to transcriptional variation and to test hypotheses about regulatory evolution. We developed a flexible Bayesian statistical approach to quantify allele-specific expression (ASE) in complex RNA-seq datasets. We identified widespread expression differences between Neanderthal and modern human alleles, indicating pervasive cisregulatory impacts of introgression. Brain regions and testes exhibited significant downregulation of Neanderthal alleles relative to other tissues, consistent with natural selection influencing the tissue-specific regulatory landscape. Our study demonstrates that Neanderthal-inherited sequences are not silent remnants of ancient interbreeding but have measurable impacts on gene expression that contribute to variation in modern human phenotypes.	[McCoy, Rajiv C.; Akey, Joshua M.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Wakefield, Jon] Univ Washington, Dept Stat, Seattle, WA 98195 USA; [Wakefield, Jon] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Akey, JM (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	akeyj@uw.edu	McCoy, Rajiv/AEW-9951-2022	McCoy, Rajiv/0000-0003-0615-146X; Akey, Joshua/0000-0002-4411-1330	NIH/NHGRI [5T32HG000035-22]; NIH [R01GM110068]; Common Fund of the Office of the Director of the NIH; NCI; NHGRI; NHLBI; NIDA; NIMH; NINDS; NCI\SAIC-Frederick (SAIC-F) [10XS170]; Roswell Park Cancer Institute [10XS171]; Science Care [X10S172]; Broad Institute [HHSN268201000029C]; Van Andel Institute [10ST1035]; SAIC-F [HHSN261200800001E]; University of Miami [DA006227, DA033684]; Glenview Capital;  [N01MH000028]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076036, R01GM110068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101782, R01MH090951, R01MH101814, R01MH101820, R01MH090948, R01MH101822, R01MH090941, R01MH101825, R01MH101810, R01MH101819, R01MH090937, R01MH090936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA006227, R01DA033684] Funding Source: NIH RePORTER	NIH/NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Common Fund of the Office of the Director of the NIH; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI\SAIC-Frederick (SAIC-F); Roswell Park Cancer Institute; Science Care; Broad Institute; Van Andel Institute; SAIC-F; University of Miami; Glenview Capital; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Joshua Schraiber for assistance estimating the proportions of mutations arising pre-and post-introgression. Thank you to Timothy Sullivan, Stephane Castel, Tuuli Lappalainen, and the GTEx Laboratory, Data Analysis, and Coordinating Center (LDACC). Thanks also to Thomas Montine, Benjamin Vernot, and members of the Akey lab for helpful feedback. R.C.M. is supported by NIH/NHGRI training grant 5T32HG000035-22 to the University of Washington. This work is also partially supported by NIH grant R01GM110068 to J.M.A. The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the NIH. Additional funds were provided by the NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS. Donors were enrolled at Biospecimen Source Sites funded by NCI\SAIC-Frederick (SAIC-F) subcontracts to the National Disease Research Interchange (10XS170), Roswell Park Cancer Institute (10XS171), and Science Care (X10S172). The LDACC was funded through a contract (HHSN268201000029C) to The Broad Institute. Biorepository operations were funded through an SAIC-F subcontract to Van Andel Institute (10ST1035). Additional data repository and project management were provided by SAIC-F (HHSN261200800001E). The Brain Bank was supported by supplements to University of Miami grants DA006227 and DA033684 and to contract N01MH000028. Statistical Methods development grants were made to the University of Geneva (MH090941 and MH101814), the University of Chicago (MH090951, MH090937, MH101820, MH101825), the University of North Carolina-Chapel Hill (MH090936 and MH101819), Harvard University (MH090948), Stanford University (MH101782), Washington University St. Louis (MH101810), and the University of Pennsylvania (MH101822). J.M.A. is a paid consultant of Glenview Capital.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alonso P, 2008, BIOL PSYCHIAT, V63, P619, DOI 10.1016/j.biopsych.2007.06.020; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Barton RA, 2014, CURR BIOL, V24, P2440, DOI 10.1016/j.cub.2014.08.056; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beck T, 2014, EUR J HUM GENET, V22, P949, DOI 10.1038/ejhg.2013.274; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beuten J, 2007, BIOL PSYCHIAT, V61, P48, DOI 10.1016/j.biopsych.2006.02.023; Blasius AL, 2010, P NATL ACAD SCI USA, V107, P19973, DOI 10.1073/pnas.1014051107; Booth JR, 2007, BRAIN RES, V1133, P136, DOI 10.1016/j.brainres.2006.11.074; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; Capra JA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0025; Chen ZM, 2008, AM J MED GENET B, V147B, P363, DOI 10.1002/ajmg.b.30607; Correia CT, 2010, GENES BRAIN BEHAV, V9, P841, DOI 10.1111/j.1601-183X.2010.00627.x; Costello J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0559-z; Currat M, 2011, P NATL ACAD SCI USA, V108, P15129, DOI 10.1073/pnas.1107450108; Dannemann M, 2016, AM J HUM GENET, V98, P22, DOI 10.1016/j.ajhg.2015.11.015; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; Deschamps M, 2016, AM J HUM GENET, V98, P5, DOI 10.1016/j.ajhg.2015.11.014; Ferguson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061575; Fu WQ, 2014, AM J HUM GENET, V95, P421, DOI 10.1016/j.ajhg.2014.09.006; Gelman A, 2014, STAT COMPUT, V24, P997, DOI 10.1007/s11222-013-9416-2; Gilad Y, 2006, NATURE, V440, P242, DOI 10.1038/nature04559; Gittelman RM, 2016, CURR BIOL, V26, P3375, DOI 10.1016/j.cub.2016.10.041; Gittelman RM, 2015, GENOME RES, V25, P1245, DOI 10.1101/gr.192591.115; Gray J, 2007, INT J OBESITY, V31, P359, DOI 10.1038/sj.ijo.0803390; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Guerrero RF, 2016, EVOLUTION, V70, P696, DOI 10.1111/evo.12875; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Harris K, 2016, GENETICS, V203, P881, DOI 10.1534/genetics.116.186890; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hublin JJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0062; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Juhasz G, 2011, BIOL PSYCHIAT, V69, P762, DOI 10.1016/j.biopsych.2010.11.019; Juric I, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006340; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kohli MA, 2010, ARCH GEN PSYCHIAT, V67, P348, DOI 10.1001/archgenpsychiatry.2009.201; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Landry CR, 2005, GENETICS, V171, P1813, DOI 10.1534/genetics.105.047449; Li MD, 2008, BIOL PSYCHIAT, V64, P951, DOI 10.1016/j.biopsych.2008.04.026; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mack KL, 2017, TRENDS GENET, V33, P68, DOI 10.1016/j.tig.2016.11.003; Marien P, 2014, CEREBELLUM, V13, P386, DOI 10.1007/s12311-013-0540-5; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Michalak P, 2003, MOL BIOL EVOL, V20, P1070, DOI 10.1093/molbev/msg119; Murphy TM, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-22; Nakagawara A, 2001, CANCER LETT, V169, P107, DOI 10.1016/S0304-3835(01)00530-4; Nedelec Y, 2016, CELL, V167, P657, DOI 10.1016/j.cell.2016.09.025; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; O'Carroll AM, 2013, J ENDOCRINOL, V219, pR13, DOI 10.1530/JOE-13-0227; Panousis NI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0467-2; Pearce E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0168; Peyregne S., 2016, BIORXIV; Pirinen M, 2015, BIOINFORMATICS, V31, P2497, DOI 10.1093/bioinformatics/btv074; Plagnol V, 2006, PLOS GENET, V2, P972, DOI 10.1371/journal.pgen.0020105; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Quach H, 2016, CELL, V167, P643, DOI 10.1016/j.cell.2016.09.024; R Development Core Team, 2009, R LANG ENV STAT COMP; Ribases M, 2005, MOL PSYCHIATR, V10, P851, DOI 10.1038/sj.mp.4001670; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Sankararaman S, 2016, CURR BIOL, V26, P1241, DOI 10.1016/j.cub.2016.03.037; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Sekhon JS, 2011, J STAT SOFTW, V42, P1; Simonti CN, 2016, SCIENCE, V351, P737, DOI 10.1126/science.aad2149; Skelly DA, 2009, ANNU REV GENOM HUM G, V10, P313, DOI 10.1146/annurev-genom-082908-150121; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Turner LM, 2014, ELIFE, V3, DOI 10.7554/eLife.02504; van de Geijn B, 2015, NAT METHODS, V12, P1061, DOI [10.1038/NMETH.3582, 10.1038/nmeth.3582]; Vernot B, 2016, SCIENCE, V352, P235, DOI 10.1126/science.aad9416; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; Watanabe S, 2010, J MACH LEARN RES, V11, P3571; Welter Danielle, 2014, Nucleic Acids Res, V42, pD1001, DOI 10.1093/nar/gkt1229; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336; Yu XH, 2014, CLIN CHIM ACTA, V428, P1, DOI 10.1016/j.cca.2013.09.001	87	73	74	3	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2017	168	5					916	+		10.1016/j.cell.2017.01.038	http://dx.doi.org/10.1016/j.cell.2017.01.038			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8YB	28235201	Green Accepted, Bronze			2022-12-28	WOS:000396284800019
J	Saunders, P				Saunders, Philippa			Supporting researchers in an era of team science	LANCET			English	Editorial Material									[Saunders, Philippa] Acad Med Sci, London W1B 1QH, England; [Saunders, Philippa] Univ Edinburgh, Edinburgh EH16 4TJ, Midlothian, Scotland	University of Edinburgh	Saunders, P (corresponding author), Acad Med Sci, London W1B 1QH, England.; Saunders, P (corresponding author), Univ Edinburgh, Edinburgh EH16 4TJ, Midlothian, Scotland.	p.saunders@ed.ac.uk	Saunders, Philippa TK/C-7489-2013	Saunders, Philippa TK/0000-0001-9051-9380	MRC [MR/N024524/1] Funding Source: UKRI; Medical Research Council [MR/N024524/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))			0	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2017	389			1			10	12		10.1016/S0140-6736(17)30202-7	http://dx.doi.org/10.1016/S0140-6736(17)30202-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO1AX	28236833	Bronze			2022-12-28	WOS:000396431100004
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Why I'm changing my mind about resuscitation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Brazier M, 2011, MED PATIENTS LAW; Etheridge Z, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2640; Masters K, 2016, BMJ; Masters K, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1084; NHS End of Life Care Programme, 2012, DNACPR DEC WHO DEC; Oliver D, 2015, HLTH SERV J; Oliver D, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1494; Oliver D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4846; Poole N, 2015, LEARNED FRIEND B MAR; Resuscitation Council (UK), 2016, RESPECT PROGR UPD; Smith J, 2016, BRIT GER SOC SPRING, P47; Sokol DK, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i26	12	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2017	356								j1143	10.1136/bmj.j1143	http://dx.doi.org/10.1136/bmj.j1143			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BP	28270417	Bronze, Green Published			2022-12-28	WOS:000396432900001
J	Lin, HX; Lee, SM; Sun, L; Spellings, M; Engel, M; Glotzer, SC; Mirkin, CA				Lin, Haixin; Lee, Sangmin; Sun, Lin; Spellings, Matthew; Engel, Michael; Glotzer, Sharon C.; Mirkin, Chad A.			Clathrate colloidal crystals	SCIENCE			English	Article							NANOPARTICLE SUPERLATTICES; COMPLEX STRUCTURES; BUILDING-BLOCKS; DNA; NUCLEATION; DESIGN; GROWTH	DNA-programmable assembly has been used to deliberately synthesize hundreds of different colloidal crystals spanning dozens of symmetries, but the complexity of the achieved structures has so far been limited to small unit cells. We assembled DNA-modified triangular bipyramids (similar to 250-nanometer long edge, 177-nanometer short edge) into clathrate architectures. Electron microscopy images revealed that at least three different structures form as large single-domain architectures or as multidomain materials. Ordered assemblies, isostructural to clathrates, were identified with the help of molecular simulations and geometric analysis. These structures are the most sophisticated architectures made via programmable assembly, and their formation can be understood based on the shape of the nanoparticle building blocks and mode of DNA functionalization.	[Lin, Haixin; Mirkin, Chad A.] Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA; [Lin, Haixin; Sun, Lin; Mirkin, Chad A.] Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA; [Lee, Sangmin; Spellings, Matthew; Glotzer, Sharon C.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Sun, Lin; Mirkin, Chad A.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Engel, Michael] Univ Erlangen Nurnberg, Inst Multiscale Simulat, D-91058 Erlangen, Germany; [Glotzer, Sharon C.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA; [Glotzer, Sharon C.] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA	Northwestern University; Northwestern University; University of Michigan System; University of Michigan; Northwestern University; University of Erlangen Nuremberg; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.; Mirkin, CA (corresponding author), Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA.; Glotzer, SC (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.; Mirkin, CA (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.; Glotzer, SC (corresponding author), Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.; Glotzer, SC (corresponding author), Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA.	sglotzer@umich.edu; chadnano@northwestern.edu	Engel, Michael/G-1778-2010; Lin, Haixin/C-4097-2017; Mirkin, Chad A/E-3911-2010	Engel, Michael/0000-0002-7031-3825; Lin, Haixin/0000-0003-4650-0062; Lee, Sangmin/0000-0002-1145-4708; Mirkin, Chad/0000-0002-6634-7627	Center for Bio-Inspired Energy Science, an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Basic Energy Sciences [DE-SC0000989]; Air Force Office of Scientific Research [FA9550-11-1-0275, FA9550-12-1-0280]; China Scholarship Council (CSC) [201306310060]; Deutsche Forschungsgemeinschaft through the Cluster of Excellence Engineering of Advanced Materials; Interdisciplinary Center for Functional Particle Systems (FPS) and Central Institute for Scientific Computing (ZISC); University of Michigan; Simons Foundation; Materials Research Science and Engineering Center program [NSF DMR-1121262]; International Institute for Nanotechnology (IIN); State of Illinois, through the IIN	Center for Bio-Inspired Energy Science, an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); China Scholarship Council (CSC)(China Scholarship Council); Deutsche Forschungsgemeinschaft through the Cluster of Excellence Engineering of Advanced Materials(German Research Foundation (DFG)); Interdisciplinary Center for Functional Particle Systems (FPS) and Central Institute for Scientific Computing (ZISC); University of Michigan(University of Michigan System); Simons Foundation; Materials Research Science and Engineering Center program; International Institute for Nanotechnology (IIN); State of Illinois, through the IIN	This work was supported as part of the Center for Bio-Inspired Energy Science, an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Basic Energy Sciences under award DE-SC0000989. C.A.M. additionally acknowledges support from the Air Force Office of Scientific Research awards FA9550-11-1-0275 and FA9550-12-1-0280. H.L. is grateful to a scholarship from the China Scholarship Council (CSC) under Grant CSC no. 201306310060. M.E. acknowledges funding by Deutsche Forschungsgemeinschaft through the Cluster of Excellence Engineering of Advanced Materials and support from the Interdisciplinary Center for Functional Particle Systems (FPS) and Central Institute for Scientific Computing (ZISC). M.S. acknowledges support from the University of Michigan Rackham Predoctoral Fellowship Program. S.C.G. was partially supported by a Simons Investigator award from the Simons Foundation. Computational resources and services were supported by Advanced Research Computing at the University of Michigan, Ann Arbor. This work made use of the Electron Probe Instrumentation Center (EPIC) facility [Northwestern University's Atomic and Nanoscale Characterization Experimental Center (NUANCE)], which has received support from the Materials Research Science and Engineering Center program (NSF DMR-1121262) at the Materials Research Center, the International Institute for Nanotechnology (IIN), and the State of Illinois, through the IIN. All results are reported in the main paper and supplementary materials. H.L. synthesized, functionalized, and assembled the particles; H.L. and L.S. synthesized and purified the DNA; H.L. collected ultraviolet-visible data; H.L. and L.S. collected EM data; S.L., M.S., M.E., and S.C.G. developed the simulation model; S.L. and M.S. implemented the model in the DEM module of HOOMD-Blue; S.L. performed the simulations; S.L., M.E., and S.C.G. analyzed and discussed the simulation data; S.L. and M.E. performed the structural identification analysis on the simulation data and on the TEM images supplied by H.L.; H.L., S.L., M.E., S.C.G., and C.A.M. wrote the paper; M.E., S.C.G., and C.A.M. supervised the research; C.A.M. is the developer of the concept of programmable colloidal crystallization and the concept of controlled valency through anisotropic particle functionalization with nucleic acids that led to the formation of the observed clathrate structures. The authors declare no competing financial interests.	ADAMS GB, 1994, PHYS REV B, V49, P8048, DOI 10.1103/PhysRevB.49.8048; Angioletti-Uberti S, 2012, NAT MATER, V11, P518, DOI [10.1038/NMAT3314, 10.1038/nmat3314]; Casey MT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2206; CLAUSSEN WF, 1951, J CHEM PHYS, V19, P259, DOI 10.1063/1.1748187; Damasceno PF, 2012, SCIENCE, V337, P453, DOI 10.1126/science.1220869; Engel M, 2015, NAT MATER, V14, P109, DOI [10.1038/nmat4152, 10.1038/NMAT4152]; Feng L, 2013, ADV MATER, V25, P2779, DOI 10.1002/adma.201204864; FRANK FC, 1958, ACTA CRYSTALLOGR, V11, P184, DOI 10.1107/S0365110X58000487; Grunwald M, 2014, ACS NANO, V8, P5891, DOI 10.1021/nn500978p; Guloy AM, 2006, NATURE, V443, P320, DOI 10.1038/nature05145; Jacobson LC, 2010, J AM CHEM SOC, V132, P11806, DOI 10.1021/ja1051445; Jones MR, 2010, NAT MATER, V9, P913, DOI [10.1038/NMAT2870, 10.1038/nmat2870]; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Knorowski C, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.215501; Liu WY, 2016, SCIENCE, V351, P582, DOI 10.1126/science.aad2080; Lu F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7912; Macfarlane RJ, 2013, ANGEW CHEM INT EDIT, V52, P5688, DOI 10.1002/anie.201209336; Macfarlane RJ, 2011, SCIENCE, V334, P204, DOI 10.1126/science.1210493; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Momma K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1196; O'Brien MN, 2014, J AM CHEM SOC, V136, P7603, DOI 10.1021/ja503509k; PAULING L, 1952, P NATL ACAD SCI USA, V38, P112, DOI 10.1073/pnas.38.2.112; Personick ML, 2011, J AM CHEM SOC, V133, P6170, DOI 10.1021/ja201826r; Rogers WB, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.8; Romano F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1968; Shevelkov AV, 2011, STRUCT BOND, V139, P97, DOI 10.1007/430_2010_25; Speranza C, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.012305; Walsh MR, 2009, SCIENCE, V326, P1095, DOI 10.1126/science.1174010; Wang YF, 2012, NATURE, V491, P51, DOI 10.1038/nature11564; Xia YN, 2009, ANGEW CHEM INT EDIT, V48, P60, DOI 10.1002/anie.200802248; Xing H, 2012, ACS NANO, V6, P802, DOI 10.1021/nn2042797	31	123	125	9	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					931	935		10.1126/science.aal3919	http://dx.doi.org/10.1126/science.aal3919			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2YM	28254936				2022-12-28	WOS:000395181700034
J	Sarafian, E; Gaetani, GA; Hauri, EH; Sarafian, AR				Sarafian, Emily; Gaetani, Glenn A.; Hauri, Erik H.; Sarafian, Adam R.			Experimental constraints on the damp peridotite solidus and oceanic mantle potential temperature	SCIENCE			English	Article							VOLATILE CONTENT; WATER; DIFFUSION; HYDROGEN; BENEATH; BASALT; MODEL; H2O	Decompression of hot mantle rock upwelling beneath oceanic spreading centers causes it to exceed the melting point (solidus), producing magmas that ascend to form basaltic crust similar to 6 to 7 kilometers thick. The oceanic upper mantle contains similar to 50 to 200 micrograms per gram of water (H2O) dissolved in nominally anhydrous minerals, which-relative to its low concentration-has a disproportionate effect on the solidus that has not been quantified experimentally. Here, we present results from an experimental determination of the peridotite solidus containing known amounts of dissolved hydrogen. Our data reveal that the H2O-undersaturated peridotite solidus is hotter than previously thought. Reconciling geophysical observations of the melting regime beneath the East Pacific Rise with our experimental results requires that existing estimates for the oceanic upper mantle potential temperature be adjusted upward by about 60 degrees C.	[Sarafian, Emily; Sarafian, Adam R.] MIT, Woods Hole Oceanog Inst Joint Program Oceanog App, Cambridge, MA 02139 USA; [Sarafian, Emily; Gaetani, Glenn A.; Sarafian, Adam R.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; [Hauri, Erik H.] Carnegie Inst Sci, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA	Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution; Carnegie Institution for Science	Sarafian, E (corresponding author), MIT, Woods Hole Oceanog Inst Joint Program Oceanog App, Cambridge, MA 02139 USA.; Sarafian, E (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA.	etursack@whoi.edu	Gaetani, Glenn/P-3870-2019	Gaetani, Glenn/0000-0002-6026-2534; Sarafian, Adam/0000-0002-5032-4383	National Science Foundation [OCE-1459649]; Woods Hole Oceanographic Institution Deep Ocean Exploration Institute; Carnegie Institution for Science; Deep Carbon Observatory	National Science Foundation(National Science Foundation (NSF)); Woods Hole Oceanographic Institution Deep Ocean Exploration Institute; Carnegie Institution for Science; Deep Carbon Observatory	Funding for this research was provided by the National Science Foundation, grant number OCE-1459649, and Woods Hole Oceanographic Institution Deep Ocean Exploration Institute. E.H.H. thanks the Carnegie Institution for Science and the Deep Carbon Observatory for support. We thank K. Key for use of the magnetotelluric data. We are grateful to three anonymous reviewers for providing constructive suggestions that improved the paper. The data reported in this study can be found in the supplementary materials. E.S. and G.A.G. initiated the project and designed the experiments. E.S. performed the experiments. E.S. and A.R.S. performed and E.H.H. oversaw the SIMS analyses. All authors contributed to developing the ideas and writing the manuscript.	Anderson D. L., 1970, PHYS EARTH PLANET IN, V4, P62, DOI [DOI 10.1016/0031-9201(70)90030-0, 10.1016/0031-9201(70)90030-0]; Asimow PD, 2003, NATURE, V421, P815, DOI 10.1038/nature01429; Aubaud C, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021341; BOYD FR, 1960, J GEOPHYS RES, V65, P741, DOI 10.1029/JZ065i002p00741; CANN JR, 1970, NATURE, V226, P928, DOI 10.1038/226928a0; Dalton CA, 2014, SCIENCE, V344, P80, DOI 10.1126/science.1249466; Demouchy S, 2006, PHYS CHEM MINER, V33, P347, DOI 10.1007/s00269-006-0081-2; Gaetani GA, 2014, CONTRIB MINERAL PETR, V167, DOI 10.1007/s00410-014-0965-y; Hauri EH, 2006, EARTH PLANET SC LETT, V248, P715, DOI 10.1016/j.epsl.2006.06.014; Hirschmann MM, 2009, PHYS EARTH PLANET IN, V176, P54, DOI 10.1016/j.pepi.2009.04.001; Hirschmann MM, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000070; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; Key K, 2013, NATURE, V495, P500, DOI 10.1038/nature11932; Kohlstedt DL, 1998, Z PHYS CHEM, V207, P147, DOI 10.1524/zpch.1998.207.Part_1_2.147; Lambart S, 2016, J GEOPHYS RES-SOL EA, V121, P5708, DOI 10.1002/2015JB012762; Langmuir C.H., 1992, MANTLE FLOW MELT GEN, V71, P183, DOI DOI 10.1029/GM071P0183; le Roux PJ, 2006, EARTH PLANET SC LETT, V251, P209, DOI 10.1016/j.epsl.2006.09.012; MCKENZIE D, 1988, J PETROL, V29, P625, DOI 10.1093/petrology/29.3.625; MICHAEL PJ, 1988, GEOCHIM COSMOCHIM AC, V52, P555, DOI 10.1016/0016-7037(88)90110-X; O'Leary JA, 2010, EARTH PLANET SC LETT, V297, P111, DOI 10.1016/j.epsl.2010.06.011; PLANK T, 1992, J GEOPHYS RES-SOL EA, V97, P19749, DOI 10.1029/92JB01769; Rudolph ML, 2015, SCIENCE, V350, P1349, DOI 10.1126/science.aad1929; Rychert CA, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004194; Saal AE, 2002, NATURE, V419, P451, DOI 10.1038/nature01073; Sarafian E, 2015, GEOCHEM GEOPHY GEOSY, V16, P1115, DOI 10.1002/2014GC005709; Searle R., 2013, MIDOCEAN RIDGES, P330; Shimizu K, 2016, GEOCHIM COSMOCHIM AC, V176, P44, DOI 10.1016/j.gca.2015.10.033	28	56	56	4	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					942	944		10.1126/science.aaj2165	http://dx.doi.org/10.1126/science.aaj2165			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2YM	28254939				2022-12-28	WOS:000395181700037
J	Spahn, V; Del Vecchio, G; Labuz, D; Rodriguez-Gaztelumendi, A; Massaly, N; Temp, J; Durmaz, V; Sabri, P; Reidelbach, M; Machelska, H; Weber, M; Stein, C				Spahn, V.; Del Vecchio, G.; Labuz, D.; Rodriguez-Gaztelumendi, A.; Massaly, N.; Temp, J.; Durmaz, V.; Sabri, P.; Reidelbach, M.; Machelska, H.; Weber, M.; Stein, C.			A nontoxic pain killer designed by modeling of pathological receptor conformations	SCIENCE			English	Article							MU-OPIOID RECEPTOR; MORPHINE; FENTANYL; INSIGHTS	Indiscriminate activation of opioid receptors provides pain relief but also severe central and intestinal side effects. We hypothesized that exploiting pathological ( rather than physiological) conformation dynamics of opioid receptor-ligand interactions might yield ligands without adverse actions. By computer simulations at low pH, a hallmark of injured tissue, we designed an agonist that, because of its low acid dissociation constant, selectively activates peripheral mu-opioid receptors at the source of pain generation. Unlike the conventional opioid fentanyl, this agonist showed pH-sensitive binding, heterotrimeric guanine nucleotide-binding protein (G protein) subunit dissociation by fluorescence resonance energy transfer, and adenosine 3',5'-monophosphate inhibition in vitro. It produced injury-restricted analgesia in rats with different types of inflammatory pain without exhibiting respiratory depression, sedation, constipation, or addiction potential.	[Spahn, V.; Del Vecchio, G.; Labuz, D.; Rodriguez-Gaztelumendi, A.; Massaly, N.; Temp, J.; Machelska, H.; Stein, C.] Charite, Free Univ Berlin, Dept Anesthesiol & Crit Care Med, Campus Benjamin Franklin,Hindenburgdamm 30, D-12203 Berlin, Germany; [Durmaz, V.; Sabri, P.; Reidelbach, M.; Weber, M.] Zuse Inst Berlin, Computat Mol Design, Takustr 7, D-14195 Berlin, Germany; [Massaly, N.] Washington Univ, Sch Med, Pain Ctr, Dept Anesthesiol, St Louis, MO 63110 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Zuse Institute Berlin; Washington University (WUSTL)	Stein, C (corresponding author), Charite, Free Univ Berlin, Dept Anesthesiol & Crit Care Med, Campus Benjamin Franklin,Hindenburgdamm 30, D-12203 Berlin, Germany.	christoph.stein@charite.de	Del Vecchio, Giovanna/H-6512-2019	Del Vecchio, Giovanna/0000-0002-2726-2014; Seitz (nee Spahn), Viola/0000-0002-8086-8090; Durmaz, Vedat/0000-0002-1633-4190; Machelska, Halina/0000-0001-6315-2958; Stein, Christoph/0000-0001-5240-6836	Bundesministerium fur Bildung und Forschung [VIP 0272/03V0364]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by Bundesministerium fur Bildung und Forschung (VIP 0272/03V0364). We thank H. Schick and C. Wedler (ASCA GmbH) for continuous consulting, N. Vogel for technical assistance, M. Adjobo-Hermans for helpful advice and for donating the Venus-G gamma<INF>2</INF> construct, O. Perepelica for initial computational simulations, P. Deuflhard and C. Zollner for stimulating discussions, and B. Kieffer for critical comments on the manuscript. The Charite-Universitatsmedizin Berlin and the Zuse Institute Berlin have filed a patent on pH-dependent opioid receptor agonists (US 9133120 B2). A patent application on the computational methods (PCT/EP2013/102681) is pending. All data can be accessed at www.zib.de/ext-data/selective-opioids/.	Baron R, 2013, ANN NEUROL, V74, P630, DOI 10.1002/ana.24017; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; BROWN DR, 1985, NEUROPHARMACOLOGY, V24, P181, DOI 10.1016/0028-3908(85)90072-3; Califf RM, 2016, NEW ENGL J MED, V374, P1480, DOI 10.1056/NEJMsr1601307; Canestrelli C, 2014, INT J NEUROPSYCHOPH, V17, P1367, DOI 10.1017/S146114571400025X; CHILDERS SR, 1988, J NEUROCHEM, V50, P543, DOI 10.1111/j.1471-4159.1988.tb02945.x; Deschamps JR, 2002, BIOPOLYMERS, V66, P287, DOI 10.1002/bip.10308; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; Dosen-Micovic L, 2006, BIOORGAN MED CHEM, V14, P2887, DOI 10.1016/j.bmc.2005.12.010; Dzau VJ, 2014, JAMA-J AM MED ASSOC, V312, P1507, DOI 10.1001/jama.2014.12986; Filizola M, 2001, J COMPUT AID MOL DES, V15, P297, DOI 10.1023/A:1011187320095; Gaveriaux-Ruff C, 2011, PAIN, V152, P1238, DOI 10.1016/j.pain.2010.12.031; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Holzer Peter, 2009, Handb Exp Pharmacol, P283, DOI 10.1007/978-3-540-79090-7_9; Huang WJ, 2015, NATURE, V524, P315, DOI 10.1038/nature14886; Jagla C, 2014, PAIN, V155, P2056, DOI 10.1016/j.pain.2014.07.011; Karimi S, 2011, IRAN J PHARM RES, V10, P605; Li JG, 1999, LIFE SCI, V65, P175, DOI 10.1016/S0024-3205(99)00234-9; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Pogozheva ID, 2005, AAPS J, V7; Richards N, 2013, BRIT J ANAESTH, V111, P46, DOI 10.1093/bja/aet216; ROY SD, 1989, PHARMACEUT RES, V6, P147, DOI 10.1023/A:1015932610010; Sawynok J, 2014, EUR J PHARMACOL, V734, P114, DOI 10.1016/j.ejphar.2014.04.006; Schumacher MA, 2009, BASIC CLIN PHARM, P531; Sounier R, 2015, NATURE, V524, P375, DOI 10.1038/nature14680; Stein C, 2016, ANNU REV MED, V67, P433, DOI 10.1146/annurev-med-062613-093100; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Thurlkill RL, 2005, J CARDIOTHOR VASC AN, V19, P759, DOI 10.1053/j.jvca.2004.11.039; Viscusi ER, 2016, PAIN, V157, P264, DOI 10.1097/j.pain.0000000000000363; Weibel R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074706; Ye LB, 2016, NATURE, V533, P265, DOI 10.1038/nature17668	32	126	128	5	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					966	+		10.1126/science.aai8636	http://dx.doi.org/10.1126/science.aai8636			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2YM	28254944				2022-12-28	WOS:000395181700043
J	Sinha, G				Sinha, Gunjan			STATELESS SCIENTISTS	NATURE			English	News Item																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2017	543	7643					24	27		10.1038/543024a	http://dx.doi.org/10.1038/543024a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0AA	28252085	Bronze			2022-12-28	WOS:000395671500013
J	Sackeim, MG				Sackeim, Maryl Goldberg			Eradicating a Genetic Mutation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sackeim, Maryl Goldberg] Hosp Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Sackeim, MG (corresponding author), Hosp Univ Penn, Philadelphia, PA 19104 USA.	maryl.goldberg@gmail.com		Sackeim, Maryl/0000-0002-3988-8161					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2017	317	8					809	809		10.1001/jama.2016.15136	http://dx.doi.org/10.1001/jama.2016.15136			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM7PW	28245326				2022-12-28	WOS:000395505600016
J	Hinman, RS; Paterson, KL; Wrigley, TV; Bennell, KL				Hinman, Rana S.; Paterson, Kade L.; Wrigley, Tim V.; Bennell, Kim L.			Unloading Shoes for Self-management of Knee Osteoarthritis RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter							FOOTWEAR; PEOPLE		[Hinman, Rana S.; Paterson, Kade L.; Wrigley, Tim V.; Bennell, Kim L.] Univ Melbourne, Melbourne, Vic, Australia	University of Melbourne	Hinman, RS (corresponding author), Univ Melbourne, Melbourne, Vic, Australia.		Paterson, Kade L/G-4715-2012; Bennell, Kim/C-7022-2014	Paterson, Kade L/0000-0002-0323-6129; Hinman, Rana/0000-0001-6368-9456; Bennell, Kim/0000-0003-4982-5639				Menz HB, 2015, J GERONTOL A-BIOL, V70, P511, DOI 10.1093/gerona/glu169; Paterson KL, 2017, OSTEOARTHR CARTILAGE, V25, P234, DOI 10.1016/j.joca.2016.10.001; Paterson KL, 2014, J FOOT ANKLE RES, V7, DOI 10.1186/s13047-014-0043-8; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	4	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2017	166	4					312	312		10.7326/L16-0630	http://dx.doi.org/10.7326/L16-0630			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7FO	28241298				2022-12-28	WOS:000394786700029
J	Voelker, R				Voelker, Rebecca			Scientists Receive Award for Meningitis Vaccine Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2017	317	7					688	688		10.1001/jama.2017.0839	http://dx.doi.org/10.1001/jama.2017.0839			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8WR	28241340				2022-12-28	WOS:000394901600009
J	Moreno, JD				Moreno, Jonathan D.			Human Gene Editing: Where Does the 2017 National Academy of Sciences Report Bring Us?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RECOMBINANT DNA-MOLECULES		[Moreno, Jonathan D.] Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Moreno, JD (corresponding author), Univ Penn, Dept Med Eth & Hlth Policy, Blockley Hall,14th Floor, Philadelphia, PA 19104 USA.	morenojd@mail.med.upenn.edu						Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; BERG P, 1975, P NATL ACAD SCI USA, V72, P1981, DOI 10.1073/pnas.72.6.1981; BERG P, 1974, SCIENCE, V185, P303, DOI 10.1126/science.185.4148.303; BERG P, 1995, P NATL ACAD SCI USA, V92, P9011, DOI 10.1073/pnas.92.20.9011; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; JACKSON DA, 1972, P NATL ACAD SCI USA, V69, P2904, DOI 10.1073/pnas.69.10.2904; National Academies of Sciences Engineering and Medicine, 2017, HUMAN GENOME EDITING, DOI [10.17226/24623, DOI 10.17226/24623]; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1982, SPLICING LIFE REPORT; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1982, SPLIC LIF REP SOC ET, P72	9	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 2	2017	166	9					667	+		10.7326/M17-0457	http://dx.doi.org/10.7326/M17-0457			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6IR	28241205				2022-12-28	WOS:000400395500013
J	Sommers, BD; Naylor, CD				Sommers, Benjamin D.; Naylor, C. David			Medicaid Block Grants and Federalism Lessons From Canada	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sommers, Benjamin D.] Harvard Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave,Kresge 406, Boston, MA 02115 USA; [Sommers, Benjamin D.] Brigham & Womens Hosp, Div Gen Med & Primary Care, 75 Francis St, Boston, MA 02115 USA; [Naylor, C. David] Univ Toronto, Dept Med, Toronto, ON, Canada; [Naylor, C. David] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; University of Toronto; University of Toronto	Sommers, BD (corresponding author), Harvard Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave,Kresge 406, Boston, MA 02115 USA.	bsommers@hsph.harvard.edu						Chatterjee P, JAMA FORUM EC MEDICA; Mahan D., 2017, HOUSE REPUBLICANS HL; Marchildon G, 2004, ROMANOW PAPERS FISCA, P320; Ryan P., 2016, BETTERWAY HLTH CARE; Sommers BD, 2017, NEW ENGL J MED, V376, DOI 10.1056/NEJMp1700156; TAYLOR MG, 1978, HLTH INSURANCE CANAD	6	4	4	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2017	317	16					1619	1620		10.1001/jama.2017.1952	http://dx.doi.org/10.1001/jama.2017.1952			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET1FW	28278320				2022-12-28	WOS:000400014000007
J	Liao, JM; Stack, CB				Liao, Joshua M.; Stack, Catharine B.			Annals Understanding Clinical Research: Implications of Missing Data Due to Dropout	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PREVENTION		[Liao, Joshua M.] Univ Penn, Dept Med, 3400 Spruce St, Philadelphia, PA 19104 USA; [Stack, Catharine B.] Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA	University of Pennsylvania; American College of Physicians	Liao, JM (corresponding author), Univ Penn, Dept Med, 3400 Spruce St, Philadelphia, PA 19104 USA.							Bell ML, 2014, STAT METHODS MED RES, V23, P440, DOI 10.1177/0962280213476378; Bronfort G, 2014, ANN INTERN MED, V161, P381, DOI 10.7326/M14-0006; Carpenter J. R., 2008, USITC PUBL, VRM03/JH17/MK; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Mallinckrodt C, 2014, THER INNOV REGUL SCI, V48, P68, DOI 10.1177/2168479013501310; Molenberghs G., 2007, MISSING DATA CLIN ST; National Research Council, 2010, PREVENTION TREATMENT; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	8	17	18	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 18	2017	166	8					596	+		10.7326/M17-0195	http://dx.doi.org/10.7326/M17-0195			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ES1RF	28241264				2022-12-28	WOS:000399304000022
J	Stephenson, AL; Sykes, J; Stanojevic, S; Quon, BS; Marshall, BC; Petren, K; Ostrenga, J; Fink, AK; Elbert, A; Goss, CH				Stephenson, Anne L.; Sykes, Jenna; Stanojevic, Sanja; Quon, Bradley S.; Marshall, Bruce C.; Petren, Kristofer; Ostrenga, Josh; Fink, Aliza K.; Elbert, Alexander; Goss, Christopher H.			Survival Comparison of Patients With Cystic Fibrosis in Canada and the United States A Population-Based Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							LUNG ALLOCATION SCORE; SOCIOECONOMIC-STATUS; TRANSPLANTATION; OUTCOMES; IMPACT; ASSOCIATION; DIAGNOSIS; REGISTRY; ADULTS; DEATH	Background: In 2011, the median age of survival of patients with cystic fibrosis reported in the United States was 36.8 years, compared with 48.5 years in Canada. Direct comparison of survival estimates between national registries is challenging because of inherent differences in methodologies used, data processing techniques, and ascertainment bias. Objective: To use a standardized approach to calculate cystic fibrosis survival estimates and to explore differences between Canada and the United States. Design: Population-based study. Setting: 42 Canadian cystic fibrosis clinics and 110 U.S. cystic fibrosis care centers. Patients: Patients followed in the Canadian Cystic Fibrosis Registry (CCFR) and U.S. Cystic Fibrosis Foundation Patient Registry (CFFPR) between 1990 and 2013. Measurements: Cox proportional hazards models were used to compare survival between patients followed in the CCFR (n = 5941) and those in the CFFPR (n = 45 448). Multivariable models were used to adjust for factors known to be associated with survival. Results: Median age of survival in patients with cystic fibrosis increased in both countries between 1990 and 2013; however, in 1995 and 2005, survival in Canada increased at a faster rate than in the United States (P < 0.001). On the basis of contemporary data from 2009 to 2013, the median age of survival in Canada was 10 years greater than in the United States (50.9 vs. 40.6 years, respectively). The adjusted risk for death was 34% lower in Canada than the United States (hazard ratio, 0.66 [95% Cl, 0.54 to 0.81]). A greater proportion of patients in Canada received transplants (10.3% vs. 6.5%, respectively [standardized difference, 13.7]). Differences in survival between U.S. and Canadian patients varied according to U.S. patients' insurance status. Limitation: Ascertainment bias due to missing data or non-random loss to follow-up might affect the results. Conclusion: Differences in cystic fibrosis survival between Canada and the United States persisted after adjustment for risk factors associated with survival, except for private-insurance status among U.S. patients. Differential access to transplantation, increased posttransplant survival, and differences in health care systems may, in part, explain the Canadian survival advantage.	Univ Toronto, St Michaels Hosp, Toronto, ON, Canada; Hosp Sick Children, Toronto, ON, Canada; [Quon, Bradley S.] Univ British Columbia, Ctr Heart Lung Innovat, Dept Med, 166-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada; [Marshall, Bruce C.; Petren, Kristofer; Ostrenga, Josh; Fink, Aliza K.; Elbert, Alexander] Cyst Fibrosis Fdn, 6931 Arlington Rd, Bethesda, MD 20814 USA; [Goss, Christopher H.] Univ Washington, Med Ctr, Div Pulm & Crit Care Med, Dept Med & Pediat, 1959 Northeast Pacific St, Seattle, WA 98195 USA; [Stephenson, Anne L.; Sykes, Jenna] St Michaels Hosp, 30 Bond St,6th Floor,Bond Wing, Toronto, ON M5B 1W8, Canada; [Stanojevic, Sanja] Univ Toronto, Inst Hlth Policy Management & Evaluat, 155 Coll St, Toronto, ON M5T 3M6, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of British Columbia; Cystic Fibrosis Foundation; University of Washington; University of Washington Seattle; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Stephenson, AL (corresponding author), St Michaels Hosp, 30 Bond St,6th Floor,Bond Wing, Toronto, ON M5B 1W8, Canada.	stephensona@smh.ca		Stanojevic, Sanja/0000-0001-7931-8051; Goss, Christopher/0000-0001-8602-0309	U.S. Cystic Fibrosis Foundation; FOOD AND DRUG ADMINISTRATION [R01FD003704] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103965, R01HL113382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089507] Funding Source: NIH RePORTER	U.S. Cystic Fibrosis Foundation; FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	U.S. Cystic Fibrosis Foundation.	Aaron SD, 2015, J CLIN EPIDEMIOL, V68, P1336, DOI 10.1016/j.jclinepi.2014.12.010; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Corey M, 1996, AM J EPIDEMIOL, V143, P1007, DOI 10.1093/oxfordjournals.aje.a008664; COREY M, 1988, J CLIN EPIDEMIOL, V41, P583, DOI 10.1016/0895-4356(88)90063-7; Cystic Fibrosis Canada, 2011, ANN REG REP; Cystic Fibrosis Foundation, 2011, CYST FIBR FDN NAT PA; Egan TM, 2006, AM J TRANSPLANT, V6, P1212, DOI 10.1111/j.1600-6143.2006.01276.x; Farrell PM, 2008, J PEDIATR-US, V153, pS4, DOI 10.1016/j.jpeds.2008.05.005; Fogarty A, 2000, CHEST, V117, P1656, DOI 10.1378/chest.117.6.1656; George PM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1008; Goss CH, 2015, THORAX, V70, P229, DOI 10.1136/thoraxjnl-2014-205718; Gries CJ, 2007, CHEST, V132, P1954, DOI 10.1378/chest.07-1160; Jackson AD, 2011, J CYST FIBROS, V10, P62, DOI 10.1016/j.jcf.2010.08.021; Kerem E, 1996, PEDIATR PULM, V22, P387, DOI 10.1002/(SICI)1099-0496(199612)22:6<387::AID-PPUL7>3.3.CO;2-Y; KOLLBERG H, 1982, ACTA PAEDIATR SCAND, V71, P197, DOI 10.1111/j.1651-2227.1982.tb09399.x; Kuczmarski RJ, 2000, ADV DATA, V2000, P2000; Lai HCJ, 2004, AM J EPIDEMIOL, V159, P537, DOI 10.1093/aje/kwh083; Liou TG, 2001, AM J EPIDEMIOL, V153, P345, DOI 10.1093/aje/153.4.345; MacKenzie T, 2014, ANN INTERN MED, V161, P233, DOI 10.7326/M13-0636; Martin B, 2012, PEDIATRICS, V129, pE348, DOI 10.1542/peds.2011-0567; McCormick Jonathan, 2005, J Cyst Fibros, V4, P115, DOI 10.1016/j.jcf.2005.01.001; McCormick J, 2010, LANCET, V375, P1007, DOI 10.1016/S0140-6736(09)62161-9; Merlo CA, 2015, AM J TRANSPLANT, V15, P1948, DOI 10.1111/ajt.13226; Merlo CA, 2009, J HEART LUNG TRANSPL, V28, P769, DOI 10.1016/j.healun.2009.04.024; Moran A., 1999, Diabetes Research and Clinical Practice, V45, P61, DOI 10.1016/S0168-8227(99)00058-3; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; Nick JA, 2010, AM J RESP CRIT CARE, V182, P614, DOI 10.1164/rccm.201001-0092OC; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Quon BS, 2012, AM J RESP CRIT CARE, V186, P1008, DOI 10.1164/rccm.201205-0949OC; Ramos KJ, 2016, J CYST FIBROS, V15, P196, DOI 10.1016/j.jcf.2015.11.005; Schechter MS, 2001, AM J RESP CRIT CARE, V163, P1331, DOI 10.1164/ajrccm.163.6.9912100; Stanojevic S, 2008, AM J RESP CRIT CARE, V177, P253, DOI 10.1164/rccm.200708-1248OC; Stephenson AL, 2015, J HEART LUNG TRANSPL, V34, P1139, DOI 10.1016/j.healun.2015.05.003; Sykes J, 2016, J CLIN EPIDEMIOL, V70, P206, DOI 10.1016/j.jclinepi.2015.08.026; van Buuren S, 2011, J STAT SOFTW, V45, P1; World Health Organization, 2006, BMI CLASSIFICATION; Yen EH, 2013, J PEDIATR-US, V162, P530, DOI 10.1016/j.jpeds.2012.08.040	37	125	127	1	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 18	2017	166	8					537	+		10.7326/M16-0858	http://dx.doi.org/10.7326/M16-0858			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ES1RF	28288488	Green Accepted			2022-12-28	WOS:000399304000013
J	Bellono, NW; Leitch, DB; Julius, D				Bellono, Nicholas W.; Leitch, Duncan B.; Julius, David			Molecular basis of ancestral vertebrate electroreception	NATURE			English	Article							OSCILLATORY RESPONSES; LATERAL-LINE; BK CHANNELS; SKATE; CONDUCTANCE; CELLS; SUBUNITS	Elasmobranch fishes, including sharks, rays, and skates, use specialized electrosensory organs called ampullae of Lorenzini to detect extremely small changes in environmental electric fields. Electrosensory cells within these ampullae can discriminate and respond to minute changes in environmental voltage gradients through an unknown mechanism. Here we show that the voltage-gated calcium channel Ca(V)1.3 and the big conductance calcium-activated potassium (BK) channel are preferentially expressed by electrosensory cells in little skate (Leucoraja erinacea) and functionally couple to mediate electrosensory cell membrane voltage oscillations, which are important for the detection of specific, weak electrical signals. Both channels exhibit unique properties compared with their mammalian orthologues that support electrosensory functions: structural adaptations in Ca(V)1.3 mediate a low-voltage threshold for activation, and alterations in BK support specifically tuned voltage oscillations. These findings reveal a molecular basis of electroreception and demonstrate how discrete evolutionary changes in ion channel structure facilitate sensory adaptation.	[Bellono, Nicholas W.; Leitch, Duncan B.; Julius, David] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA.	david.julius@ucsf.edu	Leitch, Duncan/AAU-6744-2020	Leitch, Duncan/0000-0002-8513-888X	NIH Institutional Research Service Award [T32HL007731]; Howard Hughes Medical Institute Fellowship of the Life Sciences Research Foundation; Simons Foundation Postdoctoral Fellowship; NIH [NS081115, NS055299]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081115, R01NS055299] Funding Source: NIH RePORTER	NIH Institutional Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Fellowship of the Life Sciences Research Foundation(Howard Hughes Medical Institute); Simons Foundation Postdoctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Araneda, Y. Kirichok, F. Fieni, N. Ingolia, V. Yorgan, and members of the Julius laboratory for discussions and technical assistance, R. Nicoll for critical reading of the manuscript, and S. Bennett at the Marine Biological Laboratory for help with skates. This work was supported by an NIH Institutional Research Service Award to the UCSF CVRI (T32HL007731 to N.W.B.), a Howard Hughes Medical Institute Fellowship of the Life Sciences Research Foundation (N.W.B.), a Simons Foundation Postdoctoral Fellowship to the Jane Coffin Childs Memorial Fund (D.B.L.), and grants from the NIH (NS081115 and NS055299 to D.J.).	ARANEDA RC, 1993, BIOL BULL-US, V185, P310, DOI 10.1086/BBLv185n2p310; Baker CA, 2015, ELIFE, V4, DOI 10.7554/eLife.08163; Bentzen BH, 2007, MOL PHARMACOL, V72, P1033, DOI 10.1124/mol.107.038331; Brandt A, 2003, J NEUROSCI, V23, P10832; Brelidze TI, 2003, P NATL ACAD SCI USA, V100, P9017, DOI 10.1073/pnas.1532257100; BULLOCK TH, 1982, ANNU REV NEUROSCI, V5, P121, DOI 10.1146/annurev.ne.05.030182.001005; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; CLUSIN WT, 1979, J GEN PHYSIOL, V73, P685, DOI 10.1085/jgp.73.6.685; CLUSIN WT, 1979, J GEN PHYSIOL, V73, P703, DOI 10.1085/jgp.73.6.703; COLE KS, 1960, BIOPHYS J, V1, P1, DOI 10.1016/S0006-3495(60)86871-3; Fettiplace R, 1999, ANNU REV PHYSIOL, V61, P809, DOI 10.1146/annurev.physiol.61.1.809; Fodor AA, 2009, ANNU REV PHYSIOL, V71, P19, DOI 10.1146/annurev.physiol.010908.163124; Gillis JA, 2009, J MORPHOL, V270, P628, DOI 10.1002/jmor.10710; HUDSPETH AJ, 1988, J PHYSIOL-LONDON, V400, P275, DOI 10.1113/jphysiol.1988.sp017120; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Ishii T, 2004, J NEUROCYTOL, V33, P657, DOI 10.1007/s11068-005-3334-y; KALMIJN AJ, 1971, J EXP BIOL, V55, P371; KALMIJN AJ, 1982, SCIENCE, V218, P916, DOI 10.1126/science.7134985; King BL, 2016, GENE, V578, P63, DOI 10.1016/j.gene.2015.12.010; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; LEWIS RS, 1983, NATURE, V304, P538, DOI 10.1038/304538a0; LISSMANN HW, 1958, J EXP BIOL, V35, P451; Lu J, 1995, BIOPHYS J, V69, P2467, DOI 10.1016/S0006-3495(95)80117-7; Miranda-Rottmann S, 2010, MOL CELL BIOL, V30, P3646, DOI 10.1128/MCB.00073-10; Modrell MS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1502; MUNZ H, 1984, J COMP PHYSIOL, V154, P33, DOI 10.1007/BF00605387; Nimigean CM, 2003, BIOCHEMISTRY-US, V42, P9263, DOI 10.1021/bi0348720; PETERS RC, 1989, COMP BIOCHEM PHYS C, V94, P663, DOI 10.1016/0742-8413(89)90129-1; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Ramakrishnan NA, 2002, MOL BRAIN RES, V109, P69, DOI 10.1016/S0169-328X(02)00522-3; Rosenblatt KP, 1997, NEURON, V19, P1061, DOI 10.1016/S0896-6273(00)80397-9; SCHEICH H, 1986, NATURE, V319, P401, DOI 10.1038/319401a0; Schwaller B, 1999, AM J PHYSIOL-CELL PH, V276, pC395, DOI 10.1152/ajpcell.1999.276.2.C395; SEJNOWSKI TJ, 1982, J NEUROCYTOL, V11, P897, DOI 10.1007/BF01148307; Sisneros JA, 1998, J COMP PHYSIOL A, V183, P87, DOI 10.1007/s003590050237; Soom M, 2008, CHANNELS, V2, P278, DOI 10.4161/chan.2.4.6571; Spafford J. D., 2011, JOVE-J VIS EXP, V47, P2314; TEETER JH, 1981, J COMP PHYSIOL, V142, P371, DOI 10.1007/BF00605449; Tricas TC, 1995, NEUROSCI LETT, V202, P129, DOI 10.1016/0304-3940(95)12230-3; Wu JP, 2015, SCIENCE, V350, DOI 10.1126/science.aad2395; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001	42	46	46	4	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2017	543	7645					391	+		10.1038/nature21401	http://dx.doi.org/10.1038/nature21401			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9RN	28264196	Green Accepted			2022-12-28	WOS:000396337400044
J	Berlow, RB; Dyson, HJ; Wright, PE				Berlow, Rebecca B.; Dyson, H. Jane; Wright, Peter E.			Hypersensitive termination of the hypoxic response by a disordered protein switch	NATURE			English	Article							CREB-BINDING PROTEIN; INTRINSIC DISORDER; STRUCTURAL BASIS; INDUCIBLE FACTOR-1-ALPHA; TAZ1 DOMAIN; ALLOSTERY; CITED2; TRANSACTIVATION; HYDROXYLATION; HIF-1-ALPHA	The cellular response to hypoxia is critical for cell survival and is fine-tuned to allow cells to recover from hypoxic stress and adapt to heterogeneous or fluctuating oxygen levels(1,2). The hypoxic response is mediated by the a-subunit of the transcription factor HIF-1 (HIF-1 alpha)(3), which interacts through its intrinsically disordered C-terminal transactivation domain with the TAZ1 (also known as CH1) domain of the general transcriptional coactivators CBP and p300 to control the transcription of critical adaptive genes(4-6). One such gene encodes CITED2, a negative feedback regulator that attenuates HIF-1 transcriptional activity by competing for TAZ1 binding through its own disordered transactivation domain(7-9). Little is known about the molecular mechanism by which CITED2 displaces the tightly bound HIF-1 alpha from their common cellular target. The HIF-1 alpha and CITED2 transactivation domains bind to TAZ1 through helical motifs that flank a conserved LP(Q/ E) L sequence that is essential for negative feedback regulation(5,6,8,9). Here we show that human CITED2 displaces HIF-1 alpha by forming a transient ternary complex with TAZ1 and HIF-1 alpha and competing for a shared binding site through its LPEL motif, thus promoting a conformational change in TAZ1 that increases the rate of HIF-1 alpha dissociation. Through allosteric enhancement of HIF-1 alpha release, CITED2 activates a highly responsive negative feedback circuit that rapidly and efficiently attenuates the hypoxic response, even at modest CITED2 concentrations. This hypersensitive regulatory switch is entirely dependent on the unique flexibility and binding properties of these intrinsically disordered proteins and probably exemplifies a common strategy used by the cell to respond rapidly to environmental signals.	[Berlow, Rebecca B.; Dyson, H. Jane; Wright, Peter E.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Berlow, Rebecca B.; Dyson, H. Jane; Wright, Peter E.] Scripps Res Inst, Skaggs Inst Chem Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Wright, PE (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.; Wright, PE (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	wright@scripps.edu	Dyson, Jane/D-4160-2011	Dyson, Jane/0000-0001-6855-3398; Berlow, Rebecca/0000-0003-1934-0139	National Institutes of Health [CA096865]; Skaggs Institute for Chemical Biology; American Cancer Society [125343-PF-13-202-01-DMC]; NATIONAL CANCER INSTITUTE [R01CA096865] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Martinez-Yamout for expert assistance with protein preparation and construct design, G. Kroon for NMR support, and A. Deniz for fluorimeter access. This work was supported by grant CA096865 from the National Institutes of Health (P.E.W.) and the Skaggs Institute for Chemical Biology. R.B.B. was supported by a postdoctoral fellowship from the American Cancer Society (125343-PF-13-202-01-DMC).	Anthis NJ, 2013, PROTEIN SCI, V22, P851, DOI 10.1002/pro.2253; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Berlow RB, 2015, FEBS LETT, V589, P2433, DOI 10.1016/j.febslet.2015.06.003; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; De Guzman RN, 2004, J BIOL CHEM, V279, P3042, DOI 10.1074/jbc.M310348200; De Guzman RN, 2005, BIOCHEMISTRY-US, V44, P490, DOI 10.1021/bi048161t; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ferrage F, 2009, J AM CHEM SOC, V131, P6048, DOI 10.1021/ja809526q; Ferreon ACM, 2013, NATURE, V498, P390, DOI 10.1038/nature12294; Freedman SJ, 2003, NAT STRUCT BIOL, V10, P504, DOI 10.1038/nsb936; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Goddard TD, 2006, SPARKY; Gu J, 2001, J BIOL CHEM, V276, P3550, DOI 10.1074/jbc.M009522200; Henze AT, 2010, CELL CYCLE, V9, P2749, DOI 10.4161/cc.9.14.12249; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Kohn KW, 2004, MOL BIOL CELL, V15, P3042, DOI 10.1091/mbc.e03-12-0897; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lee CW, 2010, P NATL ACAD SCI USA, V107, P19290, DOI 10.1073/pnas.1013078107; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Motlagh HN, 2012, BIOCHEM SOC T, V40, P975, DOI 10.1042/BST20120163; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16056, DOI 10.1021/bi048233g; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Shin DH, 2008, ONCOGENE, V27, P1939, DOI 10.1038/sj.onc.1210826; Sugase K, 2008, PROTEIN EXPRES PURIF, V57, P108, DOI 10.1016/j.pep.2007.10.018; Van Roey K, 2014, CHEM REV, V114, P6733, DOI 10.1021/cr400585q; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920	30	91	91	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2017	543	7645					447	+		10.1038/nature21705	http://dx.doi.org/10.1038/nature21705			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9RN	28273070	Green Accepted			2022-12-28	WOS:000396337400056
J	Mitchell, LA; Wang, A; Stracquadanio, G; Kuang, Z; Wang, XY; Yang, K; Richardson, S; Martin, JA; Zhao, Y; Walker, R; Luo, YS; Dai, HJ; Dong, K; Tang, ZJ; Yang, YL; Cai, YZ; Heguy, A; Ueberheide, B; Fenyo, D; Dai, JB; Bader, JS; Boeke, JD				Mitchell, Leslie A.; Wang, Ann; Stracquadanio, Giovanni; Kuang, Zheng; Wang, Xuya; Yang, Kun; Richardson, Sarah; Martin, J. Andrew; Zhao, Yu; Walker, Roy; Luo, Yisha; Dai, Hongjiu; Dong, Kang; Tang, Zuojian; Yang, Yanling; Cai, Yizhi; Heguy, Adriana; Ueberheide, Beatrix; Fenyo, David; Dai, Junbiao; Bader, Joel S.; Boeke, Jef D.			Synthesis, debugging, and effects of synthetic chromosome consolidation: synVI and beyond	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST; DNA; PROTEASOME; PCR; DELETION; SUBUNIT; STRAINS; LONG; ACTS	We describe design, rapid assembly, and characterization of synthetic yeast Sc2.0 chromosome VI (synVI). A mitochondrial defect in the synVI strain mapped to synonymous coding changes within PRE4 (YFR050C), encoding an essential proteasome subunit; Sc2.0 coding changes reduced Pre4 protein accumulation by half. Completing Sc2.0 specifies consolidation of 16 synthetic chromosomes into a single strain. We investigated phenotypic, transcriptional, and proteomewide consequences of Sc2.0 chromosome consolidation in poly-synthetic strains. Another "bug" was discovered through proteomic analysis, associated with alteration of the HIS2 transcription start due to transfer RNA deletion and loxPsym site insertion. Despite extensive genetic alterations across 6% of the genome, no major global changes were detected in the poly-synthetic strain " omics" analyses. This work sets the stage for completion of a designer, synthetic eukaryotic genome.	[Mitchell, Leslie A.; Kuang, Zheng; Wang, Xuya; Martin, J. Andrew; Zhao, Yu; Tang, Zuojian; Ueberheide, Beatrix; Fenyo, David; Boeke, Jef D.] NYU, Langone Sch Med, Dept Biochem & Mol Pharmacol, 550 1St Ave, New York, NY 10016 USA; [Mitchell, Leslie A.; Kuang, Zheng; Wang, Xuya; Martin, J. Andrew; Zhao, Yu; Tang, Zuojian; Fenyo, David; Boeke, Jef D.] NYU, Langone Sch Med, Inst Syst Genet, 550 1St Ave, New York, NY 10016 USA; [Wang, Ann; Stracquadanio, Giovanni; Yang, Kun; Richardson, Sarah; Bader, Joel S.] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Wang, Ann; Dai, Junbiao; Bader, Joel S.] Tsinghua Univ, Key Lab Ind Biocatalysis, Minist Educ, Key Lab Bioinformat,Ctr Synthet & Syst Biol,Sch L, Beijing 100084, Peoples R China; [Stracquadanio, Giovanni; Yang, Kun; Richardson, Sarah] Johns Hopkins Univ, Whiting Sch Engn, Dept Biomed Engn, Baltimore, MD 21218 USA; [Stracquadanio, Giovanni; Yang, Kun; Richardson, Sarah] Johns Hopkins Univ, Whiting Sch Engn, Inst Med Genet, Baltimore, MD 21218 USA; [Stracquadanio, Giovanni] Univ Essex, Sch Comp Sci & Elect Engn, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England; [Walker, Roy; Luo, Yisha; Cai, Yizhi] Univ Edinburgh, Sch Biol Sci, Ctr Synthet & Syst Biol, Edinburgh EH9 3JL, Midlothian, Scotland; [Dai, Hongjiu; Dong, Kang] GenScript, Piscataway, NJ 08854 USA; [Yang, Yanling; Ueberheide, Beatrix] NYU, Langone Sch Med, Prote Resource Ctr, Off Collaborat Sci, 550 1St Ave, New York, NY 10016 USA; [Heguy, Adriana] NYU, Langone Sch Med, Genome Technol Ctr, 550 1St Ave, New York, NY 10016 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Johns Hopkins University; Tsinghua University; Johns Hopkins University; Johns Hopkins University; University of Essex; University of Edinburgh; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Boeke, JD (corresponding author), NYU, Langone Sch Med, Dept Biochem & Mol Pharmacol, 550 1St Ave, New York, NY 10016 USA.; Boeke, JD (corresponding author), NYU, Langone Sch Med, Inst Syst Genet, 550 1St Ave, New York, NY 10016 USA.	jef.boeke@nyumc.org	Kuang, Zheng/ABG-3667-2021; Heguy, Adriana/GPP-3907-2022; Stracquadanio, Giovanni/AAL-2648-2021; Dai, Junbiao/AAB-8328-2021; Cai, Yizhi/A-3550-2010	Stracquadanio, Giovanni/0000-0001-9819-3645; Dai, Junbiao/0000-0002-5299-4700; Walker, Roy/0000-0003-0960-4591; Ueberheide, Beatrix/0000-0003-2512-0204; Richardson, Sarah/0000-0002-9820-9421; Zhao, Yu/0000-0003-4659-9832; Cai, Yizhi/0000-0003-1663-2865; Mitchell, Leslie/0000-0001-7869-9817; Fenyo, David/0000-0001-5049-3825	U.S. NSF [MCB-1026068, MCB-1158201]; Natural Sciences and Engineering Research Council of Canada; GenScript; Cancer Center Support Grant at the Laura and Isaac Perlmutter Cancer Center [P30CA016087]; University of Edinburgh; Scottish Universities Life Sciences Alliance; UK Biotechnology and Biological Sciences Research Council [BB/M005690/1, BB/M025640/1, BB/M00029X/1]; BBSRC [BB/M005690/1, BB/M005690/2, BB/M00029X/1, BB/M025640/1] Funding Source: UKRI; EPSRC [EP/P017401/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M025640/1, BBS/OS/GC/000001, BB/M005690/2, BB/M00029X/1, BB/M005690/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/P017401/1] Funding Source: researchfish; Direct For Biological Sciences [1616111] Funding Source: National Science Foundation	U.S. NSF(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); GenScript; Cancer Center Support Grant at the Laura and Isaac Perlmutter Cancer Center; University of Edinburgh; Scottish Universities Life Sciences Alliance; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by U.S. NSF grants MCB-1026068 and MCB-1158201 to J.D.B. L.A.M. was funded by a postdoctoral fellowship from the Natural Sciences and Engineering Research Council of Canada. GenScript funded the synthesis of 150 kb of synVI DNA chunks with corporate funds. We thank P. Meluh for thoughtful discussions and K. Palacios for analysis of genome sequence data. The New York University Langone Medical Center (NYULMC) Genome Technology Center is partially supported by the Cancer Center Support Grant (P30CA016087) at the Laura and Isaac Perlmutter Cancer Center. Work in the United Kingdom was funded by a Chancellor's Fellowship from the University of Edinburgh, a start-up fund from Scottish Universities Life Sciences Alliance, and UK Biotechnology and Biological Sciences Research Council grants (BB/M005690/1, BB/M025640/1, and BB/M00029X/1) to Y.C. J.D.B. and J.S.B. are founders and directors of Neochromosome Inc. J.D.B. serves as a scientific adviser to Recombinetics Inc. and Sample6 Inc. These arrangements are reviewed and managed by the committees on conflict of interest at NYULMC (J.D.B.) and Johns Hopkins University (J.S.B.). S.R. and J.D.B. designed synVI. H.D. and K.D. are employees of GenScript, who constructed most of the synVI synthetic DNA chunks. L.A.M., Y.Z., and J.A.M. (in the lab of J.D.B.), together with A.W. (in the labs of J.D.B. and J.D.) and R.W. and Y.L. (in the lab of Y.C.), performed experiments. A.H. oversaw all RNA and DNA sequencing efforts. Y.Y. (in the lab of B.U.) performed tandem mass tag proteomic experiments and analysis. G.S. and K.Y. (in the lab of J.S.B.), Z.K. (in the lab of J.D.B.), and Z.T. and X.W. (in the lab of D.F.) performed computational analyses. L.A.M. and J. D. B. wrote the manuscript, and all authors contributed to its editing. All genomic data for this paper are available under the Sc2.0 umbrella BioProject accession number PRJNA351844. Proteomic data are available through MassIVE with reference number MSV000080584. Additional information related to synVI [ design diagram, PCRTag sequences, feature summary table (WT VI, designed VI, physical strain yLM953; yeast_chr6_9_03), variants in physical strain (yeast_chr6_3_09), chunks used for assembly, and an extended yeast strain table] can be accessed on the Sc2.0 website.	Annaluru N, 2014, SCIENCE, V344, P55, DOI 10.1126/science.1249252; Brachmann CB, 1998, YEAST, V14, P115; Chan KM, 2013, PLASMID, V70, P2, DOI 10.1016/j.plasmid.2013.03.001; Chapman RE, 1997, CURR BIOL, V7, P850, DOI 10.1016/S0960-9822(06)00373-3; Dymond JS, 2013, METHOD ENZYMOL, V529, P153, DOI 10.1016/B978-0-12-418687-3.00012-4; Dymond JS, 2011, NATURE, V477, P471, DOI 10.1038/nature10403; Fourel G, 1999, EMBO J, V18, P2522, DOI 10.1093/emboj/18.9.2522; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gietz RD, 2014, METHODS MOL BIOL, V1205, P1, DOI 10.1007/978-1-4939-1363-3_1; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Heinemeyer W, 1997, J BIOL CHEM, V272, P25200, DOI 10.1074/jbc.272.40.25200; HILT W, 1993, J BIOL CHEM, V268, P3479; Humphrey SJ, 2015, NAT BIOTECHNOL, V33, P990, DOI 10.1038/nbt.3327; Lin QH, 2015, ACS SYNTH BIOL, V4, P213, DOI 10.1021/sb500241e; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MARTIN RP, 1979, BIOCHEMISTRY-US, V18, P4600, DOI 10.1021/bi00588a021; Mitchell LA, 2014, P NATL ACAD SCI USA, V111, P17003, DOI 10.1073/pnas.1414399111; Ramos PC, 2004, J BIOL CHEM, V279, P14323, DOI 10.1074/jbc.M308757200; Reid RJD, 2008, GENETICS, V180, P1799, DOI 10.1534/genetics.108.087999; Richardson SM, 2017, SCIENCE, V355, P1040, DOI 10.1126/science.aaf4557; Roncoroni M, 2011, FOOD MICROBIOL, V28, P926, DOI 10.1016/j.fm.2011.01.002; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; Schneper L, 2004, EUKARYOT CELL, V3, P108, DOI 10.1128/EC.3.1.108-120.2004; Schreve JL, 2004, BIOCHEM BIOPH RES CO, V313, P745, DOI 10.1016/j.bbrc.2003.11.172; SIKORSKI RS, 1989, GENETICS, V122, P19; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094; Wu Y, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4706; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	30	127	145	5	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI				eaaf4831	10.1126/science.aaf4831	http://dx.doi.org/10.1126/science.aaf4831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9VY	28280154				2022-12-28	WOS:000396348900032
J	Mohseni, M; Read, P; Neven, H; Boixo, S; Denchev, V; Babbush, R; Fowler, A; Smelyanskiy, V; Martinis, J				Mohseni, Masoud; Read, Peter; Neven, Hartmut; Boixo, Sergio; Denchev, Vasil; Babbush, Ryan; Fowler, Austin; Smelyanskiy, Vadim; Martinis, John			Commercialize early quantum technologies	NATURE			English	Editorial Material									[Mohseni, Masoud; Neven, Hartmut] Google Quantum Artificial Intelligence Lab, Venice, CA 90291 USA; [Read, Peter] Vitruvian Partners, London, England; [Boixo, Sergio; Denchev, Vasil; Babbush, Ryan; Fowler, Austin; Smelyanskiy, Vadim; Martinis, John] Googles Quantum AI Team, Venice, CA USA	Google Incorporated	Mohseni, M (corresponding author), Google Quantum Artificial Intelligence Lab, Venice, CA 90291 USA.	mohseni@google.com; petermread@gmail.com; neven@google.com						Boixo S, 2018, NAT PHYS, V14, P595, DOI 10.1038/s41567-018-0124-x; Boixo S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10327; Brynjolfsson E, 2014, THE SECOND MACHINE A; Denchev VS, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.031015; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Fowler AG, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.032324; Preskill J., 2011, THEORY QUANTUM WORLD, P63; Rams MM, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/aa5079; Rosenberg G, 2016, IEEE J-STSP, V10, P1053, DOI 10.1109/JSTSP.2016.2574703; Touzalin A. d., 2016, QUANTUM MANIFESTO NE; Wecker D, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.042303	11	119	119	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2017	543	7644					171	174		10.1038/543171a	http://dx.doi.org/10.1038/543171a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN0GQ	28277529	Bronze			2022-12-28	WOS:000395688700012
J	Poirazi, P				Poirazi, Panayiota			The perfect grant and how to get it	NATURE			English	Editorial Material									[Poirazi, Panayiota] Fdn Res & Technol Hellas, FENS Kavli Network Excellence, Iraklion, Greece; [Poirazi, Panayiota] Fdn Res & Technol Hellas, Computat Biol Lab, Iraklion, Greece	Foundation for Research & Technology - Hellas (FORTH); Foundation for Research & Technology - Hellas (FORTH)	Poirazi, P (corresponding author), Fdn Res & Technol Hellas, FENS Kavli Network Excellence, Iraklion, Greece.; Poirazi, P (corresponding author), Fdn Res & Technol Hellas, Computat Biol Lab, Iraklion, Greece.	poirazi@imbb.forth.gr		Poirazi, Panayiota/0000-0001-6152-595X				[Anonymous], 2016, Nature, V538, P427, DOI 10.1038/538427a	1	2	2	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2017	543	7644					151	151		10.1038/543151a	http://dx.doi.org/10.1038/543151a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN0GQ	28277521	Bronze			2022-12-28	WOS:000395688700004
J	Turgay, Y; Eibauer, M; Goldman, AE; Shimi, T; Khayat, M; Ben-Harush, K; Dubrovsky-Gaupp, A; Sapra, KT; Goldman, RD; Medalia, O				Turgay, Yagmur; Eibauer, Matthias; Goldman, Anne E.; Shimi, Takeshi; Khayat, Maayan; Ben-Harush, Kfir; Dubrovsky-Gaupp, Anna; Sapra, K. Tanuj; Goldman, Robert D.; Medalia, Ohad			The molecular architecture of lamins in somatic cells	NATURE			English	Article							NUCLEAR LAMINS; SUPRAMOLECULAR ORGANIZATION; INTERMEDIATE-FILAMENTS; ESCHERICHIA-COLI; EXPRESSION; ENVELOPE; TAIL	The nuclear lamina is a fundamental constituent of metazoan nuclei. It is composed mainly of lamins, which are intermediate filament proteins that assemble into a filamentous meshwork, bridging the nuclear envelope and chromatin(1-4). Besides providing structural stability to the nucleus(5,6), the lamina is involved in many nuclear activities, including chromatin organization, transcription and replication(7-10). However, the structural organization of the nuclear lamina is poorly understood. Here we use cryo-electron tomography to obtain a detailed view of the organization of the lamin meshwork within the lamina. Data analysis of individual lamin filaments resolves a globular-decorated fibre appearance and shows that A-and B-type lamins assemble into tetrameric filaments of 3.5 nm thickness. Thus, lamins exhibit a structure that is remarkably different from the other canonical cytoskeletal elements. Our findings define the architecture of the nuclear lamin meshworks at molecular resolution, providing insights into their role in scaffolding the nuclear lamina.	[Turgay, Yagmur; Eibauer, Matthias; Dubrovsky-Gaupp, Anna; Sapra, K. Tanuj; Medalia, Ohad] Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Goldman, Anne E.; Shimi, Takeshi; Goldman, Robert D.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave, Chicago, IL 60611 USA; [Khayat, Maayan; Medalia, Ohad] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Khayat, Maayan; Medalia, Ohad] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Ben-Harush, Kfir] Coll Engn, Dept Chem Engn, Jabotinsky 84, IL-77245 Ashdod, Israel	University of Zurich; Northwestern University; Feinberg School of Medicine; Ben Gurion University; Ben Gurion University	Medalia, O (corresponding author), Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.; Medalia, O (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.; Medalia, O (corresponding author), Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel.	omedalia@bioc.uzh.ch	Shimi, Takeshi/AAC-2322-2022	Turgay, Yagmur/0000-0002-9889-0181; Sapra, Tanuj/0000-0001-6945-0876; Shimi, Takeshi/0000-0002-9864-1820; Medalia, Ohad/0000-0003-0994-2937	Swiss National Science Foundation [SNSF 31003A 159706/1]; Maxi Foundation; Forschungskredit of the University of Zurich; National Institutes of Health [GM106023]; Progeria Research Foundation;  [GIF I-1289-412.13/2015]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106023] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Maxi Foundation; Forschungskredit of the University of Zurich; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Progeria Research Foundation; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Irobalieva for reading the manuscript, Y. Zheng for providing cell lines and L. Gerace for sharing lamin B1 antibody. This work was funded by a Swiss National Science Foundation Grant (SNSF 31003A 159706/1), the Maxi Foundation and GIF I-1289-412.13/2015 to O.M., and the Forschungskredit of the University of Zurich to Y.T. We thank the Center for Microscopy and Image Analysis at the University of Zurich (ZMB). R.D.G. was funded by National Institutes of Health grant GM106023 and the Progeria Research Foundation. We also thank K. H. Myung for her technical assistance, J. Rappaport of the Nikon Imaging Center in the Feinberg School of Medicine for support, and L. Chang of Nikon Instruments.	AARONSON RP, 1975, P NATL ACAD SCI USA, V72, P1007, DOI 10.1073/pnas.72.3.1007; AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0; Ben-Harush K, 2009, J MOL BIOL, V386, P1392, DOI 10.1016/j.jmb.2008.12.024; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Burke B, 2013, NAT REV MOL CELL BIO, V14, P13, DOI 10.1038/nrm3488; Camozzi D, 2014, NUCLEUS-PHILA, V5, P427, DOI 10.4161/nucl.36289; Dahl KN, 2005, BIOPHYS J, V89, P2855, DOI 10.1529/biophysj.105.062554; Dechat T, 2010, COLD SH Q B, V75, P533, DOI 10.1101/sqb.2010.75.018; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P17381, DOI 10.1074/jbc.C200038200; Dittmer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-222; Eibauer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8532; Eibauer M, 2012, J STRUCT BIOL, V180, P488, DOI 10.1016/j.jsb.2012.09.008; FAWCETT DW, 1966, AM J ANAT, V119, P129, DOI 10.1002/aja.1001190108; FISHER DZ, 1986, P NATL ACAD SCI USA, V83, P6450, DOI 10.1073/pnas.83.17.6450; Fletcher JM, 2012, ACS SYNTH BIOL, V1, P240, DOI 10.1021/sb300028q; Galkin VE, 2015, STRUCTURE, V23, P173, DOI 10.1016/j.str.2014.11.006; Grossman E, 2012, J STRUCT BIOL, V177, P113, DOI 10.1016/j.jsb.2011.11.002; Guo M, 2013, BIOPHYS J, V105, P1562, DOI 10.1016/j.bpj.2013.08.037; Harapin J, 2015, NAT METHODS, V12, P634, DOI [10.1038/NMETH.3401, 10.1038/nmeth.3401]; HEITLINGER E, 1991, J CELL BIOL, V113, P485, DOI 10.1083/jcb.113.3.485; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Hotaling NA, 2015, BIOMATERIALS, V61, P327, DOI 10.1016/j.biomaterials.2015.05.015; JONES JCR, 1982, CELL MOTIL CYTOSKEL, V2, P197, DOI 10.1002/cm.970020302; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Mahamid J, 2016, SCIENCE, V351, P969, DOI 10.1126/science.aad8857; Meister P, 2011, CURR OPIN GENET DEV, V21, P167, DOI 10.1016/j.gde.2011.01.023; MOIR RD, 1991, J CELL SCI, V99, P363; Nickell S, 2005, J STRUCT BIOL, V149, P227, DOI 10.1016/j.jsb.2004.10.006; NOGALES E, 1995, NATURE, V375, P424, DOI 10.1038/375424a0; PARRY DAD, 1986, BIOCHEM J, V238, P305, DOI 10.1042/bj2380305; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schirmer EC, 2001, J CELL BIOL, V153, P479, DOI 10.1083/jcb.153.3.479; Shimi T, 2015, MOL BIOL CELL, V26, P4075, DOI 10.1091/mbc.E15-07-0461; Shumaker DK, 2003, CURR OPIN CELL BIOL, V15, P358, DOI 10.1016/S0955-0674(03)00050-4; Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987; Trachtenberg S., 2010, MICROSCOPY SCI TECHN, V3, P1690; Wood CW, 2014, BIOINFORMATICS, V30, P3029, DOI 10.1093/bioinformatics/btu502; Worman HJ, 2005, INT REV CYTOL, V246, P231, DOI 10.1016/S0074-7696(05)46006-4; Worman HJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000760; Zaccai NR, 2011, NAT CHEM BIOL, V7, P935, DOI [10.1038/nchembio.692, 10.1038/NCHEMBIO.692]	41	227	231	4	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2017	543	7644					261	+		10.1038/nature21382	http://dx.doi.org/10.1038/nature21382			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0GQ	28241138	Green Accepted			2022-12-28	WOS:000395688700043
J	Haq, IJ; Battersby, AC; Eastham, K; McKean, M				Haq, Iram J.; Battersby, Alexandra C.; Eastham, Katherine; McKean, Michael			CLINICAL UPDATES Community acquired pneumonia in children	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Haq, Iram J.] Newcastle Univ, Inst Cellular Med, Paediat Resp Med, Newcastle Upon Tyne, Tyne & Wear, England; [Haq, Iram J.; McKean, Michael] Great North Childrens Hosp, Dept Paediat Resp Med, Paediat Resp Med, Newcastle Upon Tyne, Tyne & Wear, England; [McKean, Michael] Great North Childrens Hosp, Dept Paediat Resp Med, Newcastle Upon Tyne, Tyne & Wear, England; [Battersby, Alexandra C.] Great North Childrens Hosp, Dept Paediat Immunol & Infect Dis, Paediat Immunol & Infect Dis, Newcastle Upon Tyne, Tyne & Wear, England; [Eastham, Katherine] Sunderland Royal Hosp, Dept Paediat, Sunderland, Tyne & Wear, England	Newcastle University - UK; Sunderland Royal Hospital	Haq, IJ (corresponding author), Newcastle Univ, Inst Cellular Med, Paediat Resp Med, Newcastle Upon Tyne, Tyne & Wear, England.; Haq, IJ (corresponding author), Great North Childrens Hosp, Dept Paediat Resp Med, Paediat Resp Med, Newcastle Upon Tyne, Tyne & Wear, England.	iram.haq@newcastle.ac.uk		Battersby, Alexandra/0000-0002-5244-424X; Haq, Iram/0000-0002-5795-0440				Addo-Yobo E, 2004, LANCET, V364, P1141, DOI 10.1016/S0140-6736(04)17100-6; Adegbola RA, 2005, LANCET, V366, P144, DOI 10.1016/S0140-6736(05)66788-8; Atkinson M, 2007, THORAX, V62, P1102, DOI 10.1136/thx.2006.074906; Baer G, 2003, EUR J CLIN MICROBIOL, V22, P742, DOI 10.1007/s10096-003-1037-9; Balfour-Lynn IM, 2005, THORAX, V60, P1, DOI 10.1136/thx.2004.030676; Beekmann SE, 2005, INT J ANTIMICROB AG, V25, P148, DOI 10.1016/j.ijantimicag.2004.09.016; Bowen SJM, 2013, THORAX, V68, P682, DOI 10.1136/thoraxjnl-2012-203026; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; BRITTON S, 1985, BRIT MED J, V290, P1703, DOI 10.1136/bmj.290.6483.1703; BTS, 2013, 2012 2013 BTS PAED P; Bylund J, 2005, ADV EXP MED BIOL, V568, P67; Cevey-Macherel M, 2009, EUR J PEDIATR, V168, P1429, DOI 10.1007/s00431-009-0943-y; Charkaluk ML, 2006, DIAGN MICR INFEC DIS, V55, P89, DOI 10.1016/j.diagmicrobio.2005.10.013; CHERIAN T, 1988, LANCET, V2, P125; Clark JE, 2007, EPIDEMIOL INFECT, V135, P262, DOI 10.1017/S0950268806006741; Clark JE, 2007, ARCH DIS CHILD, V92, P394, DOI 10.1136/adc.2006.097402; Clark JE, 2015, ARCH DIS CHILD, V100, P193, DOI 10.1136/archdischild-2013-305742; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Davis TR, 2017, J PAEDIATR CHILD H, V53, P232, DOI 10.1111/jpc.13376; Elemraid MA, 2013, EPIDEMIOL INFECT, V141, P1697, DOI 10.1017/S0950268812002257; Elemraid MA, 2015, PEDIATR PULM, V50, P721, DOI 10.1002/ppul.23041; Harris M, 2011, THORAX, V66, pII1, DOI 10.1136/thoraxjnl-2011-200598; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Hazir T, 2008, LANCET, V371, P49, DOI 10.1016/S0140-6736(08)60071-9; Hazir T, 2006, BMJ-BRIT MED J, V333, P629, DOI 10.1136/bmj.38915.673322.80; Kahue CN, 2014, CURR OPIN OTOLARYNGO, V22, P359, DOI 10.1097/MOO.0000000000000092; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Koshy E, 2010, THORAX, V65, P770, DOI 10.1136/thx.2010.137802; Kwong JC, 2008, PLOS MED, V5, P1440, DOI 10.1371/journal.pmed.0050211; Light Richard W, 2006, Proc Am Thorac Soc, V3, P75, DOI 10.1513/pats.200510-113JH; Loharikar A, 2016, MMWR-MORBID MORTAL W, V65, P1136, DOI 10.15585/mmwr.mm6541a3; Lucero MG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004977.pub2; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; Mulholland K, 1997, LANCET, V349, P1191, DOI 10.1016/S0140-6736(96)09267-7; Paludo C, 2008, THORAX, V63, P791, DOI 10.1136/thx.2007.088195; PERUKI, 2016, CAPIT FEAS SERV EV; Principi N, 2011, THORAX, V66, P815, DOI 10.1136/thx.2010.142604; Principi Nicola, 2001, Clinical Infectious Diseases, V32, P1281, DOI 10.1086/319981; Public Health England, 2016, COMPL ROUT IMM SCHED; REDD SC, 1994, B WORLD HEALTH ORGAN, V72, P113; Rojas MX, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004979.pub2; Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P895; Scott P, 2011, VACCINE, V29, P9711, DOI 10.1016/j.vaccine.2011.07.042; Senstad AC, 2009, ACTA PAEDIATR, V98, P332, DOI 10.1111/j.1651-2227.2008.01088.x; Smyth A, 1998, ANN TROP PAEDIATR, V18, P31, DOI 10.1080/02724936.1998.11747923; Swingler GH, 1998, LANCET, V351, P404, DOI 10.1016/S0140-6736(97)07013-X; Tan TQ, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.1; Thomson A, 2011, THORAX, V66, P927, DOI 10.1136/thoraxjnl-2011-200671; World Health Organization, 2015, PNEUMONIA; World Health Organization, 2014, REV WHO CLASS TREATM	50	33	35	2	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2017	356								j686	10.1136/bmj.j686	http://dx.doi.org/10.1136/bmj.j686			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JW	28255071				2022-12-28	WOS:000395628700014
J	Christiansen, EH				Christiansen, E. H.			In left main CAD, CABG reduced major adverse cardiac or cerebrovascular events at 5 years compared with PCI	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Christiansen, E. H.] Aarhus Univ Hosp, Aarhus, Denmark	Aarhus University	Christiansen, EH (corresponding author), Aarhus Univ Hosp, Aarhus, Denmark.	evald.christiansen@dadlnet.dk							0	2	2	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2017	166	4					JC20	JC20		10.7326/ACPJC-2017-166-4-020	http://dx.doi.org/10.7326/ACPJC-2017-166-4-020			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7FO	28241293				2022-12-28	WOS:000394786700008
J	Hirschtritt, ME; Binder, RL				Hirschtritt, Matthew E.; Binder, Renee L.			Interrupting the Mental Illness-Incarceration-Recidivism Cycle	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH		[Hirschtritt, Matthew E.; Binder, Renee L.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA	University of California System; University of California San Francisco	Binder, RL (corresponding author), Univ Calif San Francisco, Sch Med, Psychiat & Law Program, 401 Parnassus Ave, San Francisco, CA 94143 USA.	reneeb@lppi.ucsf.edu		Hirschtritt, Matthew/0000-0001-8654-1825	NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH060482] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bastiampillai T, 2016, JAMA-J AM MED ASSOC, V316, P2591, DOI 10.1001/jama.2016.16989; Compton MT, 2014, PSYCHIAT SERV, V65, P523, DOI 10.1176/appi.ps.201300108; Greenberg GA, 2008, PSYCHIAT SERV, V59, P170, DOI 10.1176/ps.2008.59.2.170; Luthra S., 2016, COMMUNITY PARAMEDICS; McNiel DE, 2015, PSYCHIAT SERV, V66, P598, DOI 10.1176/appi.ps.201400203; Mulvey EP, 2017, CRIME JUSTICE, V46, P231, DOI 10.1086/688461; O'Campo P, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010581; Sisti DA, 2015, JAMA-J AM MED ASSOC, V313, P243, DOI 10.1001/jama.2014.16088; Skeem JL, 2011, PAROLEES MENTAL DISO	9	21	21	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2017	317	7					695	696		10.1001/jama.2016.20992	http://dx.doi.org/10.1001/jama.2016.20992			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL8WR	28241364				2022-12-28	WOS:000394901600013
J	Meddings, J; McMahon, LF				Meddings, Jennifer; McMahon, Laurence F., Jr.			Inpatient Notes: Legislating Quality to Prevent Infection-A Primer for Hospitalists	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MEDICARE; POLICY		Univ Michigan, Sch Med, Ann Arbor, MI USA; Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Meddings, J (corresponding author), 2800 Plymouth Rd,Bldg 16,Room 430W, Ann Arbor, MI 48109 USA.	meddings@umich.edu			Agency for Healthcare Research and Quality [2R01HS018334, 1K08HS019767]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018334] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This work was funded by Agency for Healthcare Research and Quality grants 2R01HS018334 and 1K08HS019767.	Agency for Healthcare Research and Quality, 2015, SAV LIV SAV MON HOSP; Centers for disease control and prevention (CDC), 2015, NAT STAT HEALTHC ASS; Gould C, 2015, PATIENT HARM SERIES; Kawai AT, 2015, INFECT CONT HOSP EP, V36, P871, DOI 10.1017/ice.2015.86; Waters TM, 2015, JAMA INTERN MED, V175, P347, DOI 10.1001/jamainternmed.2014.5486	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2017	166	4					H02	H03		10.7326/M16-2738	http://dx.doi.org/10.7326/M16-2738			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7FO	28241302				2022-12-28	WOS:000394786700001
J	Liu, YC; Wilkins, M; Kim, T; Malyugin, B; Mehta, JS				Liu, Yu-Chi; Wilkins, Mark; Kim, Terry; Malyugin, Boris; Mehta, Jodhbir S.			Cataracts	LANCET			English	Review							AGE-RELATED CATARACT; MULTIFOCAL INTRAOCULAR LENSES; ELECTRONIC MULTICENTER AUDIT; RANDOMIZED CLINICAL-TRIAL; LONG-TERM OUTCOMES; RISK-FACTORS; POSTERIOR CAPSULE; REFRACTIVE SURGERY; VISUAL IMPAIRMENT; UNITED-KINGDOM	An estimated 95 million people worldwide are affected by cataract. Cataract still remains the leading cause of blindness in middle-income and low-income countries. With the advancement of surgical technology and techniques, cataract surgery has evolved to small-incisional surgery with rapid visual recovery, good visual outcomes, and minimal complications in most patients. With the development of advanced technology in intraocular lenses, the combined treatment of cataract and astigmatism or presbyopia, or both, is possible. Paediatric cataracts have a different pathogenesis, surgical concerns, and postoperative clinical course from those of age-related cataracts, and the visual outcome is multifactorial and dependent on postoperative visual rehabilitation. New developments in cataract surgery will continue to improve the visual, anatomical, and patient-reported outcomes. Future work should focus on promoting the accessibility and quality of cataract surgery in developing countries.	[Liu, Yu-Chi; Mehta, Jodhbir S.] Singapore Eye Res Inst, Cornea & Refract Surg Grp, Singapore, Singapore; [Liu, Yu-Chi; Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Dept Cornea & External Eye Dis, Singapore, Singapore; [Wilkins, Mark] Moorfields Eye Hosp, Dept Cornea & External Eye Dis, London, England; [Kim, Terry] Duke Univ, Dept Ophthalmol, Dept Cornea & External Dis, Durham, NC USA; [Malyugin, Boris] S Fyodorov Eye Microsurg State Inst, Dept Cataract & Implant Surg, Moscow, Russia; [Mehta, Jodhbir S.] Duke NUS Med Sch, Dept Clin Sci, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Duke University; National University of Singapore	Mehta, JS (corresponding author), Singapore Natl Eye Ctr, Singapore 168751, Singapore.	jodmehta@gmail.com	Liu, Yu Chi/AAM-7010-2020; Malyugin, Boris E./K-2631-2016; Wilkins, Mark/N-1452-2015	Liu, Yu Chi/0000-0001-5408-0382; Wilkins, Mark/0000-0002-8742-9162	Microsurgical Technology; NovaMedica; Minosys; ValeantBausch Lomb; Morcher; Santen; Bayer Alcon; Carl Zeiss Meditec; Novartis	Microsurgical Technology; NovaMedica; Minosys; ValeantBausch Lomb; Morcher; Santen; Bayer Alcon; Carl Zeiss Meditec; Novartis(Novartis)	TK is on advisory boards for Alcon, Ocular Therapeutix, and Presbyopia Therapies. BM has received personal fees from Microsurgical Technology, NovaMedica, Minosys, ValeantBausch & Lomb, and Morcher; has received grants from Santen, Bayer Alcon, Carl Zeiss Meditec, ValeantBausch & Lomb, and Novartis; and has a patent Expansion Ring. Y-CL, MW, and JSM declare no competing interests.	Ahmed IIK, 2002, J CATARACT REFR SURG, V28, P100, DOI 10.1016/S0886-3350(01)00994-4; Al-Mezaine HS, 2009, EUR J OPHTHALMOL, V19, P804, DOI 10.1177/112067210901900519; Amaya L, 2001, J CATARACT REFR SURG, V27, P1534, DOI 10.1016/S0886-3350(01)01153-1; American Academy of Ophthalmology, 2011, CAT AD EYE PREF PRAC; Ang M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008811.pub3; Balestrazzi A, 2014, CASE REP OPHTHALM, V5, P329, DOI 10.1159/000368344; Barry P, 2007, J CATARACT REFR SURG, V33, P978, DOI 10.1016/j.jcrs.2007.02.032; Behndig A, 2011, J CATARACT REFR SURG, V37, P1539, DOI 10.1016/j.jcrs.2011.05.021; Bobrow JC, LENS AND CATARACT, P2015; Bodnar Z, 2012, J CATARACT REFR SURG, V38, P1902, DOI 10.1016/j.jcrs.2012.06.053; Bourne R, 2007, BRIT J OPHTHALMOL, V91, P420, DOI 10.1136/bjo.2006.106724; Boyer D, 2015, CLIN OPHTHALMOL, V9, P1099, DOI 10.2147/OPTH.S86208; Cao H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071731; Chang DF, 2007, OPHTHALMOLOGY, V114, P957, DOI 10.1016/j.ophtha.2007.01.011; Chang DF, 2005, J CATARACT REFR SURG, V31, P664, DOI 10.1016/j.jcrs.2005.02.027; Chee SP, 2012, J OCUL PHARMACOL TH, V28, P340, DOI 10.1089/jop.2011.0162; Chen TT, 2015, INVEST OPHTH VIS SCI, V56, P1283, DOI 10.1167/iovs.14-16263; Chen XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152088; Chen X, 2016, J CATARACT REFR SURG, V42, P163, DOI 10.1016/j.jcrs.2015.12.005; Chi XX, 2015, MOL VIS, V21, P335; Chu CJ, 2016, OPHTHALMOLOGY, V123, P316, DOI 10.1016/j.ophtha.2015.10.001; Chua J, 2015, OPHTHALMOLOGY, V122, P2169, DOI 10.1016/j.ophtha.2015.06.052; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Claesson M, 2009, ACTA OPHTHALMOL, V87, P154, DOI 10.1111/j.1755-3768.2008.01180.x; Creuzot-Garcher C, 2016, OPHTHALMOLOGY, V123, P1414, DOI 10.1016/j.ophtha.2016.02.019; Day AC, 2015, EYE, V29, P552, DOI 10.1038/eye.2015.3; de Lambert AC, 2013, JAMA OPHTHALMOL, V131, P1159, DOI 10.1001/jamaophthalmol.2013.4242; de Silva SR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008812.pub2; Deng H, 2014, EUR J MED GENET, V57, P113, DOI 10.1016/j.ejmg.2013.12.006; Dobrzynski JM, 2015, CURR ATHEROSCLER REP, V17, DOI 10.1007/s11883-014-0477-2; Donaldson KE, 2013, J CATARACT REFR SURG, V39, P1753, DOI 10.1016/j.jcrs.2013.09.002; Eisenberg JS, 2013, OPHTHALMOLOGY MANAGE, V17, P36; El-Hindy N, 2009, EYE, V23, P50, DOI 10.1038/sj.eye.6703031; ELSTON JS, 1992, BRIT J OPHTHALMOL, V76, P327, DOI 10.1136/bjo.76.6.327; Ewe SYP, 2016, OPHTHALMOLOGY, V123, P178, DOI 10.1016/j.ophtha.2015.09.026; Eydelman MB, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.04.008; Fernandez MM, 2008, CURR OPIN OPHTHALMOL, V19, P66, DOI 10.1097/ICU.0b013e3282f2d7b6; Findl O, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003738.pub3; Fong CSU, 2013, OPHTHALMOLOGY, V120, P1720, DOI 10.1016/j.ophtha.2013.02.009; Ford J, 2014, J CATARACT REFR SURG, V40, P1205, DOI 10.1016/j.jcrs.2014.05.005; Batlle JF, 2014, AM J OPHTHALMOL, V158, P242, DOI 10.1016/j.ajo.2014.04.019; Gil-Cazorla R, 2016, BRIT J OPHTHALMOL, V100, P62, DOI 10.1136/bjophthalmol-2015-306663; Gogate PM, 2003, BRIT J OPHTHALMOL, V87, P667, DOI 10.1136/bjo.87.6.667; Gower EW, 2015, OPHTHALMOLOGY, V122, P1625, DOI 10.1016/j.ophtha.2015.04.036; Grabner G, 2015, AM J OPHTHALMOL, V160, P1176, DOI 10.1016/j.ajo.2015.08.017; Guo SQ, 2015, SURV OPHTHALMOL, V60, P123, DOI 10.1016/j.survophthal.2014.08.005; GUZEK JP, 1987, OPHTHALMOLOGY, V94, P461, DOI 10.1016/S0161-6420(87)33424-4; Hammond CJ, 2000, NEW ENGL J MED, V342, P1786, DOI 10.1056/NEJM200006153422404; Hashemi H, 2016, OPHTHAL EPIDEMIOL, V23, P46, DOI 10.3109/09286586.2015.1083037; Hashemi H, 2015, CURR OPIN OPHTHALMOL, V26, P3, DOI 10.1097/ICU.0000000000000116; Hatch WV, 2009, OPHTHALMOLOGY, V116, P425, DOI 10.1016/j.ophtha.2008.09.039; Heier JS, 2000, OPHTHALMOLOGY, V107, P2034, DOI 10.1016/S0161-6420(00)00365-1; Hong AR, 2015, CURR OPIN OPHTHALMOL, V26, P16, DOI 10.1097/ICU.0000000000000113; Hood CT, 2015, CURR OPIN OPHTHALMOL, V26, P45, DOI 10.1097/ICU.0000000000000112; Huang GQ, 2015, INT J CLIN EXP MED, V8, P18455; Huelle JO, 2017, BRIT J OPHTHALMOL, V101, P97, DOI 10.1136/bjophthalmol-2015-307594; Ianchulev T, 2016, OPHTHALMOLOGY, V123, P723, DOI 10.1016/j.ophtha.2015.12.020; Jabbarvand M, 2016, OPHTHALMOLOGY, V123, P295, DOI 10.1016/j.ophtha.2015.08.023; Jakobsson G, 2009, J CATARACT REFR SURG, V35, P1699, DOI 10.1016/j.jcrs.2009.05.028; Jaycock P, 2009, EYE, V23, P38, DOI 10.1038/sj.eye.6703015; Jensen AA, 2002, OPHTHALMOLOGY, V109, P324, DOI 10.1016/S0161-6420(01)00950-2; Karahan Eyyup, 2014, Med Hypothesis Discov Innov Ophthalmol, V3, P45; Kessel L, 2016, ACTA OPHTHALMOL, V94, P10, DOI 10.1111/aos.12758; Kessel L, 2016, OPHTHALMOLOGY, V123, P275, DOI 10.1016/j.ophtha.2015.10.002; Khanna R, 2011, CURR OPIN OPHTHALMOL, V22, P10, DOI 10.1097/ICU.0b013e3283414f50; Kim SJ, 2008, RETINA-J RET VIT DIS, V28, P870, DOI 10.1097/IAE.0b013e318169d04e; Kinard K, 2013, J CATARACT REFR SURG, V39, P590, DOI 10.1016/j.jcrs.2012.11.023; Klein BEK, 2003, AM J OPHTHALMOL, V136, P506, DOI 10.1016/S0002-9394(03)00290-3; Klein R, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12789; Kong KL, 2015, BRIT J OPHTHALMOL, V99, P1025, DOI 10.1136/bjophthalmol-2014-306036; Kumar P, 2016, EXPERT REV MED DEVIC, V13, P381, DOI 10.1586/17434440.2016.1153967; Lai E, 2014, CURR OPIN OPHTHALMOL, V25, P35, DOI 10.1097/ICU.0000000000000016; Lalwani GA, 2008, OPHTHALMOLOGY, V115, P473, DOI 10.1016/j.ophtha.2007.06.006; Lambert SR, 2014, JAMA OPHTHALMOL, V132, P676, DOI 10.1001/jamaophthalmol.2014.531; Lamoureux EL, 2011, CURR OPIN OPHTHALMOL, V22, P19, DOI 10.1097/ICU.0b013e3283414284; Lansingh VC, 2007, OPHTHALMOLOGY, V114, P1670, DOI 10.1016/j.ophtha.2006.12.013; Lansingh VC, 2015, CLIN EXP OPHTHALMOL, V43, P666, DOI 10.1111/ceo.12527; Lewallen S, 2009, BRIT J OPHTHALMOL, V93, P295, DOI 10.1136/bjo.2008.140301; Li JP, 2008, DRUG SAFETY, V31, P127, DOI 10.2165/00002018-200831020-00003; Li L, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-94; Liao JM, 2014, HUM MOL GENET, V23, P6119, DOI 10.1093/hmg/ddu315; Lin HT, 2016, NATURE, V531, P323, DOI 10.1038/nature17181; Liu YC, 2013, CURR OPIN OPHTHALMOL, V24, P53, DOI 10.1097/ICU.0b013e32835a93fc; Lundstrom M, 2012, J CATARACT REFR SURG, V38, P1086, DOI 10.1016/j.jcrs.2012.03.006; Maalouf F, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/313248; McAlinden C, 2011, OPHTHALMOLOGY, V118, P2374, DOI 10.1016/j.ophtha.2011.06.008; Mitchell P, 1997, OPHTHALMOLOGY, V104, P581, DOI 10.1016/S0161-6420(97)30266-8; Mollan SP, 2007, J CATARACT REFR SURG, V33, P265, DOI 10.1016/j.jcrs.2006.10.022; Monestam E, 2016, J CATARACT REFR SURG, V42, P19, DOI 10.1016/j.jcrs.2015.07.040; Monestam EI, 2012, ACTA OPHTHALMOL, V90, P651, DOI 10.1111/j.1755-3768.2011.02138.x; Paganelli F, 2010, EXPERT OPIN DRUG DEL, V7, P955, DOI 10.1517/17425247.2010.498817; Pan CW, 2013, AM J OPHTHALMOL, V156, P1021, DOI 10.1016/j.ajo.2013.06.005; Pepose JS, 2017, CURR OPIN OPHTHALMOL, V28, P3, DOI 10.1097/ICU.0000000000000323; Pichi F, 2016, DEV OPHTHALMOL, V57, P1, DOI 10.1159/000442495; Poh S, 2016, DIABETES RES CLIN PR, V113, P86, DOI 10.1016/j.diabres.2016.01.016; Pueringer SL, 2011, AM J OPHTHALMOL, V152, P618, DOI 10.1016/j.ajo.2011.03.009; Rhee Michelle K, 2016, Int Ophthalmol Clin, V56, P117, DOI 10.1097/IIO.0000000000000122; Riaz Y, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001323.pub2; Riaz Y, 2013, COCHRANE DB SYST REV, V10, DOI DOI 10.1002/14651858.CD008813.PUB2; Richter GM, 2012, OPHTHALMOLOGY, V119, P547, DOI 10.1016/j.ophtha.2011.09.005; Rim TH, 2016, INVEST OPHTH VIS SCI, V57, P1112, DOI 10.1167/iovs.15-18276; Rodrigues EB, 2009, SURV OPHTHALMOL, V54, P576, DOI 10.1016/j.survophthal.2009.04.011; Rosen E, 2016, J CATARACT REFR SURG, V42, P310, DOI 10.1016/j.jcrs.2016.01.014; Royal College of Ophthalmologists, 2010, CAT SURG GUID; Ruit S, 1999, OPHTHALMOLOGY, V106, P1887, DOI 10.1016/S0161-6420(99)90397-4; Ruit S, 2007, AM J OPHTHALMOL, V143, P32, DOI 10.1016/j.ajo.2006.07.023; Schaumberg DA, 1998, OPHTHALMOLOGY, V105, P1213, DOI 10.1016/S0161-6420(98)97023-3; Schein OD, 2000, NEW ENGL J MED, V342, P168, DOI 10.1056/NEJM200001203420304; Schein OD, 2012, OPHTHAL EPIDEMIOL, V19, P257, DOI 10.3109/09286586.2012.698692; Schuster AK, 2015, J CATARACT REFR SURG, V41, P1088, DOI 10.1016/j.jcrs.2015.04.005; Shahbazi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142459; Signes-Soler I, 2016, MIDDLE EAST AFR J OP, V23, P187, DOI 10.4103/0974-9233.175890; Simon JW, PEDIAT OPHTHALMOLOGY, P2007; Song Zixun, 2014, Eye Sci, V29, P138; Sparrow JM, 2007, BRIT J OPHTHALMOL, V91, P852, DOI 10.1136/bjo.2006.111211; Storey P, 2013, INVEST OPHTH VIS SCI, V54, P3010, DOI 10.1167/iovs.12-11412; Studeny P, 2016, EUR J OPHTHALMOL, V26, P230, DOI 10.5301/ejo.5000653; Sun W, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0065-4; Syed ZA, 2015, BRIT J OPHTHALMOL, V99, P1460, DOI 10.1136/bjophthalmol-2014-306586; Tan Leshan, 2006, Community Eye Health, V19, P61; TAYLOR HR, 1988, NEW ENGL J MED, V319, P1429, DOI 10.1056/NEJM198812013192201; Ti SE, 2014, AM J OPHTHALMOL, V157, P180, DOI 10.1016/j.ajo.2013.08.022; Tian YH, 2015, BRIT J OPHTHALMOL, V99, P1650, DOI 10.1136/bjophthalmol-2015-306653; Tribus C, 2007, CLIN OPHTHALMOL, V1, P65; Tseng VL, 2016, OPHTHALMOLOGY, V123, P1019, DOI 10.1016/j.ophtha.2015.12.033; Varma R, 2004, OPHTHALMOLOGY, V111, P1449, DOI 10.1016/j.ophtha.2004.01.024; VINE AK, 1995, ARCH OPHTHALMOL-CHIC, V113, P1479; Vinson Joe A, 2006, Pathophysiology, V13, P151, DOI 10.1016/j.pathophys.2006.05.006; Wang JJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P1186, DOI 10.1001/archopht.119.8.1186; Wang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107820; Weikel KA, 2014, NUTR REV, V72, P30, DOI 10.1111/nure.12077; Werner L, 2001, OPHTHALMOLOGY, V108, P1675, DOI 10.1016/S0161-6420(01)00674-1; WHO, 2016, BLINDN VIS 2020 CONT; Wilkins MR, 2013, OPHTHALMOLOGY, V120, P2449, DOI 10.1016/j.ophtha.2013.07.048; World Health Organization, 2007, VIS 2020 RIGHT SIGHT; World Health Organization, 2021, BLINDN VIS IMP; Wu H, 2014, INVEST OPHTH VIS SCI, V55, P3660, DOI 10.1167/iovs.13-13695; Wu MH, 2016, MOL NEUROBIOL, V53, P4961, DOI 10.1007/s12035-015-9418-5; Yang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071003; Yonekawa Y, 2012, CURR OPIN OPHTHALMOL, V23, P26, DOI 10.1097/ICU.0b013e32834cd5f8; Yonova-Doing E, 2016, OPHTHALMOLOGY, V123, P1237, DOI 10.1016/j.ophtha.2016.01.036; Zaidi FH, 2007, BRIT J OPHTHALMOL, V91, P731, DOI 10.1136/bjo.2006.104216; Zetterstrom C, 2007, ACTA OPHTHALMOL SCAN, V85, P238, DOI 10.1111/j.1600-0420.2007.00883.x; Zhang KK, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/5438676; Zhao LQ, 2012, OPHTHALMOLOGY, V119, P659, DOI 10.1016/j.ophtha.2011.09.056; Zhao L, 2015, NATURE, V523, P607, DOI 10.1038/nature14650; Zhu JF, 2012, CHINESE MED J-PEKING, V125, P3654, DOI 10.3760/cma.j.issn.0366-6999.2012.20.010	147	334	351	21	129	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 5	2017	390	10094					600	612		10.1016/S0140-6736(17)30544-5	http://dx.doi.org/10.1016/S0140-6736(17)30544-5			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC5BM	28242111				2022-12-28	WOS:000406855800024
J	Pinsky, PF				Pinsky, Paul F.			Flexible sigmoidoscopy screening: is once enough?	LANCET			English	Editorial Material							COLORECTAL-CANCER; GUIDELINES		[Pinsky, Paul F.] NCI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pinsky, PF (corresponding author), NCI, Bethesda, MD 20892 USA.	pp4f@nih.gov						Armaroli P, 2015, CANCER EPIDEMIOL, V39, pS139, DOI 10.1016/j.canep.2015.10.021; Atkin W, 2017, LANCET; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V315, P2564, DOI 10.1001/jama.2016.5989; Ferlay J. S. I., 2013, IARC CANC BASE; Knudsen AB, 2016, JAMA-J AM MED ASSOC, V315, P2595, DOI 10.1001/jama.2016.6828; Kuntz KM, 2011, MED DECIS MAKING, V31, P530, DOI 10.1177/0272989X11408730; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Smith RA, 2015, CA-CANCER J CLIN, V65, P30, DOI 10.3322/caac.21261; Vleugels JLA, 2017, GASTROINTEST ENDOSC, V85, P1169, DOI 10.1016/j.gie.2016.12.014; von Karsa L, 2013, ENDOSCOPY, V45, P51, DOI 10.1055/s-0032-1325997	11	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 1	2017	389	10076					1275	1277		10.1016/S0140-6736(17)30542-1	http://dx.doi.org/10.1016/S0140-6736(17)30542-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EQ2OF	28236465	hybrid			2022-12-28	WOS:000397908700004
J	Zhang, WM; Zhao, GH; Luo, ZQ; Lin, YC; Wang, LH; Guo, YK; Wang, A; Jiang, SY; Jiang, QW; Gong, JH; Wang, Y; Hou, S; Huang, J; Li, TY; Qin, YR; Dong, JK; Qin, Q; Zhang, JY; Zou, XZ; He, X; Zhao, L; Xiao, YB; Xu, M; Cheng, EC; Huang, N; Zhou, T; Shen, Y; Walker, R; Luo, YS; Kuang, Z; Mitchell, LA; Yang, K; Richardson, SM; Wu, Y; Li, BZ; Yuan, YJ; Yang, HM; Lin, JW; Chen, GQ; Wu, QY; Bader, JS; Cai, YZ; Boeke, JD; Dai, JB				Zhang, Weimin; Zhao, Guanghou; Luo, Zhouqing; Lin, Yicong; Wang, Lihui; Guo, Yakun; Wang, Ann; Jiang, Shuangying; Jiang, Qingwen; Gong, Jianhui; Wang, Yun; Hou, Sha; Huang, Jing; Li, Tianyi; Qin, Yiran; Dong, Junkai; Qin, Qin; Zhang, Jiaying; Zou, Xinzhi; He, Xi; Zhao, Li; Xiao, Yibo; Xu, Meng; Cheng, Erchao; Huang, Ning; Zhou, Tong; Shen, Yue; Walker, Roy; Luo, Yisha; Kuang, Zheng; Mitchell, Leslie A.; Yang, Kun; Richardson, Sarah M.; Wu, Yi; Li, Bing-Zhi; Yuan, Ying-Jin; Yang, Huanming; Lin, Jiwei; Chen, Guo-Qiang; Wu, Qingyu; Bader, Joel S.; Cai, Yizhi; Boeke, Jef D.; Dai, Junbiao			Engineering the ribosomal DNA in a megabase synthetic chromosome	SCIENCE			English	Article							YEAST; GENES	We designed and synthesized a 976,067-base pair linear chromosome, synXII, based on native chromosome XII in Saccharomyces cerevisiae. SynXII was assembled using a twostep method, specified by successive megachunk integration and meiotic recombinationmediated assembly, producing a functional chromosome in S. cerevisiae. Minor growth defect " bugs" detected in synXII, caused by deletion of tRNA genes, were rescued by introducing an ectopic copy of a single tRNA gene. The ribosomal gene cluster (rDNA) on synXII was left intact during the assembly process and subsequently replaced by a modified rDNA unit used to regenerate rDNA at three distinct chromosomal locations. The signature sequences within rDNA, which can be used to determine species identity, were swapped to generate a Saccharomyces synXII strain that would be identified as Saccharomyces bayanus by standard DNA barcoding procedures.	[Zhang, Weimin; Zhao, Guanghou; Luo, Zhouqing; Lin, Yicong; Wang, Lihui; Guo, Yakun; Wang, Ann; Jiang, Shuangying; Jiang, Qingwen; Hou, Sha; Huang, Jing; Li, Tianyi; Qin, Yiran; Dong, Junkai; Qin, Qin; Zhang, Jiaying; Zou, Xinzhi; He, Xi; Zhao, Li; Xiao, Yibo; Xu, Meng; Cheng, Erchao; Huang, Ning; Zhou, Tong; Chen, Guo-Qiang; Wu, Qingyu; Dai, Junbiao] Tsinghua Univ, Minist Educ, Key Lab Ind Biocatalysis, Beijing 100084, Peoples R China; [Zhang, Weimin; Zhao, Guanghou; Luo, Zhouqing; Lin, Yicong; Wang, Lihui; Guo, Yakun; Wang, Ann; Jiang, Shuangying; Jiang, Qingwen; Hou, Sha; Huang, Jing; Li, Tianyi; Qin, Yiran; Dong, Junkai; Qin, Qin; Zhang, Jiaying; Zou, Xinzhi; He, Xi; Zhao, Li; Xiao, Yibo; Xu, Meng; Cheng, Erchao; Huang, Ning; Zhou, Tong; Chen, Guo-Qiang; Wu, Qingyu; Dai, Junbiao] Tsinghua Univ, Ctr Synthet & Syst Biol, Sch Life Sci, Beijing 100084, Peoples R China; [Zhang, Weimin; Li, Tianyi; Zhang, Jiaying] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Zhao, Guanghou] Peking Univ, Coll Life Sci, Peking Univ Tsinghua Univ Natl Inst Biol Sci Join, Beijing 100871, Peoples R China; [Gong, Jianhui; Wang, Yun; Shen, Yue; Yang, Huanming] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Shen, Yue; Walker, Roy; Luo, Yisha; Cai, Yizhi] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3BF, Midlothian, Scotland; [Shen, Yue] BGI Qingdao, Qingdao 266555, Peoples R China; [Kuang, Zheng; Mitchell, Leslie A.; Boeke, Jef D.] NYU, Langone Med Ctr, Inst Syst Genet, New York, NY 10011 USA; [Kuang, Zheng; Mitchell, Leslie A.; Boeke, Jef D.] NYU, Langone Med Ctr, Dept Biochem & Mol Pharmacol, New York, NY 10011 USA; [Yang, Kun; Richardson, Sarah M.; Bader, Joel S.] Johns Hopkins Univ, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Yang, Kun; Richardson, Sarah M.; Bader, Joel S.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Wu, Yi; Li, Bing-Zhi; Yuan, Ying-Jin] Tianjin Univ, Key Lab Syst Bioengn, Minist Educ,Sch Chem Engn & Technol, SynBio Res Platform,Collaborat Innovat Ctr Chem S, Tianjin 300072, Peoples R China; [Yang, Huanming] James D Watson Inst Genome Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Lin, Jiwei] Wuxi Qinglan Biotechnol Inc, Yixing 214200, Jiangsu, Peoples R China; [Wang, Ann] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Tsinghua University; Tsinghua University; Tsinghua University; Peking University; Tsinghua University; Beijing Genomics Institute (BGI); University of Edinburgh; Beijing Genomics Institute (BGI); New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Johns Hopkins University; Johns Hopkins University; Tianjin University; Icahn School of Medicine at Mount Sinai	Dai, JB (corresponding author), Tsinghua Univ, Minist Educ, Key Lab Ind Biocatalysis, Beijing 100084, Peoples R China.; Dai, JB (corresponding author), Tsinghua Univ, Ctr Synthet & Syst Biol, Sch Life Sci, Beijing 100084, Peoples R China.	jbdai@tsinghua.edu.cn	Zhao, Guanghou/GPF-3341-2022; Dai, Junbiao/AAB-8328-2021; li, bing/GWQ-9617-2022; li, bz/GVR-7133-2022; Luo, Zhouqing/E-3186-2017; Zhao, Guanghou/E-7834-2017; Kuang, Zheng/ABG-3667-2021; Cai, Yizhi/A-3550-2010	Dai, Junbiao/0000-0002-5299-4700; Luo, Zhouqing/0000-0001-5426-5176; Zhao, Guanghou/0000-0002-3192-5423; Wu, Yi/0000-0002-2539-9228; Cai, Yizhi/0000-0003-1663-2865; Richardson, Sarah/0000-0002-9820-9421; Walker, Roy/0000-0003-0960-4591; Jiang, Shuangying/0000-0002-6786-6533; Mitchell, Leslie/0000-0001-7869-9817	National Natural Science Foundation of China [31471254, 21621004, 21390203]; Chinese Ministry of Science and Technology [2012CB725201, 2012AA02A708]; Ph.D. Programs Foundation of Ministry of Education of China [20110002120055]; Research Fund for the Doctoral Program of Higher Education of China [20120002110022]; Tsinghua University Initiative grant [2011Z02296]; NSF [MCB-1026068, MCB-1158201, MCB-1445545]; BBSRC [BB/M005690/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M005690/1] Funding Source: researchfish	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Tsinghua University Initiative grant; NSF(National Science Foundation (NSF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank J. Fang of the DNA sequencing facility at Tsinghua University for providing the genome and RNA sequencing service; P. Hare for critical reading and thoughtful comments on the manuscript; and the Thousand Talent Program and Tsinghua University for initial startup funding. Supported by National Natural Science Foundation of China grant 31471254, Chinese Ministry of Science and Technology grant 2012CB725201, Ph.D. Programs Foundation of Ministry of Education of China grant 20110002120055, Research Fund for the Doctoral Program of Higher Education of China grant 20120002110022, and Tsinghua University Initiative grant 2011Z02296 (J. Dai); NSF grants MCB-1026068 and MCB-1158201 (J.D.B.) and by NSF grant MCB-1445545 (J.S.B.). Work at Tianjin University was funded by National Natural Science Foundation of China grants 21621004 and 21390203. Work at BGI was funded by Chinese Ministry of Science and Technology grant 2012AA02A708. J.D.B. and J.S.B. are founders and directors of Neochromosome Inc. J.D.B. serves on the scientific advisory boards of Sample6 Inc., Modern Meadow Inc., and Recombinetics Inc. These arrangements are reviewed and managed by the committees on conflict of interest at NYU Langone Medical Center (J.D.B.) and Johns Hopkins University (J.S.B.). J. Dai is the founder of Wuxi Qinglan Biotechnology Inc. Additional information [synXII design diagram, PCRTag sequences, feature summary table (wild-type XII, designed synXII, physical strain JDY467; yeast_chr12_9_02), variants in physical strain (yeast_chr12_9_02), PCR primers, summary of megachunks] related to synXII can be accessed on the Sc2.0 website (www.syntheticyeast.org). All genomic data for this paper are available under Sc2.0 umbrella BioProject accession number PRJNA351844.	Annaluru N, 2014, SCIENCE, V344, P55, DOI 10.1126/science.1249252; Bespalov VA, 2001, ENVIRON MOL MUTAGEN, V38, P166, DOI 10.1002/em.1068; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Brown Terry, 2004, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0409s67; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Dymond JS, 2011, NATURE, V477, P471, DOI 10.1038/nature10403; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Guo YK, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv464; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Johnston M, 1997, NATURE, V387, P87, DOI 10.1038/387s087; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; McDonald K, 2007, METHOD CELL BIOL, V79, P23, DOI 10.1016/S0091-679X(06)79002-1; Mercy G, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4597; Mitchell LA, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4831; Nierras CR, 1997, CHROMOSOMA, V105, P444; Oakes M, 1998, J CELL BIOL, V143, P23, DOI 10.1083/jcb.143.1.23; Parenteau J, 2011, CELL, V147, P320, DOI 10.1016/j.cell.2011.08.044; Pena MMO, 2000, J BIOL CHEM, V275, P33244, DOI 10.1074/jbc.M005392200; PETES TD, 1980, ANNU REV BIOCHEM, V49, P845, DOI 10.1146/annurev.bi.49.070180.004213; Richardson SM, 2017, SCIENCE, V355, P1040, DOI 10.1126/science.aaf4557; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; Shen Y, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4791; Velichutina IV, 1998, RNA, V4, P594, DOI 10.1017/S1355838298980049; Wai HH, 2000, NUCLEIC ACIDS RES, V28, P3524, DOI 10.1093/nar/28.18.3524; Wu Y, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4706	26	104	128	16	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI				eaaf3981	10.1126/science.aaf3981	http://dx.doi.org/10.1126/science.aaf3981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9VY	28280149				2022-12-28	WOS:000396348900036
J	Johnson, ZL; Chen, J				Johnson, Zachary Lee; Chen, Jue			Structural Basis of Substrate Recognition by the Multidrug Resistance Protein MRP1	CELL			English	Article							NUCLEOTIDE-BINDING DOMAINS; CHARGED AMINO-ACIDS; P-GLYCOPROTEIN; CRYSTAL-STRUCTURE; MALTOSE TRANSPORTER; LEUKOTRIENE C-4; MOLECULAR-BASIS; ATP; CFTR; GLUTATHIONE	The multidrug resistance protein MRP1 is an ATP-binding cassette (ABC) transporter that confers resistance to many anticancer drugs and plays a role in the disposition and efficacy of several opiates, antidepressants, statins, and antibiotics. In addition, MRP1 regulates redox homeostasis, inflammation, and hormone secretion. Using electron cryomicroscopy, we determined the molecular structures of bovine MRP1 in two conformations: an apo form at 3.5 angstrom without any added substrate and a complex form at 3.3 angstrom with one of its physiological substrates, leukotriene C-4. These structures show that by forming a single bipartite binding site, MRP1 can recognize a spectrum of substrates with different chemical structures. We also observed large conformational changes induced by leukotriene C-4, explaining how substrate binding primes the transporter for ATP hydrolysis. Structural comparison of MRP1 and P-glycoprotein advances our understanding of the common and unique properties of these two important molecules in multidrug resistance to chemotherapy.	[Johnson, Zachary Lee; Chen, Jue] Rockefeller Univ, Lab Membrane Biol & Biophys, 1230 York Ave, New York, NY 10065 USA; [Johnson, Zachary Lee; Chen, Jue] Howard Hughes Med Inst, 1230 York Ave, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute	Chen, J (corresponding author), Rockefeller Univ, Lab Membrane Biol & Biophys, 1230 York Ave, New York, NY 10065 USA.; Chen, J (corresponding author), Howard Hughes Med Inst, 1230 York Ave, New York, NY 10065 USA.	juechen@rockefeller.edu			Jane Coffin Childs Memorial Fund; Rockefeller University; Howard Hughes Medical Institute	Jane Coffin Childs Memorial Fund; Rockefeller University; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank Mark Ebrahim and Johanna Sotiris at Rockefeller University's Evelyn Gruss Lipper Cryo-Electron Microscopy Resource Center for assistance in data collection, Michael Oldham for assistance in EM data processing and figure making, Eric Gouaux for reagents used in the mammalian expression system, Yuxin Mao for initial screening of MRP1 constructs, Roderick MacKinnon and his lab for helpful discussions, and Sarah McCarry for editing of the manuscript. Z.J. is a fellow of the Jane Coffin Childs Memorial Fund for Medical Research. This work was supported by funds from The Rockefeller University and the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bakos E, 1998, J BIOL CHEM, V273, P32167, DOI 10.1074/jbc.273.48.32167; Bakos E, 2000, MOL PHARMACOL, V57, P760, DOI 10.1124/mol.57.4.760; Bilan F, 2004, J CELL SCI, V117, P1923, DOI 10.1242/jcs.01070; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Campbell JD, 2004, J BIOL CHEM, V279, P463, DOI 10.1074/jbc.M310711200; Cascorbi I, 2011, HANDB EXP PHARMACOL, V201, P261, DOI 10.1007/978-3-642-14541-4_6; Chan KW, 2003, EMBO J, V22, P3833, DOI 10.1093/emboj/cdg376; Chaptal V., 2014, BIOCHEM PHARMACOL, V3, P150; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cole SPC, 2006, TRENDS PHARMACOL SCI, V27, P438, DOI 10.1016/j.tips.2006.06.008; Cole SPC, 2014, ANNU REV PHARMACOL, V54, P95, DOI 10.1146/annurev-pharmtox-011613-135959; Dallas S, 2006, PHARMACOL REV, V58, P140, DOI 10.1124/pr.58.2.3; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; Deeley RG, 2006, FEBS LETT, V580, P1103, DOI 10.1016/j.febslet.2005.12.036; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fu J, 2001, J PHYSIOL-LONDON, V536, P459, DOI 10.1111/j.1469-7793.2001.0459c.xd; Gao M, 2000, J BIOL CHEM, V275, P13098, DOI 10.1074/jbc.275.17.13098; Gene GG, 2008, HUM MUTAT, V29, P738, DOI 10.1002/humu.20721; Geourjon C, 2001, TRENDS BIOCHEM SCI, V26, P539, DOI 10.1016/S0968-0004(01)01907-7; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Grant CE, 2008, DRUG METAB DISPOS, V36, P2571, DOI 10.1124/dmd.108.022491; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Grigorieff N, 2016, METHOD ENZYMOL, V579, P191, DOI 10.1016/bs.mie.2016.04.013; Haimeur A, 2004, MOL PHARMACOL, V65, P1375, DOI 10.1124/mol.65.6.1375; Haimeur A, 2002, J BIOL CHEM, V277, P41326, DOI 10.1074/jbc.M206228200; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Ito K, 2001, J BIOL CHEM, V276, P15616, DOI 10.1074/jbc.M011246200; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Jurkuvenaite A, 2006, J BIOL CHEM, V281, P3329, DOI 10.1074/jbc.M508131200; Koch J, 2004, J BIOL CHEM, V279, P10142, DOI 10.1074/jbc.M312816200; Kodan A, 2014, P NATL ACAD SCI USA, V111, P4049, DOI 10.1073/pnas.1321562111; Koike K, 2002, J BIOL CHEM, V277, P49495, DOI 10.1074/jbc.M206896200; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Leslie EM, 2003, DRUG METAB DISPOS, V31, P11, DOI 10.1124/dmd.31.1.11; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; Maeno K, 2009, DRUG METAB DISPOS, V37, P1411, DOI 10.1124/dmd.109.026633; Mao QC, 2000, J BIOL CHEM, V275, P34166, DOI 10.1074/jbc.M004584200; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagata K, 2000, J BIOL CHEM, V275, P17626, DOI 10.1074/jbc.M000792200; Naren AP, 1999, SCIENCE, V286, P544, DOI 10.1126/science.286.5439.544; Naren AP, 1998, P NATL ACAD SCI USA, V95, P10972, DOI 10.1073/pnas.95.18.10972; Nicholls RA, 2014, ACTA CRYSTALLOGR D, V70, P2487, DOI 10.1107/S1399004714016241; Oldham ML, 2016, ELIFE, V5, DOI 10.7554/eLife.21829; Oldham ML, 2016, NATURE, V529, P537, DOI 10.1038/nature16506; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Paulusma CC, 1999, BIOCHEM J, V338, P393, DOI 10.1042/0264-6021:3380393; Payen L, 2005, MOL PHARMACOL, V67, P1944, DOI 10.1124/mol.104.007708; Peters KW, 2001, PFLUG ARCH EUR J PHY, V443, pS65, DOI 10.1007/s004240100647; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prince LS, 1999, J BIOL CHEM, V274, P3602, DOI 10.1074/jbc.274.6.3602; Ren XQ, 2002, BIOCHEMISTRY-US, V41, P14132, DOI 10.1021/bi026443s; Renes J, 1999, BRIT J PHARMACOL, V126, P681, DOI 10.1038/sj.bjp.0702360; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rubinstein JL, 2015, J STRUCT BIOL, V192, P188, DOI 10.1016/j.jsb.2015.08.007; Salerno M, 2001, EUR J PHARMACOL, V421, P1, DOI 10.1016/S0014-2999(01)00992-X; SCHARSCHMIDT BF, 1979, J LAB CLIN MED, V93, P790; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Seelig A, 1998, EUR J BIOCHEM, V251, P252, DOI 10.1046/j.1432-1327.1998.2510252.x; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; Sindelar CV, 2012, J STRUCT BIOL, V180, P26, DOI 10.1016/j.jsb.2012.05.005; Situ D, 2004, J BIOL CHEM, V279, P38871, DOI 10.1074/jbc.M403832200; Slot AJ, 2011, ESSAYS BIOCHEM, V50, P179, DOI [10.1042/BSE0500179, 10.1042/bse0500179]; STEIN PE, 1994, STRUCTURE, V2, P45, DOI 10.1016/S0969-2126(00)00007-1; Szewczyk P, 2015, ACTA CRYSTALLOGR D, V71, P732, DOI 10.1107/S1399004715000978; Taguchi Y, 2002, FEBS LETT, V521, P211, DOI 10.1016/S0014-5793(02)02816-8; TENEYCK LF, 1977, ACTA CRYSTALLOGR A, V33, P486, DOI 10.1107/S0567739477001211; Ward AB, 2013, P NATL ACAD SCI USA, V110, P13386, DOI 10.1073/pnas.1309275110; Westlake CJ, 2003, BIOCHEMISTRY-US, V42, P14099, DOI 10.1021/bi035333y; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007; Zhang Z, 2016, CELL, V167, P1586, DOI 10.1016/j.cell.2016.11.014	84	210	218	5	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2017	168	6					1075	+		10.1016/j.cell.2017.01.041	http://dx.doi.org/10.1016/j.cell.2017.01.041			20	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8ZF	28238471	Bronze			2022-12-28	WOS:000396287900015
J	Bloomfield, HE; Greer, N; Kane, R; Wilt, TJ				Bloomfield, Hanna E.; Greer, Nancy; Kane, Robert; Wilt, Timothy J.			Effects on Health Outcomes of a Mediterranean Diet With No Restriction on Fat Intake RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Bloomfield, Hanna E.; Greer, Nancy; Wilt, Timothy J.] Minneapolis VA Med Ctr, Minneapolis, MN 55417 USA; [Kane, Robert] Univ Minnesota, Minneapolis, MN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities	Bloomfield, HE (corresponding author), Minneapolis VA Med Ctr, Minneapolis, MN 55417 USA.							Fung TT, 2008, ARCH INTERN MED, V168, P713, DOI 10.1001/archinte.168.7.713; Rees K, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009825.pub2	2	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2017	166	5					378	379		10.7326/L16-0617	http://dx.doi.org/10.7326/L16-0617			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BO	28265659				2022-12-28	WOS:000396432800019
J	Moberly, T				Moberly, Tom			The world class talent signing for team NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												tmoberly@bmj.com							0	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2017	356								j1036	10.1136/bmj.j1036	http://dx.doi.org/10.1136/bmj.j1036			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JT	28249892				2022-12-28	WOS:000395628400001
J	Yang, YT; Studdert, DM				Yang, Y. Tony; Studdert, David M.			Linking Immunization Status and Eligibility for Welfare and Benefits Payments The Australian "No Jab, No Pay" Legislation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VACCINE REFUSAL		[Yang, Y. Tony] George Mason Univ, Dept Hlth Adm & Policy, MS 1J3,4400 Univ Dr, Fairfax, VA 22030 USA; [Studdert, David M.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Studdert, David M.] Stanford Law Sch, Stanford, CA 94305 USA	George Mason University; Stanford University; Stanford University	Yang, YT (corresponding author), George Mason Univ, Dept Hlth Adm & Policy, MS 1J3,4400 Univ Dr, Fairfax, VA 22030 USA.	ytyang@gmu.edu	Studdert, David/AAF-3116-2021	Studdert, David/0000-0003-0585-5537				Hill Holly A, 2016, MMWR Morb Mortal Wkly Rep, V65, P1065, DOI 10.15585/mmwr.mm6539a4; Klapdor Michael., 2015, NO JAB NO PAY OTHER; Lieu TA, 2015, PEDIATRICS, V135, P280, DOI 10.1542/peds.2014-2715; Phadke VK, 2016, JAMA-J AM MED ASSOC, V315, P1149, DOI 10.1001/jama.2016.1353; Yang YT, 2016, AM J PUBLIC HEALTH, V106, P172, DOI 10.2105/AJPH.2015.302926	5	15	15	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2017	317	8					803	804		10.1001/jama.2017.0123	http://dx.doi.org/10.1001/jama.2017.0123			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM7PW	28245331				2022-12-28	WOS:000395505600013
J	Fakhouri, F; Zuber, J; Fremeaux-Bacchi, V; Loirat, C				Fakhouri, Fadi; Zuber, Julien; Fremeaux-Bacchi, Veronique; Loirat, Chantal			Haemolytic uraemic syndrome	LANCET			English	Review							STEM-CELL TRANSPLANTATION; ESCHERICHIA-COLI O104H4; COBALAMIN C DEFICIENCY; INDUCED THROMBOTIC MICROANGIOPATHY; GENETIC COMPLEMENT ABNORMALITIES; FACTOR-H ANTIBODIES; LONG-TERM OUTCOMES; ANTIPHOSPHOLIPID SYNDROME; ALTERNATIVE PATHWAY; NEUROLOGICAL INVOLVEMENT	Haemolytic uraemic syndrome is a form of thrombotic microangiopathy affecting predominantly the kidney and characterised by a triad of thrombocytopenia, mechanical haemolytic anaemia, and acute kidney injury. The term encompasses several disorders: shiga toxin-induced and pneumococcus-induced haemolytic uraemic syndrome, haemolytic uraemic syndrome associated with complement dysregulation or mutation of diacylglycerol kinase epsilon, haemolytic uraemic syndrome related to cobalamin C defect, and haemolytic uraemic syndrome secondary to a heterogeneous group of causes ( infections, drugs, cancer, and systemic diseases). In the past two decades, experimental, genetic, and clinical studies have helped to decipher the pathophysiology of these various forms of haemolytic uraemic syndrome and undoubtedly improved diagnostic approaches. Moreover, a specific mechanism-based treatment has been made available for patients affected by atypical haemolytic uraemic syndrome due to complement dysregulation. Such treatment is, however, still absent for several other disease types, including shiga toxin-induced haemolytic uraemic syndrome.	[Fakhouri, Fadi] CHU, Dept Nephrol, Nantes, France; [Fakhouri, Fadi] INSERM, UMR S1064, Nantes, France; [Zuber, Julien] Univ Paris 05, Hop Necker, Dept Nephrol & Renal Transplantat, AP HP, Paris, France; [Fremeaux-Bacchi, Veronique] Hop Europaen Georges Pompidou, Dept Biol Immunol, AP HP, Paris, France; [Fremeaux-Bacchi, Veronique] INSERM, Complement & Malad, Ctr Rech Cordeliers, UMR S1138, Paris, France; [Loirat, Chantal] Univ Paris Diderot, Hop Robert Debre, Dept Pediat Nephrol, AP HP, Sorbonne Paris Cite, Paris, France	Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Loirat, C (corresponding author), Hop Robert Debre, Dept Pediat Nephrol, F-75019 Paris, France.	chantal.loirat@aphp.fr	ZUBER, Julien/HGD-9815-2022	Fakhouri, Fadi/0000-0001-5390-8002; Zuber, Julien/0000-0001-6741-9330	Emmanuel Boussard Foundation	Emmanuel Boussard Foundation	FF, JZ, VF-B, and CL served on advisory boards or in teaching courses, or both, for Alexion Pharmaceuticals. VF-B serves as coordinator and FF serves as member of the scientific advisory board of Alexion M11-001 atypical Haemolytic Uraemic Syndrome international registry, and CL serves as coordinator for France for this registry. JZ's research is supported by the Emmanuel Boussard Foundation.	Agger M, 2015, J ANTIMICROB CHEMOTH, V70, P2440, DOI 10.1093/jac/dkv162; Al Ustwani O, 2014, J GASTROINTEST ONCOL, V5, pE30, DOI 10.3978/j.issn.2078-6891.2013.042; Al-Nouri ZL, 2015, BLOOD, V125, P616, DOI 10.1182/blood-2014-11-611335; Amorim ED, 2015, J NEPHROL, V28, P641, DOI 10.1007/s40620-015-0173-5; Ardissino G, 2016, EUR J PEDIATR, V175, P465, DOI 10.1007/s00431-015-2642-1; Ardissino G, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2153; Ardissino G, 2015, PEDIATR NEPHROL, V30, P345, DOI 10.1007/s00467-014-2918-0; Ardissino G, 2014, AM J KIDNEY DIS, V63, P652, DOI 10.1053/j.ajkd.2013.09.020; Ardissino G, 2013, OBSTET GYNECOL, V122, P487, DOI 10.1097/AOG.0b013e31828e2612; Avila A, 2015, CLIN KIDNEY J, V8, P232, DOI 10.1093/ckj/sfu144; Bakhtar O, CASE THROMBOTIC MICR; Banerjee R, 2011, PEDIATR INFECT DIS J, V30, P736, DOI 10.1097/INF.0b013e3182191c58; Baskin E, 2015, PEDIATR NEPHROL, V30, P783, DOI 10.1007/s00467-014-3003-4; Belford A, 2004, AM J HEMATOL, V76, P156, DOI 10.1002/ajh.20068; Bresin E, 2013, J AM SOC NEPHROL, V24, P475, DOI 10.1681/ASN.2012090884; Bruneau S, 2015, BLOOD, V125, P1038, DOI 10.1182/blood-2014-06-579953; Bruyand M, 2014, SURVEILLANCE SYNDROM; Bu FX, 2015, AM J KIDNEY DIS, V65, P968, DOI 10.1053/j.ajkd.2015.02.326; Bu FX, 2014, J AM SOC NEPHROL, V25, P55, DOI 10.1681/ASN.2013050453; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Cataland SR, 2014, BLOOD, V123, P3733, DOI 10.1182/blood-2013-12-547067; Chandran S, 2011, TRANSPL P, V43, P2097, DOI 10.1016/j.transproceed.2011.02.064; Chiodini BD, 2014, PEDIATRICS, V133, pE1764, DOI 10.1542/peds.2013-1594; Chiurchiu C, 2003, AM J KIDNEY DIS, V41, DOI 10.1053/ajkd.2003.50022; Chua JS, 2015, J AM SOC NEPHROL, V26, P2239, DOI 10.1681/ASN.2014050429; Cofiell R, 2015, BLOOD, V125, P3253, DOI 10.1182/blood-2014-09-600411; Combe C, 2012, LANCET, V379, P517, DOI 10.1016/S0140-6736(12)60228-1; Coppo P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010208; Coppo R, 2015, PEDIATR NEPHROL, V30, P167, DOI 10.1007/s00467-014-2944-y; Couvrat-Desvergnes G, 2014, MEDICINE, V93, P33, DOI 10.1097/MD.0000000000000015; Crovetto F, 2012, J MATERN-FETAL NEO M, V25, P2322, DOI 10.3109/14767058.2012.694923; Cugno M, 2014, J THROMB HAEMOST, V12, P1440, DOI 10.1111/jth.12615; Dallman TJ, 2015, EPIDEMIOL INFECT, V143, P1672, DOI 10.1017/S0950268814002696; Daly AS, 2002, BONE MARROW TRANSPL, V30, P709, DOI 10.1038/sj.bmt.1703710; de Fontbrune FS, 2015, TRANSPLANTATION, V99, P1953, DOI 10.1097/TP.0000000000000601; de Jorge EG, 2007, P NATL ACAD SCI USA, V104, P240, DOI 10.1073/pnas.0603420103; Delmas Y, 2014, NEPHROL DIAL TRANSPL, V29, P565, DOI 10.1093/ndt/gft470; Delvaeye M, 2009, NEW ENGL J MED, V361, P345, DOI 10.1056/NEJMoa0810739; Descombes E, 1997, MEDICINE, V76, P355, DOI 10.1097/00005792-199709000-00003; Dragon-Durey MA, 2010, J AM SOC NEPHROL, V21, P2180, DOI 10.1681/ASN.2010030315; Durkan AM, 2016, ARCH DIS CHILD, V101, P387, DOI 10.1136/archdischild-2015-309471; El-Husseini A, 2015, AM J KIDNEY DIS, V65, P127, DOI 10.1053/j.ajkd.2014.07.031; Emirova Khadizha, 2016, BMJ Case Rep, V2016, DOI 10.1136/bcr-2015-213928; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; European Centre for Disease Prevention and Control, 2014, ANN EP REP 2014 FOOD; Faguer S, 2013, CLIN KIDNEY J, V6, P484, DOI 10.1093/ckj/sft078; Fakhouri F, 2014, J AM SOC NEPHROL, V25; Fakhouri F, 2016, AM J KIDNEY DIS, V68, P84, DOI 10.1053/j.ajkd.2015.12.034; Fakhouri F, 2014, AM J KIDNEY DIS, V63, P40, DOI 10.1053/j.ajkd.2013.07.011; Fakhouri F, 2010, J AM SOC NEPHROL, V21, P859, DOI 10.1681/ASN.2009070706; Favre GA, 2014, BRIT J HAEMATOL, V166, P802, DOI 10.1111/bjh.12907; Fischer S, 2014, J INHERIT METAB DIS, V37, P831, DOI 10.1007/s10545-014-9687-6; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Freedman SB, 2016, CLIN INFECT DIS, V62, P1251, DOI 10.1093/cid/ciw099; Fremeaux-Bacchi V, 2013, CLIN J AM SOC NEPHRO, V8, P554, DOI 10.2215/CJN.04760512; Fremeaux-Bacchi V, 2008, BLOOD, V112, P4948, DOI 10.1182/blood-2008-01-133702; Frimat M, 2016, AM J KIDNEY DIS, V68, P50, DOI 10.1053/j.ajkd.2015.11.022; Gall ECL, 2014, AM J KIDNEY DIS, V63, P119, DOI 10.1053/j.ajkd.2013.08.031; Gavriilaki E, 2015, BLOOD, V125, P3637, DOI 10.1182/blood-2015-02-629683; George JN, 2008, BONE MARROW TRANSPL, V41, P917, DOI 10.1038/bmt.2008.7; George JN, 2015, LANCET, V386, P1012, DOI 10.1016/S0140-6736(15)00077-X; George James N, 2012, Presse Med, V41, pe177, DOI 10.1016/j.lpm.2011.10.026; GERAGHTY MT, 1992, J PEDIATR-US, V120, P934, DOI 10.1016/S0022-3476(05)81967-5; Gervasoni C, 2002, CLIN INFECT DIS, V35, P1534, DOI 10.1086/344778; Giannakopoulos B, 2013, NEW ENGL J MED, V368, P1033, DOI 10.1056/NEJMra1112830; Girardi G, 2003, J CLIN INVEST, V112, P1644, DOI 10.1172/JCI200318817; Gomez-Cibeira E, 2016, NEUROLOGY, V86, P399, DOI 10.1212/WNL.0000000000002312; Gould LH, 2013, FOODBORNE PATHOG DIS, V10, P453, DOI 10.1089/fpd.2012.1401; Gould LH, 2009, CLIN INFECT DIS, V49, P1480, DOI 10.1086/644621; Grange S, 2015, LANCET, V386, P1011, DOI 10.1016/S0140-6736(15)00076-8; Green H, 2014, RENAL FAILURE, V36, P1119, DOI 10.3109/0886022X.2014.917574; Greenbaum LA, 2016, KIDNEY INT, V89, P701, DOI 10.1016/j.kint.2015.11.026; Greenwood GT, 2015, INT MED CASE REP J, V8, P235, DOI 10.2147/IMCRJ.S90640; Greinacher A, 2012, LANCET, V379, P518; Greinacher A, 2011, LANCET, V378, P1166, DOI 10.1016/S0140-6736(11)61253-1; Gropp K, 2011, BLOOD, V118, P2774, DOI 10.1182/blood-2011-02-339564; Guirro M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-320; Hisano M, 2015, PEDIATR INT, V57, P313, DOI 10.1111/ped.12469; Hu HS, 2014, PEDIATR NEPHROL, V29, P1103, DOI 10.1007/s00467-013-2709-z; Huemer M, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0161-1; Ito N, 2016, CLIN EXP NEPHROL, V20, P265, DOI 10.1007/s10157-015-1142-y; Jodele S, 2016, BLOOD, V127, P989, DOI 10.1182/blood-2015-08-663435; Jodele S, 2015, BLOOD REV, V29, P191, DOI 10.1016/j.blre.2014.11.001; Jodele S, 2014, BIOL BLOOD MARROW TR, V20, P518, DOI 10.1016/j.bbmt.2013.12.565; Jodele S, 2013, BLOOD, V122, P2003, DOI 10.1182/blood-2013-05-501445; Johnson S, 2014, PEDIATR NEPHROL, V29, P1967, DOI 10.1007/s00467-014-2817-4; Kelly RJ, 2015, NEW ENGL J MED, V373, P1032, DOI 10.1056/NEJMoa1502950; Kennedy GA, 2010, BONE MARROW TRANSPL, V45, P699, DOI 10.1038/bmt.2009.233; Kielstein JT, 2012, NEPHROL DIAL TRANSPL, V27, P3807, DOI 10.1093/ndt/gfs394; Koenig JC, 2015, PEDIATR NEPHROL, V30, P1203, DOI 10.1007/s00467-015-3110-x; Kokame K, 2005, BRIT J HAEMATOL, V129, P93, DOI 10.1111/j.1365-2141.2005.05420.x; Kronbichler A, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000143; Lapeyraque AL, 2011, NEW ENGL J MED, V364, P2561, DOI 10.1056/NEJMc1100859; Laskin BL, RENAL ARTERIOLAR C4D; Le Quintrec M, 2008, AM J TRANSPLANT, V8, P1694, DOI 10.1111/j.1600-6143.2008.02297.x; Le Quintrec M, 2013, AM J TRANSPLANT, V13, P663, DOI 10.1111/ajt.12077; Lechner K, 2012, MEDICINE, V91, P195, DOI 10.1097/MD.0b013e3182603598; Legendre CM, 2013, NEW ENGL J MED, V368, P2169, DOI 10.1056/NEJMoa1208981; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lemaire M, 2013, NAT GENET, V45, P531, DOI 10.1038/ng.2590; Licht C, 2015, KIDNEY INT, V87, P1061, DOI 10.1038/ki.2014.423; Locatelli M, 2014, J AM SOC NEPHROL, V25, P1786, DOI 10.1681/ASN.2013050450; Loirat C, 2016, PEDIATR NEPHROL, V31, P15, DOI 10.1007/s00467-015-3076-8; Loirat Chantal, 2012, Presse Med, V41, pe115, DOI 10.1016/j.lpm.2011.11.013; Loos S, 2012, CLIN INFECT DIS, V55, P753, DOI 10.1093/cid/cis531; Magnus T, 2012, BRAIN, V135, P1850, DOI 10.1093/brain/aws090; Malina M, 2013, PEDIATRICS, V131, pE331, DOI 10.1542/peds.2012-0903; Manenti L, 2015, CLIN J AM SOC NEPHRO, V10, P2143, DOI 10.2215/CJN.00120115; Martinelli D, 2011, J INHERIT METAB DIS, V34, P127, DOI 10.1007/s10545-010-9161-z; Mathew RO, 2016, J AM SOC HYPERTENS, V10, P352, DOI 10.1016/j.jash.2015.12.007; Melton-Celsa AR, 2014, MICROBIOL SPECTR, V2; Menne J, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4565; Mody RK, 2015, J PEDIATR-US, V166, P1022, DOI 10.1016/j.jpeds.2014.12.064; Mody RK, 2012, ARCH PEDIAT ADOL MED, V166, P902, DOI 10.1001/archpediatrics.2012.471; Morigi M, 2011, J IMMUNOL, V187, P172, DOI 10.4049/jimmunol.1100491; Morton JM, 2016, J ONCOL PRACT, V12, P523, DOI 10.1200/JOP.2016.012096; Nathanson S, 2010, CLIN J AM SOC NEPHRO, V5, P1218, DOI 10.2215/CJN.08921209; Nitschke M, 2012, JAMA-J AM MED ASSOC, V307, P1046, DOI 10.1001/jama.2012.264; Noone D, 2014, PEDIATR NEPHROL, V29, P841, DOI 10.1007/s00467-013-2654-x; Noris M, 2014, BLOOD, V124, P1715, DOI 10.1182/blood-2014-02-558296; Noris M, 2014, NAT REV NEPHROL, V10, P174, DOI 10.1038/nrneph.2013.280; Noris M, 2010, CLIN J AM SOC NEPHRO, V5, P1844, DOI 10.2215/CJN.02210310; Noris M, 2009, NEW ENGL J MED, V361, P1676, DOI 10.1056/NEJMra0902814; Ong KL, 2012, CLIN INFECT DIS, V54, pS424, DOI 10.1093/cid/cis208; Ozaltin F, 2013, J AM SOC NEPHROL, V24, P377, DOI 10.1681/ASN.2012090903; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; Pape L, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001000; Petruzziello-Pellegrini TN, 2012, J CLIN INVEST, V122, P759, DOI 10.1172/JCI57313; Redecha P, 2007, BLOOD, V110, P2423, DOI 10.1182/blood-2007-01-070631; Rees L, 2015, PEDIATR NEPHROL, V30, P1564; Reese JA, 2015, AM J HEMATOL, V90, P406, DOI 10.1002/ajh.23960; Rerolle JP, 2004, SCAND J INFECT DIS, V36, P234, DOI 10.1080/00365540410027175; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rigothier C, 2015, AM J KIDNEY DIS, V66, P331, DOI 10.1053/j.ajkd.2015.03.039; Rivas M, 2014, MICROBIOL SPECTR, P2; Rodriguez E, 2014, BIOSCIENCE REP, V34, P635, DOI 10.1042/BSR20140117; Rosales A, 2012, CLIN INFECT DIS, V54, P1413, DOI 10.1093/cid/cis196; Safa K, 2015, CLIN NEPHROL, V83, P125, DOI 10.5414/CN108163; Safdar N, 2002, JAMA-J AM MED ASSOC, V288, P996, DOI 10.1001/jama.288.8.996; Saini A, 2015, CLIN PEDIATR, V54, P387, DOI 10.1177/0009922814534520; Salmon JE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001013; Scully M, 2014, BRIT J HAEMATOL, V164, P759, DOI 10.1111/bjh.12718; Servais A, 2012, KIDNEY INT, V82, P454, DOI 10.1038/ki.2012.63; Sheerin NS, 2016, QJM-INT J MED, V109, P27, DOI 10.1093/qjmed/hcv082; Smith KE, 2012, PEDIATR INFECT DIS J, V31, P37, DOI 10.1097/INF.0b013e31823096a8; Spinale JM, 2013, PEDIATR NEPHROL, V28, P2097, DOI 10.1007/s00467-012-2383-6; Spinale JM, 2013, CURR OPIN PEDIATR, V25, P203, DOI 10.1097/MOP.0b013e32835d7f2c; TSAI JC, 1994, P NATL ACAD SCI USA, V91, P6369, DOI 10.1073/pnas.91.14.6369; Undas A, 2005, THROMB HAEMOSTASIS, V94, P907, DOI 10.1160/TH05-05-0313; Vande Walle J, 2017, J NEPHROL, V30, P127, DOI 10.1007/s40620-016-0288-3; Veesenmeyer AF, 2013, PEDIATR INFECT DIS J, V32, P731, DOI 10.1097/INF.0b013e31828b31c8; Vonberg RP, 2013, CLIN INFECT DIS, V56, P1132, DOI 10.1093/cid/cis1218; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wilson CH, 2011, TRANSPLANTATION, V92, pE42, DOI 10.1097/TP.0b013e318230c0bd; Wong CS, 2012, CLIN INFECT DIS, V55, P33, DOI 10.1093/cid/cis299; Zeisler H, 2016, NEW ENGL J MED, V374, P13, DOI 10.1056/NEJMoa1414838; Zhu JL, 2016, AM J PHYSIOL-RENAL, V310, pF895, DOI 10.1152/ajprenal.00431.2015; Zikos TA, 2015, JCR-J CLIN RHEUMATOL, V21, P311, DOI 10.1097/RHU.0000000000000290; Zschiedrich S, 2013, ANN INTERN MED, V159, P76, DOI 10.7326/0003-4819-159-1-201307020-00023; Zuber J, 2012, NAT REV NEPHROL, V8, P643, DOI 10.1038/nrneph.2012.214	160	247	257	5	36	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 12	2017	390	10095					681	696		10.1016/S0140-6736(17)30062-4	http://dx.doi.org/10.1016/S0140-6736(17)30062-4			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD3TV	28242109				2022-12-28	WOS:000407456200024
J	Moravcik, M; Schmid, M; Burch, N; Lisy, V; Morrill, D; Bard, N; Davis, T; Waugh, K; Johanson, M; Bowling, M				Moravcik, Matej; Schmid, Martin; Burch, Neil; Lisy, Viliam; Morrill, Dustin; Bard, Nolan; Davis, Trevor; Waugh, Kevin; Johanson, Michael; Bowling, Michael			DeepStack: Expert-level artificial intelligence in heads-up no-limit poker	SCIENCE			English	Article							DEEP NEURAL-NETWORKS	Artificial intelligence has seen several breakthroughs in recent years, with games often serving as milestones. A common feature of these games is that players have perfect information. Poker, the quintessential game of imperfect information, is a long-standing challenge problem in artificial intelligence. We introduce DeepStack, an algorithm for imperfect-information settings. It combines recursive reasoning to handle information asymmetry, decomposition to focus computation on the relevant decision, and a formof intuition that is automatically learned from self-play using deep learning. In a study involving 44,000 hands of poker, DeepStack defeated, with statistical significance, professional poker players in heads-up no-limit Texas hold'em. The approach is theoretically sound and is shown to produce strategies that are more difficult to exploit than prior approaches.	[Moravcik, Matej; Schmid, Martin; Burch, Neil; Lisy, Viliam; Morrill, Dustin; Bard, Nolan; Davis, Trevor; Waugh, Kevin; Johanson, Michael; Bowling, Michael] Univ Alberta, Dept Comp Sci, Edmonton, AB T6G 2E8, Canada; [Moravcik, Matej; Schmid, Martin] Charles Univ Prague, Dept Appl Math, Prague, Czech Republic; [Lisy, Viliam] Czech Tech Univ, Dept Comp Sci, Fac Elect Engn, Prague, Czech Republic	University of Alberta; Charles University Prague; Czech Technical University Prague	Bowling, M (corresponding author), Univ Alberta, Dept Comp Sci, Edmonton, AB T6G 2E8, Canada.	bowling@cs.ualberta.ca		Lisy, Viliam/0000-0002-1647-1507; Schmid, Martin/0000-0001-5341-9209; Bowling, Michael/0000-0003-2960-8418	Alberta Innovates through Alberta Machine Intelligence Institute; Natural Sciences and Engineering Research Council of Canada; Charles University (GAUK) grant [391715]	Alberta Innovates through Alberta Machine Intelligence Institute; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Charles University (GAUK) grant	The hand histories of all games played in the human study as well as those used to generate the LBR results against DeepStack are in the supplementary materials. We thank the International Federation of Poker, all of the professional players who committed valuable time to play against DeepStack, the anonymous reviewers' invaluable feedback and suggestions, and R. Holte, A. Brown, and K. Blazkova for comments on early drafts of this article. We especially thank IBM for support of this research through an IBM faculty grant. The research was also supported by Alberta Innovates through the Alberta Machine Intelligence Institute, the Natural Sciences and Engineering Research Council of Canada, and Charles University (GAUK) grant 391715. This work could not have been done without computing resources provided by Compute Canada and Calcul Quebec. M.M. and M.S. are on leave from IBM Prague. M.J. serves as a research scientist, and M.B. as a contributing brain trust member, at Cogitai Inc. D.M. owns 200 shares of Gamehost Inc. As heads-up no-limit Texas hold'em is commonly played online for high stakes, the scientific benefit of releasing source code must be balanced with the potential for it to be used for gambling purposes. As a compromise, an implementation of the DeepStack algorithm for the toy game of no-limit Leduc hold'em is available at https://github.com/lifrordi/DeepStack-Leduc.	Allis V., 1994, THESIS; [Anonymous], 2008, WIRED; [Anonymous], 2008, P 7 AAMAS; Billings D., 2003, IJCAI, P661; Bronowski J., 1973, ASCENT MAN; Brown N., 2017, P AAAI 17 WORKSH COM; Burch N., 2017, P AAAI 17 WORKSH COM; Burch N, 2014, AAAI CONF ARTIF INTE, P602; Campbell M, 2002, ARTIF INTELL, V134, P57, DOI 10.1016/S0004-3702(01)00129-1; Chen Katherine, 2012, ADV NEURAL INF PROCE, P2078; Ganzfried S, 2015, PROCEEDINGS OF THE 2015 INTERNATIONAL CONFERENCE ON AUTONOMOUS AGENTS & MULTIAGENT SYSTEMS (AAMAS'15), P37; Gilpin A., 2007, P NAT C ART INT AAAI, P50; Gilpin A, 2007, LECT NOTES COMPUT SC, V4858, P57; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Heinrich J., 2016, ARXIV160301121CSLG; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; HUBER PJ, 1964, ANN MATH STAT, V35, P73, DOI 10.1214/aoms/1177703732; Johanson M, 2013, P 2013 INT C AUTONOM, P271; Johanson M., 2013, TR1301 U ALB DEP COM; Kingma D. P., 2014, ADAM METHOD STOCHAST; Kocsis L, 2006, LECT NOTES COMPUT SC, V4212, P282, DOI 10.1007/11871842_29; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Lisy V., 2017, P AAAI 17 WORKSH COM; Lisy V, 2016, AAAI CONF ARTIF INTE, P544; Littman Michael L., 2000, INT C COMP GAM, P333; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; Moravcik M, 2016, AAAI CONF ARTIF INTE, P572; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; SAMUEL AL, 1959, IBM J RES DEV, V3, P211, DOI 10.1147/rd.441.0206; Sandholm T, 2010, AI MAG, V31, P13, DOI 10.1609/aimag.v31i4.2311; Schaeffer J, 1995, AI MAG, V17, P21; Schnizlein D, 2009, 21ST INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-09), PROCEEDINGS, P278; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; TESAURO G, 1995, COMMUN ACM, V38, P58, DOI 10.1145/203330.203343; van den Oord A., 2016, GENERATIVE MODEL RAW; Wood J., 2015, POKERFUSE       0511; Yakovenko N, 2016, AAAI CONF ARTIF INTE, P360; Zinkevich M., 2008, ADV NEURAL INFORM PR, V20, P905	40	298	311	6	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2017	356	6337					508	+		10.1126/science.aam6960	http://dx.doi.org/10.1126/science.aam6960			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET8JM	28254783	Green Submitted			2022-12-28	WOS:000400545700031
J	Theou, O; Rockwood, K				Theou, Olga; Rockwood, Kenneth			China's oldest-old-prospects for good health in late life	LANCET			English	Editorial Material							MORTALITY; DEMENTIA		[Theou, Olga; Rockwood, Kenneth] Dalhousie Univ, Div Geriatr Med, Halifax, NS B3H 2E1, Canada	Dalhousie University	Rockwood, K (corresponding author), Dalhousie Univ, Div Geriatr Med, Halifax, NS B3H 2E1, Canada.	kenneth.rockwood@dal.ca	Theou, Olga/AAS-9923-2020; Rockwood, Kenneth/AAD-8951-2019	Theou, Olga/0000-0001-6460-782X; 	Industry Canada's Industrial Research Assessment Program; Atlantic Canada Opportunities Agency; innovacorp, an incubator crown corporation of the Nova Scotia Government; Nutricia	Industry Canada's Industrial Research Assessment Program; Atlantic Canada Opportunities Agency; innovacorp, an incubator crown corporation of the Nova Scotia Government; Nutricia(Danone Nutricia)	KR is the founder and a director of DGI Clinical, which has contracts with Roche, Shire, and Lundbeck for advanced data analytics and individualised outcome measurement; it has received support from Industry Canada's Industrial Research Assessment Program, and from the Atlantic Canada Opportunities Agency, as well as from innovacorp, an incubator crown corporation of the Nova Scotia Government. KR attended an advisory board meeting for Roche about outcome measurement in Alzheimer's disease, and received speaking fees from Nutricia in relation to using network analyses in dementia clinical trials. OT declares no competing interests.	Backman K, 2016, J GERONTOL A; Hajizadeh M, 2016, HEALTH POLICY, V120, P1040, DOI 10.1016/j.healthpol.2016.07.019; Jagger C, 2016, LANCET, V387, P779, DOI 10.1016/S0140-6736(15)00947-2; Kulminski AM, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006314; Langa KM, 2017, JAMA INTERN MED, V177, P51, DOI 10.1001/jamainternmed.2016.6807; Pincus Z, 2016, NATURE, V530, P37, DOI 10.1038/nature16873; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224; Wallace LMK, 2015, AGING CLIN EXP RES, V27, P365, DOI 10.1007/s40520-014-0271-6; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wu YT, 2016, LANCET NEUROL, V15, P116, DOI 10.1016/S1474-4422(15)00092-7; Xu Jiaquan, 2016, NCHS Data Brief, P1; Zeng Y, 2017, LANCET	12	1	1	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 22	2017	389	10079					1584	1586		10.1016/S0140-6736(17)30699-2	http://dx.doi.org/10.1016/S0140-6736(17)30699-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ES5EK	28285815				2022-12-28	WOS:000399560000005
J	Ruan, LH; Zhou, CK; Jin, EL; Kucharavy, A; Zhang, Y; Wen, ZH; Florens, L; Li, R				Ruan, Linhao; Zhou, Chuankai; Jin, Erli; Kucharavy, Andrei; Zhang, Ying; Wen, Zhihui; Florens, Laurence; Li, Rong			Cytosolic proteostasis through importing of misfolded proteins into mitochondria	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; IDENTIFICATION TECHNOLOGY; MEMBRANE; STRESS; CELLS; NEURODEGENERATION; TRANSLOCATION; AGGREGATION	Loss of proteostasis underlies ageing and neurodegeneration characterized by the accumulation of protein aggregates and mitochondrial dysfunction(1-5). Although many neurodegenerative-disease-associated proteins can be found in mitochondria(4,6), it remains unclear how mitochondrial dysfunction and protein aggregation could be related. In dividing yeast cells, protein aggregates that form under stress or during ageing are preferentially retained by the mother cell, in part through tethering to mitochondria, while the disaggregase Hsp104 helps to dissociate aggregates and thereby enables refolding or degradation of misfolded proteins(7-10). Here we show that, in yeast, cytosolic proteins prone to aggregation are imported into mitochondria for degradation. Protein aggregates that form under heat shock contain both cytosolic and mitochondrial proteins and interact with the mitochondrial import complex. Many aggregation-prone proteins enter the mitochondrial intermembrane space and matrix after heat shock, and some do so even without stress. Timely dissolution of cytosolic aggregates requires the mitochondrial import machinery and proteases. Blocking mitochondrial import but not proteasome activity causes a marked delay in the degradation of aggregated proteins. Defects in cytosolic Hsp70s leads to enhanced entry of misfolded proteins into mitochondria and elevated mitochondrial stress. We term this mitochondria-mediated proteostasis mechanism MAGIC (mitochondria as guardian in cytosol) and provide evidence that it may exist in human cells.	[Ruan, Linhao; Kucharavy, Andrei; Li, Rong] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Ctr Cell Dynam, 855 North Wolfe St, Baltimore, MD 21205 USA; [Ruan, Linhao; Jin, Erli; Kucharavy, Andrei; Li, Rong] Johns Hopkins Univ, Whiting Sch Engn, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Zhou, Chuankai; Zhang, Ying; Wen, Zhihui; Florens, Laurence] Stowers Inst Med Res, 1000 East 50th St, Kansas City, MO 64110 USA	Johns Hopkins University; Johns Hopkins University; Stowers Institute for Medical Research	Li, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Ctr Cell Dynam, 855 North Wolfe St, Baltimore, MD 21205 USA.; Li, R (corresponding author), Johns Hopkins Univ, Whiting Sch Engn, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	rong@jhu.edu		Florens, Laurence/0000-0002-9310-6650; Ruan, Linhao/0000-0002-6231-2566	National Institute of Health [R35 GM118172]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118172] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank K. Si for technical advice and reagents, and F.-U. Hartl, E. Craig, P. Silva, B. Bukau, S. Claypool and J. Wang for reagents. This work was supported by the grant R35 GM118172 from the National Institute of Health to R.L., and a fellowship from the American Heart Association to C.Z.	Fernandez-Higuero JA, 2011, J BIOL CHEM, V286, P25547, DOI 10.1074/jbc.M111.231365; Baker MJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007559; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Becker J, 1996, MOL CELL BIOL, V16, P4378; Boldogh IR, 2007, METHOD CELL BIOL, V80, P45, DOI 10.1016/S0091-679X(06)80002-6; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Collins GA, 2010, YEAST, V27, P965, DOI 10.1002/yea.1805; DeSantis ME, 2012, CELL, V151, P778, DOI 10.1016/j.cell.2012.09.038; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Doyle SM, 2013, NAT REV MOL CELL BIO, V14, P617, DOI 10.1038/nrm3660; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fehrenbacher KL, 2004, CURR BIOL, V14, P1996, DOI 10.1016/j.cub.2004.11.004; Florens Laurence, 2006, V328, P159; Gupta R, 2011, NAT METHODS, V8, P879, DOI [10.1038/NMETH.1697, 10.1038/nmeth.1697]; Hansson Petersen C. A., 2008, P NATL ACAD SCI USA, V105, P13145, DOI DOI 10.1073/PNAS.0806192105; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Kummer E, 2013, FEBS LETT, V587, P810, DOI 10.1016/j.febslet.2013.02.011; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; MARTIN J, 1991, J BIOL CHEM, V266, P18051; Miller SBM, 2015, J MOL BIOL, V427, P1564, DOI 10.1016/j.jmb.2015.02.006; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Pareek G, 2013, MOL CELL BIOL, V33, P4641, DOI 10.1128/MCB.00876-13; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Rep M, 1996, SCIENCE, V274, P103, DOI 10.1126/science.274.5284.103; Ryan MT, 2001, METHOD CELL BIOL, V65, P189, DOI 10.1016/S0091-679X(01)65012-X; Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6; SERRANO R, 1977, EUR J BIOCHEM, V80, P97, DOI 10.1111/j.1432-1033.1977.tb11861.x; Stevens HC, 2007, J BIOL CHEM, V282, P17563, DOI 10.1074/jbc.M700454200; Stojanovski D, 2007, METHOD CELL BIOL, V80, P783, DOI 10.1016/S0091-679X(06)80036-1; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tran PT, 2004, METHODS, V33, P220, DOI 10.1016/j.ymeth.2003.11.017; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Wallace EWJ, 2015, CELL, V162, P1286, DOI 10.1016/j.cell.2015.08.041; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zhou CK, 2014, CELL, V159, P530, DOI 10.1016/j.cell.2014.09.026; Zhou CK, 2011, CELL, V147, P1186, DOI 10.1016/j.cell.2011.11.002	47	245	251	4	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2017	543	7645					443	+		10.1038/nature21695	http://dx.doi.org/10.1038/nature21695			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9RN	28241148	Green Accepted			2022-12-28	WOS:000396337400055
J	Zhang, X				Zhang, Xiang			Metamaterials for perpetual cooling at large scales	SCIENCE			English	Editorial Material									[Zhang, Xiang] Univ Calif Berkeley, Nanoscale Sci & Engn Ctr, 3112 Etchverry Hall, Berkeley, CA 94720 USA; [Zhang, Xiang] Lawrence Berkeley Natl Lab, Div Mat Sci, 1 Cyclotron Rd, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Zhang, X (corresponding author), Univ Calif Berkeley, Nanoscale Sci & Engn Ctr, 3112 Etchverry Hall, Berkeley, CA 94720 USA.; Zhang, X (corresponding author), Lawrence Berkeley Natl Lab, Div Mat Sci, 1 Cyclotron Rd, Berkeley, CA 94720 USA.	xiang@berkeley.edu	Zhang, Xiang/F-6905-2011	Zhang, Xiang/0000-0002-3272-894X				Fernandez N., 2015, PNNL24904; Hillenbrand R, 2002, NATURE, V418, P159, DOI 10.1038/nature00899; Liu YM, 2011, CHEM SOC REV, V40, P2494, DOI 10.1039/c0cs00184h; Lu X, 2016, RENEW SUST ENERG REV, V65, P1079, DOI 10.1016/j.rser.2016.07.058; Raman AP, 2014, NATURE, V515, P540, DOI 10.1038/nature13883; Rephaeli E, 2013, NANO LETT, V13, P1457, DOI 10.1021/nl4004283; Schuller JA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.107401; Stacey F.D., 1977, PHYS EARTH; Zhai Y, 2017, SCIENCE, V355, DOI 10.1126/science.aai7899	9	20	23	9	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI		1023	1024		10.1126/science.aam8566	http://dx.doi.org/10.1126/science.aam8566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9VY	28280168				2022-12-28	WOS:000396348900017
J	Ho, TT; Warr, MR; Adelman, ER; Lansinger, OM; Flach, J; Verovskaya, EV; Figueroa, ME; Passegue, E				Ho, Theodore T.; Warr, Matthew R.; Adelman, Emmalee R.; Lansinger, Olivia M.; Flach, Johanna; Verovskaya, Evgenia V.; Figueroa, Maria E.; Passegue, Emmanuelle			Autophagy maintains the metabolism and function of young and old stem cells	NATURE			English	Article							PROGENITORS; MODULATION; MECHANISMS	With age, haematopoietic stem cells lose their ability to regenerate the blood system, and promote disease development. Autophagy is associated with health and longevity, and is critical for protecting haematopoietic stem cells from metabolic stress. Here we show that loss of autophagy in haematopoietic stem cells causes accumulation of mitochondria and an activated metabolic state, which drives accelerated myeloid differentiation mainly through epigenetic deregulations, and impairs haematopoietic stem-cell self-renewal activity and regenerative potential. Strikingly, most haematopoietic stem cells in aged mice share these altered metabolic and functional features. However, approximately one-third of aged haematopoietic stem cells exhibit high autophagy levels and maintain a low metabolic state with robust long-term regeneration potential similar to healthy young haematopoietic stem cells. Our results demonstrate that autophagy actively suppresses haematopoietic stem-cell metabolism by clearing active, healthy mitochondria to maintain quiescence and stemness, and becomes increasingly necessary with age to preserve the regenerative capacity of old haematopoietic stem cells.	[Ho, Theodore T.; Warr, Matthew R.; Lansinger, Olivia M.; Flach, Johanna; Verovskaya, Evgenia V.; Passegue, Emmanuelle] Univ Calif San Francisco, Dept Med, Hem Onc Div, Eli & Edythe Broad,Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Adelman, Emmalee R.; Figueroa, Maria E.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Figueroa, Maria E.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Human Genet, Miami, FL 33136 USA; [Passegue, Emmanuelle] Columbia Univ, Dept Genet & Dev, Sch Med, Columbia Stem Cell Initiat, New York, NY 10032 USA	University of California System; University of California San Francisco; University of Michigan System; University of Michigan; University of Miami; Columbia University	Passegue, E (corresponding author), Univ Calif San Francisco, Dept Med, Hem Onc Div, Eli & Edythe Broad,Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.; Passegue, E (corresponding author), Columbia Univ, Dept Genet & Dev, Sch Med, Columbia Stem Cell Initiat, New York, NY 10032 USA.	passeguee@stemcell.ucsf.edu	Figueroa, Maria/AAE-8662-2019	Passegue, Emmanuelle/0000-0002-3516-297X; Ho, Theodore T/0000-0001-8395-5547; Lansinger, Olivia/0000-0002-3883-4524; Figueroa, Maria Eugenia/0000-0003-4887-4981	AHA [T32GM008284]; LLS Special Fellow Award; Netherlands Organisation for Scientific Research (NWO) Rubicon Fellowship; BD Biosciences Stem Cell grant; National Institutes of Health [R01CA184014, P30DK063720]; Program for Breakthrough Biomedical Research New Frontier Research Award; Glenn Foundation Research Award; Leukemia & Lymphoma Society;  [T32AG000114]; NATIONAL CANCER INSTITUTE [R01CA184014] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000114] Funding Source: NIH RePORTER	AHA(American Heart Association); LLS Special Fellow Award; Netherlands Organisation for Scientific Research (NWO) Rubicon Fellowship; BD Biosciences Stem Cell grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Program for Breakthrough Biomedical Research New Frontier Research Award; Glenn Foundation Research Award; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Debnath for help with these studies, A. Brunet and S. Villeda for providing some old C57Bl/6 mice, J. Cox and D. Ruggero for the gift of Park2<SUP>-/-</SUP> mice and Ink128, respectively, S. Y. Zhang for overall assistance, J. Wong for help with Seahorse studies, J. Wong for electron microscopy analyses, J. Pollack for assistance with bioinformatics, P. Nyugen for contribution to confocal imaging, M. Lee for management of the Flow Cytometry Core Facility, and all members of the Passegue laboratory for insights and suggestions. T.T.H. is supported by an AHA Predoctoral Fellowship and T32GM008284, M.R.W by a LLS Special Fellow Award, E.A. by T32AG000114, and E.V. by a Netherlands Organisation for Scientific Research (NWO) Rubicon Fellowship and a BD Biosciences Stem Cell grant. This work was supported by National Institutes of Health R01HL126947 to M.E.F., and National Institutes of Health R01CA184014 and P30DK063720, a Program for Breakthrough Biomedical Research New Frontier Research Award, a Glenn Foundation Research Award, and a Leukemia & Lymphoma Society Scholar Award to E.P.	Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R87, 10.1186/gb-2012-13-10-r87]; Akalin A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002781; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chandel NS, 2016, NAT CELL BIOL, V18, P823, DOI 10.1038/ncb3385; Codogno P, 2012, NAT REV MOL CELL BIO, V13, P7, DOI 10.1038/nrm3249; Ergen AV, 2012, BLOOD, V119, P2500, DOI 10.1182/blood-2011-11-391730; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; Fuso A, 2001, FEBS LETT, V508, P337, DOI 10.1016/S0014-5793(01)03030-7; Garcia-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187; Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Ito K, 2016, SCIENCE, V354, P1156, DOI 10.1126/science.aaf5530; Kohli L, 2014, TRENDS CELL BIOL, V24, P479, DOI 10.1016/j.tcb.2014.04.001; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kusumbe AP, 2016, NATURE, V532, P380, DOI 10.1038/nature17638; Leveque-El Mouttie L, 2015, BLOOD, V125, P2933, DOI 10.1182/blood-2014-03-562660; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Liu F, 2010, BLOOD, V116, P4806, DOI 10.1182/blood-2010-06-288589; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Meldi K, 2015, J CLIN INVEST, V125, P1857, DOI 10.1172/JCI78752; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Niccoli T, 2012, CURR BIOL, V22, pR741, DOI 10.1016/j.cub.2012.07.024; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Pietras EM, 2015, CELL STEM CELL, V17, P35, DOI 10.1016/j.stem.2015.05.003; Puleston DJ, 2014, ELIFE, V3, DOI 10.7554/eLife.03706; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rodgers JT, 2014, NATURE, V510, P393, DOI 10.1038/nature13255; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Tang AH, 2014, EMBO J, V33, P2782, DOI 10.15252/embj.201488278; Vannini N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13125; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	41	460	489	10	218	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2017	543	7644					205	+		10.1038/nature21388	http://dx.doi.org/10.1038/nature21388			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0GQ	28241143	Green Accepted			2022-12-28	WOS:000395688700031
J	Stone, R				Stone, Richard			NUCLEAR FORENSICS Test blasts simulate a nuclear attack on a port	SCIENCE			English	News Item																			0	1	1	2	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					897	897		10.1126/science.355.6328.897	http://dx.doi.org/10.1126/science.355.6328.897			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2YM	28254893				2022-12-28	WOS:000395181700014
J	Weiss, KR				Weiss, Kenneth R.			INTO THE TWILIGHT ZONE	SCIENCE			English	Editorial Material																			0	8	8	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					900	904		10.1126/science.355.6328.900	http://dx.doi.org/10.1126/science.355.6328.900			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM2YM	28254896				2022-12-28	WOS:000395181700017
J	McCoy, MS; Carniol, M; Chockley, K; Urwin, JW; Emanuel, EJ; Schmidt, H				McCoy, Matthew S.; Carniol, Michael; Chockley, Katherine; Urwin, John W.; Emanuel, Ezekiel J.; Schmidt, Harald			Conflicts of Interest for Patient-Advocacy Organizations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISCLOSURE; INDUSTRY		[McCoy, Matthew S.; Chockley, Katherine; Urwin, John W.; Emanuel, Ezekiel J.; Schmidt, Harald] Univ Penn, Dept Med Eth & Hlth Policy, Perelman Sch Med, Blockley Hall,14th Fl,423 Guardian Dr, Philadelphia, PA 19104 USA; [Carniol, Michael] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	McCoy, MS (corresponding author), Univ Penn, Dept Med Eth & Hlth Policy, Perelman Sch Med, Blockley Hall,14th Fl,423 Guardian Dr, Philadelphia, PA 19104 USA.	mmcco@mail.med.upenn.edu	Carniol, Michael/K-9297-2019	Carniol, Michael/0000-0002-4613-9572				Abola MV, 2016, MAYO CLIN PROC, V91, P1668, DOI 10.1016/j.mayocp.2016.08.015; [Anonymous], 2010, CHRONICLE PHILA 0906; Ball DE, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-201; Claypool R., 2016, PATIENTS GROUPS BIG; Davis C., 2013, UNHEALTHY PHARM REGU, V1st ed; Dresser R., 2001, SCI OFFERS SALVATION; EMANUEL EJ, 1995, NEW ENGL J MED, V332, P262, DOI 10.1056/NEJM199501263320412; Jacobson MF, 2003, LIFTING VEIL SECRECY; Kreis J, 2013, J HEALTH POLIT POLIC, V38, P89, DOI 10.1215/03616878-1898812; Lo B, 2009, CONFLICT INTEREST ME; Marshall J., 2006, NEW SCI; McCoy MS, 2016, NAT REV CLIN ONCOL, V13, P267, DOI 10.1038/nrclinonc.2016.54; Meyer B., 2009, FIBROMYALGIA DRUGMAK; National Health Council, 2016, MEMB DIR; O'Donnell Jayne, 2016, US TODAY; Pham-Kanter G, J GEN INTER IN PRESS; Rose SL, 2013, J LAW MED ETHICS, V41, P680, DOI 10.1111/jlme.12078; Rosenberg M., 2016, BONE ASS FUNDED BIG; Rothman SM, 2011, AM J PUBLIC HEALTH, V101, P602, DOI 10.2105/AJPH.2010.300027; Thomas Katie, 2016, NY TIMES; Weisman R., 2016, BOSTON GLOBE	21	89	89	1	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2017	376	9					880	885		10.1056/NEJMsr1610625	http://dx.doi.org/10.1056/NEJMsr1610625			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9JK	28249131	Bronze			2022-12-28	WOS:000395627500015
J	Wadhwa, V				Wadhwa, Vivek			Boost visas for foreign entrepreneurs	NATURE			English	Editorial Material									[Wadhwa, Vivek] Carnegie Mellon Univ, Integrated Innovat Inst, Mountain View, CA 94035 USA	Carnegie Mellon University	Wadhwa, V (corresponding author), Carnegie Mellon Univ, Integrated Innovat Inst, Mountain View, CA 94035 USA.	wadhwa@cmu.edu						Anderson S., 2016, IMMIGRANTS BILLION D; Jasso G, 2010, INT MIGR REV, V44, P477, DOI 10.1111/j.1747-7379.2010.00812.x; Saxenian A., 1999, SILICON VALLEYS NEW; Siciliano F. D., 2012, 127 ROCK CTR CORP GO; Stangler D., 2013, GIVE ME YOUR ENTREPR; Wadhwa V., 2007, 23 DUK SCI TECHN INN; Wadhwa V., 2009, LOSING WORLD BEST BR; Wadhwa V., 2007, INTELLECTUAL PROPERT	8	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2017	543	7643					28	30		10.1038/543029a	http://dx.doi.org/10.1038/543029a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN0AA	28252096	Bronze			2022-12-28	WOS:000395671500014
J	McAllister, K; Goodson, N; Warburton, L; Rogers, G				McAllister, Katherine; Goodson, Nicola; Warburton, Louise; Rogers, Gabriel			GUIDELINES Spondyloarthritis: diagnosis and management: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[McAllister, Katherine] Natl Inst Hlth & Care Excellence, Manchester M1 4BT, Lancs, England; [Rogers, Gabriel] Natl Inst Hlth & Care Excellence, Hlth Econ, Manchester M1 4BT, Lancs, England; [Goodson, Nicola] Univ Liverpool, Inst Ageing & Chron Dis, Dept Musculoskeletal Biol 1, Rheumatol Res Grp,Rheumatol, Liverpool L69 3BX, Merseyside, England; [Warburton, Louise] Shropshire Community Hlth NHS Trust, Rheumatol, Shrewsbury SY3 8XL, Salop, England; [Warburton, Louise] Shropshire Community Hlth NHS Trust, Telford Musculoskeletal Serv, Shrewsbury SY3 8XL, Salop, England; [Warburton, Louise] Shropshire Community Hlth NHS Trust, Primary Care, Shrewsbury SY3 8XL, Salop, England; [Warburton, Louise] Keele Univ, Dept Primary Care & Hlth Sci, Rheumatol, Keele ST5 5BG, Staffs, England; [Warburton, Louise] Keele Univ, Dept Primary Care & Hlth Sci, Telford Musculoskeletal Serv, Keele ST5 5BG, Staffs, England; [Warburton, Louise] Keele Univ, Dept Primary Care & Hlth Sci, Primary Care, Keele ST5 5BG, Staffs, England	National Institute for Health & Care Excellence; National Institute for Health & Care Excellence; University of Liverpool; Keele University; Keele University; Keele University	Rogers, G (corresponding author), Natl Inst Hlth & Care Excellence, Hlth Econ, Manchester M1 4BT, Lancs, England.	Gabriel.Rogers@nice.org.uk	Goodson, Nicola j/A-7854-2012; Goodson, Nicola/L-7880-2019	Goodson, Nicola j/0000-0003-0714-3568; McAllister, Katherine/0000-0002-3685-736X; Rogers, Gabriel/0000-0001-9339-7374	Department of Health	Department of Health	During the development of this work, GR and KM were both employees of NICE, which is commissioned and funded by the Department of Health to develop clinical guidelines. No authors received specific funding to write this summary.	Hamilton L, 2011, RHEUMATOLOGY, V50, P1991, DOI 10.1093/rheumatology/ker013; National Institute for Health and Care Excellence, 2016, TNF ALPH INH ANK SPO; National Institute for Health and Care Excellence, 2017, APR TREAT ACT PSOR A; National Institute for Health and Care Excellence, 2016, SEC ACT ANK SPOND TR; National Institute for Health and Care Excellence, 2011, GOL TREATM PSOR ARTH; National Institute for Health and Care Excellence, 2010, ET INFL AD TREATM PS; National Institute for Health and Care Excellence, 2015, UST TREAT ACT PSOR A; National Institute for Health and Care Excellence, 2016, SPOND 16S DIAGN MAN	8	7	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2017	356								j839	10.1136/bmj.j839	http://dx.doi.org/10.1136/bmj.j839			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JT	28249891				2022-12-28	WOS:000395628400007
J	Dabelea, D; Stafford, JM; Mayer-Davis, EJ; D'Agostino, R; Dolan, L; Imperatore, G; Linder, B; Lawrence, JM; Marcovina, SM; Mottl, AK; Black, MH; Pop-Busui, R; Saydah, S; Hamman, RF; Pihoker, C				Dabelea, Dana; Stafford, Jeanette M.; Mayer-Davis, Elizabeth J.; D'Agostino, Ralph; Dolan, Lawrence; Imperatore, Giuseppina; Linder, Barbara; Lawrence, Jean M.; Marcovina, Santica M.; Mottl, Amy K.; Black, Mary Helen; Pop-Busui, Rodica; Saydah, Sharon; Hamman, Richard F.; Pihoker, Catherine		SEARCH Diabet Youth Res Grp	Association of Type 1 Diabetes vs Type 2 Diabetes Diagnosed During Childhood and Adolescence With Complications During Teenage Years and Young Adulthood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERIPHERAL NEUROPATHY; ONSET TYPE-1; RISK-FACTORS; YOUTH; SEARCH; PREVALENCE; MORTALITY; COHORT; TRIAL/EPIDEMIOLOGY; INTERVENTIONS	IMPORTANCE The burden and determinants of complications and comorbidities in contemporary youth-onset diabetes are unknown. OBJECTIVE To determine the prevalence of and risk factors for complications related to type 1 diabetes vs type 2 diabetes among teenagers and young adults who had been diagnosed with diabetes during childhood and adolescence. DESIGN, SETTING, AND PARTICIPANTS Observational study from 2002 to 2015 in 5 US locations, including 2018 participants with type 1 and type 2 diabetes diagnosed at younger than 20 years, with single outcome measures between 2011 and 2015. EXPOSURES Type 1 and type 2 diabetes and established risk factors (hemoglobin A(1c) level, body mass index, waist-height ratio, and mean arterial blood pressure). MAIN OUTCOMES AND MEASURES Diabetic kidney disease, retinopathy, peripheral neuropathy, cardiovascular autonomic neuropathy, arterial stiffness, and hypertension. RESULTS Of 2018 participants, 1746 had type 1 diabetes (mean age, 17.9 years [SD 4.1]; 1327 non-Hispanic white [76.0%]; 867 female patients [49.7%]), and 272 had type 2 (mean age, 22.1 years [SD 3.5]; 72 non-Hispanic white [26.5%]; 181 female patients [66.5%]). Mean diabetes duration was 7.9 years (both groups). Patients with type 2 diabetes vs those with type 1 had higher age-adjusted prevalence of all measured complications except cardiovascular autonomic neuropathy. After adjustment for established risk factors measured over time, participants with type 2 diabetes vs those with type 1 had significantly higher odds of diabetic kidney disease, retinopathy, and peripheral neuropathy but no significant difference in the odds of arterial stiffness and hypertension. [GRAPHICS] CONCLUSIONS AND RELEVANCE Among teenagers and young adults who had been diagnosed with diabetes during childhood or adolescence, the prevalence of complications and comorbidities was higher among those with type 2 diabetes compared with type 1, but frequent in both groups. These findings support early monitoring of youth with diabetes for development of complications.	[Dabelea, Dana; Hamman, Richard F.] Colorado Sch Publ Hlth, Dept Epidemiol, B-119, Aurora, CO 80045 USA; [Stafford, Jeanette M.; D'Agostino, Ralph] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Mayer-Davis, Elizabeth J.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA; [Mayer-Davis, Elizabeth J.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Dolan, Lawrence] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Imperatore, Giuseppina; Saydah, Sharon] Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA USA; [Linder, Barbara] Natl Inst Diabet & Digest & Kidney Dis, Div Diabet Endocrinol & Metab Dis, Bethesda, MD USA; [Lawrence, Jean M.; Black, Mary Helen] Kaiser Permanente Southern Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA; [Marcovina, Santica M.] Univ Washington, Northwest Lipid Res Lab, Seattle, WA USA; [Mottl, Amy K.] Univ N Carolina, Sch Med, Div Nephrol & Hypertens, Chapel Hill, NC USA; [Pop-Busui, Rodica] Univ Michigan, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Pihoker, Catherine] Univ Washington, Dept Pediat, Seattle, WA 98195 USA	Colorado School of Public Health; Wake Forest University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Cincinnati Children's Hospital Medical Center; Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Kaiser Permanente; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle	Dabelea, D (corresponding author), Colorado Sch Publ Hlth, Dept Epidemiol, B-119, Aurora, CO 80045 USA.	dana.dabelea@ucdenver.edu		Nelson, Bryce/0000-0003-2400-5415; Lawrence, Jean/0000-0002-2480-8480; Reboussin, Beth/0000-0002-7318-9081; Pop-Busui, Rodica/0000-0002-2042-1350	National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases; Centers for Disease Control and Prevention (CDC); CDC [RFP DP15-002]; NIH, National Institute of Diabetes and Digestive and Kidney Diseases; Kaiser Permanente Southern California [U18DP006133, U48/CCU919219, U01 DP000246, U18DP002714]; University of Colorado-Denver [U18DP006139, U48/CCU819241-3, U01 DP000247, U18DP000247-06A1]; Cincinnati's Children's Hospital Medical Center [U18DP006134, U48/CCU519239, U01 DP000248, 1U18DP002709]; University of North Carolina at Chapel Hill [U18DP006138, U48/CCU419249, U01 DP000254, U18DP002708]; Seattle Children's Hospital [U18DP006136, U58/CCU019235-4, U01 DP000244, U18DP002710-01]; Wake Forest University School of Medicine [U18DP006131, U48/CC U919219, U01 DP000250, 200-2010-35171]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002319, UL1TR001450, UL1TR000423, UL1TR000154, UL1TR001425] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U01DP000244, U18DP002714, U01DP000246, U18DP006131, U18DP002710, U18DP006138, U18DP002709, U18DP006136, U01DP000254, U18DP006134, U01DP000248, U01DP000247, U18DP006133, U01DP000250, U18DP002708, U18DP006139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057516, UC4DK108173, K23DK093804, P30DK056350] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NIH, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Kaiser Permanente Southern California; University of Colorado-Denver; Cincinnati's Children's Hospital Medical Center; University of North Carolina at Chapel Hill; Seattle Children's Hospital; Wake Forest University School of Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The SEARCH for Diabetes in Youth Cohort Study (1UC4DK108173-01) is funded by the National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases and supported by the Centers for Disease Control and Prevention (CDC). The Population Based Registry of Diabetes in Youth Study (RFP DP15-002) is funded by the CDC and supported by the NIH, National Institute of Diabetes and Digestive and Kidney Diseases. Sites: Kaiser Permanente Southern California (U18DP006133, U48/CCU919219, U01 DP000246, and U18DP002714), University of Colorado-Denver (U18DP006139, U48/CCU819241-3, U01 DP000247, and U18DP000247-06A1), Cincinnati's Children's Hospital Medical Center (U18DP006134, U48/CCU519239, U01 DP000248, and 1U18DP002709), University of North Carolina at Chapel Hill (U18DP006138, U48/CCU419249, U01 DP000254, and U18DP002708), Seattle Children's Hospital (U18DP006136, U58/CCU019235-4, U01 DP000244, and U18DP002710-01), and Wake Forest University School of Medicine (U18DP006131, U48/CC U919219, U01 DP000250, and 200-2010-35171).	Al-Saeed AH, 2016, DIABETES CARE, V39, P823, DOI 10.2337/dc15-0991; Anderson BJ, 2011, PEDIATR DIABETES, V12, P197, DOI 10.1111/j.1399-5448.2010.00667.x; Badaru A, 2014, DIABETES CARE, V37, P64, DOI 10.2337/dc13-1124; Baranowski T, 2006, DIABETES CARE, V29, P212; Bjornstad P, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0633-2; Bonifacio E, 2010, J CLIN ENDOCR METAB, V95, P3360, DOI 10.1210/jc.2010-0293; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Constantino MI, 2013, DIABETES CARE, V36, P3863, DOI 10.2337/dc12-2455; Dabelea D, 1998, DIABETOLOGIA, V41, P904, DOI 10.1007/s001250051006; Dabelea D, 2011, DIABETOLOGIA, V54, P78, DOI 10.1007/s00125-010-1911-9; Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201; Dabelea D, 2011, DIABETES CARE, V34, P1628, DOI 10.2337/dc10-2324; Dart AB, 2014, DIABETES CARE, V37, P436, DOI 10.2337/dc13-0954; Dolan LM, 2005, J PEDIATR-US, V146, P751, DOI 10.1016/j.jpeds.2005.01.045; Eppens MC, 2006, DIABETES CARE, V29, P1300, DOI 10.2337/dc05-2470; Gubitosi-Klug RA, 2014, DIABETES CARE, V37, P44, DOI 10.2337/dc13-2148; Guo, 2002, VITAL HLTH STAT, V11, DOI DOI 10.1016/J.BBRC.2015.06.114; Hamman RF, 2014, DIABETES CARE, V37, P3336, DOI 10.2337/dc14-0574; Herman WH, 2012, DIABETIC MED, V29, P937, DOI 10.1111/j.1464-5491.2012.03644.x; Ingram Deborah D, 2003, Vital Health Stat 2, P1; Jaiswal M, 2013, DIABETES CARE, V36, P3903, DOI 10.2337/dc13-1213; Jaiswal M, 2013, DIABETES CARE, V36, P157, DOI 10.2337/dc12-0463; KLEIN R, 1986, OPHTHALMOLOGY, V93, P1183; Lampasona V, 2011, CLIN CHEM, V57, P1693, DOI 10.1373/clinchem.2011.170662; Levitsky LL, 2013, DIABETES CARE, V36, P1772, DOI 10.2337/dc12-2387; Luk AOY, 2014, DIABETES CARE, V37, P149, DOI 10.2337/dc13-1336; Mayer-Davis EJ, 2012, DIABETIC MED, V29, P1148, DOI 10.1111/j.1464-5491.2012.03591.x; McGrath NM, 1999, DIABETES RES CLIN PR, V43, P205, DOI 10.1016/S0168-8227(99)00003-0; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Patterson CC, 2012, DIABETOLOGIA, V55, P2142, DOI 10.1007/s00125-012-2571-8; Pihoker C, 2013, DIABETES CARE, V36, P27, DOI 10.2337/dc12-0720; PinhasHamiel O, 1996, J PEDIATR-US, V128, P608, DOI 10.1016/S0022-3476(96)80124-7; Rajalakshmi R, 2014, J DIABETES COMPLICAT, V28, P291, DOI 10.1016/j.jdiacomp.2013.12.008; Scott Adrian, 2006, N Z Med J, V119, pU2015; Song SH, 2015, BMJ OPEN DIAB RES CA, V3, DOI 10.1136/bmjdrc-2014-000044; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Urbina EM, 2010, J PEDIATR-US, V156, P731, DOI 10.1016/j.jpeds.2009.11.011; Wong J, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-014-0566-1; Yokoyama H, 2000, KIDNEY INT, V58, P302, DOI 10.1046/j.1523-1755.2000.00166.x	39	308	315	7	53	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2017	317	8					825	835		10.1001/jama.2017.0686	http://dx.doi.org/10.1001/jama.2017.0686			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM7PW	28245334	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000395505600020
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Deflecting blame for the NHS crisis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						[Anonymous], 2015, BBC NEWS; [Anonymous], 2015, DAILY MIRROR; Boseley S, 2016, GUARDIAN; Donnelly L., 2017, DAILY TELEGRAPH; Edwards N., 2016, NUFFIELD TRUST BLOG; Full Fact, 2016, HLTH TOUR WHATS COST; Gallagher J., 2015, BBC NEWS; Glaze B, 2016, DAILY MIRROR; Hughes L., 2017, TELEGRAPH; Hunt J, 2017, COMMUNICATION   0109; Iacobucci G, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5377; King's Fund, 2015, IS NHS HEAD FIN CRIS; McCartney M, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j246; Oliver D, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j436; Paton C., 2014, PAYING THE PRICE FOR; Pearson A., 2017, DAILY TELEGRAPH; Rimmer A., 2017, BMJ CAREERS; Timmins N, 2012, NEVER AGAIN STORY HL	18	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 28	2017	356								j1026	10.1136/bmj.j1026	http://dx.doi.org/10.1136/bmj.j1026			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JQ	28246079	Green Published, Bronze			2022-12-28	WOS:000395628100003
J	Assir, MZK				Assir, Muhammad Zaman Khan			Time to stop prophylactic platelet transfusion for adult dengue	LANCET			English	Editorial Material							HEMORRHAGE		[Assir, Muhammad Zaman Khan] Allama Iqbal Med Coll, Dept Med, Lahore 54550, Pakistan; [Assir, Muhammad Zaman Khan] Jinnah Hosp, Lahore 54550, Pakistan		Assir, MZK (corresponding author), Allama Iqbal Med Coll, Dept Med, Lahore 54550, Pakistan.; Assir, MZK (corresponding author), Jinnah Hosp, Lahore 54550, Pakistan.	dr.zamankhan@yahoo.com		Assir, Muhammad/0000-0002-8940-9747	NUS	NUS(National University of Singapore)	I presented my research work at the National University of Singapore (NUS) to David C Lye and his colleagues in 2012, with travel and accommodation sponsored by NUS.	Assir MZK, 2013, TRANSFUS MED HEMOTH, V40, P362, DOI 10.1159/000354837; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; de Azeredo EL, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/313842; GAYDOS LA, 1962, NEW ENGL J MED, V266, P905, DOI 10.1056/NEJM196205032661802; Lee TH, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004576; Lye DC, 2009, CLIN INFECT DIS, V48, P1262, DOI 10.1086/597773; Lye DC, 2017, LANCET; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Slichter SJ, 2010, NEW ENGL J MED, V362, P600, DOI 10.1056/NEJMoa0904084; Whitehorn J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001716; Wong JGX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148579	11	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 22	2017	389	10079					1583	1584		10.1016/S0140-6736(17)30545-7	http://dx.doi.org/10.1016/S0140-6736(17)30545-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ES5EK	28283287				2022-12-28	WOS:000399560000004
J	Williams, HC; Wojnarowska, F; Kirtschig, G; Mason, J; Godec, TR; Schmidt, E; Chalmers, JR; Childs, M; Walton, S; Harman, K; Chapman, A; Whitham, D; Nunn, AJ				Williams, Hywel C.; Wojnarowska, Fenella; Kirtschig, Gudula; Mason, James; Godec, Thomas R.; Schmidt, Enno; Chalmers, Joanne R.; Childs, Margaret; Walton, Shernaz; Harman, Karen; Chapman, Anna; Whitham, Diane; Nunn, Andrew J.		UK Dermatology Clinical Trials	Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial	LANCET			English	Article							TOPICAL CORTICOSTEROIDS; ASSOCIATION; DERMATOLOGISTS; MANAGEMENT; UK	Background Bullous pemphigoid is a blistering skin disorder with increased mortality. We tested whether a strategy of starting treatment with doxycycline gives acceptable short-term blister control while conferring long-term safety advantages over starting treatment with oral corticosteroids. Methods We did a pragmatic, multicentre, parallel-group randomised controlled trial of adults with bullous pemphigoid (three or more blisters at two or more sites and linear basement membrane IgG or C3). Participants were randomly assigned to doxycycline (200 mg per day) or prednisolone (0.5 mg/kg per day) using random permuted blocks of randomly varying size, and stratified by baseline severity (3-9, 10-30, and >30 blisters for mild, moderate, and severe disease, respectively). Localised adjuvant potent topical corticosteroids (<30 g per week) were permitted during weeks 1-3. The non-inferiority primary effectiveness outcome was the proportion of participants with three or fewer blisters at 6 weeks. We assumed that doxycycline would be 25% less effective than corticosteroids with a 37% acceptable margin of non-inferiority. The primary safety outcome was the proportion with severe, life-threatening, or fatal (grade 3-5) treatment-related adverse events by 52 weeks. Analysis (modified intention to treat [ mITT] for the superiority safety analysis and mITT and per protocol for non-inferiority effectiveness analysis) used a regression model adjusting for baseline disease severity, age, and Karnofsky score, with missing data imputed. The trial is registered at ISRCTN, number ISRCTN13704604. Findings Between March 1, 2009, and Oct 31, 2013, 132 patients were randomly assigned to doxycycline and 121 to prednisolone from 54 UK and seven German dermatology centres. Mean age was 77.7 years (SD 9.7) and 173 (68%) of 253 patients had moderate-to-severe baseline disease. For those starting doxycycline, 83 (74%) of 112 patients had three or fewer blisters at 6 weeks compared with 92 (91%) of 101 patients on prednisolone, an adjusted difference of 18.6% (90% CI 11.1-26.1) favouring prednisolone (upper limit of 90% CI, 26.1%, within the predefined 37% margin). Related severe, life-threatening, and fatal events at 52 weeks were 18% (22 of 121) for those starting doxycycline and 36% (41 of 113) for prednisolone (mITT), an adjusted difference of 19.0% (95% CI 7.9-30.1), p=0.001. Interpretation Starting patients on doxycycline is non-inferior to standard treatment with oral prednisolone for short-term blister control in bullous pemphigoid and significantly safer in the long-term. Copyright (C) The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license.	[Williams, Hywel C.; Kirtschig, Gudula; Chalmers, Joanne R.] Univ Nottingham, Ctr Evidence Based Dermatol, Kings Meadow Campus, Nottingham NG7 2NR, England; [Wojnarowska, Fenella] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Kirtschig, Gudula] Univ Tubingen, Inst Gen Med & Interprofess Care, Tubingen, Germany; [Mason, James] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England; [Godec, Thomas R.; Nunn, Andrew J.] UCL, Clin Trials Unit, Med Res Council, London, England; [Schmidt, Enno] Univ Lubeck, Dept Dermatol, Lubeck, Germany; [Childs, Margaret; Whitham, Diane] Nottingham Hlth Sci Partners, Nottingham Clin Trials Unit, Nottingham, England; [Walton, Shernaz] Hull Royal Infirm, Dermatol Dept, Kingston Upon Hull, N Humberside, England; [Harman, Karen] Leicester Royal Infirm, Dermatol Dept, Leicester, Leics, England; [Chapman, Anna] Queen Elizabeth Hosp, Dermatol Dept, London, England	University of Nottingham; University of Oxford; Eberhard Karls University of Tubingen; University of Warwick; Medical Research Council Clinical Trials Unit; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; University College London; University of Lubeck; University of Hull; University of Leicester	Williams, HC (corresponding author), Univ Nottingham, Ctr Evidence Based Dermatol, Kings Meadow Campus, Nottingham NG7 2NR, England.	hywel.williams@nottingham.ac.uk	Mason, James M/D-9904-2011; Schmidt, Enno/C-4008-2009	Mason, James M/0000-0001-9210-4082; Hampton, Philip/0000-0001-6797-2697; Ravenscroft, Jane/0000-0002-1609-7084; Schmidt, Enno/0000-0002-1206-8913; Levell, Nick/0000-0003-3393-8305; Layton, Alison/0000-0003-0473-3319; williams, hywel/0000-0002-5646-3093	NIHR Health Technology Assessment Programme; National Institute for Health Research (NIHR) Health Technology Assessment Programme; UK Dermatology Clinical Trials Network (DCTN); British Association of Dermatologists; University of Nottingham; UK NIHR Clinical Research Network; National Institute for Health Research (NIHR) Health Technology Assessment Programme [06/403/51]; National Institute for Health Research [06/403/51] Funding Source: researchfish	NIHR Health Technology Assessment Programme(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR) Health Technology Assessment Programme(National Institute for Health Research (NIHR)); UK Dermatology Clinical Trials Network (DCTN); British Association of Dermatologists; University of Nottingham; UK NIHR Clinical Research Network; National Institute for Health Research (NIHR) Health Technology Assessment Programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	NIHR Health Technology Assessment Programme.; We thank the members of our Trial Oversight Committees, all those from the Nottingham and Medical Research Council Clinical Trials Units who contributed to trial management and statistics support throughout the trial, and everyone who contributed to recruitment and follow-up from the recruiting centres. We thank the National Institute for Health Research (NIHR) Health Technology Assessment Programme for funding and monitoring the study progress. This trial would not have been possible without the support of the UK Dermatology Clinical Trials Network (DCTN) who helped with various surveys before the main study and was key in identifying recruitment centres. The UK DCTN is grateful to the British Association of Dermatologists and the University of Nottingham for financial support of the Network. We would like to acknowledge the support of the UK NIHR Clinical Research Network, particularly in providing research nurse support at the many centres around the UK. We would also like to thank Natasha Rogers for help with writing, editing, and formatting the report; Kim Thomas (Centre of Evidence-Based Dermatology at the University of Nottingham, Nottingham, UK) for helpful comments and proof-reading, Angelika Huppe (Universitat zu Lubeck, Lubeck, Germany) for her assistance with obtaining approvals for the German sites and the team from the Immunodermatology Laboratory at St John's Institute (St Thomas's Hospital, London, UK) for doing the immunofluorescence studies. This publication presents independent research funded by the National Institute for Health Research (NIHR) Health Technology Assessment Programme (06/403/51). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the NIHR Health Technology Assessment Programme, the NIHR, National Health Service, or the Department of Health.	Bastuji-Garin S, 2011, J INVEST DERMATOL, V131, P637, DOI 10.1038/jid.2010.301; Bratton DJ, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-50; Brick KE, 2014, J AM ACAD DERMATOL, V71, P1191, DOI 10.1016/j.jaad.2014.07.052; Chalmers JR, 2015, BRIT J DERMATOL, V173, P227, DOI 10.1111/bjd.13729; Chalmers JR, HLTH TECHNO IN PRESS; D'Agostino RB, 2003, STAT MED, V22, P169, DOI 10.1002/sim.1425; Feliciani C, 2015, BRIT J DERMATOL, V172, P867, DOI 10.1111/bjd.13717; FIVENSON DP, 1994, ARCH DERMATOL, V130, P753, DOI 10.1001/archderm.130.6.753; Goon A. T. J., 2000, SMJ Singapore Medical Journal, V41, P327; Hofmann SC, 2015, BRIT J DERMATOL, V173, P17, DOI 10.1111/bjd.13844; Joly P, 2002, NEW ENGL J MED, V346, P321, DOI 10.1056/NEJMoa011592; Joly P, 2012, J INVEST DERMATOL, V132, P1998, DOI 10.1038/jid.2012.35; Joly P, 2009, J INVEST DERMATOL, V129, P1681, DOI 10.1038/jid.2008.412; Kirtschig G, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002292.pub3; Langan SM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a180; LEVER WF, 1953, MEDICINE, V32, P1; Lloyd-Lavery A, 2013, JAMA DERMATOL, V149, P58, DOI 10.1001/2013.jamadermatol.376; Meijer JM, 2016, CLIN EXP DERMATOL, V41, P506, DOI 10.1111/ced.12831; Monk E, 2011, PHARMACOL RES, V63, P130, DOI 10.1016/j.phrs.2010.10.007; Murrell DF, 2012, J AM ACAD DERMATOL, V66, P479, DOI 10.1016/j.jaad.2011.06.032; Offen W, 2007, DRUG INF J, V41, P31, DOI 10.1177/009286150704100105; RIOND JL, 1988, VET HUM TOXICOL, V30, P431; ROUJEAU JC, 1984, LANCET, V2, P486; SAVIN JA, 1979, BRIT J DERMATOL, V101, P521, DOI 10.1111/j.1365-2133.1979.tb11881.x; Schmidt E, 2013, LANCET, V381, P320, DOI 10.1016/S0140-6736(12)61140-4; Schulze F, 2015, J INVEST DERMATOL, V135, P1445, DOI 10.1038/jid.2014.547; Sobocinski V, 2016, BRIT J DERMATOL, V174, P919, DOI 10.1111/bjd.14285; Taghipour K, 2013, CLIN EXP DERMATOL, V38, P311, DOI 10.1111/ced.12042; Taghipour K, 2010, ARCH DERMATOL, V146, P1251, DOI 10.1001/archdermatol.2010.322; Venning VA, 2012, BRIT J DERMATOL, V167, P1200, DOI 10.1111/bjd.12072	30	109	110	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 22	2017	389	10079					1630	1638		10.1016/S0140-6736(17)30560-3	http://dx.doi.org/10.1016/S0140-6736(17)30560-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ES5EK	28279484	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000399560000030
J	Verhulst, FC				Verhulst, Frank C.			Early life deprivation: is the damage already done?	LANCET			English	Editorial Material							AMBLYOPIA; CHILDREN		[Verhulst, Frank C.] Erasmus Univ, Ctr Med, Dept Child & Adolescent Psychiat, NL-3000 CB Rotterdam, Netherlands	Erasmus University Rotterdam	Verhulst, FC (corresponding author), Erasmus Univ, Ctr Med, Dept Child & Adolescent Psychiat, NL-3000 CB Rotterdam, Netherlands.	f.verhulst@erasmusmc.nl						Astle AT, 2011, OPHTHAL PHYSL OPT, V31, P564, DOI 10.1111/j.1475-1313.2011.00873.x; Bowlby J, 1939, BRIT MED J, V2, P1202, DOI 10.1136/bmj.2.4119.1202-b; Bowlby John, 1952, MATERNAL CARE MENTAL; Daw NW, 1998, ARCH OPHTHALMOL-CHIC, V116, P502, DOI 10.1001/archopht.116.4.502; Jensen PS, 1997, J AM ACAD CHILD PSY, V36, P1672, DOI 10.1097/00004583-199712000-00015; Johnson R, 2006, TRAUMA VIOLENCE ABUS, V7, P34, DOI 10.1177/1524838005283696; Kreppner JM, 2007, DEV PSYCHOL, V43, P931, DOI 10.1037/0012-1649.43.4.931; Rutter ML, 2001, BRIT J PSYCHIAT, V179, P97, DOI 10.1192/bjp.179.2.97; Sonuga-Barke EJS, 2017, LANCET; Teicher MH, 2016, J CHILD PSYCHOL PSYC, V57, P241, DOI 10.1111/jcpp.12507	10	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 15	2017	389	10078					1496	1497		10.1016/S0140-6736(17)30541-X	http://dx.doi.org/10.1016/S0140-6736(17)30541-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ER7OP	28237266	Green Published, hybrid			2022-12-28	WOS:000399002900006
J	Bennell, KL; Nelligan, R; Dobson, F; Rini, C; Keefe, F; Kasza, J; French, S; Bryant, C; Dalwood, A; Abbott, JH; Hinman, RS				Bennell, Kim L.; Nelligan, Rachel; Dobson, Fiona; Rini, Christine; Keefe, Francis; Kasza, Jessica; French, Simon; Bryant, Christina; Dalwood, Andrew; Abbott, J. Haxby; Hinman, Rana S.			Effectiveness of an Internet-Delivered Exercise and Pain-Coping Skills Training Intervention for Persons With Chronic Knee Pain A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							IN-HOME TELEREHABILITATION; PHYSICAL-ACTIVITY PROGRAM; HIP OSTEOARTHRITIS; SELF-MANAGEMENT; HEALTH-CARE; ARTHRITIS; PEOPLE; ARTHROPLASTY; ADULTS; IMPACT	Background: Effective, accessible biopsychosocial treatments are needed to manage chronic knee pain on a population level. Objective: To evaluate the effectiveness of Internet-delivered, physiotherapist-prescribed home exercise and pain-coping skills training (PCST). Design: Pragmatic parallel-group randomized, controlled trial. (Australian New Zealand Clinical Trials Registry: ACTRN12614000243617) Setting: Community (Australia). Patients: 148 persons aged 50 years or older with chronic knee pain. Intervention: The intervention was delivered via the Internet and included educational material, 7 videoconferencing (Skype [Microsoft]) sessions with a physiotherapist for home exercise, and a PCST program over 3 months. The control was Internetbased educational material. Measurements: Primary outcomes were pain during walking (11-point numerical rating scale) and physical function (Western Ontario and McMaster Universities Osteoarthritis Index) at 3 months. Secondary outcomes were knee pain, quality of life, global change (overall, pain, and functional status), arthritis selfefficacy, coping, and pain catastrophizing. Outcomes were also measured at 9 months. Results: Of participants enrolled, 139 (94%) completed primary outcome measures at 3 months and 133 (90%) completed secondary outcome measures at 9 months; multiple imputation was used for missing data. The intervention group reported significantly more improvement in pain (mean difference, 1.6 units [95% CI, 0.9 to 2.3 units]) and physical function (mean difference, 9.3 units [CI, 5.9 to 12.7 units]) than the control group at 3 months, and improvements were sustained at 9 months (mean differences, 1.1 units [CI, 0.4 to 1.8 units] and 7.0 units [CI, 3.4 to 10.5 units], respectively). Intervention participants showed significantly more improvement in most secondary outcomes than control participants. At both time points, significantly more intervention participants reported global improvements. Limitation: Participants were unblinded. Conclusion: For persons with chronic knee pain, Internetdelivered, physiotherapist-prescribed exercise and PCST provide clinically meaningful improvements in pain and function that are sustained for at least 6 months.	[Bennell, Kim L.; Nelligan, Rachel; Dobson, Fiona; Hinman, Rana S.] Univ Melbourne, Ctr Hlth Exercise & Sports Med, Dept Physiotherapy, Level 7,Alan Gilbert Bldg,161 Barry St, Melbourne, Vic 3010, Australia; [Kasza, Jessica] Monash Univ, Alfred Ctr, Dept Epidemiol & Prevent Med, 99 Commercial Rd, Melbourne, Vic 3004, Australia; Royal Womens Hosp, Melbourne, Vic, Australia; Physioworks Hlth Grp, Melbourne, Vic, Australia; UNC Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; Duke Univ, Durham, NC USA; [French, Simon] Queens Univ, Sch Rehabil Therapy, Fac Hlth Sci, Louise D Acton Bldg,31 George St, Kingston, ON K7L 3N6, Canada; [Abbott, J. Haxby] Univ Otago, Dunedin Sch Med, Dept Surg Sci, Ctr Musculoskeletal Outcomes Res,Orthopaed Surg S, POB 913, Dunedin 9054, New Zealand; [Rini, Christine] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Campus Box 7440,319C Rosenau Hall, Chapel Hill, NC 27599 USA; [Keefe, Francis] Duke Pain Prevent & Treatment Res Program, Suite 340,2200 West Main St, Durham, NC 27705 USA; [Bryant, Christina] Chelsea House,Suite 225,55 Flemington Rd, North Melbourne, Vic 3051, Australia; [Dalwood, Andrew] Waverley Pk Physiotherapy Ctr, 439 Police Rd, Mulgrave, Vic 3170, Australia	University of Melbourne; Monash University; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Queens University - Canada; University of Otago; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Bennell, KL (corresponding author), Univ Melbourne, Ctr Hlth Exercise & Sports Med, Dept Physiotherapy, Level 7,Alan Gilbert Bldg,161 Barry St, Melbourne, Vic 3010, Australia.	k.bennell@unimelb.edu.au; jessica.kasza@monash.edu	Abbott, J. Haxby/AAK-4346-2020; /AAB-3060-2019; ABBOTT, J. Haxby/AAH-3262-2019; Bennell, Kim/C-7022-2014	Abbott, J. Haxby/0000-0001-6468-7284; Hinman, Rana/0000-0001-6368-9456; Rini, Christine/0000-0002-3169-3626; Nelligan, Rachel/0000-0002-8689-6594; Bryant, Christina/0000-0003-4728-981X; Bennell, Kim/0000-0003-4982-5639; French, Simon/0000-0002-7061-7706	National Health and Medical Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	National Health and Medical Research Council.	Ackerman IN, 2012, BEST PRACT RES CL RH, V26, P561, DOI 10.1016/j.berh.2012.08.002; Beatty L, 2013, CLIN PSYCHOL REV, V33, P609, DOI 10.1016/j.cpr.2013.03.004; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; BELLAMY N, 1992, J RHEUMATOL, V19, P444; Bennell KL, 2017, ARTHRIT CARE RES, V69, P84, DOI 10.1002/acr.22915; Bennell KL, 2016, ARTHRIT CARE RES, V68, P590, DOI 10.1002/acr.22744; Bennell KL, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-246; Bini SA, 2017, J TELEMED TELECARE, V23, P239, DOI 10.1177/1357633X16634518; Bossen D, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2662; Brand CA, 2014, ARTHRIT CARE RES, V66, P551, DOI 10.1002/acr.22197; Carpenter J. R., 2013, MULTIPLE IMPUTATION; Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763; Day ML, 2004, J STRENGTH COND RES, V18, P353, DOI 10.1519/00124278-200405000-00027; Dixon KE, 2007, HEALTH PSYCHOL, V26, P241, DOI 10.1037/0278-6133.26.3.241; Dobson F, 2016, AM J PHYS MED REHAB, V95, P372, DOI 10.1097/PHM.0000000000000448; Dobson Fiona, 2014, BMC Musculoskelet Disord, V15, P279, DOI 10.1186/1471-2474-15-279; Fransen M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-095424; Gierisch JM, 2014, ANN INTERN MED, V160, P836, DOI 10.7326/M14-0318; Hawthorne G, 2005, AUST NZ J PUBL HEAL, V29, P136, DOI 10.1111/j.1467-842X.2005.tb00063.x; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hunter DJ, 2014, NAT REV RHEUMATOL, V10, P437, DOI 10.1038/nrrheum.2014.44; Jinks C, 2004, RHEUMATOLOGY, V43, P55, DOI 10.1093/rheumatology/keg438; Juhl C, 2014, ARTHRITIS RHEUMATOL, V66, P622, DOI 10.1002/art.38290; Kairy D, 2013, INT J ENV RES PUB HE, V10, P3998, DOI 10.3390/ijerph10093998; KEEFE FJ, 1987, J CONSULT CLIN PSYCH, V55, P208, DOI 10.1037/0022-006X.55.2.208; Kelders SM, 2012, J MED INTERNET RES, V14, P17, DOI 10.2196/jmir.2104; Kroon FPB, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008963.pub2; LORIG K, 1989, ARTHRITIS RHEUM, V32, P37, DOI 10.1002/anr.1780320107; McAlindon TE, 2015, OSTEOARTHR CARTILAGE, V23, P747, DOI 10.1016/j.joca.2015.03.005; Moffet H, 2015, J BONE JOINT SURG AM, V97A, P1129, DOI 10.2106/JBJS.N.01066; Muller CJ, 2014, INT J EPIDEMIOL, V43, P962, DOI 10.1093/ije/dyu029; Murphy LB, 2012, ARTHRIT CARE RES, V64, P968, DOI 10.1002/acr.21685; National Clinical Guideline Centre, 2014, OST CAR MAN AD NICE; Nelson AE, 2014, SEMIN ARTHRITIS RHEU, V43, P701, DOI 10.1016/j.semarthrit.2013.11.012; Odole AC, 2014, INT J TELEMED APPL, V2014, DOI 10.1155/2014/903816; Odole AC, 2013, INT J TELEREHABILITA, V5, P11, DOI 10.5195/ijt.2013.6125; Osborne RH, 2003, J CLIN EPIDEMIOL, V56, P138, DOI 10.1016/S0895-4356(02)00601-7; Osman A, 2000, J BEHAV MED, V23, P351, DOI 10.1023/A:1005548801037; Pereira D, 2011, OSTEOARTHR CARTILAGE, V19, P1270, DOI 10.1016/j.joca.2011.08.009; Pietrzak E, 2013, TELEMED E-HEALTH, V19, P800, DOI 10.1089/tmj.2012.0288; Piqueras M, 2013, J REHABIL MED, V45, P392, DOI 10.2340/16501977-1119; Rini C, 2015, PAIN, V156, P837, DOI 10.1097/j.pain.0000000000000121; Rini Christine, 2014, J Med Internet Res, V16, pe245, DOI 10.2196/jmir.3374; Rini C, 2012, TRANSL BEHAV MED, V2, P82, DOI 10.1007/s13142-011-0107-2; ROSENSTIEL AK, 1983, PAIN, V17, P33, DOI 10.1016/0304-3959(83)90125-2; Russell TG, 2011, J BONE JOINT SURG AM, V93A, P113, DOI 10.2106/JBJS.I.01375; Shukla H, 2017, J TELEMED TELECARE, V23, P339, DOI 10.1177/1357633X16628996; Tousignant M, 2011, TELEMED E-HEALTH, V17, P376, DOI 10.1089/tmj.2010.0198; Tubach F, 2005, ANN RHEUM DIS, V64, P29, DOI 10.1136/ard.2004.022905; Turkiewicz A, 2014, OSTEOARTHR CARTILAGE, V22, P1826, DOI 10.1016/j.joca.2014.07.015; White IR, 2011, STAT MED, V30, P3192, DOI 10.1002/sim.4360; White IR, 2005, STAT MED, V24, P993, DOI 10.1002/sim.1981; Wong YK, 2005, J TELEMED TELECARE, V11, P310, DOI 10.1258/1357633054893346; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013; Zickuhr K, 2012, PEW INTERNET AM LIFE; Ziebland S, 2015, BRIT J PAIN, V9, P62, DOI 10.1177/2049463714555438; Zou K, 2016, ANN RHEUM DIS, V75, P1964, DOI 10.1136/annrheumdis-2015-208387	57	125	126	4	65	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 4	2017	166	7					453	+		10.7326/M16-1714	http://dx.doi.org/10.7326/M16-1714			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EQ4PT	28241215				2022-12-28	WOS:000398061100007
J	Xie, ZX; Li, BZ; Mitchell, LA; Wu, Y; Qi, X; Jin, Z; Jia, B; Wang, X; Zeng, BX; Liu, HM; Wu, XL; Feng, Q; Zhang, WZ; Liu, W; Ding, MZ; Li, X; Zhao, GR; Qiao, JJ; Cheng, JS; Zhao, M; Kuang, Z; Wang, XY; Martin, JA; Stracquadanio, G; Yang, K; Bai, X; Zhao, J; Hu, ML; Lin, QH; Zhang, WQ; Shen, MH; Chen, S; Su, W; Wang, EX; Guo, R; Zhai, F; Guo, XJ; Du, HX; Zhu, JQ; Song, TQ; Dai, JJ; Li, FF; Jiang, GZ; Han, SL; Liu, SY; Yu, ZC; Yang, XN; Chen, K; Hu, C; Li, DS; Jia, N; Liu, Y; Wang, LT; Wang, S; Wei, XT; Fu, MQ; Qu, LM; Xin, SY; Liu, T; Tian, KR; Li, XN; Zhang, JH; Song, LX; Liu, JG; Lv, JF; Xu, H; Tao, R; Wang, Y; Zhang, TT; Deng, YX; Wang, YR; Li, T; Ye, GX; Xu, XR; Xia, ZB; Zhang, W; Yang, SL; Liu, YL; Ding, WQ; Liu, ZN; Zhu, JQ; Liu, NZ; Walker, R; Luo, YS; Wang, Y; Shen, Y; Yang, HM; Cai, YZ; Ma, PS; Zhang, CT; Bader, JS; Boeke, JD; Yuan, YJ				Xie, Ze-Xiong; Li, Bing-Zhi; Mitchell, Leslie A.; Wu, Yi; Qi, Xin; Jin, Zhu; Jia, Bin; Wang, Xia; Zeng, Bo-Xuan; Liu, Hui-Min; Wu, Xiao-Le; Feng, Qi; Zhang, Wen-Zheng; Liu, Wei; Ding, Ming-Zhu; Li, Xia; Zhao, Guang-Rong; Qiao, Jian-Jun; Cheng, Jing-Sheng; Zhao, Meng; Kuang, Zheng; Wang, Xuya; Martin, J. Andrew; Stracquadanio, Giovanni; Yang, Kun; Bai, Xue; Zhao, Juan; Hu, Meng-Long; Lin, Qiu-Hui; Zhang, Wen-Qian; Shen, Ming-Hua; Chen, Si; Su, Wan; Wang, En-Xu; Guo, Rui; Zhai, Fang; Guo, Xue-Jiao; Du, Hao-Xing; Zhu, Jia-Qing; Song, Tian-Qing; Dai, Jun-Jun; Li, Fei-Fei; Jiang, Guo-Zhen; Han, Shi-Lei; Liu, Shi-Yang; Yu, Zhi-Chao; Yang, Xiao-Na; Chen, Ken; Hu, Cheng; Li, Da-Shuai; Jia, Nan; Liu, Yue; Wang, Lin-Ting; Wang, Su; Wei, Xiao-Tong; Fu, Mei-Qing; Qu, Lan-Meng; Xin, Si-Yu; Liu, Ting; Tian, Kai-Ren; Li, Xue-Nan; Zhang, Jin-Hua; Song, Li-Xiang; Liu, Jin-Gui; Lv, Jia-Fei; Xu, Hang; Tao, Ran; Wang, Yan; Zhang, Ting-Ting; Deng, Ye-Xuan; Wang, Yi-Ran; Li, Ting; Ye, Guang-Xin; Xu, Xiao-Ran; Xia, Zheng-Bao; Zhang, Wei; Yang, Shi-Lan; Liu, Yi-Lin; Ding, Wen-Qi; Liu, Zhen-Ning; Zhu, Jun-Qi; Liu, Ning-Zhi; Walker, Roy; Luo, Yisha; Wang, Yun; Shen, Yue; Yang, Huanming; Cai, Yizhi; Ma, Ping-Sheng; Zhang, Chun-Ting; Bader, Joel S.; Boeke, Jef D.; Yuan, Ying-Jin			"Perfect" designer chromosome V and behavior of a ring derivative	SCIENCE			English	Article							GENOME; YEAST	Perfect matching of an assembled physical sequence to a specified designed sequence is crucial to verify design principles in genome synthesis. We designed and de novo synthesized 536,024-base pair chromosome synV in the " Build-A-Genome China" course. We corrected an initial isolate of synV to perfectly match the designed sequence using integrative cotransformation and clustered regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9)-mediated editing in 22 steps; synV strains exhibit high fitness under a variety of culture conditions, compared with that of wild-type V strains. A ring synV derivative was constructed, which is fully functional in Saccharomyces cerevisiae under all conditions tested and exhibits lower spore viability during meiosis. Ring synV chromosome can extends Sc2.0 design principles and provides a model with which to study genomic rearrangement, ring chromosome evolution, and human ring chromosome disorders.	[Xie, Ze-Xiong; Li, Bing-Zhi; Wu, Yi; Qi, Xin; Jin, Zhu; Jia, Bin; Wang, Xia; Zeng, Bo-Xuan; Liu, Hui-Min; Wu, Xiao-Le; Feng, Qi; Zhang, Wen-Zheng; Liu, Wei; Ding, Ming-Zhu; Li, Xia; Zhao, Guang-Rong; Qiao, Jian-Jun; Cheng, Jing-Sheng; Zhao, Meng; Bai, Xue; Zhao, Juan; Hu, Meng-Long; Lin, Qiu-Hui; Zhang, Wen-Qian; Shen, Ming-Hua; Chen, Si; Su, Wan; Wang, En-Xu; Guo, Rui; Zhai, Fang; Guo, Xue-Jiao; Du, Hao-Xing; Zhu, Jia-Qing; Song, Tian-Qing; Dai, Jun-Jun; Li, Fei-Fei; Jiang, Guo-Zhen; Han, Shi-Lei; Liu, Shi-Yang; Yu, Zhi-Chao; Yang, Xiao-Na; Chen, Ken; Hu, Cheng; Li, Da-Shuai; Jia, Nan; Liu, Yue; Wang, Lin-Ting; Wang, Su; Wei, Xiao-Tong; Fu, Mei-Qing; Qu, Lan-Meng; Xin, Si-Yu; Liu, Ting; Tian, Kai-Ren; Li, Xue-Nan; Zhang, Jin-Hua; Song, Li-Xiang; Liu, Jin-Gui; Lv, Jia-Fei; Xu, Hang; Tao, Ran; Wang, Yan; Zhang, Ting-Ting; Deng, Ye-Xuan; Wang, Yi-Ran; Li, Ting; Ye, Guang-Xin; Xu, Xiao-Ran; Xia, Zheng-Bao; Zhang, Wei; Yang, Shi-Lan; Liu, Yi-Lin; Ding, Wen-Qi; Liu, Zhen-Ning; Zhu, Jun-Qi; Liu, Ning-Zhi; Ma, Ping-Sheng; Zhang, Chun-Ting; Yuan, Ying-Jin] Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China; [Xie, Ze-Xiong; Li, Bing-Zhi; Wu, Yi; Qi, Xin; Jin, Zhu; Jia, Bin; Wang, Xia; Zeng, Bo-Xuan; Liu, Hui-Min; Wu, Xiao-Le; Feng, Qi; Zhang, Wen-Zheng; Liu, Wei; Ding, Ming-Zhu; Li, Xia; Zhao, Guang-Rong; Qiao, Jian-Jun; Cheng, Jing-Sheng; Zhao, Meng; Stracquadanio, Giovanni; Bai, Xue; Zhao, Juan; Hu, Meng-Long; Lin, Qiu-Hui; Zhang, Wen-Qian; Shen, Ming-Hua; Chen, Si; Su, Wan; Wang, En-Xu; Guo, Rui; Zhai, Fang; Guo, Xue-Jiao; Du, Hao-Xing; Zhu, Jia-Qing; Song, Tian-Qing; Dai, Jun-Jun; Li, Fei-Fei; Jiang, Guo-Zhen; Han, Shi-Lei; Liu, Shi-Yang; Yu, Zhi-Chao; Yang, Xiao-Na; Chen, Ken; Hu, Cheng; Li, Da-Shuai; Jia, Nan; Liu, Yue; Wang, Lin-Ting; Wang, Su; Wei, Xiao-Tong; Fu, Mei-Qing; Qu, Lan-Meng; Xin, Si-Yu; Liu, Ting; Tian, Kai-Ren; Li, Xue-Nan; Zhang, Jin-Hua; Song, Li-Xiang; Liu, Jin-Gui; Lv, Jia-Fei; Xu, Hang; Tao, Ran; Wang, Yan; Zhang, Ting-Ting; Deng, Ye-Xuan; Wang, Yi-Ran; Li, Ting; Ye, Guang-Xin; Xu, Xiao-Ran; Xia, Zheng-Bao; Zhang, Wei; Yang, Shi-Lan; Liu, Yi-Lin; Ding, Wen-Qi; Liu, Zhen-Ning; Zhu, Jun-Qi; Liu, Ning-Zhi; Yuan, Ying-Jin] Tianjin Univ, SynBio Res Platform, Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Tianjin 300072, Peoples R China; [Mitchell, Leslie A.; Kuang, Zheng; Wang, Xuya; Martin, J. Andrew; Boeke, Jef D.] NYU, Inst Syst Genet, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Mitchell, Leslie A.; Kuang, Zheng; Wang, Xuya; Martin, J. Andrew; Boeke, Jef D.] NYU, Dept Biochem & Mol Pharmacol, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Stracquadanio, Giovanni; Yang, Kun; Bader, Joel S.] Johns Hopkins Univ, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Stracquadanio, Giovanni; Yang, Kun; Bader, Joel S.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA; [Stracquadanio, Giovanni] Univ Essex, Sch Comp Sci & Elect Engn, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England; [Walker, Roy; Luo, Yisha; Cai, Yizhi] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3BF, Midlothian, Scotland; [Wang, Yun; Shen, Yue; Yang, Huanming] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Yang, Huanming] James D Watson Inst Genome Sci, Hangzhou 310058, Zhejiang, Peoples R China	Tianjin University; Tianjin University; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Johns Hopkins University; Johns Hopkins University; University of Essex; University of Edinburgh; Beijing Genomics Institute (BGI)	Yuan, YJ (corresponding author), Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.; Yuan, YJ (corresponding author), Tianjin Univ, SynBio Res Platform, Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Tianjin 300072, Peoples R China.	yjyuan@tju.edu.cn	li, bz/GVR-7133-2022; Wang, Yixuan/GZK-6559-2022; Wang, Yin/HCI-9352-2022; Tao, Rongjia/K-3133-2017; wang, yi/GVT-8516-2022; Wang, Yijun/GXW-1763-2022; wang, yixuan/GXW-2866-2022; li, bing/GWQ-9617-2022; Kuang, Zheng/ABG-3667-2021; Stracquadanio, Giovanni/AAL-2648-2021; Cai, Yizhi/A-3550-2010	Tao, Rongjia/0000-0001-5058-4401; Stracquadanio, Giovanni/0000-0001-9819-3645; Liu, Yue/0000-0002-8051-5156; Boeke, Jef/0000-0001-5322-4946; Wu, Yi/0000-0002-2539-9228; Xie, Zexiong/0000-0002-6214-9009; Mitchell, Leslie/0000-0001-7869-9817; Walker, Roy/0000-0003-0960-4591; Cai, Yizhi/0000-0003-1663-2865	"863" program [2012AA02A708]; International Cooperative Project [2015DFA00960]; "973" program [2014CB745100]; National Natural Science Foundation of China program [21390203, 21621004]; U.S. NSF [MCB-1026068, MCB-1158201, MCB-1445545]; BBSRC [BB/M005690/1] Funding Source: UKRI; Div Of Molecular and Cellular Bioscience [1616111] Funding Source: National Science Foundation; Biotechnology and Biological Sciences Research Council [BB/M005690/1] Funding Source: researchfish	"863" program(National High Technology Research and Development Program of China); International Cooperative Project; "973" program(National Basic Research Program of China); National Natural Science Foundation of China program(National Natural Science Foundation of China (NSFC)); U.S. NSF(National Science Foundation (NSF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work in TJU was funded by the "863" program, 2012AA02A708; the International Cooperative Project, 2015DFA00960; the "973" program, 2014CB745100; and the National Natural Science Foundation of China program, 21390203 and 21621004. Work in the United States was funded by U.S. NSF grants MCB-1026068 and MCB-1158201 to J.D.B. and U.S. NSF grant MCB-1445545 to J.S.B. J.D.B. and J.S.B. are founders and directors of Neochromosome. J.D.B. serves as a scientific advisor to Recombinetics and Sample6. These arrangements are reviewed and managed by the Committees on Conflict of Interest at New York University (NYU) Langone Medical Center (J.D.B.) and Johns Hopkins University (J.S.B.). We thank A. Heguy and her staff at NYU's Genome Technology Center for outstanding deep sequencing services. We thank P. Hare for the help with editing and N. Agmon for assistance with use of CRISPR/Cas9. Additional information [synV design diagram, PCRTag sequences, Feature summary table (wild-type V, designed synV, physical strains; yeast_chr05_9_01 to yeast_chr05_9_22), variants in physical strains (yeast_chr05_9_01 to yeast_chr05_9_22), PCR primers, and a summary of BBs and minichunks] related to synV can be accessed on the Sc2.0 website (www.syntheticyeast.org). All genomic data for this paper are available under the Sc2.0 umbrella BioProject accession no. PRJNA351844. Requests for materials should be addressed to Y.-J.Y. (Email: yjyuan@tju.edu.cn).	Annaluru N, 2014, SCIENCE, V344, P55, DOI 10.1126/science.1249252; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; Ciuladaite Z, 2015, MOL CYTOGENET, V8, DOI 10.1186/s13039-015-0124-9; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dietrich FS, 1997, NATURE, V387, P78, DOI 10.1038/387s078; Dymond JS, 2011, NATURE, V477, P471, DOI 10.1038/nature10403; Dymond JS, 2009, GENETICS, V181, P13, DOI 10.1534/genetics.108.096784; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; HABER JE, 1984, GENETICS, V106, P185; Han JS, 2004, NATURE, V429, P314, DOI 10.1038/nature02535; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hou LH, 2010, APPL BIOCHEM BIOTECH, V160, P1084, DOI 10.1007/s12010-009-8552-9; Hou LH, 2009, BIOTECHNOL LETT, V31, P671, DOI 10.1007/s10529-009-9916-5; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Jovicevic D, 2014, BIOESSAYS, V36, P855, DOI 10.1002/bies.201400086; Kaboli S, 2014, NUCLEIC ACIDS RES, V42, P9838, DOI 10.1093/nar/gku576; Kim T, 2014, NUCLEUS-PHILA, V5, P391, DOI 10.4161/nucl.36300; Lin QH, 2015, ACS SYNTH BIOL, V4, P213, DOI 10.1021/sb500241e; Mitchell LA, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4831; OCHMAN H, 1988, GENETICS, V120, P621; Reid RJD, 2008, GENETICS, V180, P1799, DOI 10.1534/genetics.108.087999; Richardson SM, 2017, SCIENCE, V355, P1040, DOI 10.1126/science.aaf4557; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; Severino M, 2015, MOL CYTOGENET, V8, DOI 10.1186/s13039-015-0121-z; Shen Y, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4791; Sibbesen EL, 2013, AM J MED GENET A, V161A, P1447, DOI 10.1002/ajmg.a.35901; Sivendran S, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-25; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Specchio N, 2012, EPILEPSY BEHAV, V25, P585, DOI 10.1016/j.yebeh.2012.09.032; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; Vaudano AE, 2015, EPILEPSY BEHAV, V45, P155, DOI 10.1016/j.yebeh.2015.02.002; Wu Y, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4706; Zhang WM, 2017, SCIENCE, V355, DOI 10.1126/science.aaf3981	36	143	185	35	232	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI				eaaf4704	10.1126/science.aaf4704	http://dx.doi.org/10.1126/science.aaf4704			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9VY	28280151				2022-12-28	WOS:000396348900033
J	Coombes, R				Coombes, Rebecca			We need to talk about resuscitation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmj.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2017	356								j1216	10.1136/bmj.j1216	http://dx.doi.org/10.1136/bmj.j1216			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BU	28279959	Green Published, Bronze			2022-12-28	WOS:000396433400005
J	Friedmann, PD; Andrews, CM; Humphreys, K				Friedmann, Peter D.; Andrews, Christina M.; Humphreys, Keith			How ACA Repeal Would Worsen the Opioid Epidemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Friedmann, Peter D.] Univ Massachusetts, Med Sch Baystate, Springfield, MA 01103 USA; [Friedmann, Peter D.] Baystate Hlth, Springfield, MA 01199 USA; [Andrews, Christina M.] Univ South Carolina, Coll Social Work, Columbia, SC 29208 USA; [Humphreys, Keith] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Humphreys, Keith] Stanford Univ, Stanford, CA 94305 USA	University of Massachusetts System; University of South Carolina System; University of South Carolina Columbia; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Friedmann, PD (corresponding author), Univ Massachusetts, Med Sch Baystate, Springfield, MA 01103 USA.; Friedmann, PD (corresponding author), Baystate Hlth, Springfield, MA 01199 USA.							Department of Health and Human Services (HHS) Office of the Surgeon U.S. General, 2016, FAC ADD AM SURG GEN; Florence CS, 2016, MED CARE, V54, P901, DOI 10.1097/MLR.0000000000000625; Strang J, 2012, LANCET, V379, P71, DOI 10.1016/S0140-6736(11)61674-7; Substance Abuse and Mental Health Services Administration.Center for Behavioral Health Statistics and Quality, 2015, NSDUH SERIES	4	18	18	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2017	376	10							e16	10.1056/NEJMp1700834	http://dx.doi.org/10.1056/NEJMp1700834			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9JA	28273016	Bronze			2022-12-28	WOS:000395626500006
J	Ho, CCM; Chhabra, A; Starkl, P; Schnorr, PJ; Wilmes, S; Moraga, I; Kwon, HS; Gaudenzio, N; Sibilano, R; Wehrman, TS; Gakovic, M; Sockolosky, JT; Tiffany, MR; Ring, AM; Piehler, J; Weissman, IL; Galli, SJ; Shizuru, JA; Garcia, KC				Ho, Chia Chi M.; Chhabra, Akanksha; Starkl, Philipp; Schnorr, Peter-John; Wilmes, Stephan; Moraga, Ignacio; Kwon, Hye-Sook; Gaudenzio, Nicolas; Sibilano, Riccardo; Wehrman, Tom S.; Gakovic, Milica; Sockolosky, Jonathan T.; Tiffany, Matthew R.; Ring, Aaron M.; Piehler, Jacob; Weissman, Irving L.; Galli, Stephen J.; Shizuru, Judith A.; Garcia, K. Christopher			Decoupling the Functional Pleiotropy of Stem Cell Factor by Tuning c-Kit Signaling	CELL			English	Article							RECEPTOR TYROSINE KINASE; MAST-CELL; IN-VIVO; CYTOKINE PLEIOTROPY; PROGENITOR CELLS; STRUCTURAL BASIS; ACTIVATION; MICE; LIGAND; DIMERIZATION	Most secreted growth factors and cytokines are functionally pleiotropic because their receptors are expressed on diverse cell types. While important for normal mammalian physiology, pleiotropy limits the efficacy of cytokines and growth factors as therapeutics. Stem cell factor (SCF) is a growth factor that acts through the c-Kit receptor tyrosine kinase to elicit hematopoietic progenitor expansion but can be toxic when administered in vivo because it concurrently activates mast cells. We engineered a mechanismbased SCF partial agonist that impaired c-Kit dimerization, truncating downstream signaling amplitude. This SCF variant elicited biased activation of hematopoietic progenitors over mast cells in vitro and in vivo. Mouse models of SCF-mediated anaphylaxis, radioprotection, and hematopoietic expansion revealed that this SCF partial agonist retained therapeutic efficacy while exhibiting virtually no anaphylactic offtarget effects. The approach of biasing cell activation by tuning signaling thresholds and outputs has applications to many dimeric receptor-ligand systems.	[Ho, Chia Chi M.] Stanford Univ, Sch Engn, Dept Bioengn, 443 Via Ortega, Stanford, CA 94305 USA; [Wilmes, Stephan; Piehler, Jacob] Univ Osnabruck, Dept Biol, Barbarastr 11, D-49076 Osnabruck, Germany; [Chhabra, Akanksha; Schnorr, Peter-John; Kwon, Hye-Sook; Shizuru, Judith A.] Stanford Univ, Sch Med, Dept Blood & Marrow Transplantat, 300 Pasteur Dr, Stanford, CA 94305 USA; [Ho, Chia Chi M.; Moraga, Ignacio; Gakovic, Milica; Sockolosky, Jonathan T.; Ring, Aaron M.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 279 Campus Dr, Stanford, CA 94305 USA; [Ring, Aaron M.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, 299 Campus Dr, Stanford, CA 94305 USA; [Starkl, Philipp; Gaudenzio, Nicolas; Sibilano, Riccardo; Weissman, Irving L.; Galli, Stephen J.] Stanford Univ, Sch Med, Dept Pathol, 300 Pasteur Dr, Stanford, CA 94305 USA; [Starkl, Philipp] Med Univ Vienna, Dept Med 1, Waehringer Guertel 18-20, A-1090 Vienna, Austria; [Galli, Stephen J.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, 299 Campus Dr, Stanford, CA 94305 USA; [Tiffany, Matthew R.] Stanford Univ, Sch Med, Dept Pediat & Genet, 300 Pasteur Dr, Stanford, CA 94305 USA; [Moraga, Ignacio; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, 279 Campus Dr, Stanford, CA 94305 USA; [Ho, Chia Chi M.; Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, 265 Campus Dr, Stanford, CA 94305 USA; [Weissman, Irving L.] Stanford Univ, Sch Med, Ludwig Ctr Canc Stem Cell Res & Med, 265 Campus Dr, Stanford, CA 94305 USA; [Wehrman, Tom S.] Prim Bio, 48383 Fremont Blvd,Suite 118, Fremont, CA 94538 USA; [Chhabra, Akanksha; Schnorr, Peter-John; Kwon, Hye-Sook; Weissman, Irving L.; Shizuru, Judith A.] Stanford Univ, Sch Med, Stanford Canc Inst, 265 Campus Dr, Stanford, CA 94305 USA	Stanford University; University Osnabruck; Stanford University; Stanford University; Stanford University; Stanford University; Medical University of Vienna; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford Cancer Institute; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 279 Campus Dr, Stanford, CA 94305 USA.; Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, 299 Campus Dr, Stanford, CA 94305 USA.; Garcia, KC (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, 279 Campus Dr, Stanford, CA 94305 USA.	kcgarcia@stanford.edu		Wilmes, Stephan/0000-0002-4112-710X; Starkl, Philipp/0000-0001-7521-129X; Gaudenzio, Nicolas/0000-0002-5648-509X; Moraga, Ignacio/0000-0001-9909-0701; Ring, Aaron/0000-0003-3699-2446; Schnorr, Peter/0000-0003-3226-0950	Siebel Stem Cell Institute; Max Kade Fellowship of the Max Kade Foundation; Austrian Academy of Sciences; Schroedinger Fellowship of the Austrian Science Fund [FWF: J3399-B21]; Stanford Molecular and Cellular Immunobiology NIH postdoctoral training grant [5T32 AI072905]; NIH; National Cancer Institute; California Institute for Regenerative Medicine; Deutsche Forschungsgemeinschaft [SFB 944]; Ludwig Foundation; Mathers Foundation; NIH [RO1-AI51321]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI072905, R37AI051321] Funding Source: NIH RePORTER	Siebel Stem Cell Institute; Max Kade Fellowship of the Max Kade Foundation; Austrian Academy of Sciences; Schroedinger Fellowship of the Austrian Science Fund; Stanford Molecular and Cellular Immunobiology NIH postdoctoral training grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ludwig Foundation; Mathers Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Waghray, S. Fischer, N. Goriatcheva, T. Storm, L. Jerabek, J.P. Volkmer, J. Poyser, S. Jungers, and M. Tsai for technical assistance, discussions, and reagents. We thank Stanford Shared FACS facility and Stanford SIM1 FACS facility for access to high throughput FACS analyzers. We thank Xiaolin He for providing mouse c-Kit and SCF cDNAs. This work was supported by the Siebel Stem Cell Institute (to C.C.M.H. and K.C.G.); a Max Kade Fellowship of the Max Kade Foundation and the Austrian Academy of Sciences and a Schroedinger Fellowship of the Austrian Science Fund (FWF: J3399-B21 to P.S.); Stanford Molecular and Cellular Immunobiology NIH postdoctoral training grant (5T32 AI072905 to J.T.S.); the NIH and National Cancer Institute (to S.J.G. and I.L.W.); the California Institute for Regenerative Medicine (to J.A.S.); the Deutsche Forschungsgemeinschaft (SFB 944 to J.P.); and the Ludwig Foundation, Mathers Foundation, NIH grant RO1-AI51321 (to K.C.G.), and the Howard Hughes Medical Institute (to K.C.G.).	Akahoshi M, 2011, J CLIN INVEST, V121, P4180, DOI 10.1172/JCI46139; Atanasova M, 2012, CRIT REV BIOCHEM MOL, V47, P502, DOI 10.3109/10409238.2012.729561; Baldo BA, 2014, DRUG SAFETY, V37, P921, DOI 10.1007/s40264-014-0226-z; Bendall LJ, 2014, CYTOKINE GROWTH F R, V25, P355, DOI 10.1016/j.cytogfr.2014.07.011; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; BLECHMAN JM, 1995, CELL, V80, P103, DOI 10.1016/0092-8674(95)90455-7; BRIDDELL RA, 1993, BLOOD, V82, P1720; Costa JJ, 1996, J EXP MED, V183, P2681, DOI 10.1084/jem.183.6.2681; da Silva MG, 2004, BONE MARROW TRANSPL, V34, P683, DOI 10.1038/sj.bmt.1704602; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Floros T, 2015, SEMIN ONCOL, V42, P539, DOI 10.1053/j.seminoncol.2015.05.015; Gagari E, 1997, BLOOD, V89, P2654, DOI 10.1182/blood.V89.8.2654; GALLI SJ, 1993, J CLIN INVEST, V91, P148, DOI 10.1172/JCI116164; Gardner RV, 1998, STEM CELLS, V16, P112, DOI 10.1002/stem.160112; Gaudenzio N, 2016, J CLIN INVEST, V126, P3981, DOI 10.1172/JCI85538; Gaudenzio N, 2015, JOVE-J VIS EXP, DOI 10.3791/52753; Gilfillan AM, 2009, IMMUNOL RES, V43, P15, DOI 10.1007/s12026-008-8046-9; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Hart Y, 2014, CELL, V158, P1022, DOI 10.1016/j.cell.2014.07.033; Hill PB, 1996, IMMUNOLOGY, V87, P326, DOI 10.1046/j.1365-2567.1996.455545.x; Hsu YR, 1997, J BIOL CHEM, V272, P6406, DOI 10.1074/jbc.272.10.6406; Jiang XL, 2000, EMBO J, V19, P3192, DOI 10.1093/emboj/19.13.3192; Kalesnikoff J, 2011, METHODS MOL BIOL, V677, P207, DOI 10.1007/978-1-60761-869-0_15; Kirchhofer A, 2010, NAT STRUCT MOL BIOL, V17, P133, DOI 10.1038/nsmb.1727; Klemm JD, 1998, ANNU REV IMMUNOL, V16, P569, DOI 10.1146/annurev.immunol.16.1.569; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Leibowitz BJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4494; LEIGH BR, 1995, RADIAT RES, V142, P12, DOI 10.2307/3578961; Levin D, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004998; LI CL, 1994, BLOOD, V84, P408, DOI 10.1182/blood.V84.2.408.bloodjournal842408; Lilla JN, 2011, BLOOD, V118, P6930, DOI 10.1182/blood-2011-03-343962; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; Liu HL, 2007, EMBO J, V26, P891, DOI 10.1038/sj.emboj.7601545; Macdonald-Obermann JL, 2014, J BIOL CHEM, V289, P26178, DOI 10.1074/jbc.M114.586826; Mitra S, 2015, IMMUNITY, V42, P826, DOI 10.1016/j.immuni.2015.04.018; Moraga I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab2677; Moraga I, 2015, CELL, V160, P1196, DOI 10.1016/j.cell.2015.02.011; Moraga I, 2014, ADV IMMUNOL, V121, P1, DOI 10.1016/B978-0-12-800100-4.00001-5; Moskowitz CH, 1997, BLOOD, V89, P3136; Nepom GT, 2013, CLIN IMMUNOL, V149, P279, DOI 10.1016/j.clim.2013.02.003; NICOLA NA, 1994, STEM CELLS, V12, P3; Reshetnyak AV, 2015, MOL CELL, V57, P191, DOI 10.1016/j.molcel.2014.11.021; Riese DJ, 2011, EXPERT OPIN DRUG DIS, V6, P185, DOI 10.1517/17460441.2011.547468; Roder F, 2014, ACS CHEM BIOL, V9, P2479, DOI 10.1021/cb5005806; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; Stroud Robert M, 2004, Sci STKE, V2004, pre7, DOI 10.1126/stke.2312004re7; Taketomi Y, 2007, J IMMUNOL, V178, P7042, DOI 10.4049/jimmunol.178.11.7042; TAYLOR AM, 1995, IMMUNOLOGY, V86, P427; Thomas D, 2004, EXPERT OPIN BIOL TH, V4, P869, DOI 10.1517/14712598.4.6.869; TONG J, 1993, BLOOD, V82, P784, DOI 10.1182/blood.V82.3.784.bloodjournal823784; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518; Wada T, 2010, J CLIN INVEST, V120, P2867, DOI 10.1172/JCI42680; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Weiskopf K, 2013, SCIENCE, V341, P88, DOI 10.1126/science.1238856; WILLIAMS DE, 1992, J CELL BIOCHEM, V50, P221, DOI 10.1002/jcb.240500302; Wilmes S, 2015, J CELL BIOL, V209, P579, DOI 10.1083/jcb.201412049; Yea K, 2015, CURR OPIN CHEM BIOL, V26, P1, DOI 10.1016/j.cbpa.2015.01.002; YEE NS, 1994, J BIOL CHEM, V269, P31991; You CJ, 2014, ANAL CHEM, V86, P8593, DOI 10.1021/ac501127r; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055; Zhang ZT, 2000, P NATL ACAD SCI USA, V97, P7732, DOI 10.1073/pnas.97.14.7732	64	45	46	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2017	168	6					1041	+		10.1016/j.cell.2017.02.011	http://dx.doi.org/10.1016/j.cell.2017.02.011			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8ZF	28283060	Green Accepted, Bronze			2022-12-28	WOS:000396287900012
J	Rohr, R				Rohr, Richard			Why Physician Leaders of Health Care Organizations Should Participate in Direct Patient Care	ANNALS OF INTERNAL MEDICINE			English	Letter																		Detsky AS, 2016, ANN INTERN MED, V165, P519, DOI 10.7326/M16-0820	1	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2017	166	5					376	376		10.7326/L16-0626	http://dx.doi.org/10.7326/L16-0626			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BO	28265662				2022-12-28	WOS:000396432800015
J	Friedrich, MJ				Friedrich, M. J.			Atypical Leishmaniasis Linked to Genetic Variants of Leishmania	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2017	317	7					687	687		10.1001/jama.2017.0055	http://dx.doi.org/10.1001/jama.2017.0055			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8WR	28241365				2022-12-28	WOS:000394901600004
J	Steinberg, DI				Steinberg, Daniel I.			Pooled RCTs: In sepsis, continuous (vs intermittent) antibiotic infusion reduced hospital mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Steinberg, Daniel I.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Steinberg, DI (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.							Lexicomp Online Lexidrugs, 2016, PIP TAZ ADM STOR ISS; Lexicomp Online Lexidrugs, 2016, MER ADM STOR ISS; Roberts JA, 2009, CRIT CARE MED, V37, P840, DOI 10.1097/CCM.0b013e3181961bff	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2017	166	4					JC19	JC19		10.7326/ACPJC-2017-166-4-019	http://dx.doi.org/10.7326/ACPJC-2017-166-4-019			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7FO	28241292				2022-12-28	WOS:000394786700007
J	Kidia, KK				Kidia, Khameer K.			American Health Is Global Health	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kidia, Khameer K.] Icahn Sch Med Mt Sinai, Arnhold Inst Global Hlth, 1 Gustave Levy Pl, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Kidia, KK (corresponding author), Icahn Sch Med Mt Sinai, Arnhold Inst Global Hlth, 1 Gustave Levy Pl, New York, NY 10029 USA.	kkidia@gmail.com						Aizenman N, 2016, NATL PUBLIC RADIO; Armstrong K, 2017, NEW ENGL J MED, DOI [10.1056/NEJMp1701339, DOI 10.1056/NEJMP.17011339]; Chibanda D, 2016, JAMA-J AM MED ASSOC, V316, P2618, DOI 10.1001/jama.2016.19102; Drange Matt, 2017, FORBES; Education Commission for Foreign Medical Graduates, 2015, ECFMG 2015 ANN REP; Kidia KK, 2016, NEW ENGL J MED, V374, P909, DOI 10.1056/NEJMp1512888	6	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 18	2017	166	8					589	+		10.7326/M17-0323	http://dx.doi.org/10.7326/M17-0323			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ES1RF	28241269				2022-12-28	WOS:000399304000020
J	Mandl, LA				Mandl, Lisa A.			Improving Symptoms in Knee Osteoarthritis: Can We Get There From Here?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							OLDER-ADULTS; PEOPLE; CARE; PAIN		[Mandl, Lisa A.] Hosp Special Surg, Weill Cornell Med, 535 E 70th St, New York, NY 10021 USA	Cornell University	Mandl, LA (corresponding author), Hosp Special Surg, 535 East 70th St, New York, NY 10024 USA.	MandlL@hss.edu			NATIONAL INSTITUTE ON AGING [P30AG022845, K24AG053462] Funding Source: NIH RePORTER; NIA NIH HHS [P30 AG022845, K24 AG053462] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Beissner K, 2012, J AGING PHYS ACTIV, V20, P246, DOI 10.1123/japa.20.2.246; Bennell KL, 2017, ANN INTERN MED, V166, P453, DOI 10.7326/M16-1714; Deshpande BR, 2016, ARTHRIT CARE RES, V68, P1743, DOI 10.1002/acr.22897; Dobson F, 2016, AM J PHYS MED REHAB, V95, P372, DOI 10.1097/PHM.0000000000000448; Hawker GA, 2013, ARTHRITIS RHEUM-US, V65, P1243, DOI 10.1002/art.37901; Li LC, 2011, J RHEUMATOL, V38, P2230, DOI 10.3899/jrheum.110264; Mallen CD, 2013, JAMA INTERN MED, V173, P1119, DOI 10.1001/jamainternmed.2013.962; Murphy L, 2008, ARTHRIT RHEUM-ARTHR, V59, P1207, DOI 10.1002/art.24021; Yang SB, 2013, CLIN THER, V35, P1690, DOI 10.1016/j.clinthera.2013.09.022	9	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 4	2017	166	7					531	532		10.7326/M17-0330	http://dx.doi.org/10.7326/M17-0330			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ4PT	28241277	Green Accepted			2022-12-28	WOS:000398061100014
J	Gallego, EM; Portilla, MT; Paris, C; Leon-Escamilla, A; Boronat, M; Moliner, M; Corma, A				Maria Gallego, Eva; Teresa Portilla, M.; Paris, Cecilia; Leon-Escamilla, Alejandro; Boronat, Mercedes; Moliner, Manuel; Corma, Avelino			"Ab initio" synthesis of zeolites for preestablished catalytic reactions	SCIENCE			English	Article							STRUCTURE-DIRECTING AGENTS; FERRIERITE LAYERS; ETHYLBENZENE ISOMERIZATION; SILICA; ADAMANTANE; MECHANISM; DISPROPORTIONATION; REARRANGEMENTS; CARBONYLATION; SPECIFICITY	Unlike homogeneous catalysts that are often designed for particular reactions, zeolites are heterogeneous catalysts that are explored and optimized in a heuristic fashion. We present a methodology for synthesizing active and selective zeolites by using organic structure-directing agents that mimic the transition state (TS) of preestablished reactions to be catalyzed. In these zeolites, the pores and cavities could be generated approaching a molecular-recognition pattern. For disproportionation of toluene and isomerization of ethylbenzene into xylenes, the TSs are larger than the reaction products. Zeolite ITQ-27 showed high disproportionation activity, and ITQ-64 showed high selectivity for the desired para and ortho isomers. For the case of a product and TS of similar size, we synthesized a catalyst, MIT-1, for the isomerization of endo-dicyclopentane into adamantane.	[Maria Gallego, Eva; Teresa Portilla, M.; Paris, Cecilia; Leon-Escamilla, Alejandro; Boronat, Mercedes; Moliner, Manuel; Corma, Avelino] Univ Politecn Valencia, Inst Tecnol Quim, Consejo Super Invest Cient, Ave Naranjos S-N, E-46022 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Tecnologia Quimica (ITQ)	Corma, A (corresponding author), Univ Politecn Valencia, Inst Tecnol Quim, Consejo Super Invest Cient, Ave Naranjos S-N, E-46022 Valencia, Spain.	acorma@itq.upv.es	GALLEGO, EVA MARIA/U-3013-2019; CANOS, AVELINO CORMA/A-3040-2013; MOLINER, MANUEL/D-4404-2013; boronat, mercedes/H-9968-2015	CANOS, AVELINO CORMA/0000-0002-2232-3527; MOLINER, MANUEL/0000-0002-5440-716X; GALLEGO, EVA MARIA/0000-0001-6025-0122; boronat, mercedes/0000-0002-6211-5888	European Union through the European Research Council (SynCatMatch) [ERC-AdG-2014-671093]; Spanish government through the "Severo Ochoa Program" [SEV 2012-0267]	European Union through the European Research Council (SynCatMatch)(European Research Council (ERC)); Spanish government through the "Severo Ochoa Program"	This work has been supported by the European Union through the European Research Council (grant ERC-AdG-2014-671093, SynCatMatch) and the Spanish government through the "Severo Ochoa Program" (grant SEV 2012-0267). The Electron Microscopy Service of the Universitat Politecnica de Valencia (UPV) is acknowledged for help with sample characterization. The Red Espanola de Supercomputacion (RES) and Centre de Calcul de la Universitat de Valencia are gratefully acknowledged for computational facilities and technical assistance. E.M.G. acknowledges "La Caixa-Severo Ochoa" International Ph.D. Fellowship (call 2015). We thank I. Millet for technical assistance and V. J. Margarit and A. Cantin for helpful discussions.	Acton Q. A., 2013, ADV ADAMANTANE RES A; Ahmad WR, 1996, CATAL LETT, V40, P109, DOI 10.1007/BF00807466; Bhan A, 2007, J AM CHEM SOC, V129, P4919, DOI 10.1021/ja070094d; Boronat M, 2008, J AM CHEM SOC, V130, P16316, DOI 10.1021/ja805607m; Burton A, 2000, CHEM MATER, V12, P2936, DOI 10.1021/cm000243q; Butler J. R., 2008, U. S. Patent, Patent No. [20,080,319,243, 20080319243]; Cejka J, 2002, CATAL REV, V44, P375, DOI 10.1081/CR-120005741; Climent MJ, 2011, CHEM REV, V111, P1072, DOI 10.1021/cr1002084; Corma A, 1998, NATURE, V396, P353, DOI 10.1038/24592; Dapsens PY, 2012, ACS CATAL, V2, P1487, DOI 10.1021/cs300124m; Davis ME, 2014, CHEM MATER, V26, P239, DOI 10.1021/cm401914u; De Vos DE, 2005, MICROPOR MESOPOR MAT, V82, P293, DOI 10.1016/j.micromeso.2005.01.038; Diaz-Cabanas M. J., 2000, U.S. Patent, Patent No. [6,077,498, 6077498]; Dorset DL, 2004, J PHYS CHEM B, V108, P15216, DOI 10.1021/jp040305q; Dorset DL, 2006, J AM CHEM SOC, V128, P8862, DOI 10.1021/ja061206o; Eliasova P, 2015, CHEM SOC REV, V44, P7177, DOI 10.1039/c5cs00045a; ENGLER EM, 1973, J AM CHEM SOC, V95, P5769, DOI 10.1021/ja00798a059; Fernandes LD, 1998, J CATAL, V177, P363, DOI 10.1006/jcat.1998.2111; GAO Z, 1994, CHINESE J CHEM, V12, P52; HEILMANN J, 1994, ANGEW CHEM INT EDIT, V33, P471, DOI 10.1002/anie.199404711; HONNA K, 1986, CHEM LETT, P315, DOI 10.1246/cl.1986.315; Ikeda T, 2010, J PHYS CHEM C, V114, P3466, DOI 10.1021/jp912026n; Ikeda T, 2009, J MATER CHEM, V19, P5518, DOI 10.1039/b905415d; Jacobs PA, 2014, ANGEW CHEM INT EDIT, V53, P8621, DOI 10.1002/anie.201400922; Katz A, 2000, NATURE, V403, P286, DOI 10.1038/35002032; Knight LM, 2007, STUD SURF SCI CATAL, V170, P338; LAU GC, 1987, LANGMUIR, V3, P164, DOI 10.1021/la00074a004; Lofgreen JE, 2014, CHEM SOC REV, V43, P911, DOI 10.1039/c3cs60276a; Luo HY, 2015, CHEM SCI, V6, P6320, DOI 10.1039/c5sc01912e; Margarit VJ, 2015, ANGEW CHEM INT EDIT, V54, P13724, DOI 10.1002/anie.201506822; Millini R, 2004, MICROPOR MESOPOR MAT, V74, P59, DOI 10.1016/j.micromeso.2004.06.007; Moliner M, 2013, ANGEW CHEM INT EDIT, V52, P13880, DOI 10.1002/anie.201304713; Moreau F, 2001, J CATAL, V202, P402, DOI 10.1006/jcat.2001.3294; Navratilova M, 2000, APPL CATAL A-GEN, V203, P127, DOI 10.1016/S0926-860X(00)00477-4; PINES H, 1961, J ORG CHEM, V26, P1052, DOI 10.1021/jo01063a020; ROBSCHLAGER KH, 1979, IND ENG CHEM PROD RD, V18, P347, DOI 10.1021/i360072a023; Ruan JF, 2009, CHEM MATER, V21, P2904, DOI 10.1021/cm900645c; Schleyer PV, 1960, J AM CHEM SOC, V82, P4645; SCHLEYER PV, 1957, J AM CHEM SOC, V79, P3292; Schmidt JE, 2014, ANGEW CHEM INT EDIT, V53, P8372, DOI 10.1002/anie.201404076; Schreyeck L, 1996, MICROPOROUS MATER, V6, P259, DOI 10.1016/0927-6513(96)00032-6; Tsai TC, 1999, APPL CATAL A-GEN, V181, P355, DOI 10.1016/S0926-860X(98)00396-2; Vermeiren W, 2009, TOP CATAL, V52, P1131, DOI 10.1007/s11244-009-9271-8; WULFF G, 1986, J AM CHEM SOC, V108, P1089, DOI 10.1021/ja00265a045; Xiao X., 2006, U. S. Patent, Patent No. [20,060,211,902, 20060211902]; XIONG YS, 1995, J AM CHEM SOC, V117, P9427, DOI 10.1021/ja00142a007; Zones S.I., 1985, U.S. Patent, Patent No. [4,544,538, 4544538]	47	150	150	9	256	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI				aal0121	10.1126/science.aal0121	http://dx.doi.org/10.1126/science.aal0121			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9VY	28280200	Green Submitted, Green Published			2022-12-28	WOS:000396348900038
J	Palmer, J				Palmer, Jane			Chile's glacial lakes pose newly recognized flood threat	SCIENCE			English	News Item																			0	5	5	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI		1004	1005		10.1126/science.355.6329.1004	http://dx.doi.org/10.1126/science.355.6329.1004			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9VY	28280160				2022-12-28	WOS:000396348900010
J	Richardson, SM; Mitchell, LA; Stracquadanio, G; Yang, K; Dymond, JS; DiCarlo, JE; Lee, D; Huang, CLV; Chandrasegaran, S; Cai, YZ; Boeke, JD; Bader, JS				Richardson, Sarah M.; Mitchell, Leslie A.; Stracquadanio, Giovanni; Yang, Kun; Dymond, Jessica S.; DiCarlo, James E.; Lee, Dongwon; Huang, Cheng Lai Victor; Chandrasegaran, Srinivasan; Cai, Yizhi; Boeke, Jef D.; Bader, Joel S.			Design of a synthetic yeast genome	SCIENCE			English	Article							AUTOMATED DESIGN; GENES; DNA; MANIPULATION; GENERATION; GENEDESIGN; INTRONS; SYSTEM; SITE; PCR	We describe complete design of a synthetic eukaryotic genome, Sc2.0, a highly modified Saccharomyces cerevisiae genome reduced in size by nearly 8%, with 1.1 megabases of the synthetic genome deleted, inserted, or altered. Sc2.0 chromosome designwas implemented with BioStudio, an open-source framework developed for eukaryotic genome design, which coordinates design modifications from nucleotide to genome scales and enforces version control to systematically track edits. To achieve complete Sc2.0 genome synthesis, individual synthetic chromosomes built by Sc2.0 Consortium teams around the world will be consolidated into a single strain by " endoreduplication intercross." Chemically synthesized genomes like Sc2.0 are fully customizable and allow experimentalists to ask otherwise intractable questions about chromosome structure, function, and evolution with a bottom-up design strategy.	[Richardson, Sarah M.; Stracquadanio, Giovanni; Yang, Kun; Lee, Dongwon; Bader, Joel S.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA; [Richardson, Sarah M.; Mitchell, Leslie A.; Stracquadanio, Giovanni; Yang, Kun; Dymond, Jessica S.; DiCarlo, James E.; Huang, Cheng Lai Victor; Cai, Yizhi; Boeke, Jef D.; Bader, Joel S.] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Mitchell, Leslie A.; Boeke, Jef D.] NYU, Langone Med Ctr, Inst Syst Genet, 550 1St Ave, New York, NY 10016 USA; [Mitchell, Leslie A.; Boeke, Jef D.] NYU, Langone Med Ctr, Dept Biochem & Mol Pharmacol, 550 1St Ave, New York, NY 10016 USA; [Stracquadanio, Giovanni] Univ Essex, Sch Comp Sci & Elect Engn, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England; [Chandrasegaran, Srinivasan] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; [Cai, Yizhi] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3BF, Midlothian, Scotland; [Richardson, Sarah M.] Ignit Genom, Unit 703, 12240 Roundwood Rd, Lutherville Timonium, MD 21093 USA; [Dymond, Jessica S.] Johns Hopkins Univ, Appl Phys Lab, Res & Exploratory Dev Dept, Biol Sci, 11100 Johns Hopkins Rd,Mail Stop 21-N352, Laurel, MD 20723 USA; [DiCarlo, James E.] Columbia Univ, Coll Phys & Surg, Dept Ophthalmol, New York, NY 10032 USA; [Lee, Dongwon] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; University of Essex; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Edinburgh; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Columbia University; Johns Hopkins University	Bader, JS (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA.; Boeke, JD; Bader, JS (corresponding author), Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA.; Boeke, JD (corresponding author), NYU, Langone Med Ctr, Inst Syst Genet, 550 1St Ave, New York, NY 10016 USA.; Boeke, JD (corresponding author), NYU, Langone Med Ctr, Dept Biochem & Mol Pharmacol, 550 1St Ave, New York, NY 10016 USA.	jef.boeke@nyumc.org; joel.bader@jhu.edu	Stracquadanio, Giovanni/AAL-2648-2021; DiCarlo, James/AAJ-1579-2021; Cai, Yizhi/A-3550-2010	Stracquadanio, Giovanni/0000-0001-9819-3645; DiCarlo, James/0000-0003-4728-3186; Mitchell, Leslie/0000-0001-7869-9817; Cai, Yizhi/0000-0003-1663-2865; Richardson, Sarah/0000-0002-9820-9421; Lee, Dongwon/0000-0002-1568-2249	NSF [MCB-0718846, MCB-1026068, MCB-1616111, MCB-0546446, MCB-1445545]; Department of Energy [DE-FG02097ER25308]; NSERC; Microsoft Research; BBSRC [BB/M005690/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M005690/1] Funding Source: researchfish; Direct For Biological Sciences [1445537] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [1616111] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Microsoft Research(Microsoft); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by funding from NSF (grants MCB-0718846 and MCB-1026068 to J.D.B. and J.S.B., MCB-1616111 to J.D.B., MCB-0546446 and MCB-1445545 to J.S.B.), the Department of Energy (grant number DE-FG02097ER25308 to S.M.R.); NSERC Postdoctoral Fellowship to L.A.M.; and Microsoft Research (to J.S.B.). We thank all Sc2.0 Consortium members and members of the S. cerevisiae community for their helpful comments during the design phase of this project. We thank the leadership and staff of the SGD for helping make this project possible. J.D.B. and J.S.B. are founders and directors of Neochromosome, Inc. J.D.B. serves as a scientific advisor to Recombinetics, Inc., and Sample6, Inc. These arrangements are reviewed and managed by the committees on conflict of interest at NYU Langone Medical Center (J.D.B.) and Johns Hopkins University (J.S.B.). Additional information including design diagrams, PCRTag sequences, feature summary tables, and variants in the physical strains corresponding to Sc2.0 synthetic chromosomes can be accessed on the Sc2.0 website, www.syntheticyeast.org.	Admire A, 2006, GENE DEV, V20, P159, DOI 10.1101/gad.1392506; Annaluru N, 2014, SCIENCE, V344, P55, DOI 10.1126/science.1249252; BARNETT RW, 1990, NUCLEIC ACIDS RES, V18, P3094, DOI 10.1093/nar/18.10.3094; Berliner B., 1990, Proceedings of the Winter 1990 USENIX Conference, P341; Chacon S., 2014, PROGIT, V2nd, DOI 10.1007/978-1-4842-0076-6_6; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; CICCARELLI RB, 1991, NUCLEIC ACIDS RES, V19, P6007, DOI 10.1093/nar/19.21.6007; Dymond J, 2012, BIOENGINEERED, V3, P168, DOI 10.4161/bbug.19543; Dymond JS, 2011, NATURE, V477, P471, DOI 10.1038/nature10403; Fisk DG, 2006, YEAST, V23, P857, DOI 10.1002/yea.1400; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; HILL A, 1987, MOL CELL BIOL, V7, P2397, DOI 10.1128/MCB.7.7.2397; HOESS RH, 1986, NUCLEIC ACIDS RES, V14, P2287, DOI 10.1093/nar/14.5.2287; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; JI H, 1993, CELL, V73, P1007, DOI 10.1016/0092-8674(93)90278-X; Lajoie MJ, 2013, SCIENCE, V342, P361, DOI 10.1126/science.1241460; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; Mitchell LA, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4831; Mitchell LA, 2015, JOVE-J VIS EXP, DOI 10.3791/52941; Muller Heloise, 2012, Methods Mol Biol, V852, P133, DOI 10.1007/978-1-61779-564-0_11; Parenteau J, 2008, MOL BIOL CELL, V19, P1932, DOI 10.1091/mbc.E07-12-1254; Parenteau J, 2011, CELL, V147, P320, DOI 10.1016/j.cell.2011.08.044; Pilato C. M., 2008, VERSION CONTROL SUBV; Reid RJD, 2008, GENETICS, V180, P1799, DOI 10.1534/genetics.108.087999; Richardson SM, 2010, LECT NOTES COMPUT SC, V6068, P280; Richardson SM, 2010, NUCLEIC ACIDS RES, V38, P2603, DOI 10.1093/nar/gkq143; Richardson SM, 2006, GENOME RES, V16, P550, DOI 10.1101/gr.4431306; Salim HMW, 2008, PROTIST, V159, P283, DOI 10.1016/j.protis.2007.11.003; Shen Y, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4791; Shen Y, 2016, GENOME RES, V26, P36, DOI 10.1101/gr.193433.115; Skinner ME, 2009, GENOME RES, V19, P1630, DOI 10.1101/gr.094607.109; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Wu Y, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4706; Xie ZX, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4704; Zhang WM, 2017, SCIENCE, V355, DOI 10.1126/science.aaf3981	36	298	321	15	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI		1040	1044		10.1126/science.aaf4557	http://dx.doi.org/10.1126/science.aaf4557			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9VY	28280199				2022-12-28	WOS:000396348900031
J	Xie, Y				Xie, Y.			It's whom you know that counts	SCIENCE			English	Editorial Material									[Xie, Y.] Princeton Univ, Dept Sociol, Princeton, NJ 08544 USA; [Xie, Y.] Peking Univ, Ctr Social Res, Beijing 100871, Peoples R China	Princeton University; Peking University	Xie, Y (corresponding author), Princeton Univ, Dept Sociol, Princeton, NJ 08544 USA.; Xie, Y (corresponding author), Peking Univ, Ctr Social Res, Beijing 100871, Peoples R China.	yuxie@princeton.edu						Cao C., 2004, CHINAS SCI ELITE; Cole J. R., 1973, SOCIAL STRATIFICATIO; Fisman R., 2017, 23130 NBER; LIN N, 2001, CHINESE TRIANGLE MAI, P153; LONG JS, 1979, AM SOCIOL REV, V44, P816, DOI 10.2307/2094529; Merton R. K., 1973, SOCIOLOGY SCI, P286; Merton RobertK., 1973, SOCIOLOGY SCI, P267; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; Shi YG, 2010, SCIENCE, V329, P1128, DOI 10.1126/science.1196916; Xie Y., 2012, IS AM SCI DECLINE; Xie Y, 2014, P NATL ACAD SCI USA, V111, P9437, DOI 10.1073/pnas.1407709111; Zhang CN, 2013, URBAN STUD, V50, P3011, DOI 10.1177/0042098013482499; Zuckerman H., 1977, SCI ELITE NOBEL LAUR	13	7	7	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI		1022	1023		10.1126/science.aam5408	http://dx.doi.org/10.1126/science.aam5408			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9VY	28280167				2022-12-28	WOS:000396348900016
J	Papadaki, A; Martinez, JA				Papadaki, Angeliki; Martinez, J. Alfredo			Effects on Health Outcomes of a Mediterranean Diet With No Restriction on Fat Intake	ANNALS OF INTERNAL MEDICINE			English	Letter							ADHERENCE		[Papadaki, Angeliki] Univ Bristol, Bristol, Avon, England; [Martinez, J. Alfredo] Univ Navarra, CIBERobn Nutr, Pamplona, Spain	University of Bristol; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Navarra	Papadaki, A (corresponding author), Univ Bristol, Bristol, Avon, England.		Martinez-Gonzalez, Miguel A./AAE-7669-2019	Papadaki, Angeliki/0000-0002-5728-3975				Bloomfield HE, 2016, ANN INTERN MED, V165, P491, DOI 10.7326/M16-0361; Fung TT, 2008, ARCH INTERN MED, V168, P713, DOI 10.1001/archinte.168.7.713; Papadaki A, 2009, NUTR DIET RES PROG, P285; Sayon-Orea C, 2015, MENOPAUSE, V22, P750, DOI 10.1097/GME.0000000000000378; Sofi F, 2014, PUBLIC HEALTH NUTR, V17, P2769, DOI 10.1017/S1368980013003169	5	1	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2017	166	5					377	378		10.7326/L16-0590	http://dx.doi.org/10.7326/L16-0590			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BO	28265658				2022-12-28	WOS:000396432800017
J	Desai, RJ; Bateman, BT; Huybrechts, KF; Patorno, E; Hernandez-Diaz, S; Park, Y; Dejene, SZ; Cohen, J; Mogun, H; Kim, SC				Desai, Rishi J.; Bateman, Brian T.; Huybrechts, Krista F.; Patorno, Elisabetta; Hernandez-Diaz, Sonia; Park, Yoonyoung; Dejene, Sara Z.; Cohen, Jacqueline; Mogun, Helen; Kim, Seoyoung C.			Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SYSTEMIC GLUCOCORTICOID THERAPY; RHEUMATOID-ARTHRITIS; CROHNS-DISEASE; OUTCOMES; LUPUS; RECOMMENDATIONS; PREDICTORS; MANAGEMENT; HYDROXYCHLOROQUINE; CORTICOSTEROIDS	OBJECTIVE To compare the risk of serious infections associated with use of systemic steroids, non-biologic agents, or tumor necrosis factor alpha (TNF) inhibitors in pregnancy. DESIGN Observational cohort study. SETTING Public (Medicaid, 2001-10) or private (Optum Clinformatics, 2004-15) health insurance programs in the US. PARTICIPANTS 4961 pregnant women treated with immunosuppressive drugs for rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, psoriatic arthritis, or inflammatory bowel disease. EXPOSURE FOR OBSERVATIONAL STUDIES Exposure was classified into steroid, non-biologic, or TNF inhibitors on first filled prescription during pregnancy. Because TNF inhibitors are not used to treat systemic lupus erythematosus, patients with this condition were excluded from comparisons involving TNF inhibitors. MAIN OUTCOME MEASURE The main outcome was occurrence of serious infections during pregnancy, defined by hospital admission for bacterial or opportunistic infections. Hazard ratios were derived using Cox proportional hazard regression models after adjustment for confounding with propensity score fine stratification. A logistic regression model was used to conduct a dose-response analysis among women filling at least one steroid prescription. RESULTS 71 out of 4961 pregnant women (0.2%) treated with immunosuppressive agents experienced serious infections. The crude incidence rates of serious infections per 100 person years among 2598 steroid users, 1587 non-biologic users, and 776 TNF inhibitors users included in this study were 3.4 (95% confidence interval 2.5 to 4.7), 2.3 (1.5 to 3.5), and 1.5 (0.7 to 3.0), respectively. No statistically significant differences in the risk of serious infections during pregnancy were observed among users of the three immunosuppressive drug classes: non-biologics v steroids, hazard ratio 0.81 (95% confidence interval 0.48 to 1.37), TNF inhibitors v steroids 0.91 (0.36 to 2.26), and TNF inhibitors v non-biologics 1.36 (0.47 to 3.93). In the dose-response analysis, higher steroid dose was associated with an increased risk of serious infections during pregnancy (coefficient for each unit increase in average prednisone equivalent mg daily dose= 0.019, P= 0.02). CONCLUSIONS Risk of serious infections is similar among pregnant women with systemic inflammatory conditions using steroids, non-biologics, and TNF inhibitors. However, high dose steroid use is an independent risk factor of serious infections in pregnancy.	[Desai, Rishi J.; Bateman, Brian T.; Huybrechts, Krista F.; Patorno, Elisabetta; Dejene, Sara Z.; Mogun, Helen; Kim, Seoyoung C.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; [Desai, Rishi J.; Bateman, Brian T.; Huybrechts, Krista F.; Patorno, Elisabetta; Dejene, Sara Z.; Mogun, Helen; Kim, Seoyoung C.] Harvard Med Sch, Boston, MA 02120 USA; [Bateman, Brian T.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA USA; [Hernandez-Diaz, Sonia; Park, Yoonyoung; Cohen, Jacqueline] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Desai, RJ (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA.; Desai, RJ (corresponding author), Harvard Med Sch, Boston, MA 02120 USA.	rdesai@bwh.harvard.edu	Cohen, Jacqueline M./H-6517-2019; Kim, Seoyoung/L-6561-2019; Desai, Rishi/AAH-8988-2021	Cohen, Jacqueline M./0000-0002-7300-0488; Kim, Seoyoung/0000-0002-2517-3579; 	Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital; Harvard Medical School; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD075831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH099141, R01MH100216] Funding Source: NIH RePORTER	Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital; Harvard Medical School; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The investigators conducted the research independently through funding from internal sources of the Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School.	Aberra FN, 2003, GASTROENTEROLOGY, V125, P320, DOI 10.1016/S0016-5085(03)00883-7; Akbari M, 2013, INFLAMM BOWEL DIS, V19, P15, DOI 10.1002/ibd.22948; Bjorn AMB, 2015, BASIC CLIN PHARMACOL, V116, P308, DOI 10.1111/bcpt.12367; Buyon JP, 2015, ANN INTERN MED, V163, P153, DOI 10.7326/M14-2235; Clowse MEB, 2007, RHEUM DIS CLIN N AM, V33, P237, DOI 10.1016/j.rdc.2007.01.002; Clowse MEB, 2006, ARTHRITIS RHEUM, V54, P3640, DOI 10.1002/art.22159; Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004; Crowson CS, 2012, ARTHRITIS RHEUM-US, V64, P2847, DOI 10.1002/art.34530; Crowther CA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003935.pub3; de Man YA, 2009, ARTHRITIS RHEUM-US, V60, P3196, DOI 10.1002/art.24914; Desai RJ, 2017, EPIDEMIOLOGY, V28, P249, DOI 10.1097/EDE.0000000000000595; Desai RJ, 2016, ARTHRITIS RHEUMATOL, V68, P1183, DOI 10.1002/art.39521; Dixon WG, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3453; Doran MF, 2002, ARTHRITIS RHEUM, V46, P2294, DOI 10.1002/art.10529; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; Hoes JN, 2007, ANN RHEUM DIS, V66, P1560, DOI 10.1136/ard.2007.072157; Kaplan YC, 2016, BRIT J CLIN PHARMACO, V81, P835, DOI 10.1111/bcp.12872; Kappelman MD, 2007, CLIN GASTROENTEROL H, V5, P1424, DOI 10.1016/j.cgh.2007.07.012; Kavanaugh A, 2015, ARTHRIT CARE RES, V67, P313, DOI 10.1002/acr.22516; Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566; Lesko SM, 2006, TXB PHARMACOEPIDEMIO, P311; Lichtenstein GR, 2006, CLIN GASTROENTEROL H, V4, P621, DOI 10.1016/j.cgh.2006.03.002; Manager R., 2014, REVMAN VERSION 5 3; Margulis AV, 2013, PHARMACOEPIDEM DR S, V22, P16, DOI 10.1002/pds.3284; Mecacci F, 2007, SEMIN PERINATOL, V31, P223, DOI 10.1053/j.semperi.2007.05.005; Myers JA, 2011, AM J EPIDEMIOL, V174, P1213, DOI 10.1093/aje/kwr364; Nielsen OH, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-174; Ostensen M, 2004, ANN RHEUM DIS, V63, P1212, DOI 10.1136/ard.2003.016881; Palmsten K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067405; Pearl J, 2011, AM J EPIDEMIOL, V174, P1223, DOI 10.1093/aje/kwr352; Ramiro S, 2014, ANN RHEUM DIS, V73, P529, DOI 10.1136/annrheumdis-2013-204575; Ruiz-Irastorza G, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2764; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; Schneeweiss S, 2007, J CLIN EPIDEMIOL, V60, P397, DOI 10.1016/j.jclinepi.2006.07.011; Viktil KK, 2012, SCAND J RHEUMATOL, V41, P196, DOI 10.3109/03009742.2011.626442; Winthrop KL, 2012, RHEUM DIS CLIN N AM, V38, P727, DOI 10.1016/j.rdc.2012.08.019	36	33	35	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2017	356								j895	10.1136/bmj.j895	http://dx.doi.org/10.1136/bmj.j895			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BH	28264814	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000396432100009
J	Hart, L; Horton, R				Hart, Laura; Horton, Richard			Syndemics: committing to a healthier future	LANCET			English	Editorial Material									[Hart, Laura; Horton, Richard] Lancet, London EC2Y 5AS, England		Hart, L (corresponding author), Lancet, London EC2Y 5AS, England.							Mendenhall E, 2017, LANCET, V389, P951, DOI 10.1016/S0140-6736(17)30402-6; Singer M., 2009, INTRO SYNDEMICS CRIT; Singer M, 2017, LANCET, V389, P941, DOI 10.1016/S0140-6736(17)30003-X; Tsai AC, 2017, LANCET, V389, P978, DOI 10.1016/S0140-6736(17)30403-8; Willen SS, 2017, LANCET, V389, P964, DOI 10.1016/S0140-6736(17)30261-1	5	25	25	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 4	2017	389	10072					888	889						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM4DL	28271826				2022-12-28	WOS:000395263400008
J	Mendenhall, E; Kohrt, BA; Norris, SA; Ndetei, D; Prabhakaran, D				Mendenhall, Emily; Kohrt, Brandon A.; Norris, Shane A.; Ndetei, David; Prabhakaran, Dorairaj			Non-communicable disease syndemics: poverty, depression, and diabetes among low-income populations	LANCET			English	Article							ADVERSE CHILDHOOD EXPERIENCES; ANTIDEPRESSANT MEDICATION USE; COMMUNITY-HEALTH WORKERS; COMMON MENTAL-DISORDERS; POOR GLYCEMIC CONTROL; SOUTH-AFRICA; RISK-FACTOR; HIV-INFECTION; OLDER-PEOPLE; LIFETIME PREVALENCE	The co-occurrence of health burdens in transitioning populations, particularly in specific socioeconomic and cultural contexts, calls for conceptual frameworks to improve understanding of risk factors, so as to better design and implement prevention and intervention programmes to address comorbidities. The concept of a syndemic, developed by medical anthropologists, provides such a framework for preventing and treating comorbidities. The term syndemic refers to synergistic health problems that affect the health of a population within the context of persistent social and economic inequalities. Until now, syndemic theory has been applied to comorbid health problems in poor immigrant communities in high-income countries with limited translation, and in low-income or middle-income countries. In this Series paper, we examine the application of syndemic theory to comorbidities and multimorbidities in low-income and middle-income countries. We employ diabetes as an exemplar and discuss its comorbidity with HIV in Kenya, tuberculosis in India, and depression in South Africa. Using a model of syndemics that addresses transactional pathophysiology, socioeconomic conditions, health system structures, and cultural context, we illustrate the different syndemics across these countries and the potential benefit of syndemic care to patients. We conclude with recommendations for research and systems of care to address syndemics in low-income and middle-income country settings.	[Mendenhall, Emily] Georgetown Univ, Sch Foreign Serv, Washington, DC 20057 USA; [Kohrt, Brandon A.] Duke Univ, Dept Psychiat, Duke Global Hlth Inst, Durham, NC 27706 USA; [Norris, Shane A.] Univ Witwatersrand, Fac Hlth, MRC, Dev Pathways Hlth Res Unit, Johannesburg, South Africa; [Ndetei, David] Univ Nairobi, Dept Psychiat, Nairobi, Kenya; [Ndetei, David] Africa Mental Hlth Fdn, Nairobi, Kenya; [Prabhakaran, Dorairaj] Publ Hlth Fdn India, Ctr Chron Dis Control, New Delhi, India; [Prabhakaran, Dorairaj] London Sch Hyg & Trop Med, London, England	Georgetown University; Duke University; University of Witwatersrand; University of Nairobi; Public Health Foundation of India; University of London; London School of Hygiene & Tropical Medicine	Mendenhall, E (corresponding author), Georgetown Univ, Sch Foreign Serv, Washington, DC 20057 USA.	em1061@georgetown.edu	Norris, Shane/C-4664-2014; Prabhakaran, Dorairaj/B-4147-2011	Norris, Shane/0000-0001-7124-3788; Prabhakaran, Dorairaj/0000-0002-3172-834X	National Institutes of Health Fogarty International Center [R24 TW007988]; Georgetown University's School of Foreign Service; South African Medical Research Council; National Science Foundation; Northwestern University's Cells; US National Institute of Mental Health (NIMH) through Reducing Barriers to Mental Health Task Sharing [K01MH104310-01]; UK MRC/DfID Africa Research Leader Scheme; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH104310] Funding Source: NIH RePORTER	National Institutes of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Georgetown University's School of Foreign Service; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Science Foundation(National Science Foundation (NSF)); Northwestern University's Cells; US National Institute of Mental Health (NIMH) through Reducing Barriers to Mental Health Task Sharing; UK MRC/DfID Africa Research Leader Scheme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This paper discusses research conducted in India, Kenya, South Africa, and the USA funded by the following institutions: National Institutes of Health Fogarty International Center (R24 TW007988), Georgetown University's School of Foreign Service, the South African Medical Research Council, the National Science Foundation, and Northwestern University's Cells to Society. BAK is funded by the US National Institute of Mental Health (NIMH) through Reducing Barriers to Mental Health Task Sharing (K01MH104310-01). SAN is supported by the UK MRC/DfID Africa Research Leader Scheme. This research study would have been impossible without the hundreds of people with diabetes willing to share their life stories and health-care experiences with us; we are grateful for their time, patience, and openness. This study would also be impossible without the institutions and especially research assistants who hosted, facilitated, and accompanied these projects, including the Public Health Foundation of India and Centre for Chronic Disease Control in New Delhi, India; Africa Mental Health Foundation in Nairobi, Kenya; MRC/Wits University's Developmental Pathways for Health Research Unit in Johannesburg, South Africa; and John H. Stroger, Jr. Hospital of Cook County in Chicago, USA. We thank H Stowe McMurray for assistance with the table.	Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; Aillon JL, 2014, SOC PSYCH PSYCH EPID, V49, P1257, DOI 10.1007/s00127-013-0755-2; Alisjahbana B, 2006, INT J TUBERC LUNG D, V10, P696; American Diabetes Association, 2014, NAT DIAB STAT REP 20; Anderson RJ, 2002, INT J PSYCHIAT MED, V32, P235, DOI 10.2190/KLGD-4H8D-4RYL-TWQ8; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; [Anonymous], 2014, LANCET DIABETES ENDO, V2, P677, DOI 10.1016/S2213-8587(14)70192-5; Ayah R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-371; Barnard K, 2013, DIABETES CARE, V36, P3337, DOI 10.2337/dc13-0560; Basu S, 2012, PUBLIC HEALTH NUTR, V16, P1, DOI [http://dx.doi.org/10.1007/S1368980012003758, DOI 10.1017/S1368980012003758]; Beaglehole R, IMPROVING PREVENTION; Bloomfield GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022288; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; CDC, 2013, REP TUB US; Center for Behavioral Health Statistics and Quality, BEH HLTH TRENDS US R; Chachra Vaibhav, 2014, Indian J Tuberc, V61, P65; Claassens M, 2014, EVIDENCE INFORM S AF; Closser S, 2015, ANN ANTHROPL PRACT, V39, P16, DOI 10.1111/napa.12061; Corburn J, 2015, J ENVIRON PUBLIC HEA, V2015, DOI 10.1155/2015/209505; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; Crowther NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048883; Danese A, 2009, ARCH PEDIAT ADOL MED, V163, P1135, DOI 10.1001/archpediatrics.2009.214; Daniels ME, 2014, EMERGING GLOBAL HLTH; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; de Groot M, 2006, DIABETES CARE, V29, P549, DOI 10.2337/diacare.29.03.06.dc05-1396; Denning P, COMMUNITIES CRISIS I; Deuschle M, 2013, CURR OPIN PSYCHIATR, V26, P60, DOI 10.1097/YCO.0b013e32835a4206; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Druss BG, 2010, AM J PSYCHIAT, V167, P151, DOI 10.1176/appi.ajp.2009.09050691; Everson SA, 2002, J PSYCHOSOM RES, V53, P891, DOI 10.1016/S0022-3999(02)00303-3; Farmer P, 2001, LANCET, V358, P404, DOI 10.1016/S0140-6736(01)05550-7; Farmer P., 2009, GLOBAL HLTH TIMES VI, P137; Farmer PE, 2006, PLOS MED, V3, P1686, DOI 10.1371/journal.pmed.0030449; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; GAVARD JA, 1993, DIABETES CARE, V16, P1167, DOI 10.2337/diacare.16.8.1167; Gerhard T, 2014, J CLIN PSYCHIAT, V75, P490, DOI 10.4088/JCP.13m08675; Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751; Gomez-Olive FX, 2014, INT J EPIDEMIOL, V43, P1531, DOI 10.1093/ije/dyu093; Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Hall H, 2015, MMWR-MORBID MORTAL W, V64, P667; Health and Development Africa, 2012, GLOB AIDS RESP; Herman AA, 2009, SAMJ S AFR MED J, V99, P339; Hoffmann R, 2015, EUR J PUBLIC HEALTH, V25, P849, DOI 10.1093/eurpub/ckv090; Holt RIG, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0491-3; Hulzebosch A, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0112-1; International Diabetes Federation, 2020, IDF DIABETES ATLAS; International Union Against Tuberculosis and Lung Disease, UN HLTH SOL POOR; Jaspers L, 2015, EUR J EPIDEMIOL, V30, P163, DOI 10.1007/s10654-014-9983-3; Kant L, 2003, INDIAN J TUBERC, V50, P83; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Kessler R. C., 2011, EPIDEMIOL PSICHIAT S, V18, P23, DOI [10.1016/S0140-6736(13)61781-X, DOI 10.1017/S1121189X00001421]; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; Kidder A, 2011, CHRONIC CARE INTEGRA; Kivimaki M, 2011, BIOL PSYCHIAT, V70, P978, DOI 10.1016/j.biopsych.2011.07.008; Kivimaki M, 2010, DIABETES CARE, V33, P2611, DOI 10.2337/dc10-1187; Kleinman A, 2010, LANCET, V375, P1518, DOI 10.1016/S0140-6736(10)60646-0; Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x; Lawn SD, 2006, CLIN INFECT DIS, V42, P1040, DOI 10.1086/501018; Lee C, 2012, SOC SCI MED, V29, P997; Leone T, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-39; Lewin S, 2008, LANCET, V372, P928, DOI 10.1016/S0140-6736(08)61403-8; Lonnroth K, 2014, LANCET DIABETES ENDO, V2, P730, DOI 10.1016/S2213-8587(14)70109-3; Lohrmann GM, 2012, S AFR J HIV MED, V13, P2010; Luhrman TM, 2001, 2 MINDS ANTHR LOOKS; Lund C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001359; Lund C, 2010, SOC SCI MED, V71, P517, DOI 10.1016/j.socscimed.2010.04.027; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Madise NJ, 2012, HEALTH PLACE, V18, P1144, DOI 10.1016/j.healthplace.2012.04.003; Maes K, 2015, STUD COMP INT DEV, V50, P455, DOI 10.1007/s12116-015-9197-z; Maes K, 2015, ANN ANTHROPL PRACT, V39, P42, DOI 10.1111/napa.12064; Maes K, 2015, ANN ANTHROPL PRACT, V39, P1, DOI 10.1111/napa.12060; Magadi MA, 2013, AIDS BEHAV, V17, P1645, DOI 10.1007/s10461-012-0217-y; Mayosi BM, 2012, LANCET, V380, P2029, DOI 10.1016/S0140-6736(12)61814-5; McGuire M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074090; Mendenhall E., 2012, SYNDEMIC SUFFERING S, DOI DOI 10.4324/9781315419459; Mendenhall E., 2015, GLOBAL MENTAL HLTH A; Mendenhall E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2615-3; Mendenhall E, 2016, MED ANTHROPOL Q, V30, P462, DOI 10.1111/maq.12215; Mendenhall E, 2015, SOC SCI MED, V146, P11, DOI 10.1016/j.socscimed.2015.10.015; Mendenhall E, 2014, ANN ANTHROPL PRACT, V38, P300, DOI 10.1111/napa.12058; Mendenhall E, 2015, GLOB PUBLIC HEALTH, V10, P449, DOI 10.1080/17441692.2014.998698; Mendenhall E, 2014, DIABETES RES CLIN PR, V103, P276, DOI 10.1016/j.diabres.2014.01.001; Mendenhall E, 2012, SOC SCI MED, V75, P2522, DOI 10.1016/j.socscimed.2012.09.040; Mendenhall E, 2012, CULT MED PSYCHIAT, V36, P136, DOI 10.1007/s11013-011-9240-0; Meyer PA, 2013, MMWR-MORBID MORTAL W, V62, P3; Mezuk B, 2013, HEALTH PLACE, V23, P63, DOI 10.1016/j.healthplace.2013.05.004; Ministry of Health and Family Welfare Government of India, 2007, NAT FAM HLTH SURV NF; Misra A, 2001, INT J OBESITY, V25, P1722, DOI 10.1038/sj.ijo.0801748; Mohan V, 2007, INDIAN J MED RES, V125, P217; Molosankwe I, 2012, J AFFECT DISORDERS, V142, pS42, DOI 10.1016/S0165-0327(12)70008-3; Monteiro CA, 2013, OBES REV, V14, P21, DOI 10.1111/obr.12107; Moulton CD, 2015, LANCET DIABETES ENDO, V3, P461, DOI 10.1016/S2213-8587(15)00134-5; Mugisha JO, 2016, GLOBAL HLTH ACTION, V1, P1; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Musselman DL, 2003, BIOL PSYCHIAT, V54, P317, DOI 10.1016/S0006-3223(03)00569-9; National AIDS and STI Control Programme, KEN HIV EST 2014; Ndetei David M, 2009, Ann Gen Psychiatry, V8, P1, DOI 10.1186/1744-859X-8-1; Needham B, 2010, SOC SCI MED, V71, P1472, DOI 10.1016/j.socscimed.2010.07.016; Neupane D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117329; Nichter M, 2016, MED ANTHROPOL Q, V30, P536, DOI 10.1111/maq.12319; Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x; Nyirenda M, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.19201; Nyirenda M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-259; Ogaro TD, 2012, AFR J HLTH SCI, V20, P82; Omran A, 1971, MILBANK MEM FUND Q, V49, P38; Oni T, 2015, INT HLTH, V7, P1; Oni T, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0750-1; Oni T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-575; Oti SO, 2013, TROP MED INT HEALTH, V18, P1520, DOI 10.1111/tmi.12200; Oxlade O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047533; PablosMendez A, 1997, AM J PUBLIC HEALTH, V87, P574, DOI 10.2105/AJPH.87.4.574; Padmanathan P, 2013, SOC SCI MED, V97, P82, DOI 10.1016/j.socscimed.2013.08.004; Panter-Brick C, 2014, GLOB HLTH ACTION, V7, P1; Pastakia SD, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-21; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Patel V, 2016, LANCET, V387, P1672, DOI 10.1016/S0140-6736(15)00390-6; Peer N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043336; Pillay Y, 2014, JOINT REV HIV TB PMT; Ponce-De-Leon A, 2004, DIABETES CARE, V27, P1584, DOI 10.2337/diacare.27.7.1584; Poongothai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007185; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; Popkin BM, 2016, LANCET DIABETES ENDO, V4, P174, DOI 10.1016/S2213-8587(15)00419-2; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Pratt LA, 2014, DEPRESSION US HOUSEH; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Quigley Fran, 2009, WALKING TOGETHER WAL; Rahman A, 2008, LANCET, V372, P902, DOI 10.1016/S0140-6736(08)61400-2; Rahman A, 2008, TROP MED INT HEALTH, V13, P579, DOI 10.1111/j.1365-3156.2008.02036.x; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Renn BN, 2011, CLIN PSYCHOL REV, V31, P1239, DOI 10.1016/j.cpr.2011.08.001; Riza AL, 2014, LANCET DIABETES ENDO, V2, P740, DOI 10.1016/S2213-8587(14)70110-X; Saito S, 2016, JAIDS-J ACQ IMM DEF, V71, pe96, DOI 10.1097/QAI.0000000000000896; Samb B, 2010, LANCET, V376, P1785, DOI 10.1016/S0140-6736(10)61353-0; Schmitz N, 2014, DIABETES CARE, V37, P970, DOI 10.2337/dc13-1832; Scholten F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-886; Shiffman J, 2008, HEALTH POLICY PLANN, V23, P95, DOI 10.1093/heapol/czm045; Shippee ND, 2012, J CLIN EPIDEMIOL, V65, P1041, DOI 10.1016/j.jclinepi.2012.05.005; Singer M, 2003, MED ANTHROPOL Q, V17, P423, DOI 10.1525/maq.2003.17.4.423; SINGER M, 1994, SOC SCI MED, V39, P931, DOI 10.1016/0277-9536(94)90205-4; Singer M., 2009, INTRO SYNDEMICS CRIT; Singer M., 1996, FREE INQ CREAT SOCIO, V24, P99, DOI [10.1093/jn/nxaa361, DOI 10.1093/jn/nxaa361]; Singer MC, 2006, SOC SCI MED, V63, P2010, DOI 10.1016/j.socscimed.2006.05.012; Singla DR, 2015, LANCET GLOB HEALTH, V3, pE458, DOI 10.1016/S2214-109X(15)00099-6; South Africa Government, 2010, NEG SERV DEL AGR OUT; Spielmans GI, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001403; Steel Z, 2014, INT J EPIDEMIOL, V43, P476, DOI 10.1093/ije/dyu038; Stein DJ, 2008, BRIT J PSYCHIAT, V192, P112, DOI 10.1192/bjp.bp.106.029280; Talbot F, 2000, DIABETES CARE, V23, P1556, DOI 10.2337/diacare.23.10.1556; Urban Health Division Ministry of Health and Family Welfare, 2007, HLTH URB POOR IND KE; Van der Feltz-Cornelis CM, 2010, GEN HOSP PSYCHIAT, V32, P380, DOI 10.1016/j.genhosppsych.2010.03.011; van Dooren FEP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057058; Vellakkal S, 2015, J EPIDEMIOL COMMUN H, V69, P218, DOI 10.1136/jech-2014-204621; Vellakkal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068219; Weaver LJ, 2014, MED ANTHROPOL, V33, P92, DOI 10.1080/01459740.2013.808637; WHO, 2014, GLOB TUB REP 2014; World Health Organization, 2008, TASK SHIFT RAT RED T; Wu CS, 2014, J CLIN PSYCHIAT, V75, P31, DOI 10.4088/JCP.13m08421; Yoon JM, 2013, KOREAN J FAM MED, V34, P228, DOI 10.4082/kjfm.2013.34.4.228	159	210	221	6	113	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 4	2017	389	10072					951	963						13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM4DL	28271846	Green Accepted			2022-12-28	WOS:000395263400035
J	Asimow, PD				Asimow, Paul D.			A measure of mantle melting	SCIENCE			English	Editorial Material									[Asimow, Paul D.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology	Asimow, PD (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	asimow@gps.caltech.edu	Asimow, Paul D/E-7451-2010	Asimow, Paul D/0000-0001-6025-8925				Hirschmann MM, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000070; Katz RF, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000433; Sarafian E, 2017, SCIENCE, V355, P942, DOI 10.1126/science.aaj2165	3	3	3	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					908	+		10.1126/science.aam7807	http://dx.doi.org/10.1126/science.aam7807			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM2YM	28254900				2022-12-28	WOS:000395181700021
J	Dixon, D				Dixon, Deborah			Crystalline	SCIENCE			English	Book Review									[Dixon, Deborah] Univ Glasgow East Quadrangle, Sch Geog & Earth Sci, Univ Ave, Glasgow G12 8QQ, Lanark, Scotland		Dixon, D (corresponding author), Univ Glasgow East Quadrangle, Sch Geog & Earth Sci, Univ Ave, Glasgow G12 8QQ, Lanark, Scotland.	deborah.dixon@glasgow.ac.uk						MCDONALD S, 2017, CRYSTALLINE	1	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					916	916		10.1126/science.aam8822	http://dx.doi.org/10.1126/science.aam8822			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM2YM	28254905				2022-12-28	WOS:000395181700026
J	Ribeil, JA; Hacein-Bey-Abina, S; Payen, E; Magnani, A; Semeraro, M; Magrin, E; Caccavelli, L; Neven, B; Bourget, P; El Nemer, W; Bartolucci, P; Weber, L; Puy, H; Meritet, JF; Grevent, D; Beuzard, Y; Chretien, S; Lefebvre, T; Ross, RW; Negre, O; Veres, G; Sandler, L; Soni, S; de Montalembert, M; Blanche, S; Leboulch, P; Cavazzana, M				Ribeil, Jean-Antoine; Hacein-Bey-Abina, Salima; Payen, Emmanuel; Magnani, Alessandra; Semeraro, Michaela; Magrin, Elisa; Caccavelli, Laure; Neven, Benedicte; Bourget, Philippe; El Nemer, Wassim; Bartolucci, Pablo; Weber, Leslie; Puy, Herve; Meritet, Jean-Francois; Grevent, David; Beuzard, Yves; Chretien, Stany; Lefebvre, Thibaud; Ross, Robert W.; Negre, Olivier; Veres, Gabor; Sandler, Laura; Soni, Sandeep; de Montalembert, Mariane; Blanche, Stephane; Leboulch, Philippe; Cavazzana, Marina			Gene Therapy in a Patient with Sickle Cell Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MARROW-TRANSPLANTATION; BETA-THALASSEMIA; HEMOGLOBINOPATHIES; AVAILABILITY; INTEGRATION; EFFICACY; VECTOR; ANEMIA; DONORS	Sickle cell disease results from a homozygous missense mutation in the beta-globin gene that causes polymerization of hemoglobin S. Gene therapy for patients with this disorder is complicated by the complex cellular abnormalities and challenges in achieving effective, persistent inhibition of polymerization of hemoglobin S. We describe our first patient treated with lentiviral vector-mediated addition of an antisickling beta-globin gene into autologous hematopoietic stem cells. Adverse events were consistent with busulfan conditioning. Fifteen months after treatment, the level of therapeutic antisickling beta-globin remained high (approximately 50% of beta-like-globin chains) without recurrence of sickle crises and with correction of the biologic hallmarks of the disease.	[Ribeil, Jean-Antoine; Magnani, Alessandra; Magrin, Elisa; Caccavelli, Laure; Cavazzana, Marina] Necker Childrens Hosp, AP HP, Biotherapy Dept, 149 Rue Sevres, F-75015 Paris, France; [Bourget, Philippe] Necker Childrens Hosp, AP HP, Dept Clin Pharm, Paris, France; [Grevent, David] Necker Childrens Hosp, AP HP, Dept Pediat Neuroradiol, Paris, France; [de Montalembert, Mariane] Necker Childrens Hosp, AP HP, Dept Gen Pediat, Paris, France; [Neven, Benedicte; Blanche, Stephane] Necker Childrens Hosp, AP HP, Pediat Immunol Hematol Unit, Paris, France; [Ribeil, Jean-Antoine; Magnani, Alessandra; Magrin, Elisa; Caccavelli, Laure; Weber, Leslie; Cavazzana, Marina] Grp Hosp Univ Ouest, AP HP, Biotherapy Clin Invest Ctr, INSERM, Paris, France; [Hacein-Bey-Abina, Salima] Univ Paris 05, Unite Technol Chim & Biol Sante, Ctr Natl Rech Sci Unite Mixte Rech 8258, INSERM U1022,Fac Pharm Paris,Chim ParisTech, Paris, France; [Hacein-Bey-Abina, Salima] Grp Hosp Univ Paris Sud, Hop Kremlin Bicetre, AP HP, Immunol Lab, Le Kremlin Bicetre, France; [Semeraro, Michaela; Neven, Benedicte; Weber, Leslie; Cavazzana, Marina] Univ Paris 05, Sorbonne Paris Cite, Inst Emerging Dis & Innovat Therapies, Imagine Inst, Paris, France; [Semeraro, Michaela] Grp Hosp Necker Cochin, Mere Enfant Clin Invest Ctr, Paris, France; [El Nemer, Wassim] Univ Paris Diderot, Sorbonne Paris Cite Univ, Inst Natl Transfus Sanguine, INSERM,Unite Biol Integree Globule Rouge,Lab Exce, Paris, France; [Meritet, Jean-Francois] Hop Cochin, Lab Virol, Paris, France; [Payen, Emmanuel; Beuzard, Yves; Chretien, Stany; Leboulch, Philippe] Univ Paris Sud, Atom & Alternat Energy Commiss, Fontenay Aux Roses, France; [Bartolucci, Pablo] Ctr Hosp Univ Henri Mondor, AP HP, Inst Mondor Rech Biomed,Lab Excellence GR Ex, Equipe 2,Ctr Reference Syndromes Drepanocytaires, Creteil, France; [Puy, Herve; Lefebvre, Thibaud] Univ Paris Diderot, Sorbonne Paris Cite Univ, Hop Louis Mourier, AP HP,INSERM U1149,Lab Excellence GR Ex, Colombes, France; [Ross, Robert W.; Negre, Olivier; Veres, Gabor; Sandler, Laura; Soni, Sandeep] Bluebird Bio, Cambridge, MA USA; [Leboulch, Philippe] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Leboulch, Philippe] Harvard Med Sch, Boston, MA USA; [Leboulch, Philippe] Mahidol Univ, Ramathibodi Hosp, Bangkok, Thailand	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Chimie ParisTech; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Mahidol University	Cavazzana, M (corresponding author), Necker Childrens Hosp, AP HP, Biotherapy Dept, 149 Rue Sevres, F-75015 Paris, France.; Leboulch, P (corresponding author), Inst Emerging Dis & Innovat Therapies, 18 Rte Panorama BP-6, F-92265 Fontenay Aux Roses, France.	pleboulch@rics.bwh.harvard.edu; m.cavazzana@aphp.fr	Ribeil, Jean-Antoine/F-7896-2017; Payen, Emmanuel/S-5357-2018; Ribeil, Jean-Antoine/AAK-7979-2020; Nemer, Wassim El/N-4247-2017; Magnani, Alessandra/H-8231-2017; NEGRE, Olivier/AAA-2027-2022; Chretien, Stany/M-5166-2018; PUY, HERVE/O-1785-2017; Magrin, Elisa/H-8220-2017; Caccavelli, Laure/H-8880-2017	Ribeil, Jean-Antoine/0000-0002-5733-9123; Payen, Emmanuel/0000-0002-1329-2327; Ribeil, Jean-Antoine/0000-0002-4549-4783; Nemer, Wassim El/0000-0001-8184-427X; Magnani, Alessandra/0000-0002-0674-9288; PUY, HERVE/0000-0003-3362-2634; Lefebvre, Thibaud/0000-0003-1398-6473; Magrin, Elisa/0000-0001-6660-9482; Bartolucci, Pablo/0000-0002-7007-1344; Cavazzana, Marina/0000-0002-0264-0891; Caccavelli, Laure/0000-0001-6324-2304; Grevent, David/0000-0001-6557-2331	Assistance Publique-Hopitaux de Paris; INSERM	Assistance Publique-Hopitaux de Paris; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	Supported by Bluebird Bio and by a grant to the Biotherapy Clinical Investigation Center from Assistance Publique-Hopitaux de Paris and INSERM.	Alsultan A, 2014, BRIT J HAEMATOL, V164, P597, DOI 10.1111/bjh.12650; Bernaudin F, 2007, BLOOD, V110, P2749, DOI 10.1182/blood-2007-03-079665; Bhatia M, 2008, BONE MARROW TRANSPL, V41, P109, DOI 10.1038/sj.bmt.1705943; Brousseau DC, 2010, AM J HEMATOL, V85, P77, DOI 10.1002/ajh.21570; Cavazzana M, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.202.202; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; INGRAM VM, 1956, NATURE, V178, P792, DOI 10.1038/178792a0; Kanter J, 2016, 58 ANN M AM SOC HEM; Krishnamurti L, 2003, BONE MARROW TRANSPL, V31, P547, DOI 10.1038/sj.bmt.1703887; Malik P., 2007, RENAISSANCE SICKLE C, P295; MENTZER WC, 1994, AM J PEDIAT HEMATOL, V16, P27; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Negre O, 2016, HUM GENE THER, V27, P148, DOI 10.1089/hum.2016.007; Negre O, 2015, CURR GENE THER, V15, P64; Pawliuk R, 2001, SCIENCE, V294, P2368, DOI 10.1126/science.1065806; Strouse JJ, 2008, PEDIATRICS, V122, P1332, DOI 10.1542/peds.2008-0441; TAKEKOSHI KJ, 1995, P NATL ACAD SCI USA, V92, P3014, DOI 10.1073/pnas.92.7.3014; Thompson AA, 2016, 58 ANN M AM SOC HEM; Walters MC, 2001, BIOL BLOOD MARROW TR, V7, P665, DOI 10.1053/bbmt.2001.v7.pm11787529; Walters MC, 2015, BLOOD, V126, P201; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413	24	428	432	9	247	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2017	376	9					848	855		10.1056/NEJMoa1609677	http://dx.doi.org/10.1056/NEJMoa1609677			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JK	28249145				2022-12-28	WOS:000395627500008
J	Shrank, WH; Saunders, RS; McClellan, M				Shrank, William H.; Saunders, Robert S.; McClellan, Mark			Better Evidence to Guide Payment Reforms Recognizing the Importance of Perspective	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Shrank, William H.] UPMC Hlth Plan, US Steel Tower,55th Floor,600 Grant St, Pittsburgh, PA 15219 USA; [Saunders, Robert S.; McClellan, Mark] Duke Margolis Ctr Hlth Policy, Washington, DC USA		Shrank, WH (corresponding author), UPMC Hlth Plan, US Steel Tower,55th Floor,600 Grant St, Pittsburgh, PA 15219 USA.	shrankwh@upmc.edu						Abrams MK, 2015, AFFORDABLE CARE ACTS; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Shrank W, 2013, HEALTH AFFAIR, V32, P807, DOI 10.1377/hlthaff.2013.0216; Spitalnic P., 2016, CERTIFICATION MEDICA; Spitalnic Paul, 2015, CERTIFICATION PIONEE	5	5	5	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2017	317	8					805	806		10.1001/jama.2017.0034	http://dx.doi.org/10.1001/jama.2017.0034			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM7PW	28245330				2022-12-28	WOS:000395505600014
J	Slomski, A				Slomski, Anita			Crizanlizumab Prevents Sickle Cell Pain Crises	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2017	317	8					798	798		10.1001/jama.2017.0355	http://dx.doi.org/10.1001/jama.2017.0355			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM7PW	28245319				2022-12-28	WOS:000395505600007
J	Belknap, SM				Belknap, Steven M.			Current vs past use of NSAIDs was linked to increased risk for first HF hospitalization; risk varied by drug	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Belknap, Steven M.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Belknap, SM (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.			Belknap, Steven/0000-0002-3670-7409				Centers for Disease Control and Prevention, THER DRUG US; Lederle FA, 2016, ANN INTERN MED, V165, P663, DOI 10.7326/M16-1208; Shah NH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124653	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2017	166	4					JC23	JC23		10.7326/ACPJC-2017-166-4-023	http://dx.doi.org/10.7326/ACPJC-2017-166-4-023			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7FO	28241296				2022-12-28	WOS:000394786700011
J	Bilecen, S; de Groot, JAH; Kalkman, CJ; Spanjersberg, AJ; Bruinsma, GJBB; Moons, KGM; Nierich, AP				Bilecen, Suleyman; de Groot, Joris A. H.; Kalkman, Cor J.; Spanjersberg, Alexander J.; Bruinsma, George J. Brandon Bravo; Moons, Karel G. M.; Nierich, Arno P.			Effect of Fibrinogen Concentrate on Intraoperative Blood Loss Among Patients With Intraoperative Bleeding During High-Risk Cardiac Surgery A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLASMA-FIBRINOGEN; CARDIOPULMONARY BYPASS; REPLACEMENT; THERAPY; STROKE; TRANSFUSION; DEFINITION; MANAGEMENT; EFFICACY; UPDATE	IMPORTANCE Fibrinogen concentrate might partly restore coagulation defects and reduce intraoperative bleeding. OBJECTIVE To determine whether fibrinogen concentrate infusion dosed to achieve a plasma fibrinogen level of 2.5 g/L in high-risk cardiac surgery patients with intraoperative bleeding reduces intraoperative blood loss. DESIGN, SETTING, AND PARTICIPANTS A randomized, placebo-controlled, double-blind clinical trial conducted in Isala Zwolle, the Netherlands (February 2011-January 2015), involving patients undergoing elective, high-risk cardiac surgery (ie, combined coronary artery bypass graft [CABG] surgery and valve repair or replacement surgery, the replacement of multiple valves, aortic root reconstruction, or reconstruction of the ascending aorta or aortic arch) with intraoperative bleeding (blood volume between 60 and 250 mL suctioned from the thoracic cavity in a period of 5 minutes) were randomized to receive either fibrinogen concentrate or placebo. INTERVENTIONS Intravenous, single-dose administration of fibrinogen concentrate (n = 60) or placebo (n = 60), targeted to achieve a postinfusion plasma fibrinogen level of 2.5 g/L. MAIN OUTCOMES AND MEASURES The primary outcomewas blood loss in milliliters between intervention (ie, after removal of cardiopulmonary bypass) and closure of chest. Safety variables (within 30 days) included: in-hospital mortality, myocardial infarction, cerebrovascular accident or transient ischemic attack, renal insufficiency or failure, venous thromboembolism, pulmonary embolism, and operative complications. RESULTS Among 120 patients (mean age; 71 [SD, 10] years, 37women [31%]) included in the study, combined CABG and valve repair or replacement surgery comprised 72% of procedures and had a mean (SD) cardiopulmonary bypass time of 200 minutes (83) minutes. For the primary outcome, median blood loss in the fibrinogen groupwas 50mL (interquartile range [IQR], 29-100 mL) compared with 70 mL (IQR, 33-145 mL) in the control group (P=.19), the absolute difference 20 mL (95% CI, -13 to 35 mL). Therewere 6 cases of stroke or transient ischemic attack (4 in the fibrinogen group); 4 myocardial infarctions (3 in the fibrinogen group); 2 deaths (both in the fibrinogen group); 5 cases with renal insufficiency or failure (3 in the fibrinogen group); and 9 cases with reoperative thoracotomy (4 in the fibrinogen group). CONCLUSIONS AND RELEVANCE Among patients with intraoperative bleeding during high-risk cardiac surgery, administration of fibrinogen concentrate, compared with placebo, resulted in no significant difference in the amount of intraoperative blood loss.	[Bilecen, Suleyman; Kalkman, Cor J.; Moons, Karel G. M.] Univ Med Ctr Utrecht, Div Anesthesiol Intens Care & Emergency Med, POB 85500,Mailstop Q 04-2-313, NL-3508 GA Utrecht, Netherlands; [Bilecen, Suleyman; Spanjersberg, Alexander J.; Nierich, Arno P.] Dept Cardiothorac Anesthesia & Intens Care, Isala Zwolle, Netherlands; [de Groot, Joris A. H.; Moons, Karel G. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Bruinsma, George J. Brandon Bravo] Dept Cardiothorac Surg, Isala Zwolle, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Bilecen, S (corresponding author), Univ Med Ctr Utrecht, Div Anesthesiol Intens Care & Emergency Med, POB 85500,Mailstop Q 04-2-313, NL-3508 GA Utrecht, Netherlands.	s.bilecen@umcutrecht.nl	Kalkman, Cor/O-3215-2019	Kalkman, Cor/0000-0002-8372-6960; de Groot, Joris/0000-0002-4846-5697	CSL Behring	CSL Behring	CSL Behring sponsored this study and donated the bottles of study medication.	Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bilecen S, 2014, TRANSFUSION, V54, P708, DOI 10.1111/trf.12346; Bilecen S, 2013, J CARDIOTHOR VASC AN, V27, P12, DOI 10.1053/j.jvca.2012.06.006; Bolliger D, 2009, BRIT J ANAESTH, V102, P793, DOI 10.1093/bja/aep098; Brennan SO, 2015, BBA CLIN, V3, P221, DOI 10.1016/j.bbacli.2015.02.007; Bucerius J, 2003, ANN THORAC SURG, V75, P472, DOI 10.1016/S0003-4975(02)04370-9; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; Danes AF, 2008, VOX SANG, V94, P221, DOI 10.1111/j.1423-0410.2007.01024.x; Ferraris VA, 2011, ANN THORAC SURG, V91, P944, DOI 10.1016/j.athoracsur.2010.11.078; Fries D, 2006, BRIT J ANAESTH, V97, P460, DOI 10.1093/bja/ael191; Haas T, 2008, ANESTH ANALG, V106, P1360, DOI 10.1213/01.ane.0b013e3181684339; HIIPPALA ST, 1995, ANESTH ANALG, V81, P360, DOI 10.1097/00000539-199508000-00026; Karkouti K, 2010, ANESTH ANALG, V110, P1533, DOI 10.1213/ANE.0b013e3181db7991; Kindo M, 2014, THROMB RES, V134, P360, DOI 10.1016/j.thromres.2014.05.008; Klomp WWJ, 2016, INT J VASC MED, V2016, DOI 10.1155/2016/4726094; Lang T, 2009, ANESTH ANALG, V108, P751, DOI 10.1213/ane.0b013e3181966675; Levy JH, 2012, ANESTH ANALG, V114, P261, DOI 10.1213/ANE.0b013e31822e1853; Likosky DS, 2003, STROKE, V34, P2830, DOI 10.1161/01.STR.0000098650.12386.B3; McKhann GM, 2006, STROKE, V37, P562, DOI 10.1161/01.STR.0000199032.78782.6c; Mohnle P, 2011, INTENS CARE MED, V37, P97, DOI 10.1007/s00134-010-2017-z; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Rahe-Meyer N, 2009, BRIT J ANAESTH, V102, P785, DOI 10.1093/bja/aep089; Rahe-Meyer N, 2013, ANESTHESIOLOGY, V118, P40, DOI 10.1097/ALN.0b013e3182715d4d; RAHEMEYER N, 2009, THORAC CARDIOVASC SU, V138, P694, DOI DOI 10.1016/J.JTCVS.2008.11.065; Ranucci M, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002066; Ranucci M, 2013, ANN THORAC SURG, V96, P478, DOI 10.1016/j.athoracsur.2013.03.015; Selim M, 2007, NEW ENGL J MED, V356, P706, DOI 10.1056/NEJMra062668; Solomon C, 2013, BRIT J ANAESTH, V110, P947, DOI 10.1093/bja/aes576; Solomon C, 2010, BRIT J ANAESTH, V104, P555, DOI 10.1093/bja/aeq058; Svircevic V, 2009, ANESTH ANALG, V108, P727, DOI 10.1213/ane.0b013e318193c423; Tennent GA, 2007, BLOOD, V109, P1971, DOI 10.1182/blood-2006-08-040956; Thygesen K, 2007, EUR HEART J, V28, P2525; Walden K, 2014, ANN THORAC SURG, V97, P1199, DOI 10.1016/j.athoracsur.2013.11.064; Warren OJ, 2009, J CARDIOTHOR VASC AN, V23, P223, DOI 10.1053/j.jvca.2008.08.007; Wikkelso A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008864.pub2	36	56	58	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2017	317	7					738	747		10.1001/jama.2016.21037	http://dx.doi.org/10.1001/jama.2016.21037			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8WR	28241354	Green Published			2022-12-28	WOS:000394901600021
J	Arijs, I; Cleynen, I				Arijs, Ingrid; Cleynen, Isabelle			RISK stratification in paediatric Crohn's disease	LANCET			English	Editorial Material							INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; PHENOTYPES; BEHAVIOR		[Arijs, Ingrid] Hasselt Univ, Fac Med & Life Sci, Campus Diepenbeek,Agoralaan Gebouw D, B-3590 Diepenbeek, Hasselt, Belgium; [Arijs, Ingrid] Jessa Hosp, Hasselt, Belgium; [Arijs, Ingrid] Katholieke Univ Leuven, Translat Res Gastrointestinal Disorders TARGID, Dept Clin & Expt Med, Leuven, Belgium; [Cleynen, Isabelle] Katholieke Univ Leuven, Dept Human Genet, Lab Complex Genet, Leuven, Belgium	Hasselt University; KU Leuven; KU Leuven	Arijs, I (corresponding author), Hasselt Univ, Fac Med & Life Sci, Campus Diepenbeek,Agoralaan Gebouw D, B-3590 Diepenbeek, Hasselt, Belgium.; Arijs, I (corresponding author), Jessa Hosp, Hasselt, Belgium.; Arijs, I (corresponding author), Katholieke Univ Leuven, Translat Res Gastrointestinal Disorders TARGID, Dept Clin & Expt Med, Leuven, Belgium.	ingrid.arijs@uhasselt.be	Arijs, Ingrid/AAJ-3163-2020	Arijs, Ingrid/0000-0002-9415-083X				Arijs I, 2009, GUT, V58, P1612, DOI 10.1136/gut.2009.178665; Arijs I, 2010, INFLAMM BOWEL DIS, V16, P2090, DOI 10.1002/ibd.21301; Beaugerie L, 2006, GASTROENTEROLOGY, V130, P650, DOI 10.1053/j.gastro.2005.12.019; Benchimol EI, 2014, GASTROENTEROLOGY, V147, P803, DOI 10.1053/j.gastro.2014.06.023; Billiet Thomas, 2014, Curr Gastroenterol Rep, V16, P416, DOI 10.1007/s11894-014-0416-y; Billiet T, 2014, EXPERT OPIN BIOL TH, V14, P75, DOI 10.1517/14712598.2014.858695; Cleynen I, 2016, LANCET, V387, P156, DOI 10.1016/S0140-6736(15)00465-1; Cleynen I, 2012, NAT REV GASTRO HEPAT, V9, P496, DOI 10.1038/nrgastro.2012.125; Duricova D, 2017, EUR J GASTROEN HEPAT, V29, P125, DOI 10.1097/MEG.0000000000000761; Ferrante M, 2007, GUT, V56, P1394, DOI 10.1136/gut.2006.108043; Kugathasan S, 2017, LANCET; Lee JC, 2011, J CLIN INVEST, V121, P4170, DOI 10.1172/JCI59255; Lee JW, 2012, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2012-7; Peck BCE, 2015, INFLAMM BOWEL DIS, V21, P2178, DOI 10.1097/MIB.0000000000000478; The Crohn's & Colitis Foundation of America, PED RISK STRAT STUD	15	3	3	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2017	389	10080					1672	1674		10.1016/S0140-6736(17)30634-7	http://dx.doi.org/10.1016/S0140-6736(17)30634-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ET3BG	28259485				2022-12-28	WOS:000400151000005
J	Weyrich, LS; Duchene, S; Soubrier, J; Arriola, L; Llamas, B; Breen, J; Morris, AG; Alt, KW; Caramelli, D; Dresely, V; Farrell, M; Farrer, AG; Francken, M; Gully, N; Haak, W; Hardy, K; Harvati, K; Held, P; Holmes, EC; Kaidonis, J; Lalueza-Fox, C; De la Rasilla, M; Rosas, A; Semal, P; Soltysiak, A; Townsend, G; Usai, D; Wahl, J; Huson, DH; Dobney, K; Cooper, A				Weyrich, Laura S.; Duchene, Sebastian; Soubrier, Julien; Arriola, Luis; Llamas, Bastien; Breen, James; Morris, Alan G.; Alt, Kurt W.; Caramelli, David; Dresely, Veit; Farrell, Milly; Farrer, Andrew G.; Francken, Michael; Gully, Neville; Haak, Wolfgang; Hardy, Karen; Harvati, Katerina; Held, Petra; Holmes, Edward C.; Kaidonis, John; Lalueza-Fox, Carles; De la Rasilla, Marco; Rosas, Antonio; Semal, Patrick; Soltysiak, Arkadiusz; Townsend, Grant; Usai, Donatella; Wahl, Joachim; Huson, Daniel H.; Dobney, Keith; Cooper, Alan			Neanderthal behaviour, diet, and disease inferred from ancient DNA in dental calculus	NATURE			English	Article							ISOTOPIC EVIDENCE; RAST SERVER; EL-SIDRON; MICROBIOME; HEALTH; PLAQUE	Recent genomic data have revealed multiple interactions between Neanderthals and modern humans(1), but there is currently little genetic evidence regarding Neanderthal behaviour, diet, or disease. Here we describe the shotgun-sequencing of ancient DNA from five specimens of Neanderthal calcified dental plaque (calculus) and the characterization of regional differences in Neanderthal ecology. At Spy cave, Belgium, Neanderthal diet was heavily meat based and included woolly rhinoceros and wild sheep (mouflon), characteristic of a steppe environment. In contrast, no meat was detected in the diet of Neanderthals from El Sidron cave, Spain, and dietary components of mushrooms, pine nuts, and moss reflected forest gathering(2,3). Differences in diet were also linked to an overall shift in the oral bacterial community (microbiota) and suggested that meat consumption contributed to substantial variation within Neanderthal microbiota. Evidence for self-medication was detected in an El Sidron Neanderthal with a dental abscess(4) and a chronic gastrointestinal pathogen (Enterocytozoon bieneusi). Metagenomic data from this individual also contained a nearly complete genome of the archaeal commensal Methanobrevibacter oralis (10.2x depth of coverage)-the oldest draft microbial genome generated to date, at around 48,000 years old. DNA preserved within dental calculus represents a notable source of information about the behaviour and health of ancient hominin specimens, as well as a unique system that is useful for the study of long-term microbial evolution.	[Weyrich, Laura S.; Soubrier, Julien; Arriola, Luis; Llamas, Bastien; Breen, James; Farrer, Andrew G.; Haak, Wolfgang; Cooper, Alan] Univ Adelaide, Australian Ctr Ancient DNA, Sch Biol Sci, Adelaide, SA, Australia; [Weyrich, Laura S.; Duchene, Sebastian; Soubrier, Julien; Arriola, Luis; Llamas, Bastien; Breen, James; Farrer, Andrew G.; Haak, Wolfgang; Holmes, Edward C.; Cooper, Alan] Univ Adelaide, Inst Environm, Adelaide, SA, Australia; [Duchene, Sebastian; Holmes, Edward C.] Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia; [Duchene, Sebastian; Alt, Kurt W.; Holmes, Edward C.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Morris, Alan G.] Univ Cape Town, Dept Human Biol, Cape Town, South Africa; [Alt, Kurt W.] Danube Private Univ, Krems, Austria; [Alt, Kurt W.; Dresely, Veit] State Off Heritage Management & Archaeol, Saxony Anhalt, Germany; [Alt, Kurt W.; Dresely, Veit] Heritage Museum, Halle, Germany; [Alt, Kurt W.] Basel Univ, Inst Prehist & Archaeol Sci, Basel, Switzerland; [Caramelli, David] Univ Florence, Dept Biol, Florence, Italy; [Farrell, Milly] Oxford Brookes Univ, Human Origins & Palaeo Environm Grp, Oxford, England; [Francken, Michael; Harvati, Katerina] Eberhard Karls Univ Tubingen, Senckenberg Ctr Human Evolut & Paleoenvironm, Paleoanthropol, Tubingen, Germany; [Gully, Neville; Kaidonis, John; Townsend, Grant] Univ Adelaide, Sch Dent, Adelaide, SA, Australia; [Hardy, Karen] Catalan Inst Res & Adv Studies ICREA, Pg Lluis Co 23, Barcelona 08010, Catalonia, Spain; [Hardy, Karen] Univ Autonoma Barcelona, Fac Filosofia & Lletres, Dept Prehist, Barcelona, Catalonia, Spain; [Held, Petra] Johannes Gutenberg Univ Mainz, Inst Anthropol, Mainz, Germany; [Lalueza-Fox, Carles] Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Barcelona, Spain; [De la Rasilla, Marco] Univ Oviedo, Dept Hist, Area Prehist, Oviedo, Spain; [Rosas, Antonio] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, Paleoanthropol Grp, Madrid, Spain; [Semal, Patrick] Royal Belgian Inst Nat Sci, Sci Serv Heritage, Brussels, Belgium; [Soltysiak, Arkadiusz] Univ Warsaw, Inst Archaeol, Dept Bioarchaeol, Warsaw, Poland; [Usai, Donatella] Ist Italiano Africa & Oriente IsIAO, Rome, Italy; [Wahl, Joachim] State Off Cultural Heritage Management Baden Wurt, Esslingen, Germany; [Huson, Daniel H.] Univ Tubingen, Dept Algorithms Bioinformat, Tubingen, Germany; [Dobney, Keith] Univ Liverpool, Sch Hist Languages & Cultures, Dept Archaeol Class & Egyptol, Liverpool, Merseyside, England; [Dobney, Keith] Univ Aberdeen, Dept Archaeol, Aberdeen, Scotland; [Dobney, Keith] Simon Fraser Univ, Dept Archaeol, Burnaby, BC, Canada	University of Adelaide; University of Adelaide; University of Sydney; University of Sydney; University of Cape Town; University of Florence; Oxford Brookes University; Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); University of Adelaide; ICREA; Autonomous University of Barcelona; Johannes Gutenberg University of Mainz; Consejo Superior de Investigaciones Cientificas (CSIC); Pompeu Fabra University; University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Royal Belgian Institute of Natural Sciences; University of Warsaw; Eberhard Karls University of Tubingen; University of Liverpool; University of Aberdeen; Simon Fraser University	Weyrich, LS; Cooper, A (corresponding author), Univ Adelaide, Australian Ctr Ancient DNA, Sch Biol Sci, Adelaide, SA, Australia.; Weyrich, LS; Cooper, A (corresponding author), Univ Adelaide, Inst Environm, Adelaide, SA, Australia.	laura.weyrich@adelaide.edu.au; alan.cooper@adelaide.edu.au	Huson, Daniel H./AAC-5494-2019; Rosas, Antonio/D-9742-2016; Llamas, Bastien/AAK-1693-2021; Holmes, Edward/Y-2789-2019; LALUEZA-FOX, CARLES/AAG-5341-2020; Llamas, Bastien/Y-2781-2018; Harvati, Katerina/A-5197-2008; Haak, Wolfgang/Z-4947-2019; Usai, Donatella/AAY-4536-2020; Holmes, Edward/GVR-9499-2022; Breen, Jimmy/HHZ-1361-2022; Soubrier, Julien/AAX-9560-2021; Morris, Alan G/V-7363-2019	Rosas, Antonio/0000-0002-5829-9952; Llamas, Bastien/0000-0002-5550-9176; Holmes, Edward/0000-0001-9596-3552; LALUEZA-FOX, CARLES/0000-0002-1730-5914; Llamas, Bastien/0000-0002-5550-9176; Haak, Wolfgang/0000-0003-2475-2007; Usai, Donatella/0000-0001-9379-9015; Soubrier, Julien/0000-0001-9350-7369; Weyrich, Laura/0000-0001-5243-4634; Semal, Patrick/0000-0002-4048-7728; Morris, Alan G/0000-0003-0130-6688; Breen, James/0000-0001-6184-0925; Duchene, Sebastian/0000-0002-2863-0907; Dobney, Keith/0000-0001-9036-4681; Cooper, Alan/0000-0002-7738-7851; Soltysiak, Arkadiusz/0000-0002-9040-5022	Australian Research Council; ICREA Funding Source: Custom	Australian Research Council(Australian Research Council); ICREA(ICREA)	We thank G. Manzi, the Odontological Collection of the Royal College of Surgeons, Royal Belgian Institute of Natural Sciences, Museo Nacional de Ciencias Naturales, and Adelaide University for access to dental calculus material. We thank A. Croxford for DNA sequencing and A. Walker, J. Krause and A. Herbig for feedback. The Australian Research Council supported this work through the Discovery Project and Fellowship schemes. We acknowledge the fundamental contribution of D. Brothwell (1933-2016) to this research by initiating the archaeological study of dental calculus.	Adler CJ, 2013, NAT GENET, V45, P450, DOI 10.1038/ng.2536; Aronesty E., 2011, EA UTILS COMMAND LIN; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bocherens H, 2005, J HUM EVOL, V49, P71, DOI 10.1016/j.jhevol.2005.03.003; Brotherton P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2656; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Cregut-Bonnoure Evelyne, 2006, Munibe (Antropologia - Arkeologia), V57, P205; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; El Zaatari S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153277; Fiorenza L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014769; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Germonpre M., 2012, ANTHR PRAEHISTORICA, V123, P298; Ginolhac A, 2011, BIOINFORMATICS, V27, P2153, DOI 10.1093/bioinformatics/btr347; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hardy K, 2012, NATURWISSENSCHAFTEN, V99, P617, DOI 10.1007/s00114-012-0942-0; Herbig A, 2016, PREPRINT; Higham T, 2014, NATURE, V512, P306, DOI 10.1038/nature13621; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Leonard WR, 2002, HUMAN BIOL PASTORAL; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Longo MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016410; MARSH PD, 1995, J IND MICROBIOL, V15, P169, DOI 10.1007/BF01569822; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Naito YI, 2016, J HUM EVOL, V93, P82, DOI 10.1016/j.jhevol.2016.01.009; O'Regan HJ, 2016, J ARCHAEOL SCI, V75, P139, DOI 10.1016/j.jas.2016.09.009; Patou-Mathis M, 2000, INT J OSTEOARCHAEOL, V10, P379, DOI 10.1002/1099-1212(200009/10)10:5<379::AID-OA558>3.0.CO;2-4; Richards MP, 2009, P NATL ACAD SCI USA, V106, P16034, DOI 10.1073/pnas.0903821106; Rosas A, 2006, P NATL ACAD SCI USA, V103, P19266, DOI 10.1073/pnas.0609662104; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Schubert M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-178; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Signat B, 2011, CURR ISSUES MOL BIOL, V13, P25; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stringer C, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0237; Topic Berislav, 2012, Acta Med Acad, V41, P119, DOI 10.5644/ama2006-124.45; Tumwine JK, 2002, AM J TROP MED HYG, V67, P299, DOI 10.4269/ajtmh.2002.67.299; Warinner C, 2014, NAT GENET, V46, P336, DOI 10.1038/ng.2906; Weyrich LS, 2015, J HUM EVOL, V79, P119, DOI 10.1016/j.jhevol.2014.06.018; Wood RE, 2013, ARCHAEOMETRY, V55, P148, DOI 10.1111/j.1475-4754.2012.00671.x; Ziesemer KA, 2015, SCI REP-UK, V5, DOI 10.1038/srep16498	46	238	242	7	239	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 20	2017	544	7650					357	+		10.1038/nature21674	http://dx.doi.org/10.1038/nature21674			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES4SG	28273061	Green Submitted			2022-12-28	WOS:000399524400038
J	Farr, OM; Mantzoros, CS				Farr, Olivia M.; Mantzoros, Christos S.			Treating prediabetes in the obese: are GLP-1 analogues the answer?	LANCET			English	Editorial Material							LIFE-STYLE; GLUCOSE-TOLERANCE; WEIGHT; PREVENTION		[Farr, Olivia M.; Mantzoros, Christos S.] Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Farr, OM (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA.	ofarr@bidmc.harvard.edu	Mantzoros, Christos/Y-2902-2019; Farr, Olivia/H-6929-2019	Farr, Olivia/0000-0002-5182-3432	Eisai; Novo Nordisk; Takeda; Astra Zeneca	Eisai(Eisai Co Ltd); Novo Nordisk(Novo Nordisk); Takeda(Takeda Pharmaceutical Company Ltd); Astra Zeneca(AstraZeneca)	CSM reports grants and non-financial support from Eisai, grants, personal fees, and non-financial support from Novo Nordisk, and personal fees from Takeda and Astra Zeneca, outside the submitted work. OMF declares no competing interests.	Aronis KN, 2014, METABOLISM, V63, P979, DOI 10.1016/j.metabol.2014.05.009; Astrup A, 2012, INT J OBESITY, V36, P843, DOI 10.1038/ijo.2011.158; Astrup A, 2009, LANCET, V374, P1606, DOI 10.1016/S0140-6736(09)61375-1; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Khera R, 2016, JAMA-J AM MED ASSOC, V315, P2424, DOI 10.1001/jama.2016.7602; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; le Roux CW, 2017, LANCET, V389, P1399, DOI 10.1016/S0140-6736(17)30069-7; Li CL, 1999, DIABETIC MED, V16, P477, DOI 10.1046/j.1464-5491.1999.00090.x; Pi-Sunyer X, 2015, NEW ENGL J MED, V373, P1781, DOI 10.1056/NEJMc1509759; Rosenstock J, 2010, DIABETES CARE, V33, P1173, DOI 10.2337/dc09-1203; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801	13	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 8	2017	389	10077					1371	1372		10.1016/S0140-6736(17)30315-X	http://dx.doi.org/10.1016/S0140-6736(17)30315-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EQ8OJ	28237265				2022-12-28	WOS:000398345100006
J	Greenbaum, D				Greenbaum, Dov			Matters of life and death	SCIENCE			English	Editorial Material									[Greenbaum, Dov] Zvi Meitar Inst Legal Implicat Emerging Technol, Herzliyya, Israel; [Greenbaum, Dov] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Greenbaum, D (corresponding author), Zvi Meitar Inst Legal Implicat Emerging Technol, Herzliyya, Israel.; Greenbaum, D (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	dov.greenbaum@gmail.com	Greenbaum, Dov/ABG-8539-2021	Greenbaum, Dov/0000-0003-4440-3090					0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI		1029	1029						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9VY	28280172				2022-12-28	WOS:000396348900021
J	Kho, JSB; Howlett, DC				Kho, James S. B.; Howlett, David C.			SPOT DIAGNOSIS Dyspnoea and an unusual chest radiograph	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kho, James S. B.] Brighton & Sussex Univ Hosp NHS Trust, Brighton, E Sussex, England; [Howlett, David C.] East Sussex Healthcare NHS Trust, Eastbourne, England	Brighton and Sussex University Hospitals NHS Trust; University of Brighton	Kho, JSB (corresponding author), Brighton & Sussex Univ Hosp NHS Trust, Brighton, E Sussex, England.	jamesksb@gmail.com		Kho, James Swee Beng/0000-0002-4839-1632				Ferguson EC, 2010, CLIN RADIOL, V65, P685, DOI 10.1016/j.crad.2009.12.016; Ling LH, 2000, ANN INTERN MED, V132, P444, DOI 10.7326/0003-4819-132-6-200003210-00004; MACGREGOR JH, 1987, AM J ROENTGENOL, V148, P675, DOI 10.2214/ajr.148.4.675; Nguyen T, 2014, WORLD J CLIN CASES, V2, P455, DOI 10.12998/wjcc.v2.i9.455	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2017	356								j986	10.1136/bmj.j986	http://dx.doi.org/10.1136/bmj.j986			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BU	28279962				2022-12-28	WOS:000396433400016
J	Van de Perre, P; Kankasa, C; Nagot, N; Meda, N; Tumwine, JK; Coutsoudis, A; Tyllesar, T; Coovadia, H				Van de Perre, Philippe; Kankasa, Chipepo; Nagot, Nicolas; Meda, Nicolas; Tumwine, James K.; Coutsoudis, Anna; Tyllesar, Thorkild; Coovadia, Hoosen			Pre-exposure prophylaxis for infants exposed to HIV through breast feeding	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Van de Perre, Philippe; Nagot, Nicolas] Univ Montpellier, Pathogenesis & Control Chron Infect, UMR INSERM 1058, Montpellier, France; [Van de Perre, Philippe; Nagot, Nicolas] CHU Montpellier, Montpellier, France; [Kankasa, Chipepo] Univ Teaching Hosp, Dept Paediat & Child Hlth, Lusaka, Zambia; [Meda, Nicolas] Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Meda, Nicolas] Univ Ouagadougou, Ctr Int Res Hlth, Fac Hlth Sci, Ouagadougou, Burkina Faso; [Tumwine, James K.] Makerere Univ, Dept Paediat & Child Hlth, Coll Hlth Sci, Kampala, Uganda; [Coutsoudis, Anna] Univ KwaZulu Natal, Dept Paediat & Child Hlth, Durban, South Africa; [Tyllesar, Thorkild] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Coovadia, Hoosen] Univ Witwatersrand, Sch Publ Hlth, Match Hlth Syst, Johannesburg, South Africa	Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; University of Zambia; Centre Muraz; Makerere University; University of Kwazulu Natal; University of Bergen; University of Witwatersrand	Van de Perre, P (corresponding author), Univ Montpellier, Pathogenesis & Control Chron Infect, UMR INSERM 1058, Montpellier, France.; Van de Perre, P (corresponding author), CHU Montpellier, Montpellier, France.	p-van_de_perre@chu-montpellier.fr	Van de Perre, Philippe/B-9692-2008; Tylleskär, Thorkild/S-5529-2017	Van de Perre, Philippe/0000-0002-3912-0427; Tylleskär, Thorkild/0000-0003-4801-4324; Nagot, Nicolas/0000-0002-3493-2821				Abrams EJ, 2016, C RETR OPP INF BOST; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Coovadia HM, 2012, LANCET, V379, P221, DOI 10.1016/S0140-6736(11)61653-X; Foissac F, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01869-16; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Kilewo C, 2008, JAIDS-J ACQ IMM DEF, V48, P315, DOI 10.1097/QAI.0b013e31816e395c; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Maman D, 2015, C RETR OPP INF SEATT; Manigart O, 2004, J INFECT DIS, V190, P1422, DOI 10.1086/424569; Mofenson LM, 2017, 2 WORKSH PREV TRIALS; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Nagot N, 2016, LANCET, V387, P566, DOI 10.1016/S0140-6736(15)00984-8; Price JT, 2016, JAIDS-J ACQ IMM DEF, V72, pS145, DOI 10.1097/QAI.0000000000001063; Rollins N, 2012, SEX TRANSM INFECT, V88, pI44, DOI 10.1136/sextrans-2012-050709; Shapiro RL, 2013, ANTIVIR THER, V18, P585, DOI 10.3851/IMP2474; Smith JA, 2016, LANCET HIV, V3, pE289, DOI 10.1016/S2352-3018(16)30036-4; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; UNAIDS, 2016 PREV GAP REP; Van de Perre P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003327; WHO, 2015, WHO TECHN UPD PRE EX; WHO, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2016, GUID UPD HIV INF FEE	22	8	8	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2017	356								j1053	10.1136/bmj.j1053	http://dx.doi.org/10.1136/bmj.j1053			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BU	28279960	Green Published			2022-12-28	WOS:000396433400001
J	Bibbins-Domingo, K; Grossman, DC; Curry, SJ; Barry, MJ; Davidson, KW; Doubeni, CA; Epling, J; Garcia, FAR; Kemper, AR; Krist, AH; Kurth, AE; Landefeld, CS; Mangione, CM; Phillips, WR; Phipps, MG; Silverstein, M; Simon, M; Siu, AL; Tseng, CW				Bibbins-Domingo, Kirsten; Grossman, David C.; Curry, Susan J.; Barry, Michael J.; Davidson, Karina W.; Doubeni, Chyke A.; Epling, Johnw., Jr.; Garcia, Francisco A. R.; Kemper, Alex R.; Krist, Alex H.; Kurth, Ann E.; Landefeld, C. Seth; Mangione, Carol M.; Phillips, William R.; Phipps, Maureen G.; Silverstein, Michael; Simon, Melissa; Siu, Albert L.; Tseng, Chien-Wen		US Preventive Serv Task Force	Screening for Gynecologic Conditions With Pelvic Examination US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OVARIAN-CANCER; CLINICAL MANIFESTATIONS	IMPORTANCE Many conditions that can affect women's health are often evaluated through pelvic examination. Although the pelvic examination is a common part of the physical examination, it is unclear whether performing screening pelvic examinations in asymptomatic women has a significant effect on disease morbidity and mortality. OBJECTIVE To issue a new US Preventive Services Task Force(USPSTF) recommendation on screening for gynecologic conditions with pelvic examination for conditions other than cervical cancer, gonorrhea, and chlamydia, for which the USPSTF has already made specific recommendations. EVIDENCE REVIEW The USPSTF reviewed the evidence on the accuracy, benefits, and potential harms of performing screening pelvic examinations in asymptomatic, nonpregnant adult women 18 years and older who are not at increased risk for any specific gynecologic condition. FINDINGS Overall, the USPSTF found inadequate evidence on screening pelvic examinations for the early detection and treatment of a range of gynecologic conditions in asymptomatic, nonpregnant adult women. CONCLUSIONS AND RECOMMENDATION The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of performing screening pelvic examinations in asymptomatic, nonpregnant adult women. (I statement) This statement does not apply to specific disorders for which the USPSTF already recommends screening (ie, screening for cervical cancer with a Papanicolaou smear, screening for gonorrhea and chlamydia).	[Bibbins-Domingo, Kirsten] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Grossman, David C.] Grp Hlth Res Inst, Seattle, WA USA; [Curry, Susan J.] Univ Iowa, Iowa City, IA USA; [Barry, Michael J.] Harvard Med Sch, Boston, MA USA; [Davidson, Karina W.] Columbia Univ, New York, NY USA; [Doubeni, Chyke A.] Univ Penn, Philadelphia, PA 19104 USA; [Epling, Johnw., Jr.] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Garcia, Francisco A. R.] Pima Cty Dept Hlth, Tucson, AZ USA; [Kemper, Alex R.] Duke Univ, Durham, NC USA; [Krist, Alex H.] Fairfax Family Practice Residency, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Kurth, Ann E.] Yale Univ, New Haven, CT USA; [Landefeld, C. Seth] Univ Alabama Birmingham, Birmingham, AL USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Phillips, William R.] Univ Washington, Seattle, WA 98195 USA; [Phipps, Maureen G.] Brown Univ, Providence, RI 02912 USA; [Silverstein, Michael] Boston Univ, Boston, MA 02215 USA; [Simon, Melissa] Northwestern Univ, Evanston, IL USA; [Siu, Albert L.] Mt Sinai Hosp, New York, NY 10029 USA; [Siu, Albert L.] James J Peters Vet Affairs Med Ctr, Bronx, NY USA; [Tseng, Chien-Wen] Univ Hawaii Manoa, Honolulu, HI 96822 USA	University of California System; University of California San Francisco; University of Iowa; Harvard University; Harvard Medical School; Columbia University; University of Pennsylvania; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Duke University; Virginia Commonwealth University; Yale University; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; Brown University; Boston University; Northwestern University; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; University of Hawaii System; University of Hawaii Manoa	Bibbins-Domingo, K (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	chair@uspstf.net	Davidson, Karina/AAG-2388-2019; Davidson, Karina/GWC-0996-2022; Epling, John W/J-1097-2019; Phillips, William R./V-1065-2017	Davidson, Karina/0000-0002-9162-477X; Davidson, Karina/0000-0002-9162-477X; Epling, John W/0000-0001-9445-8669; Phillips, William R./0000-0003-2802-4349; Kemper, Alex/0000-0001-5491-3997	USPSTF; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER	USPSTF; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.	Adonakis GL, 1996, EUR J OBSTET GYN R B, V65, P221, DOI 10.1016/0301-2115(95)02369-0; Buys SS, 2005, AM J OBSTET GYNECOL, V193, P1630, DOI 10.1016/j.ajog.2005.05.005; Committee on Gynecologic Practice, 2012, Obstet Gynecol, V120, P421, DOI 10.1097/AOG.0b013e3182680517; Conry JA, 2015, OBSTET GYNECOL, V126, P697, DOI 10.1097/AOG.0000000000001055; Doroudi M, 2017, J MED SCREEN, V24, P220, DOI 10.1177/0969141316680381; ESCHENBACH DA, 1988, AM J OBSTET GYNECOL, V158, P819, DOI 10.1016/0002-9378(88)90078-6; Goldshore M, 2013, AM J OBSTET GYNECOL, V208, pS166, DOI 10.1016/j.ajog.2012.10.543; GROVER S, 1995, INT J GYNECOL CANCER, V5, P291, DOI 10.1046/j.1525-1438.1995.05040291.x; Guirguis-Blake JM, 2017, JAMA-J AM MED ASSOC, V317, P954, DOI 10.1001/jama.2016.12819; Guirguis-Blake JM, 2017, AHRQ PUBLICATION, V15-05220-EF-1; Gutman RE, 2005, OBSTET GYNECOL, V105, P551, DOI 10.1097/01.AOG.0000145752.97999.67; JACOBS I, 1988, LANCET, V1, P268; KOUTSKY LA, 1992, NEW ENGL J MED, V326, P1533, DOI 10.1056/NEJM199206043262305; LeFevre ML, 2014, ANN INTERN MED, V161, P894, DOI 10.7326/M14-1965; LeFevre ML, 2014, ANN INTERN MED, V161, P902, DOI 10.7326/M14-1981; Moyer V. A, 2012, ANN INTERN MED, V156, pW312, DOI [10.7326/0003-4819-156-12-201206190-00424., DOI 10.7326/0003-4819-156-12-201206190-00424]; Moyer VA, 2013, ANN INTERN MED, V159, P856, DOI 10.7326/0003-4819-159-12-201312170-00016; Moyer VA, 2012, ANN INTERN MED, V157, P900, DOI 10.7326/0003-4819-157-11-201212040-00539; Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424; Qaseem A, 2014, ANN INTERN MED, V161, P67, DOI 10.7326/M14-0701; Stormo AR, 2012, PREV MED, V54, P415, DOI 10.1016/j.ypmed.2012.03.012; Tiemstra JD, 2011, J AM BOARD FAM MED, V24, P290, DOI 10.3122/jabfm.2011.03.100209; WOLNERHANSSEN P, 1989, JAMA-J AM MED ASSOC, V261, P571	23	45	46	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2017	317	9					947	953		10.1001/jama.2017.0807	http://dx.doi.org/10.1001/jama.2017.0807			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM8DM	28267862	Bronze			2022-12-28	WOS:000395541500014
J	Pinnock, H; Barwick, M; Carpenter, CR; Eldridge, S; Grandes, G; Griffiths, CJ; Rycroft-Malone, J; Meissner, P; Murray, E; Patel, A; Sheikh, A; Taylor, SJC				Pinnock, Hilary; Barwick, Melanie; Carpenter, Christopher R.; Eldridge, Sandra; Grandes, Gonzalo; Griffiths, Chris J.; Rycroft-Malone, Jo; Meissner, Paul; Murray, Elizabeth; Patel, Anita; Sheikh, Aziz; Taylor, Stephanie J. C.		StaRI Grp	Standards for Reporting Implementation Studies (StaRI) Statement	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COMPLEX INTERVENTIONS; FRAMEWORK	Implementation studies are often poorly reported and indexed, reducing their potential to inform initiatives to improve healthcare services. The Standards for Reporting Implementation Studies (StaRI) initiative aimed to develop guidelines for transparent and accurate reporting of implementation studies. Informed by the findings of a systematic review and a consensus-building e-Delphi exercise, an international working group of implementation science experts discussed and agreed the StaRI Checklist comprising 27 items. It prompts researchers to describe both the implementation strategy (techniques used to promote implementation of an underused evidence-based intervention) and the effectiveness of the intervention that was being implemented. An accompanying Explanation and Elaboration document (published in BMJ Open, doi: 10.1136/bmjopen-2016-013318) details each of the items, explains the rationale, and provides examples of good reporting practice. Adoption of StaRI will improve the reporting of implementation studies, potentially facilitating translation of research into practice and improving the health of individuals and populations.	[Pinnock, Hilary; Sheikh, Aziz] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Asthma UK Ctr Appl Res, Edinburgh EH8 9AG, Midlothian, Scotland; [Barwick, Melanie] Hosp Sick Children, Res Inst, Toronto, ON, Canada; [Barwick, Melanie] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Barwick, Melanie] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Carpenter, Christopher R.] Washington Univ, Sch Med St Louis, Div Emergency Med, St Louis, MO 63130 USA; [Eldridge, Sandra] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Pragmat Clin Trials Unit,Ctr Primary Care & Publ, London, England; [Grandes, Gonzalo] Basque Hlth Serv, Primary Care Res Unit Bizkaia, Vitoria, Spain; [Griffiths, Chris J.; Patel, Anita; Taylor, Stephanie J. C.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Primary Care & Publ Hlth, London, England; [Rycroft-Malone, Jo] Bangor Univ, Bangor Inst Hlth & Med Res, Bangor, Gwynedd, Wales; [Meissner, Paul] Univ Hosp, Albert Einstein Coll Med, Montefiore Med Ctr, New York, NY USA; [Murray, Elizabeth] UCL, Res Dept Primary Care & Populat Hlth, London, England	University of Edinburgh; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Saint Louis University; Washington University (WUSTL); University of London; Queen Mary University London; University of London; Queen Mary University London; Bangor University; Montefiore Medical Center; State University of New York (SUNY) System; Yeshiva University; University of London; University College London	Pinnock, H (corresponding author), Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Asthma UK Ctr Appl Res, Edinburgh EH8 9AG, Midlothian, Scotland.	hilary.pinnock@ed.ac.uk	Blanco, Leire/O-5114-2017; Carpenter, Christopher R./E-3720-2013; Barwick, Melanie/AAF-5629-2020; TAYLOR, STEPHANIE/GYV-4768-2022	Carpenter, Christopher R./0000-0002-2603-7157; Barwick, Melanie/0000-0002-2478-604X; Murray, Elizabeth/0000-0002-8932-3695; Taylor, Stephanie/0000-0001-7454-6354; Eldridge, Sandra/0000-0001-5638-2317; Patel, Anita/0000-0003-0769-1732; Meissner, Paul/0000-0003-3424-2481; Sheikh, Aziz/0000-0001-7022-3056	Asthma UK Centre for Applied Research [AC-2012-01]; Chief Scientist Office, Scottish Government Health and Social Care Directorates [PCRCA_08_01]; Centre for Primary Care and Public Health, Queen Mary University of London; PRISMS team NIHR HSDR Grant [11/1014/04]; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Bart's Health NHS Trust; Farr Institute; National Institute for Health Research [11/1014/04] Funding Source: researchfish; Chief Scientist Office [PCRCA/08/01] Funding Source: researchfish; Asthma UK [AUK-AC-2012-01] Funding Source: researchfish	Asthma UK Centre for Applied Research; Chief Scientist Office, Scottish Government Health and Social Care Directorates; Centre for Primary Care and Public Health, Queen Mary University of London; PRISMS team NIHR HSDR Grant; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Bart's Health NHS Trust; Farr Institute; National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; Asthma UK	The StaRI initiative and workshop were funded by contributions from the Asthma UK Centre for Applied Research (AC-2012-01); Chief Scientist Office, Scottish Government Health and Social Care Directorates (PCRCA_08_01); the Centre for Primary Care and Public Health, Queen Mary University of London; and with contributions in kind from the PRISMS team (NIHR HS&DR Grant 11/1014/04). ST was (in part) supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Bart's Health NHS Trust. AS is supported by the Farr Institute. The funding bodies had no role in the design, in the collection, analysis, and interpretation of data; in the writing of the manuscript; nor in the decision to submit the manuscript for publication.	Barwick M., 2014, INT ED RES, V2, P1, DOI DOI 10.12735/IER.V2I4P01; Bauer Mark S, 2015, BMC Psychol, V3, P32, DOI 10.1186/s40359-015-0089-9; Brownson R. C., 2012, DISSEMINATION IMPLEM; Chalkidou K, COMP EFFECTIVENESS R; Craig P., 2008, DEV EVALUATING COMPL; Curran GM, 2012, MED CARE, V50, P217, DOI 10.1097/MLR.0b013e3182408812; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Foy R, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0240-2; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Hawe P, 2004, BMJ-BRIT MED J, V328, P1561, DOI 10.1136/bmj.328.7455.1561; Lansdverk J, 2012, DISSEMINATION IMPLEM; Loudon K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2147; Neta G, 2015, AM J PUBLIC HEALTH, V105, P49, DOI 10.2105/AJPH.2014.302206; Peters DH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6753; Pinnock H, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013318; Pinnock H, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0361-0; Pinnock H, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0235-z; Pinnock Hilary, 2014, Ann Am Thorac Soc, V11 Suppl 2, pS118, DOI 10.1513/AnnalsATS.201308-259RM; Rycroft-Malone J, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-28; Rycroft-Malone J, 2011, WORLDV EVID-BASED NU, V8, P189, DOI 10.1111/j.1741-6787.2011.00232.x	20	408	414	2	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2017	356								i6795	10.1136/bmj.i6795	http://dx.doi.org/10.1136/bmj.i6795			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BH	28264797	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-28	WOS:000396432100001
J	Gan, P				Gan, Pearl			Picturing health: making malaria visible in Asia-Pacific	LANCET			English	Editorial Material									[Gan, Pearl] Oxford Univ Clin Res Unit, Ho Chi Minh City, Vietnam; [Gan, Pearl] Eijkman Oxford Clin Res Unit, Jakarta, Indonesia	Eijkman Institute	Gan, P (corresponding author), Oxford Univ Clin Res Unit, Ho Chi Minh City, Vietnam.; Gan, P (corresponding author), Eijkman Oxford Clin Res Unit, Jakarta, Indonesia.								0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 25	2017	389	10071					789	798		10.1016/S0140-6736(17)30516-0	http://dx.doi.org/10.1016/S0140-6736(17)30516-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9UU	28248167				2022-12-28	WOS:000394966400019
J	Palabindala, V				Palabindala, Venkataraman			Guideline: In acute gout, steroids, NSAIDs, or low-dose colchicine are recommended; lifestyle changes are not supported	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Palabindala, Venkataraman] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center	Palabindala, V (corresponding author), Univ Mississippi, Med Ctr, Jackson, MS 39216 USA.							Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772	1	1	1	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2017	166	4					JC14	JC14		10.7326/ACPJC-2017-166-4-014	http://dx.doi.org/10.7326/ACPJC-2017-166-4-014			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7FO	28241287				2022-12-28	WOS:000394786700002
J	Makarova, KS; Zhang, F; Koonin, EV				Makarova, Kira S.; Zhang, Feng; Koonin, Eugene V.			SnapShot: Class 1 CRISPR-Cas Systems	CELL			English	Editorial Material							IMMUNITY		[Makarova, Kira S.; Koonin, Eugene V.] NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; [Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Zhang, Feng] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA	National Institutes of Health (NIH) - USA; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Makarova, KS (corresponding author), NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA.							Kazlauskiene M, 2016, MOL CELL, V62, P295, DOI 10.1016/j.molcel.2016.03.024; Koonin EV, 2015, NAT REV GENET, V16, P184, DOI 10.1038/nrg3859; Leenay RT, 2016, MOL CELL, V62, P137, DOI 10.1016/j.molcel.2016.02.031; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00102; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Silas S, 2016, SCIENCE, V351, DOI 10.1126/science.aad4234	9	138	163	22	138	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2017	168	5					946	+						2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8YB	28235204				2022-12-28	WOS:000396284800023
J	Saxton, RA; Sabatini, DM				Saxton, Robert A.; Sabatini, David M.			mTOR Signaling in Growth, Metabolism, and Disease	CELL			English	Review							TUMOR-SUPPRESSOR COMPLEX; TUBEROUS SCLEROSIS COMPLEX-2; RAPAMYCIN-SENSITIVE PATHWAY; ACTIVATING PROTEIN COMPLEX; MESSENGER-RNA TRANSLATION; NOVO PYRIMIDINE SYNTHESIS; T-CELL DIFFERENTIATION; AMINO-ACID DEPRIVATION; ADVANCED SOLID TUMORS; MAMMALIAN LIFE-SPAN	The mechanistic target of rapamycin (mTOR) coordinates eukaryotic cell growth and metabolism with environmental inputs, including nutrients and growth factors. Extensive research over the past two decades has established a central role for mTOR in regulating many fundamental cell processes, from protein synthesis to autophagy, and deregulated mTOR signaling is implicated in the progression of cancer and diabetes, as well as the aging process. Here, we review recent advances in our understanding of mTOR function, regulation, and importance in mammalian physiology. We also highlight how the mTOR signaling network contributes to human disease and discuss the current and future prospects for therapeutically targeting mTOR in the clinic.	[Saxton, Robert A.; Sabatini, David M.] Whitehead Inst Biomed Res, 455 Main St, Cambridge, MA 02142 USA; [Saxton, Robert A.; Sabatini, David M.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Saxton, Robert A.; Sabatini, David M.] Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Saxton, Robert A.; Sabatini, David M.] Broad Inst Harvard & Massachusetts Inst Technol, 415 Main St, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 455 Main St, Cambridge, MA 02142 USA.; Sabatini, DM (corresponding author), MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA.; Sabatini, DM (corresponding author), Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Sabatini, DM (corresponding author), Broad Inst Harvard & Massachusetts Inst Technol, 415 Main St, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu		/0000-0002-1446-7256; Saxton, Robert/0000-0001-9777-8270	NIH [R01CA103866, R01CA129105, AI47389]; U.S. Department of Defense [W81XWH-07-0448]; David H. Koch Graduate Fellowship Fund; NATIONAL CANCER INSTITUTE [R01CA129105, R01CA103866] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); David H. Koch Graduate Fellowship Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all members of the Sabatini Lab for helpful discussions; in particular, W.C. Comb, T. Wang, R.L. Wolfson, and G.A. Wyant for critical reading of the manuscript. We apologize to everyone in the mTOR field whose work could not be included due to space constraints. This work was supported by grants from the NIH (R01CA103866, R01CA129105, and AI47389) and the U.S. Department of Defense (W81XWH-07-0448) to D.M.S. and fellowship support to R.A.S. from the David H. Koch Graduate Fellowship Fund. D.M.S. is a founder and a member of the scientific advisory board for Navitor Pharmaceuticals, which targets the mTORC1 pathway for therapeutic benefit. D.M.S. is an Investigator of the Howard Hughes Medical Institute.	Alain T, 2012, CANCER RES, V72, P6468, DOI 10.1158/0008-5472.CAN-12-2395; Anthony JC, 2000, J NUTR, V130, P2413; Apelo SIA, 2016, AGING CELL, V15, P28, DOI 10.1111/acel.12405; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Aylett CHS, 2016, SCIENCE, V351, P48, DOI 10.1126/science.aaa3870; Baar K, 1999, AM J PHYSIOL-CELL PH, V276, pC120, DOI 10.1152/ajpcell.1999.276.1.C120; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Baretic D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11016; Basel-Vanagaite L, 2013, AM J HUM GENET, V93, P524, DOI 10.1016/j.ajhg.2013.07.005; Ben-Sahra I, 2016, SCIENCE, V351, P728, DOI 10.1126/science.aad0489; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; CAFFERKEY R, 1993, MOL CELL BIOL, V13, P6012, DOI 10.1128/MCB.13.10.6012; Castets P, 2013, CELL METAB, V17, P731, DOI 10.1016/j.cmet.2013.03.015; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gan XQ, 2012, NAT CELL BIOL, V14, P686, DOI 10.1038/ncb2507; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Grabiner BC, 2014, CANCER DISCOV, V4, P554, DOI 10.1158/2159-8290.CD-13-0929; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Hietakangas V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-282; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Jung J, 2015, MOL CELL BIOL, V35, P2479, DOI 10.1128/MCB.00125-15; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kang SA, 2013, SCIENCE, V341, P364, DOI 10.1126/science.1236566; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07; Kumar A, 2010, DIABETES, V59, P1397, DOI 10.2337/db09-1061; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Lamming DW, 2013, CELL METAB, V18, P465, DOI 10.1016/j.cmet.2013.08.002; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Lee PL, 2016, MOL METAB, V5, P422, DOI 10.1016/j.molmet.2016.04.001; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Li X, 2014, EMBO REP, V15, P191, DOI 10.1002/embr.201338119; Lipton JO, 2014, NEURON, V84, P275, DOI 10.1016/j.neuron.2014.09.034; Liu PD, 2015, CANCER DISCOV, V5, P1194, DOI 10.1158/2159-8290.CD-15-0460; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Mannick JB, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009892; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; MARTEL RR, 1977, CAN J PHYSIOL PHARM, V55, P48, DOI 10.1139/y77-007; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Matsumoto A, 2017, NATURE, V541, P228, DOI 10.1038/nature21034; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Mori H, 2009, AM J PHYSIOL-ENDOC M, V297, pE1013, DOI 10.1152/ajpendo.00262.2009; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Okosun J, 2016, NAT GENET, V48, P183, DOI 10.1038/ng.3473; Palm W, 2015, CELL, V162, P259, DOI 10.1016/j.cell.2015.06.017; Panchaud N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004112; Parmigiani A, 2014, CELL REP, V9, P1281, DOI 10.1016/j.celrep.2014.10.019; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Peng M., 2017, NATURE; Peng M, 2014, CELL, V159, P122, DOI 10.1016/j.cell.2014.08.038; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Petit CS, 2013, J CELL BIOL, V202, P1107, DOI 10.1083/jcb.201307084; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Pollizzi KN, 2016, NAT IMMUNOL, V17, P704, DOI 10.1038/ni.3438; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Powis K, 2015, CELL RES, V25, P1043, DOI 10.1038/cr.2015.86; Rangwala R, 2014, AUTOPHAGY, V10, P1391, DOI 10.4161/auto.29119; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Ricos MG, 2016, ANN NEUROL, V79, P120, DOI 10.1002/ana.24547; Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007; Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Rodrik-Outmezguine VS, 2016, NATURE, V534, P272, DOI 10.1038/nature17963; Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Rousseau A, 2016, NATURE, V536, P184, DOI 10.1038/nature18943; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Saxton RA, 2016, NATURE, V536, P229, DOI 10.1038/nature19079; Saxton RA, 2016, SCIENCE, V351, P53, DOI 10.1126/science.aad2087; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Shigeyama Y, 2008, MOL CELL BIOL, V28, P2971, DOI 10.1128/MCB.01695-07; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Tabernero J, 2008, J CLIN ONCOL, V26, P1603, DOI 10.1200/JCO.2007.14.5482; Tang YF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11365; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217; Thomanetz V, 2013, J CELL BIOL, V201, P293, DOI 10.1083/jcb.201205030; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Verbist KC, 2016, NATURE, V532, P389, DOI 10.1038/nature17442; VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721; Wagle N, 2014, NEW ENGL J MED, V371, P1426, DOI 10.1056/NEJMoa1403352; Wagle N, 2014, CANCER DISCOV, V4, P546, DOI 10.1158/2159-8290.CD-13-0353; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Wolfson R.L., 2017, NATURE; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Woo SY, 2007, J BIOL CHEM, V282, P25604, DOI 10.1074/jbc.M704343200; Wu JJ, 2013, CELL REP, V4, P913, DOI 10.1016/j.celrep.2013.07.030; Yang G, 2015, CELL REP, V12, P937, DOI 10.1016/j.celrep.2015.07.016; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Ye JB, 2015, GENE DEV, V29, P2331, DOI 10.1101/gad.269324.115; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Yuan MS, 2012, J BIOL CHEM, V287, P29579, DOI 10.1074/jbc.M112.386854; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zhang TL, 2012, STRUCTURE, V20, P2151, DOI 10.1016/j.str.2012.09.019; Zhang YN, 2014, NATURE, V513, P440, DOI 10.1038/nature13492; Zhao JH, 2015, P NATL ACAD SCI USA, V112, P15790, DOI 10.1073/pnas.1521919112; Zheng Y, 2007, J IMMUNOL, V178, P2163, DOI 10.4049/jimmunol.178.4.2163; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	173	3921	4065	98	1091	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2017	168	6					960	976		10.1016/j.cell.2017.02.004	http://dx.doi.org/10.1016/j.cell.2017.02.004			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8ZF	28388417	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000396287900006
J	Bachelet, M				Bachelet, Michelle			Women, power, and the cancer divide	LANCET			English	Editorial Material									[Bachelet, Michelle] Palacio de La Moneda S-N, Santiago, Region Metropol, Chile		Bachelet, M (corresponding author), Palacio de La Moneda S-N, Santiago, Region Metropol, Chile.	auriarte@presidencia.cl						Bastias G, 2008, CAN MED ASSOC J, V179, P1289, DOI 10.1503/cmaj.071843; Denny L., 2016, LANCET; Ferlay, 2016, CANC TODAY; Ginsburg O., 2016, LANCET; Ginsburg OM, 2011, BREAST J, V17, P289, DOI 10.1111/j.1524-4741.2011.01067.x; Knaul F, 2012, CLOSING CANC DIVIDE; Mistral G, 1998, TIERRA TIENE ACTITUD; UN, 2015, 2030 AG SUST DEV; WHO, 2010, WORLD HLTH REP HLTH; Wild CP, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju353	10	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 25	2017	389	10071					773	774		10.1016/S0140-6736(17)30071-5	http://dx.doi.org/10.1016/S0140-6736(17)30071-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9UU	27814967				2022-12-28	WOS:000394966400009
